##GENOME_BUILD=GRCh38
##CREATION_DATE=2025-04-16
##ANALYSISTYPE=GERMLINE_TRIO
##PIPELINE=megSAP 2025_03-48-g29809670
##SAMPLE=<ID=GS140127_01,Gender=male,ExternalSampleName=131787,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=affected>
##SAMPLE=<ID=GS140550_01,Gender=male,ExternalSampleName=131751,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=control>
##SAMPLE=<ID=GS140549_01,Gender=female,ExternalSampleName=131752,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=control>
##FILTER=PASS=All filters passed
##FILTER=MONOALLELIC=Site represents one ALT allele in a region with multiple variants that could not be unified into non-overlapping multi-allelic sites
##FILTER=low_conf_region=Variant marked as 'low_conf_region'.
##FILTER=low_mappability=Variant marked as 'low_mappability'.
##DESCRIPTION=GS140127_01=genotype of sample GS140127_01
##DESCRIPTION=GS140550_01=genotype of sample GS140550_01
##DESCRIPTION=GS140549_01=genotype of sample GS140549_01
##DESCRIPTION=filter=Annotations for filtering and ranking variants.
##DESCRIPTION=quality=Quality parameters - variant quality (QUAL), depth (DP), quality divided by depth (QD), allele frequency (AF), mean mapping quality of alternate allele (MQM), probability of strand bias for alternate bases as phred score (SAP), probability of allele ballance as phred score (ABP)
##DESCRIPTION=gene=Affected gene list (comma-separated).
##DESCRIPTION=variant_type=Variant type.
##DESCRIPTION=coding_and_splicing=Coding and splicing details (Gene, ENST number, type, impact, exon/intron number, HGVS.c, HGVS.p, Pfam domain).
##DESCRIPTION=regulatory=Regulatory consequence details.
##DESCRIPTION=OMIM=OMIM database annotation.
##DESCRIPTION=ClinVar=ClinVar database annotation.
##DESCRIPTION=HGMD=HGMD database annotation.
##DESCRIPTION=RepeatMasker=RepeatMasker annotation.
##DESCRIPTION=dbSNP=Identifier in dbSNP database.
##DESCRIPTION=gnomAD=Allele frequency in gnomAD project.
##DESCRIPTION=gnomAD_sub=Sub-population allele frequenciens (AFR,AMR,EAS,NFE,SAS) in gnomAD project.
##DESCRIPTION=gnomAD_hom_hemi=Homoyzgous/hemizygous case count of gnomAD project (genome data).
##DESCRIPTION=gnomAD_het=Heterozygous allele count of the gnomAD project (genome data).
##DESCRIPTION=gnomAD_wt=Wildtype allele count of the gnomAD project (genome data).
##DESCRIPTION=phyloP=phyloP (100way vertebrate) annotation. Deleterious threshold > 1.6.
##DESCRIPTION=CADD=CADD pathogenicity prediction scores (scaled phred-like). Deleterious threshold > 10-20.
##DESCRIPTION=REVEL=REVEL pathogenicity prediction score. Deleterious threshold > 0.5.
##DESCRIPTION=AlphaMissense=AlphaMissense pathogenicity score. Deleterious threshold > 0.564.
##DESCRIPTION=MaxEntScan=MaxEntScan reference score and alternate score for (1) native splice site, (2) acceptor gain and (3) donor gain. Comma-separated list if there are different predictions for several transcripts.
##DESCRIPTION=COSMIC=COSMIC somatic variant database anntotation.
##DESCRIPTION=SpliceAI=SpliceAI prediction. These include delta scores (DS) and delta positions (DP) for acceptor gain (AG), acceptor loss (AL), donor gain (DG), and donor loss (DL). Format: GENE|DS_AG|DS_AL|DS_DG|DS_DL|DP_AG|DP_AL|DP_DG|DP_DL.
##DESCRIPTION=PubMed=PubMed ids to publications on the given variant.
##DESCRIPTION=NGSD_hom=Homozygous variant count in NGSD.
##DESCRIPTION=NGSD_het=Heterozygous variant count in NGSD.
##DESCRIPTION=NGSD_mosaic=Mosaic variant count in NGSD.
##DESCRIPTION=NGSD_group=Homozygous / heterozygous variant count in NGSD with the same disease group.
##DESCRIPTION=classification=Classification from the NGSD.
##DESCRIPTION=classification_comment=Classification comment from the NGSD.
##DESCRIPTION=validation=Validation information from the NGSD. Validation results of other samples are listed in brackets!
##DESCRIPTION=comment=Variant comments from the NGSD.
##DESCRIPTION=gene_info=Gene information from NGSD (inheritance mode, gnomAD o/e scores).
##FILTER=low_conf_region=Low confidence region for small variant calling based on gnomAD AC0/RF filters and IMGAG trio/twin data.
#chr	start	end	ref	obs	GS140127_01	GS140550_01	GS140549_01	filter	quality	gene	variant_type	coding_and_splicing	regulatory	OMIM	ClinVar	HGMD	RepeatMasker	dbSNP	gnomAD	gnomAD_sub	gnomAD_hom_hemi	gnomAD_het	gnomAD_wt	phyloP	CADD	REVEL	AlphaMissense	MaxEntScan	COSMIC	SpliceAI	PubMed	NGSD_hom	NGSD_het	NGSD_mosaic	NGSD_group	classification	classification_comment	validation	comment	gene_info
chr1	1022518	1022518	G	T	hom	het	hom		QUAL=25;DP=65,56,45;AF=0.97,0.64,1.00	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron2/35:c.463+56G>T::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron2/38:c.49+56G>T::	regulatory_region_variant:open_chromatin_region	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677944 [benign DISEASE=not provided GENE=AGRN];			rs2799064	0.34489	0.35903,0.25013,0.18932,0.35457,0.37163	9382,	33661	99579	-0.4950	2.70			/0.0>0.0/0.0>2.9	COSV65071508	AGRN|0.00|0.00|0.00|0.00|14|-1|-2|-20		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1022587	1022587	-	TGTAGTCTGACCTGTGGTCTGAC	hom	hom	hom		QUAL=25;DP=45,15,20;AF=0.38,0.60,0.50	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron2/35:c.463+128_463+129insAGTCTGACCTGTGGTCTGACTGT::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron2/38:c.49+128_49+129insAGTCTGACCTGTGGTCTGACTGT::	regulatory_region_variant:open_chromatin_region	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs6143083	0.91277	0.71675,0.96455,0.92190,0.99732,0.98776	64486,	9803	13263		2.83			/0.0>0.8/0.6>0.6				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1035498	1035498	C	T	het	het	wt		QUAL=24;DP=68,185,89;AF=0.53,0.43,0.00	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron3/35:c.511+174C>T::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron3/38:c.97+174C>T::	regulatory_region_variant:open_chromatin_region	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs151122070	0.00016	0.00002,0.00013,0.00019,0.00022,0.00000	0,	24	152236	-0.9310	1.99			/0.0>0.0/0.0>0.0		AGRN|0.00|0.00|0.00|0.00|10|-8|-20|25		0	12	0	0 / 0					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1041777	1041823	CGGCCAGTGCCAGGGTCGAGGTGGGCGGCTCCCCCGGGGGAGGGCTG	-	wt	hom	hom	low_conf_region	QUAL=24;DP=10,33,23;AF=0.00,1.00,1.00	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron6/35:c.1177+109_1178-99del::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron6/38:c.763+109_764-99del::	regulatory_region_variant:enhancer	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	679581 [benign DISEASE=not provided GENE=AGRN];			rs70949546	0.57034	0.24799,0.69993,0.74368,0.68949,0.68093	35172,	5268	56962	1.6880	1.37			/0.0>0.0/6.3>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1041950	1041950	T	C	hom	hom	hom		QUAL=24;DP=13,26,20;AF=1.00,1.00,1.00	AGRN	splice_region&intron	AGRN:ENST00000379370.7:splice_region_variant&intron_variant:LOW:intron6/35:c.1178-6T>C::,AGRN:ENST00000620552.4:splice_region_variant&intron_variant:LOW:intron6/38:c.764-6T>C::	regulatory_region_variant:enhancer	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128292 [benign DISEASE=not specified,Congenital myasthenic syndrome 8,not provided GENE=AGRN];			rs2799066	0.87273	0.71611,0.92175,0.99981,0.92182,0.95666	58337,	15354	19254	-0.8440	0.90			6.8>6.9/6.8>6.9/0.0>0.0		AGRN|0.00|0.00|0.00|0.00|-7|11|11|39	25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1042190	1042190	G	A	hom	hom	hom		QUAL=24;DP=18,21,15;AF=1.00,1.00,1.00	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron7/35:c.1384+28G>A::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron7/38:c.970+28G>A::	regulatory_region_variant:enhancer	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263159 [benign DISEASE=not specified,not provided,Congenital myasthenic syndrome 8 GENE=AGRN];			rs2710876	0.78743	0.44051,0.88350,0.96812,0.91755,0.94576	50654,	18533	32351	-1.7260	0.15			/0.0>0.0/2.0>4.4		AGRN|0.00|0.00|0.02|0.00|2|-2|2|-28	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1045080	1045080	G	A	het	hom	hom		QUAL=26;DP=4,14,9;AF=0.75,1.00,1.00	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron12/35:c.2255-81G>A::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron12/38:c.1841-81G>A::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677948 [benign DISEASE=Congenital myasthenic syndrome 8,not provided GENE=AGRN];			rs3128097	0.89849	0.79444,0.93309,0.99981,0.92932,0.96203	61742,	13183	15441	2.3760	9.01			/0.0>0.0/6.6>3.3				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1045707	1045707	A	G	hom	hom	hom		QUAL=24;DP=70,65,51;AF=1.00,1.00,1.00	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron14/35:c.2537-26A>G::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron14/38:c.2123-26A>G::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263172 [benign DISEASE=Congenital myasthenic syndrome 8,not provided,not specified GENE=AGRN];			rs3128098	0.85363	0.64383,0.91051,0.99981,0.92779,0.96130	56745,	16453	22281	-0.8630	5.55			/0.0>0.0/0.0>0.0			25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1046551	1046551	A	G	hom	hom	hom		QUAL=24;DP=44,60,55;AF=1.00,1.00,1.00	AGRN	synonymous	AGRN:ENST00000379370.7:synonymous_variant:LOW:exon18/36:c.3066A>G:p.Ser1022=:,AGRN:ENST00000620552.4:synonymous_variant:LOW:exon18/39:c.2652A>G:p.Ser884=:		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128297 [benign DISEASE=not specified,Congenital myasthenic syndrome 8,not provided GENE=AGRN];			rs2465128	0.80106	0.51310,0.88136,0.96212,0.90993,0.89090	51075,	19416	30190	-1.0320	0.12			/0.0>0.0/0.0>0.0	COSV65068047		25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1047064	1047064	A	G	hom	hom	hom		QUAL=25;DP=70,155,114;AF=1.00,1.00,0.99	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron19/35:c.3388+107A>G::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron19/38:c.2974+107A>G::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677950 [benign DISEASE=not provided GENE=AGRN];			rs3128099	0.81680	0.54251,0.89304,0.96802,0.91815,0.94679	52908,	18414	27864	1.1180	6.43			/0.0>0.0/0.0>0.0		AGRN|0.00|0.00|0.03|0.00|-21|-27|-28|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1047082	1047082	T	C	hom	hom	hom		QUAL=24;DP=77,139,105;AF=1.00,1.00,1.00	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron19/35:c.3388+125T>C::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron19/38:c.2974+125T>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677951 [benign DISEASE=not provided GENE=AGRN];			rs3128100	0.98582	0.95371,0.99092,0.99981,0.99906,0.99896	74006,	2067	2159	-4.5630	0.17			/0.0>0.2/5.1>7.4				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1047133	1047133	T	C	hom	hom	hom		QUAL=24;DP=46,77,70;AF=1.00,1.00,1.00	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron19/35:c.3388+176T>C::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron19/38:c.2974+176T>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677952 [benign DISEASE=not provided GENE=AGRN];			rs3128101	0.91280	0.84506,0.93682,0.99981,0.92929,0.96275	63594,	11786	13276	-0.0520	20.10			/0.0>0.0/5.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1047561	1047561	T	C	hom	hom	hom		QUAL=24;DP=48,149,105;AF=1.00,1.00,1.00	AGRN	splice_region&intron	AGRN:ENST00000379370.7:splice_region_variant&intron_variant:LOW:intron20/35:c.3517-12T>C::,AGRN:ENST00000620552.4:splice_region_variant&intron_variant:LOW:intron20/38:c.3103-12T>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263181 [benign DISEASE=not provided,Congenital myasthenic syndrome 8,not specified GENE=AGRN];			rs3128102	0.79333	0.46306,0.88362,0.96790,0.91710,0.94617	51070,	18642	31464	-0.1470	3.13			6.8>6.3/6.8>6.3/0.0>0.0		AGRN|0.04|0.01|0.00|0.00|37|12|37|13	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1047614	1047614	T	C	hom	hom	hom		QUAL=24;DP=139,208,143;AF=0.99,1.00,1.00	AGRN	synonymous	AGRN:ENST00000379370.7:synonymous_variant:LOW:exon21/36:c.3558T>C:p.Phe1186=:PF01390 [SEA domain],AGRN:ENST00000620552.4:synonymous_variant:LOW:exon21/39:c.3144T>C:p.Phe1048=:PF01390 [SEA domain]		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128302 [benign DISEASE=not provided,Congenital myasthenic syndrome 8,not specified GENE=AGRN];			rs10267	0.81916	0.53736,0.89617,0.99923,0.92000,0.95594	53400,	17924	27534	2.1470	6.58			/0.0>0.0/0.0>0.0	COSV65071416		25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1048922	1048922	T	C	het	hom	wt		QUAL=24;DP=10,19,16;AF=0.60,1.00,0.00	AGRN	synonymous	AGRN:ENST00000379370.7:synonymous_variant:LOW:exon24/36:c.4161T>C:p.Thr1387=:,AGRN:ENST00000620552.4:synonymous_variant:LOW:exon24/39:c.3747T>C:p.Thr1249=:		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128307 [benign DISEASE=not specified,Congenital myasthenic syndrome 8,not provided GENE=AGRN];			rs9442391	0.50408	0.29246,0.64709,0.81827,0.56200,0.56675	20796,	34666	75024	-1.2460	0.24			/0.0>0.1/0.0>0.0		AGRN|0.00|0.00|0.00|0.00|-26|18|0|-2	25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1049886	1049886	C	T	het	hom	wt		QUAL=25;DP=8,20,11;AF=0.50,1.00,0.00	AGRN	splice_region&intron	AGRN:ENST00000379370.7:splice_region_variant&intron_variant:LOW:intron26/35:c.4745-17C>T::,AGRN:ENST00000620552.4:splice_region_variant&intron_variant:LOW:intron26/38:c.4331-17C>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263188 [benign DISEASE=not specified,Congenital myasthenic syndrome 8,not provided GENE=AGRN];			rs2275813	0.45195	0.16047,0.62502,0.80866,0.53729,0.54792	18227,	31996	83006	-1.7470	0.76			11.5>11.3/11.5>11.3/0.0>0.0		AGRN|0.00|0.00|0.00|0.00|17|-4|25|-11	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1050070	1050070	G	A	hom	wt	hom	low_conf_region	QUAL=26;DP=9,11,11;AF=0.56,0.00,1.00	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron27/35:c.4879+33G>A::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron27/38:c.4465+33G>A::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	1232566 [benign DISEASE=not provided GENE=AGRN];			rs397834473	0.50289	0.68305,0.46954,0.58246,0.41201,0.43129	19448,	34679	72729	-0.3950	0.78			/0.0>0.0/0.0>0.0	COSV65068887	AGRN|0.00|0.00|0.00|0.00|42|31|-33|37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1051063	1051063	C	T	hom	hom	hom		QUAL=25;DP=18,7,11;AF=1.00,1.00,1.00	AGRN	intron,splice_region&intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron30/35:c.5254-190C>T::,AGRN:ENST00000620552.4:splice_region_variant&intron_variant:LOW:intron31/38:c.4851+20C>T::	regulatory_region_variant:CTCF_binding_site	103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677954 [benign DISEASE=Congenital myasthenic syndrome 8,not provided GENE=AGRN];			rs2710887	0.78197	0.43324,0.88275,0.99515,0.91038,0.90112	50077,	18745	33151	-0.0930	0.70			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1051820	1051820	C	T	hom	hom	hom		QUAL=24;DP=63,150,134;AF=0.97,0.99,1.00	AGRN	splice_region&intron	AGRN:ENST00000379370.7:splice_region_variant&intron_variant:LOW:intron33/35:c.5651+5C>T::,AGRN:ENST00000620552.4:splice_region_variant&intron_variant:LOW:intron34/38:c.5249+5C>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128317 [benign DISEASE=not specified,Congenital myasthenic syndrome 8,not provided GENE=AGRN];			rs9803031	0.78685	0.45187,0.88575,0.99477,0.91069,0.88589	50443,	18872	32442	-1.1710	0.56			9.6>8.7/0.0>0.0/9.6>8.7			25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1053552	1053552	G	C	hom	hom	het		QUAL=24;DP=11,7,4;AF=1.00,1.00,0.50	AGRN	intron	AGRN:ENST00000379370.7:intron_variant:MODIFIER:intron33/35:c.5652-201G>C::,AGRN:ENST00000620552.4:intron_variant:MODIFIER:intron36/38:c.5306+59G>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	677955 [benign DISEASE=Congenital myasthenic syndrome 8,not provided GENE=AGRN];			rs2710871	0.75081	0.42948,0.86791,0.99476,0.85926,0.89041	45929,	22307	37891	-0.5450	0.17			/1.4>1.7/0.0>0.0	COSV65071518		33589840	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1054900	1054900	C	T	wt	het	het		QUAL=24;DP=49,207,175;AF=0.00,0.59,0.51	AGRN	synonymous	AGRN:ENST00000379370.7:synonymous_variant:LOW:exon36/36:c.6057C>T:p.Asp2019=:PF00054 [Laminin G domain],AGRN:ENST00000620552.4:synonymous_variant:LOW:exon39/39:c.5712C>T:p.Asp1904=:PF00054 [Laminin G domain]		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	128319 [benign DISEASE=not provided,Congenital myasthenic syndrome 8,not specified GENE=AGRN];			rs4275402	0.59117	0.32261,0.72000,0.81185,0.69604,0.60747	28846,	32235	62191	-0.7120	0.36			/0.0>0.0/2.6>1.8	COSV65070964	AGRN|0.00|0.00|0.00|0.00|37|2|-23|-4	25741868,18414213	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055000	1055000	C	T	hom	het	het		QUAL=24;DP=153,432,333;AF=0.97,0.49,0.44	AGRN	3'UTR	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*19C>T::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*19C>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	263157 [benign DISEASE=not provided,not specified,Congenital myasthenic syndrome 8 GENE=AGRN];			rs3121561	0.35141	0.50754,0.25340,0.18317,0.29461,0.31820	10257,	32949	98675	-0.4130	1.15			/0.0>0.0/0.0>0.0	COSV65069616	AGRN|0.00|0.00|0.00|0.00|7|-7|7|26	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055037	1055037	T	C	hom	het	het		QUAL=24;DP=178,502,389;AF=0.99,0.49,0.46	AGRN	3'UTR	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*56T>C::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*56T>C::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	1292868 [benign DISEASE=not provided GENE=AGRN];			rs2465136	0.38581	0.60182,0.27010,0.18798,0.30304,0.36816	12849,	33013	93465	0.2810	12.94			/0.0>0.1/0.0>0.0	COSV65069776	AGRN|0.00|0.00|0.00|0.00|-44|29|8|-30	36224396	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055137	1055137	C	T	hom	hom	het		QUAL=24;DP=116,372,285;AF=1.00,1.00,0.48	AGRN	3'UTR	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*156C>T::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*156C>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]	1185529 [benign DISEASE=Congenital myasthenic syndrome 8,not provided GENE=AGRN];			rs2710872	0.87989	0.84066,0.92217,0.99961,0.87543,0.94410	59093,	15830	18294	0.1560	5.33			/0.0>0.0/0.0>0.0			32314116	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055393	1055393	C	T	hom	hom	het		QUAL=24;DP=152,337,296;AF=1.00,1.00,0.54	AGRN	3'UTR	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*412C>T::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*412C>T::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs2799072	0.81712	0.64465,0.89860,0.99499,0.86700,0.89747	51738,	20922	27842	-1.0550	4.32			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055426	1055426	G	A	hom	hom	het		QUAL=24;DP=184,379,312;AF=0.97,1.00,0.54	AGRN	3'UTR	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*445G>A::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*445G>A::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs2799073	0.81721	0.64490,0.89875,0.99499,0.86699,0.89785	51748,	20917	27829	-0.1780	2.79			/3.7>2.5/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1055604	1055604	G	A	hom	hom	het		QUAL=24;DP=123,228,190;AF=1.00,1.00,0.59	AGRN	3'UTR	AGRN:ENST00000379370.7:3_prime_UTR_variant:MODIFIER:exon36/36:c.*623G>A::,AGRN:ENST00000620552.4:3_prime_UTR_variant:MODIFIER:exon39/39:c.*623G>A::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs8014	0.88379	0.85295,0.92416,0.99961,0.87591,0.94555	59583,	15437	17699	-1.8980	0.10			/0.0>0.0/0.1>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	1056279	1056279	C	-	hom	hom	het		QUAL=25;DP=12,99,71;AF=0.92,1.00,0.55	AGRN	downstream_gene	AGRN:ENST00000379370.7:downstream_gene_variant:MODIFIER::::,AGRN:ENST00000620552.4:downstream_gene_variant:MODIFIER::::		103320_[GENE=AGRN_PHENOS=Myasthenic syndrome, congenital, 8, with pre- and postsynaptic defects, 615120 (3), Autosomal recessive]				rs60286592	0.88395	0.85347,0.92419,0.99961,0.87588,0.94590	59537,	15414	17656	0.3350	0.78							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGRN (inh=AR oe_syn=1.20 oe_mis=0.98 oe_lof=0.32)
chr1	2024923	2024923	G	A	hom	het	het		QUAL=24;DP=74,161,173;AF=1.00,0.49,0.49	GABRD	splice_region&intron	GABRD:ENST00000378585.7:splice_region_variant&intron_variant:LOW:intron1/8:c.69-19G>A::,GABRD:ENST00000640067.1:splice_region_variant&intron_variant:LOW:intron1/8:c.69-19G>A::,GABRD:ENST00000638771.1:splice_region_variant&intron_variant:LOW:intron1/7:c.69-19G>A::,GABRD:ENST00000640949.1:splice_region_variant&intron_variant:LOW:intron1/8:c.69-19G>A::		137163_[GENE=GABRD_PHENOS={?Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]	256824 [benign DISEASE=not provided,Idiopathic generalized epilepsy,not specified,Epilepsy, idiopathic generalized, susceptibility to, 10 GENE=GABRD];			rs2376805	0.81265	0.79503,0.76742,0.71980,0.83045,0.78010	50323,	23094	28528	-0.2210	1.09			7.7>6.2/7.7>6.2/0.0>0.0	COSV66080160	GABRD|0.02|0.00|0.00|0.00|2|19|2|43	25741868,34160285,20561060,36614162,36804572,33887383	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2025598	2025598	T	C	het	het	wt		QUAL=24;DP=149,369,97;AF=0.53,0.49,0.00	GABRD	synonymous	GABRD:ENST00000378585.7:synonymous_variant:LOW:exon4/9:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain],GABRD:ENST00000640067.1:synonymous_variant:LOW:exon4/9:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain],GABRD:ENST00000638771.1:synonymous_variant:LOW:exon4/8:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain],GABRD:ENST00000640949.1:synonymous_variant:LOW:exon4/9:c.330T>C:p.Gly110=:PF02931 [Neurotransmitter-gated ion-channel ligand binding domain]		137163_[GENE=GABRD_PHENOS={?Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]	256823 [benign DISEASE=Idiopathic generalized epilepsy,not specified,not provided,Epilepsy, idiopathic generalized, susceptibility to, 10 GENE=GABRD];			rs2229110	0.65417	0.72824,0.59903,0.34050,0.65552,0.46389	33159,	33189	52605	-1.2170	10.35			/1.9>0.7/0.0>0.0	COSV66080001	GABRD|0.00|0.00|0.00|0.00|-50|9|48|-2	25741868,34160285,36804572,33887383	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2025781	2025781	G	-	het	het	wt		QUAL=24;DP=60,82,16;AF=0.52,0.54,0.00	GABRD	intron	GABRD:ENST00000378585.7:intron_variant:MODIFIER:intron4/8:c.470+45del::,GABRD:ENST00000640067.1:intron_variant:MODIFIER:intron4/8:c.470+45del::,GABRD:ENST00000638771.1:intron_variant:MODIFIER:intron4/7:c.470+45del::,GABRD:ENST00000640949.1:intron_variant:MODIFIER:intron4/8:c.470+45del::		137163_[GENE=GABRD_PHENOS={?Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]				rs3831907	0.12880	0.20624,0.08041,0.03360,0.11529,0.07143	1491,	16624	132616	-3.0860	0.13			/0.0>0.0/0.0>0.0		GABRD|0.00|0.00|0.00|0.01|-47|48|31|-42		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2027822	2027822	A	G	hom	het	het		QUAL=24;DP=70,180,136;AF=0.99,0.55,0.55	GABRD	intron	GABRD:ENST00000378585.7:intron_variant:MODIFIER:intron5/8:c.553+163A>G::,GABRD:ENST00000640067.1:intron_variant:MODIFIER:intron5/8:c.553+163A>G::,GABRD:ENST00000638771.1:intron_variant:MODIFIER:intron5/7:c.553+163A>G::,GABRD:ENST00000640949.1:intron_variant:MODIFIER:intron5/8:c.553+163A>G::		137163_[GENE=GABRD_PHENOS={?Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]				rs28574670	0.86489	0.96360,0.79440,0.79787,0.83275,0.82128	57282,	17086	20566	-0.0360	7.77			/0.0>0.0/0.0>0.0	COSV66080172	GABRD|0.00|0.00|0.00|0.00|-27|-30|19|23	36914875	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2028422	2028422	-	C	n/a	het	het		QUAL=24;DP=0,13,8;AF=,0.46,0.50	GABRD	intron	GABRD:ENST00000378585.7:intron_variant:MODIFIER:intron6/8:c.691+131dup::,GABRD:ENST00000640067.1:intron_variant:MODIFIER:intron6/8:c.775+131dup::,GABRD:ENST00000638771.1:intron_variant:MODIFIER:intron6/7:c.691+131dup::,GABRD:ENST00000640949.1:intron_variant:MODIFIER:intron6/8:c.691+131dup::		137163_[GENE=GABRD_PHENOS={?Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]				rs138736063	0.23354	0.21836,0.21603,0.48773,0.21693,0.39245	4489,	26284	115728		3.33			/0.0>1.7/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2029235	2029235	C	T	het	wt	het		QUAL=24;DP=121,30,267;AF=0.49,0.00,0.56	GABRD	synonymous	GABRD:ENST00000378585.7:synonymous_variant:LOW:exon7/9:c.816C>T:p.Ser272=:PF02932 [Neurotransmitter-gated ion-channel transmembrane region],GABRD:ENST00000640067.1:synonymous_variant:LOW:exon7/9:c.900C>T:p.Ser300=:PF02932 [Neurotransmitter-gated ion-channel transmembrane region],GABRD:ENST00000638771.1:synonymous_variant:LOW:exon7/8:c.816C>T:p.Ser272=:PF02932 [Neurotransmitter-gated ion-channel transmembrane region],GABRD:ENST00000640949.1:synonymous_variant:LOW:exon7/9:c.816C>T:p.Ser272=:PF02932 [Neurotransmitter-gated ion-channel transmembrane region]		137163_[GENE=GABRD_PHENOS={?Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]	256825 [benign DISEASE=not specified,Idiopathic generalized epilepsy,not provided GENE=GABRD];			rs28408173	0.12635	0.03150,0.15900,0.43222,0.13591,0.26738	1800,	15643	133059	-0.4760	2.19			/3.7>4.4/0.0>0.0	COSV66080067	GABRD|0.00|0.00|0.00|0.00|21|0|-18|31	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2029487	2029487	T	C	hom	het	het		QUAL=24;DP=53,139,118;AF=1.00,0.50,0.37	GABRD	intron	GABRD:ENST00000378585.7:intron_variant:MODIFIER:intron7/8:c.848-64T>C::,GABRD:ENST00000640067.1:intron_variant:MODIFIER:intron7/8:c.932-64T>C::,GABRD:ENST00000638771.1:intron_variant:MODIFIER:intron7/7:c.848-64T>C::,GABRD:ENST00000640949.1:intron_variant:MODIFIER:intron7/8:c.848-133T>C::		137163_[GENE=GABRD_PHENOS={?Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]				rs28581504	0.83734	0.86787,0.78484,0.79868,0.83225,0.82104	53428,	20571	24753	-1.4640	1.13			/0.0>0.0/0.0>0.1	COSV66081616	GABRD|0.00|0.00|0.00|0.00|16|-3|-48|-15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2029969	2029969	C	T	het	wt	het		QUAL=24;DP=69,33,64;AF=0.58,0.00,0.50	GABRD	splice_region&intron,synonymous	GABRD:ENST00000378585.7:splice_region_variant&intron_variant:LOW:intron8/8:c.1060-14C>T::,GABRD:ENST00000640067.1:splice_region_variant&intron_variant:LOW:intron8/8:c.1144-14C>T::,GABRD:ENST00000638771.1:synonymous_variant:LOW:exon8/8:c.1266C>T:p.Thr422=:,GABRD:ENST00000640949.1:splice_region_variant&intron_variant:LOW:intron8/8:c.991-14C>T::		137163_[GENE=GABRD_PHENOS={?Generalized epilepsy with febrile seizures plus, type 5, susceptibility to}, 613060 (3), Autosomal dominant]	256822 [benign DISEASE=not provided,not specified,Idiopathic generalized epilepsy GENE=GABRD];			rs28431879	0.12629	0.03150,0.15837,0.45414,0.13497,0.25973	1836,	15565	133085	-0.9510	0.06			7.6>6.9/7.6>6.9/0.0>0.0,/7.6>6.9/0.0>0.0	COSV66079834	GABRD|0.00|0.00|0.00|0.00|14|-44|24|19	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GABRD (inh=AD oe_syn=1.24 oe_mis=0.64 oe_lof=0.05)
chr1	2406687	2406687	C	A	wt	het	het		QUAL=24;DP=20,55,45;AF=0.00,0.49,0.49	PEX10,RER1	intron,downstream_gene	PEX10:ENST00000288774.8:intron_variant:MODIFIER:intron4/5:c.836+33G>T::,PEX10:ENST00000447513.7:intron_variant:MODIFIER:intron4/5:c.776+33G>T::,PEX10:ENST00000507596.5:intron_variant:MODIFIER:intron4/5:c.776+33G>T::,RER1:ENST00000378513.7:downstream_gene_variant:MODIFIER::::,RER1:ENST00000378518.5:downstream_gene_variant:MODIFIER::::,RER1:ENST00000605895.6:downstream_gene_variant:MODIFIER::::,RER1:ENST00000378512.5:downstream_gene_variant:MODIFIER::::,RER1:ENST00000488353.2:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	602859_[GENE=PEX10_PHENOS=Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3), Autosomal recessive; Peroxisome biogenesis disorder 6B, 614871 (3), Autosomal recessive]	1180486 [benign DISEASE=not provided,Peroxisome biogenesis disorder 6A (Zellweger),Peroxisome biogenesis disorder 6B GENE=PEX10];			rs3795269	0.38759	0.28800,0.42494,0.27109,0.43296,0.36769	12035,	34885	93151	0.5960	1.11			/0.0>0.0/0.0>0.0	COSV56579855	PEX10|0.00|0.00|0.00|0.00|-31|-41|31|33	35213538	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1 (inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	2407130	2407130	T	C	het	hom	het		QUAL=24;DP=12,4,5;AF=0.58,1.00,0.60	PEX10,RER1	intron,downstream_gene	PEX10:ENST00000288774.8:intron_variant:MODIFIER:intron3/5:c.601-175A>G::,PEX10:ENST00000447513.7:intron_variant:MODIFIER:intron3/5:c.601-235A>G::,PEX10:ENST00000507596.5:intron_variant:MODIFIER:intron3/5:c.601-235A>G::,RER1:ENST00000378513.7:downstream_gene_variant:MODIFIER::::,RER1:ENST00000378518.5:downstream_gene_variant:MODIFIER::::,RER1:ENST00000605895.6:downstream_gene_variant:MODIFIER::::,RER1:ENST00000378512.5:downstream_gene_variant:MODIFIER::::,RER1:ENST00000488353.2:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	602859_[GENE=PEX10_PHENOS=Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3), Autosomal recessive; Peroxisome biogenesis disorder 6B, 614871 (3), Autosomal recessive]	1259297 [benign DISEASE=not provided GENE=PEX10];			rs2494427	0.81249	0.63632,0.81945,0.83031,0.89438,0.82346	51221,	21240	28544	-1.9020	0.76			/0.0>0.0/5.7>1.9				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1 (inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	2408761	2408761	T	C	wt	het	het		QUAL=24;DP=18,48,39;AF=0.00,0.54,0.44	PEX10,RER1	synonymous,downstream_gene	PEX10:ENST00000288774.8:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region],PEX10:ENST00000447513.7:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region],PEX10:ENST00000507596.5:synonymous_variant:LOW:exon3/6:c.291A>G:p.Thr97=:PF04757 [Pex2 / Pex12 amino terminal region],RER1:ENST00000378513.7:downstream_gene_variant:MODIFIER::::,RER1:ENST00000605895.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	602859_[GENE=PEX10_PHENOS=Peroxisome biogenesis disorder 6A (Zellweger), 614870 (3), Autosomal recessive; Peroxisome biogenesis disorder 6B, 614871 (3), Autosomal recessive]	129884 [benign DISEASE=not provided,Zellweger spectrum disorders,Peroxisome biogenesis disorder, complementation group 7,not specified,Peroxisome biogenesis disorder 6A (Zellweger),Peroxisome biogenesis disorder 6B GENE=PEX10];			rs2494598	0.74278	0.59851,0.77034,0.72491,0.81199,0.73123	42754,	27463	39121	-6.5220	0.02			/0.0>0.0/0.8>2.9	COSV56581176	PEX10|0.00|0.00|0.00|0.00|6|-34|-33|6	25741868,15542397	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RER1 (inh=n/a oe_syn=1.20 oe_mis=0.46 oe_lof=0.22), PEX10 (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.48)
chr1	5862774	5862774	C	A	het	hom	wt		QUAL=24;DP=54,42,16;AF=0.35,1.00,0.00	MIR4689,NPHP4	upstream_gene,downstream_gene	MIR4689:ENST00000582517.1:upstream_gene_variant:MODIFIER::::,NPHP4:ENST00000378156.9:downstream_gene_variant:MODIFIER::::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]				rs12133533	0.12668	0.03424,0.11879,0.08282,0.17766,0.14259	1585,	16119	132975	-0.3670	0.03							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5863728	5863728	T	G	hom	hom	het		QUAL=24;DP=16,11,9;AF=1.00,1.00,0.56	NPHP4,MIR4689	intron,upstream_gene	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron29/29:c.4140+162A>C::,MIR4689:ENST00000582517.1:upstream_gene_variant:MODIFIER::::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1290771 [benign DISEASE=not provided GENE=NPHP4];			rs11121648	0.56633	0.59778,0.50990,0.28477,0.57916,0.54576	24715,	36704	65958	-1.7180	0.04			/4.7>6.1/0.0>0.0		NPHP4|0.00|0.00|0.00|0.00|-8|-49|14|32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5864686	5864686	T	C	het	hom	n/a		QUAL=24;DP=10,4,2;AF=0.90,1.00,0.00	NPHP4,MIR4689	intron,upstream_gene	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron27/29:c.3817-169A>G::,MIR4689:ENST00000582517.1:upstream_gene_variant:MODIFIER::::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1287643 [benign DISEASE=not provided GENE=NPHP4];			rs1287635	0.36410	0.24521,0.37387,0.27297,0.41933,0.43234	10588,	34206	96724	-2.0590	1.08			/0.5>0.0/0.0>0.0	COSV65394658			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5866447	5866447	T	C	het	hom	wt		QUAL=24;DP=277,183,26;AF=0.50,0.99,0.00	NPHP4,MIR4689	synonymous,upstream_gene	NPHP4:ENST00000378156.9:synonymous_variant:LOW:exon26/30:c.3570A>G:p.Glu1190=:,MIR4689:ENST00000582517.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	95683 [benign DISEASE=Nephronophthisis 4,Nephronophthisis,Senior-Loken syndrome 4,not provided,not specified GENE=NPHP4];			rs555164	0.35366	0.20854,0.36940,0.27079,0.41965,0.42979	10239,	33286	98260	0.3050	1.18			/0.0>0.0/0.0>1.0	COSV65394708	NPHP4|0.00|0.00|0.00|0.00|11|-22|20|-22	25741868,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5866971	5866971	A	G	het	hom	wt		QUAL=25;DP=81,97,16;AF=0.48,1.00,0.00	NPHP4,MIR4689	intron,upstream_gene	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron25/29:c.3558+59T>C::,MIR4689:ENST00000582517.1:upstream_gene_variant:MODIFIER::::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1233249 [benign DISEASE=not provided GENE=NPHP4];			rs12122135	0.12856	0.04044,0.12201,0.08324,0.17732,0.14832	1580,	16408	132644	-0.2330	2.17			/3.2>3.3/0.0>0.0	COSV65397177	NPHP4|0.00|0.00|0.00|0.00|-41|-14|-14|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5867678	5867678	G	A	het	hom	wt		QUAL=25;DP=125,193,16;AF=0.50,1.00,0.00	NPHP4,MIR4689	intron,upstream_gene	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron24/29:c.3472+62C>T::,MIR4689:ENST00000582517.1:upstream_gene_variant:MODIFIER::::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1289471 [benign DISEASE=not provided GENE=NPHP4];			rs2297791	0.13417	0.05400,0.13405,0.10305,0.17694,0.15164	1631,	17165	131819	0.0360	3.37			/0.0>0.0/0.0>0.0	COSV65397184	NPHP4|0.00|0.00|0.00|0.00|-16|23|9|-39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR4689 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5874430	5874430	A	G	hom	hom	het		QUAL=25;DP=69,112,68;AF=0.99,1.00,0.49	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron22/29:c.3231+41T>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	260554 [benign DISEASE=not provided,Nephronophthisis 4,not specified GENE=NPHP4];			rs868163	0.64017	0.70570,0.56161,0.28801,0.64495,0.61345	31664,	33713	54545	-4.9310	0.04			/0.0>0.0/0.0>0.0	COSV65397189	NPHP4|0.00|0.00|0.00|0.00|40|-39|-37|-4	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5874777	5874777	C	T	hom	hom	het		QUAL=24;DP=86,191,169;AF=0.99,1.00,0.50	NPHP4	intron,downstream_gene	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron21/29:c.3044+97G>A::,NPHP4:ENST00000622020.4:downstream_gene_variant:MODIFIER::::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1294884 [benign DISEASE=not provided GENE=NPHP4];			rs1287638	0.51255	0.59547,0.37518,0.08505,0.52762,0.43123	20836,	36084	73948	-1.6980	0.08			/0.0>0.0/0.0>0.0	COSV65398749	NPHP4|0.00|0.00|0.00|0.00|-2|4|-2|-45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5875102	5875102	T	A	het	het	wt		QUAL=24;DP=84,128,65;AF=0.62,0.48,0.00	NPHP4	splice_acceptor,downstream_gene	NPHP4:ENST00000378156.9:splice_acceptor_variant:HIGH:intron20/29:c.2818-2A>T:p.?:,NPHP4:ENST00000622020.4:downstream_gene_variant:MODIFIER::::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]		CS057899 [CLASS=FP MUT=ALT PHEN="Altered splicing" GENE=NPHP4];		rs1287637	0.15429	0.10910,0.18770,0.18245,0.17734,0.16549	1977,	19533	128735	5.3340	23.60			9.3>0.9/9.3>4.3/0.0>0.0		NPHP4|0.91|1.00|0.00|0.00|-8|-2|-44|-43	20844548,26578562,23402433	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5875162	5875162	T	C	hom	hom	hom		QUAL=24;DP=44,69,66;AF=1.00,1.00,1.00	NPHP4	intron,downstream_gene	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron20/29:c.2818-62A>G::,NPHP4:ENST00000622020.4:downstream_gene_variant:MODIFIER::::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1269681 [benign DISEASE=not provided GENE=NPHP4];			rs963030	0.43658	0.39263,0.38862,0.25010,0.49511,0.36562	14835,	36696	85646	-1.5800	0.25			/0.0>0.0/0.0>0.0	COSV65393027	NPHP4|0.00|0.00|0.00|0.00|-1|-16|41|15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5904931	5904931	T	C	hom	hom	hom		QUAL=24;DP=63,122,91;AF=1.00,1.00,1.00	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron15/29:c.1956-127A>G::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron15/19:c.1953-127A>G::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1277940 [benign DISEASE=not provided GENE=NPHP4];			rs3737234	0.83543	0.93457,0.76518,0.83011,0.80458,0.74886	53359,	20420	25044	-0.1200	1.64			/1.3>0.7/0.0>0.0		NPHP4|0.00|0.00|0.00|0.00|-33|-26|-49|-33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5905119	5905119	A	G	het	het	het		QUAL=25;DP=59,27,26;AF=0.53,0.63,0.58	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron15/29:c.1955+173T>C::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron15/19:c.1952+173T>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1252595 [benign DISEASE=not provided GENE=NPHP4];			rs11122125	0.40366	0.31190,0.47058,0.74691,0.40780,0.48257	12984,	35408	90672	0.0030	0.82			/0.6>0.0/0.0>0.0	COSV65393924	NPHP4|0.00|0.00|0.00|0.00|22|-11|-47|9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5907004	5907004	G	T	het	wt	het		QUAL=24;DP=45,19,68;AF=0.53,0.00,0.38	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron13/29:c.1611+111C>A::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron13/19:c.1611+111C>A::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1242867 [benign DISEASE=not provided GENE=NPHP4];			rs9628990	0.14300	0.05911,0.12132,0.00830,0.20323,0.11532	1864,	18031	130403	-2.2950	0.03			/0.0>0.0/0.0>0.0		NPHP4|0.00|0.00|0.00|0.00|-2|20|46|22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5947386	5947386	C	T	hom	hom	hom		QUAL=24;DP=19,7,9;AF=1.00,1.00,1.00	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron8/29:c.993-156G>A::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron8/19:c.993-156G>A::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1235266 [benign DISEASE=not provided GENE=NPHP4];			rs551207	0.84985	0.84453,0.80065,0.75193,0.86818,0.82091	55080,	19240	22862	-1.1100	0.22			/0.0>0.2/0.0>0.0			17903299	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5947414	5947414	G	A	het	hom	het		QUAL=24;DP=13,4,7;AF=0.38,1.00,0.29	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron8/29:c.993-184C>T::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron8/19:c.993-184C>T::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1287789 [benign DISEASE=not provided GENE=NPHP4];			rs10779677	0.52719	0.66406,0.50536,0.97685,0.42559,0.50517	22641,	34954	71960	-0.8700	0.44			/2.2>1.8/0.0>0.0		NPHP4|0.00|0.00|0.00|0.00|-40|0|28|-48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5967107	5967107	C	A	hom	het	hom		QUAL=24;DP=20,7,7;AF=1.00,0.71,1.00	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron5/29:c.517+192G>T::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron5/19:c.517+192G>T::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1249471 [benign DISEASE=not provided GENE=NPHP4];			rs875574	0.66079	0.69819,0.63809,0.75955,0.63705,0.62821	33173,	34200	51614	0.4750	3.13			/0.0>0.0/0.0>0.0		NPHP4|0.00|0.00|0.00|0.00|-8|-1|22|-18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5967192	5967192	A	G	hom	het	hom		QUAL=25;DP=28,29,25;AF=1.00,0.55,1.00	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron5/29:c.517+107T>C::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron5/19:c.517+107T>C::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1250302 [benign DISEASE=not provided GENE=NPHP4];			rs875573	0.64045	0.62807,0.63129,0.75975,0.63665,0.62800	31119,	35200	54702	-1.2340	0.02			/3.3>2.3/0.0>0.0	COSV65394014	NPHP4|0.00|0.00|0.00|0.00|36|-21|6|14		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5967533	5967533	G	A	het	het	wt		QUAL=25;DP=21,27,12;AF=0.43,0.30,0.00	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron4/29:c.453-170C>T::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron4/19:c.453-170C>T::	regulatory_region_variant:open_chromatin_region	607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1233320 [benign DISEASE=not provided GENE=NPHP4];			rs75504751	0.04511	0.01203,0.04769,0.00039,0.06878,0.02007	241,	6391	145475	-0.1060	1.98			/0.0>0.0/0.0>0.0		NPHP4|0.00|0.00|0.00|0.00|-47|-49|35|-49		80	1706	0	0 / 0					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5969027	5969027	A	-	hom	het	hom	low_conf_region	QUAL=24;DP=148,65,54;AF=0.80,0.65,0.72	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron4/29:c.452+60del::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron4/19:c.452+60del::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1273587 [benign DISEASE=not provided GENE=NPHP4];		AluSz6 (SINE/Alu)	rs34702999	0.65169	0.64042,0.64712,0.76559,0.64950,0.64594	26920,	34387	47155	-0.3090	0.74			/4.7>4.7/0.0>0.0		NPHP4|0.00|0.00|0.00|0.00|-7|-3|50|23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5978523	5978523	G	C	hom	hom	hom		QUAL=24;DP=77,157,119;AF=1.00,1.00,1.00	NPHP4	intron	NPHP4:ENST00000378156.9:intron_variant:MODIFIER:intron2/29:c.136-110C>G::,NPHP4:ENST00000622020.4:intron_variant:MODIFIER:intron2/19:c.136-110C>G::		607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1244964 [benign DISEASE=not provided GENE=NPHP4];			rs4908639	0.83945	0.93763,0.77878,0.83624,0.80696,0.75627	53774,	19953	24385	-0.7120	0.90			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78)
chr1	5992521	5992521	G	A	n/a	hom	het		QUAL=25;DP=2,34,28;AF=1.00,1.00,0.68	KCNAB2,NPHP4	5'UTR,upstream_gene	KCNAB2:ENST00000378097.6:5_prime_UTR_variant:MODIFIER:exon1/16:c.-320G>A::,NPHP4:ENST00000378156.9:upstream_gene_variant:MODIFIER::::,NPHP4:ENST00000622020.4:upstream_gene_variant:MODIFIER::::,KCNAB2:ENST00000666163.1:upstream_gene_variant:MODIFIER::::,KCNAB2:ENST00000671676.1:upstream_gene_variant:MODIFIER::::,KCNAB2:ENST00000653262.1:upstream_gene_variant:MODIFIER::::,KCNAB2:ENST00000341524.6:upstream_gene_variant:MODIFIER::::,KCNAB2:ENST00000462676.3:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	607215_[GENE=NPHP4_PHENOS=Senior-Loken syndrome 4, 606996 (3), Autosomal recessive; Nephronophthisis 4, 606966 (3), Autosomal recessive]	1252161 [benign DISEASE=not provided GENE=NPHP4];			rs806109	0.83607	0.94523,0.85904,0.99127,0.76178,0.86398	53651,	19945	24949	-0.3260	5.92			/0.0>0.0/0.0>0.0			34648354	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHP4 (inh=AR oe_syn=1.10 oe_mis=1.02 oe_lof=0.78), KCNAB2 (inh=n/a oe_syn=0.95 oe_mis=0.55 oe_lof=0.18)
chr1	6465948	6465948	A	G	het	het	wt		QUAL=24;DP=8,7,4;AF=0.50,0.43,0.00	TNFRSF25,PLEKHG5	intron,downstream_gene	TNFRSF25:ENST00000356876.8:intron_variant:MODIFIER:intron1/9:c.39+121T>C::,TNFRSF25:ENST00000377782.7:intron_variant:MODIFIER:intron1/9:c.39+121T>C::,TNFRSF25:ENST00000351959.9:intron_variant:MODIFIER:intron1/8:c.39+121T>C::,TNFRSF25:ENST00000348333.7:intron_variant:MODIFIER:intron1/8:c.39+121T>C::,TNFRSF25:ENST00000351748.7:intron_variant:MODIFIER:intron1/4:c.39+121T>C::,PLEKHG5:ENST00000535355.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400913.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377725.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000340850.10:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377728.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377748.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377732.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400915.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000673471.2:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377740.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675694.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675123.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]				rs3007416	0.19001	0.49749,0.10453,0.00078,0.06860,0.08662	5521,	17833	123089	0.1330	9.98			/7.2>7.2/0.0>0.0		TNFRSF25|0.00|0.00|0.00|0.00|-50|-18|-30|12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466123	6466123	G	A	het	het	wt		QUAL=24;DP=14,20,4;AF=0.43,0.70,0.00	TNFRSF25,PLEKHG5	5'UTR,upstream_gene,downstream_gene	TNFRSF25:ENST00000356876.8:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,TNFRSF25:ENST00000377782.7:5_prime_UTR_variant:MODIFIER:exon1/10:c.-16C>T::,TNFRSF25:ENST00000351959.9:5_prime_UTR_variant:MODIFIER:exon1/9:c.-16C>T::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000535355.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400913.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377725.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000340850.10:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377728.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377748.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377732.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400915.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000673471.2:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377740.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675694.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675123.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297904 [benign DISEASE=Neuronopathy, distal hereditary motor, autosomal recessive 4,not provided GENE=TNFRSF25];			rs3007417	0.18891	0.49448,0.10400,0.00078,0.06857,0.08603	5440,	17792	123104	-0.6470	11.64			/0.0>0.0/0.0>0.0	COSV61068166	PLEKHG5|0.00|0.00|0.00|0.00|2|46|2|-13,TNFRSF25|0.00|0.00|0.00|0.00|-25|46|2|46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466143	6466150	CGTGCTCT	-	het	het	wt		QUAL=24;DP=12,21,6;AF=0.58,0.67,0.00	TNFRSF25,PLEKHG5	5'UTR,upstream_gene,downstream_gene	TNFRSF25:ENST00000356876.8:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::,TNFRSF25:ENST00000377782.7:5_prime_UTR_variant:MODIFIER:exon1/10:c.-43_-36del::,TNFRSF25:ENST00000351959.9:5_prime_UTR_variant:MODIFIER:exon1/9:c.-43_-36del::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000535355.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400913.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377725.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000340850.10:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377728.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377748.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377732.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400915.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000673471.2:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377740.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675694.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675123.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297905 [benign DISEASE=Distal spinal muscular atrophy GENE=TNFRSF25];			rs45616733	0.18928	0.49489,0.10419,0.00078,0.06930,0.08655	5437,	17861	123079	0.5380	7.47			/0.0>0.0/0.0>0.0		PLEKHG5|0.00|0.00|0.00|0.00|0|27|13|6,TNFRSF25|0.00|0.00|0.00|0.00|0|27|13|6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466181	6466184	CGCC	-	hom	het	wt		QUAL=24;DP=6,16,3;AF=1.00,0.69,0.00	TNFRSF25,PLEKHG5	upstream_gene,downstream_gene	TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000535355.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400913.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377725.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000340850.10:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377728.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377748.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377732.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400915.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000673471.2:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377740.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675694.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675123.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297906 [benign DISEASE=Distal spinal muscular atrophy GENE=PLEKHG5];			rs45542640	0.18875	0.49455,0.10403,0.00078,0.06843,0.08613	5439,	17790	123216	1.5390	10.37					PLEKHG5|0.00|0.00|0.00|0.00|40|-11|-43|24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466259	6466259	C	T	het	het	wt		QUAL=24;DP=31,33,16;AF=0.35,0.39,0.00	TNFRSF25,PLEKHG5	upstream_gene,downstream_gene	TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000535355.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400913.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377725.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000340850.10:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377728.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377748.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377732.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400915.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000673471.2:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377740.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675694.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675123.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297910 [benign DISEASE=Neuronopathy, distal hereditary motor, autosomal recessive 4,not provided GENE=PLEKHG5];			rs45604837	0.08836	0.17572,0.06577,0.00058,0.05905,0.07512	828,	11793	138753	-1.4900	5.34							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6466405	6466405	C	G	het	het	wt		QUAL=24;DP=78,197,16;AF=0.47,0.53,0.00	TNFRSF25,PLEKHG5	upstream_gene,downstream_gene	TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000535355.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400913.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377725.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000340850.10:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377728.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377748.6:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377732.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000400915.8:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000673471.2:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000377740.5:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675694.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000675123.1:downstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297912 [benign DISEASE=Neuronopathy, distal hereditary motor, autosomal recessive 4,not provided GENE=PLEKHG5];		MIR3 (SINE/MIR)	rs2986754	0.18840	0.50448,0.10649,0.00077,0.06812,0.08613	5668,	17336	123516	-0.5600	2.00							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6467273	6467273	A	G	het	het	wt		QUAL=24;DP=76,59,16;AF=0.50,0.47,0.00	PLEKHG5,TNFRSF25	3'UTR,upstream_gene,downstream_gene	PLEKHG5:ENST00000535355.6:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000400913.6:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377725.5:3_prime_UTR_variant:MODIFIER:exon22/22:c.*318T>C::,PLEKHG5:ENST00000340850.10:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377728.8:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000377748.6:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000377732.5:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000400915.8:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000673471.2:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000377740.5:3_prime_UTR_variant:MODIFIER:exon22/22:c.*290T>C::,PLEKHG5:ENST00000675694.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*290T>C::,PLEKHG5:ENST00000675123.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*290T>C::,TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::,PLEKHG5:ENST00000537245.6:downstream_gene_variant:MODIFIER::::		611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297928 [benign DISEASE=not provided,Neuronopathy, distal hereditary motor, autosomal recessive 4 GENE=PLEKHG5];			rs14708	0.26170	0.58010,0.15865,0.00483,0.14265,0.16059	8198,	23432	112364	2.4130	12.31			/0.9>0.8/0.0>0.0		PLEKHG5|0.00|0.00|0.00|0.00|-1|50|40|-23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6467685	6467685	C	T	het	het	wt		QUAL=24;DP=86,170,16;AF=0.47,0.56,0.00	PLEKHG5,TNFRSF25	intron,upstream_gene	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron20/20:c.3219-113G>A::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron20/20:c.3012-113G>A::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron21/21:c.*19-113G>A::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron20/20:c.3012-113G>A::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron20/20:c.3012-113G>A::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron21/21:c.3186-113G>A::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron20/20:c.3123-113G>A::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron21/21:c.3123-113G>A::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron21/21:c.3309-113G>A::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron21/21:c.3012-113G>A::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron20/20:c.3012-113G>A::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron19/19:c.2319-113G>A::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron21/21:c.3123-113G>A::,TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::		611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	667940 [benign DISEASE=not provided GENE=PLEKHG5];			rs9435269	0.19411	0.52554,0.10874,0.00077,0.06687,0.09561	6136,	17278	122684	-3.0990	0.00			/0.0>0.0/2.6>4.9		PLEKHG5|0.00|0.00|0.00|0.00|-2|6|-2|-48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6469123	6469125	TCC	-	het	het	wt		QUAL=25;DP=71,140,79;AF=0.63,0.56,0.19	PLEKHG5,TNFRSF25	inframe_deletion,upstream_gene	PLEKHG5:ENST00000535355.6:inframe_deletion:MODERATE:exon19/21:c.2373_2375del:p.Glu792del:,PLEKHG5:ENST00000400913.6:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377725.5:inframe_deletion:MODERATE:exon19/22:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000340850.10:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377728.8:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000377748.6:inframe_deletion:MODERATE:exon20/22:c.2340_2342del:p.Glu781del:,PLEKHG5:ENST00000377732.5:inframe_deletion:MODERATE:exon19/21:c.2277_2279del:p.Glu760del:,PLEKHG5:ENST00000400915.8:inframe_deletion:MODERATE:exon20/22:c.2277_2279del:p.Glu760del:,PLEKHG5:ENST00000673471.2:inframe_deletion:MODERATE:exon20/22:c.2463_2465del:p.Glu822del:,PLEKHG5:ENST00000377740.5:inframe_deletion:MODERATE:exon20/22:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000675694.1:inframe_deletion:MODERATE:exon19/21:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000675123.1:inframe_deletion:MODERATE:exon18/20:c.2166_2168del:p.Glu723del:,PLEKHG5:ENST00000537245.6:inframe_deletion:MODERATE:exon20/22:c.2277_2279del:p.Glu760del:,TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::		611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	194979 [benign/likely benign DISEASE=not provided,not specified,Distal spinal muscular atrophy,Charcot-Marie-Tooth disease recessive intermediate C,Neuronopathy, distal hereditary motor, autosomal recessive 4 GENE=PLEKHG5];		(TCC)n (Simple_repeat)	rs113541584	0.08767	0.18172,0.06898,0.00407,0.05977,0.08535	711,	11319	132595	0.9800	14.29			/0.0>0.0/1.4>1.4		PLEKHG5|0.00|0.00|0.00|0.00|11|-23|6|-1	28993730	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6469383	6469383	A	G	het	het	wt		QUAL=24;DP=208,488,24;AF=0.51,0.48,0.00	PLEKHG5,TNFRSF25	synonymous,upstream_gene	PLEKHG5:ENST00000535355.6:synonymous_variant:LOW:exon18/21:c.2208T>C:p.Ser736=:,PLEKHG5:ENST00000400913.6:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377725.5:synonymous_variant:LOW:exon18/22:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000340850.10:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377728.8:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000377748.6:synonymous_variant:LOW:exon19/22:c.2175T>C:p.Ser725=:,PLEKHG5:ENST00000377732.5:synonymous_variant:LOW:exon18/21:c.2112T>C:p.Ser704=:,PLEKHG5:ENST00000400915.8:synonymous_variant:LOW:exon19/22:c.2112T>C:p.Ser704=:,PLEKHG5:ENST00000673471.2:synonymous_variant:LOW:exon19/22:c.2298T>C:p.Ser766=:,PLEKHG5:ENST00000377740.5:synonymous_variant:LOW:exon19/22:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000675694.1:synonymous_variant:LOW:exon18/21:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000675123.1:synonymous_variant:LOW:exon17/20:c.2001T>C:p.Ser667=:,PLEKHG5:ENST00000537245.6:synonymous_variant:LOW:exon19/22:c.2112T>C:p.Ser704=:,TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::		611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	194881 [benign DISEASE=Charcot-Marie-Tooth disease recessive intermediate C,Neuronopathy, distal hereditary motor, autosomal recessive 4,not specified,not provided GENE=PLEKHG5];			rs730600	0.26275	0.58136,0.15813,0.00502,0.14316,0.17785	8249,	23498	112226	-0.1930	5.03			/0.0>0.0/1.2>0.0		PLEKHG5|0.02|0.00|0.00|0.00|30|38|-48|6	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6469747	6469747	C	T	het	het	wt		QUAL=24;DP=90,88,24;AF=0.51,0.47,0.00	PLEKHG5,TNFRSF25	intron,upstream_gene	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron16/20:c.2008-71G>A::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron16/20:c.1801-71G>A::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron16/21:c.1801-71G>A::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron16/20:c.1801-71G>A::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron16/20:c.1801-71G>A::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron17/21:c.1975-71G>A::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron16/20:c.1912-71G>A::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron17/21:c.1912-71G>A::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron17/21:c.2098-71G>A::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron17/21:c.1801-71G>A::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron16/20:c.1801-71G>A::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron15/19:c.1801-71G>A::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron17/21:c.1912-71G>A::,TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::		611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	1233170 [benign DISEASE=not provided GENE=PLEKHG5];			rs77492523	0.06914	0.10832,0.05922,0.00058,0.05920,0.07359	431,	9664	141726	0.6490	8.71			/0.0>0.0/2.4>3.4		PLEKHG5|0.02|0.00|0.00|0.00|46|2|-2|40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6469763	6469763	G	C	het	het	wt		QUAL=24;DP=84,70,24;AF=0.58,0.47,0.00	PLEKHG5,TNFRSF25	intron,upstream_gene	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron16/20:c.2008-87C>G::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron16/20:c.1801-87C>G::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron16/21:c.1801-87C>G::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron16/20:c.1801-87C>G::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron16/20:c.1801-87C>G::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron17/21:c.1975-87C>G::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron16/20:c.1912-87C>G::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron17/21:c.1912-87C>G::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron17/21:c.2098-87C>G::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron17/21:c.1801-87C>G::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron16/20:c.1801-87C>G::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron15/19:c.1801-87C>G::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron17/21:c.1912-87C>G::,TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::		611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	1180014 [benign DISEASE=not provided GENE=PLEKHG5];			rs3007420	0.06966	0.10880,0.05915,0.00058,0.05923,0.08575	431,	9743	141641	0.8840	5.86			/0.0>0.0/0.0>0.6		PLEKHG5|0.00|0.00|0.00|0.00|41|30|1|24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6470129	6470129	G	A	het	het	wt		QUAL=24;DP=22,10,4;AF=0.41,0.50,0.00	PLEKHG5,TNFRSF25	intron,upstream_gene	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron16/20:c.2007+107C>T::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron16/20:c.1800+107C>T::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron16/21:c.1800+107C>T::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron16/20:c.1800+107C>T::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron16/20:c.1800+107C>T::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron17/21:c.1974+107C>T::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron16/20:c.1911+107C>T::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron17/21:c.1911+107C>T::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron17/21:c.2097+107C>T::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron17/21:c.1800+107C>T::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron16/20:c.1800+107C>T::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron15/19:c.1800+107C>T::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron17/21:c.1911+107C>T::,TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::		611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	667938 [benign DISEASE=not provided GENE=PLEKHG5];			rs3007421	0.17655	0.31810,0.12595,0.00483,0.13172,0.15512	2974,	20919	125315	0.9560	6.15			/1.2>1.1/0.0>0.0		PLEKHG5|0.00|0.00|0.00|0.00|2|31|16|-16	19136949,21537399,21537453,28628558,24076602	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6470375	6470375	A	G	het	het	wt		QUAL=24;DP=40,55,18;AF=0.45,0.53,0.00	PLEKHG5,TNFRSF25	splice_region&intron,upstream_gene	PLEKHG5:ENST00000535355.6:splice_region_variant&intron_variant:LOW:intron15/20:c.1888-20T>C::,PLEKHG5:ENST00000400913.6:splice_region_variant&intron_variant:LOW:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000377725.5:splice_region_variant&intron_variant:LOW:intron15/21:c.1681-20T>C::,PLEKHG5:ENST00000340850.10:splice_region_variant&intron_variant:LOW:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000377728.8:splice_region_variant&intron_variant:LOW:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000377748.6:splice_region_variant&intron_variant:LOW:intron16/21:c.1855-20T>C::,PLEKHG5:ENST00000377732.5:splice_region_variant&intron_variant:LOW:intron15/20:c.1792-20T>C::,PLEKHG5:ENST00000400915.8:splice_region_variant&intron_variant:LOW:intron16/21:c.1792-20T>C::,PLEKHG5:ENST00000673471.2:splice_region_variant&intron_variant:LOW:intron16/21:c.1978-20T>C::,PLEKHG5:ENST00000377740.5:splice_region_variant&intron_variant:LOW:intron16/21:c.1681-20T>C::,PLEKHG5:ENST00000675694.1:splice_region_variant&intron_variant:LOW:intron15/20:c.1681-20T>C::,PLEKHG5:ENST00000675123.1:splice_region_variant&intron_variant:LOW:intron14/19:c.1681-20T>C::,PLEKHG5:ENST00000537245.6:splice_region_variant&intron_variant:LOW:intron16/21:c.1792-20T>C::,TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::		611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	1260549 [benign DISEASE=not provided,Neuronopathy, distal hereditary motor, autosomal recessive 4,Charcot-Marie-Tooth disease recessive intermediate C GENE=PLEKHG5];			rs2986753	0.18199	0.33710,0.12706,0.00445,0.13196,0.15463	3238,	21200	124396	-0.3690	0.51			7.8>7.8/7.8>7.8/0.0>0.0		PLEKHG5|0.02|0.00|0.00|0.00|-29|34|-29|6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6470905	6470905	-	G	hom	hom	hom		QUAL=24;DP=47,136,108;AF=0.98,0.98,0.95	PLEKHG5,TNFRSF25	intron,upstream_gene	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron13/20:c.1600-22dup::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron13/21:c.1393-22dup::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron14/21:c.1567-22dup::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron13/20:c.1504-22dup::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron14/21:c.1504-22dup::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron14/21:c.1690-22dup::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron14/21:c.1393-22dup::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron13/20:c.1393-22dup::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron12/19:c.1393-22dup::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron14/21:c.1504-22dup::,TNFRSF25:ENST00000356876.8:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000377782.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351959.9:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000348333.7:upstream_gene_variant:MODIFIER::::,TNFRSF25:ENST00000351748.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	670557 [benign DISEASE=Neuronopathy, distal hereditary motor, autosomal recessive 4,Charcot-Marie-Tooth disease recessive intermediate C,not provided GENE=PLEKHG5];			rs111312565	0.99997	1.00000,1.00000,1.00000,0.99994,1.00000	75941,	4	4		2.33			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TNFRSF25 (inh=n/a oe_syn=0.88 oe_mis=0.74 oe_lof=0.33), PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6471529	6471529	C	T	het	het	wt		QUAL=24;DP=37,114,17;AF=0.68,0.45,0.00	PLEKHG5	missense	PLEKHG5:ENST00000535355.6:missense_variant:MODERATE:exon12/21:c.1447G>A:p.Ala483Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000400913.6:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377725.5:missense_variant:MODERATE:exon12/22:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000340850.10:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377728.8:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377748.6:missense_variant:MODERATE:exon13/22:c.1414G>A:p.Ala472Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377732.5:missense_variant:MODERATE:exon12/21:c.1351G>A:p.Ala451Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000400915.8:missense_variant:MODERATE:exon13/22:c.1351G>A:p.Ala451Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000673471.2:missense_variant:MODERATE:exon13/22:c.1537G>A:p.Ala513Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000377740.5:missense_variant:MODERATE:exon13/22:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000675694.1:missense_variant:MODERATE:exon12/21:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000675123.1:missense_variant:MODERATE:exon11/20:c.1240G>A:p.Ala414Thr:PF00621 [RhoGEF domain],PLEKHG5:ENST00000537245.6:missense_variant:MODERATE:exon13/22:c.1351G>A:p.Ala451Thr:PF00621 [RhoGEF domain]		611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	297959 [benign DISEASE=Neuronopathy, distal hereditary motor, autosomal recessive 4,not provided,Charcot-Marie-Tooth disease recessive intermediate C GENE=PLEKHG5];			rs74809741	0.06101	0.08358,0.05497,0.00058,0.05873,0.05526	309,	8675	143029	0.9380	18.02	0.041	0.07	/0.0>1.8/0.0>0.0	COSV61699881	PLEKHG5|0.00|0.00|0.00|0.00|-12|15|-41|5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6471906	6471906	C	T	het	het	wt		QUAL=24;DP=83,184,17;AF=0.49,0.47,0.00	PLEKHG5	intron	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron10/20:c.1288-98G>A::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron10/20:c.1081-98G>A::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron10/21:c.1081-98G>A::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron10/20:c.1081-98G>A::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron10/20:c.1081-98G>A::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron11/21:c.1255-98G>A::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron10/20:c.1192-98G>A::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron11/21:c.1192-98G>A::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron11/21:c.1378-98G>A::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron11/21:c.1081-98G>A::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron10/20:c.1081-98G>A::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron9/19:c.1081-98G>A::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron11/21:c.1192-98G>A::	regulatory_region_variant:promoter,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	1253676 [benign DISEASE=not provided GENE=PLEKHG5];			rs75682285	0.04698	0.05584,0.04392,0.00039,0.05002,0.05050	182,	6791	145147	-0.2320	2.47			/0.0>0.0/2.5>0.0		PLEKHG5|0.00|0.00|0.00|0.00|-2|45|-36|45		39	1602	0	0 / 0					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6473333	6473333	G	C	het	het	wt		QUAL=24;DP=27,25,18;AF=0.48,0.56,0.00	PLEKHG5	missense	PLEKHG5:ENST00000535355.6:missense_variant:MODERATE:exon8/21:c.920C>G:p.Thr307Ser:,PLEKHG5:ENST00000400913.6:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377725.5:missense_variant:MODERATE:exon8/22:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000340850.10:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377728.8:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000377748.6:missense_variant:MODERATE:exon9/22:c.887C>G:p.Thr296Ser:,PLEKHG5:ENST00000377732.5:missense_variant:MODERATE:exon8/21:c.824C>G:p.Thr275Ser:,PLEKHG5:ENST00000400915.8:missense_variant:MODERATE:exon9/22:c.824C>G:p.Thr275Ser:,PLEKHG5:ENST00000673471.2:missense_variant:MODERATE:exon9/22:c.1010C>G:p.Thr337Ser:,PLEKHG5:ENST00000377740.5:missense_variant:MODERATE:exon9/22:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000675694.1:missense_variant:MODERATE:exon8/21:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000675123.1:missense_variant:MODERATE:exon7/20:c.713C>G:p.Thr238Ser:,PLEKHG5:ENST00000537245.6:missense_variant:MODERATE:exon9/22:c.824C>G:p.Thr275Ser:		611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	198895 [benign DISEASE=Neuronopathy, distal hereditary motor, autosomal recessive 4,Charcot-Marie-Tooth disease recessive intermediate C,not provided,not specified GENE=PLEKHG5];			rs61741379	0.27698	0.63187,0.16329,0.00732,0.14310,0.16784	9579,	23025	110115	0.8540	3.29	0.072	0.06	/0.0>0.0/0.0>0.0	COSV61700195	PLEKHG5|0.01|0.00|0.00|0.00|23|-10|1|-25	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6474721	6474721	G	A	het	het	wt		QUAL=24;DP=5,6,6;AF=0.40,0.50,0.00	PLEKHG5	intron	PLEKHG5:ENST00000535355.6:intron_variant:MODIFIER:intron5/20:c.510-134C>T::,PLEKHG5:ENST00000400913.6:intron_variant:MODIFIER:intron5/20:c.303-134C>T::,PLEKHG5:ENST00000377725.5:intron_variant:MODIFIER:intron5/21:c.303-134C>T::,PLEKHG5:ENST00000340850.10:intron_variant:MODIFIER:intron5/20:c.303-134C>T::,PLEKHG5:ENST00000377728.8:intron_variant:MODIFIER:intron5/20:c.303-134C>T::,PLEKHG5:ENST00000377748.6:intron_variant:MODIFIER:intron6/21:c.477-134C>T::,PLEKHG5:ENST00000377732.5:intron_variant:MODIFIER:intron5/20:c.414-134C>T::,PLEKHG5:ENST00000400915.8:intron_variant:MODIFIER:intron6/21:c.414-134C>T::,PLEKHG5:ENST00000673471.2:intron_variant:MODIFIER:intron6/21:c.600-134C>T::,PLEKHG5:ENST00000377740.5:intron_variant:MODIFIER:intron6/21:c.303-134C>T::,PLEKHG5:ENST00000675694.1:intron_variant:MODIFIER:intron5/20:c.303-134C>T::,PLEKHG5:ENST00000675123.1:intron_variant:MODIFIER:intron4/19:c.303-134C>T::,PLEKHG5:ENST00000537245.6:intron_variant:MODIFIER:intron6/21:c.414-134C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	667937 [benign DISEASE=not provided GENE=PLEKHG5];			rs2986751	0.16456	0.37425,0.13559,0.00119,0.07188,0.08619	2598,	15557	105363	-1.6160	2.16			/2.3>2.2/0.0>0.7	COSV100556630	PLEKHG5|0.00|0.00|0.25|0.00|-25|29|2|-24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38)
chr1	6519461	6519461	G	C	het	het	het		QUAL=24;DP=83,86,77;AF=0.55,0.52,0.45	PLEKHG5,NOL9	5'UTR,downstream_gene	PLEKHG5:ENST00000377740.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-181C>G::,NOL9:ENST00000377705.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	670484 [likely benign DISEASE=not provided GENE=PLEKHG5];			rs17438786	0.02199	0.00558,0.01964,0.00000,0.03236,0.01663	48,	3251	148875	0.1090	3.27	0.088		/3.6>2.4/0.0>0.0				37	1470	0	0 / 0					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	6519547	6519547	C	T	hom	hom	hom		QUAL=24;DP=112,260,205;AF=1.00,1.00,1.00	PLEKHG5,NOL9	5'UTR,downstream_gene	PLEKHG5:ENST00000377740.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-267G>A::,NOL9:ENST00000377705.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	380860 [benign DISEASE=Neuronopathy, distal hereditary motor, autosomal recessive 4,not provided,Charcot-Marie-Tooth disease recessive intermediate C,not specified GENE=PLEKHG5];			rs1556035	0.78309	0.52859,0.86465,0.81006,0.88426,0.86667	48534,	22060	32998	0.6350	5.62			/0.0>0.0/0.0>0.9				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	6519783	6519783	C	T	hom	hom	hom		QUAL=24;DP=187,550,457;AF=0.99,1.00,1.00	PLEKHG5,NOL9	5'UTR,downstream_gene	PLEKHG5:ENST00000377740.5:5_prime_UTR_variant:MODIFIER:exon1/22:c.-503G>A::,NOL9:ENST00000377705.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	667919 [benign DISEASE=not provided GENE=PLEKHG5];			rs1010584	0.77286	0.52446,0.84892,0.78917,0.87343,0.85217	47343,	23010	34590	-0.5550	2.39			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	6520176	6520176	G	C	hom	hom	hom		QUAL=24;DP=14,6,4;AF=1.00,1.00,1.00	PLEKHG5,NOL9	upstream_gene,downstream_gene	PLEKHG5:ENST00000377740.5:upstream_gene_variant:MODIFIER::::,NOL9:ENST00000377705.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	679849 [benign DISEASE=not provided GENE=PLEKHG5];			rs4908903	0.97509	0.91739,0.99314,0.96495,0.99965,0.99689	72559,	3481	3797	0.0970	2.09							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	6520190	6520190	C	T	het	n/a	hom		QUAL=25;DP=9,2,3;AF=0.89,1.00,1.00	PLEKHG5,NOL9	upstream_gene,downstream_gene	PLEKHG5:ENST00000377740.5:upstream_gene_variant:MODIFIER::::,NOL9:ENST00000377705.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	611101_[GENE=PLEKHG5_PHENOS=Neuronopathy, distal hereditary motor, autosomal recessive 4, 611067 (3), Autosomal recessive; Charcot-Marie-Tooth disease, recessive intermediate C, 615376 (3), Autosomal recessive]	679848 [benign DISEASE=not provided GENE=PLEKHG5];			rs4908904	0.77287	0.52426,0.84892,0.78889,0.87367,0.85247	47348,	23001	34589	0.6950	6.97							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLEKHG5 (inh=AR oe_syn=1.01 oe_mis=0.84 oe_lof=0.38), NOL9 (inh=n/a oe_syn=1.08 oe_mis=0.77 oe_lof=0.31)
chr1	10275257	10275257	G	A	hom	hom	hom		QUAL=24;DP=132,16,16;AF=0.99,1.00,1.00	KIF1B	intron	KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron9/20:c.865-171G>A::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron10/48:c.883-171G>A::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron9/46:c.865-171G>A::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron9/47:c.865-171G>A::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron9/47:c.865-171G>A::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron9/47:c.865-171G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron10/48:c.883-171G>A::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron9/20:c.865-171G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron9/47:c.883-171G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron9/46:c.883-171G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron9/47:c.883-171G>A::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1226716 [benign DISEASE=not provided GENE=KIF1B];			rs6685773	0.99241	0.99762,0.99386,1.00000,0.98783,0.99627	75025,	1139	1157	-0.2060	0.26			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10282571	10282571	G	A	wt	het	het		QUAL=24;DP=70,224,217;AF=0.00,0.50,0.49	KIF1B	intron	KIF1B:ENST00000377093.9:intron_variant:MODIFIER:intron13/20:c.1296+38G>A::,KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron15/48:c.1434+38G>A::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron13/46:c.1296+38G>A::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron13/47:c.1296+38G>A::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron13/47:c.1296+38G>A::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron13/47:c.1296+38G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron15/48:c.1434+38G>A::,KIF1B:ENST00000377083.5:intron_variant:MODIFIER:intron13/20:c.1296+38G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron14/47:c.1434+38G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron13/46:c.1392+38G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron14/47:c.1356+38G>A::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1292705 [benign DISEASE=not provided GENE=KIF1B];		L3 (LINE/CR1)	rs3748576	0.70441	0.92650,0.68956,0.52316,0.60171,0.62075	39429,	28322	44976	-0.5210	0.27			/1.7>2.2/0.0>0.0	COSV55814192	KIF1B|0.00|0.00|0.00|0.00|-38|4|-10|-38		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10324118	10324118	-	TTGAAA	het	het	het	low_conf_region	QUAL=24;DP=187,206,150;AF=0.39,0.40,0.46	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron25/48:c.2537+57_2537+58insTGAAAT::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron23/46:c.2399+57_2399+58insTGAAAT::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron23/47:c.2399+57_2399+58insTGAAAT::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron24/47:c.2462+57_2462+58insTGAAAT::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron24/47:c.2462+57_2462+58insTGAAAT::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron25/48:c.2537+57_2537+58insTGAAAT::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron24/47:c.2537+57_2537+58insTGAAAT::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron23/46:c.2495+57_2495+58insTGAAAT::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron24/47:c.2459+57_2459+58insTGAAAT::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1241982 [benign DISEASE=not provided GENE=KIF1B];			rs3831405	0.23937	0.09280,0.31194,0.27927,0.29630,0.25042	5006,	26347	115535		3.36			/0.0>0.0/0.0>0.0		KIF1B|0.00|0.00|0.10|0.00|4|-17|4|-29	32986753	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10334478	10334478	C	G	het	het	het		QUAL=24;DP=248,219,152;AF=0.53,0.53,0.48	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron27/48:c.2925-42C>G::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron25/46:c.2787-42C>G::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron25/47:c.2787-42C>G::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron26/47:c.2850-42C>G::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron26/47:c.2850-42C>G::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron27/48:c.2925-42C>G::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron26/47:c.2925-42C>G::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron25/46:c.2883-42C>G::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron26/47:c.2847-42C>G::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1179832 [benign DISEASE=not provided GENE=KIF1B];			rs2276100	0.32823	0.32039,0.36895,0.35775,0.32038,0.27819	8337,	33258	102194	-0.1170	5.01			/0.1>0.0/0.0>0.0	COSV55805280	KIF1B|0.00|0.00|0.00|0.00|42|35|50|-47		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10341952	10341952	A	-	het	het	het	low_conf_region	QUAL=24;DP=90,93,78;AF=0.53,0.66,0.49	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron32/48:c.3514-82del::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron30/46:c.3376-82del::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron30/47:c.3376-82del::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron31/47:c.3439-82del::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron31/47:c.3439-82del::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron32/48:c.3514-82del::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron31/47:c.3514-82del::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron30/46:c.3472-82del::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron31/47:c.3436-82del::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1251637 [benign DISEASE=not provided GENE=KIF1B];		AluJb (SINE/Alu)	rs33942183	0.50997	0.52918,0.53110,0.43508,0.49595,0.52303	12745,	36238	59314	1.0050	0.44			/0.0>0.0/0.0>0.0		KIF1B|0.00|0.00|0.00|0.00|-15|-50|-50|-15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10343424	10343424	G	A	het	het	het		QUAL=25;DP=182,125,99;AF=0.51,0.48,0.46	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron34/48:c.3688+137G>A::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron32/46:c.3550+137G>A::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron32/47:c.3550+137G>A::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron33/47:c.3613+137G>A::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron33/47:c.3613+137G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron34/48:c.3688+137G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron33/47:c.3688+137G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron32/46:c.3646+137G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron33/47:c.3610+137G>A::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1233883 [benign DISEASE=not provided GENE=KIF1B];			rs1556916	0.34737	0.32545,0.38349,0.35839,0.34871,0.27831	9332,	34118	99166	0.1300	0.62			/5.0>4.3/4.0>0.0	COSV55805410	KIF1B|0.00|0.00|0.00|0.00|0|8|6|-5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10360860	10360860	G	A	het	het	het		QUAL=24;DP=198,308,259;AF=0.56,0.49,0.50	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron38/48:c.4056-69G>A::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron36/46:c.3918-69G>A::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron37/47:c.4119-69G>A::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron37/47:c.3981-69G>A::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron37/47:c.3981-69G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron38/48:c.4056-69G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron37/47:c.4056-69G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron36/46:c.4014-69G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron37/47:c.3978-69G>A::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1292713 [benign DISEASE=not provided GENE=KIF1B];			rs3748578	0.29233	0.27124,0.33719,0.27582,0.29828,0.25083	6599,	31245	107589	-0.6940	0.47			/0.0>0.0/0.0>0.0	COSV55805417	KIF1B|0.00|0.00|0.00|0.00|-11|-40|-26|1	23028799,27122668,31475028,36353205	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10360879	10360879	C	T	het	het	het		QUAL=24;DP=233,373,298;AF=0.53,0.50,0.51	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron38/48:c.4056-50C>T::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron36/46:c.3918-50C>T::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron37/47:c.4119-50C>T::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron37/47:c.3981-50C>T::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron37/47:c.3981-50C>T::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron38/48:c.4056-50C>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron37/47:c.4056-50C>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron36/46:c.4014-50C>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron37/47:c.3978-50C>T::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1248757 [benign DISEASE=not provided GENE=KIF1B];			rs3748579	0.32818	0.32047,0.36982,0.35758,0.32011,0.27780	8321,	33233	102101	-0.6290	2.88			/1.1>1.3/3.7>3.2	COSV55805298	KIF1B|0.00|0.00|0.00|0.00|50|-30|-45|-30		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10365060	10365060	T	-	het	het	het		QUAL=24;DP=86,116,92;AF=0.57,0.53,0.46	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron41/48:c.4367-33del::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron39/46:c.4229-33del::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron40/47:c.4430-33del::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron40/47:c.4292-33del::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron40/47:c.4292-33del::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron41/48:c.4367-33del::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron40/47:c.4367-33del::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron39/46:c.4325-33del::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron40/47:c.4289-33del::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1260773 [benign DISEASE=not provided GENE=KIF1B];			rs34161257	0.52790	0.65938,0.50656,0.36327,0.47525,0.46096	21636,	36168	71042	1.3520	1.74			/0.0>0.0/0.0>0.0		KIF1B|0.01|0.00|0.00|0.00|49|48|50|40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10368394	10368394	G	A	het	het	het		QUAL=24;DP=168,306,253;AF=0.50,0.49,0.46	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron43/48:c.4753-73G>A::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron41/46:c.4615-73G>A::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron42/47:c.4816-73G>A::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron42/47:c.4678-73G>A::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron42/47:c.4678-73G>A::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron43/48:c.4753-73G>A::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron42/47:c.4753-73G>A::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron41/46:c.4711-73G>A::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron42/47:c.4675-73G>A::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1292718 [benign DISEASE=not provided GENE=KIF1B];		MER21B (LTR/ERVL)	rs12130563	0.32823	0.32044,0.36946,0.35712,0.32020,0.27828	8339,	33232	102150	-0.1800	2.07			/0.0>0.0/1.8>4.0	COSV55805423	KIF1B|0.01|0.00|0.02|0.00|47|-10|2|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10371100	10371100	T	C	het	het	het		QUAL=24;DP=220,224,155;AF=0.45,0.53,0.47	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron44/48:c.4825-41T>C::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron42/46:c.4687-41T>C::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron43/47:c.4888-41T>C::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron43/47:c.4750-41T>C::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron43/47:c.4750-41T>C::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron44/48:c.4825-41T>C::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron43/47:c.4825-41T>C::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron42/46:c.4783-41T>C::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron43/47:c.4747-41T>C::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1228335 [benign DISEASE=not provided GENE=KIF1B];			rs17411502	0.25791	0.15351,0.32168,0.27602,0.29785,0.25093	5489,	28278	112950	-0.5520	4.76			/0.0>0.0/0.0>0.0	COSV55805429	KIF1B|0.01|0.00|0.00|0.00|-10|23|47|23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10375112	10375112	T	C	het	het	het		QUAL=24;DP=266,218,183;AF=0.46,0.45,0.50	KIF1B	intron	KIF1B:ENST00000676179.1:intron_variant:MODIFIER:intron47/48:c.5289+66T>C::,KIF1B:ENST00000263934.10:intron_variant:MODIFIER:intron45/46:c.5151+66T>C::,KIF1B:ENST00000696502.1:intron_variant:MODIFIER:intron46/47:c.5352+66T>C::,KIF1B:ENST00000696503.1:intron_variant:MODIFIER:intron46/47:c.5214+66T>C::,KIF1B:ENST00000696504.1:intron_variant:MODIFIER:intron46/47:c.5214+66T>C::,KIF1B:ENST00000377086.5:intron_variant:MODIFIER:intron47/48:c.5289+66T>C::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron46/47:c.5289+66T>C::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron45/46:c.5247+66T>C::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron46/47:c.5211+66T>C::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	1239662 [benign DISEASE=not provided GENE=KIF1B];			rs11121551	0.34726	0.32455,0.38360,0.35872,0.34881,0.27895	9340,	34111	99231	0.5700	3.88			/0.6>0.9/0.0>0.0	COSV55805435	KIF1B|0.00|0.00|0.00|0.00|16|-31|10|-31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10375266	10375266	C	A	het	het	het		QUAL=24;DP=291,148,114;AF=0.46,0.52,0.58	KIF1B	synonymous	KIF1B:ENST00000676179.1:synonymous_variant:LOW:exon48/49:c.5301C>A:p.Thr1767=:PF00169 [PH domain],KIF1B:ENST00000263934.10:synonymous_variant:LOW:exon46/47:c.5163C>A:p.Thr1721=:PF00169 [PH domain],KIF1B:ENST00000696502.1:synonymous_variant:LOW:exon47/48:c.5364C>A:p.Thr1788=:PF00169 [PH domain],KIF1B:ENST00000696503.1:synonymous_variant:LOW:exon47/48:c.5226C>A:p.Thr1742=:PF00169 [PH domain],KIF1B:ENST00000696504.1:synonymous_variant:LOW:exon47/48:c.5226C>A:p.Thr1742=:PF00169 [PH domain],KIF1B:ENST00000377086.5:synonymous_variant:LOW:exon48/49:c.5301C>A:p.Thr1767=:PF00169 [PH domain],KIF1B:ENST00000377081.5:synonymous_variant:LOW:exon47/48:c.5301C>A:p.Thr1767=:PF00169 [PH domain],KIF1B:ENST00000620295.2:synonymous_variant:LOW:exon46/47:c.5259C>A:p.Thr1753=:PF00169 [PH domain],KIF1B:ENST00000622724.3:synonymous_variant:LOW:exon47/48:c.5223C>A:p.Thr1741=:PF00169 [PH domain]		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	129401 [benign DISEASE=not provided,not specified,Charcot-Marie-Tooth disease type 2A1,Pheochromocytoma,Charcot-Marie-Tooth disease type 2,Neuroblastoma,Charcot-Marie-Tooth disease GENE=KIF1B];			rs11121552	0.24019	0.09288,0.31279,0.27636,0.29756,0.25041	5109,	26337	115639	-0.5900	5.73			/4.3>3.2/0.0>0.0	COSV55805449	KIF1B|0.01|0.00|0.00|0.00|40|-11|-7|22	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10376834	10376834	-	AC	het	wt	het		QUAL=24;DP=100,16,156;AF=0.31,0.00,0.48	KIF1B	3'UTR,intron	KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279_*280dup::,KIF1B:ENST00000263934.10:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279_*280dup::,KIF1B:ENST00000696502.1:3_prime_UTR_variant:MODIFIER:exon48/48:c.*279_*280dup::,KIF1B:ENST00000696503.1:3_prime_UTR_variant:MODIFIER:exon48/48:c.*279_*280dup::,KIF1B:ENST00000696504.1:3_prime_UTR_variant:MODIFIER:exon48/48:c.*279_*280dup::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279_*280dup::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron47/47:c.5409-1473_5409-1472dup::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron46/46:c.5367-1473_5367-1472dup::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron47/47:c.5331-1473_5331-1472dup::	regulatory_region_variant:enhancer	605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291586 [uncertain significance DISEASE=not provided,Pheochromocytoma,Charcot-Marie-Tooth disease type 2,Neuroblastoma GENE=KIF1B];			rs111663673	0.05443	0.06022,0.04435,0.04696,0.05535,0.02278	195,	7449	136171		2.22			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10376866	10376866	C	T	het	het	wt		QUAL=24;DP=103,180,80;AF=0.50,0.54,0.00	KIF1B	3'UTR,intron	KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279C>T::,KIF1B:ENST00000263934.10:3_prime_UTR_variant:MODIFIER:exon47/47:c.*279C>T::,KIF1B:ENST00000696502.1:3_prime_UTR_variant:MODIFIER:exon48/48:c.*279C>T::,KIF1B:ENST00000696503.1:3_prime_UTR_variant:MODIFIER:exon48/48:c.*279C>T::,KIF1B:ENST00000696504.1:3_prime_UTR_variant:MODIFIER:exon48/48:c.*279C>T::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*279C>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron47/47:c.5409-1473C>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron46/46:c.5367-1473C>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron47/47:c.5331-1473C>T::	regulatory_region_variant:enhancer	605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291594 [benign DISEASE=not provided,Neuroblastoma GENE=KIF1B];		(AC)n (Simple_repeat)	rs78490707	0.00789	0.00112,0.00170,0.11888,0.00324,0.03497	48,	1006	138508	-1.7410	0.38			/1.2>1.4/0.0>0.0		KIF1B|0.00|0.00|0.00|0.00|9|1|-2|38		9	308	0	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10377948	10377948	A	T	het	wt	het		QUAL=24;DP=39,39,55;AF=0.44,0.00,0.53	KIF1B	3'UTR,intron,downstream_gene	KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*1361A>T::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*1361A>T::,KIF1B:ENST00000377081.5:intron_variant:MODIFIER:intron47/47:c.5409-391A>T::,KIF1B:ENST00000620295.2:intron_variant:MODIFIER:intron46/46:c.5367-391A>T::,KIF1B:ENST00000622724.3:intron_variant:MODIFIER:intron47/47:c.5331-391A>T::,KIF1B:ENST00000263934.10:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000696502.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000696503.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000696504.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291610 [benign DISEASE=not provided,Neuroblastoma GENE=KIF1B];		AluSg (SINE/Alu)	rs2847347	0.03799	0.01105,0.03540,0.00598,0.05997,0.01140	152,	5480	146474	0.2090	0.57			/0.0>0.4/0.0>0.0				8	58	0	0 / 0					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10378629	10378629	C	T	het	het	het		QUAL=24;DP=72,198,203;AF=0.56,0.48,0.48	KIF1B	3'UTR,downstream_gene	KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2042C>T::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2042C>T::,KIF1B:ENST00000377081.5:3_prime_UTR_variant:MODIFIER:exon48/48:c.*227C>T::,KIF1B:ENST00000620295.2:3_prime_UTR_variant:MODIFIER:exon47/47:c.*227C>T::,KIF1B:ENST00000622724.3:3_prime_UTR_variant:MODIFIER:exon48/48:c.*227C>T::,KIF1B:ENST00000263934.10:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000696502.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000696503.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000696504.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291618 [benign DISEASE=not provided,Neuroblastoma GENE=KIF1B];			rs1536262	0.55214	0.73802,0.51584,0.36464,0.47663,0.45795	24336,	35289	68105	-1.2380	1.13			/6.3>7.2/0.0>0.0			27980619,31477794	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10378834	10378834	G	A	het	het	het		QUAL=24;DP=75,114,114;AF=0.51,0.54,0.54	KIF1B	3'UTR,downstream_gene	KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2247G>A::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*2247G>A::,KIF1B:ENST00000377081.5:3_prime_UTR_variant:MODIFIER:exon48/48:c.*432G>A::,KIF1B:ENST00000620295.2:3_prime_UTR_variant:MODIFIER:exon47/47:c.*432G>A::,KIF1B:ENST00000622724.3:3_prime_UTR_variant:MODIFIER:exon48/48:c.*432G>A::,KIF1B:ENST00000263934.10:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000696502.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000696503.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000696504.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291619 [benign DISEASE=not provided,Neuroblastoma GENE=KIF1B];			rs1002076	0.32810	0.32013,0.36936,0.35792,0.32018,0.27819	8327,	33237	102169	0.4980	5.67			/1.4>0.4/0.0>0.0			25854172	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10380498	10380498	A	G	het	het	het		QUAL=25;DP=91,162,151;AF=0.52,0.48,0.48	KIF1B	3'UTR,downstream_gene	KIF1B:ENST00000676179.1:3_prime_UTR_variant:MODIFIER:exon49/49:c.*3911A>G::,KIF1B:ENST00000377086.5:3_prime_UTR_variant:MODIFIER:exon49/49:c.*3911A>G::,KIF1B:ENST00000377081.5:3_prime_UTR_variant:MODIFIER:exon48/48:c.*2096A>G::,KIF1B:ENST00000620295.2:3_prime_UTR_variant:MODIFIER:exon47/47:c.*2096A>G::,KIF1B:ENST00000622724.3:3_prime_UTR_variant:MODIFIER:exon48/48:c.*2096A>G::,KIF1B:ENST00000263934.10:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000696502.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000696503.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000696504.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	291652 [benign DISEASE=not provided,Neuroblastoma GENE=KIF1B];		AluSx (SINE/Alu)	rs1138791	0.35743	0.35921,0.38794,0.35895,0.34903,0.27895	9854,	34632	97690	-1.5530	1.66			/0.0>0.0/5.2>4.9				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	10381606	10381606	T	C	het	het	het		QUAL=24;DP=246,348,272;AF=0.53,0.50,0.44	KIF1B	downstream_gene	KIF1B:ENST00000676179.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000263934.10:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000696502.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000696503.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000696504.1:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000377086.5:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000377081.5:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000620295.2:downstream_gene_variant:MODIFIER::::,KIF1B:ENST00000622724.3:downstream_gene_variant:MODIFIER::::		605995_[GENE=KIF1B_PHENOS={Neuroblastoma, susceptibility to, 1}, 256700 (3), Autosomal dominant, Somatic mutation; Charcot-Marie-Tooth disease, type 2A1, 118210 (3), Autosomal dominant]	368794 [benign DISEASE=not provided,Neuroblastoma,Pheochromocytoma,Charcot-Marie-Tooth disease type 2 GENE=KIF1B];			rs3748581	0.53244	0.66999,0.50924,0.36473,0.47580,0.46295	22238,	36447	71063	0.4330	10.54							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KIF1B (inh=AD oe_syn=0.99 oe_mis=0.68 oe_lof=0.10)
chr1	11012522	11012522	T	C	hom	hom	hom		QUAL=25;DP=5,11,10;AF=1.00,1.00,1.00	TARDBP	intron,upstream_gene	TARDBP:ENST00000639083.1:intron_variant:MODIFIER:intron1/5:c.-13+42T>C::,TARDBP:ENST00000629725.2:upstream_gene_variant:MODIFIER::::,TARDBP:ENST00000240185.8:upstream_gene_variant:MODIFIER::::,TARDBP:ENST00000315091.7:upstream_gene_variant:MODIFIER::::,TARDBP:ENST00000649624.1:upstream_gene_variant:MODIFIER::::,TARDBP:ENST00000616545.4:upstream_gene_variant:MODIFIER::::,TARDBP:ENST00000621790.4:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]				rs968545	0.95019	0.98853,0.96391,0.99961,0.93230,0.95015	68890,	6944	7586	-0.9450	4.54			/4.5>3.9/0.0>0.0			34002018,18068872,18802454	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06)
chr1	11012828	11012828	C	T	het	hom	het		QUAL=24;DP=15,12,4;AF=0.33,1.00,0.50	TARDBP	intron,upstream_gene	TARDBP:ENST00000639083.1:intron_variant:MODIFIER:intron1/5:c.-13+348C>T::,TARDBP:ENST00000629725.2:intron_variant:MODIFIER:intron1/6:c.-13+85C>T::,TARDBP:ENST00000240185.8:intron_variant:MODIFIER:intron1/5:c.-13+85C>T::,TARDBP:ENST00000315091.7:upstream_gene_variant:MODIFIER::::,TARDBP:ENST00000649624.1:upstream_gene_variant:MODIFIER::::,TARDBP:ENST00000616545.4:upstream_gene_variant:MODIFIER::::,TARDBP:ENST00000621790.4:upstream_gene_variant:MODIFIER::::		605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]				rs4133584	0.63874	0.25709,0.72667,0.65277,0.81194,0.69408	35467,	26298	54992	0.3350	12.67			/0.0>0.0/0.0>0.0			18802454,21832997,17434264	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06)
chr1	11019020	11019020	A	G	het	hom	het		QUAL=24;DP=102,52,39;AF=0.54,1.00,0.51	TARDBP,MASP2	intron,downstream_gene	TARDBP:ENST00000639083.1:intron_variant:MODIFIER:intron4/5:c.543+147A>G::,TARDBP:ENST00000629725.2:intron_variant:MODIFIER:intron4/6:c.543+147A>G::,TARDBP:ENST00000240185.8:intron_variant:MODIFIER:intron4/5:c.543+147A>G::,TARDBP:ENST00000315091.7:intron_variant:MODIFIER:intron3/5:c.543+147A>G::,TARDBP:ENST00000649624.1:intron_variant:MODIFIER:intron3/5:c.543+147A>G::,TARDBP:ENST00000616545.4:intron_variant:MODIFIER:intron3/5:c.543+147A>G::,TARDBP:ENST00000621790.4:intron_variant:MODIFIER:intron3/5:c.543+147A>G::,MASP2:ENST00000700088.1:downstream_gene_variant:MODIFIER::::		605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]&605102_[GENE=MASP2_PHENOS=MASP2 deficiency, 613791 (3), Autosomal recessive]	1293144 [benign DISEASE=not provided GENE=TARDBP];			rs2273348	0.63958	0.25884,0.72727,0.65739,0.81215,0.69357	35502,	26299	54833	0.1640	1.52			/0.0>0.0/0.0>1.2		TARDBP|0.00|0.00|0.00|0.00|-17|-50|-5|3	19005574,21937999,18545701,22550220,33462484,17614162,17434264	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06), MASP2 (inh=AR oe_syn=1.07 oe_mis=0.99 oe_lof=0.81)
chr1	11020666	11020666	-	G	het	hom	het		QUAL=25;DP=103,102,66;AF=0.53,0.99,0.64	TARDBP,MASP2	intron,downstream_gene	TARDBP:ENST00000639083.1:intron_variant:MODIFIER:intron5/5:c.714+69dup::,TARDBP:ENST00000629725.2:intron_variant:MODIFIER:intron5/6:c.714+69dup::,TARDBP:ENST00000240185.8:intron_variant:MODIFIER:intron5/5:c.714+69dup::,TARDBP:ENST00000315091.7:intron_variant:MODIFIER:intron4/5:c.714+69dup::,TARDBP:ENST00000649624.1:intron_variant:MODIFIER:intron4/5:c.714+69dup::,TARDBP:ENST00000616545.4:intron_variant:MODIFIER:intron4/5:c.714+69dup::,TARDBP:ENST00000621790.4:intron_variant:MODIFIER:intron4/5:c.714+69dup::,MASP2:ENST00000700088.1:downstream_gene_variant:MODIFIER::::		605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]&605102_[GENE=MASP2_PHENOS=MASP2 deficiency, 613791 (3), Autosomal recessive]	522225 [benign DISEASE=not specified,not provided,Amyotrophic lateral sclerosis type 10 GENE=TARDBP];		AluSc (SINE/Alu)	rs143130606	0.88021	0.96817,0.89912,0.92441,0.83454,0.86832	58972,	15403	18147		1.10			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06), MASP2 (inh=AR oe_syn=1.07 oe_mis=0.99 oe_lof=0.81)
chr1	11021998	11021998	G	-	het	hom	het		QUAL=25;DP=46,64,47;AF=0.50,1.00,0.49	TARDBP,MASP2	intron,downstream_gene	TARDBP:ENST00000639083.1:intron_variant:MODIFIER:intron5/5:c.715-126del::,TARDBP:ENST00000629725.2:intron_variant:MODIFIER:intron5/6:c.715-126del::,TARDBP:ENST00000240185.8:intron_variant:MODIFIER:intron5/5:c.715-126del::,TARDBP:ENST00000315091.7:intron_variant:MODIFIER:intron4/5:c.715-126del::,TARDBP:ENST00000649624.1:intron_variant:MODIFIER:intron4/5:c.715-126del::,TARDBP:ENST00000616545.4:intron_variant:MODIFIER:intron4/5:c.715-126del::,TARDBP:ENST00000621790.4:intron_variant:MODIFIER:intron4/5:c.715-126del::,MASP2:ENST00000700088.1:downstream_gene_variant:MODIFIER::::,MASP2:ENST00000700091.1:downstream_gene_variant:MODIFIER::::,MASP2:ENST00000700092.1:downstream_gene_variant:MODIFIER::::,MASP2:ENST00000700093.1:downstream_gene_variant:MODIFIER::::,MASP2:ENST00000700095.1:downstream_gene_variant:MODIFIER::::,MASP2:ENST00000400897.8:downstream_gene_variant:MODIFIER::::,MASP2:ENST00000699958.1:downstream_gene_variant:MODIFIER::::		605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]&605102_[GENE=MASP2_PHENOS=MASP2 deficiency, 613791 (3), Autosomal recessive]	1221094 [benign DISEASE=not provided GENE=TARDBP];			rs3835416	0.63869	0.25717,0.72707,0.65538,0.81174,0.69204	35426,	26310	54964	0.1340	2.43			/0.0>0.0/0.0>0.0		TARDBP|0.00|0.00|0.00|0.00|33|2|-15|-24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06), MASP2 (inh=AR oe_syn=1.07 oe_mis=0.99 oe_lof=0.81)
chr1	11024947	11024947	-	TGTTT	het	hom	het		QUAL=24;DP=219,294,279;AF=0.46,0.95,0.49	TARDBP,MASP2	3'UTR,intron,downstream_gene	TARDBP:ENST00000240185.8:3_prime_UTR_variant:MODIFIER:exon6/6:c.*2294_*2295insGTTTT::,MASP2:ENST00000700088.1:intron_variant:MODIFIER:intron11/11:c.1396+1802_1396+1803insAAACA::,TARDBP:ENST00000639083.1:downstream_gene_variant:MODIFIER::::,TARDBP:ENST00000629725.2:downstream_gene_variant:MODIFIER::::,TARDBP:ENST00000315091.7:downstream_gene_variant:MODIFIER::::,TARDBP:ENST00000649624.1:downstream_gene_variant:MODIFIER::::,TARDBP:ENST00000616545.4:downstream_gene_variant:MODIFIER::::,TARDBP:ENST00000621790.4:downstream_gene_variant:MODIFIER::::,MASP2:ENST00000700091.1:downstream_gene_variant:MODIFIER::::,MASP2:ENST00000700092.1:downstream_gene_variant:MODIFIER::::,MASP2:ENST00000700093.1:downstream_gene_variant:MODIFIER::::,MASP2:ENST00000700095.1:downstream_gene_variant:MODIFIER::::,MASP2:ENST00000400897.8:downstream_gene_variant:MODIFIER::::,MASP2:ENST00000699958.1:downstream_gene_variant:MODIFIER::::,MASP2:ENST00000700097.1:downstream_gene_variant:MODIFIER::::		605078_[GENE=TARDBP_PHENOS=Frontotemporal lobar degeneration, TARDBP-related, 612069 (3), Autosomal dominant; Amyotrophic lateral sclerosis 10, with or without FTD, 612069 (3), Autosomal dominant]&605102_[GENE=MASP2_PHENOS=MASP2 deficiency, 613791 (3), Autosomal recessive]	291763 [benign DISEASE=Frontotemporal dementia,Amyotrophic Lateral Sclerosis, Dominant,Immunodeficiency due to MASP-2 deficiency GENE=TARDBP];			rs3059695	0.88034	0.96983,0.89854,0.92525,0.83406,0.86955	59143,	15394	18170		7.09			/0.1>1.0/0.0>0.0,/0.0>0.0/2.7>5.4				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TARDBP (inh=AD oe_syn=1.10 oe_mis=0.32 oe_lof=0.06), MASP2 (inh=AR oe_syn=1.07 oe_mis=0.99 oe_lof=0.81)
chr1	11786035	11786035	-	T	hom	hom	hom		QUAL=24;DP=90,56,37;AF=0.79,0.91,0.89	C1orf167,MTHFR	intron,3'UTR,downstream_gene	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron16/20:c.3081+757dup::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron16/20:c.3567+757dup::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4644dup::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4644dup::,MTHFR:ENST00000423400.7:downstream_gene_variant:MODIFIER::::,MTHFR:ENST00000641407.1:downstream_gene_variant:MODIFIER::::,MTHFR:ENST00000641820.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	292153 [benign DISEASE=Neural tube defects, folate-sensitive GENE=MTHFR];			rs55740775	0.98386	0.96149,0.99424,0.99689,0.99313,0.99915	72511,	2351	2417		0.66			/1.8>3.3/0.0>0.0,/0.0>0.0/0.0>0.0		C1orf167|0.00|0.00|0.01|0.00|-25|-24|-25|23,MTHFR|0.00|0.00|0.00|0.00|11|9|17|9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11786195	11786195	G	A	hom	het	het		QUAL=24;DP=196,181,159;AF=1.00,0.54,0.50	C1orf167,MTHFR	intron,3'UTR,downstream_gene	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron16/20:c.3081+906G>A::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron16/20:c.3567+906G>A::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4485C>T::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4485C>T::,MTHFR:ENST00000423400.7:downstream_gene_variant:MODIFIER::::,MTHFR:ENST00000641407.1:downstream_gene_variant:MODIFIER::::,MTHFR:ENST00000641820.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]			Tigger15a (DNA/TcMar-Tigger)	rs4846048	0.67793	0.54506,0.77637,0.89526,0.70613,0.66819	35706,	31682	48978	0.4760	1.68			/0.0>0.0/0.0>0.4,/4.6>5.6/0.0>0.0		C1orf167|0.00|0.00|0.00|0.00|2|-41|2|12,MTHFR|0.00|0.00|0.00|0.00|-14|21|-6|-2	31637880,21273288,19493349,34126931,19593234,20056627,22747749,26046315,28963520,33223666,20692813,24853127,25566964,32117640,18221821,24687778,28969008,29299150,29340069,31694048,32073761,18180959,31601265,31750632,31737664,31671528,23292069,26770518,34163215,25165408,23430981,36538104,23166529,25349462,36364857,23848401,35987633	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11786390	11786390	G	A	hom	hom	hom		QUAL=24;DP=232,216,181;AF=1.00,1.00,1.00	C1orf167,MTHFR	intron,3'UTR,downstream_gene	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron16/20:c.3082-998G>A::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron16/20:c.3568-998G>A::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4290C>T::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4290C>T::,MTHFR:ENST00000423400.7:downstream_gene_variant:MODIFIER::::,MTHFR:ENST00000641407.1:downstream_gene_variant:MODIFIER::::,MTHFR:ENST00000641820.1:downstream_gene_variant:MODIFIER::::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs4845884	0.93941	0.79095,0.97451,1.00000,0.99934,0.99959	67850,	7352	9226	-0.8090	0.54			/0.0>0.0/0.0>0.0			26046315	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11786603	11786606	TTTT	-	hom	het	hom		QUAL=24;DP=70,76,51;AF=0.74,0.68,0.59	C1orf167,MTHFR	intron,3'UTR,downstream_gene	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron16/20:c.3082-770_3082-767del::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron16/20:c.3568-770_3568-767del::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*4074_*4077del::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*4074_*4077del::,MTHFR:ENST00000423400.7:downstream_gene_variant:MODIFIER::::,MTHFR:ENST00000641407.1:downstream_gene_variant:MODIFIER::::,MTHFR:ENST00000641820.1:downstream_gene_variant:MODIFIER::::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	292164 [likely benign DISEASE=Neural tube defects, folate-sensitive GENE=MTHFR];		AluJr (SINE/Alu)	rs55780505	0.54135	0.38620,0.68974,0.75817,0.57521,0.45307	21334,	34215	65137	0.3080	0.47			/10.7>9.9/0.0>0.0,/0.0>0.0/0.0>0.0			26046315	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11787277	11787277	-	GAA	hom	het	het		QUAL=24;DP=131,229,138;AF=0.98,0.42,0.58	C1orf167,MTHFR	intron,3'UTR,downstream_gene	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron16/20:c.3082-108_3082-106dup::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron16/20:c.3568-108_3568-106dup::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*3400_*3402dup::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*3400_*3402dup::,MTHFR:ENST00000423400.7:downstream_gene_variant:MODIFIER::::,MTHFR:ENST00000641407.1:downstream_gene_variant:MODIFIER::::,MTHFR:ENST00000641820.1:downstream_gene_variant:MODIFIER::::		607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs35134728	0.56532	0.39860,0.70490,0.76959,0.60829,0.47261	25343,	35188	66030		0.64			/0.0>0.0/0.0>0.0,/1.6>1.6/0.0>0.0		C1orf167|0.02|0.00|0.00|0.00|-18|5|-18|-27,MTHFR|0.00|0.00|0.00|0.00|26|-40|-14|-40	26046315,21478897,28990296	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11787702	11787702	C	T	hom	het	het		QUAL=25;DP=81,145,155;AF=0.98,0.50,0.48	C1orf167,MTHFR	intron,3'UTR,downstream_gene	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron17/20:c.3188-171C>T::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron17/20:c.3674-171C>T::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2978G>A::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*2978G>A::,MTHFR:ENST00000423400.7:downstream_gene_variant:MODIFIER::::,MTHFR:ENST00000641407.1:downstream_gene_variant:MODIFIER::::,MTHFR:ENST00000641820.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs3737966	0.55237	0.37389,0.69418,0.77327,0.59995,0.44979	24374,	35300	68110	0.6820	5.53			/4.6>5.4/0.0>0.0,/3.4>2.6/0.0>0.0	COSV57172225	C1orf167|0.00|0.00|0.00|0.00|6|10|-17|18,MTHFR|0.00|0.00|0.00|0.00|-8|27|-8|27	26046315,30339177,32117640,21478897,36284378,36364857,28990296	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11788082	11788082	G	A	wt	het	het		QUAL=24;DP=36,63,52;AF=0.00,0.44,0.58	C1orf167,MTHFR	intron,3'UTR,downstream_gene	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron18/20:c.3362+35G>A::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron18/20:c.3848+35G>A::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2598C>T::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*2598C>T::,MTHFR:ENST00000423400.7:downstream_gene_variant:MODIFIER::::,MTHFR:ENST00000641407.1:downstream_gene_variant:MODIFIER::::,MTHFR:ENST00000641820.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:open_chromatin_region	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs11559040	0.13535	0.03924,0.11095,0.10178,0.18183,0.24275	1756,	17097	131661	-1.3250	2.49			/0.0>1.2/1.3>1.6,/2.9>2.5/0.0>0.0	COSV57171817	C1orf167|0.00|0.00|0.00|0.00|3|48|-9|-35,MTHFR|0.00|0.00|0.00|0.00|-40|47|31|-35	26046315,36562046,37674888	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11788822	11788822	A	G	hom	hom	hom		QUAL=24;DP=111,128,98;AF=1.00,1.00,1.00	C1orf167,MTHFR	intron,3'UTR,downstream_gene	C1orf167:ENST00000433342.6:intron_variant:MODIFIER:intron20/20:c.3672+76A>G::,C1orf167:ENST00000688073.1:intron_variant:MODIFIER:intron20/20:c.4173+76A>G::,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1858T>C::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1858T>C::,MTHFR:ENST00000423400.7:downstream_gene_variant:MODIFIER::::,MTHFR:ENST00000641407.1:downstream_gene_variant:MODIFIER::::,MTHFR:ENST00000641820.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs2077360	0.93699	0.78232,0.97399,1.00000,0.99931,0.99979	67548,	7580	9594	-0.5450	0.95			/0.0>0.1/0.0>0.0,/1.1>0.6/10.2>8.7			26046315	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11789390	11789390	A	G	hom	hom	hom		QUAL=24;DP=68,130,119;AF=1.00,0.99,1.00	C1orf167,MTHFR	missense,3'UTR,downstream_gene	C1orf167:ENST00000433342.6:missense_variant:MODERATE:exon21/21:c.3793A>G:p.Arg1265Gly:,C1orf167:ENST00000688073.1:missense_variant:MODERATE:exon21/21:c.4294A>G:p.Arg1432Gly:,MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1290T>C::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1290T>C::,MTHFR:ENST00000423400.7:downstream_gene_variant:MODIFIER::::,MTHFR:ENST00000641407.1:downstream_gene_variant:MODIFIER::::,MTHFR:ENST00000641820.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]				rs868014	0.93954	0.79120,0.97471,1.00000,0.99934,0.99979	67828,	7329	9201	-5.2110	0.01	0.029	0.04	/0.0>0.0/0.0>0.0	COSV57171235		30182779,28171870,34953598,26046315,31671528,23292069,34298760,33239899	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11790308	11790308	T	G	hom	het	het		QUAL=24;DP=111,180,204;AF=1.00,0.46,0.47	MTHFR,C1orf167	3'UTR,downstream_gene	MTHFR:ENST00000376592.6:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000376590.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000376583.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,MTHFR:ENST00000376585.6:3_prime_UTR_variant:MODIFIER:exon13/13:c.*372A>C::,MTHFR:ENST00000423400.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*372A>C::,C1orf167:ENST00000433342.6:downstream_gene_variant:MODIFIER::::,C1orf167:ENST00000688073.1:downstream_gene_variant:MODIFIER::::,MTHFR:ENST00000641407.1:downstream_gene_variant:MODIFIER::::,MTHFR:ENST00000641820.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	292223 [benign DISEASE=not provided,Homocystinuria due to methylene tetrahydrofolate reductase deficiency GENE=MTHFR];			rs4846049	0.63178	0.49359,0.75121,0.77498,0.67415,0.54395	31086,	33916	56002	-0.8740	0.24			/0.0>0.0/0.0>0.0		MTHFR|0.00|0.00|0.00|0.00|-8|-22|-15|36	22100073,31637880,20556870,24991086,31469255,19683694,21448238,19593234,20056627,20962791,26046315,28657672,28722783,28963520,34027569,24391914,33223666,23227261,25723397,32117640,24315498,32791502,31601265,21515602,22647417,25882505,26690224,27454313,29379315,31737664,28855605,27106592,30518802,34707639,34885097,23303660,28587112,27980618,29871275,29657307,30781868,29434917,29666641,36538104,24006081,29534533,36364857,35987633	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11790946	11790946	G	C	wt	het	het		QUAL=24;DP=70,180,167;AF=0.00,0.43,0.49	MTHFR,C1orf167	intron,downstream_gene	MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron11/11:c.1753-48C>G::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron11/11:c.1753-48C>G::,MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron11/11:c.1876-48C>G::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron12/12:c.1876-48C>G::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron11/11:c.1873-48C>G::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron10/10:c.1753-230C>G::,MTHFR:ENST00000641820.1:intron_variant:MODIFIER:intron7/7:c.1018-48C>G::,C1orf167:ENST00000433342.6:downstream_gene_variant:MODIFIER::::,C1orf167:ENST00000688073.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1224887 [benign DISEASE=not provided,Homocystinuria due to methylene tetrahydrofolate reductase deficiency GENE=MTHFR];			rs3818762	0.23500	0.14779,0.17299,0.22296,0.27819,0.41732	4601,	26535	116337	-2.2640	0.01			/2.4>1.9/0.3>1.3	COSV100453746	MTHFR|0.00|0.04|0.00|0.00|30|-48|1|-3	22100073,21273288,22241680,35700037,31502714,23874907	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11791061	11791061	A	G	hom	hom	hom		QUAL=24;DP=119,127,126;AF=1.00,1.00,1.00	MTHFR,C1orf167	intron,downstream_gene	MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron11/11:c.1752+146T>C::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron11/11:c.1752+146T>C::,MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron11/11:c.1875+146T>C::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron12/12:c.1875+146T>C::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron11/11:c.1872+146T>C::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron10/10:c.1752+146T>C::,MTHFR:ENST00000641820.1:intron_variant:MODIFIER:intron7/7:c.1017+146T>C::,C1orf167:ENST00000433342.6:downstream_gene_variant:MODIFIER::::,C1orf167:ENST00000688073.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1177028 [benign DISEASE=Homocystinuria due to methylene tetrahydrofolate reductase deficiency,not provided GENE=MTHFR];			rs7518348	0.90902	0.68818,0.96158,0.99864,0.99850,0.99876	64290,	9776	13848	0.0820	5.05			/4.1>3.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11792243	11792243	C	T	wt	het	het		QUAL=24;DP=66,209,198;AF=0.00,0.48,0.47	MTHFR,C1orf167	intron,downstream_gene	MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron10/11:c.1632+35G>A::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron10/11:c.1632+35G>A::,MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron10/11:c.1755+35G>A::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron11/12:c.1755+35G>A::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron10/11:c.1752+35G>A::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron9/10:c.1632+35G>A::,MTHFR:ENST00000641820.1:intron_variant:MODIFIER:intron6/7:c.897+35G>A::,C1orf167:ENST00000433342.6:downstream_gene_variant:MODIFIER::::,C1orf167:ENST00000688073.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1170841 [benign DISEASE=not provided,Homocystinuria due to methylene tetrahydrofolate reductase deficiency GENE=MTHFR];			rs1476413	0.23440	0.16082,0.17277,0.23132,0.26995,0.41355	4505,	26659	116503	-1.1200	2.72			/0.0>0.0/0.0>0.0	COSV57171175	MTHFR|0.00|0.00|0.00|0.00|34|35|35|0	21273288,33195260,27437086,19493349,19048631,21254358,21254359,34126931,19593234,20056627,20962791,22039442,22155867,22241680,22747749,22903727,23893618,26646537,32993083,35700037,20692813,22495907,28266606,30339177,29421402,29732742,31502714,35548064,19064567,24314549,34734498,35677930,36160803,36467057,37376109,23430981,32825595,23166529,25084201,36364857,19075497,28361099,20356773	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11794400	11794400	G	A	hom	hom	hom		QUAL=24;DP=113,263,205;AF=1.00,1.00,1.00	MTHFR,C1orf167	synonymous,downstream_gene	MTHFR:ENST00000376592.6:synonymous_variant:LOW:exon8/12:c.1305C>T:p.Phe435=:,MTHFR:ENST00000376590.9:synonymous_variant:LOW:exon8/12:c.1305C>T:p.Phe435=:,MTHFR:ENST00000376583.7:synonymous_variant:LOW:exon8/12:c.1428C>T:p.Phe476=:,MTHFR:ENST00000376585.6:synonymous_variant:LOW:exon9/13:c.1428C>T:p.Phe476=:,MTHFR:ENST00000423400.7:synonymous_variant:LOW:exon8/12:c.1425C>T:p.Phe475=:,MTHFR:ENST00000641407.1:synonymous_variant:LOW:exon7/11:c.1305C>T:p.Phe435=:,MTHFR:ENST00000641820.1:synonymous_variant:LOW:exon4/8:c.570C>T:p.Phe190=:,C1orf167:ENST00000433342.6:downstream_gene_variant:MODIFIER::::,C1orf167:ENST00000688073.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	167306 [benign DISEASE=Homocystinuria due to methylene tetrahydrofolate reductase deficiency,not specified,not provided GENE=MTHFR];			rs4846051	0.90932	0.68910,0.96129,0.99864,0.99850,0.99876	64268,	9739	13789	0.6480	1.95			/3.6>3.6/0.0>0.0			28871186,19591822,19493349,34126931,34169999,29193749,22241680,32993083,25110414,31208817,16439441,18483346,23300409,25982422,36160803,37376109,36358396,19144510	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11794419	11794419	T	G	wt	het	het		QUAL=24;DP=43,284,229;AF=0.00,0.55,0.54	MTHFR,C1orf167	missense,downstream_gene	MTHFR:ENST00000376592.6:missense_variant:MODERATE:exon8/12:c.1286A>C:p.Glu429Ala:,MTHFR:ENST00000376590.9:missense_variant:MODERATE:exon8/12:c.1286A>C:p.Glu429Ala:,MTHFR:ENST00000376583.7:missense_variant:MODERATE:exon8/12:c.1409A>C:p.Glu470Ala:,MTHFR:ENST00000376585.6:missense_variant:MODERATE:exon9/13:c.1409A>C:p.Glu470Ala:,MTHFR:ENST00000423400.7:missense_variant:MODERATE:exon8/12:c.1406A>C:p.Glu469Ala:,MTHFR:ENST00000641407.1:missense_variant:MODERATE:exon7/11:c.1286A>C:p.Glu429Ala:,MTHFR:ENST00000641820.1:missense_variant:MODERATE:exon4/8:c.551A>C:p.Glu184Ala:,C1orf167:ENST00000433342.6:downstream_gene_variant:MODIFIER::::,C1orf167:ENST00000688073.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	3521 [benign/likely benign,other DISEASE=Homocystinuria due to methylene tetrahydrofolate reductase deficiency,MTHFR THERMOLABILE POLYMORPHISM,Schizophrenia, susceptibility to,not provided,not specified,Gastrointestinal stromal tumor,Neural tube defects, folate-sensitive,MTHFR-related disorder GENE=MTHFR];	CM981315 [CLASS=DFP MUT=ALT PHEN="Neural tube defect increased risk association with" GENE=MTHFR];		rs1801131	0.26334	0.16735,0.20680,0.22065,0.31586,0.40773	5754,	28519	111971	3.7560	19.46	0.197	0.08	/0.0>0.0/1.6>2.1	COSV57171183	MTHFR|0.00|0.00|0.00|0.00|-39|-4|2|3	21467728,18603647,21146954,21533139,21919968,22100073,23205182,27348238,29972410,30182779,30409984,30571812,34137427,34276231,20078877,26446360,26451011,31818908,34308116,22281051,33128086,18992148,16642433,21273288,24944790,21514219,23946381,25928231,34540891,25294155,18936436,19538716,19591822,20417488,20556870,21857382,21935354,22540831,22707612,22992668,23776350,25266489,26091847,27018927,27233804,28086795,31646966,33519226,34142473,34958284,35040003,25214541,34862210,28827732,30337837,30793520,31361092,32728337,33195260,19493349,33262486,21658613,22486600,12970910,28253266,19048631,26884752,30877365,35582139,21254358,21254359,34126931,22927710,26843965,22496743,30235667,28927418,27369588,22022476,18191955,21204206,19442614,29694444,34169999,19064578,22655231,23175176,29193749,27583843,26870349,30203425,19683694,21274745,27808252,24340057,27217270,30607769,35633991,20718043,28822116,32355262,19593234,20056627,20962791,22155867,22241680,22747749,22903727,22792358,24130171,21748308,19062539,34768452,3574174	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	M	"[M] ahdeics1 15.04.2024"		"auch: MTHFR 1298A>C bzw. rs1801131; Chemotoxizität nach Methotrexat-Gabe bei Leukämie (u.a. Hepatotoxizität, hämatologische Toxizität und Mucositis); Literatur umstritten, DPWG Guideline: No recommendation"	C1ORF167 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.84), MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11794614	11794614	C	A	wt	het	het		QUAL=24;DP=43,107,100;AF=0.00,0.52,0.51	MTHFR	intron	MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron7/11:c.1167-76G>T::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron7/11:c.1167-76G>T::,MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron7/11:c.1290-76G>T::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron8/12:c.1290-76G>T::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron7/11:c.1287-76G>T::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron6/10:c.1167-76G>T::,MTHFR:ENST00000641820.1:intron_variant:MODIFIER:intron3/7:c.432-76G>T::	regulatory_region_variant:open_chromatin_region	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1177041 [benign/likely benign DISEASE=not provided,not specified,Homocystinuria due to methylene tetrahydrofolate reductase deficiency GENE=MTHFR];			rs12121543	0.21332	0.14352,0.15617,0.20773,0.24861,0.33700	3722,	24989	119607	-0.1370	6.20			/0.0>0.0/1.8>0.0	COSV64877122	MTHFR|0.02|0.00|0.00|0.00|-41|0|2|1	21273288,20056627,22039442,22241680,35700037,22933837,24853127,25566964,22103680,22649255,35677930,25165408,24006081,36364857	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11794698	11794698	G	A	hom	het	het		QUAL=24;DP=71,54,57;AF=1.00,0.39,0.46	MTHFR	intron	MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron7/11:c.1166+31C>T::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron7/11:c.1166+31C>T::,MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron7/11:c.1289+31C>T::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron8/12:c.1289+31C>T::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron7/11:c.1286+31C>T::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron6/10:c.1166+31C>T::,MTHFR:ENST00000641820.1:intron_variant:MODIFIER:intron3/7:c.431+31C>T::	regulatory_region_variant:open_chromatin_region	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1177042 [benign DISEASE=not provided,not specified,Homocystinuria due to methylene tetrahydrofolate reductase deficiency GENE=MTHFR];			rs1994798	0.56198	0.43626,0.68824,0.75943,0.58555,0.48337	24790,	35845	66581	-4.4220	0.02			/0.0>0.4/0.0>0.0	COSV64877997	MTHFR|0.00|0.00|0.04|0.00|2|-48|2|-45	20718043,20056627,22241680,11781870,18538037,32073761,35677930,20356773	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11800063	11800063	T	C	hom	het	het		QUAL=24;DP=74,134,102;AF=0.99,0.46,0.55	MTHFR	intron,upstream_gene	MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron4/11:c.586+149A>G::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron4/11:c.586+149A>G::,MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron4/11:c.709+149A>G::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron5/12:c.709+149A>G::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron4/11:c.706+149A>G::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron3/10:c.586+149A>G::,MTHFR:ENST00000641820.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1295234 [benign DISEASE=not provided GENE=MTHFR];			rs11121832	0.74674	0.69168,0.81528,0.89432,0.75244,0.69431	42568,	28283	38467	-0.9060	0.30			/0.0>0.5/0.0>0.0		MTHFR|0.00|0.00|0.00|0.00|23|13|-16|13	20056627,22039442,20692813,28266606,22252258	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11800401	11800401	C	T	wt	het	het		QUAL=24;DP=68,317,242;AF=0.00,0.49,0.54	MTHFR	intron,upstream_gene	MTHFR:ENST00000376592.6:intron_variant:MODIFIER:intron3/11:c.476-79G>A::,MTHFR:ENST00000376590.9:intron_variant:MODIFIER:intron3/11:c.476-79G>A::,MTHFR:ENST00000376583.7:intron_variant:MODIFIER:intron3/11:c.599-79G>A::,MTHFR:ENST00000376585.6:intron_variant:MODIFIER:intron4/12:c.599-79G>A::,MTHFR:ENST00000423400.7:intron_variant:MODIFIER:intron3/11:c.596-79G>A::,MTHFR:ENST00000641407.1:intron_variant:MODIFIER:intron2/10:c.476-79G>A::,MTHFR:ENST00000641820.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	607093_[GENE=MTHFR_PHENOS={Vascular disease, susceptibility to} (3); Homocystinuria due to MTHFR deficiency, 236250 (3), Autosomal recessive; {Thromboembolism, susceptibility to}, 188050 (3), Autosomal dominant; {Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant; {Neural tube defects, susceptibility to}, 601634 (3), Autosomal recessive]	1180162 [benign DISEASE=not provided GENE=MTHFR];			rs2066471	0.12249	0.03025,0.10209,0.09773,0.16598,0.20544	1443,	15752	133516	0.2400	5.72			/6.6>2.4/0.0>0.0	COSV64701666	MTHFR|0.00|0.00|0.00|0.00|-2|21|6|-7	18778477,21085059,20692813,30339177,31671528,23292069,23350966,36364857	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTHFR (inh=AR+AD oe_syn=1.14 oe_mis=0.87 oe_lof=0.63)
chr1	11949898	11949898	C	T	het	het	het		QUAL=24;DP=125,247,190;AF=0.46,0.49,0.53	PLOD1	synonymous	PLOD1:ENST00000196061.5:synonymous_variant:LOW:exon3/19:c.294C>T:p.Phe98=:		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	255803 [benign DISEASE=not provided,not specified,Ehlers-Danlos syndrome, kyphoscoliotic type 1,Familial thoracic aortic aneurysm and aortic dissection GENE=PLOD1];			rs7529452	0.25387	0.06348,0.28944,0.37777,0.31474,0.43068	6299,	26010	113468	1.0800	13.46			/10.7>10.9/0.0>0.0	COSV52144592	PLOD1|0.00|0.00|0.00|0.00|5|-32|-12|12	25741868,35140610,20357209,20072119,19442614,21527992	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11950721	11950721	A	G	het	het	hom		QUAL=24;DP=36,13,8;AF=0.50,0.46,1.00	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron4/18:c.466+201A>G::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1265885 [benign DISEASE=not provided GENE=PLOD1];		L2 (LINE/L2)	rs60895266	0.55652	0.70198,0.45179,0.70667,0.48214,0.66750	24608,	35336	67378	0.1120	4.81			/0.0>0.0/0.0>0.0		PLOD1|0.04|0.00|0.00|0.00|-33|2|-48|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11952923	11952923	G	A	het	het	het		QUAL=24;DP=44,18,15;AF=0.52,0.44,0.40	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron5/18:c.579+188G>A::	regulatory_region_variant:open_chromatin_region	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1290288 [benign DISEASE=not provided GENE=PLOD1];		MLT1A0 (LTR/ERVL-MaLR)	rs58495963	0.28141	0.12289,0.30535,0.40973,0.33154,0.44352	7073,	28643	109261	0.3250	6.80			/0.0>0.0/0.0>0.0		PLOD1|0.00|0.00|0.00|0.00|2|5|5|45	35501403	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11955097	11955097	G	A	het	het	het		QUAL=24;DP=86,74,54;AF=0.60,0.54,0.44	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron6/18:c.643+204G>A::	regulatory_region_variant:enhancer	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1250242 [benign DISEASE=not provided GENE=PLOD1];			rs2273288	0.28208	0.12597,0.30543,0.40753,0.33138,0.44302	7087,	28764	109282	-0.9050	1.33			/0.0>0.0/6.4>7.5		PLOD1|0.00|0.00|0.01|0.00|-3|41|-3|40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11958321	11958321	C	G	het	het	het		QUAL=24;DP=17,11,10;AF=0.41,0.73,0.50	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron8/18:c.844-195C>G::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1231062 [benign DISEASE=not provided GENE=PLOD1];			rs2273290	0.28101	0.12270,0.30500,0.40279,0.33141,0.44163	7051,	28602	109260	-0.5240	2.29			/4.1>2.6/0.0>0.0		PLOD1|0.02|0.00|0.00|0.00|-18|6|39|-19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11964178	11964178	C	T	het	het	het		QUAL=25;DP=18,53,36;AF=0.56,0.53,0.39	PLOD1	synonymous	PLOD1:ENST00000196061.5:synonymous_variant:LOW:exon12/19:c.1206C>T:p.Asn402=:		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	255799 [benign DISEASE=Familial thoracic aortic aneurysm and aortic dissection,Ehlers-Danlos syndrome, kyphoscoliotic type 1,not provided,not specified GENE=PLOD1];			rs1130529	0.33122	0.29489,0.31984,0.39570,0.32525,0.45042	8723,	32890	101638	-0.7380	6.93			/0.0>0.0/2.5>1.6	COSV52140468	PLOD1|0.00|0.00|0.00|0.00|-20|-42|-21|-4	25741868,20357209,19442614,21527992,37203300	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11965296	11965296	T	C	het	het	hom		QUAL=24;DP=36,26,21;AF=0.53,0.46,1.00	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron13/18:c.1471-184T>C::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1263662 [benign DISEASE=not provided GENE=PLOD1];		L2b (LINE/L2)	rs2273291	0.57769	0.80836,0.46522,0.68191,0.46885,0.65742	27365,	32997	64131	-2.0320	0.56			/5.8>6.0/0.0>0.0		PLOD1|0.02|0.00|0.00|0.00|-31|9|36|-3	20357209,19442614,21527992,29273593	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11967147	11967147	C	T	het	het	hom		QUAL=24;DP=42,211,205;AF=0.48,0.52,1.00	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron16/18:c.1755+56C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site,TF_binding_site_variant	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1297286 [benign DISEASE=not provided GENE=PLOD1];			rs2273293	0.50395	0.57489,0.43487,0.63808,0.46132,0.62915	19909,	36774	75390	-3.2240	0.75			/0.0>0.0/0.0>0.0	COSV52142788	PLOD1|0.00|0.00|0.00|0.00|28|-23|-5|22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11967251	11967251	G	A	het	het	hom		QUAL=24;DP=151,82,82;AF=0.58,0.61,1.00	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron16/18:c.1755+160G>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1285712 [benign DISEASE=not provided GENE=PLOD1];			rs3818157	0.50583	0.57594,0.43515,0.63564,0.46456,0.62917	20013,	36726	74984	0.7040	2.37			/0.0>0.0/0.0>0.0		PLOD1|0.01|0.00|0.00|0.00|-16|-13|-16|-13	19005574,21937999,21527992	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11970938	11970938	A	G	het	het	hom	low_conf_region	QUAL=25;DP=29,31,26;AF=0.45,0.29,0.81	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron17/18:c.1902+122A>G::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1257523 [benign DISEASE=not provided GENE=PLOD1];			rs59235751	0.42475	0.62511,0.40793,0.65977,0.35425,0.65039	2948,	6522	16818	0.3120	0.41			/0.0>0.0/2.4>0.7		PLOD1|0.00|0.00|0.00|0.00|-2|2|-45|40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11973056	11973056	A	G	het	het	hom		QUAL=24;DP=134,264,209;AF=0.52,0.48,1.00	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron18/18:c.2028+59A>G::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1278494 [benign DISEASE=not provided GENE=PLOD1];			rs3737961	0.56720	0.77615,0.46240,0.67997,0.46723,0.65849	26109,	33681	65545	-0.1100	2.76			/0.0>0.0/0.2>0.0	COSV52144992	PLOD1|0.00|0.00|0.00|0.00|39|14|-9|38		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11973063	11973063	G	C	het	het	hom		QUAL=24;DP=115,252,199;AF=0.57,0.48,0.99	PLOD1	intron	PLOD1:ENST00000196061.5:intron_variant:MODIFIER:intron18/18:c.2028+66G>C::		153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]	1280245 [benign DISEASE=not provided GENE=PLOD1];			rs3820190	0.57503	0.80375,0.46452,0.67956,0.46720,0.65911	27024,	33043	64363	0.8350	2.49			/0.0>0.0/0.2>0.5	COSV52151982	PLOD1|0.00|0.00|0.00|0.00|31|17|31|-16	32221480	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69)
chr1	11980146	11980146	A	G	wt	het	hom		QUAL=24;DP=24,24,20;AF=0.42,0.46,1.00	PLOD1,MFN2	downstream_gene,upstream_gene	PLOD1:ENST00000196061.5:downstream_gene_variant:MODIFIER::::,MFN2:ENST00000444836.5:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000674817.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675053.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675817.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675298.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000674548.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000674658.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000674910.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675231.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675113.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000235329.10:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675919.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000676293.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]&608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1290963 [benign DISEASE=not provided GENE=MFN2];			rs2236053	0.50150	0.59052,0.42788,0.64009,0.44826,0.62448	19734,	36647	75659	-0.8990	1.74							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11980267	11980267	A	G	het	het	hom		QUAL=24;DP=30,123,101;AF=0.47,0.36,1.00	MFN2,PLOD1	5'UTR,downstream_gene,upstream_gene	MFN2:ENST00000444836.5:5_prime_UTR_variant:MODIFIER:exon1/18:c.-222A>G::,MFN2:ENST00000674817.1:5_prime_UTR_variant:MODIFIER:exon1/18:c.-222A>G::,MFN2:ENST00000675053.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-270A>G::,MFN2:ENST00000675817.1:5_prime_UTR_variant:MODIFIER:exon1/20:c.-367A>G::,MFN2:ENST00000675298.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-367A>G::,MFN2:ENST00000674548.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-312A>G::,PLOD1:ENST00000196061.5:downstream_gene_variant:MODIFIER::::,MFN2:ENST00000674658.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000674910.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675231.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675113.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000235329.10:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675919.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000676293.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]&608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292362 [benign DISEASE=Ehlers-Danlos syndrome, kyphoscoliotic type 1,Hereditary motor and sensory neuropathy,not provided,Hereditary motor and sensory neuropathy with optic atrophy,Charcot-Marie-Tooth disease type 2 GENE=MFN2];			rs2236054	0.50662	0.61052,0.42961,0.64016,0.44744,0.62344	20267,	36435	74957	-0.9010	1.54			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11980422	11980422	T	C	het	het	hom		QUAL=24;DP=54,128,113;AF=0.44,0.43,1.00	MFN2,PLOD1	5'UTR,downstream_gene,upstream_gene	MFN2:ENST00000444836.5:5_prime_UTR_variant:MODIFIER:exon1/18:c.-67T>C::,MFN2:ENST00000674817.1:5_prime_UTR_variant:MODIFIER:exon1/18:c.-67T>C::,MFN2:ENST00000675053.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-115T>C::,MFN2:ENST00000675817.1:5_prime_UTR_variant:MODIFIER:exon1/20:c.-212T>C::,MFN2:ENST00000675298.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-212T>C::,MFN2:ENST00000674548.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-157T>C::,MFN2:ENST00000674658.1:5_prime_UTR_variant:MODIFIER:exon1/18:c.-310T>C::,MFN2:ENST00000674910.1:5_prime_UTR_variant:MODIFIER:exon1/19:c.-189T>C::,MFN2:ENST00000675231.1:5_prime_UTR_variant:MODIFIER:exon1/20:c.-440T>C::,PLOD1:ENST00000196061.5:downstream_gene_variant:MODIFIER::::,MFN2:ENST00000675113.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000235329.10:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000675919.1:upstream_gene_variant:MODIFIER::::,MFN2:ENST00000676293.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	153454_[GENE=PLOD1_PHENOS=Ehlers-Danlos syndrome, kyphoscoliotic type, 1, 225400 (3), Autosomal recessive]&608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292368 [benign DISEASE=Ehlers-Danlos syndrome, kyphoscoliotic type 1,not provided,Hereditary motor and sensory neuropathy,Hereditary motor and sensory neuropathy with optic atrophy,Charcot-Marie-Tooth disease type 2 GENE=MFN2];			rs2180183	0.53266	0.69310,0.44115,0.68233,0.44803,0.63429	22824,	35321	71041	-0.2290	7.25			/4.1>3.4/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PLOD1 (inh=AR oe_syn=1.04 oe_mis=0.95 oe_lof=0.69), MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11982204	11982204	A	G	het	het	hom		QUAL=24;DP=194,154,102;AF=0.53,0.49,1.00	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron1/17:c.-5+1720A>G::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron1/17:c.-5+1720A>G::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron2/18:c.-5+90A>G::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron2/19:c.-5+90A>G::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron2/18:c.-5+90A>G::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron1/18:c.-95+1720A>G::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron2/17:c.-103+90A>G::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron1/18:c.-127+1720A>G::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron2/19:c.-73+90A>G::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron2/19:c.-67+90A>G::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron2/18:c.-5+90A>G::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron2/19:c.-95+90A>G::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron2/19:c.-127+90A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:open_chromatin_region	608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1279097 [benign DISEASE=not provided GENE=MFN2];			rs2236055	0.57139	0.78309,0.46308,0.67995,0.47040,0.60947	26561,	33723	65145	1.7780	14.51			/0.0>0.0/0.0>0.0			20940517,26816493,28513770,32782719,30940795,34469753,34594039,37522325	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11992348	11992348	G	A	hom	hom	hom		QUAL=24;DP=127,31,38;AF=1.00,1.00,1.00	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron2/17:c.176-207G>A::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron2/17:c.176-207G>A::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron3/18:c.176-207G>A::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron3/19:c.176-207G>A::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron3/18:c.176-207G>A::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron3/18:c.176-207G>A::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron3/17:c.-34-3808G>A::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron3/18:c.176-207G>A::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron4/19:c.176-207G>A::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron4/19:c.176-207G>A::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron3/18:c.176-207G>A::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron4/19:c.176-207G>A::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron4/19:c.176-207G>A::		608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	683180 [benign DISEASE=not provided GENE=MFN2];		MIR (SINE/MIR)	rs6675934	0.88590	0.97049,0.88021,0.99961,0.83090,0.97225	60164,	14579	17375	0.7390	2.73			/0.0>0.0/0.0>0.0		MFN2|0.00|0.00|0.00|0.00|7|-28|-17|-28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	11996383	11996383	C	T	hom	hom	hom		QUAL=24;DP=164,169,177;AF=1.00,1.00,0.99	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron4/17:c.474+65C>T::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron4/17:c.474+65C>T::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron5/18:c.474+65C>T::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron5/19:c.474+65C>T::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron5/18:c.474+65C>T::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron5/18:c.474+65C>T::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron4/17:c.129+65C>T::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron5/18:c.474+65C>T::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron6/19:c.474+65C>T::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron6/19:c.474+65C>T::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron5/18:c.474+65C>T::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron6/19:c.474+65C>T::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron6/19:c.474+65C>T::		608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1180064 [benign DISEASE=not provided GENE=MFN2];			rs2236056	0.64951	0.68589,0.54428,0.63808,0.64783,0.68180	32500,	33830	53330	-1.0310	0.39			/8.5>8.2/0.0>0.0	COSV52421940	MFN2|0.00|0.00|0.00|0.00|23|19|-21|44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12001293	12001293	G	A	het	het	wt		QUAL=24;DP=41,64,25;AF=0.49,0.44,0.00	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron7/17:c.817-108G>A::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron7/17:c.817-108G>A::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron8/18:c.817-108G>A::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron8/19:c.817-108G>A::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron8/18:c.817-108G>A::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron8/18:c.817-108G>A::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron7/17:c.472-108G>A::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron8/18:c.817-108G>A::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron9/19:c.817-108G>A::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron9/19:c.817-108G>A::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron8/18:c.817-108G>A::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron9/19:c.817-108G>A::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron9/19:c.817-108G>A::		608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	1200078 [likely benign DISEASE=not provided GENE=MFN2];		AluSx1 (SINE/Alu)	rs139807696	0.02420	0.00842,0.01464,0.00000,0.04060,0.00290	62,	3563	148643	-0.2120	0.88			/0.0>0.0/0.0>0.0		MFN2|0.00|0.00|0.00|0.00|18|47|-3|-1		23	834	0	0 / 0					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12002148	12002148	A	G	hom	hom	hom		QUAL=24;DP=92,156,139;AF=0.98,0.99,0.99	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron10/17:c.1160+45A>G::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron10/17:c.1160+45A>G::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron11/19:c.1160+45A>G::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron10/17:c.815+45A>G::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron11/18:c.1160+45A>G::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron12/19:c.1160+45A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]				rs2236057	0.64885	0.64711,0.55288,0.68168,0.66298,0.70849	32398,	33970	53450	-2.3750	0.76			/0.0>0.0/0.0>0.0	COSV52420984	MFN2|0.00|0.00|0.00|0.00|50|3|26|3	26816493,32782719,26916081,30940795,37522325	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12002304	12002304	C	G	hom	hom	hom		QUAL=24;DP=56,48,31;AF=1.00,0.98,1.00	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron10/17:c.1160+201C>G::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron10/17:c.1160+201C>G::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron11/18:c.1160+201C>G::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron11/19:c.1160+201C>G::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron11/18:c.1160+201C>G::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron11/18:c.1160+201C>G::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron10/17:c.815+201C>G::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron11/18:c.1160+201C>G::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron12/19:c.1160+201C>G::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron12/19:c.1160+201C>G::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron11/18:c.1160+201C>G::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron12/19:c.1160+201C>G::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron12/19:c.1160+201C>G::	regulatory_region_variant:enhancer,TF_binding_site_variant	608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	683181 [benign DISEASE=not provided GENE=MFN2];			rs2236058	0.57381	0.52775,0.49856,0.55528,0.60570,0.63288	25492,	36331	64851	0.0370	4.03			/6.6>6.0/0.0>0.0		MFN2|0.00|0.00|0.00|0.00|16|36|5|-32	26816493,22778543,30940795,36827438,34163214,37522325	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12006987	12006987	T	G	hom	hom	hom		QUAL=24;DP=105,66,38;AF=1.00,0.98,1.00	MFN2	intron	MFN2:ENST00000444836.5:intron_variant:MODIFIER:intron15/17:c.1873-66T>G::,MFN2:ENST00000674817.1:intron_variant:MODIFIER:intron15/17:c.1873-66T>G::,MFN2:ENST00000675053.1:intron_variant:MODIFIER:intron16/18:c.1873-66T>G::,MFN2:ENST00000675817.1:intron_variant:MODIFIER:intron17/19:c.2005-66T>G::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron16/18:c.1873-66T>G::,MFN2:ENST00000674548.1:intron_variant:MODIFIER:intron16/18:c.1873-66T>G::,MFN2:ENST00000674658.1:intron_variant:MODIFIER:intron15/17:c.1528-66T>G::,MFN2:ENST00000674910.1:intron_variant:MODIFIER:intron16/18:c.1873-66T>G::,MFN2:ENST00000675231.1:intron_variant:MODIFIER:intron17/19:c.1873-66T>G::,MFN2:ENST00000675113.1:intron_variant:MODIFIER:intron17/19:c.1873-66T>G::,MFN2:ENST00000235329.10:intron_variant:MODIFIER:intron16/18:c.1873-66T>G::,MFN2:ENST00000675919.1:intron_variant:MODIFIER:intron17/19:c.1873-66T>G::,MFN2:ENST00000676293.1:intron_variant:MODIFIER:intron17/19:c.1873-66T>G::		608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	676150 [benign DISEASE=not provided GENE=MFN2];			rs7550536	0.54439	0.44161,0.48901,0.55556,0.59662,0.62090	23205,	36376	69284	-0.1560	0.79			/0.0>0.7/0.7>6.4	COSV52424175	MFN2|0.02|0.00|0.04|0.00|46|13|-5|-2	20031578	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12011623	12011623	A	G	hom	hom	hom		QUAL=24;DP=119,337,325;AF=0.98,1.00,0.99	MFN2	3'UTR,intron	MFN2:ENST00000444836.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::,MFN2:ENST00000674817.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::,MFN2:ENST00000675053.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000675817.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron18/18:c.2204+1897A>G::,MFN2:ENST00000674548.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000674658.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*58A>G::,MFN2:ENST00000674910.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000675231.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:ENST00000675113.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:ENST00000235329.10:3_prime_UTR_variant:MODIFIER:exon19/19:c.*58A>G::,MFN2:ENST00000675919.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::,MFN2:ENST00000676293.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*58A>G::		608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292381 [benign DISEASE=Charcot-Marie-Tooth disease type 2,not specified,Hereditary motor and sensory neuropathy with optic atrophy,not provided GENE=MFN2];			rs1042842	0.70831	0.84879,0.58244,0.69279,0.66389,0.70497	39062,	29617	44369	-0.7360	0.16			/7.2>7.6/0.7>0.0	COSV52422477	MFN2|0.00|0.00|0.00|0.00|16|-26|-1|1	29352517,17940179,21686698	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	12012461	12012461	G	C	hom	hom	hom		QUAL=24;DP=44,133,128;AF=0.98,1.00,1.00	MFN2	3'UTR,intron	MFN2:ENST00000444836.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*896G>C::,MFN2:ENST00000674817.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*896G>C::,MFN2:ENST00000675053.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000675817.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:ENST00000675298.1:intron_variant:MODIFIER:intron18/18:c.2205-1796G>C::,MFN2:ENST00000674548.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000674658.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*896G>C::,MFN2:ENST00000674910.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000675231.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:ENST00000675113.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:ENST00000235329.10:3_prime_UTR_variant:MODIFIER:exon19/19:c.*896G>C::,MFN2:ENST00000675919.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::,MFN2:ENST00000676293.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*896G>C::	regulatory_region_variant:enhancer	608507_[GENE=MFN2_PHENOS=Lipomatosis, multiple symmetric, with or without peripheral neuropathy, 151800 (3), Autosomal recessive; Charcot-Marie-Tooth disease, axonal, type 2A2A, 609260 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2A2B, 617087 (3), Autosomal recessive; Hereditary motor and sensory neuropathy VIA, 601152 (3), Autosomal dominant]	292393 [benign DISEASE=Charcot-Marie-Tooth disease type 2,not provided,Hereditary motor and sensory neuropathy with optic atrophy GENE=MFN2];			rs3088064	0.55448	0.46605,0.49391,0.59290,0.59968,0.62641	23928,	36355	67663	0.1930	4.93			/2.1>3.7/0.0>0.0		MFN2|0.00|0.00|0.00|0.00|11|-8|-9|-34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MFN2 (inh=AR+AD oe_syn=1.05 oe_mis=0.77 oe_lof=0.13)
chr1	16044572	16044572	G	T	het	hom	n/a		QUAL=24;DP=4,5,1;AF=0.75,1.00,0.00	CLCNKB,FAM131C2P	missense,upstream_gene	CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon5/23:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon2/20:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon3/21:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon4/22:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon2/20:c.80G>T:p.Arg27Leu:,CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon2/20:c.80G>T:p.Arg27Leu:,FAM131C2P:ENST00000447882.1:upstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375667.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447107 [benign DISEASE=not specified,Bartter disease type 3,Bartter disease type 4B,not provided GENE=CLCNKB];			rs2015352	0.54802	0.30038,0.66697,0.66414,0.64114,0.68263	24645,	33914	68624	0.0080	18.57	0.295	0.12	/1.6>2.6/0.0>0.0	COSV65159885	CLCNKB|0.00|0.00|0.00|0.00|-19|-22|11|31	32327693,23550235,16109321	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FAM131C2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16045377	16045377	C	G	het	hom	het		QUAL=25;DP=70,40,36;AF=0.56,1.00,0.50	CLCNKB	intron,upstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron5/22:c.101-181C>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron2/19:c.101-181C>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron3/20:c.101-181C>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron4/21:c.101-181C>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron2/19:c.101-181C>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron2/19:c.101-181C>G::,CLCNKB:ENST00000375667.7:upstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1287171 [benign DISEASE=not provided GENE=CLCNKB];			rs6604908	0.54515	0.27960,0.66540,0.70453,0.64176,0.71242	24686,	33487	69135	-0.8840	0.15			/1.9>0.0/0.0>0.0	COSV65160125	CLCNKB|0.00|0.00|0.00|0.00|-41|35|25|-46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16045437	16045437	A	C	hom	hom	hom		QUAL=24;DP=55,76,77;AF=1.00,1.00,1.00	CLCNKB	intron,upstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron5/22:c.101-121A>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron2/19:c.101-121A>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron3/20:c.101-121A>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron4/21:c.101-121A>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron2/19:c.101-121A>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron2/19:c.101-121A>C::,CLCNKB:ENST00000375667.7:upstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1183407 [benign DISEASE=not provided GENE=CLCNKB];			rs6604909	0.82709	0.54421,0.90297,0.99961,0.94151,0.93831	54480,	16902	26312	-1.9550	1.54			/0.0>0.0/0.0>0.0		CLCNKB|0.05|0.00|0.00|0.00|30|50|30|-35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16045508	16045508	G	C	het	hom	het		QUAL=25;DP=54,149,129;AF=0.43,1.00,0.48	CLCNKB	intron,upstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron5/22:c.101-50G>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron2/19:c.101-50G>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron3/20:c.101-50G>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron4/21:c.101-50G>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron2/19:c.101-50G>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron2/19:c.101-50G>C::,CLCNKB:ENST00000375667.7:upstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209775 [benign DISEASE=Bartter disease type 3,not provided,Bartter disease type 4B GENE=CLCNKB];			rs6604910	0.54496	0.27965,0.66582,0.70295,0.64163,0.71114	24677,	33518	69198	-0.4740	5.18			/0.0>0.0/0.0>0.0	COSV65160072	CLCNKB|0.00|0.00|0.00|0.00|50|-41|50|49	17652939	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16045788	16045788	T	G	hom	hom	wt		QUAL=24;DP=9,67,18;AF=1.00,1.00,1.00	CLCNKB	intron,upstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron6/22:c.229+102T>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron3/19:c.229+102T>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron4/20:c.229+102T>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron5/21:c.229+102T>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron3/19:c.229+102T>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron3/19:c.229+102T>G::,CLCNKB:ENST00000375667.7:upstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1281750 [benign DISEASE=not provided GENE=CLCNKB];			rs6604911	0.65608	0.40596,0.73747,0.76935,0.72889,0.77119	24063,	33257	42661	0.0300	7.63			/0.0>0.0/0.0>0.0		CLCNKB|0.00|0.00|0.01|0.00|-16|-23|-23|-37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16046416	16046416	G	A	hom	hom	hom		QUAL=24;DP=99,92,88;AF=0.98,1.00,1.00	CLCNKB	intron,upstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron6/22:c.230-119G>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron3/19:c.230-119G>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron4/20:c.230-119G>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron5/21:c.230-119G>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron3/19:c.230-119G>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron3/19:c.230-119G>A::,CLCNKB:ENST00000375667.7:upstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1279049 [benign DISEASE=not provided GENE=CLCNKB];			rs2014848	0.70211	0.38850,0.82923,0.98776,0.80909,0.89153	40504,	25634	45246	0.3310	5.05			/0.0>0.0/0.0>1.7		CLCNKB|0.01|0.00|0.00|0.00|43|-42|-3|37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16046476	16046476	G	A	hom	hom	hom		QUAL=24;DP=80,182,142;AF=1.00,1.00,1.00	CLCNKB	intron,upstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron6/22:c.230-59G>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron3/19:c.230-59G>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron4/20:c.230-59G>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron5/21:c.230-59G>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron3/19:c.230-59G>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron3/19:c.230-59G>A::,CLCNKB:ENST00000375667.7:upstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209776 [benign DISEASE=Bartter disease type 3,not provided,Bartter disease type 4B GENE=CLCNKB];			rs2014841	0.70227	0.38862,0.82943,0.98780,0.80922,0.89189	40573,	25638	45272	0.0580	1.14			/0.0>0.0/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|-1|-17|-23|-15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16046629	16046629	A	G	hom	hom	hom		QUAL=24;DP=183,313,248;AF=0.98,1.00,1.00	CLCNKB	synonymous,upstream_gene	CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon7/23:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon4/20:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon5/21:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon6/22:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon4/20:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon4/20:c.324A>G:p.Ser108=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375667.7:upstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447104 [benign DISEASE=not specified,Bartter disease type 3,Bartter disease type 4B,not provided GENE=CLCNKB];			rs5257	0.70245	0.38909,0.82932,0.98759,0.80915,0.89189	40556,	25628	45214	-3.8900	0.18			/11.2>8.2/0.0>0.0		CLCNKB|0.23|0.00|0.00|0.05|13|2|-49|34	23550235,26045835,35107781	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16046705	16046707	CTT	-	hom	hom	het	low_conf_region	QUAL=24;DP=143,232,155;AF=0.99,0.99,0.48	CLCNKB	intron,upstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron7/22:c.358+44_358+46del::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron4/19:c.358+44_358+46del::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron5/20:c.358+44_358+46del::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron6/21:c.358+44_358+46del::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron4/19:c.358+44_358+46del::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron4/19:c.358+44_358+46del::,CLCNKB:ENST00000375667.7:upstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1280604 [benign DISEASE=not provided GENE=CLCNKB];			rs35820664	0.67585	0.36707,0.81123,0.98758,0.78018,0.86987	37683,	27213	49199	1.7440	8.04			/5.6>3.2/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|-41|9|-41|-37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16046787	16046787	A	G	hom	hom	hom		QUAL=24;DP=114,91,78;AF=0.98,1.00,1.00	CLCNKB	intron,upstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron7/22:c.358+124A>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron4/19:c.358+124A>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron5/20:c.358+124A>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron6/21:c.358+124A>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron4/19:c.358+124A>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron4/19:c.358+124A>G::,CLCNKB:ENST00000375667.7:upstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1230357 [benign DISEASE=not provided GENE=CLCNKB];		MIR3 (SINE/MIR)	rs2095540	0.70167	0.38871,0.82872,0.98761,0.80825,0.89167	40530,	25698	45390	-2.1740	0.01			/4.9>5.0/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|-33|4|37|4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16047835	16047835	A	G	hom	het	het	low_conf_region	QUAL=25;DP=11,5,4;AF=1.00,1.00,1.00	CLCNKB	intron,upstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron7/22:c.359-70A>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron4/19:c.359-70A>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron5/20:c.359-70A>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron6/21:c.359-70A>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron4/19:c.359-70A>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron4/19:c.359-70A>G::,CLCNKB:ENST00000375667.7:upstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209691 [benign DISEASE=Bartter disease type 3,not provided,Bartter disease type 4B GENE=CLCNKB];			rs945403	0.84451	0.60362,0.91193,0.99961,0.94169,0.93836	56065,	16359	23657	-3.8870	0.49			/2.7>2.3/0.0>0.0		CLCNKB|0.00|0.00|0.03|0.00|-41|6|5|8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048038	16048038	G	C	het	hom	hom		QUAL=24;DP=5,3,5;AF=1.00,1.00,1.00	CLCNKB	synonymous,upstream_gene	CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon8/23:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon5/20:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon6/21:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon7/22:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon5/20:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon5/20:c.492G>C:p.Gly164=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375667.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447105 [benign DISEASE=not specified,Bartter disease type 3,Bartter disease type 4B,not provided GENE=CLCNKB];			rs2014562	0.89054	0.76375,0.92792,0.99961,0.94223,0.93875	60846,	13730	16646	-0.5020	10.78			/1.8>2.0/2.6>0.0		CLCNKB|0.00|0.00|0.08|0.00|-15|6|18|-48	23550235	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048161	16048161	A	G	hom	hom	n/a		QUAL=24;DP=13,5,2;AF=1.00,1.00,1.00	CLCNKB	intron,upstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron8/22:c.498+117A>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron5/19:c.498+117A>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron6/20:c.498+117A>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron7/21:c.498+117A>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron5/19:c.498+117A>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron5/19:c.498+117A>G::,CLCNKB:ENST00000375667.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1265585 [benign DISEASE=not provided GENE=CLCNKB];		L2c (LINE/L2)	rs2902490	0.70266	0.38972,0.82961,0.98781,0.80925,0.89186	40608,	25629	45213	-0.2570	2.21			/8.4>1.1/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|22|2|-38|32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048499	16048499	C	T	hom	hom	hom	low_mappability	QUAL=24;DP=158,245,204;AF=0.99,1.00,1.00	CLCNKB	splice_region&intron,upstream_gene	CLCNKB:ENST00000684324.1:splice_region_variant&intron_variant:LOW:intron9/22:c.577-5C>T::,CLCNKB:ENST00000684545.1:splice_region_variant&intron_variant:LOW:intron6/19:c.577-5C>T::,CLCNKB:ENST00000683578.1:splice_region_variant&intron_variant:LOW:intron7/20:c.577-5C>T::,CLCNKB:ENST00000682338.1:splice_region_variant&intron_variant:LOW:intron8/21:c.577-5C>T::,CLCNKB:ENST00000682793.1:splice_region_variant&intron_variant:LOW:intron6/19:c.577-5C>T::,CLCNKB:ENST00000375679.9:splice_region_variant&intron_variant:LOW:intron6/19:c.577-5C>T::,CLCNKB:ENST00000375667.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	381050 [benign DISEASE=not specified,Bartter disease type 4B,Bartter disease type 3,not provided GENE=CLCNKB];			rs1889788	0.70035	0.38632,0.82705,0.98754,0.80758,0.88942	40346,	25718	45528	-0.3220	5.03			4.3>4.2/4.3>4.2/0.0>0.0	COSV65161773	CLCNKB|0.00|0.01|0.00|0.00|-16|5|11|47		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048568	16048568	C	G	hom	hom	hom	low_mappability	QUAL=24;DP=202,229,179;AF=1.00,1.00,1.00	CLCNKB	missense,upstream_gene	CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon10/23:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon7/20:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon8/21:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon9/22:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon7/20:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon7/20:c.641C>G:p.Ala214Gly:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375667.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	504916 [benign DISEASE=not specified,Bartter disease type 4B,Bartter disease type 3,not provided GENE=CLCNKB];			rs1889789	0.82553	0.57071,0.89606,0.99922,0.92409,0.93625	53689,	17897	26477	-0.2280	5.53	0.215	0.06	/2.5>1.6/0.0>0.0	COSV65159497	CLCNKB|0.00|0.00|0.00|0.00|-30|-6|14|11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048569	16048569	A	C	hom	hom	hom	low_mappability	QUAL=25;DP=205,225,178;AF=0.99,1.00,1.00	CLCNKB	synonymous,upstream_gene	CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon10/23:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon7/20:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon8/21:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon9/22:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon7/20:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon7/20:c.642A>C:p.Ala214=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375667.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	504915 [benign DISEASE=not specified,Bartter disease type 4B,Bartter disease type 3,not provided GENE=CLCNKB];			rs1889790	0.82555	0.57083,0.89599,0.99922,0.92408,0.93628	53688,	17898	26472	-2.9260	0.64			/2.5>8.8/0.0>0.0	COSV65161020	CLCNKB|0.00|0.00|0.00|0.02|12|-31|12|13		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048715	16048715	G	A	het	hom	wt		QUAL=24;DP=96,100,89;AF=0.48,0.99,0.00	CLCNKB	intron,upstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron10/22:c.655+133G>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron7/19:c.655+133G>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron8/20:c.655+133G>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron9/21:c.655+133G>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron7/19:c.655+133G>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron7/19:c.655+133G>A::,CLCNKB:ENST00000375667.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1290690 [benign DISEASE=not provided GENE=CLCNKB];			rs9633514	0.29850	0.10570,0.36291,0.70419,0.36128,0.37432	8210,	28914	106540	0.0370	4.90			/2.2>0.0/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|-10|7|38|-39	32888494	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16048859	16048859	C	T	hom	hom	hom		QUAL=24;DP=170,237,201;AF=1.00,1.00,1.00	CLCNKB	intron,5'UTR	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron10/22:c.656-261C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron7/19:c.656-261C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron8/20:c.656-261C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron9/21:c.656-261C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron7/19:c.656-261C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron7/19:c.656-261C>T::,CLCNKB:ENST00000375667.7:5_prime_UTR_variant:MODIFIER:exon1/13:c.-113C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1259614 [benign DISEASE=not provided GENE=CLCNKB];		MIR (SINE/MIR)	rs9442227	0.69092	0.37107,0.81452,0.98782,0.79921,0.88942	39502,	26090	47014	0.4180	7.37			/0.6>1.5/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|18|1|-40|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049343	16049343	C	G	hom	hom	hom		QUAL=25;DP=22,17,14;AF=1.00,1.00,1.00	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron11/22:c.781+98C>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron8/19:c.781+98C>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron9/20:c.781+98C>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron10/21:c.781+98C>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron8/19:c.781+98C>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron8/19:c.781+98C>G::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron1/12:c.274+98C>G::	regulatory_region_variant:open_chromatin_region	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1279349 [benign DISEASE=not provided GENE=CLCNKB];			rs7545067	0.71197	0.39492,0.83388,0.98779,0.82261,0.89344	41719,	24865	43815	-2.2830	0.34			/0.0>2.5/0.0>0.0	COSV65162067	CLCNKB|0.00|0.00|0.00|0.00|1|49|-1|-25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049696	16049696	C	T	hom	hom	hom		QUAL=24;DP=179,405,313;AF=0.99,1.00,1.00	CLCNKB	missense	CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon12/23:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon9/20:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon10/21:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon11/22:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon9/20:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon9/20:c.860C>T:p.Ala287Val:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375667.7:missense_variant:MODERATE:exon2/13:c.353C>T:p.Ala118Val:PF00654 [Voltage gated chloride channel]	regulatory_region_variant:open_chromatin_region	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447108 [benign DISEASE=not specified,Bartter disease type 3,Bartter disease type 4B,not provided GENE=CLCNKB];			rs7367494	0.83460	0.56921,0.90672,0.99782,0.94113,0.93663	54696,	16567	24963	-0.1040	0.09	0.221	0.06	/0.0>0.3/0.0>0.0	COSV65159503	CLCNKB|0.00|0.00|0.01|0.00|-16|-50|-2|10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049735	16049735	-	T	hom	hom	hom		QUAL=24;DP=102,467,355;AF=0.97,0.99,0.99	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron12/22:c.866+33_866+34insT::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron9/19:c.866+33_866+34insT::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron10/20:c.866+33_866+34insT::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron11/21:c.866+33_866+34insT::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron9/19:c.866+33_866+34insT::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron9/19:c.866+33_866+34insT::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron2/12:c.359+33_359+34insT::	regulatory_region_variant:open_chromatin_region	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1277184 [benign DISEASE=not provided GENE=CLCNKB];			rs59006537	0.83447	0.56851,0.90697,0.99902,0.94122,0.93763	54726,	16596	25004		0.05			/0.3>0.9/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|4|18|-29|-33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049737	16049737	A	T	hom	hom	hom		QUAL=24;DP=94,456,353;AF=1.00,1.00,1.00	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron12/22:c.866+35A>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron9/19:c.866+35A>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron10/20:c.866+35A>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron11/21:c.866+35A>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron9/19:c.866+35A>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron9/19:c.866+35A>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron2/12:c.359+35A>T::	regulatory_region_variant:open_chromatin_region	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209692 [benign DISEASE=Bartter disease type 3,not provided,Bartter disease type 4B GENE=CLCNKB];			rs59924562	0.83446	0.56854,0.90704,0.99902,0.94124,0.93763	54752,	16603	25017	-2.4980	0.51			/0.3>3.2/0.0>0.0	COSV65161540	CLCNKB|0.01|0.00|0.00|0.00|16|2|-31|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049744	16049744	C	-	hom	hom	hom		QUAL=24;DP=97,472,359;AF=0.99,0.99,0.96	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron12/22:c.866+47del::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron9/19:c.866+47del::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron10/20:c.866+47del::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron11/21:c.866+47del::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron9/19:c.866+47del::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron9/19:c.866+47del::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron2/12:c.359+47del::	regulatory_region_variant:open_chromatin_region	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209750 [benign DISEASE=not provided,Bartter disease type 3,Bartter disease type 4B GENE=CLCNKB];			rs34589727	0.83486	0.56945,0.90733,0.99921,0.94125,0.93763	54785,	16554	24948	-0.1770	1.22			/0.3>0.7/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|49|10|-37|-41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049783	16049783	G	A	hom	hom	hom		QUAL=24;DP=142,502,364;AF=0.99,1.00,1.00	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron12/22:c.867-32G>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron9/19:c.867-32G>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron10/20:c.867-32G>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron11/21:c.867-32G>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron9/19:c.867-32G>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron9/19:c.867-32G>A::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron2/12:c.360-32G>A::	regulatory_region_variant:open_chromatin_region	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209751 [benign DISEASE=not provided,Bartter disease type 3,Bartter disease type 4B GENE=CLCNKB];			rs7365182	0.83277	0.56303,0.90651,0.99961,0.94134,0.93693	54771,	16732	25358	0.7450	8.19			/0.0>1.2/0.0>0.4		CLCNKB|0.02|0.00|0.00|0.00|2|32|-4|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049824	16049824	T	C	hom	hom	hom		QUAL=24;DP=181,484,361;AF=1.00,1.00,1.00	CLCNKB	synonymous	CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon13/23:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon10/20:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon11/21:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon12/22:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon10/20:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon10/20:c.876T>C:p.Cys292=:PF00654 [Voltage gated chloride channel],CLCNKB:ENST00000375667.7:synonymous_variant:LOW:exon3/13:c.369T>C:p.Cys123=:PF00654 [Voltage gated chloride channel]	regulatory_region_variant:open_chromatin_region	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	377683 [benign DISEASE=Bartter disease type 4B,Bartter disease type 3,not provided,not specified GENE=CLCNKB];			rs7368151	0.83457	0.56968,0.90667,0.99942,0.94126,0.93724	55003,	16657	25107	-4.6600	0.02			/5.7>5.8/0.0>0.0	COSV65161411	CLCNKB|0.00|0.00|0.00|0.00|-9|15|28|-45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049963	16049963	T	C	hom	hom	hom		QUAL=24;DP=130,260,183;AF=0.99,1.00,1.00	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron13/22:c.968+47T>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron10/19:c.968+47T>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron11/20:c.968+47T>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron12/21:c.968+47T>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron10/19:c.968+47T>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron10/19:c.968+47T>C::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron3/12:c.461+47T>C::	regulatory_region_variant:open_chromatin_region	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209752 [benign DISEASE=Bartter disease type 3,not provided,Bartter disease type 4B GENE=CLCNKB];			rs7368166	0.83244	0.56552,0.90370,0.99804,0.93889,0.93281	54396,	16908	25302	-3.1490	1.45			/0.0>0.0/0.0>0.0	COSV65161797	CLCNKB|0.00|0.00|0.00|0.00|-47|25|-47|-44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16049999	16049999	C	G	het	wt	het		QUAL=24;DP=125,90,101;AF=0.46,0.00,0.58	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron13/22:c.968+83C>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron10/19:c.968+83C>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron11/20:c.968+83C>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron12/21:c.968+83C>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron10/19:c.968+83C>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron10/19:c.968+83C>G::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron3/12:c.461+83C>G::	regulatory_region_variant:open_chromatin_region	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1288632 [benign DISEASE=not provided GENE=CLCNKB];			rs72651918	0.35869	0.14927,0.47055,0.58340,0.47278,0.50825	1924,	18748	40400	-1.0310	5.09			/0.0>0.0/0.0>0.0	COSV65161943	CLCNKB|0.00|0.00|0.00|0.00|-11|30|43|-32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16050336	16050336	C	T	hom	hom	hom		QUAL=25;DP=36,44,40;AF=1.00,1.00,1.00	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron13/22:c.969-180C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron10/19:c.969-180C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron11/20:c.969-180C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron12/21:c.969-180C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron10/19:c.969-180C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron10/19:c.969-180C>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron3/12:c.462-180C>T::	regulatory_region_variant:open_chromatin_region	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1249220 [benign DISEASE=not provided GENE=CLCNKB];			rs10803412	0.71286	0.39237,0.83473,0.98797,0.82449,0.89315	41852,	24671	43653	-0.3660	3.93			/2.3>2.6/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|-35|17|37|1	20975947,33398198	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16052154	16052154	C	G	het	wt	het		QUAL=24;DP=19,11,19;AF=0.58,0.00,0.68	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron17/22:c.1409-44C>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron14/19:c.1409-44C>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron15/20:c.1409-44C>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron16/21:c.1409-44C>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron14/19:c.1409-44C>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron14/19:c.1409-44C>G::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron7/12:c.902-44C>G::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1232843 [benign DISEASE=not provided GENE=CLCNKB];			rs2297726	0.14530	0.06959,0.15736,0.27875,0.16724,0.17986	1849,	18426	130140	0.0340	9.46			/0.0>0.0/0.0>0.0	COSV65160804	CLCNKB|0.00|0.00|0.00|0.00|17|-40|-35|17		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16052513	16052513	C	T	hom	hom	hom		QUAL=24;DP=11,8,4;AF=1.00,1.00,1.00	CLCNKB	intron	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron18/22:c.1622+102C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron15/19:c.1622+102C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron16/20:c.1622+102C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron17/21:c.1622+102C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron15/19:c.1622+102C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron15/19:c.1622+102C>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron8/12:c.1115+102C>T::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1252498 [benign DISEASE=not provided GENE=CLCNKB];		MIR3 (SINE/MIR)	rs2050522	0.72001	0.41538,0.84009,0.98800,0.82448,0.89315	42306,	24878	42578	-2.4820	0.23			/0.0>0.0/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|23|50|50|24	23550235,17652939	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93)
chr1	16053701	16053701	T	C	hom	hom	hom		QUAL=24;DP=300,372,251;AF=1.00,1.00,1.00	CLCNKB,FAM131C	missense,downstream_gene	CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon19/23:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon16/20:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon17/21:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon18/22:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon16/20:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon16/20:c.1685T>C:p.Met562Thr:PF00571 [CBS domain],CLCNKB:ENST00000375667.7:missense_variant:MODERATE:exon9/13:c.1178T>C:p.Met393Thr:PF00571 [CBS domain],FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447094 [benign DISEASE=not provided,Bartter disease type 3,Bartter disease type 4B,not specified GENE=CLCNKB];			rs5253	0.88769	0.69595,0.92816,0.81952,0.98491,0.91947	61143,	12772	17088	-1.3380	0.02	0.279	0.06	/0.0>0.0/0.0>0.0			25919862,23550235,36305246	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16053748	16053748	A	G	hom	hom	het		QUAL=25;DP=139,314,232;AF=1.00,0.99,0.42	CLCNKB,FAM131C	missense,downstream_gene	CLCNKB:ENST00000684324.1:missense_variant:MODERATE:exon19/23:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000684545.1:missense_variant:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000683578.1:missense_variant:MODERATE:exon17/21:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000682338.1:missense_variant:MODERATE:exon18/22:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000682793.1:missense_variant:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000375679.9:missense_variant:MODERATE:exon16/20:c.1732A>G:p.Lys578Glu:PF00571 [CBS domain],CLCNKB:ENST00000375667.7:missense_variant:MODERATE:exon9/13:c.1225A>G:p.Lys409Glu:PF00571 [CBS domain],FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447096 [benign DISEASE=not provided,Bartter disease type 3,Bartter disease type 4B,not specified GENE=CLCNKB];	CM1514575 [CLASS=DM? MUT=ALT PHEN="Migraine without aura" GENE=CLCNKB];		rs2275166	0.69464	0.79818,0.57601,0.80598,0.66105,0.58184	37137,	31152	46344	1.0120	4.06	0.158	0.05	/0.0>0.0/0.5>0.0		CLCNKB|0.00|0.00|0.00|0.00|-8|1|24|1	25919862,23550235,36305246	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16053757	16053757	C	T	hom	hom	het		QUAL=24;DP=125,303,219;AF=1.00,1.00,0.43	CLCNKB,FAM131C	synonymous,downstream_gene	CLCNKB:ENST00000684324.1:synonymous_variant:LOW:exon19/23:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000684545.1:synonymous_variant:LOW:exon16/20:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000683578.1:synonymous_variant:LOW:exon17/21:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000682338.1:synonymous_variant:LOW:exon18/22:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000682793.1:synonymous_variant:LOW:exon16/20:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000375679.9:synonymous_variant:LOW:exon16/20:c.1741C>T:p.Leu581=:PF00571 [CBS domain],CLCNKB:ENST00000375667.7:synonymous_variant:LOW:exon9/13:c.1234C>T:p.Leu412=:PF00571 [CBS domain],FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	447097 [benign DISEASE=not provided,Bartter disease type 3,Bartter disease type 4B,not specified GENE=CLCNKB];			rs2275167	0.62042	0.58467,0.53396,0.79950,0.64558,0.53121	29525,	35085	57593	0.5150	13.58			/0.0>0.0/0.0>0.0	COSV65152867	CLCNKB|0.00|0.00|0.31|0.00|-8|-17|-8|47	23550235	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16053908	16053908	A	T	hom	hom	het		QUAL=24;DP=63,96,108;AF=1.00,1.00,0.47	CLCNKB,FAM131C	intron,downstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron19/22:c.1756+136A>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron16/19:c.1756+136A>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron17/20:c.1756+136A>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron18/21:c.1756+136A>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron16/19:c.1756+136A>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron16/19:c.1756+136A>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron9/12:c.1249+136A>T::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:TF_binding_site	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1231115 [benign DISEASE=not provided GENE=CLCNKB];		MIRb (SINE/MIR)	rs2275168	0.55323	0.34908,0.49357,0.80857,0.65173,0.52024	24849,	34244	67788	-0.1600	4.07			/0.0>0.0/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|-30|28|-10|26		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16055227	16055227	C	T	hom	hom	het		QUAL=24;DP=48,23,23;AF=1.00,1.00,0.39	CLCNKB,FAM131C	intron,downstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron19/22:c.1757-208C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron16/19:c.1757-208C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron17/20:c.1757-208C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron18/21:c.1757-208C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron16/19:c.1757-208C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron16/19:c.1757-208C>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron9/12:c.1250-208C>T::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1251205 [benign DISEASE=not provided GENE=CLCNKB];		MIR (SINE/MIR)	rs12691552	0.40573	0.22865,0.41544,0.80407,0.46717,0.44338	13718,	34227	90317	0.2610	9.53			/0.0>0.0/0.0>0.0	COSV65153247	CLCNKB|0.00|0.00|0.00|0.00|-17|-50|-49|25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16055297	16055297	T	A	hom	hom	het		QUAL=25;DP=29,46,43;AF=1.00,1.00,0.33	CLCNKB,FAM131C	intron,downstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron19/22:c.1757-138T>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron16/19:c.1757-138T>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron17/20:c.1757-138T>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron18/21:c.1757-138T>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron16/19:c.1757-138T>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron16/19:c.1757-138T>A::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron9/12:c.1250-138T>A::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1295187 [benign DISEASE=not provided GENE=CLCNKB];		MIR (SINE/MIR)	rs12047858	0.42524	0.29635,0.42031,0.80430,0.46779,0.44357	14496,	35600	87304	-0.4460	0.27			/2.8>0.9/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|12|32|-9|12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16055321	16055321	C	T	hom	hom	het		QUAL=24;DP=40,57,43;AF=1.00,1.00,0.35	CLCNKB,FAM131C	intron,downstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron19/22:c.1757-114C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron16/19:c.1757-114C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron17/20:c.1757-114C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron18/21:c.1757-114C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron16/19:c.1757-114C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron16/19:c.1757-114C>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron9/12:c.1250-114C>T::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1297841 [benign DISEASE=not provided GENE=CLCNKB];		MIR (SINE/MIR)	rs12029508	0.42537	0.29661,0.42035,0.80457,0.46773,0.44334	14511,	35606	87306	-0.6690	1.57			/0.0>0.0/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|-1|40|-12|40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16055591	16055591	C	T	hom	hom	het		QUAL=24;DP=47,94,59;AF=0.98,1.00,0.51	CLCNKB,FAM131C	intron,downstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron20/22:c.1845+68C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron17/19:c.1845+68C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron18/20:c.1845+68C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron19/21:c.1845+68C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron17/19:c.1845+68C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron17/19:c.1845+68C>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron10/12:c.1338+68C>T::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1229089 [benign DISEASE=not provided GENE=CLCNKB];			rs2297727	0.42542	0.29793,0.41992,0.80510,0.46741,0.44192	14487,	35531	87121	-1.2050	0.19			/0.0>0.0/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|29|9|20|4	19058262	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056223	16056223	T	C	hom	hom	het		QUAL=24;DP=26,46,42;AF=1.00,1.00,0.48	CLCNKB,FAM131C	intron,downstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-199T>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-199T>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-199T>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-199T>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-199T>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-199T>C::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-199T>C::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1277187 [benign DISEASE=not provided GENE=CLCNKB];			rs12048851	0.43757	0.34511,0.42580,0.80273,0.46694,0.44241	14987,	36392	85304	-0.0840	5.81			/4.3>3.9/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|-8|-23|19|-9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056235	16056235	C	T	hom	hom	het		QUAL=24;DP=31,56,46;AF=1.00,1.00,0.48	CLCNKB,FAM131C	intron,downstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-187C>T::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-187C>T::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-187C>T::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-187C>T::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-187C>T::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-187C>T::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-187C>T::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1241174 [benign DISEASE=not provided GENE=CLCNKB];			rs12030469	0.41836	0.28346,0.42016,0.80214,0.46366,0.44179	14050,	35354	88218	-2.4240	1.51			/4.3>5.4/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|-20|-21|-20|-21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056296	16056296	G	C	hom	hom	het		QUAL=24;DP=48,89,77;AF=1.00,1.00,0.51	CLCNKB,FAM131C	intron,downstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-126G>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-126G>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-126G>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-126G>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-126G>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-126G>C::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-126G>C::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1295162 [benign DISEASE=not provided GENE=CLCNKB];			rs12023153	0.42179	0.28438,0.42246,0.80421,0.46730,0.44190	14311,	35366	87718	-1.7360	0.03			/2.1>3.4/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|27|-37|8|-5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056333	16056335	TCT	-	hom	hom	het		QUAL=25;DP=74,132,119;AF=0.99,0.99,0.54	CLCNKB,FAM131C	intron,downstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-87_1930-85del::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-87_1930-85del::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-87_1927-85del::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-87_1930-85del::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-87_1930-85del::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-87_1930-85del::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-87_1420-85del::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1180108 [benign DISEASE=not provided GENE=CLCNKB];			rs77508204	0.37131	0.11618,0.40013,0.80281,0.46473,0.43524	12648,	31062	95422	0.3780	5.95			/6.9>6.7/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|-9|-40|21|38		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056336	16056336	T	A	hom	hom	het		QUAL=24;DP=73,131,122;AF=0.99,1.00,0.52	CLCNKB,FAM131C	intron,downstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-86T>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-86T>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-86T>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-86T>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-86T>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-86T>A::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-86T>A::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1295221 [benign DISEASE=not provided GENE=CLCNKB];			rs61769890	0.37148	0.11627,0.40043,0.80281,0.46475,0.43560	12648,	31067	95363	-0.0050	6.03			/6.9>4.0/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|13|11|12|34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056339	16056339	T	A	hom	hom	het		QUAL=25;DP=68,134,120;AF=1.00,1.00,0.53	CLCNKB,FAM131C	intron,downstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-83T>A::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-83T>A::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-83T>A::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-83T>A::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-83T>A::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-83T>A::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-83T>A::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1266107 [benign DISEASE=not provided GENE=CLCNKB];			rs61769891	0.37139	0.11613,0.40035,0.80218,0.46477,0.43565	12647,	31074	95410	-0.3090	4.55			/6.9>7.4/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|2|-16|31|14		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056382	16056382	A	G	hom	hom	hom		QUAL=25;DP=51,171,147;AF=1.00,1.00,0.99	CLCNKB,FAM131C	intron,downstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron21/22:c.1930-40A>G::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron18/19:c.1930-40A>G::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron19/20:c.1927-40A>G::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron20/21:c.1930-40A>G::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron18/19:c.1930-40A>G::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron18/19:c.1930-40A>G::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron11/12:c.1420-40A>G::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter,TF_binding_site_variant	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209753 [benign DISEASE=Bartter disease type 3,not provided,Bartter disease type 4B GENE=CLCNKB];			rs7517792	0.76849	0.70753,0.84655,0.81561,0.78586,0.83748	45057,	26560	35148	-2.2960	0.33			/4.5>5.6/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|44|40|39|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056834	16056834	-	C	wt	hom	het	low_conf_region	QUAL=25;DP=19,17,30;AF=0.00,0.41,0.23	CLCNKB,FAM131C	intron,downstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron22/22:c.2017-29dup::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron19/19:c.2017-29dup::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron20/20:c.2014-29dup::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron21/21:c.2017-29dup::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron19/19:c.2017-29dup::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron19/19:c.2017-29dup::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron12/12:c.1507-29dup::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1246688 [benign DISEASE=not provided GENE=CLCNKB];			rs138507185	0.65999	0.43886,0.77633,0.80530,0.73355,0.79380	29221,	27029	44033		0.58			/0.9>1.7/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|11|35|35|41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056841	16056841	G	C	hom	hom	het	low_conf_region	QUAL=25;DP=9,10,32;AF=1.00,1.00,0.31	CLCNKB,FAM131C	intron,downstream_gene	CLCNKB:ENST00000684324.1:intron_variant:MODIFIER:intron22/22:c.2017-28G>C::,CLCNKB:ENST00000684545.1:intron_variant:MODIFIER:intron19/19:c.2017-28G>C::,CLCNKB:ENST00000683578.1:intron_variant:MODIFIER:intron20/20:c.2014-28G>C::,CLCNKB:ENST00000682338.1:intron_variant:MODIFIER:intron21/21:c.2017-28G>C::,CLCNKB:ENST00000682793.1:intron_variant:MODIFIER:intron19/19:c.2017-28G>C::,CLCNKB:ENST00000375679.9:intron_variant:MODIFIER:intron19/19:c.2017-28G>C::,CLCNKB:ENST00000375667.7:intron_variant:MODIFIER:intron12/12:c.1507-28G>C::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209827 [benign DISEASE=Bartter disease type 3,not provided,Bartter disease type 4B GENE=CLCNKB];			rs12746138	0.72110	0.57799,0.81545,0.81306,0.76345,0.82070	33006,	27336	36104	-2.2870	0.03			/0.9>0.0/0.0>0.0		CLCNKB|0.00|0.00|0.00|0.00|28|34|-6|28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16056953	16056953	A	C	hom	hom	hom	low_conf_region	QUAL=25;DP=214,234,241;AF=0.69,0.89,1.00	CLCNKB,FAM131C	3'UTR,downstream_gene	CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*37A>C::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*37A>C::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*37A>C::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*37A>C::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*37A>C::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*37A>C::,CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*37A>C::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]	1209828 [benign DISEASE=Bartter disease type 3,not provided,Bartter disease type 4B GENE=CLCNKB];			rs10803415	0.72700	0.64764,0.77831,0.53290,0.77373,0.69382	29969,	34922	35622	-1.8020	4.08			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057086	16057086	G	T	hom	hom	het		QUAL=24;DP=237,498,383;AF=0.85,0.79,0.51	CLCNKB,FAM131C	3'UTR,downstream_gene	CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*170G>T::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*170G>T::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*170G>T::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*170G>T::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*170G>T::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*170G>T::,CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*170G>T::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057844	0.51498	0.40710,0.61259,0.50493,0.55167,0.56498	10458,	55405	71881	-1.4160	0.58			/0.0>0.0/0.7>0.7				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057110	16057110	A	G	hom	hom	het		QUAL=25;DP=190,524,404;AF=0.74,0.76,0.53	CLCNKB,FAM131C	3'UTR,downstream_gene	CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*194A>G::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*194A>G::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*194A>G::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*194A>G::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*194A>G::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*194A>G::,CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*194A>G::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057845	0.50655	0.40244,0.60081,0.49704,0.54160,0.55381	9221,	56613	73113	-0.6030	1.46			/2.2>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057173	16057173	T	G	hom	hom	hom		QUAL=24;DP=170,546,360;AF=0.99,1.00,1.00	CLCNKB,FAM131C	3'UTR,downstream_gene	CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*257T>G::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*257T>G::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*257T>G::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*257T>G::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*257T>G::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*257T>G::,CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*257T>G::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs6660218	0.99999	1.00000,1.00000,1.00000,0.99997,1.00000	76163,	2	2	0.3150	3.27			/0.0>0.0/0.0>3.6				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057247	16057247	C	G	hom	hom	hom		QUAL=24;DP=345,516,224;AF=0.55,0.53,1.00	CLCNKB,FAM131C	3'UTR,downstream_gene	CLCNKB:ENST00000684324.1:3_prime_UTR_variant:MODIFIER:exon23/23:c.*331C>G::,CLCNKB:ENST00000684545.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*331C>G::,CLCNKB:ENST00000683578.1:3_prime_UTR_variant:MODIFIER:exon21/21:c.*331C>G::,CLCNKB:ENST00000682338.1:3_prime_UTR_variant:MODIFIER:exon22/22:c.*331C>G::,CLCNKB:ENST00000682793.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*331C>G::,CLCNKB:ENST00000375679.9:3_prime_UTR_variant:MODIFIER:exon20/20:c.*331C>G::,CLCNKB:ENST00000375667.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*331C>G::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::		602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs1057857	0.62935	0.58512,0.66820,0.49344,0.65273,0.60168	19828,	55422	55996	-0.3610	3.80	0.020		/0.0>0.0/0.0>0.0	COSV65153970			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057419	16057419	C	T	hom	het	hom		QUAL=24;DP=39,50,24;AF=0.85,0.66,0.46	CLCNKB,FAM131C	downstream_gene	CLCNKB:ENST00000684324.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000684545.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000683578.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682338.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682793.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375679.9:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375667.7:downstream_gene_variant:MODIFIER::::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs10927896,rs2100239049,rs2100239058,rs2100239096	0.31128	0.15978,0.33660,0.48544,0.36932,0.35397	1670,	43084	102716	-2.0060	0.80							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16057491	16057491	G	A	het	het	wt		QUAL=25;DP=36,13,4;AF=0.25,0.31,0.00	CLCNKB,FAM131C	downstream_gene	CLCNKB:ENST00000684324.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000684545.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000683578.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682338.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000682793.1:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375679.9:downstream_gene_variant:MODIFIER::::,CLCNKB:ENST00000375667.7:downstream_gene_variant:MODIFIER::::,FAM131C:ENST00000375662.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	602023_[GENE=CLCNKB_PHENOS=Bartter syndrome, type 3, 607364 (3), Autosomal recessive; Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive]				rs2100211313,rs2100211328,rs2100211338,rs2100211357,rs2100211363,rs6604912	0.36916	0.43027,0.31891,0.46802,0.34753,0.38057	1,	55425	94717	1.0980	7.67							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLCNKB (inh=AR oe_syn=1.21 oe_mis=1.08 oe_lof=0.93), FAM131C (inh=n/a oe_syn=1.09 oe_mis=1.04 oe_lof=0.42)
chr1	16986248	16986248	C	T	het	het	hom		QUAL=24;DP=18,25,19;AF=0.39,0.44,0.95	ATP13A2	missense,synonymous	ATP13A2:ENST00000341676.9:missense_variant:MODERATE:exon27/27:c.3214G>A:p.Ala1072Thr:,ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon29/29:c.3516G>A:p.Pro1172=:,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon29/29:c.3501G>A:p.Pro1167=:		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128475 [benign DISEASE=not provided,Inborn genetic diseases,Kufor-Rakeb syndrome,Autosomal recessive spastic paraplegia type 78,not specified GENE=ATP13A2];			rs3170740	0.41075	0.19828,0.44638,0.27544,0.52656,0.43444	14378,	33576	89420	-2.7740	0.21	0.241		/1.3>0.0/0.0>0.0	COSV58697923	ATP13A2|0.00|0.00|0.00|0.00|-23|8|40|-23	25741868,18414213,19085912,22743658,30232368,28170284,32327693,30034773,31562340,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16986662	16986662	G	A	het	het	hom		QUAL=24;DP=82,298,218;AF=0.40,0.50,1.00	ATP13A2	intron	ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron26/26:c.3103+143C>T::,ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron27/28:c.3236-30C>T::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron27/28:c.3221-30C>T::	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	559000 [benign DISEASE=not provided,Kufor-Rakeb syndrome,not specified,Autosomal recessive spastic paraplegia type 78 GENE=ATP13A2];			rs2076605	0.41729	0.21847,0.44711,0.28058,0.52709,0.45330	14622,	34096	88448	2.1340	11.26			/0.0>0.0/0.0>0.0	COSV58702203	ATP13A2|0.00|0.01|0.00|0.00|-14|-30|22|-12	19085912	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16986750	16986761	CCCAGGGCTCCT	-	het	het	wt		QUAL=24;DP=77,231,173;AF=0.38,0.52,0.00	ATP13A2	intron	ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron26/26:c.3103+44_3103+55del::,ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron27/28:c.3235+44_3235+55del::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron27/28:c.3220+44_3220+55del::	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	1174788 [benign DISEASE=not provided,not specified GENE=ATP13A2];			rs143483351	0.24094	0.15669,0.33783,0.56128,0.23092,0.24626	4938,	26736	115346	1.8490	3.13			/0.0>0.0/0.6>0.0		ATP13A2|0.00|0.00|0.01|0.00|-44|-15|-25|1	33246661	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16986848	16986848	G	A	het	het	hom		QUAL=24;DP=92,282,200;AF=0.48,0.50,1.00	ATP13A2	synonymous	ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon26/27:c.3060C>T:p.Ala1020=:,ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon27/29:c.3192C>T:p.Ala1064=:,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon27/29:c.3177C>T:p.Ala1059=:	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128473 [benign DISEASE=not specified,Kufor-Rakeb syndrome,Autosomal recessive spastic paraplegia type 78,Inborn genetic diseases,not provided GENE=ATP13A2];			rs9435659	0.41167	0.19380,0.44804,0.28146,0.52929,0.45283	14514,	33563	89451	-0.3600	0.68			/5.6>6.4/0.0>0.0	COSV58700662	ATP13A2|0.00|0.00|0.01|0.00|1|27|0|-43	25741868,18414213,19085912,22743658,30232368,30034773	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16986959	16986959	G	A	het	het	wt		QUAL=24;DP=59,178,91;AF=0.47,0.44,0.00	ATP13A2	splice_region&intron	ATP13A2:ENST00000341676.9:splice_region_variant&intron_variant:LOW:intron25/26:c.2952-3C>T::,ATP13A2:ENST00000326735.13:splice_region_variant&intron_variant:LOW:intron26/28:c.3084-3C>T::,ATP13A2:ENST00000452699.5:splice_region_variant&intron_variant:LOW:intron26/28:c.3069-3C>T::	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128471 [benign DISEASE=Inborn genetic diseases,Kufor-Rakeb syndrome,Autosomal recessive spastic paraplegia type 78,not provided,not specified GENE=ATP13A2];			rs7531163	0.24278	0.16577,0.33821,0.55821,0.23037,0.24405	4955,	26907	114831	0.7470	6.96			9.3>9.9/9.3>9.9/8.0>4.2	COSV104399909	ATP13A2|0.00|0.00|0.00|0.00|-21|-26|-50|-2	25741868,18414213,19085912	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16987159	16987159	C	T	het	het	hom		QUAL=25;DP=66,282,246;AF=0.52,0.47,1.00	ATP13A2	synonymous	ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon25/27:c.2838G>A:p.Val946=:,ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon26/29:c.2970G>A:p.Val990=:,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon26/29:c.2955G>A:p.Val985=:	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128470 [benign DISEASE=not specified,Kufor-Rakeb syndrome,Autosomal recessive spastic paraplegia type 78,Inborn genetic diseases,not provided GENE=ATP13A2];			rs761421	0.41759	0.22033,0.44747,0.27384,0.52715,0.45334	14650,	34192	88552	-0.8540	0.12			/0.0>0.0/6.5>8.9	COSV58699127	ATP13A2|0.00|0.00|0.01|0.00|-39|49|3|49	25741868,18414213,19085912,22743658,30232368,30034773	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16988207	16988207	C	T	het	het	wt		QUAL=24;DP=207,524,52;AF=0.48,0.50,0.00	ATP13A2	synonymous	ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon24/27:c.2658G>A:p.Ser886=:,ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon25/29:c.2790G>A:p.Ser930=:,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon25/29:c.2775G>A:p.Ser925=:	regulatory_region_variant:CTCF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128468 [benign DISEASE=Kufor-Rakeb syndrome,Autosomal recessive spastic paraplegia type 78,not specified,Inborn genetic diseases,not provided GENE=ATP13A2];			rs3738815	0.21175	0.14759,0.30524,0.56056,0.18758,0.23933	4003,	24210	119924	-2.3080	0.85			/5.1>5.6/0.0>0.0	COSV58700021	ATP13A2|0.05|0.00|0.00|0.00|-16|27|-14|6	25741868,18414213,19085912,22285144,34021172,22743658,30232368	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16988447	16988447	G	A	het	het	hom		QUAL=24;DP=219,290,262;AF=0.49,0.46,0.99	ATP13A2	synonymous	ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon23/27:c.2505C>T:p.Gly835=:PF00702 [haloacid dehalogenase-like hydrolase],ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon24/29:c.2637C>T:p.Gly879=:,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon24/29:c.2622C>T:p.Gly874=:		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128466 [benign DISEASE=Inborn genetic diseases,Kufor-Rakeb syndrome,Autosomal recessive spastic paraplegia type 78,not provided,not specified GENE=ATP13A2];			rs9435662	0.41053	0.19390,0.44532,0.28188,0.52744,0.45440	14427,	33565	89625	-5.0290	2.60			/0.0>0.0/0.0>1.2	COSV58700683	ATP13A2|0.00|0.00|0.00|0.00|-25|4|28|-33	25741868,18414213,19085912,22743658,30232368,30034773	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16991570	16991570	T	C	het	het	wt		QUAL=24;DP=43,20,16;AF=0.56,0.50,0.00	ATP13A2	intron	ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron20/26:c.2236+164A>G::,ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron20/28:c.2251+164A>G::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron20/28:c.2236+164A>G::		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	1281617 [benign DISEASE=not provided GENE=ATP13A2];		MIRb (SINE/MIR)	rs2076604	0.21182	0.14674,0.30543,0.56627,0.18765,0.23975	4025,	24170	119894	-1.0580	23.30			/1.8>10.6/1.3>0.4		ATP13A2|0.94|0.00|0.00|0.00|-1|-28|0|-3	19085912	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16992516	16992516	G	A	het	het	hom		QUAL=24;DP=74,152,128;AF=0.47,0.48,1.00	ATP13A2	synonymous	ATP13A2:ENST00000341676.9:synonymous_variant:LOW:exon17/27:c.1800C>T:p.Pro600=:PF00702 [haloacid dehalogenase-like hydrolase],ATP13A2:ENST00000326735.13:synonymous_variant:LOW:exon17/29:c.1815C>T:p.Pro605=:,ATP13A2:ENST00000452699.5:synonymous_variant:LOW:exon17/29:c.1800C>T:p.Pro600=:		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	128465 [benign DISEASE=Kufor-Rakeb syndrome,Autosomal recessive spastic paraplegia type 78,Inborn genetic diseases,not provided,not specified GENE=ATP13A2];			rs2076603	0.54749	0.44077,0.54051,0.28002,0.63515,0.49626	23521,	36237	68831	-0.0780	5.12			/0.0>0.0/0.0>0.0	COSV58700878	ATP13A2|0.00|0.00|0.01|0.00|20|-30|-24|21	25741868,18414213,19085912,33335927,22743658,30232368,30034773,33821002,30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16996703	16996703	A	T	het	het	n/a		QUAL=24;DP=33,7,1;AF=0.52,0.86,0.00	ATP13A2	intron	ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron12/26:c.1181-207T>A::,ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron12/28:c.1196-207T>A::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron12/28:c.1181-207T>A::		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	1270970 [benign DISEASE=not provided GENE=ATP13A2];			rs2076602	0.21144	0.14625,0.30453,0.56400,0.18762,0.23933	4007,	24157	119983	0.1770	6.14			/0.7>0.0/0.0>0.0		ATP13A2|0.00|0.00|0.00|0.00|17|-3|4|49	22285144	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16996871	16996871	-	G	het	het	wt		QUAL=24;DP=38,47,16;AF=0.34,0.53,0.00	ATP13A2	intron	ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron12/26:c.1180+148dup::,ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron12/28:c.1195+148dup::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron12/28:c.1180+148dup::		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	1245001 [benign DISEASE=not provided GENE=ATP13A2];		MIR3 (SINE/MIR)	rs55682704	0.21485	0.15979,0.30188,0.56379,0.18765,0.23942	4062,	24532	119340		0.14			/0.0>0.3/0.0>0.0		ATP13A2|0.00|0.00|0.00|0.00|-34|-31|15|-6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	16996954	16996954	T	C	hom	hom	hom		QUAL=24;DP=38,88,68;AF=0.97,1.00,1.00	ATP13A2	intron	ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron12/26:c.1180+66A>G::,ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron12/28:c.1195+66A>G::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron12/28:c.1180+66A>G::		610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	1192485 [benign DISEASE=Kufor-Rakeb syndrome,not specified,not provided,Autosomal recessive spastic paraplegia type 78 GENE=ATP13A2];		MIR3 (SINE/MIR)	rs9435736	0.80664	0.74599,0.87260,0.84591,0.82417,0.73652	49717,	23282	29416	-1.1830	0.84			/0.0>0.0/1.0>0.0		ATP13A2|0.00|0.00|0.00|0.00|9|-6|9|-6	19085912,30232368	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	17005181	17005181	A	G	het	het	het		QUAL=24;DP=105,126,83;AF=0.43,0.44,0.49	ATP13A2	intron	ATP13A2:ENST00000341676.9:intron_variant:MODIFIER:intron3/26:c.289-109T>C::,ATP13A2:ENST00000326735.13:intron_variant:MODIFIER:intron3/28:c.289-109T>C::,ATP13A2:ENST00000452699.5:intron_variant:MODIFIER:intron3/28:c.289-109T>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	610513_[GENE=ATP13A2_PHENOS=Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive]	1270274 [benign DISEASE=not provided,not specified GENE=ATP13A2];		MIR3 (SINE/MIR)	rs3738814	0.51819	0.64556,0.51152,0.71498,0.42849,0.57874	21091,	36574	73228	-0.0320	1.04			/0.8>0.3/0.0>0.0	COSV58699306	ATP13A2|0.00|0.00|0.00|0.00|-7|-29|24|-29	34021172,20189936,36653477,25429064,31217584,24067417,36329257,35831902,28448500,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ATP13A2 (inh=AR oe_syn=1.04 oe_mis=0.85 oe_lof=0.42)
chr1	18871570	18871570	T	G	het	het	wt		QUAL=25;DP=54,185,23;AF=0.46,0.47,0.00	ALDH4A1	3'UTR,downstream_gene	ALDH4A1:ENST00000290597.9:3_prime_UTR_variant:MODIFIER:exon16/16:c.*262A>C::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1275A>C::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1275A>C::,ALDH4A1:ENST00000538309.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294333 [benign DISEASE=Hyperprolinemia type 2,not provided GENE=ALDH4A1];			rs1138333	0.24198	0.21564,0.23386,0.03504,0.27688,0.15920	4699,	27384	115224	0.9220	12.52			/0.0>0.0/0.2>0.0		ALDH4A1|0.00|0.00|0.00|0.00|3|-31|-30|25,RP13-279N23.2|0.00|0.00|0.00|0.00|-38|3|-30|27		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18871606	18871606	C	G	het	het	wt		QUAL=24;DP=52,166,23;AF=0.50,0.49,0.00	ALDH4A1	3'UTR,downstream_gene	ALDH4A1:ENST00000290597.9:3_prime_UTR_variant:MODIFIER:exon16/16:c.*226G>C::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1239G>C::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1239G>C::,ALDH4A1:ENST00000538309.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294334 [benign DISEASE=not provided,Hyperprolinemia type 2 GENE=ALDH4A1];			rs1138328	0.23478	0.20853,0.22891,0.00193,0.27283,0.12692	4487,	26755	116449	0.1220	5.80			/1.2>0.0/0.0>0.0	COSV51895732	ALDH4A1|0.00|0.00|0.00|0.00|17|-1|17|-11,RP13-279N23.2|0.00|0.00|0.00|0.00|-9|-1|17|40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18871647	18871647	T	C	het	het	wt		QUAL=25;DP=64,146,23;AF=0.53,0.48,0.00	ALDH4A1	3'UTR,downstream_gene	ALDH4A1:ENST00000290597.9:3_prime_UTR_variant:MODIFIER:exon16/16:c.*185A>G::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*1198A>G::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1198A>G::,ALDH4A1:ENST00000538309.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294336 [benign DISEASE=Hyperprolinemia type 2,not provided GENE=ALDH4A1];			rs7366541	0.24199	0.21573,0.23351,0.03498,0.27696,0.15927	4704,	27393	115277	-1.1350	0.59			/1.5>0.0/0.0>0.0	COSV51895747			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18871920	18871920	G	A	het	het	wt		QUAL=24;DP=98,207,23;AF=0.52,0.51,0.00	ALDH4A1	intron,3'UTR,downstream_gene	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-130C>T::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*925C>T::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*925C>T::,ALDH4A1:ENST00000538309.5:downstream_gene_variant:MODIFIER::::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294341 [benign DISEASE=Hyperprolinemia type 2,not provided GENE=ALDH4A1];			rs1140477	0.25162	0.25159,0.23724,0.03471,0.27584,0.15928	4962,	28336	113798	0.5890	5.48			/2.4>3.8/0.7>0.8				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18871924	18871924	C	T	het	het	wt		QUAL=24;DP=101,200,23;AF=0.51,0.50,0.00	ALDH4A1	intron,3'UTR,downstream_gene	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-134G>A::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*921G>A::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*921G>A::,ALDH4A1:ENST00000538309.5:downstream_gene_variant:MODIFIER::::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294342 [benign DISEASE=not provided,Hyperprolinemia type 2 GENE=ALDH4A1];			rs1138269	0.25159	0.25142,0.23737,0.03450,0.27589,0.15921	4963,	28329	113797	0.1370	4.29			/2.4>0.0/0.7>0.1				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872082	18872082	A	G	hom	hom	hom		QUAL=24;DP=212,312,238;AF=0.99,0.99,1.00	ALDH4A1	intron,3'UTR,downstream_gene	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-292T>C::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*763T>C::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*763T>C::,ALDH4A1:ENST00000538309.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294344 [benign DISEASE=Hyperprolinemia type 2,not provided GENE=ALDH4A1];			rs1138267	0.65880	0.52359,0.76438,0.71523,0.70102,0.75436	33654,	32934	51916	-4.5340	0.03			/9.2>8.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872133	18872133	G	A	het	het	wt		QUAL=24;DP=173,263,193;AF=0.48,0.45,0.00	ALDH4A1	intron,3'UTR,downstream_gene	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-343C>T::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*712C>T::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*712C>T::,ALDH4A1:ENST00000538309.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294346 [benign DISEASE=Hyperprolinemia type 2,not provided GENE=ALDH4A1];			rs14311	0.25078	0.24623,0.23814,0.03484,0.27612,0.15914	4988,	28197	114047	-0.0090	3.60			/4.8>4.5/0.0>0.0			12970910	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872143	18872143	G	A	het	het	hom		QUAL=24;DP=140,258,206;AF=0.50,0.54,1.00	ALDH4A1	intron,3'UTR,downstream_gene	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-353C>T::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*702C>T::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*702C>T::,ALDH4A1:ENST00000538309.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294347 [benign DISEASE=not provided,Hyperprolinemia type 2 GENE=ALDH4A1];			rs3202002	0.39845	0.24447,0.52235,0.67981,0.42480,0.59569	13025,	34589	91549	-0.2920	5.25			/4.8>4.6/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872188	18872188	C	-	het	het	hom		QUAL=24;DP=70,203,185;AF=0.47,0.57,0.98	ALDH4A1	intron,3'UTR,downstream_gene	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*42-398del::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*657del::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*657del::,ALDH4A1:ENST00000538309.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294349 [likely benign DISEASE=Hyperprolinemia GENE=ALDH4A1];			rs11311839	0.40729	0.24982,0.52935,0.68539,0.43726,0.60141	13599,	34780	90194	-3.2790	0.04			/0.0>0.0/0.0>0.0		ALDH4A1|0.00|0.00|0.00|0.00|-21|-3|-21|29,RP13-279N23.2|0.00|0.00|0.00|0.00|-22|44|-21|45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872401	18872401	A	G	het	het	wt		QUAL=24;DP=111,199,132;AF=0.41,0.42,0.00	ALDH4A1	intron,3'UTR,downstream_gene	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*41+403T>C::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*444T>C::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*444T>C::,ALDH4A1:ENST00000538309.5:downstream_gene_variant:MODIFIER::::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294353 [benign DISEASE=not provided,Hyperprolinemia type 2 GENE=ALDH4A1];			rs9117	0.18379	0.08525,0.19600,0.00193,0.24980,0.10840	3073,	21836	124270	0.2290	2.82			/2.1>2.4/0.0>0.0			12970910	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872727	18872727	C	T	het	het	hom		QUAL=24;DP=127,372,368;AF=0.39,0.47,1.00	ALDH4A1	intron,3'UTR,downstream_gene	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron15/15:c.*41+77G>A::,ALDH4A1:ENST00000375341.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*118G>A::,ALDH4A1:ENST00000538839.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*118G>A::,ALDH4A1:ENST00000538309.5:downstream_gene_variant:MODIFIER::::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294359 [benign DISEASE=Hyperprolinemia type 2,not provided GENE=ALDH4A1];			rs11740	0.39939	0.24635,0.52441,0.67314,0.42587,0.59284	13051,	34577	91249	-0.7970	0.60			/0.1>5.5/0.0>0.0	COSV51892981	ALDH4A1|0.00|0.00|0.00|0.00|-2|-50|-1|-23,RP13-279N23.2|0.00|0.00|0.00|0.00|-2|-50|-1|-23	18843385,12970910,24686056	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872979	18872979	T	A	het	het	hom		QUAL=24;DP=87,226,212;AF=0.45,0.50,0.99	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron14/15:c.1580-22A>T::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron14/14:c.1580-22A>T::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron13/13:c.1427-22A>T::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron14/14:c.1400-22A>T::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188868 [benign DISEASE=not provided,Hyperprolinemia type 2 GENE=ALDH4A1];			rs28700162	0.40015	0.24670,0.52478,0.67391,0.42672,0.59698	13125,	34622	91252	0.0000	7.31			/0.0>0.0/0.0>0.0	COSV51895558	ALDH4A1|0.01|0.00|0.00|0.00|-5|23|23|3,RP13-279N23.2|0.00|0.00|0.00|0.00|-5|23|2|23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18872993	18872993	A	G	het	het	wt		QUAL=24;DP=62,201,40;AF=0.60,0.49,0.00	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron14/15:c.1580-36T>C::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron14/14:c.1580-36T>C::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron13/13:c.1427-36T>C::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron14/14:c.1400-36T>C::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]				rs35255325	0.18803	0.10002,0.19808,0.00174,0.24938,0.10916	3132,	22360	123608	0.0900	5.33			/6.6>6.0/0.0>0.0		ALDH4A1|0.02|0.00|0.00|0.00|9|-9|48|-9,RP13-279N23.2|0.01|0.00|0.00|0.00|9|-36|-36|9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18874401	18874401	C	T	het	het	wt		QUAL=24;DP=117,143,21;AF=0.42,0.52,0.00	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron14/15:c.1579+62G>A::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron14/14:c.1579+62G>A::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron13/13:c.1426+62G>A::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron14/14:c.1399+62G>A::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]				rs35657817	0.28621	0.37171,0.25501,0.00193,0.27653,0.12982	6716,	30098	108560	-1.0310	0.05			/0.0>0.0/1.4>0.0		ALDH4A1|0.00|0.00|0.00|0.00|-25|37|22|6,RP13-279N23.2|0.00|0.00|0.00|0.00|-25|37|22|6	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18874414	18874414	G	C	het	het	hom		QUAL=24;DP=104,166,122;AF=0.55,0.46,1.00	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron14/15:c.1579+49C>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron14/14:c.1579+49C>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron13/13:c.1426+49C>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron14/14:c.1399+49C>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188869 [benign DISEASE=not provided,Hyperprolinemia type 2 GENE=ALDH4A1];			rs28529092	0.46240	0.42897,0.55574,0.67789,0.44214,0.62261	16524,	37239	81717	3.1040	8.84			/0.0>0.0/0.0>0.0	COSV51895606	ALDH4A1|0.00|0.00|0.00|0.00|-38|49|49|9,RP13-279N23.2|0.00|0.00|0.00|0.00|-47|49|49|9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18874690	18874690	G	C	hom	hom	hom		QUAL=25;DP=99,134,111;AF=0.99,0.99,0.98	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron13/15:c.1461-109C>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron13/14:c.1461-109C>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron12/13:c.1308-109C>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron13/14:c.1281-109C>G::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]				rs6665917	0.64599	0.52729,0.74984,0.71928,0.68070,0.73508	32254,	33796	53872	-2.4860	0.22			/0.0>0.0/0.0>0.0		ALDH4A1|0.00|0.00|0.00|0.00|47|-21|-21|-19,RP13-279N23.2|0.00|0.00|0.00|0.00|47|-21|-21|-19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18874717	18874717	-	G	hom	hom	hom		QUAL=24;DP=64,99,95;AF=0.98,0.94,1.00	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron13/15:c.1461-137dup::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron13/14:c.1461-137dup::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron12/13:c.1308-137dup::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron13/14:c.1281-137dup::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188871 [benign DISEASE=Hyperprolinemia type 2 GENE=ALDH4A1];		MIRb (SINE/MIR)	rs35163726	0.64139	0.52945,0.74654,0.67630,0.67693,0.70291	31728,	34100	54544		1.08			/0.0>0.0/0.0>0.0		ALDH4A1|0.00|0.00|0.00|0.00|-44|-48|-48|36,RP13-279N23.2|0.00|0.00|0.00|0.00|-44|-48|-48|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18875462	18875462	A	G	hom	hom	hom		QUAL=24;DP=308,138,131;AF=1.00,1.00,1.00	ALDH4A1	synonymous	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon13/16:c.1380T>C:p.Asp460=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon13/15:c.1380T>C:p.Asp460=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:synonymous_variant:LOW:exon12/14:c.1227T>C:p.Asp409=:,ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon13/15:c.1200T>C:p.Asp400=:PF00171 [Aldehyde dehydrogenase family]	regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294369 [benign DISEASE=Hyperprolinemia type 2,not provided,not specified GENE=ALDH4A1];			rs2230708	0.71469	0.68482,0.79248,0.72157,0.71551,0.76513	38916,	30793	43365	-1.3090	0.03			/0.0>0.0/0.0>0.0		ALDH4A1|0.00|0.00|0.00|0.00|38|-36|-27|16,RP13-279N23.2|0.00|0.00|0.00|0.00|38|-36|-27|16	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18876276	18876276	T	C	hom	hom	hom		QUAL=24;DP=49,54,30;AF=1.00,1.00,1.00	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron12/15:c.1338+39A>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron12/14:c.1338+39A>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron11/13:c.1186-773A>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron12/14:c.1158+39A>G::	regulatory_region_variant:CTCF_binding_site	606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188872 [benign DISEASE=not provided,Hyperprolinemia type 2 GENE=ALDH4A1];			rs7550822	0.92155	0.77815,0.95672,0.99981,0.97879,0.98133	65191,	9889	11941	-0.0870	0.92			/0.0>0.0/0.0>0.0			18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18876402	18876402	G	A	hom	hom	het		QUAL=25;DP=134,96,73;AF=0.99,0.99,0.33	ALDH4A1	synonymous,intron	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon12/16:c.1251C>T:p.Ala417=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon12/15:c.1251C>T:p.Ala417=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron11/13:c.1185+806C>T::,ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon12/15:c.1071C>T:p.Ala357=:PF00171 [Aldehyde dehydrogenase family]		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294374 [benign DISEASE=Hyperprolinemia type 2,not provided GENE=ALDH4A1];			rs2230707	0.47749	0.43597,0.60639,0.61555,0.46617,0.49938	17668,	37258	79438	-9.1790	0.02			/0.0>0.0/0.0>0.0	COSV51891838	ALDH4A1|0.00|0.00|0.00|0.00|1|47|-4|-10,RP13-279N23.2|0.00|0.00|0.00|0.00|1|47|-4|-10	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18876423	18876423	T	C	hom	hom	hom		QUAL=24;DP=99,87,74;AF=1.00,0.99,0.97	ALDH4A1	synonymous,intron	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon12/16:c.1230A>G:p.Ser410=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon12/15:c.1230A>G:p.Ser410=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron11/13:c.1185+785A>G::,ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon12/15:c.1050A>G:p.Ser350=:PF00171 [Aldehyde dehydrogenase family]		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294375 [benign DISEASE=Hyperprolinemia type 2,not specified,not provided GENE=ALDH4A1];			rs7550938	0.64279	0.48571,0.75111,0.72170,0.69464,0.74657	31993,	33431	54137	-6.0680	0.09			/3.9>3.7/0.0>0.0	COSV51894187	ALDH4A1|0.03|0.00|0.00|0.00|26|-6|-29|-31,RP13-279N23.2|0.03|0.00|0.00|0.00|26|-6|-29|-31	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18876432	18876432	T	C	hom	hom	hom		QUAL=24;DP=64,86,73;AF=1.00,0.99,0.96	ALDH4A1	synonymous,intron	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon12/16:c.1221A>G:p.Ala407=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon12/15:c.1221A>G:p.Ala407=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron11/13:c.1185+776A>G::,ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon12/15:c.1041A>G:p.Ala347=:PF00171 [Aldehyde dehydrogenase family]		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294376 [benign DISEASE=Hyperprolinemia type 2,not specified,not provided GENE=ALDH4A1];			rs2230706	0.64217	0.48543,0.75075,0.72012,0.69363,0.74677	31953,	33445	54247	0.1280	0.62			/3.9>5.0/0.0>0.0	COSV51893163	ALDH4A1|0.02|0.00|0.00|0.00|17|-15|-34|-40,RP13-279N23.2|0.02|0.00|0.00|0.00|17|-15|-34|-40	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18877503	18877503	C	G	hom	hom	hom		QUAL=25;DP=84,107,56;AF=0.98,1.00,1.00	ALDH4A1	synonymous	ALDH4A1:ENST00000290597.9:synonymous_variant:LOW:exon10/16:c.1050G>C:p.Ala350=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000375341.8:synonymous_variant:LOW:exon10/15:c.1050G>C:p.Ala350=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538839.5:synonymous_variant:LOW:exon10/14:c.1050G>C:p.Ala350=:PF00171 [Aldehyde dehydrogenase family],ALDH4A1:ENST00000538309.5:synonymous_variant:LOW:exon10/15:c.870G>C:p.Ala290=:PF00171 [Aldehyde dehydrogenase family]		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	294382 [benign DISEASE=Hyperprolinemia type 2,not provided GENE=ALDH4A1];			rs2230705	0.70992	0.72137,0.71813,0.45606,0.71950,0.58178	38646,	30725	44137	1.5970	8.68			/2.7>3.2/0.0>0.0	COSV51892136	ALDH4A1|0.00|0.00|0.00|0.00|31|11|-15|25,RP13-279N23.2|0.00|0.00|0.00|0.00|31|11|-15|25	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18877660	18877660	G	A	het	wt	hom		QUAL=25;DP=14,18,8;AF=0.43,0.00,1.00	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron9/15:c.941-48C>T::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron9/14:c.941-48C>T::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron9/13:c.941-48C>T::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron9/14:c.761-48C>T::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188873 [benign DISEASE=not provided,Hyperprolinemia type 2 GENE=ALDH4A1];			rs6426813	0.72426	0.69977,0.82373,0.95513,0.69933,0.85481	40377,	29391	41935	-0.8390	1.43			/0.0>0.0/0.5>0.0		ALDH4A1|0.00|0.00|0.00|0.00|-48|-50|30|49,RP13-279N23.2|0.00|0.00|0.00|0.00|-48|-50|30|49	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18877679	18877679	A	G	hom	hom	het		QUAL=25;DP=14,20,7;AF=0.93,1.00,0.43	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron9/15:c.941-67T>C::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron9/14:c.941-67T>C::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron9/13:c.941-67T>C::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron9/14:c.761-67T>C::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188910 [benign DISEASE=not provided,Hyperprolinemia type 2 GENE=ALDH4A1];			rs6426814	0.82135	0.87817,0.84155,0.87243,0.79008,0.75042	51487,	21986	27180	-1.3820	1.35			/0.0>0.0/0.0>0.0		ALDH4A1|0.00|0.00|0.00|0.00|-31|6|34|11,RP13-279N23.2|0.00|0.00|0.00|0.00|-31|6|34|11	35470798	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18877815	18877815	G	A	het	het	n/a		QUAL=24;DP=14,6,0;AF=0.57,0.67,	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron9/15:c.941-203C>T::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron9/14:c.941-203C>T::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron9/13:c.941-203C>T::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron9/14:c.761-203C>T::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]			MIR3 (SINE/MIR)	rs41302007	0.31968	0.20752,0.26245,0.17410,0.38990,0.32612	8494,	31641	103489	-0.4680	0.40			/0.0>0.0/0.0>0.0		ALDH4A1|0.00|0.00|0.00|0.00|-14|3|-3|-33,RP13-279N23.2|0.00|0.00|0.00|0.00|-14|3|-3|-33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18879178	18879178	T	G	het	hom	het		QUAL=24;DP=83,76,96;AF=0.48,0.99,0.55	ALDH4A1,MIR4695	intron,downstream_gene	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron9/15:c.940+122A>C::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron9/14:c.940+122A>C::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron9/13:c.940+122A>C::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron9/14:c.760+122A>C::,MIR4695:ENST00000577305.1:downstream_gene_variant:MODIFIER::::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]				rs28497538	0.42715	0.48871,0.46731,0.36438,0.38364,0.42404	14332,	36280	87096	-3.6300	0.13			/1.4>1.9/0.1>0.0		ALDH4A1|0.00|0.00|0.00|0.00|-46|2|21|3,RP13-279N23.2|0.00|0.00|0.00|0.00|-46|2|21|3	18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	18881651	18881651	-	GGTTGCCT	hom	hom	hom		QUAL=24;DP=10,19,9;AF=0.70,0.95,0.89	ALDH4A1,MIR4695	intron,downstream_gene	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron8/15:c.866+48_866+49insAGGCAACC::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron8/14:c.866+48_866+49insAGGCAACC::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron8/13:c.866+48_866+49insAGGCAACC::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron8/14:c.686+48_686+49insAGGCAACC::,MIR4695:ENST00000577305.1:downstream_gene_variant:MODIFIER::::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]				rs112548638	0.98442	0.94607,0.99431,1.00000,0.99975,0.99959	73766,	2254	2370		1.48			/0.0>0.0/0.0>0.9				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	18883049	18883049	A	G	hom	hom	hom		QUAL=24;DP=86,145,156;AF=0.99,1.00,0.99	ALDH4A1,MIR4695	intron,downstream_gene	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron7/15:c.678+75T>C::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron7/14:c.678+75T>C::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron7/13:c.678+75T>C::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron7/14:c.498+75T>C::,MIR4695:ENST00000577305.1:downstream_gene_variant:MODIFIER::::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188911 [benign DISEASE=not provided,Hyperprolinemia type 2 GENE=ALDH4A1];			rs6426611	0.97000	0.89588,0.98962,0.99981,0.99959,0.99938	71835,	4109	4571	-1.8660	0.00			/3.6>2.4/0.0>0.0			18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	18883524	18883524	G	A	het	hom	wt		QUAL=24;DP=46,28,16;AF=0.41,1.00,0.00	ALDH4A1,MIR4695	intron,upstream_gene	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron5/15:c.454-96C>T::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron5/14:c.454-96C>T::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron5/13:c.454-96C>T::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron5/14:c.274-96C>T::,MIR4695:ENST00000577305.1:upstream_gene_variant:MODIFIER::::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]				rs28508407	0.30478	0.45325,0.34153,0.24167,0.21984,0.23311	8047,	30273	105765	-3.5190	0.07			/2.0>2.6/0.0>0.0	COSV51893250	ALDH4A1|0.00|0.00|0.00|0.00|-26|4|-8|39,RP13-279N23.2|0.00|0.00|0.00|0.00|-26|4|-8|39	35470798	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45), MIR4695 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	18889340	18889340	T	C	hom	hom	hom		QUAL=24;DP=120,143,95;AF=1.00,1.00,1.00	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron3/15:c.249+22A>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron3/14:c.249+22A>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron3/13:c.249+22A>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron3/14:c.69+22A>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]	1188912 [benign DISEASE=not provided,Hyperprolinemia type 2 GENE=ALDH4A1];			rs941495	0.96897	0.99266,0.97053,0.99961,0.95430,0.99068	71521,	4551	4727	-0.5210	3.34			/0.0>0.0/0.0>0.0			18843385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	18890554	18890554	A	C	het	wt	het		QUAL=24;DP=84,18,37;AF=0.49,0.00,0.43	ALDH4A1	intron	ALDH4A1:ENST00000290597.9:intron_variant:MODIFIER:intron1/15:c.63-449T>G::,ALDH4A1:ENST00000375341.8:intron_variant:MODIFIER:intron1/14:c.63-449T>G::,ALDH4A1:ENST00000538839.5:intron_variant:MODIFIER:intron1/13:c.63-449T>G::,ALDH4A1:ENST00000538309.5:intron_variant:MODIFIER:intron1/14:c.-119+140T>G::		606811_[GENE=ALDH4A1_PHENOS=Hyperprolinemia, type II, 239510 (3), Autosomal recessive]			AluSz (SINE/Alu)							0.4610	4.17			/3.0>2.2/0.0>0.0		ALDH4A1|0.00|0.00|0.00|0.00|-35|16|32|16,RP13-279N23.2|0.00|0.00|0.00|0.00|-35|16|32|16		0	0	0	0 / 0					ALDH4A1 (inh=AR oe_syn=0.96 oe_mis=1.01 oe_lof=0.45)
chr1	21554325	21554325	-	ATAT	het	het	wt		QUAL=24;DP=35,22,15;AF=0.43,0.55,0.00	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron2/11:c.61+195_61+198dup::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron1/9:c.-54-6289_-54-6286dup::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron1/10:c.-104-6289_-104-6286dup::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron2/11:c.61+195_61+198dup::	regulatory_region_variant:enhancer	171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	1253752 [benign DISEASE=not provided GENE=ALPL];			rs61491376	0.63921	0.44010,0.66333,0.46286,0.75061,0.67737	31186,	31023	52715		0.30			/0.1>0.1/0.0>0.0		ALPL|0.00|0.00|0.00|0.00|-27|29|-27|-14		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21563142	21563142	T	C	hom	het	hom		QUAL=24;DP=30,125,90;AF=0.97,0.52,1.00	ALPL	synonymous	ALPL:ENST00000374840.8:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:PF00245 [Alkaline phosphatase],ALPL:ENST00000539907.5:synonymous_variant:LOW:exon3/10:c.99T>C:p.Ser33=:PF00245 [Alkaline phosphatase],ALPL:ENST00000540617.5:synonymous_variant:LOW:exon4/11:c.165T>C:p.Ser55=:PF00245 [Alkaline phosphatase],ALPL:ENST00000374832.5:synonymous_variant:LOW:exon5/12:c.330T>C:p.Ser110=:PF00245 [Alkaline phosphatase]		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	197678 [benign DISEASE=Adult hypophosphatasia,Infantile hypophosphatasia,Childhood hypophosphatasia,Hypophosphatasia,not specified,not provided GENE=ALPL];			rs1780316	0.92600	0.86696,0.95275,0.98762,0.94390,0.95588	65398,	10227	11269	-0.8670	1.19			/0.9>1.2/0.0>0.0	COSV66379629		34213743,25972531,27507156,23823483,30283886,25147783	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21563893	21563893	G	A	hom	het	hom		QUAL=25;DP=16,5,6;AF=1.00,0.40,1.00	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron5/11:c.473-148G>A::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron3/9:c.242-148G>A::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron4/10:c.308-148G>A::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron5/11:c.473-148G>A::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	1188974 [benign DISEASE=not provided,Childhood hypophosphatasia GENE=ALPL];			rs1256335	0.80111	0.77329,0.85043,0.98431,0.78859,0.81146	48679,	23870	30098	-1.5660	0.19			/0.0>0.0/0.0>0.0	COSV66379633	ALPL|0.00|0.00|0.00|0.00|2|-16|50|49	30583557,19744961,19888898,25972531,23823483,25760040,32230794,36376304,34648354,25147783	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21563971	21563971	A	G	hom	hom	hom		QUAL=24;DP=19,51,31;AF=1.00,1.00,1.00	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron5/11:c.473-70A>G::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron3/9:c.242-70A>G::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron4/10:c.308-70A>G::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron5/11:c.473-70A>G::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	1177630 [benign DISEASE=Adult hypophosphatasia,Infantile hypophosphatasia,Childhood hypophosphatasia,not provided GENE=ALPL];		(GGGA)n (Simple_repeat)	rs1767428	0.98664	0.95401,0.99413,0.99980,0.99968,0.99979	72724,	1916	1996	-0.3600	0.61			/0.0>0.0/1.1>0.8				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21568455	21568455	G	A	het	het	wt		QUAL=25;DP=35,23,18;AF=0.54,0.57,0.00	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron7/11:c.792+208G>A::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron5/9:c.561+208G>A::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron6/10:c.627+208G>A::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron7/11:c.792+208G>A::	regulatory_region_variant:enhancer	171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	1297879 [benign DISEASE=not provided GENE=ALPL];			rs35526713	0.07790	0.05456,0.07024,0.02720,0.08920,0.06918	476,	10901	140309	0.5610	5.60			/0.0>0.0/0.0>0.0		ALPL|0.00|0.00|0.00|0.00|2|-18|2|-50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21570432	21570432	C	T	het	het	wt		QUAL=24;DP=187,305,28;AF=0.49,0.55,0.00	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron8/11:c.862+58C>T::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron6/9:c.631+58C>T::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron7/10:c.697+58C>T::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron8/11:c.862+58C>T::	regulatory_region_variant:enhancer	171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	1177590 [benign DISEASE=Childhood hypophosphatasia,Adult hypophosphatasia,not provided,Infantile hypophosphatasia GENE=ALPL];			rs2275375	0.26101	0.30650,0.29396,0.47973,0.19998,0.30216	5493,	28676	112296	-1.1040	0.45			/0.0>1.1/0.1>1.3	COSV66376176	ALPL|0.00|0.00|0.00|0.00|46|48|-2|48	34213743,19500388	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21573927	21573927	A	G	hom	het	hom		QUAL=24;DP=76,97,78;AF=1.00,0.53,1.00	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron9/11:c.997+128A>G::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron7/9:c.766+128A>G::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron8/10:c.832+128A>G::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron9/11:c.997+128A>G::	regulatory_region_variant:CTCF_binding_site	171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	1236467 [benign DISEASE=not provided GENE=ALPL];			rs2275370	0.76348	0.70644,0.79291,0.80325,0.78313,0.76834	44445,	27293	35993	-0.3860	3.36			/0.0>0.0/0.0>0.0	COSV66376031	ALPL|0.00|0.00|0.00|0.00|-6|-22|-37|1	19888898,25972531,19931660	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21573966	21573966	A	C	het	wt	het		QUAL=24;DP=69,33,49;AF=0.55,0.00,0.51	ALPL	intron	ALPL:ENST00000374840.8:intron_variant:MODIFIER:intron9/11:c.997+167A>C::,ALPL:ENST00000539907.5:intron_variant:MODIFIER:intron7/9:c.766+167A>C::,ALPL:ENST00000540617.5:intron_variant:MODIFIER:intron8/10:c.832+167A>C::,ALPL:ENST00000374832.5:intron_variant:MODIFIER:intron9/11:c.997+167A>C::	regulatory_region_variant:CTCF_binding_site	171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	1241664 [benign DISEASE=not provided GENE=ALPL];			rs35488260	0.21434	0.12631,0.18571,0.00019,0.28974,0.08299	3994,	24649	119633	0.5160	7.90			/0.0>1.4/0.0>0.0	COSV66376032	ALPL|0.00|0.00|0.00|0.00|11|33|39|38		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21577770	21577770	C	-	het	wt	het		QUAL=24;DP=206,16,244;AF=0.51,0.00,0.53	ALPL	3'UTR	ALPL:ENST00000374840.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::,ALPL:ENST00000539907.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*124del::,ALPL:ENST00000540617.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*124del::,ALPL:ENST00000374832.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*124del::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	295560 [benign/likely benign DISEASE=Hypophosphatasia,not provided GENE=ALPL];			rs140511985	0.04581	0.01868,0.03869,0.00000,0.06813,0.02388	213,	6541	145125	0.9820	14.59			/0.0>0.0/0.0>0.0		ALPL|0.00|0.00|0.00|0.00|-23|-39|-13|14		120	1348	0	0 / 0					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21577774	21577774	A	G	hom	hom	hom		QUAL=24;DP=211,295,245;AF=1.00,1.00,0.98	ALPL	3'UTR	ALPL:ENST00000374840.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::,ALPL:ENST00000539907.5:3_prime_UTR_variant:MODIFIER:exon10/10:c.*126A>G::,ALPL:ENST00000540617.5:3_prime_UTR_variant:MODIFIER:exon11/11:c.*126A>G::,ALPL:ENST00000374832.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*126A>G::		171760_[GENE=ALPL_PHENOS=Odontohypophosphatasia, 146300 (3), Autosomal recessive, Autosomal dominant; Hypophosphatasia, infantile, 241500 (3), Autosomal recessive; Hypophosphatasia, childhood, 241510 (3), Autosomal recessive; Hypophosphatasia, adult, 146300 (3), Autosomal recessive, Autosomal dominant]	295561 [benign DISEASE=Hypophosphatasia,not provided GENE=ALPL];			rs1697406	0.87193	0.85200,0.87283,0.81218,0.88555,0.93071	57898,	16896	19490	0.1730	14.70			/0.0>0.0/0.0>0.5			27468225,28899360	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALPL (inh=AR+AD oe_syn=1.07 oe_mis=0.80 oe_lof=0.41)
chr1	21822690	21822690	G	C	het	hom	wt		QUAL=24;DP=26,42,19;AF=0.58,1.00,0.00	LDLRAD2,HSPG2	3'UTR,intron	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*475G>C::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*218+257G>C::,HSPG2:ENST00000374695.8:3_prime_UTR_variant:MODIFIER:exon97/97:c.*626C>G::	regulatory_region_variant:open_chromatin_region	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295685 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided GENE=HSPG2];			rs1049644	0.29967	0.40721,0.21944,0.16719,0.25469,0.40246	7272,	30880	106158	1.9690	7.77			/0.0>0.0/0.0>3.5,/7.8>6.0/0.0>0.0	COSV60827857			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823442	21823442	T	C	hom	hom	hom		QUAL=24;DP=87,232,142;AF=1.00,1.00,1.00	LDLRAD2,HSPG2	3'UTR,intron,synonymous	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1227T>C::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-468T>C::,HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon97/97:c.13050A>G:p.Ser4350=:PF00054 [Laminin G domain]	regulatory_region_variant:open_chromatin_region	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295695 [benign DISEASE=Schwartz-Jampel syndrome,Lethal Kniest-like syndrome,not provided GENE=HSPG2];			rs897467	0.79172	0.71802,0.76697,0.82315,0.82509,0.82967	47863,	24700	31680	-3.7920	0.33			/0.0>0.0/0.0>0.0,/1.0>3.3/0.0>0.0	COSV60827391	HSPG2|0.01|0.00|0.00|0.00|-11|-2|29|-27,LDLRAD2|0.00|0.00|0.00|0.00|4|24|18|-25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823627	21823627	C	T	het	het	wt		QUAL=24;DP=121,317,107;AF=0.46,0.55,0.00	LDLRAD2,HSPG2	3'UTR,intron,missense	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1412C>T::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-283C>T::,HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon96/97:c.12992G>A:p.Ser4331Asn:PF00054 [Laminin G domain]	regulatory_region_variant:open_chromatin_region	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295700 [benign DISEASE=Schwartz-Jampel syndrome,not provided,Lethal Kniest-like syndrome GENE=HSPG2];			rs3736360	0.15287	0.08275,0.13091,0.16634,0.17596,0.29552	1950,	19367	128933	0.0090	10.82	0.124	0.08	/0.0>0.0/0.0>0.0	COSV60827612	HSPG2|0.00|0.00|0.00|0.00|30|-1|-11|-17,LDLRAD2|0.00|0.00|0.00|0.00|12|-26|-8|-29	20072119,33462484,37228872,18559102	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823667	21823667	G	T	het	het	wt		QUAL=24;DP=237,324,107;AF=0.49,0.55,0.00	LDLRAD2,HSPG2	3'UTR,intron,synonymous	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1452G>T::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-243G>T::,HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon96/97:c.12952C>A:p.Arg4318=:PF00054 [Laminin G domain]	regulatory_region_variant:open_chromatin_region	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295701 [benign DISEASE=Schwartz-Jampel syndrome,not provided,Lethal Kniest-like syndrome GENE=HSPG2];			rs3736358	0.14003	0.03710,0.12763,0.16731,0.17599,0.29536	1837,	17636	130874	3.7350	11.54			/0.0>0.8/0.0>0.0,/3.8>0.0/0.0>1.2	COSV60828118,COSV60829904	HSPG2|0.00|0.00|0.00|0.00|-2|40|21|-47,LDLRAD2|0.00|0.00|0.00|0.00|13|1|-20|-48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21823764	21823764	C	T	het	wt	hom		QUAL=24;DP=62,56,108;AF=0.52,0.00,0.99	LDLRAD2,HSPG2	3'UTR,intron	LDLRAD2:ENST00000344642.7:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1549C>T::,LDLRAD2:ENST00000543870.1:intron_variant:MODIFIER:intron5/5:c.*219-146C>T::,HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron95/96:c.12900-45G>A::	regulatory_region_variant:open_chromatin_region	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1225015 [benign DISEASE=not provided GENE=HSPG2];			rs3736357	0.39105	0.14022,0.47580,0.64507,0.48657,0.33223	13597,	32261	92583	1.1280	9.13			/4.2>4.3/0.0>0.0,/0.0>0.0/1.7>1.1		HSPG2|0.02|0.00|0.00|0.00|-34|-49|-45|39,LDLRAD2|0.00|0.00|0.00|0.00|20|50|-16|-30		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21828352	21828352	A	G	het	hom	wt		QUAL=24;DP=43,32,23;AF=0.37,0.97,0.00	HSPG2,LDLRAD2	synonymous,downstream_gene	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon89/97:c.12312T>C:p.Asp4104=:,LDLRAD2:ENST00000344642.7:downstream_gene_variant:MODIFIER::::,LDLRAD2:ENST00000543870.1:downstream_gene_variant:MODIFIER::::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295707 [benign DISEASE=Schwartz-Jampel syndrome,not provided,Lethal Kniest-like syndrome GENE=HSPG2];			rs2228347	0.25270	0.13674,0.21403,0.16641,0.30490,0.48094	5428,	27583	113675	1.3570	7.40			/0.6>1.5/0.0>0.0	COSV60827859	HSPG2|0.01|0.00|0.01|0.00|36|-22|-10|38		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21828494	21828494	G	A	het	hom	wt		QUAL=25;DP=19,15,14;AF=0.47,1.00,0.00	HSPG2,LDLRAD2	intron,downstream_gene	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron88/96:c.12238-68C>T::,LDLRAD2:ENST00000344642.7:downstream_gene_variant:MODIFIER::::,LDLRAD2:ENST00000543870.1:downstream_gene_variant:MODIFIER::::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1267772 [benign DISEASE=not provided GENE=HSPG2];			rs10917052	0.24165	0.13198,0.20253,0.16602,0.28834,0.47811	4931,	26837	115167	-0.3470	1.61			/3.8>2.9/0.0>0.0	COSV60827793	HSPG2|0.00|0.00|0.00|0.00|-33|-43|-7|35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21829230	21829230	T	C	hom	hom	hom		QUAL=24;DP=42,33,17;AF=0.98,1.00,1.00	HSPG2,LDLRAD2	intron,downstream_gene	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron87/96:c.11993-151A>G::,LDLRAD2:ENST00000344642.7:downstream_gene_variant:MODIFIER::::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	439796 [benign DISEASE=not provided,not specified GENE=HSPG2];		MIRb (SINE/MIR)	rs7518070	0.77252	0.70630,0.74761,0.81408,0.79861,0.82133	45575,	26436	34626	-1.9710	0.74			/0.0>0.0/0.0>0.0			27223085	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21829348	21829348	T	C	het	het	wt		QUAL=24;DP=38,75,18;AF=0.53,0.52,0.00	HSPG2,LDLRAD2	intron,downstream_gene	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron87/96:c.11992+35A>G::,LDLRAD2:ENST00000344642.7:downstream_gene_variant:MODIFIER::::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	618168 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided GENE=HSPG2];			rs12042189	0.14042	0.03681,0.12891,0.16647,0.17596,0.29412	1839,	17697	130847	-0.9940	0.37			/0.0>0.0/0.0>0.0	COSV60828432	HSPG2|0.00|0.00|0.00|0.00|34|-32|35|40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21829360	21829360	C	T	het	het	wt		QUAL=24;DP=60,83,18;AF=0.38,0.54,0.00	HSPG2,LDLRAD2	intron,downstream_gene	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron87/96:c.11992+23G>A::,LDLRAD2:ENST00000344642.7:downstream_gene_variant:MODIFIER::::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	618169 [benign DISEASE=not specified,Schwartz-Jampel syndrome,Lethal Kniest-like syndrome,not provided GENE=HSPG2];			rs12023794	0.15306	0.08438,0.13142,0.17067,0.17561,0.28613	1947,	19406	128930	-1.2010	1.82			/0.0>0.0/0.0>0.0	COSV60829275	HSPG2|0.00|0.00|0.00|0.00|-2|44|23|28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LDLRAD2 (inh=AR oe_syn=1.10 oe_mis=1.04 oe_lof=0.66), HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21831196	21831196	G	A	hom	hom	hom		QUAL=24;DP=96,257,205;AF=0.99,1.00,1.00	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron84/96:c.11562+19C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1174648 [benign DISEASE=Schwartz-Jampel syndrome,Lethal Kniest-like syndrome,not provided,not specified GENE=HSPG2];			rs3736355	0.77039	0.70150,0.74673,0.81226,0.79768,0.81364	45305,	26571	34925	-2.8120	0.06			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21831627	21831627	G	T	het	het	wt		QUAL=24;DP=81,143,30;AF=0.52,0.55,0.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron82/96:c.11352+25C>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1261831 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided GENE=HSPG2];			rs2270701	0.14654	0.05896,0.12981,0.16557,0.17559,0.29872	1896,	18506	129866	-3.4990	0.02			/4.4>3.4/0.0>0.0		HSPG2|0.10|0.00|0.00|0.00|-29|-47|43|25	21146954	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21831870	21831870	G	A	het	wt	hom		QUAL=24;DP=10,4,4;AF=0.20,0.00,1.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron81/96:c.11208-74C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1237413 [benign DISEASE=not provided GENE=HSPG2];			rs4654771	0.35839	0.10151,0.40008,0.44162,0.48033,0.27471	11782,	30880	97468	0.0080	1.93			/4.2>4.4/0.0>0.0	COSV65932968	HSPG2|0.02|0.00|0.00|0.00|-17|34|4|29	27223085	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21833281	21833281	G	A	het	het	wt		QUAL=24;DP=139,237,29;AF=0.45,0.50,0.00	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon80/97:c.11082C>T:p.Pro3694=:PF00054 [Laminin G domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295724 [benign DISEASE=Schwartz-Jampel syndrome,not provided,Lethal Kniest-like syndrome GENE=HSPG2];			rs2229486	0.10070	0.17109,0.06797,0.00039,0.08046,0.10950	928,	13471	136875	-3.3340	1.02			/2.3>2.8/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|41|-8|-10|-13		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21833550	21833550	C	T	het	het	wt		QUAL=24;DP=190,284,29;AF=0.44,0.49,0.00	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon79/97:c.10895G>A:p.Arg3632Gln:PF07679 [Immunoglobulin I-set domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295727 [benign DISEASE=Schwartz-Jampel syndrome,not provided,Lethal Kniest-like syndrome GENE=HSPG2];			rs2229493	0.10081	0.17140,0.06776,0.00039,0.08052,0.11007	925,	13479	136723	0.0570	13.42	0.053	0.06	/4.5>4.0/0.0>0.0	COSV105928417	HSPG2|0.05|0.00|0.00|0.00|3|38|-8|-14	20072119	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21833655	21833655	C	T	het	wt	hom		QUAL=24;DP=104,21,131;AF=0.61,0.00,1.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron78/96:c.10831-41G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1223305 [benign DISEASE=not provided GENE=HSPG2];			rs7547731	0.39069	0.14164,0.47495,0.64471,0.48626,0.32905	13562,	32334	92730	-2.8300	0.48			/0.0>0.0/0.0>0.0		HSPG2|0.03|0.00|0.00|0.00|-24|-30|-24|41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21835760	21835760	C	G	het	het	wt		QUAL=24;DP=155,78,17;AF=0.50,0.49,0.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron75/96:c.10356-123G>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1296079 [benign DISEASE=not provided GENE=HSPG2];		AluSz (SINE/Alu)	rs71636991	0.10053	0.17063,0.06780,0.00039,0.08057,0.11008	921,	13436	136702	-2.5810	0.30			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-13|-37|-38|6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21836660	21836660	A	C	het	wt	hom		QUAL=25;DP=73,16,38;AF=0.58,0.00,1.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron75/96:c.10355+142T>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1245162 [benign DISEASE=not provided GENE=HSPG2];		MIRb (SINE/MIR)	rs12567651	0.29057	0.08220,0.34079,0.33540,0.39021,0.22409	7728,	28750	107928	0.0320	10.93			/1.0>0.2/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-44|2|-13|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21836717	21836717	C	A	het	het	wt		QUAL=24;DP=113,93,16;AF=0.58,0.40,0.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron75/96:c.10355+85G>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	810881 [benign DISEASE=not specified,not provided GENE=HSPG2];			rs35423650	0.04048	0.00945,0.03417,0.00019,0.05862,0.10357	178,	5810	146156	1.1510	7.02			/0.0>0.0/0.0>6.2		HSPG2|0.00|0.00|0.00|0.00|2|-49|2|31		57	1789	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21836897	21836897	G	A	het	het	wt		QUAL=24;DP=184,353,16;AF=0.52,0.40,0.00	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon75/97:c.10260C>T:p.His3420=:PF07679 [Immunoglobulin I-set domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295741 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided GENE=HSPG2];			rs35444472	0.10032	0.17020,0.06766,0.00058,0.08038,0.11028	922,	13433	137005	2.2680	7.23			/6.1>5.7/0.0>0.0	COSV65932770	HSPG2|0.01|0.00|0.00|0.00|-15|50|12|-22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21839408	21839408	A	G	het	het	wt		QUAL=24;DP=83,87,16;AF=0.65,0.67,0.00	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon73/97:c.9852T>C:p.Ala3284=:PF07679 [Immunoglobulin I-set domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295750 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided GENE=HSPG2];			rs2291826	0.33544	0.53637,0.23603,0.16809,0.25942,0.39124	9743,	31518	101048	-3.3420	0.02			/0.0>0.0/0.0>0.6	COSV65933346	HSPG2|0.00|0.00|0.00|0.00|46|-37|-37|28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21839703	21839703	C	T	het	het	wt		QUAL=24;DP=79,69,16;AF=0.54,0.58,0.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron72/96:c.9709+119G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1266053 [benign DISEASE=not provided GENE=HSPG2];			rs35570238	0.09792	0.16192,0.06623,0.00155,0.08031,0.10984	857,	13184	137240	-0.5230	1.09			/0.5>0.1/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-20|22|-1|21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21841112	21841112	C	T	het	het	wt		QUAL=24;DP=35,183,17;AF=0.40,0.42,0.00	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon71/97:c.9502G>A:p.Ala3168Thr:PF13927 [Immunoglobulin domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295758 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided GENE=HSPG2];			rs2228349	0.09810	0.16235,0.06627,0.00039,0.08043,0.11010	860,	13220	137350	0.9590	5.61	0.118	0.07	/3.4>3.6/0.0>1.5		HSPG2|0.00|0.00|0.01|0.00|-2|49|-2|-11	20072119,23049933	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21841723	21841723	C	T	het	wt	hom		QUAL=24;DP=58,138,182;AF=0.57,0.00,1.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron69/96:c.9194-50G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1231634 [benign DISEASE=not provided GENE=HSPG2];			rs7556412	0.61590	0.50579,0.59274,0.81912,0.65645,0.61153	29305,	35000	58380	-0.1040	1.79			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-12|-50|-12|-11	21146954,23593148,31970092,30646882	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21841783	21841783	G	T	het	het	wt		QUAL=25;DP=111,148,71;AF=0.50,0.51,0.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron69/96:c.9194-110C>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1271902 [benign DISEASE=not provided GENE=HSPG2];			rs34470509	0.04049	0.00957,0.03417,0.00019,0.05853,0.10436	179,	5809	146125	-0.2560	5.08			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|5|-24|-4|10		56	1813	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21841817	21841817	A	G	het	het	wt		QUAL=25;DP=147,132,71;AF=0.50,0.52,0.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron69/96:c.9194-144T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1226588 [benign DISEASE=not provided GENE=HSPG2];			rs12043008	0.26217	0.30115,0.20194,0.17286,0.24996,0.38990	5275,	29318	112200	-0.2220	3.31			/0.0>0.0/0.0>0.0		HSPG2|0.06|0.00|0.00|0.00|36|-29|-38|-29	30646882	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21842308	21842308	T	C	het	het	wt		QUAL=24;DP=63,87,16;AF=0.46,0.43,0.00	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon68/97:c.8983A>G:p.Ser2995Gly:PF13895 [Immunoglobulin domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295764 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided GENE=HSPG2];			rs2229491	0.10259	0.17803,0.06812,0.00039,0.08042,0.10916	970,	13682	136654	-0.1830	2.11	0.037	0.05	/4.9>5.1/0.0>0.0		HSPG2|0.04|0.00|0.00|0.00|2|23|18|24	20072119	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21842352	21842352	A	T	het	het	wt		QUAL=24;DP=41,57,16;AF=0.54,0.39,0.00	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon68/97:c.8939T>A:p.Leu2980His:PF13895 [Immunoglobulin domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295765 [benign DISEASE=Connective tissue disorder,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided GENE=HSPG2];			rs2229489	0.04057	0.00961,0.03422,0.00019,0.05861,0.10427	179,	5817	146045	3.3680	15.27	0.070	0.04	/2.0>1.6/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|28|-21|-24|-20	20452482,20072119	155	4906	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21842489	21842489	T	C	het	het	wt		QUAL=24;DP=41,11,7;AF=0.51,0.64,0.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron67/96:c.8911-109A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1296076 [benign DISEASE=not provided GENE=HSPG2];			rs7528408	0.10014	0.16937,0.06646,0.00039,0.08052,0.11210	913,	13413	136941	-0.1850	3.81			/0.0>0.0/0.9>0.0		HSPG2|0.00|0.00|0.01|0.00|38|22|-28|-4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21842646	21842646	G	C	het	het	wt		QUAL=24;DP=53,86,23;AF=0.36,0.58,0.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron67/96:c.8910+124C>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1256741 [benign DISEASE=not provided GENE=HSPG2];		MIR3 (SINE/MIR)	rs7536441	0.10003	0.16922,0.06583,0.00039,0.08055,0.11141	909,	13406	136970	-0.1020	0.91			/0.0>0.0/0.4>0.0		HSPG2|0.00|0.00|0.00|0.00|5|17|10|-37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21842693	21842693	A	G	het	het	wt		QUAL=24;DP=65,157,23;AF=0.49,0.59,0.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron67/96:c.8910+77T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1228779 [benign DISEASE=not provided GENE=HSPG2];			rs75779078	0.04076	0.01008,0.03412,0.00019,0.05861,0.10622	182,	5836	145896	-2.2780	0.08			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|23|-12|47|37		56	1801	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21845965	21845965	T	C	hom	hom	hom		QUAL=24;DP=12,34,38;AF=1.00,1.00,1.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron64/96:c.8464+143A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1245045 [benign DISEASE=not provided GENE=HSPG2];			rs7355045	0.77551	0.70085,0.70947,0.82147,0.81456,0.82063	46024,	25973	34165	-1.4080	5.67			/3.7>3.3/0.0>0.0	COSV65970143	HSPG2|0.06|0.00|0.07|0.00|19|-12|-30|-1	21146954,20072119	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21846651	21846651	C	T	het	het	wt		QUAL=24;DP=106,416,38;AF=0.55,0.51,0.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron62/96:c.8165-52G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1182109 [benign DISEASE=not provided GENE=HSPG2];			rs34792235	0.04056	0.00950,0.03425,0.00019,0.05858,0.10589	181,	5816	146130	-0.3120	1.40			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-28|31|37|50		84	2764	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21847184	21847184	T	C	het	het	wt		QUAL=25;DP=35,46,29;AF=0.43,0.48,0.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron62/96:c.8164+170A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1296073 [benign DISEASE=not provided GENE=HSPG2];		MER3 (DNA/hAT-Charlie)	rs12757119	0.04058	0.00950,0.03419,0.00019,0.05861,0.10602	181,	5819	146131	-4.5280	0.01			/5.4>3.2/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-1|-4|-1|50		64	1649	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21847243	21847243	C	T	het	het	wt		QUAL=24;DP=95,90,29;AF=0.55,0.49,0.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron62/96:c.8164+111G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1250728 [benign DISEASE=not provided GENE=HSPG2];			rs35921133	0.04063	0.00953,0.03431,0.00019,0.05871,0.10597	181,	5827	146123	-0.5830	2.94			/0.0>0.0/1.4>0.0		HSPG2|0.00|0.00|0.00|0.00|-2|-9|-2|43		58	1844	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21847497	21847497	A	G	het	het	wt		QUAL=25;DP=109,289,29;AF=0.54,0.50,0.00	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron61/96:c.8026-5T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295781 [benign DISEASE=Connective tissue disorder,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided GENE=HSPG2];			rs35917892	0.04055	0.00951,0.03414,0.00019,0.05854,0.10581	180,	5813	146071	-2.0680	0.56			4.4>3.7/4.4>3.8/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|41|-5|-5|-36		159	4893	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21847933	21847933	T	G	het	hom	wt		QUAL=24;DP=124,226,29;AF=0.47,0.99,0.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron60/96:c.7873+25A>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1256801 [benign DISEASE=Schwartz-Jampel syndrome,not provided,Lethal Kniest-like syndrome GENE=HSPG2];			rs2290501	0.36982	0.52581,0.26741,0.17338,0.31153,0.48213	11185,	33859	95815	-0.6650	6.97	0.030		/0.0>0.0/0.8>0.0	COSV65971017	HSPG2|0.00|0.00|0.00|0.00|25|43|26|25	23593148,20072119	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21848025	21848025	G	T	het	het	wt		QUAL=25;DP=176,243,29;AF=0.43,0.50,0.00	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon60/97:c.7806C>A:p.Val2602=:PF13927 [Immunoglobulin domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295785 [benign DISEASE=Connective tissue disorder,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided GENE=HSPG2];			rs12737091	0.04051	0.00950,0.03410,0.00019,0.05852,0.10605	178,	5813	146119	2.1420	21.30			/0.3>0.0/5.4>10.2		HSPG2|0.00|0.00|0.98|0.00|-14|38|3|-49	37566063	157	4893	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21848107	21848107	A	G	hom	hom	hom		QUAL=24;DP=59,169,189;AF=1.00,1.00,0.99	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron59/96:c.7738-14T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295787 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided GENE=HSPG2];			rs3767138	0.77736	0.70790,0.70930,0.82063,0.81442,0.82016	46223,	25828	33874	0.2490	15.38			10.4>10.3/10.4>10.3/0.0>0.0	COSV65970146	HSPG2|0.02|0.00|0.00|0.00|-44|-14|-14|-43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21848603	21848603	T	C	het	het	wt		QUAL=24;DP=63,78,16;AF=0.48,0.56,0.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron59/96:c.7737+40A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1236320 [benign DISEASE=not provided GENE=HSPG2];			rs34726153	0.04082	0.00954,0.03435,0.00019,0.05905,0.10575	180,	5849	145895	-1.0900	0.07			/0.0>0.0/0.0>0.4		HSPG2|0.00|0.00|0.00|0.00|-34|25|25|40		84	2780	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21849969	21849969	C	T	het	het	wt		QUAL=24;DP=45,131,20;AF=0.47,0.52,0.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron57/96:c.7446+72G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1296070 [benign DISEASE=not provided GENE=HSPG2];		AluSg (SINE/Alu)	rs71636993	0.04056	0.00962,0.03424,0.00019,0.05849,0.10605	180,	5818	146144	-2.0650	0.17			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-37|-43|27|-42		59	1808	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21850276	21850276	C	T	het	het	wt		QUAL=24;DP=35,200,20;AF=0.49,0.50,0.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron56/96:c.7295-84G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1222260 [benign DISEASE=not provided GENE=HSPG2];			rs34719083	0.04056	0.00947,0.03417,0.00019,0.05856,0.10597	182,	5813	146131	-1.4550	0.26			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-26|11|9|17		57	1860	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21850626	21850626	A	G	het	wt	hom		QUAL=24;DP=9,18,19;AF=0.56,0.00,1.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron55/96:c.7159-128T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1267282 [benign DISEASE=not provided GENE=HSPG2];			rs61777200	0.36482	0.10661,0.40804,0.44265,0.48392,0.28370	12165,	31144	96586	-1.8450	0.78			/6.8>5.9/0.0>0.0	COSV65968900	HSPG2|0.00|0.00|0.00|0.00|-39|-12|-47|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21851385	21851385	A	G	het	het	wt		QUAL=25;DP=79,49,32;AF=0.43,0.47,0.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron55/96:c.7158+161T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1247546 [benign DISEASE=not provided GENE=HSPG2];		MIR (SINE/MIR)	rs12750012	0.04055	0.00947,0.03423,0.00019,0.05854,0.10614	181,	5816	146168	0.1220	5.32			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|41|-34|-50|27		65	1494	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21851976	21851976	A	G	het	het	wt		QUAL=24;DP=66,89,32;AF=0.61,0.48,0.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron53/96:c.6871-50T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1223987 [benign DISEASE=not provided GENE=HSPG2];			rs34346159	0.04053	0.00946,0.03424,0.00019,0.05851,0.10606	181,	5809	146073	0.4620	9.21			/1.3>1.1/0.0>0.0		HSPG2|0.05|0.00|0.00|0.00|24|-18|-49|10		84	2774	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21852498	21852498	C	T	het	het	wt		QUAL=24;DP=72,79,60;AF=0.50,0.63,0.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron52/96:c.6724+202G>A::	regulatory_region_variant:enhancer,TF_binding_site_variant	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1296069 [benign DISEASE=not provided GENE=HSPG2];			rs35337242	0.04054	0.00948,0.03424,0.00019,0.05856,0.10584	179,	5815	146103	-1.6520	0.46			/3.9>4.1/0.0>0.2		HSPG2|0.00|0.00|0.00|0.00|30|2|3|50		54	1701	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21852543	21852543	G	A	het	het	wt		QUAL=24;DP=49,90,60;AF=0.43,0.56,0.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron52/96:c.6724+157C>T::	regulatory_region_variant:enhancer	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1296067 [benign DISEASE=not provided GENE=HSPG2];			rs35999331	0.04051	0.00950,0.03423,0.00039,0.05851,0.10600	178,	5815	146171	0.1990	5.29			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.03|0.00|8|6|8|5		58	1730	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21852751	21852751	C	T	het	het	wt		QUAL=24;DP=86,203,60;AF=0.43,0.51,0.00	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon52/97:c.6673G>A:p.Gly2225Ser:	regulatory_region_variant:enhancer,TF_binding_site_variant	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295807 [benign DISEASE=Connective tissue disorder,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided GENE=HSPG2];			rs35669711	0.04056	0.00954,0.03419,0.00019,0.05852,0.10616	177,	5811	145837	0.0570	13.75	0.225	0.09	/4.1>2.2/0.0>0.0		HSPG2|0.00|0.00|0.02|0.00|-2|-10|33|-50		155	4894	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21852958	21852958	C	T	het	het	wt		QUAL=24;DP=77,434,60;AF=0.49,0.46,0.00	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon51/97:c.6552G>A:p.Thr2184=:PF13927 [Immunoglobulin domain]	regulatory_region_variant:enhancer,TF_binding_site_variant	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295810 [benign DISEASE=Connective tissue disorder,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided GENE=HSPG2];			rs34443576	0.04057	0.00970,0.03430,0.00019,0.05851,0.10556	180,	5817	146071	-8.1810	0.03			/0.0>0.0/3.3>2.2	COSV65974636	HSPG2|0.00|0.00|0.00|0.00|-21|17|-2|6		155	4889	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21853180	21853180	T	C	het	wt	hom		QUAL=24;DP=56,56,146;AF=0.59,0.00,0.99	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron50/96:c.6440-110A>G::	regulatory_region_variant:enhancer,regulatory_region_variant:CTCF_binding_site,TF_binding_site_variant	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1237465 [benign DISEASE=not provided GENE=HSPG2];			rs12049614	0.39888	0.14896,0.44375,0.63881,0.50321,0.33320	14043,	32580	91426	-0.3830	1.86			/0.0>0.0/0.0>0.0	COSV65970151	HSPG2|0.00|0.00|0.00|0.00|13|-22|26|-22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21854055	21854055	T	C	hom	hom	hom		QUAL=24;DP=84,32,21;AF=1.00,1.00,1.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron50/96:c.6439+138A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1293473 [benign DISEASE=not provided GENE=HSPG2];			rs12117402	0.72920	0.61495,0.67247,0.62856,0.79517,0.76120	40987,	28891	41171	-0.1030	4.05			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|2|32|37|-5	27223085	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21854230	21854230	C	T	het	het	wt		QUAL=24;DP=87,196,16;AF=0.46,0.51,0.00	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon50/97:c.6402G>A:p.Val2134=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	285614 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,Connective tissue disorder,not specified,not provided GENE=HSPG2];			rs12742444	0.04035	0.00945,0.03405,0.00019,0.05832,0.10531	178,	5789	146145	0.0570	1.87			/2.0>1.5/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-27|41|7|-49	34648354,37566063	156	4874	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21854829	21854829	A	G	het	het	wt		QUAL=24;DP=45,74,16;AF=0.53,0.43,0.00	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron48/96:c.6133+19T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1242960 [benign DISEASE=not provided,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome GENE=HSPG2];			rs36080251	0.04064	0.00953,0.03421,0.00019,0.05871,0.10630	181,	5823	145993	-1.1260	0.10			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|18|-45|18|19		137	4336	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21855402	21855402	C	T	het	het	wt		QUAL=24;DP=137,240,16;AF=0.49,0.56,0.00	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon47/97:c.5899G>A:p.Val1967Ile:PF13927 [Immunoglobulin domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295823 [benign DISEASE=Connective tissue disorder,Schwartz-Jampel syndrome,Lethal Kniest-like syndrome,not provided GENE=HSPG2];			rs2229475	0.04040	0.00948,0.03412,0.00019,0.05840,0.10494	179,	5795	146139	1.9340	24.30	0.236	0.15	/0.0>0.0/0.0>0.0		HSPG2|0.01|0.00|0.00|0.00|28|-35|22|1	20072119,37566063	155	4883	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21856978	21856978	A	C	hom	hom	hom		QUAL=24;DP=19,13,7;AF=1.00,1.00,1.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron44/96:c.5575+37T>G::	regulatory_region_variant:enhancer	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1293461 [benign DISEASE=not provided GENE=HSPG2];			rs12024579	0.76191	0.66647,0.70435,0.81887,0.80816,0.80357	44504,	26823	36197	-0.9590	0.61			/2.8>0.9/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21857246	21857246	A	G	hom	het	hom		QUAL=24;DP=97,114,120;AF=1.00,0.48,1.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron43/96:c.5394+39T>C::	regulatory_region_variant:enhancer	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1220862 [benign DISEASE=not provided GENE=HSPG2];			rs2305562	0.50013	0.42806,0.48009,0.45982,0.54816,0.37500	19234,	37516	75946	1.6720	6.86			/0.0>0.0/0.0>0.0	COSV65970004	HSPG2|0.00|0.00|0.01|0.00|-16|49|31|37	21146954,20072119,27223085	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21859741	21859741	A	G	hom	hom	hom		QUAL=24;DP=95,278,234;AF=1.00,1.00,1.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron41/96:c.5183-65T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1293460 [benign DISEASE=not provided GENE=HSPG2];			rs10917056	0.94137	0.81206,0.97668,0.95479,0.99799,0.99316	67955,	7432	8928	-0.1920	1.60			/0.6>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21864961	21864961	G	A	het	wt	hom		QUAL=24;DP=124,24,210;AF=0.40,0.00,1.00	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon36/97:c.4508C>T:p.Ala1503Val:PF00052 [Laminin B (Domain IV)]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	291236 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided,not specified GENE=HSPG2];			rs897471	0.70390	0.61222,0.77153,0.88568,0.73188,0.56779	38067,	30983	45059	4.3150	23.50	0.150	0.12	/1.1>1.7/0.0>0.0	COSV65969427	HSPG2|0.01|0.00|0.00|0.00|-7|-13|2|-28	20072119,37228872	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21872588	21872588	A	T	hom	hom	hom		QUAL=25;DP=55,80,82;AF=0.98,1.00,1.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron32/96:c.4029+32T>A::	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1233017 [benign DISEASE=Schwartz-Jampel syndrome,not provided,Lethal Kniest-like syndrome GENE=HSPG2];			rs2501266	0.98294	0.94131,0.99412,0.99981,0.99949,0.99959	73623,	2448	2598	-2.1080	0.09			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21872752	21872752	C	T	het	wt	hom		QUAL=24;DP=44,39,80;AF=0.64,0.00,1.00	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon32/97:c.3897G>A:p.Val1299=:PF00053 [Laminin EGF domain]	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	285755 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not specified,not provided GENE=HSPG2];			rs2229482	0.50714	0.28208,0.45533,0.42590,0.62804,0.50125	21450,	34143	74875	0.2560	6.25			/1.7>0.6/1.6>6.7	COSV65968754	HSPG2|0.01|0.00|0.00|0.00|-2|2|3|-46	28552196	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21873328	21873328	G	A	het	wt	hom		QUAL=24;DP=44,16,32;AF=0.48,0.00,1.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron30/96:c.3793+47C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1235752 [benign DISEASE=not provided GENE=HSPG2];			rs2454290	0.75172	0.48557,0.84977,0.97377,0.85217,0.73373	45166,	24036	37774	0.0950	2.50			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-20|-23|47|-47	21146954	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21873489	21873489	G	A	het	het	wt		QUAL=25;DP=18,14,7;AF=0.50,0.36,0.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron29/96:c.3744-65C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	810883 [benign/likely benign DISEASE=not specified,not provided GENE=HSPG2];			rs34855688	0.03552	0.00830,0.03123,0.00019,0.05023,0.10228	154,	5102	146902	0.5720	1.69			/0.5>0.2/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-48|33|35|33		64	2403	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21873574	21873574	A	G	hom	het	hom		QUAL=24;DP=16,5,3;AF=1.00,0.40,1.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron29/96:c.3744-150T>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1252344 [benign DISEASE=not provided GENE=HSPG2];		MIR3 (SINE/MIR)	rs2247741	0.50845	0.22577,0.45922,0.20556,0.67716,0.54723	22921,	31524	74796	0.0600	5.18			/8.4>8.8/0.0>0.0	COSV65975718	HSPG2|0.00|0.00|0.00|0.00|-34|-9|30|-24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21873589	21873589	T	C	hom	hom	n/a		QUAL=24;DP=9,5,2;AF=1.00,1.00,1.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron29/96:c.3744-165A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1248137 [benign DISEASE=not provided GENE=HSPG2];		MIR3 (SINE/MIR)	rs2445136	0.98005	0.93147,0.99353,1.00000,0.99932,0.99814	73221,	2822	3038	-1.7210	0.49			/0.0>0.0/1.4>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21874342	21874342	C	G	hom	hom	hom		QUAL=24;DP=60,171,107;AF=1.00,1.00,1.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron28/96:c.3656+64G>C::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1293451 [benign DISEASE=not provided GENE=HSPG2];			rs2445135	0.98225	0.93894,0.99379,1.00000,0.99946,0.99979	73532,	2540	2704	-0.8630	0.89			/6.5>8.1/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21875616	21875616	C	T	hom	hom	hom		QUAL=24;DP=115,271,241;AF=0.97,1.00,1.00	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron25/96:c.3302+13G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295864 [benign DISEASE=not provided,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome GENE=HSPG2];		MIRb (SINE/MIR)	rs2501265	0.94916	0.82448,0.98080,1.00000,0.99894,0.99897	69076,	6436	7744	-6.5350	0.00			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21878013	21878013	C	T	het	het	het		QUAL=24;DP=48,56,71;AF=0.54,0.57,0.44	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron21/96:c.2685+173G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1260883 [benign DISEASE=not provided GENE=HSPG2];		MIR3 (SINE/MIR)	rs747546	0.14492	0.25808,0.12525,0.04126,0.09599,0.13142	2025,	18016	130200	-1.3340	0.10			/0.0>0.0/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|8|-29|11|-29		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21878915	21878915	T	C	hom	hom	hom		QUAL=24;DP=76,41,44;AF=1.00,1.00,1.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron18/96:c.2471+79A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1293450 [benign DISEASE=not provided GENE=HSPG2];		MIR3 (SINE/MIR)	rs2454294	0.97744	0.92171,0.99301,1.00000,0.99946,0.99979	72870,	3163	3437	-1.3790	0.63			/0.0>0.0/0.5>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21878973	21878973	T	C	hom	hom	hom	low_conf_region	QUAL=24;DP=35,35,49;AF=0.97,1.00,1.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron18/96:c.2471+21A>G::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1263480 [benign DISEASE=Lethal Kniest-like syndrome,Schwartz-Jampel syndrome,not provided GENE=HSPG2];			rs2454293	0.96520	0.87989,0.98811,0.99845,0.99919,0.99876	71140,	4709	5299	-0.5580	1.96			/0.0>0.0/4.0>0.0	COSV65975893			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21879262	21879262	C	A	het	het	het		QUAL=24;DP=29,17,19;AF=0.45,0.35,0.68	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron17/96:c.2344-141G>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1180925 [benign DISEASE=not provided GENE=HSPG2];		L3 (LINE/CR1)	rs55728940	0.06392	0.04620,0.08088,0.04052,0.06401,0.12070	343,	9044	142488	0.8450	5.89			/0.8>2.2/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21880156	21880156	T	C	hom	hom	hom		QUAL=24;DP=172,255,237;AF=0.99,1.00,1.00	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon17/97:c.2294A>G:p.Asn765Ser:PF00053 [Laminin EGF domain]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295881 [benign DISEASE=not provided,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome GENE=HSPG2];			rs989994	0.94013	0.79210,0.97837,0.99961,0.99928,0.99917	67984,	7280	9122	0.8000	13.57	0.136	0.06	/0.3>5.7/0.0>0.0			26648445,20072119,22257501	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21880449	21880449	G	A	hom	hom	hom		QUAL=24;DP=107,73,61;AF=1.00,1.00,1.00	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon16/97:c.2109C>T:p.Ala703=:PF00052 [Laminin B (Domain IV)]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295882 [benign DISEASE=Lethal Kniest-like syndrome,not provided,Schwartz-Jampel syndrome GENE=HSPG2];			rs1874793	0.94020	0.79229,0.97837,0.99942,0.99928,0.99917	67950,	7264	9106	1.5060	10.50			/0.0>0.0/0.0>0.0	COSV65974984		34946941	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21880572	21880572	G	A	het	het	wt		QUAL=24;DP=29,52,35;AF=0.31,0.48,0.00	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron15/96:c.1999-13C>T::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295886 [benign DISEASE=not provided,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome GENE=HSPG2];			rs77828146	0.01124	0.00269,0.00686,0.00000,0.01599,0.02195	20,	1673	150645	-1.8390	0.22			5.4>5.4/5.4>5.4/0.0>0.0		HSPG2|0.00|0.00|0.00|0.00|-13|-49|-25|-49		15	1276	0	0 / 0					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21880742	21880742	T	C	hom	hom	hom		QUAL=24;DP=137,132,75;AF=0.99,1.00,1.00	HSPG2	missense	HSPG2:ENST00000374695.8:missense_variant:MODERATE:exon15/97:c.1912A>G:p.Met638Val:PF00052 [Laminin B (Domain IV)]		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295887 [benign DISEASE=not provided,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome GENE=HSPG2];			rs1874792	0.97764	0.92251,0.99301,0.99981,0.99944,0.99959	72876,	3139	3405	1.1480	6.55	0.073	0.05	/0.0>0.0/0.0>1.9				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21881312	21881324	CCCAGGGTGGCAG	-	hom	hom	hom		QUAL=24;DP=73,157,104;AF=0.97,0.98,1.00	HSPG2	splice_region&intron	HSPG2:ENST00000374695.8:splice_region_variant&intron_variant:LOW:intron14/96:c.1818+15_1818+27del::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1267614 [benign DISEASE=Lethal Kniest-like syndrome,not provided,Schwartz-Jampel syndrome type 1 GENE=HSPG2];			rs60267433	0.96535	0.87961,0.98876,1.00000,0.99935,0.99917	71133,	4678	5274	1.2990	2.24			/0.0>0.0/0.8>0.8				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21881537	21881537	C	T	het	het	hom		QUAL=24;DP=68,124,94;AF=0.44,0.43,1.00	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron13/96:c.1655-35G>A::		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	439797 [benign DISEASE=not specified,not provided,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome GENE=HSPG2];			rs921847	0.93155	0.79887,0.97184,1.00000,0.98329,0.97657	66583,	8677	10423	-0.3390	1.16			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21884729	21884729	T	C	het	het	het		QUAL=24;DP=76,302,246;AF=0.47,0.47,0.43	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron12/96:c.1507+38A>G::	regulatory_region_variant:CTCF_binding_site	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1248089 [benign DISEASE=Schwartz-Jampel syndrome,not provided,Lethal Kniest-like syndrome GENE=HSPG2];			rs4654994	0.90562	0.85209,0.90898,0.96006,0.93305,0.90025	62524,	12827	14369	-1.0400	1.38			/2.3>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21885632	21885632	C	A	het	het	het		QUAL=24;DP=41,61,69;AF=0.61,0.48,0.57	HSPG2	intron	HSPG2:ENST00000374695.8:intron_variant:MODIFIER:intron9/96:c.1079-181G>T::	regulatory_region_variant:open_chromatin_region	142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	1238974 [benign DISEASE=not provided GENE=HSPG2];			rs28653609	0.13841	0.23277,0.12184,0.04072,0.09799,0.11030	1769,	17519	131075	-0.6070	0.62			/1.3>2.5/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21887634	21887634	A	G	hom	hom	het		QUAL=25;DP=119,175,181;AF=0.97,1.00,0.50	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon8/97:c.744T>C:p.Leu248=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295909 [benign DISEASE=not provided,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome GENE=HSPG2];			rs2229478	0.44913	0.63777,0.51021,0.63098,0.33634,0.39913	16892,	34443	83683	-1.8380	0.54	0.156		/2.4>1.9/0.0>0.0	COSV65929973	HSPG2|0.00|0.00|0.00|0.00|40|-7|-26|26	20072119	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	21890615	21890615	G	A	hom	hom	hom		QUAL=25;DP=236,333,277;AF=1.00,1.00,1.00	HSPG2	synonymous	HSPG2:ENST00000374695.8:synonymous_variant:LOW:exon4/97:c.324C>T:p.Phe108=:		142461_[GENE=HSPG2_PHENOS=Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive]	295913 [benign DISEASE=not provided,Lethal Kniest-like syndrome,Schwartz-Jampel syndrome GENE=HSPG2];			rs2501260	0.95654	0.84952,0.98326,1.00000,0.99943,0.99979	70019,	5597	6617	2.0910	13.33			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSPG2 (inh=AR oe_syn=1.05 oe_mis=0.94 oe_lof=0.34)
chr1	22452666	22452666	T	C	hom	hom	hom		QUAL=24;DP=138,395,256;AF=1.00,1.00,1.00	ZBTB40	intron,5'UTR	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron1/17:c.-70+662T>C::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron1/15:c.-70+662T>C::,ZBTB40:ENST00000404138.5:5_prime_UTR_variant:MODIFIER:exon2/19:c.-350T>C::	regulatory_region_variant:open_chromatin_region				MER58B (DNA/hAT-Charlie)	rs10737466	0.97764	0.92295,0.99144,1.00000,0.99954,0.99979	72890,	3132	3406	-1.5700	0.46			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22489769	22489769	T	C	hom	hom	het		QUAL=24;DP=56,144,113;AF=1.00,1.00,0.46	ZBTB40	intron	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron1/17:c.-69-111T>C::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron1/15:c.-69-111T>C::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron2/18:c.-69-111T>C::	regulatory_region_variant:enhancer					rs1267005	0.72204	0.89099,0.78553,0.89664,0.61529,0.70029	40927,	27983	42283	0.8330	12.02			/0.0>0.0/0.0>0.0	COSV65144913	ZBTB40|0.00|0.00|0.00|0.00|-34|43|17|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22491224	22491224	A	G	hom	hom	het		QUAL=24;DP=69,8,4;AF=1.00,1.00,0.75	ZBTB40	intron	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron2/17:c.698-176A>G::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron2/15:c.698-176A>G::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron3/18:c.698-176A>G::	regulatory_region_variant:enhancer					rs12566074	0.25624	0.07029,0.21331,0.31904,0.34619,0.37864	6344,	26313	113203	-1.7510	0.09			/0.0>0.0/0.0>0.0	COSV65144915	ZBTB40|0.00|0.00|0.00|0.00|-1|-7|-50|19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22506250	22506250	A	T	hom	hom	het		QUAL=24;DP=193,209,168;AF=1.00,0.99,0.55	ZBTB40	splice_region&intron	ZBTB40:ENST00000375647.5:splice_region_variant&intron_variant:LOW:intron6/17:c.1360+9A>T::,ZBTB40:ENST00000374651.8:splice_region_variant&intron_variant:LOW:intron4/15:c.1024+9A>T::,ZBTB40:ENST00000404138.5:splice_region_variant&intron_variant:LOW:intron7/18:c.1360+9A>T::						rs209732	0.72188	0.89132,0.78544,0.89845,0.61481,0.69979	40900,	27995	42301	0.9000	12.88			/0.0>0.0/0.0>0.0	COSV65144922	ZBTB40|0.00|0.00|0.00|0.00|-1|-34|-9|-3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22509184	22509184	A	G	hom	hom	het		QUAL=24;DP=339,306,273;AF=1.00,1.00,0.53	ZBTB40	missense	ZBTB40:ENST00000375647.5:missense_variant:MODERATE:exon9/18:c.1784A>G:p.Tyr595Cys:,ZBTB40:ENST00000374651.8:missense_variant:MODERATE:exon7/16:c.1448A>G:p.Tyr483Cys:,ZBTB40:ENST00000404138.5:missense_variant:MODERATE:exon10/19:c.1784A>G:p.Tyr595Cys:			1260804 [benign DISEASE=not provided GENE=ZBTB40];			rs209729	0.78796	0.90750,0.83732,0.89786,0.71488,0.70578	47794,	24204	32236	0.2260	10.16	0.018	0.07	/0.0>0.0/0.0>0.0	COSV65144925	ZBTB40|0.00|0.00|0.00|0.00|20|-34|49|-3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22511094	22511094	T	-	hom	hom	het		QUAL=24;DP=100,43,46;AF=0.69,0.63,0.57	ZBTB40	intron	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron9/17:c.1834-69del::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron7/15:c.1498-69del::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron10/18:c.1834-69del::					(T)n (Simple_repeat)	rs34404742	0.29981	0.11017,0.27352,0.48332,0.37686,0.42034	6530,	27972	95830	-0.0480	8.04			/13.6>12.7/0.0>0.0		ZBTB40|0.00|0.00|0.00|0.00|-17|20|-6|-44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22511451	22511451	T	C	hom	hom	het		QUAL=24;DP=43,72,43;AF=0.98,1.00,0.49	ZBTB40	intron	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron10/17:c.2002+104T>C::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron8/15:c.1666+104T>C::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron11/18:c.2002+104T>C::						rs2073168	0.32288	0.19344,0.27120,0.46014,0.38514,0.41888	8755,	31596	102980	-0.7320	0.33			/0.0>0.0/2.2>0.0	COSV65144929	ZBTB40|0.00|0.00|0.00|0.00|3|-1|2|-3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22520216	22520216	G	A	hom	hom	hom		QUAL=24;DP=173,136,94;AF=1.00,1.00,1.00	ZBTB40,ZBTB40-IT1	missense,downstream_gene	ZBTB40:ENST00000375647.5:missense_variant:MODERATE:exon14/18:c.2989G>A:p.Val997Met:PF00096 [Zinc finger C2H2 type],ZBTB40:ENST00000374651.8:missense_variant:MODERATE:exon12/16:c.2653G>A:p.Val885Met:PF00096 [Zinc finger C2H2 type],ZBTB40:ENST00000404138.5:missense_variant:MODERATE:exon15/19:c.2989G>A:p.Val997Met:PF00096 [Zinc finger C2H2 type],ZBTB40-IT1:ENST00000438551.1:downstream_gene_variant:MODIFIER::::						rs209720	0.99685	0.99892,0.99725,1.00000,0.99458,0.99959	75680,	478	480	1.8680	17.04	0.172	0.05	/0.0>0.0/2.5>2.5			18840274	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50), ZBTB40-IT1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	22521304	22521304	G	A	hom	hom	het		QUAL=24;DP=127,17,31;AF=1.00,1.00,0.35	ZBTB40,ZBTB40-IT1	intron,downstream_gene	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron14/17:c.3049-192G>A::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron12/15:c.2713-192G>A::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron15/18:c.3049-192G>A::,ZBTB40-IT1:ENST00000438551.1:downstream_gene_variant:MODIFIER::::					MIRb (SINE/MIR)	rs12754103	0.28557	0.09099,0.25441,0.45820,0.37076,0.41577	7652,	28148	108708	-0.9840	0.20			/1.6>1.1/0.0>0.0	COSV65144938	ZBTB40|0.00|0.00|0.00|0.00|34|-12|5|8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50), ZBTB40-IT1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	22522510	22522510	A	C	hom	hom	het		QUAL=24;DP=173,257,199;AF=0.99,0.99,0.48	ZBTB40,ZBTB40-IT1	intron,downstream_gene	ZBTB40:ENST00000375647.5:intron_variant:MODIFIER:intron16/17:c.3298+47A>C::,ZBTB40:ENST00000374651.8:intron_variant:MODIFIER:intron14/15:c.2962+47A>C::,ZBTB40:ENST00000404138.5:intron_variant:MODIFIER:intron17/18:c.3298+47A>C::,ZBTB40-IT1:ENST00000438551.1:downstream_gene_variant:MODIFIER::::					MIR (SINE/MIR)	rs998978	0.30670	0.16022,0.26393,0.45830,0.37277,0.41677	8099,	30433	105409	-6.2610	0.01			/0.0>0.5/0.0>0.0	COSV65144854	ZBTB40|0.00|0.00|0.00|0.01|22|-18|-43|-47		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50), ZBTB40-IT1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	22526222	22526222	G	C	hom	hom	het		QUAL=24;DP=91,135,108;AF=0.99,0.99,0.46	ZBTB40	synonymous	ZBTB40:ENST00000375647.5:synonymous_variant:LOW:exon18/18:c.3546G>C:p.Pro1182=:,ZBTB40:ENST00000374651.8:synonymous_variant:LOW:exon16/16:c.3210G>C:p.Pro1070=:,ZBTB40:ENST00000404138.5:synonymous_variant:LOW:exon19/19:c.3546G>C:p.Pro1182=:			3060178 [benign DISEASE=ZBTB40-related disorder GENE=ZBTB40];			rs881646	0.30633	0.16004,0.26406,0.45782,0.37229,0.41653	8085,	30420	105502	-1.1450	0.16			/2.1>2.8/0.0>0.0	COSV65144952	ZBTB40|0.00|0.00|0.00|0.00|-4|-20|-21|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22526648	22526648	G	A	hom	hom	het		QUAL=24;DP=79,308,234;AF=1.00,1.00,0.50	ZBTB40	3'UTR	ZBTB40:ENST00000375647.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*252G>A::,ZBTB40:ENST00000374651.8:3_prime_UTR_variant:MODIFIER:exon16/16:c.*252G>A::,ZBTB40:ENST00000404138.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*252G>A::						rs2281354	0.25624	0.06951,0.21578,0.31938,0.34550,0.37754	6339,	26304	113152	0.1690	3.23			/0.0>1.1/0.0>0.0	COSV65144954	ZBTB40|0.00|0.00|0.00|0.00|-35|-12|-13|45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22530108	22530108	T	C	hom	hom	het		QUAL=24;DP=100,230,216;AF=0.99,1.00,0.49	ZBTB40	3'UTR	ZBTB40:ENST00000375647.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*3712T>C::,ZBTB40:ENST00000374651.8:3_prime_UTR_variant:MODIFIER:exon16/16:c.*3712T>C::,ZBTB40:ENST00000404138.5:3_prime_UTR_variant:MODIFIER:exon19/19:c.*3712T>C::	regulatory_region_variant:enhancer					rs1062663	0.31608	0.18836,0.26651,0.45804,0.37513,0.41781	8353,	31200	103658	-2.4240	0.05			/0.2>0.7/0.0>0.0	COSV65144958			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZBTB40 (inh=n/a oe_syn=0.98 oe_mis=0.88 oe_lof=0.50)
chr1	22638945	22638945	A	G	het	het	n/a		QUAL=24;DP=14,5,2;AF=0.64,0.60,1.00	C1QA,C1QC	5'UTR,3'UTR,synonymous,upstream_gene	C1QA:ENST00000695738.1:5_prime_UTR_variant:MODIFIER:exon2/2:c.-100A>G::,C1QA:ENST00000695739.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*270A>G::,C1QA:ENST00000695740.1:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:PF01391 [Collagen triple helix repeat (20 copies)],C1QA:ENST00000695741.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*563A>G::,C1QA:ENST00000695742.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*490A>G::,C1QA:ENST00000695743.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*820A>G::,C1QA:ENST00000695744.1:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:PF01391 [Collagen triple helix repeat (20 copies)],C1QA:ENST00000695745.1:5_prime_UTR_variant:MODIFIER:exon2/2:c.-100A>G::,C1QA:ENST00000695746.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*270A>G::,C1QA:ENST00000374642.8:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:PF01391 [Collagen triple helix repeat (20 copies)],C1QA:ENST00000402322.2:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:PF01391 [Collagen triple helix repeat (20 copies)],C1QA:ENST00000438241.2:synonymous_variant:LOW:exon3/3:c.276A>G:p.Gly92=:PF01391 [Collagen triple helix repeat (20 copies)],C1QC:ENST00000695749.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000695750.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000695751.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000695752.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000695753.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000374640.9:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000374639.7:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000374637.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	120550_[GENE=C1QA_PHENOS=C1q deficiency 1, 613652 (3), Autosomal recessive]&120575_[GENE=C1QC_PHENOS=C1q deficiency 3, 620322 (3), Autosomal recessive]	1167796 [benign DISEASE=not provided,C1Q deficiency,not specified GENE=C1QA];			rs172378	0.51212	0.73245,0.53237,0.58967,0.38496,0.60664	21743,	34405	74203	-0.7330	1.34	0.061		/0.0>0.0/0.0>0.0	COSV65889459	C1QA|0.00|0.00|0.00|0.00|26|-19|-33|34	25294155,19440201,19493541,20528885,25817358,20003265,20332777,21060334,25326229,26085599,26798662,32556499,34519938,35645665,29795138,31019999,36157263,22897949,35024943,26683148,22236909,33058021,25637052,29230368	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QA (inh=AR oe_syn=0.91 oe_mis=0.70 oe_lof=0.55), C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22639734	22639734	T	G	het	het	het		QUAL=24;DP=141,257,222;AF=0.52,0.47,0.54	C1QA,C1QC	downstream_gene,upstream_gene	C1QA:ENST00000695738.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695739.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695740.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695741.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695742.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695743.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695744.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695745.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000695746.1:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000374642.8:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000402322.2:downstream_gene_variant:MODIFIER::::,C1QA:ENST00000438241.2:downstream_gene_variant:MODIFIER::::,C1QC:ENST00000695749.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000695750.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000695751.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000695752.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000695753.1:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000374640.9:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000374639.7:upstream_gene_variant:MODIFIER::::,C1QC:ENST00000374637.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:open_chromatin_region	120550_[GENE=C1QA_PHENOS=C1q deficiency 1, 613652 (3), Autosomal recessive]&120575_[GENE=C1QC_PHENOS=C1q deficiency 3, 620322 (3), Autosomal recessive]			AluSq2 (SINE/Alu)	rs10917274	0.35780	0.42690,0.43512,0.45006,0.29894,0.45328	10162,	34058	97608	-2.9250	0.23							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QA (inh=AR oe_syn=0.91 oe_mis=0.70 oe_lof=0.55), C1QC (inh=AR oe_syn=1.15 oe_mis=0.90 oe_lof=0.42)
chr1	22653162	22653162	T	G	het	het	het		QUAL=24;DP=26,16,22;AF=0.62,0.31,0.41	C1QB	upstream_gene	C1QB:ENST00000695754.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695755.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695756.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695757.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695758.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695759.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695760.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695761.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000695762.1:upstream_gene_variant:MODIFIER::::,C1QB:ENST00000509305.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	120570_[GENE=C1QB_PHENOS=C1q deficiency 2, 620321 (3), Autosomal recessive]				rs291990	0.58374	0.84072,0.53552,0.64823,0.46271,0.60954	28015,	32712	63282	-1.0180	2.28				COSV59246057			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22653406	22653406	T	C	het	het	het		QUAL=24;DP=46,21,17;AF=0.41,0.48,0.59	C1QB	intron,5'UTR	C1QB:ENST00000695754.1:intron_variant:MODIFIER:intron1/2:c.-24+38T>C::,C1QB:ENST00000695755.1:5_prime_UTR_variant:MODIFIER:exon1/3:c.-88T>C::,C1QB:ENST00000695756.1:intron_variant:MODIFIER:intron1/3:c.-177+38T>C::,C1QB:ENST00000695757.1:5_prime_UTR_variant:MODIFIER:exon1/3:c.-44T>C::,C1QB:ENST00000695758.1:intron_variant:MODIFIER:intron1/2:c.-24+103T>C::,C1QB:ENST00000695759.1:intron_variant:MODIFIER:intron1/2:c.-24+103T>C::,C1QB:ENST00000695760.1:intron_variant:MODIFIER:intron1/2:c.-24+103T>C::,C1QB:ENST00000695761.1:intron_variant:MODIFIER:intron1/2:c.-24+103T>C::,C1QB:ENST00000695762.1:intron_variant:MODIFIER:intron1/2:c.-24+103T>C::,C1QB:ENST00000509305.6:intron_variant:MODIFIER:intron1/2:c.-24+103T>C::	regulatory_region_variant:open_chromatin_region	120570_[GENE=C1QB_PHENOS=C1q deficiency 2, 620321 (3), Autosomal recessive]			MER5A (DNA/hAT-Charlie)	rs291989	0.58367	0.84051,0.53551,0.64936,0.46246,0.60929	28039,	32721	63339	-0.6110	2.95			/0.4>0.0/1.4>1.6				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22653494	22653494	C	A	het	het	het		QUAL=24;DP=23,16,6;AF=0.48,0.50,0.33	C1QB	intron	C1QB:ENST00000695754.1:intron_variant:MODIFIER:intron1/2:c.-24+126C>A::,C1QB:ENST00000695755.1:intron_variant:MODIFIER:intron1/2:c.-24+24C>A::,C1QB:ENST00000695756.1:intron_variant:MODIFIER:intron1/3:c.-177+126C>A::,C1QB:ENST00000695757.1:intron_variant:MODIFIER:intron1/2:c.-24+68C>A::,C1QB:ENST00000695758.1:intron_variant:MODIFIER:intron1/2:c.-24+191C>A::,C1QB:ENST00000695759.1:intron_variant:MODIFIER:intron1/2:c.-24+191C>A::,C1QB:ENST00000695760.1:intron_variant:MODIFIER:intron1/2:c.-24+191C>A::,C1QB:ENST00000695761.1:intron_variant:MODIFIER:intron1/2:c.-24+191C>A::,C1QB:ENST00000695762.1:intron_variant:MODIFIER:intron1/2:c.-24+191C>A::,C1QB:ENST00000509305.6:intron_variant:MODIFIER:intron1/2:c.-24+191C>A::	regulatory_region_variant:open_chromatin_region	120570_[GENE=C1QB_PHENOS=C1q deficiency 2, 620321 (3), Autosomal recessive]				rs913243	0.43016	0.45944,0.42969,0.43830,0.41621,0.51474	14184,	37053	86663	0.7930	7.43			/1.9>2.2/0.0>0.0			21951915,29795138	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22659293	22659296	GATG	-	het	het	wt	low_conf_region	QUAL=24;DP=63,57,47;AF=0.32,0.60,0.00	C1QB	intron,upstream_gene	C1QB:ENST00000695754.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000695755.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000695756.1:intron_variant:MODIFIER:intron2/3:c.-23-115_-23-112del::,C1QB:ENST00000695757.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000695758.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000695759.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000695760.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000695761.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000695762.1:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000509305.6:intron_variant:MODIFIER:intron1/2:c.-23-115_-23-112del::,C1QB:ENST00000695763.1:upstream_gene_variant:MODIFIER::::		120570_[GENE=C1QB_PHENOS=C1q deficiency 2, 620321 (3), Autosomal recessive]	1252299 [benign DISEASE=not provided GENE=C1QB];		(GGAT)n (Simple_repeat)	rs56917855	0.08396	0.06819,0.06060,0.07120,0.09109,0.18088	468,	9875	117957	2.2220	1.41			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22659347	22659350	GATG	-	het	het	het	low_conf_region	QUAL=26;DP=107,83,67;AF=0.79,0.60,0.60	C1QB	intron,upstream_gene	C1QB:ENST00000695754.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000695755.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000695756.1:intron_variant:MODIFIER:intron2/3:c.-23-49_-23-46del::,C1QB:ENST00000695757.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000695758.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000695759.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000695760.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000695761.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000695762.1:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000509305.6:intron_variant:MODIFIER:intron1/2:c.-23-49_-23-46del::,C1QB:ENST00000695763.1:upstream_gene_variant:MODIFIER::::		120570_[GENE=C1QB_PHENOS=C1q deficiency 2, 620321 (3), Autosomal recessive]			(GGAT)n (Simple_repeat)	rs140338008	0.48124	0.50089,0.57521,0.60269,0.45338,0.47655	13970,	35102	67958	0.5560	1.89			/0.0>0.0/0.0>0.0		C1QB|0.00|0.00|0.00|0.00|-2|-14|8|4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	22661465	22661465	A	G	hom	hom	hom		QUAL=25;DP=192,373,348;AF=1.00,1.00,1.00	C1QB	3'UTR	C1QB:ENST00000695754.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:ENST00000695755.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:ENST00000695756.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*79A>G::,C1QB:ENST00000695757.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:ENST00000695758.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*405A>G::,C1QB:ENST00000695759.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*405A>G::,C1QB:ENST00000695760.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:ENST00000695761.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*405A>G::,C1QB:ENST00000695762.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:ENST00000509305.6:3_prime_UTR_variant:MODIFIER:exon3/3:c.*79A>G::,C1QB:ENST00000695763.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1004A>G::		120570_[GENE=C1QB_PHENOS=C1q deficiency 2, 620321 (3), Autosomal recessive]	1258616 [benign DISEASE=not provided GENE=C1QB];			rs10580	0.98407	0.99600,0.98974,1.00000,0.97598,0.99171	73711,	2389	2425	-1.0460	3.89			/0.0>1.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1QB (inh=AR oe_syn=1.09 oe_mis=0.71 oe_lof=0.33)
chr1	23796496	23796496	C	T	het	wt	het	low_conf_region	QUAL=24;DP=42,53,49;AF=0.57,0.00,0.41	GALE,LYPLA2	splice_region&intron,downstream_gene	GALE:ENST00000617979.5:splice_region_variant&intron_variant:LOW:intron10/11:c.873+13G>A::,GALE:ENST00000374497.7:splice_region_variant&intron_variant:LOW:intron10/11:c.873+13G>A::,LYPLA2:ENST00000374503.8:downstream_gene_variant:MODIFIER::::,LYPLA2:ENST00000374514.8:downstream_gene_variant:MODIFIER::::,LYPLA2:ENST00000374501.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	606953_[GENE=GALE_PHENOS=Thrombocytopenia 13, syndromic, 620776 (3), Autosomal recessive; Galactose epimerase deficiency, 230350 (3), Autosomal recessive]	92889 [benign DISEASE=not provided,UDPglucose-4-epimerase deficiency,not specified GENE=GALE];		G-rich (Low_complexity)	rs760941	0.67041	0.62064,0.69382,0.65214,0.68242,0.76515	19768,	33043	35681	-0.7980	1.78			/0.0>0.0/0.0>0.0	COSV100994767,COSV65720422,COSV65720626	GALE|0.00|0.00|0.00|0.00|39|-34|13|10	25741868,24033266,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYPLA2 (inh=n/a oe_syn=1.05 oe_mis=0.60 oe_lof=0.07), GALE (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.91)
chr1	23801977	23801977	C	T	hom	hom	het		QUAL=24;DP=129,321,306;AF=1.00,1.00,0.50	HMGCL,GALE	3'UTR,upstream_gene	HMGCL:ENST00000374490.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*486G>A::,HMGCL:ENST00000436439.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*486G>A::,GALE:ENST00000617979.5:upstream_gene_variant:MODIFIER::::,GALE:ENST00000374497.7:upstream_gene_variant:MODIFIER::::		606953_[GENE=GALE_PHENOS=Thrombocytopenia 13, syndromic, 620776 (3), Autosomal recessive; Galactose epimerase deficiency, 230350 (3), Autosomal recessive]&613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	296841 [benign DISEASE=not provided,Deficiency of hydroxymethylglutaryl-CoA lyase,UDPglucose-4-epimerase deficiency GENE=GALE];			rs11714	0.91301	0.92885,0.87822,0.83108,0.91382,0.87334	63512,	12050	13250	-0.9180	8.96			/4.6>3.7/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALE (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.91), HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23802636	23802636	A	G	het	hom	wt		QUAL=24;DP=51,135,93;AF=0.51,0.99,0.00	HMGCL,GALE	intron,upstream_gene	HMGCL:ENST00000374490.8:intron_variant:MODIFIER:intron8/8:c.877-72T>C::,HMGCL:ENST00000436439.6:intron_variant:MODIFIER:intron6/6:c.664-72T>C::,GALE:ENST00000617979.5:upstream_gene_variant:MODIFIER::::,GALE:ENST00000374497.7:upstream_gene_variant:MODIFIER::::		606953_[GENE=GALE_PHENOS=Thrombocytopenia 13, syndromic, 620776 (3), Autosomal recessive; Galactose epimerase deficiency, 230350 (3), Autosomal recessive]&613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	1177625 [benign DISEASE=not provided,Deficiency of hydroxymethylglutaryl-CoA lyase GENE=HMGCL];			rs2076343	0.26895	0.13721,0.24709,0.26507,0.33786,0.15679	6127,	28676	111256	1.3650	14.96			/0.9>0.0/0.0>0.0	COSV52526949	HMGCL|0.05|0.00|0.00|0.00|15|7|-20|17		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GALE (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.91), HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23804204	23804204	G	A	het	wt	het		QUAL=24;DP=75,18,30;AF=0.56,0.00,0.37	HMGCL,GALE	intron,upstream_gene	HMGCL:ENST00000374490.8:intron_variant:MODIFIER:intron8/8:c.876+196C>T::,HMGCL:ENST00000436439.6:intron_variant:MODIFIER:intron6/6:c.663+196C>T::,GALE:ENST00000617979.5:upstream_gene_variant:MODIFIER::::,GALE:ENST00000374497.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	606953_[GENE=GALE_PHENOS=Thrombocytopenia 13, syndromic, 620776 (3), Autosomal recessive; Galactose epimerase deficiency, 230350 (3), Autosomal recessive]&613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]			FRAM (SINE/Alu)	rs551491388	0.00175	0.00055,0.00079,0.00000,0.00307,0.00145	1,	264	151952	-0.5680	5.46			/0.0>0.0/0.0>0.0		HMGCL|0.00|0.00|0.00|0.00|-3|37|48|-17		0	126	0	0 / 0					GALE (inh=AR oe_syn=1.00 oe_mis=1.06 oe_lof=0.91), HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23807972	23807972	C	T	hom	hom	het		QUAL=24;DP=89,40,38;AF=0.99,1.00,0.63	HMGCL	intron	HMGCL:ENST00000374490.8:intron_variant:MODIFIER:intron7/8:c.750+163G>A::,HMGCL:ENST00000436439.6:intron_variant:MODIFIER:intron5/6:c.537+163G>A::	regulatory_region_variant:enhancer	613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	684182 [benign DISEASE=not provided GENE=HMGCL];		L2c (LINE/L2)	rs719399	0.92299	0.96618,0.88768,0.79078,0.91441,0.86686	64939,	10593	11721	-0.1450	1.00			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23808231	23808231	T	C	hom	hom	het		QUAL=24;DP=295,287,225;AF=1.00,1.00,0.53	HMGCL	synonymous	HMGCL:ENST00000374490.8:synonymous_variant:LOW:exon7/9:c.654A>G:p.Leu218=:PF00682 [HMGL-like],HMGCL:ENST00000436439.6:synonymous_variant:LOW:exon5/7:c.441A>G:p.Leu147=:PF00682 [HMGL-like]	regulatory_region_variant:enhancer	613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	92602 [benign DISEASE=not provided,Deficiency of hydroxymethylglutaryl-CoA lyase,not specified GENE=HMGCL];			rs719400	0.92294	0.96575,0.88770,0.79107,0.91454,0.86703	64921,	10602	11726	1.2340	8.60	0.080		/8.3>8.7/0.0>0.0		HMGCL|0.00|0.00|0.00|0.00|-20|-16|1|35	25741868,17847002,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23814521	23814521	C	T	het	hom	wt		QUAL=24;DP=97,44,17;AF=0.54,0.98,0.00	HMGCL	intron	HMGCL:ENST00000374490.8:intron_variant:MODIFIER:intron4/8:c.349-183G>A::,HMGCL:ENST00000436439.6:intron_variant:MODIFIER:intron4/6:c.348+2154G>A::		613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	673763 [benign DISEASE=not provided GENE=HMGCL];		AluSg (SINE/Alu)	rs11591205	0.26533	0.13207,0.23932,0.26152,0.33585,0.15311	5983,	28367	111679	0.2740	2.58			/1.1>1.4/2.6>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23817442	23817442	A	G	hom	hom	het		QUAL=24;DP=186,181,117;AF=0.99,1.00,0.50	HMGCL	intron	HMGCL:ENST00000374490.8:intron_variant:MODIFIER:intron3/8:c.252+34T>C::,HMGCL:ENST00000436439.6:intron_variant:MODIFIER:intron3/6:c.252+34T>C::		613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	255488 [benign DISEASE=Deficiency of hydroxymethylglutaryl-CoA lyase,not specified,not provided GENE=HMGCL];			rs2076344	0.92314	0.96578,0.88850,0.79147,0.91481,0.86703	64996,	10586	11704	-1.1720	1.32			/2.5>2.0/0.0>1.8			25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23825506	23825506	C	A	het	hom	het		QUAL=24;DP=23,35,34;AF=0.26,1.00,0.47	HMGCL	upstream_gene	HMGCL:ENST00000374490.8:upstream_gene_variant:MODIFIER::::,HMGCL:ENST00000436439.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	613898_[GENE=HMGCL_PHENOS=HMG-CoA lyase deficiency, 246450 (3), Autosomal recessive]	1177626 [benign DISEASE=not provided,Deficiency of hydroxymethylglutaryl-CoA lyase GENE=HMGCL];			rs6697805	0.40517	0.38251,0.38553,0.46471,0.42127,0.28374	12267,	36442	89518	-2.8170	0.73							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HMGCL (inh=AR oe_syn=1.02 oe_mis=0.90 oe_lof=0.67)
chr1	23845053	23845053	C	G	het	hom	het		QUAL=24;DP=30,36,40;AF=0.47,0.97,0.60	FUCA1	downstream_gene	FUCA1:ENST00000374479.4:downstream_gene_variant:MODIFIER::::		612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]				rs4649119	0.36537	0.22735,0.36023,0.47600,0.43135,0.28791	10654,	34166	96354	-0.2530	1.85						19442614	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	23854472	23854472	T	C	het	hom	wt		QUAL=24;DP=256,202,21;AF=0.50,1.00,0.00	FUCA1	missense	FUCA1:ENST00000374479.4:missense_variant:MODERATE:exon5/8:c.857A>G:p.Gln286Arg:PF01120 [Alpha-L-fucosidase]	regulatory_region_variant:CTCF_binding_site	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	691 [benign DISEASE=FU1/FU2 POLYMORPHISM,Fucosidosis,not provided GENE=FUCA1];			rs13551	0.26825	0.14471,0.23871,0.26438,0.33510,0.14777	6033,	28750	111340	0.6870	16.70	0.057	0.08	/0.0>0.0/0.0>0.0	COSV65698861	FUCA1|0.00|0.00|0.00|0.00|33|4|22|-2	7815431,17427030,8504303	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	23854687	23854687	C	T	het	hom	wt		QUAL=24;DP=137,27,21;AF=0.51,1.00,0.00	FUCA1	intron	FUCA1:ENST00000374479.4:intron_variant:MODIFIER:intron4/7:c.769-127G>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	683990 [benign DISEASE=not provided GENE=FUCA1];		MER20 (DNA/hAT-Charlie)	rs12748109	0.26511	0.13421,0.23689,0.26392,0.33509,0.14722	5940,	28419	111709	-0.3500	9.01			/1.3>0.9/0.0>0.0	COSV65698864	FUCA1|0.00|0.00|0.00|0.00|-15|32|-6|-27		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62)
chr1	23865710	23865710	A	G	het	hom	het		QUAL=24;DP=204,138,100;AF=0.53,0.99,0.55	FUCA1,CNR2	intron,downstream_gene	FUCA1:ENST00000374479.4:intron_variant:MODIFIER:intron1/7:c.390-85T>C::,CNR2:ENST00000374472.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region,TF_binding_site_variant	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	683925 [benign DISEASE=not provided GENE=FUCA1];			rs34902309	0.37618	0.26384,0.36812,0.47352,0.43151,0.28817	11107,	35019	94909	0.9330	8.59			/0.9>0.0/0.0>0.0	COSV65692469	FUCA1|0.00|0.00|0.00|0.00|37|10|47|37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	23868280	23868280	C	G	het	wt	het		QUAL=24;DP=148,16,107;AF=0.47,0.00,0.45	FUCA1,CNR2	missense,downstream_gene	FUCA1:ENST00000374479.4:missense_variant:MODERATE:exon1/8:c.7G>C:p.Ala3Pro:,CNR2:ENST00000374472.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	612280_[GENE=FUCA1_PHENOS=Fucosidosis, 230000 (3), Autosomal recessive]	296895 [benign/likely benign DISEASE=not provided,FUCA1-related disorder,Fucosidosis GENE=FUCA1];			rs61996282	0.00942	0.00226,0.04222,0.00000,0.00840,0.01636	21,	1393	150835	-2.1530	1.54	0.067	0.08	/0.0>0.0/0.0>0.0		FUCA1|0.00|0.00|0.00|0.00|8|-27|-13|16	25741868,34861174	4	633	0	0 / 0					FUCA1 (inh=AR oe_syn=0.97 oe_mis=0.85 oe_lof=0.62), CNR2 (inh=n/a oe_syn=1.04 oe_mis=0.86 oe_lof=0.97)
chr1	25800934	25800934	G	A	hom	het	hom		QUAL=24;DP=91,127,93;AF=1.00,0.56,1.00	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron1/12:c.184-109G>A::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron1/11:c.184-109G>A::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron1/11:c.184-109G>A::	regulatory_region_variant:open_chromatin_region	606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	669827 [benign DISEASE=not provided GENE=SELENON];			rs6659086	0.63202	0.77967,0.67510,0.64860,0.54880,0.73258	31206,	33508	55848	-0.9560	3.53			/0.0>0.0/0.0>0.0	COSV62525010	SEPN1|0.00|0.00|0.00|0.00|-23|1|12|-39	29777993	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25804968	25804968	G	A	het	wt	hom		QUAL=24;DP=115,20,34;AF=0.53,0.00,1.00	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron3/12:c.404-174G>A::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron2/11:c.302-174G>A::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron2/11:c.302-174G>A::	regulatory_region_variant:open_chromatin_region	606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	669829 [benign DISEASE=not provided GENE=SELENON];		MIRb (SINE/MIR)	rs11247735	0.50847	0.49222,0.62993,0.61133,0.48255,0.68433	19905,	37395	74633	-0.0180	2.59			/0.4>8.3/0.0>0.0	COSV62524936	SEPN1|0.01|0.00|0.00|0.00|2|-24|43|-24	22615972,27186328,31027226,25330801,29793041	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25805163	25805163	G	A	hom	het	hom		QUAL=24;DP=164,333,221;AF=0.99,0.52,1.00	SELENON	missense	SELENON:ENST00000361547.7:missense_variant:MODERATE:exon4/13:c.425G>A:p.Cys142Tyr:,SELENON:ENST00000374315.1:missense_variant:MODERATE:exon3/12:c.323G>A:p.Cys108Tyr:,SELENON:ENST00000354177.9:missense_variant:MODERATE:exon3/12:c.323G>A:p.Cys108Tyr:	regulatory_region_variant:open_chromatin_region	606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	95963 [benign DISEASE=not provided,not specified,Eichsfeld type congenital muscular dystrophy,SEPN1-related disorder GENE=SELENON];			rs7349185	0.79505	0.78067,0.85327,0.93493,0.78073,0.88655	48238,	24332	31142	0.8690	14.40	0.043		/2.4>1.6/0.0>1.8	COSV62525203		25741868,24033266,18414213,23757202,23800289,26673400,25332755,32817544	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25809961	25809961	A	C	hom	het	hom		QUAL=24;DP=62,141,88;AF=1.00,0.46,1.00	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron7/12:c.1010+141A>C::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron6/11:c.908+141A>C::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron6/11:c.839+141A>C::	regulatory_region_variant:open_chromatin_region	606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	669830 [benign DISEASE=not provided GENE=SELENON];			rs6686366	0.76800	0.67366,0.84060,0.97768,0.78237,0.89087	45277,	26188	35266	0.0430	4.57			/0.5>0.9/0.0>0.0		SEPN1|0.00|0.00|0.00|0.00|16|-29|15|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25811645	25811645	C	A	hom	het	hom		QUAL=24;DP=122,286,279;AF=1.00,0.53,1.00	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron8/12:c.1093-46C>A::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron7/11:c.991-46C>A::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron7/11:c.922-46C>A::	regulatory_region_variant:CTCF_binding_site	606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	261271 [benign DISEASE=Eichsfeld type congenital muscular dystrophy,not provided,not specified GENE=SELENON];			rs760598	0.69889	0.46892,0.80480,0.96584,0.76574,0.88517	38906,	28491	45799	0.9110	5.27			/0.0>0.0/0.0>0.0		SEPN1|0.00|0.00|0.00|0.00|16|46|-43|22	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25811771	25811771	T	C	hom	het	hom		QUAL=24;DP=180,372,353;AF=1.00,0.51,1.00	SELENON	synonymous	SELENON:ENST00000361547.7:synonymous_variant:LOW:exon9/13:c.1173T>C:p.Pro391=:,SELENON:ENST00000374315.1:synonymous_variant:LOW:exon8/12:c.1071T>C:p.Pro357=:,SELENON:ENST00000354177.9:synonymous_variant:LOW:exon8/12:c.1002T>C:p.Pro334=:	regulatory_region_variant:CTCF_binding_site	606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	95956 [benign DISEASE=Eichsfeld type congenital muscular dystrophy,not specified,SEPN1-related disorder,not provided GENE=SELENON];			rs760597	0.74941	0.61691,0.82813,0.96634,0.78122,0.88732	43500,	27063	38141	0.3020	9.18			/4.1>4.6/0.0>0.0	COSV62525913	SEPN1|0.00|0.00|0.00|0.00|19|5|4|17	25741868,24033266,18414213,23757202,23800289	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25811960	25811960	A	G	hom	het	hom		QUAL=24;DP=54,141,127;AF=1.00,0.49,0.99	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron9/12:c.1281+81A>G::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron8/11:c.1179+81A>G::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron8/11:c.1110+81A>G::		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	669832 [benign DISEASE=not provided GENE=SELENON];			rs11247744	0.74951	0.61677,0.82821,0.96658,0.78129,0.88721	43494,	27055	38113	0.0640	5.16			/4.3>4.0/0.0>0.0		SEPN1|0.00|0.00|0.00|0.00|-10|18|-1|5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25812480	25812480	C	T	hom	n/a	hom	low_conf_region	QUAL=25;DP=22,1,7;AF=1.00,0.00,1.00	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron9/12:c.1282-207C>T::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron8/11:c.1180-207C>T::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron8/11:c.1111-207C>T::		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]			(CA)n (Simple_repeat)	rs116343724	0.00018	0.00010,0.00020,0.00000,0.00024,0.00021	1,	26	151424	-2.7320	0.07			/0.0>0.0/0.0>0.0		SEPN1|0.00|0.00|0.00|0.00|31|23|-2|38		7728	11649	0	0 / 0					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25812646	25812646	C	T	hom	het	hom		QUAL=24;DP=19,70,54;AF=1.00,0.54,1.00	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron9/12:c.1282-41C>T::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron8/11:c.1180-41C>T::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron8/11:c.1111-41C>T::		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	261274 [benign DISEASE=not specified,Eichsfeld type congenital muscular dystrophy,not provided GENE=SELENON];			rs10902685	0.65816	0.29955,0.79306,0.96669,0.77998,0.88475	36519,	25894	51384	-0.0280	1.19			/0.0>0.0/0.0>0.0		SEPN1|0.00|0.00|0.00|0.00|41|-24|-34|40	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25812901	25812901	A	G	hom	het	hom		QUAL=24;DP=34,56,40;AF=1.00,0.45,1.00	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron10/12:c.1387+109A>G::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron9/11:c.1285+109A>G::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron9/11:c.1216+109A>G::		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	669834 [benign DISEASE=not provided GENE=SELENON];			rs3738451	0.75004	0.61882,0.82762,0.96594,0.78130,0.88684	43503,	27013	37999	-1.6750	0.10			/1.1>1.3/1.4>0.0		SEPN1|0.00|0.00|0.00|0.00|-15|13|-12|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25812953	25812953	G	A	hom	het	hom		QUAL=24;DP=20,25,25;AF=1.00,0.40,1.00	SELENON	intron	SELENON:ENST00000361547.7:intron_variant:MODIFIER:intron10/12:c.1387+161G>A::,SELENON:ENST00000374315.1:intron_variant:MODIFIER:intron9/11:c.1285+161G>A::,SELENON:ENST00000354177.9:intron_variant:MODIFIER:intron9/11:c.1216+161G>A::		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	669835 [benign DISEASE=not provided GENE=SELENON];		MIRc (SINE/MIR)	rs10751726	0.64978	0.29867,0.78438,0.96618,0.76489,0.88407	35929,	26894	53226	0.3650	7.81			/0.0>2.2/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25814082	25814082	C	A	hom	het	hom		QUAL=24;DP=172,438,326;AF=1.00,0.50,1.00	SELENON	missense	SELENON:ENST00000361547.7:missense_variant:MODERATE:exon12/13:c.1506C>A:p.Asn502Lys:,SELENON:ENST00000374315.1:missense_variant:MODERATE:exon11/12:c.1404C>A:p.Asn468Lys:,SELENON:ENST00000354177.9:missense_variant:MODERATE:exon11/12:c.1335C>A:p.Asn445Lys:		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	95959 [benign DISEASE=not specified,Eichsfeld type congenital muscular dystrophy,not provided,SEPN1-related disorder GENE=SELENON];			rs2294228	0.65823	0.30108,0.79254,0.96618,0.77964,0.88581	36901,	26313	51983	0.1400	13.56	0.085		/0.0>0.0/0.0>0.0	COSV62525671	RP1-317E23.6|0.01|0.02|0.00|0.00|22|-5|-5|47,SEPN1|0.33|0.00|0.00|0.00|22|-27|25|47	25741868,24033266,18414213,23757202,22615972,23800289,26673400,25332755	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69)
chr1	25817213	25817213	-	TTTTG	hom	het	hom		QUAL=24;DP=218,270,223;AF=0.82,0.39,0.98	SELENON,MTFR1L	3'UTR,downstream_gene,upstream_gene	SELENON:ENST00000361547.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1511_*1515dup::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1511_*1515dup::,SELENON:ENST00000354177.9:downstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000474295.5:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000374303.7:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000526894.5:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000524618.5:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000374307.9:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000374301.7:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000374300.7:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000466284.1:upstream_gene_variant:MODIFIER::::		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]				rs3033477	0.72253	0.52576,0.81685,0.96629,0.77964,0.88670	40681,	27549	41825		0.70			/0.0>0.6/0.0>0.0		RP1-317E23.6|0.00|0.00|0.00|0.00|23|47|17|-38,SEPN1|0.00|0.00|0.00|0.00|23|47|-8|-40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	25817330	25817330	T	C	hom	het	hom		QUAL=24;DP=128,269,179;AF=1.00,0.45,0.98	SELENON,MTFR1L	3'UTR,downstream_gene,upstream_gene	SELENON:ENST00000361547.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1612T>C::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1612T>C::,SELENON:ENST00000354177.9:downstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000474295.5:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000374303.7:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000526894.5:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000524618.5:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000374307.9:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000374301.7:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000374300.7:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000466284.1:upstream_gene_variant:MODIFIER::::		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	297050 [benign DISEASE=not provided,SEPN1-related disorder GENE=SELENON];		AluSx (SINE/Alu)	rs3203750	0.72058	0.51686,0.81703,0.96659,0.78059,0.88725	40899,	27706	42462	0.3080	2.46			/1.6>1.9/0.0>0.0			27586304	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	25817440	25817440	T	C	hom	het	hom		QUAL=24;DP=158,332,229;AF=1.00,0.45,1.00	SELENON,MTFR1L	3'UTR,downstream_gene,upstream_gene	SELENON:ENST00000361547.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*1722T>C::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1722T>C::,SELENON:ENST00000354177.9:downstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000474295.5:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000374303.7:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000526894.5:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000524618.5:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000374307.9:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000374301.7:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000374300.7:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000466284.1:upstream_gene_variant:MODIFIER::::		606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	297053 [benign DISEASE=SEPN1-related disorder,not provided GENE=SELENON];		AluSx (SINE/Alu)	rs4659383	0.81025	0.82382,0.85041,0.97740,0.78259,0.89166	50167,	22949	28871	-1.2160	0.84			/5.5>4.8/0.0>0.0		RP1-317E23.6|0.00|0.00|0.00|0.00|-43|11|-43|10,SEPN1|0.00|0.00|0.00|0.00|-40|11|46|10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	25817947	25817947	C	-	hom	het	hom		QUAL=24;DP=59,115,93;AF=0.98,0.64,1.00	SELENON,MTFR1L	3'UTR,downstream_gene,upstream_gene	SELENON:ENST00000361547.7:3_prime_UTR_variant:MODIFIER:exon13/13:c.*2236del::,SELENON:ENST00000374315.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2236del::,SELENON:ENST00000354177.9:downstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000474295.5:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000374303.7:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000526894.5:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000524618.5:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000374307.9:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000374301.7:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000374300.7:upstream_gene_variant:MODIFIER::::,MTFR1L:ENST00000466284.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site	606210_[GENE=SELENON_PHENOS=Congenital myopathy 3 with rigid spine, 602771 (3), Autosomal recessive]	297061 [uncertain significance DISEASE=SEPN1-related disorder,not provided GENE=SELENON];			rs371383269	0.72524	0.52796,0.82171,0.96653,0.78263,0.88660	41218,	27603	41689	-0.8170	1.26			/7.8>8.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SELENON (inh=AR+AD oe_syn=1.15 oe_mis=0.93 oe_lof=0.69), MTFR1L (inh=n/a oe_syn=1.16 oe_mis=0.77 oe_lof=0.24)
chr1	26177705	26177705	C	G	het	wt	het		QUAL=24;DP=140,28,107;AF=0.60,0.00,0.48	CNKSR1	intron,upstream_gene	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron1/20:c.52+106C>G::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron1/20:c.52+106C>G::,CNKSR1:ENST00000531191.5:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region				AluSx1 (SINE/Alu)	rs2783707	0.41063	0.59806,0.50144,0.65093,0.28714,0.48277	14638,	33172	89632	-0.9920	1.21			/0.0>0.0/4.4>3.5		CNKSR1|0.00|0.00|0.00|0.00|-5|39|-1|39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26180262	26180262	A	G	het	wt	het		QUAL=25;DP=50,6,5;AF=0.42,0.00,0.40	CNKSR1	intron,5'UTR	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron1/20:c.53-191A>G::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron1/20:c.53-191A>G::,CNKSR1:ENST00000531191.5:5_prime_UTR_variant:MODIFIER:exon1/20:c.-913A>G::					MER5A (DNA/hAT-Charlie)	rs1889737	0.25150	0.45450,0.36890,0.63934,0.09949,0.39917	7397,	23465	113867	0.0920	6.40			/0.6>0.0/0.0>0.0		CNKSR1|0.00|0.00|0.00|0.00|-42|-36|-44|-36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26180299	26180299	A	G	het	wt	het		QUAL=24;DP=59,16,16;AF=0.47,0.00,0.31	CNKSR1	intron,5'UTR	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron1/20:c.53-154A>G::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron1/20:c.53-154A>G::,CNKSR1:ENST00000531191.5:5_prime_UTR_variant:MODIFIER:exon1/20:c.-876A>G::					MIRb (SINE/MIR)	rs1889738	0.25131	0.45427,0.36861,0.63926,0.09957,0.39866	7374,	23438	113762	0.8660	4.64			/6.7>2.6/0.0>0.0		CNKSR1|0.00|0.00|0.00|0.00|26|2|43|35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26181802	26181802	G	A	het	wt	het		QUAL=24;DP=109,56,206;AF=0.50,0.00,0.51	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron3/20:c.393-55G>A::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron3/20:c.393-55G>A::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron2/19:c.-382-55G>A::	regulatory_region_variant:promoter				MIRb (SINE/MIR)	rs3819033	0.12497	0.02701,0.31389,0.60050,0.09626,0.39531	2682,	13649	133127	0.6040	7.27			/0.0>0.0/0.0>0.0	COSV64163468	CNKSR1|0.00|0.00|0.00|0.00|-44|-49|-23|-49	24560374,32450446	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26181989	26181989	T	C	het	wt	het		QUAL=24;DP=116,56,246;AF=0.43,0.00,0.53	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron4/20:c.477+48T>C::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron4/20:c.477+48T>C::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron3/19:c.-298+48T>C::	regulatory_region_variant:promoter					rs2275945	0.16450	0.15727,0.32849,0.64438,0.09716,0.39880	3425,	18188	127166	0.3060	8.72			/0.0>0.0/0.0>0.0		CNKSR1|0.00|0.00|0.00|0.00|37|31|42|-48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26185209	26185209	A	G	hom	hom	hom		QUAL=24;DP=161,265,212;AF=1.00,1.00,1.00	CNKSR1	intron	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron14/20:c.1308+23A>G::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron14/20:c.1329+23A>G::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron13/19:c.534+23A>G::						rs2783680	0.59057	0.46814,0.69949,0.97214,0.58871,0.80739	27523,	34664	62194	-0.7820	0.07			/2.1>0.0/9.9>7.5		CNKSR1|0.00|0.00|0.00|0.00|9|1|-23|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00)
chr1	26189039	26189045	CCAGACT	-	hom	hom	hom		QUAL=24;DP=32,41,30;AF=0.94,1.00,1.00	CNKSR1,CATSPER4	intron,upstream_gene	CNKSR1:ENST00000361530.11:intron_variant:MODIFIER:intron20/20:c.1872+101_1872+107del::,CNKSR1:ENST00000374253.9:intron_variant:MODIFIER:intron20/20:c.1893+101_1893+107del::,CNKSR1:ENST00000531191.5:intron_variant:MODIFIER:intron19/19:c.1098+101_1098+107del::,CATSPER4:ENST00000456354.7:upstream_gene_variant:MODIFIER::::						rs11278474	0.95305	0.83884,0.98054,0.99942,0.99882,0.99917	69372,	5993	7131	1.0370	3.72			/1.3>1.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CNKSR1 (inh=n/a oe_syn=1.00 oe_mis=0.92 oe_lof=1.00), CATSPER4 (inh=n/a oe_syn=0.99 oe_mis=0.94 oe_lof=0.77)
chr1	27369520	27369520	C	T	hom	hom	hom		QUAL=24;DP=146,211,231;AF=1.00,1.00,1.00	FCN3,MAP3K6	intron,upstream_gene,downstream_gene	FCN3:ENST00000270879.9:intron_variant:MODIFIER:intron7/7:c.659-43G>A::,FCN3:ENST00000354982.2:intron_variant:MODIFIER:intron6/6:c.626-43G>A::,MAP3K6:ENST00000357582.3:upstream_gene_variant:MODIFIER::::,MAP3K6:ENST00000374040.7:upstream_gene_variant:MODIFIER::::,FCN3:ENST00000699963.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:open_chromatin_region	604973_[GENE=FCN3_PHENOS=Immunodeficiency due to ficolin 3 deficiency, 613860 (3), Autosomal recessive]			MIRb (SINE/MIR)	rs10218730	0.99253	0.97374,0.99791,1.00000,0.99997,0.99979	75066,	1108	1138	-0.5380	1.56			/0.0>0.0/0.0>2.2				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MAP3K6 (inh=n/a oe_syn=0.86 oe_mis=0.87 oe_lof=0.58), FCN3 (inh=AR oe_syn=0.74 oe_mis=0.91 oe_lof=0.45)
chr1	27372958	27372958	A	T	hom	hom	hom		QUAL=24;DP=31,9,16;AF=1.00,1.00,1.00	FCN3	intron	FCN3:ENST00000270879.9:intron_variant:MODIFIER:intron5/7:c.393+178T>A::,FCN3:ENST00000354982.2:intron_variant:MODIFIER:intron4/6:c.360+178T>A::,FCN3:ENST00000699963.1:intron_variant:MODIFIER:intron5/6:c.393+178T>A::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	604973_[GENE=FCN3_PHENOS=Immunodeficiency due to ficolin 3 deficiency, 613860 (3), Autosomal recessive]	992482 [uncertain significance DISEASE=Rheumatic heart disease GENE=FCN3];			rs10794501	0.69450	0.54014,0.76474,0.89969,0.73950,0.79257	37474,	30510	46390	-0.1530	3.56			/0.0>0.0/4.0>1.4			22471352,33591573,19220833,33499929	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FCN3 (inh=AR oe_syn=0.74 oe_mis=0.91 oe_lof=0.45)
chr1	32780201	32780201	C	G	het	het	het		QUAL=24;DP=263,252,187;AF=0.54,0.46,0.61	YARS1	synonymous	YARS1:ENST00000373477.9:synonymous_variant:LOW:exon11/13:c.1218G>C:p.Leu406=:PF01588 [Putative tRNA binding domain],YARS1:ENST00000675785.2:synonymous_variant:LOW:exon10/12:c.1071G>C:p.Leu357=:PF01588 [Putative tRNA binding domain]		603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	297151 [benign DISEASE=not provided,not specified,Charcot-Marie-Tooth disease dominant intermediate C GENE=YARS1];			rs699005	0.10356	0.10041,0.16713,0.00174,0.10200,0.05903	907,	13946	136430	3.9130	6.69			/0.0>0.0/3.9>0.0		YARS|0.00|0.00|0.02|0.00|-7|49|12|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32780839	32780839	T	C	het	wt	het		QUAL=24;DP=98,37,35;AF=0.42,0.00,0.54	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron10/12:c.1140+209A>G::,YARS1:ENST00000675785.2:intron_variant:MODIFIER:intron9/11:c.993+209A>G::	regulatory_region_variant:promoter,TF_binding_site_variant	603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	1253354 [benign DISEASE=not provided GENE=YARS1];			rs2282293	0.13724	0.03401,0.12243,0.21034,0.18015,0.22978	1784,	17326	131350	-0.2280	2.70			/0.0>0.0/0.0>0.0	COSV65113845	YARS|0.00|0.00|0.00|0.00|13|-49|-12|7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32782196	32782196	G	T	het	het	het		QUAL=25;DP=40,23,30;AF=0.50,0.48,0.57	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron9/12:c.1042+208C>A::,YARS1:ENST00000675785.2:intron_variant:MODIFIER:intron8/11:c.895+208C>A::	regulatory_region_variant:promoter	603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	670891 [benign DISEASE=not provided GENE=YARS1];			rs699004	0.07912	0.01776,0.15595,0.00174,0.10112,0.05904	668,	10692	140002	-0.2010	3.16			/0.0>5.1/0.0>0.6		YARS|0.00|0.00|0.00|0.00|-2|23|40|-22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32786499	32786521	CACATGCATGACTATTCCTAGCC	-	het	wt	het		QUAL=24;DP=165,29,284;AF=0.33,0.00,0.56	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron7/12:c.821-74_821-52del::,YARS1:ENST00000675785.2:intron_variant:MODIFIER:intron6/11:c.674-74_674-52del::		603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	1175561 [benign DISEASE=not provided GENE=YARS1];		L2d (LINE/L2)	rs149745059	0.13685	0.03398,0.12176,0.21009,0.17963,0.22809	1776,	17263	131291	1.7760	12.59			/2.0>0.0/5.0>5.0		YARS|0.00|0.00|0.00|0.00|-50|-6|-20|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32791044	32791044	G	C	het	het	het		QUAL=24;DP=192,92,63;AF=0.57,0.57,0.52	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron6/12:c.684+118C>G::,YARS1:ENST00000675785.2:intron_variant:MODIFIER:intron5/11:c.537+118C>G::		603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	670889 [benign DISEASE=not provided GENE=YARS1];			rs881393	0.17358	0.26297,0.21444,0.00212,0.13846,0.06698	2667,	21059	125655	0.5200	3.02			/2.9>1.4/0.0>0.0		YARS|0.00|0.00|0.00|0.00|0|17|1|12	27903959	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32791283	32791283	C	A	hom	het	hom		QUAL=24;DP=239,263,165;AF=0.99,0.52,0.99	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron5/12:c.592-29G>T::,YARS1:ENST00000675785.2:intron_variant:MODIFIER:intron4/11:c.445-29G>T::		603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	670888 [benign DISEASE=not provided GENE=YARS1];			rs1765223	0.31188	0.30041,0.33737,0.21260,0.31852,0.29714	7504,	32387	104573	1.2110	9.38			/0.0>0.0/0.0>0.0	COSV65113032	YARS|0.00|0.00|0.00|0.00|-29|-32|-41|-29		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32810823	32810823	G	A	hom	hom	hom		QUAL=24;DP=149,212,158;AF=0.99,1.00,1.00	YARS1	intron	YARS1:ENST00000373477.9:intron_variant:MODIFIER:intron2/12:c.205-57C>T::,YARS1:ENST00000675785.2:intron_variant:MODIFIER:intron1/11:c.58-57C>T::	regulatory_region_variant:enhancer	603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	670335 [benign DISEASE=not provided GENE=YARS1];			rs4951787	0.98736	0.95636,0.99555,1.00000,0.99979,1.00000	74226,	1840	1924	-0.4320	0.39			/0.0>0.0/5.6>1.5				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37)
chr1	32817174	32817174	C	A	het	het	het		QUAL=24;DP=123,103,71;AF=0.49,0.44,0.51	YARS1,S100PBP	splice_region&intron,upstream_gene	YARS1:ENST00000373477.9:splice_region_variant&intron_variant:LOW:intron1/12:c.57+14G>T::,YARS1:ENST00000675785.2:splice_region_variant&intron_variant:LOW:intron1/11:c.57+14G>T::,S100PBP:ENST00000373476.5:upstream_gene_variant:MODIFIER::::,S100PBP:ENST00000373475.10:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	603623_[GENE=YARS1_PHENOS=Infantile-onset multisystem neurologic, endocrine, and pancreatic disease 2, 619418 (3), Autosomal recessive; Charcot-Marie-Tooth disease, dominant intermediate C, 608323 (3), Autosomal dominant]	297163 [benign DISEASE=not provided,Charcot-Marie-Tooth disease dominant intermediate C,not specified GENE=YARS1];			rs72654020	0.10194	0.09484,0.16656,0.00173,0.10194,0.05814	892,	13738	136742	-0.2670	5.70			/0.0>0.0/0.0>0.0		YARS|0.00|0.00|0.01|0.01|13|34|-34|14		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					YARS1 (inh=AR+AD oe_syn=1.10 oe_mis=0.81 oe_lof=0.37), S100PBP (inh=n/a oe_syn=1.12 oe_mis=0.99 oe_lof=0.11)
chr1	34782639	34782639	G	C	wt	het	het		QUAL=24;DP=47,36,22;AF=0.00,0.50,0.36	GJB3	intron	GJB3:ENST00000373366.3:intron_variant:MODIFIER:intron1/1:c.-26+861G>C::,GJB3:ENST00000373362.3:intron_variant:MODIFIER:intron1/1:c.-26+197G>C::	regulatory_region_variant:open_chromatin_region	603324_[GENE=GJB3_PHENOS=Deafness, digenic, GJB2/GJB3, 220290 (3), Autosomal recessive, Digenic dominant; Erythrokeratodermia variabilis et progressiva 1, 133200 (3), Autosomal recessive, Autosomal dominant; Deafness, autosomal dominant 2B, with or without peripheral neuropathy, 612644 (3), Autosomal dominant]				rs9426014	0.29425	0.52880,0.17454,0.14319,0.21034,0.09097	8298,	28110	107224	0.1660	5.98			/2.4>10.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJB3 (inh=AR+AD oe_syn=0.87 oe_mis=1.11 oe_lof=0.63)
chr1	34785628	34785628	G	A	wt	het	het		QUAL=24;DP=50,249,291;AF=0.00,0.47,0.55	GJB3	3'UTR	GJB3:ENST00000373366.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::,GJB3:ENST00000373362.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*53G>A::	regulatory_region_variant:CTCF_binding_site	603324_[GENE=GJB3_PHENOS=Deafness, digenic, GJB2/GJB3, 220290 (3), Autosomal recessive, Digenic dominant; Erythrokeratodermia variabilis et progressiva 1, 133200 (3), Autosomal recessive, Autosomal dominant; Deafness, autosomal dominant 2B, with or without peripheral neuropathy, 612644 (3), Autosomal dominant]	297196 [benign DISEASE=not provided,Erythrokeratodermia variabilis et progressiva 1 GENE=GJB3];			rs476220	0.47813	0.61855,0.38701,0.17729,0.44120,0.26674	18272,	36073	79261	-0.1210	2.57			/1.7>0.0/3.3>1.3	COSV64904373	GJB3|0.00|0.00|0.00|0.00|2|10|9|-40	33126609	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJB3 (inh=AR+AD oe_syn=0.87 oe_mis=1.11 oe_lof=0.63)
chr1	39026255	39026255	G	C	het	het	hom		QUAL=24;DP=72,103,84;AF=0.46,0.50,1.00	NDUFS5	upstream_gene	NDUFS5:ENST00000372967.3:upstream_gene_variant:MODIFIER::::,NDUFS5:ENST00000372969.8:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant					rs1984600	0.70339	0.49507,0.66360,0.42134,0.84907,0.50042	39653,	27466	45024	-0.2760	5.51							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39026408	39026408	G	T	het	het	hom		QUAL=24;DP=93,115,91;AF=0.53,0.48,1.00	NDUFS5	splice_region&intron	NDUFS5:ENST00000372967.3:splice_region_variant&intron_variant:LOW:intron1/2:c.-3+10G>T::,NDUFS5:ENST00000372969.8:splice_region_variant&intron_variant:LOW:intron1/2:c.-3+6G>T::	regulatory_region_variant:open_chromatin_region,TF_binding_site_variant					rs1122472	0.70133	0.48780,0.66319,0.42243,0.84909,0.50021	39521,	27474	45362	-1.2850	0.43			/0.0>0.0/6.5>7.9			37810965	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39028994	39028994	-	T	wt	het	hom	low_conf_region	QUAL=24;DP=148,112,87;AF=0.23,0.32,0.69	NDUFS5	intron	NDUFS5:ENST00000372967.3:intron_variant:MODIFIER:intron2/2:c.216+69dup::,NDUFS5:ENST00000372969.8:intron_variant:MODIFIER:intron2/2:c.216+69dup::	regulatory_region_variant:open_chromatin_region					rs35464164	0.69563	0.48151,0.65848,0.42168,0.84376,0.49978	35857,	26009	42759		0.45			/3.8>3.9/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39029015	39029015	G	A	het	het	hom	low_conf_region	QUAL=25;DP=177,127,99;AF=0.42,0.45,1.00	NDUFS5	intron	NDUFS5:ENST00000372967.3:intron_variant:MODIFIER:intron2/2:c.216+75G>A::,NDUFS5:ENST00000372969.8:intron_variant:MODIFIER:intron2/2:c.216+75G>A::	regulatory_region_variant:open_chromatin_region				AluSq10 (SINE/Alu)	rs3768323	0.70381	0.49359,0.66458,0.42037,0.84943,0.49978	38541,	26591	43629	0.6170	3.01			/3.8>2.1/0.0>0.0		NDUFS5|0.00|0.00|0.00|0.00|23|-2|-8|26		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	39029088	39029088	G	A	het	het	hom		QUAL=24;DP=109,65,43;AF=0.48,0.40,1.00	NDUFS5	intron	NDUFS5:ENST00000372967.3:intron_variant:MODIFIER:intron2/2:c.216+148G>A::,NDUFS5:ENST00000372969.8:intron_variant:MODIFIER:intron2/2:c.216+148G>A::	regulatory_region_variant:open_chromatin_region				AluSq10 (SINE/Alu)	rs3768322	0.70353	0.49446,0.66384,0.42060,0.84917,0.50147	39427,	27280	44726	0.4830	7.11			/5.5>5.1/2.8>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NDUFS5 (inh=n/a oe_syn=0.73 oe_mis=1.00 oe_lof=0.53)
chr1	40073404	40073404	C	T	hom	het	het		QUAL=24;DP=123,225,208;AF=1.00,0.51,0.39	PPT1,CAP1	3'UTR,downstream_gene	PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*657G>A::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*657G>A::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*657G>A::,PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*657G>A::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*788G>A::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*657G>A::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*657G>A::,CAP1:ENST00000372797.7:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000372802.5:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000372792.7:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000372805.8:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000372798.5:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000340450.7:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297230 [benign DISEASE=not provided,Neuronal ceroid lipofuscinosis 1 GENE=PPT1];			rs1126973	0.70161	0.62049,0.69552,0.65711,0.74153,0.66390	37605,	31483	45375	0.4510	8.55			/0.0>0.0/1.2>0.0		PPT1|0.00|0.00|0.00|0.00|49|-39|21|6	17145094	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40073531	40073531	-	TGAT	hom	het	het		QUAL=24;DP=142,382,358;AF=0.87,0.46,0.43	PPT1,CAP1	3'UTR,downstream_gene	PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*526_*529dup::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*526_*529dup::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*526_*529dup::,PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*526_*529dup::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*657_*660dup::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*526_*529dup::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*526_*529dup::,CAP1:ENST00000372797.7:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000372802.5:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000372792.7:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000372805.8:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000372798.5:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000340450.7:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297233 [benign DISEASE=not provided,Neuronal ceroid lipofuscinosis 1,Neuronal Ceroid-Lipofuscinosis, Recessive GENE=PPT1];			rs397730033	0.66048	0.49599,0.66041,0.61801,0.73865,0.65774	33892,	32417	51509		6.86			/3.5>3.5/0.0>0.0		PPT1|0.00|0.00|0.00|0.00|-40|40|40|24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40073556	40073556	G	C	hom	het	het		QUAL=24;DP=154,418,403;AF=1.00,0.47,0.46	PPT1,CAP1	3'UTR,downstream_gene	PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*505C>G::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*505C>G::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*505C>G::,PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*505C>G::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*636C>G::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*505C>G::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*505C>G::,CAP1:ENST00000372797.7:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000372802.5:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000372792.7:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000372805.8:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000372798.5:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000340450.7:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297234 [benign DISEASE=not provided,Neuronal ceroid lipofuscinosis 1 GENE=PPT1];			rs1126972	0.69730	0.60613,0.69458,0.65652,0.74123,0.66348	37205,	31597	46019	-0.6230	4.19			/7.1>0.6/5.9>4.8		PPT1|0.00|0.00|0.00|0.00|15|-3|1|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40073776	40073776	A	C	hom	het	het		QUAL=24;DP=262,354,391;AF=0.99,0.44,0.52	PPT1,CAP1	3'UTR,downstream_gene	PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*285T>G::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*285T>G::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*285T>G::,PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*285T>G::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*416T>G::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*285T>G::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*285T>G::,CAP1:ENST00000372797.7:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000372802.5:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000372792.7:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000372805.8:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000372798.5:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000340450.7:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297240 [benign DISEASE=not provided,Neuronal ceroid lipofuscinosis 1 GENE=PPT1];			rs1126970	0.69747	0.60628,0.69420,0.65763,0.74149,0.66404	37233,	31602	46008	1.3970	12.47			/0.0>0.0/0.8>0.0		PPT1|0.00|0.00|0.00|0.00|0|30|0|-41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40073900	40073900	A	G	het	het	wt		QUAL=24;DP=101,207,22;AF=0.55,0.47,0.00	PPT1,CAP1	3'UTR,downstream_gene	PPT1:ENST00000641471.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*161T>C::,PPT1:ENST00000530076.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*161T>C::,PPT1:ENST00000642050.2:3_prime_UTR_variant:MODIFIER:exon9/9:c.*161T>C::,PPT1:ENST00000433473.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*161T>C::,PPT1:ENST00000641319.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*292T>C::,PPT1:ENST00000439754.6:3_prime_UTR_variant:MODIFIER:exon8/8:c.*161T>C::,PPT1:ENST00000449045.7:3_prime_UTR_variant:MODIFIER:exon6/6:c.*161T>C::,CAP1:ENST00000372797.7:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000372802.5:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000372792.7:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000372805.8:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000372798.5:downstream_gene_variant:MODIFIER::::,CAP1:ENST00000340450.7:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297242 [benign DISEASE=not provided,Neuronal ceroid lipofuscinosis 1 GENE=PPT1];			rs11552578	0.11557	0.16539,0.09941,0.15472,0.07396,0.19988	1194,	15204	134630	2.4760	16.05			/0.0>0.0/0.0>0.0	COSV61222731	PPT1|0.00|0.00|0.00|0.00|17|2|-37|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAP1 (inh=n/a oe_syn=0.93 oe_mis=0.78 oe_lof=0.30), PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40080292	40080292	T	G	hom	het	het		QUAL=24;DP=282,144,126;AF=1.00,0.47,0.45	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron7/9:c.714+105A>C::,PPT1:ENST00000530076.6:intron_variant:MODIFIER:intron2/4:c.-31+105A>C::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron6/8:c.627+105A>C::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron6/8:c.624+105A>C::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron6/9:c.627+105A>C::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron6/7:c.627+105A>C::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron3/5:c.318+105A>C::		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	1180456 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not specified,not provided GENE=PPT1];			rs3122428	0.73933	0.71146,0.70753,0.74487,0.74999,0.75901	41554,	29288	39628	-0.6460	1.49			/4.9>5.4/0.0>0.0	COSV65655125	PPT1|0.00|0.00|0.00|0.00|2|-33|-13|-4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40080537	40080537	C	T	het	het	wt		QUAL=24;DP=237,290,48;AF=0.49,0.49,0.00	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron6/9:c.624-50G>A::,PPT1:ENST00000530076.6:intron_variant:MODIFIER:intron1/4:c.-121-50G>A::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron5/8:c.537-50G>A::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron5/8:c.534-50G>A::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron5/9:c.537-50G>A::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron5/7:c.537-50G>A::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron2/5:c.228-50G>A::	regulatory_region_variant:enhancer	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	1180457 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided GENE=PPT1];			rs77623018	0.05934	0.01622,0.06840,0.13543,0.05569,0.14712	443,	8136	143012	-2.3850	0.42			/4.0>3.5/0.0>0.0	COSV65655090	PPT1|0.00|0.00|0.00|0.00|-18|36|30|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40089649	40089649	C	T	het	wt	het	low_conf_region	QUAL=24;DP=89,39,63;AF=0.49,0.00,0.46	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron5/9:c.521-137G>A::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron4/8:c.434-137G>A::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron4/8:c.431-137G>A::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron4/9:c.434-137G>A::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron4/7:c.434-137G>A::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-137G>A::		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	668044 [benign DISEASE=not specified,not provided GENE=PPT1];			rs3131651	0.50612	0.29676,0.52393,0.44882,0.61696,0.46707	21018,	34903	75077	-2.7140	0.01			/2.0>1.1/0.0>0.0	COSV65655885	PPT1|0.00|0.00|0.00|0.00|-23|8|22|-41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40091250	40091250	T	C	hom	hom	hom		QUAL=24;DP=136,191,173;AF=1.00,1.00,1.00	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron5/9:c.520+79A>G::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron4/8:c.433+79A>G::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron4/8:c.430+79A>G::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron4/9:c.433+79A>G::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron4/7:c.433+79A>G::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-1738A>G::	regulatory_region_variant:open_chromatin_region	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	1180458 [benign DISEASE=not specified,Neuronal ceroid lipofuscinosis 1,not provided GENE=PPT1];			rs3122439	0.99445	0.98030,0.99882,1.00000,1.00000,0.99979	75341,	821	845	-0.2180	0.25			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40091361	40091361	A	G	het	het	wt		QUAL=24;DP=434,350,23;AF=0.45,0.48,0.00	PPT1	missense,intron	PPT1:ENST00000641471.1:missense_variant:MODERATE:exon5/10:c.488T>C:p.Ile163Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000642050.2:missense_variant:MODERATE:exon4/9:c.401T>C:p.Ile134Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000433473.8:missense_variant:MODERATE:exon4/9:c.398T>C:p.Ile133Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000641319.1:missense_variant:MODERATE:exon4/10:c.401T>C:p.Ile134Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000439754.6:missense_variant:MODERATE:exon4/8:c.401T>C:p.Ile134Thr:PF02089 [Palmitoyl protein thioesterase],PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-1849T>C::	regulatory_region_variant:open_chromatin_region	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	130022 [benign DISEASE=not provided,not specified,Neuronal ceroid lipofuscinosis 1,Inborn genetic diseases GENE=PPT1];			rs1800205	0.04676	0.00963,0.03506,0.12293,0.04698,0.12718	303,	6511	145089	0.6890	17.86	0.199	0.17	/0.0>0.0/0.0>0.0	COSV65655693	PPT1|0.00|0.00|0.00|0.00|30|38|43|-32	25741868,19054571	111	3163	0	0 / 0					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40091984	40091984	G	A	hom	hom	het		QUAL=24;DP=99,60,68;AF=1.00,1.00,0.49	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron4/9:c.449+61C>T::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron3/8:c.362+61C>T::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron3/8:c.359+61C>T::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron3/9:c.362+61C>T::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron3/7:c.362+61C>T::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-2472C>T::		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	670733 [benign DISEASE=not provided,not specified,Neuronal ceroid lipofuscinosis 1 GENE=PPT1];			rs6672053	0.64659	0.49235,0.61302,0.67317,0.71892,0.67296	32547,	33218	53734	0.5120	2.58			/10.0>9.7/0.6>0.0		PPT1|0.00|0.00|0.00|0.00|-27|-3|44|-3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40092584	40092584	C	G	hom	hom	hom		QUAL=24;DP=136,97,68;AF=1.00,1.00,1.00	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron2/9:c.212-77G>C::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron1/8:c.125-77G>C::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron1/8:c.125-80G>C::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron1/9:c.125-77G>C::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron1/7:c.125-77G>C::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-3072G>C::		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	1180459 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided GENE=PPT1];		L1MB5 (LINE/L1)	rs4481840	0.99501	0.98227,0.99889,1.00000,1.00000,0.99979	75425,	741	761	0.2390	3.59			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40092673	40092673	T	A	hom	hom	het		QUAL=24;DP=62,15,14;AF=1.00,1.00,0.43	PPT1	intron	PPT1:ENST00000641471.1:intron_variant:MODIFIER:intron2/9:c.212-166A>T::,PPT1:ENST00000642050.2:intron_variant:MODIFIER:intron1/8:c.125-166A>T::,PPT1:ENST00000433473.8:intron_variant:MODIFIER:intron1/8:c.125-169A>T::,PPT1:ENST00000641319.1:intron_variant:MODIFIER:intron1/9:c.125-166A>T::,PPT1:ENST00000439754.6:intron_variant:MODIFIER:intron1/7:c.125-166A>T::,PPT1:ENST00000449045.7:intron_variant:MODIFIER:intron1/5:c.125-3161A>T::		600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	668040 [benign DISEASE=not provided GENE=PPT1];		L1MB5 (LINE/L1)	rs4492608	0.64801	0.49275,0.61408,0.67356,0.72115,0.67499	32546,	33209	53397	-1.1650	0.84			/0.0>0.5/0.0>0.0		PPT1|0.00|0.00|0.00|0.00|43|-27|25|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40097321	40097321	T	C	hom	hom	hom		QUAL=24;DP=36,97,57;AF=1.00,1.00,1.00	PPT1	upstream_gene	PPT1:ENST00000641471.1:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000642050.2:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000433473.8:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000641319.1:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000439754.6:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000449045.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297250 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided,not specified GENE=PPT1];			rs6600313	0.84409	0.75479,0.83201,0.88420,0.88793,0.88022	54496,	19484	23730	-0.6120	5.65					PPT1|0.00|0.00|0.00|0.00|-48|6|1|7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40097347	40097347	G	T	het	het	wt		QUAL=25;DP=30,83,18;AF=0.60,0.53,0.00	PPT1	upstream_gene	PPT1:ENST00000641471.1:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000642050.2:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000433473.8:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000641319.1:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000439754.6:upstream_gene_variant:MODIFIER::::,PPT1:ENST00000449045.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	600722_[GENE=PPT1_PHENOS=Ceroid lipofuscinosis, neuronal, 1, 256730 (3), Autosomal recessive]	297251 [benign DISEASE=Neuronal ceroid lipofuscinosis 1,not provided GENE=PPT1];			rs41301070	0.08649	0.17230,0.03868,0.02009,0.04487,0.10431	822,	11529	139131	-0.5190	0.46							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PPT1 (inh=AR oe_syn=1.18 oe_mis=0.99 oe_lof=0.52)
chr1	40271844	40271844	T	G	hom	hom	hom		QUAL=24;DP=124,126,105;AF=1.00,1.00,1.00	ZMPSTE24	intron	ZMPSTE24:ENST00000372759.4:intron_variant:MODIFIER:intron5/9:c.628-50T>G::		606480_[GENE=ZMPSTE24_PHENOS=Mandibuloacral dysplasia with type B lipodystrophy, 608612 (3), Autosomal recessive; Restrictive dermopathy 1, 275210 (3), Autosomal recessive]	140535 [benign DISEASE=not specified,not provided GENE=ZMPSTE24];			rs6677717	0.98749	0.99829,0.99582,1.00000,0.98576,0.98965	74279,	1846	1906	-0.2280	1.26			/5.2>4.1/0.0>0.0			25741868,21108632,19680556,19645629	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ZMPSTE24 (inh=AR oe_syn=0.88 oe_mis=0.93 oe_lof=0.94)
chr1	42733353	42733353	C	T	het	het	wt		QUAL=24;DP=100,233,16;AF=0.49,0.51,0.00	CLDN19	3'UTR,downstream_gene	CLDN19:ENST00000296387.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1733G>A::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2409G>A::,CLDN19:ENST00000372539.3:downstream_gene_variant:MODIFIER::::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	297316 [benign DISEASE=not provided,Renal hypomagnesemia 5 with ocular involvement GENE=CLDN19];		AluSx1 (SINE/Alu)	rs112310775	0.12180	0.13250,0.12052,0.20616,0.11531,0.06846	1173,	16186	133624	-0.2000	1.80			/1.2>1.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42733444	42733444	A	G	het	het	wt		QUAL=24;DP=183,302,16;AF=0.50,0.49,0.00	CLDN19	3'UTR,downstream_gene	CLDN19:ENST00000296387.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1642T>C::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2318T>C::,CLDN19:ENST00000372539.3:downstream_gene_variant:MODIFIER::::		610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	297318 [benign DISEASE=not provided,Renal hypomagnesemia 5 with ocular involvement GENE=CLDN19];			rs56345167	0.18938	0.27115,0.16981,0.20716,0.15549,0.12500	3006,	22793	123295	1.0130	4.27			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42734855	42734855	T	C	het	het	het		QUAL=24;DP=43,75,85;AF=0.49,0.51,0.39	CLDN19	3'UTR,downstream_gene	CLDN19:ENST00000296387.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*231A>G::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*907A>G::,CLDN19:ENST00000372539.3:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	297335 [benign DISEASE=not provided,Renal hypomagnesemia 5 with ocular involvement GENE=CLDN19];			rs912075	0.58376	0.53791,0.59766,0.66576,0.59627,0.65787	26102,	36513	63257	-1.7400	1.00			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42735184	42735184	G	A	het	het	het		QUAL=24;DP=80,161,176;AF=0.51,0.46,0.55	CLDN19	intron,3'UTR	CLDN19:ENST00000296387.6:intron_variant:MODIFIER:intron4/4:c.627-50C>T::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*578C>T::,CLDN19:ENST00000372539.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*684C>T::	regulatory_region_variant:open_chromatin_region	610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	1276324 [benign DISEASE=not provided GENE=CLDN19];			rs74885359	0.09395	0.02475,0.07302,0.00097,0.13797,0.03561	941,	12417	137905	-1.0660	2.40			/8.6>9.8/0.0>0.0		CLDN19|0.01|0.00|0.00|0.00|-50|-11|39|31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42735545	42735545	A	C	het	het	het		QUAL=24;DP=130,231,230;AF=0.45,0.52,0.49	CLDN19	intron,3'UTR	CLDN19:ENST00000296387.6:intron_variant:MODIFIER:intron4/4:c.626+333T>G::,CLDN19:ENST00000539749.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*217T>G::,CLDN19:ENST00000372539.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*323T>G::	regulatory_region_variant:open_chromatin_region	610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	1287286 [benign DISEASE=not provided GENE=CLDN19];		L2b (LINE/L2)	rs12141833	0.53886	0.38571,0.58045,0.66609,0.59429,0.65692	22922,	36068	70098	-1.3840	0.41			/0.0>0.0/0.0>0.1		CLDN19|0.00|0.00|0.00|0.00|43|-29|1|-3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42735863	42735863	G	A	het	het	wt		QUAL=24;DP=63,160,123;AF=0.40,0.58,0.00	CLDN19	splice_region&intron,missense,3'UTR	CLDN19:ENST00000296387.6:splice_region_variant&intron_variant:LOW:intron4/4:c.626+15C>T::,CLDN19:ENST00000539749.5:missense_variant:MODERATE:exon3/3:c.556C>T:p.Arg186Cys:,CLDN19:ENST00000372539.3:3_prime_UTR_variant:MODIFIER:exon4/4:c.*5C>T::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:open_chromatin_region	610036_[GENE=CLDN19_PHENOS=Hypomagnesemia 5, renal, with ocular involvement, 248190 (3), Autosomal recessive]	297339 [benign DISEASE=not provided,Renal hypomagnesemia 5 with ocular involvement GENE=CLDN19];			rs4660658	0.18604	0.23657,0.22007,0.23234,0.15552,0.12676	2766,	22766	123806	0.4830	0.13	0.124		/4.3>4.8/0.0>0.0	COSV56418053	CLDN19|0.00|0.00|0.03|0.00|10|15|15|11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CLDN19 (inh=AR oe_syn=0.77 oe_mis=0.81 oe_lof=0.51)
chr1	42746440	42746440	C	T	het	het	het		QUAL=24;DP=144,206,180;AF=0.52,0.48,0.54	P3H1	3'UTR	P3H1:ENST00000397054.7:3_prime_UTR_variant:MODIFIER:exon15/15:c.*393G>A::,P3H1:ENST00000296388.10:3_prime_UTR_variant:MODIFIER:exon15/15:c.*257G>A::,P3H1:ENST00000236040.8:3_prime_UTR_variant:MODIFIER:exon14/14:c.*472G>A::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	873598 [benign DISEASE=Osteogenesis imperfecta type 8,not provided,Osteogenesis Imperfecta, Recessive GENE=P3H1];			rs6882	0.64195	0.55559,0.65201,0.70800,0.67545,0.77483	31661,	34384	54496	0.2250	5.38			/1.4>1.1/0.0>0.0		P3H1|0.00|0.00|0.00|0.00|-13|-32|-3|-11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42747198	42747198	A	T	het	het	wt		QUAL=24;DP=60,126,62;AF=0.45,0.50,0.00	P3H1	intron,missense	P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron14/14:c.2074+55T>A::,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron14/14:c.2055+74T>A::,P3H1:ENST00000236040.8:missense_variant:MODERATE:exon14/14:c.2129T>A:p.Phe710Tyr:	regulatory_region_variant:TF_binding_site,regulatory_region_variant:CTCF_binding_site	610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674902 [benign DISEASE=not provided GENE=P3H1];			rs3738496	0.11096	0.07228,0.16518,0.24274,0.11491,0.07063	1061,	14772	135354	0.2420	6.58	0.021		/3.9>2.7/0.0>0.0	COSV52536380	P3H1|0.00|0.00|0.00|0.00|-2|-26|3|9	27335225	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42747828	42747828	C	T	het	het	het		QUAL=24;DP=96,220,136;AF=0.46,0.48,0.49	P3H1	intron	P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron12/14:c.1839-30G>A::,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron12/14:c.1839-30G>A::,P3H1:ENST00000236040.8:intron_variant:MODIFIER:intron12/13:c.1839-30G>A::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674901 [benign DISEASE=not provided,Osteogenesis imperfecta type 8 GENE=P3H1];			rs3738499	0.53387	0.36132,0.57871,0.66537,0.59547,0.68605	22678,	35783	70843	-1.4520	0.60			/0.0>0.0/0.0>0.0		P3H1|0.00|0.00|0.00|0.00|-30|6|50|34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42747939	42747939	T	C	het	het	het		QUAL=24;DP=105,93,53;AF=0.47,0.48,0.42	P3H1	intron	P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron12/14:c.1839-141A>G::,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron12/14:c.1839-141A>G::,P3H1:ENST00000236040.8:intron_variant:MODIFIER:intron12/13:c.1839-141A>G::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	667664 [benign DISEASE=not provided GENE=P3H1];			rs7552138	0.72976	0.75461,0.71324,0.71490,0.71942,0.83902	40598,	29737	41081	-1.0290	1.08			/0.1>1.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42748126	42748126	A	G	het	het	wt		QUAL=24;DP=49,20,21;AF=0.37,0.65,0.00	P3H1	intron	P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron12/14:c.1838+74T>C::,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron12/14:c.1838+74T>C::,P3H1:ENST00000236040.8:intron_variant:MODIFIER:intron12/13:c.1838+74T>C::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674900 [benign DISEASE=not provided GENE=P3H1];			rs3738500	0.11101	0.07067,0.16586,0.24671,0.11537,0.07107	1073,	14750	135304	0.5450	4.11			/4.7>4.6/0.0>0.0	COSV52532624	P3H1|0.00|0.00|0.00|0.00|-37|-13|-47|44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42762196	42762196	G	A	het	het	het		QUAL=24;DP=138,62,43;AF=0.51,0.65,0.51	P3H1	intron	P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron2/14:c.618+127C>T::,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron2/14:c.618+127C>T::,P3H1:ENST00000236040.8:intron_variant:MODIFIER:intron2/13:c.618+127C>T::		610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	667661 [benign DISEASE=not provided GENE=P3H1];		AluJr4 (SINE/Alu)	rs2760070	0.70057	0.65813,0.70058,0.70883,0.71707,0.83181	37365,	31613	45451	-0.4280	2.53			/0.0>0.0/0.0>0.0	COSV52532167	P3H1|0.00|0.00|0.00|0.00|47|-50|-39|-50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91)
chr1	42762518	42762518	T	A	hom	hom	hom		QUAL=25;DP=184,258,217;AF=1.00,1.00,1.00	P3H1,C1orf50	intron,upstream_gene	P3H1:ENST00000397054.7:intron_variant:MODIFIER:intron1/14:c.466-43A>T::,P3H1:ENST00000296388.10:intron_variant:MODIFIER:intron1/14:c.466-43A>T::,P3H1:ENST00000236040.8:intron_variant:MODIFIER:intron1/13:c.466-43A>T::,C1orf50:ENST00000372525.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674899 [benign DISEASE=not provided GENE=P3H1];			rs2816593	0.98819	0.99713,0.99510,0.99981,0.98388,0.99212	74332,	1753	1797	-0.1310	1.36			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91), C1ORF50 (inh=n/a oe_syn=0.92 oe_mis=1.08 oe_lof=0.41)
chr1	42767136	42767136	C	G	het	het	het		QUAL=24;DP=11,18,22;AF=0.73,0.56,0.64	P3H1,C1orf50	upstream_gene	P3H1:ENST00000397054.7:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000296388.10:upstream_gene_variant:MODIFIER::::,P3H1:ENST00000236040.8:upstream_gene_variant:MODIFIER::::,C1orf50:ENST00000372525.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610339_[GENE=P3H1_PHENOS=Osteogenesis imperfecta, type VIII, 610915 (3), Autosomal recessive]	674898 [benign DISEASE=not provided GENE=P3H1];			rs3738504	0.59970	0.58850,0.61088,0.70465,0.58998,0.75362	27573,	36117	60917	0.7320	7.75							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					P3H1 (inh=AR oe_syn=0.95 oe_mis=0.90 oe_lof=0.91), C1ORF50 (inh=n/a oe_syn=0.92 oe_mis=1.08 oe_lof=0.41)
chr1	42927574	42927574	-	GGTGAGAAAT	wt	het	het		QUAL=24;DP=43,101,113;AF=0.00,0.36,0.35	SLC2A1	intron	SLC2A1:ENST00000426263.10:intron_variant:MODIFIER:intron9/9:c.1278+30_1278+31insATTTCTCACC::,SLC2A1:ENST00000674765.1:intron_variant:MODIFIER:intron8/8:c.1030-718_1030-717insATTTCTCACC::		138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal recessive, Autosomal dominant; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	1222935 [benign DISEASE=not specified,not provided GENE=SLC2A1];			rs3831326	0.57000	0.77409,0.59300,0.48307,0.47153,0.60374	25965,	34491	65195		2.10			/4.7>4.7/0.0>0.0		SLC2A1|0.00|0.00|0.00|0.00|-19|39|31|41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	42943295	42943295	G	A	het	wt	het		QUAL=24;DP=298,30,350;AF=0.44,0.00,0.52	SLC2A1	synonymous	SLC2A1:ENST00000426263.10:synonymous_variant:LOW:exon2/10:c.45C>T:p.Ala15=:,SLC2A1:ENST00000674765.1:synonymous_variant:LOW:exon2/9:c.45C>T:p.Ala15=:	regulatory_region_variant:promoter,TF_binding_site_variant	138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal recessive, Autosomal dominant; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	95413 [benign DISEASE=Hereditary cryohydrocytosis with reduced stomatin,not provided,not specified,Childhood onset GLUT1 deficiency syndrome 2,GLUT1 deficiency syndrome 1, autosomal recessive,Inborn genetic diseases,Encephalopathy due to GLUT1 deficiency,Dystonia 9 GENE=SLC2A1];			rs1385129	0.21924	0.17663,0.28663,0.29180,0.21641,0.27407	3828,	25691	118753	-1.8290	6.15			/0.0>0.0/0.0>0.0	COSV65287476	SLC2A1|0.00|0.00|0.00|0.00|23|26|46|23	25741868,25512783,33522072,18414213,23757202,22707195,29867928,25701507,18212354,21135204,36131844,36421383,34488469,26944167,31222984,31965635,34708297,25381171,35883738,37841371,30051631,37649488	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	42943508	42943508	G	T	wt	het	het		QUAL=24;DP=78,90,61;AF=0.00,0.50,0.51	SLC2A1	intron	SLC2A1:ENST00000426263.10:intron_variant:MODIFIER:intron1/9:c.19-187C>A::,SLC2A1:ENST00000674765.1:intron_variant:MODIFIER:intron1/8:c.19-187C>A::	regulatory_region_variant:promoter	138140_[GENE=SLC2A1_PHENOS=Dystonia 9, 601042 (3), Autosomal dominant; GLUT1 deficiency syndrome 1, infantile onset, severe, 606777 (3), Autosomal recessive, Autosomal dominant; Stomatin-deficient cryohydrocytosis with neurologic defects, 608885 (3), Autosomal dominant; {Epilepsy, idiopathic generalized, susceptibility to, 12}, 614847 (3), Autosomal dominant; GLUT1 deficiency syndrome 2, childhood onset, 612126 (3), Autosomal dominant]	670109 [benign DISEASE=not provided GENE=SLC2A1];			rs12718444	0.15704	0.10833,0.12971,0.16847,0.17786,0.18501	1985,	19915	128215	1.6540	14.59			/0.0>0.0/0.0>0.0		SLC2A1|0.00|0.00|0.00|0.00|-34|24|5|-33	34641739,35456489,36604111,30595370,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC2A1 (inh=AR+AD oe_syn=0.99 oe_mis=0.53 oe_lof=0.05)
chr1	43346404	43346404	G	A	het	het	wt		QUAL=24;DP=79,133,16;AF=0.59,0.53,0.00	MPL	intron	MPL:ENST00000372470.9:intron_variant:MODIFIER:intron6/11:c.981-41G>A::,MPL:ENST00000413998.7:intron_variant:MODIFIER:intron6/11:c.960-41G>A::	regulatory_region_variant:enhancer	159530_[GENE=MPL_PHENOS=Myelofibrosis with myeloid metaplasia, somatic, 254450 (3); Amegakaryocytic thrombocytopenia, congenital, 1, 604498 (3), Autosomal recessive; Thrombocythemia 2, 601977 (3), Autosomal dominant, Somatic mutation]	259760 [benign DISEASE=not provided,not specified GENE=MPL];			rs1760670	0.31224	0.22449,0.36643,0.07339,0.37313,0.13906	7925,	31608	104536	0.5750	9.81			/0.1>0.0/0.0>1.2	COSV65245058	MPL|0.00|0.01|0.00|0.00|-27|41|1|-32	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPL (inh=AR+AD oe_syn=0.74 oe_mis=0.94 oe_lof=0.53)
chr1	43349193	43349193	T	C	het	het	wt		QUAL=24;DP=52,41,16;AF=0.54,0.41,0.00	MPL	intron	MPL:ENST00000372470.9:intron_variant:MODIFIER:intron9/11:c.1469-70T>C::,MPL:ENST00000413998.7:intron_variant:MODIFIER:intron9/11:c.1448-70T>C::	regulatory_region_variant:promoter	159530_[GENE=MPL_PHENOS=Myelofibrosis with myeloid metaplasia, somatic, 254450 (3); Amegakaryocytic thrombocytopenia, congenital, 1, 604498 (3), Autosomal recessive; Thrombocythemia 2, 601977 (3), Autosomal dominant, Somatic mutation]	1250463 [benign DISEASE=not provided GENE=MPL];			rs839995	0.30089	0.17932,0.36175,0.09817,0.37372,0.14815	7547,	30550	106052	-0.1820	2.25			/0.0>0.0/0.0>0.0		MPL|0.00|0.00|0.00|0.00|-41|48|36|-42	23575445	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPL (inh=AR+AD oe_syn=0.74 oe_mis=0.94 oe_lof=0.53)
chr1	43792353	43792353	-	GT	het	wt	het		QUAL=24;DP=93,48,51;AF=0.51,0.00,0.33	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron2/11:c.119-22536_119-22535dup::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron2/10:c.119-22536_119-22535dup::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron2/4:c.119-22536_119-22535dup::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron2/7:c.164-22536_164-22535dup::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron3/6:c.211+206_211+207dup::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron3/10:c.166+206_166+207dup::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron3/12:c.166+206_166+207dup::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron3/10:c.166+206_166+207dup::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron3/12:c.211+206_211+207dup::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron3/11:c.166+206_166+207dup::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron3/11:c.211+206_211+207dup::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron3/9:c.166+206_166+207dup::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron2/8:c.119-22536_119-22535dup::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron3/12:c.166+206_166+207dup::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron4/12:c.166+206_166+207dup::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron3/12:c.166+206_166+207dup::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron3/12:c.211+206_211+207dup::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron3/12:c.166+206_166+207dup::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron3/11:c.166+206_166+207dup::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron3/11:c.166+206_166+207dup::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron2/10:c.166+206_166+207dup::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron1/10:c.119-22536_119-22535dup::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron2/5:c.166+206_166+207dup::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron1/4:c.119-22536_119-22535dup::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron2/7:c.166+206_166+207dup::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron1/6:c.164-22536_164-22535dup::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron2/10:c.166+206_166+207dup::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron1/6:c.119-22536_119-22535dup::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron1/3:c.119-22536_119-22535dup::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron1/6:c.119-22536_119-22535dup::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron2/5:c.211+206_211+207dup::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron1/6:c.164-22536_164-22535dup::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1261624 [benign DISEASE=not provided GENE=ST3GAL3];			rs34077566	0.37011	0.25031,0.31180,0.59231,0.42839,0.43255	11059,	34098	95676		0.91			/2.1>2.3/0.0>1.0		ST3GAL3|0.00|0.00|0.00|0.00|-48|42|0|42		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43814709	43814709	A	T	hom	hom	hom		QUAL=24;DP=122,110,99;AF=0.98,1.00,1.00	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron2/11:c.119-182A>T::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron2/10:c.119-182A>T::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron2/4:c.119-182A>T::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron2/7:c.164-182A>T::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron3/6:c.212-182A>T::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron3/10:c.167-182A>T::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron3/12:c.167-182A>T::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron3/10:c.167-182A>T::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron3/12:c.212-182A>T::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron3/11:c.167-182A>T::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron3/11:c.212-182A>T::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron3/9:c.167-182A>T::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron2/8:c.119-182A>T::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron3/12:c.167-182A>T::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron4/12:c.167-182A>T::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron3/12:c.167-182A>T::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron3/12:c.212-182A>T::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron3/12:c.167-182A>T::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron3/11:c.167-182A>T::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron3/11:c.167-182A>T::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron2/10:c.167-182A>T::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron1/10:c.119-182A>T::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron2/5:c.167-182A>T::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron1/4:c.119-182A>T::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron2/7:c.167-182A>T::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron1/6:c.164-182A>T::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron2/10:c.167-182A>T::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron1/6:c.119-182A>T::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron1/3:c.119-182A>T::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron1/6:c.119-182A>T::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron2/5:c.212-182A>T::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron1/6:c.164-182A>T::	regulatory_region_variant:promoter	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1241211 [benign DISEASE=not provided GENE=ST3GAL3];			rs37468	0.90483	0.96743,0.83152,0.91647,0.89631,0.77425	62582,	12633	14493	1.0620	9.62			/5.9>7.3/0.0>0.0		ST3GAL3|0.00|0.00|0.00|0.00|12|11|45|11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43814753	43814753	T	G	het	wt	het		QUAL=24;DP=209,59,131;AF=0.50,0.00,0.56	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron2/11:c.119-138T>G::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron2/10:c.119-138T>G::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron2/4:c.119-138T>G::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron2/7:c.164-138T>G::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron3/6:c.212-138T>G::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron3/10:c.167-138T>G::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron3/12:c.167-138T>G::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron3/10:c.167-138T>G::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron3/12:c.212-138T>G::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron3/11:c.167-138T>G::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron3/11:c.212-138T>G::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron3/9:c.167-138T>G::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron2/8:c.119-138T>G::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron3/12:c.167-138T>G::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron4/12:c.167-138T>G::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron3/12:c.167-138T>G::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron3/12:c.212-138T>G::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron3/12:c.167-138T>G::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron3/11:c.167-138T>G::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron3/11:c.167-138T>G::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron2/10:c.167-138T>G::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron1/10:c.119-138T>G::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron2/5:c.167-138T>G::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron1/4:c.119-138T>G::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron2/7:c.167-138T>G::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron1/6:c.164-138T>G::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron2/10:c.167-138T>G::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron1/6:c.119-138T>G::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron1/3:c.119-138T>G::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron1/6:c.119-138T>G::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron2/5:c.212-138T>G::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron1/6:c.164-138T>G::	regulatory_region_variant:promoter	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1229033 [benign DISEASE=not provided GENE=ST3GAL3];			rs3791064	0.39549	0.32982,0.32100,0.58862,0.43278,0.43486	12259,	35633	91941	0.0160	3.39			/4.7>2.9/0.0>1.7	COSV53515144	ST3GAL3|0.00|0.00|0.02|0.00|1|43|-33|-31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43824858	43824858	A	G	het	hom	het		QUAL=24;DP=267,112,116;AF=0.46,0.98,0.41	ST3GAL3	missense,intron	ST3GAL3:ENST00000372372.7:missense_variant:MODERATE:exon4/12:c.289A>G:p.Thr97Ala:,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron3/10:c.161+9925A>G::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron3/4:c.161+9925A>G::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron3/7:c.206+9925A>G::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron4/6:c.254+9925A>G::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron4/10:c.209+9925A>G::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron4/12:c.209+9925A>G::,ST3GAL3:ENST00000647237.1:missense_variant:MODERATE:exon5/11:c.337A>G:p.Thr113Ala:,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron4/12:c.254+9925A>G::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron4/11:c.254+9925A>G::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron4/9:c.209+9925A>G::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron3/8:c.161+9925A>G::,ST3GAL3:ENST00000351035.8:missense_variant:MODERATE:exon5/13:c.337A>G:p.Thr113Ala:,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron5/12:c.209+9925A>G::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron4/12:c.209+9925A>G::,ST3GAL3:ENST00000262915.8:missense_variant:MODERATE:exon5/13:c.382A>G:p.Thr128Ala:,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron4/12:c.209+9925A>G::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron4/11:c.209+9925A>G::,ST3GAL3:ENST00000372368.7:missense_variant:MODERATE:exon4/11:c.337A>G:p.Thr113Ala:,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron2/10:c.161+9925A>G::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron3/5:c.209+9925A>G::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron2/4:c.161+9925A>G::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron3/7:c.209+9925A>G::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron2/6:c.206+9925A>G::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron3/10:c.209+9925A>G::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron2/6:c.161+9925A>G::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron2/3:c.161+9925A>G::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron2/6:c.161+9925A>G::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron3/5:c.254+9925A>G::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron2/6:c.206+9925A>G::	regulatory_region_variant:enhancer	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	130378 [benign DISEASE=not provided,not specified,Intellectual disability, autosomal recessive 12,Developmental and epileptic encephalopathy, 15 GENE=ST3GAL3];		MER5B (DNA/hAT-Charlie)	rs37458	0.31769	0.31573,0.27550,0.14068,0.34709,0.13895	7883,	32562	103794	-0.1460	2.30	0.005		/0.0>0.2/0.0>0.0	COSV53510755	ST3GAL3|0.01|0.00|0.13|0.00|-26|2|34|-1	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43899785	43899785	A	G	het	het	wt		QUAL=24;DP=119,157,23;AF=0.48,0.56,0.00	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron9/11:c.858+58A>G::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron8/10:c.696+58A>G::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-30347A>G::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*22+496A>G::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.442+5308A>G::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron8/10:c.651+58A>G::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron9/12:c.744+58A>G::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.906+58A>G::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron9/12:c.789+58A>G::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron9/11:c.789+58A>G::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.744+58A>G::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.696+58A>G::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron10/12:c.906+58A>G::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron10/12:c.744+58A>G::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron9/12:c.744+58A>G::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron10/12:c.951+58A>G::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron10/12:c.837+58A>G::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron9/11:c.744+58A>G::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron9/10:c.906+58A>G::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron7/10:c.696+58A>G::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.397+5308A>G::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.349+5308A>G::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*22+496A>G::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.554+522A>G::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron8/10:c.744+58A>G::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.509+522A>G::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-30347A>G::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.603+58A>G::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.442+5308A>G::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*22+496A>G::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1233138 [benign DISEASE=not provided GENE=ST3GAL3];			rs783304	0.23732	0.41880,0.24255,0.21821,0.14159,0.27939	5432,	25234	116012	-0.0920	1.40			/0.0>5.4/0.0>0.0	COSV53512272	ST3GAL3|0.00|0.00|0.00|0.00|1|24|1|33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43899857	43899857	G	A	hom	hom	hom		QUAL=24;DP=102,66,44;AF=1.00,1.00,0.98	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron9/11:c.858+130G>A::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron8/10:c.696+130G>A::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-30275G>A::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*22+568G>A::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.442+5380G>A::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron8/10:c.651+130G>A::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron9/12:c.744+130G>A::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.906+130G>A::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron9/12:c.789+130G>A::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron9/11:c.744+130G>A::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron9/11:c.789+130G>A::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.744+130G>A::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.696+130G>A::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron10/12:c.906+130G>A::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron10/12:c.744+130G>A::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron9/12:c.744+130G>A::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron10/12:c.951+130G>A::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron10/12:c.837+130G>A::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron9/11:c.744+130G>A::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron9/11:c.744+130G>A::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron9/10:c.906+130G>A::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron7/10:c.696+130G>A::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.397+5380G>A::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.349+5380G>A::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*22+568G>A::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.554+594G>A::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron8/10:c.744+130G>A::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.509+594G>A::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-30275G>A::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.603+130G>A::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.442+5380G>A::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*22+568G>A::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1275447 [benign DISEASE=not provided GENE=ST3GAL3];			rs783303	0.81248	0.64405,0.85126,0.83462,0.89084,0.81509	51157,	21284	28526	0.4930	3.66			/0.0>0.0/0.0>0.0		ST3GAL3|0.00|0.00|0.00|0.00|22|-48|-39|32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43920633	43920633	C	T	hom	hom	hom		QUAL=24;DP=143,133,86;AF=0.99,0.99,0.99	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron10/11:c.1005+83C>T::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron9/10:c.843+83C>T::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-9499C>T::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*23-9499C>T::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.443-9499C>T::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron9/10:c.798+83C>T::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron10/12:c.891+83C>T::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.907-9499C>T::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron10/12:c.936+83C>T::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron10/11:c.891+83C>T::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron10/11:c.936+83C>T::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.745-9499C>T::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.697-9499C>T::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron11/12:c.1053+83C>T::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron11/12:c.891+83C>T::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron10/12:c.891+83C>T::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron11/12:c.1098+83C>T::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron11/12:c.984+83C>T::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron10/11:c.891+83C>T::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron10/11:c.891+83C>T::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron10/10:c.1053+83C>T::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron8/10:c.843+83C>T::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.398-9499C>T::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.350-9499C>T::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*23-9499C>T::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.555-9499C>T::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron9/10:c.801+83C>T::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.510-9499C>T::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-9499C>T::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.604-9499C>T::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.443-9499C>T::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*23-9499C>T::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1259769 [benign DISEASE=not provided GENE=ST3GAL3];			rs3120802	0.79611	0.50660,0.85939,0.84086,0.92547,0.87096	50828,	19348	30990	-0.3250	6.31			/1.7>1.3/0.0>0.0	COSV53517032			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43920943	43920943	A	G	hom	hom	hom		QUAL=24;DP=77,210,128;AF=0.99,1.00,0.98	ST3GAL3	splice_region&intron,intron	ST3GAL3:ENST00000372372.7:splice_region_variant&intron_variant:LOW:intron11/11:c.1152+15A>G::,ST3GAL3:ENST00000361400.9:splice_region_variant&intron_variant:LOW:intron10/10:c.990+15A>G::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-9189A>G::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*23-9189A>G::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.443-9189A>G::,ST3GAL3:ENST00000372374.7:splice_region_variant&intron_variant:LOW:intron10/10:c.945+15A>G::,ST3GAL3:ENST00000643252.1:splice_region_variant&intron_variant:LOW:intron11/12:c.1038+15A>G::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.907-9189A>G::,ST3GAL3:ENST00000642331.1:splice_region_variant&intron_variant:LOW:intron11/12:c.1083+15A>G::,ST3GAL3:ENST00000347631.8:splice_region_variant&intron_variant:LOW:intron11/11:c.1038+15A>G::,ST3GAL3:ENST00000361392.9:splice_region_variant&intron_variant:LOW:intron11/11:c.1083+15A>G::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.745-9189A>G::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.697-9189A>G::,ST3GAL3:ENST00000351035.8:splice_region_variant&intron_variant:LOW:intron12/12:c.1200+15A>G::,ST3GAL3:ENST00000646971.1:splice_region_variant&intron_variant:LOW:intron12/12:c.1038+15A>G::,ST3GAL3:ENST00000647148.1:splice_region_variant&intron_variant:LOW:intron11/12:c.1038+15A>G::,ST3GAL3:ENST00000262915.8:splice_region_variant&intron_variant:LOW:intron12/12:c.1245+15A>G::,ST3GAL3:ENST00000361746.9:splice_region_variant&intron_variant:LOW:intron12/12:c.1131+15A>G::,ST3GAL3:ENST00000645034.1:splice_region_variant&intron_variant:LOW:intron11/11:c.1038+15A>G::,ST3GAL3:ENST00000644195.1:splice_region_variant&intron_variant:LOW:intron11/11:c.1038+15A>G::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron10/10:c.1053+393A>G::,ST3GAL3:ENST00000646686.1:splice_region_variant&intron_variant:LOW:intron9/10:c.990+15A>G::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.398-9189A>G::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.350-9189A>G::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*23-9189A>G::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.555-9189A>G::,ST3GAL3:ENST00000372369.5:splice_region_variant&intron_variant:LOW:intron10/10:c.948+15A>G::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.510-9189A>G::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-9189A>G::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.604-9189A>G::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.443-9189A>G::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*23-9189A>G::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	262909 [benign DISEASE=Intellectual disability, autosomal recessive 12,not provided,Early infantile epileptic encephalopathy with suppression bursts,not specified,Developmental and epileptic encephalopathy, 15 GENE=ST3GAL3];			rs3120803	0.85115	0.69874,0.87587,0.84876,0.92586,0.87199	55837,	17695	22625	-1.2040	0.13			/0.0>0.0/6.2>1.3			25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43920970	43920970	G	C	het	het	wt		QUAL=24;DP=87,158,17;AF=0.51,0.64,0.00	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron11/11:c.1152+42G>C::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron10/10:c.990+42G>C::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-9162G>C::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*23-9162G>C::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.443-9162G>C::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron10/10:c.945+42G>C::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron11/12:c.1038+42G>C::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.907-9162G>C::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron11/12:c.1083+42G>C::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron11/11:c.1038+42G>C::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron11/11:c.1083+42G>C::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.745-9162G>C::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.697-9162G>C::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron12/12:c.1200+42G>C::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron12/12:c.1038+42G>C::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron11/12:c.1038+42G>C::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron12/12:c.1245+42G>C::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron12/12:c.1131+42G>C::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron11/11:c.1038+42G>C::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron11/11:c.1038+42G>C::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron10/10:c.1053+420G>C::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron9/10:c.990+42G>C::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.398-9162G>C::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.350-9162G>C::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*23-9162G>C::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.555-9162G>C::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron10/10:c.948+42G>C::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.510-9162G>C::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-9162G>C::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.604-9162G>C::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.443-9162G>C::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*23-9162G>C::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	1261387 [benign DISEASE=not provided GENE=ST3GAL3];			rs3764833	0.05549	0.08219,0.04608,0.12969,0.03835,0.04431	296,	7854	143770	1.2920	7.91			/0.0>0.0/0.0>1.5	COSV53519387	ST3GAL3|0.00|0.00|0.00|0.00|23|-30|-42|-30		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43921089	43921089	A	-	het	het	wt		QUAL=25;DP=28,47,17;AF=0.57,0.62,0.00	ST3GAL3	intron	ST3GAL3:ENST00000372372.7:intron_variant:MODIFIER:intron11/11:c.1152+162del::,ST3GAL3:ENST00000361400.9:intron_variant:MODIFIER:intron10/10:c.990+162del::,ST3GAL3:ENST00000330208.6:intron_variant:MODIFIER:intron4/4:c.255-9042del::,ST3GAL3:ENST00000335430.10:intron_variant:MODIFIER:intron7/7:c.*23-9042del::,ST3GAL3:ENST00000545417.5:intron_variant:MODIFIER:intron6/6:c.443-9042del::,ST3GAL3:ENST00000372374.7:intron_variant:MODIFIER:intron10/10:c.945+162del::,ST3GAL3:ENST00000643252.1:intron_variant:MODIFIER:intron11/12:c.1038+162del::,ST3GAL3:ENST00000647237.1:intron_variant:MODIFIER:intron10/10:c.907-9042del::,ST3GAL3:ENST00000642331.1:intron_variant:MODIFIER:intron11/12:c.1083+162del::,ST3GAL3:ENST00000347631.8:intron_variant:MODIFIER:intron11/11:c.1038+162del::,ST3GAL3:ENST00000361392.9:intron_variant:MODIFIER:intron11/11:c.1083+162del::,ST3GAL3:ENST00000353126.8:intron_variant:MODIFIER:intron9/9:c.745-9042del::,ST3GAL3:ENST00000642934.1:intron_variant:MODIFIER:intron8/8:c.697-9042del::,ST3GAL3:ENST00000351035.8:intron_variant:MODIFIER:intron12/12:c.1200+162del::,ST3GAL3:ENST00000646971.1:intron_variant:MODIFIER:intron12/12:c.1038+162del::,ST3GAL3:ENST00000647148.1:intron_variant:MODIFIER:intron11/12:c.1038+162del::,ST3GAL3:ENST00000262915.8:intron_variant:MODIFIER:intron12/12:c.1245+162del::,ST3GAL3:ENST00000361746.9:intron_variant:MODIFIER:intron12/12:c.1131+162del::,ST3GAL3:ENST00000645034.1:intron_variant:MODIFIER:intron11/11:c.1038+162del::,ST3GAL3:ENST00000644195.1:intron_variant:MODIFIER:intron11/11:c.1038+162del::,ST3GAL3:ENST00000372368.7:intron_variant:MODIFIER:intron10/10:c.1053+540del::,ST3GAL3:ENST00000646686.1:intron_variant:MODIFIER:intron9/10:c.990+162del::,ST3GAL3:ENST00000372362.6:intron_variant:MODIFIER:intron5/5:c.398-9042del::,ST3GAL3:ENST00000531451.5:intron_variant:MODIFIER:intron4/4:c.350-9042del::,ST3GAL3:ENST00000372365.5:intron_variant:MODIFIER:intron7/7:c.*23-9042del::,ST3GAL3:ENST00000372367.5:intron_variant:MODIFIER:intron6/6:c.555-9042del::,ST3GAL3:ENST00000372369.5:intron_variant:MODIFIER:intron10/10:c.948+162del::,ST3GAL3:ENST00000528371.5:intron_variant:MODIFIER:intron6/6:c.510-9042del::,ST3GAL3:ENST00000531816.1:intron_variant:MODIFIER:intron3/3:c.255-9042del::,ST3GAL3:ENST00000531993.6:intron_variant:MODIFIER:intron6/6:c.604-9042del::,ST3GAL3:ENST00000361812.9:intron_variant:MODIFIER:intron5/5:c.443-9042del::,ST3GAL3:ENST00000372366.6:intron_variant:MODIFIER:intron6/6:c.*23-9042del::		606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]				rs3835022	0.04012	0.02899,0.04173,0.12762,0.03815,0.04258	143,	5817	146013	-0.2410	0.88			/3.8>4.9/0.0>0.0		ST3GAL3|0.03|0.00|0.00|0.00|36|35|-25|-47		48	1076	0	0 / 0					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36)
chr1	43930114	43930114	C	T	het	het	hom		QUAL=24;DP=97,257,184;AF=0.42,0.46,1.00	ST3GAL3,ARTN	splice_region&intron,upstream_gene	ST3GAL3:ENST00000372372.7:splice_region_variant&intron_variant:LOW:intron11/11:c.1153-18C>T::,ST3GAL3:ENST00000361400.9:splice_region_variant&intron_variant:LOW:intron10/10:c.991-18C>T::,ST3GAL3:ENST00000330208.6:splice_region_variant&intron_variant:LOW:intron4/4:c.255-18C>T::,ST3GAL3:ENST00000335430.10:splice_region_variant&intron_variant:LOW:intron7/7:c.*23-18C>T::,ST3GAL3:ENST00000545417.5:splice_region_variant&intron_variant:LOW:intron6/6:c.443-18C>T::,ST3GAL3:ENST00000372374.7:splice_region_variant&intron_variant:LOW:intron10/10:c.946-18C>T::,ST3GAL3:ENST00000643252.1:splice_region_variant&intron_variant:LOW:intron12/12:c.1235-18C>T::,ST3GAL3:ENST00000647237.1:splice_region_variant&intron_variant:LOW:intron10/10:c.907-18C>T::,ST3GAL3:ENST00000642331.1:splice_region_variant&intron_variant:LOW:intron12/12:c.1280-18C>T::,ST3GAL3:ENST00000347631.8:splice_region_variant&intron_variant:LOW:intron11/11:c.1039-18C>T::,ST3GAL3:ENST00000361392.9:splice_region_variant&intron_variant:LOW:intron11/11:c.1084-18C>T::,ST3GAL3:ENST00000353126.8:splice_region_variant&intron_variant:LOW:intron9/9:c.745-18C>T::,ST3GAL3:ENST00000642934.1:splice_region_variant&intron_variant:LOW:intron8/8:c.697-18C>T::,ST3GAL3:ENST00000351035.8:splice_region_variant&intron_variant:LOW:intron12/12:c.1201-18C>T::,ST3GAL3:ENST00000646971.1:splice_region_variant&intron_variant:LOW:intron12/12:c.1039-18C>T::,ST3GAL3:ENST00000647148.1:splice_region_variant&intron_variant:LOW:intron12/12:c.1166-18C>T::,ST3GAL3:ENST00000262915.8:splice_region_variant&intron_variant:LOW:intron12/12:c.1246-18C>T::,ST3GAL3:ENST00000361746.9:splice_region_variant&intron_variant:LOW:intron12/12:c.1132-18C>T::,ST3GAL3:ENST00000644195.1:splice_region_variant&intron_variant:LOW:intron11/11:c.1039-18C>T::,ST3GAL3:ENST00000372368.7:splice_region_variant&intron_variant:LOW:intron10/10:c.1054-18C>T::,ST3GAL3:ENST00000646686.1:splice_region_variant&intron_variant:LOW:intron10/10:c.1187-18C>T::,ST3GAL3:ENST00000372362.6:splice_region_variant&intron_variant:LOW:intron5/5:c.398-18C>T::,ST3GAL3:ENST00000531451.5:splice_region_variant&intron_variant:LOW:intron4/4:c.350-18C>T::,ST3GAL3:ENST00000372365.5:splice_region_variant&intron_variant:LOW:intron7/7:c.*23-18C>T::,ST3GAL3:ENST00000372367.5:splice_region_variant&intron_variant:LOW:intron6/6:c.555-18C>T::,ST3GAL3:ENST00000372369.5:splice_region_variant&intron_variant:LOW:intron10/10:c.949-18C>T::,ST3GAL3:ENST00000528371.5:splice_region_variant&intron_variant:LOW:intron6/6:c.510-18C>T::,ST3GAL3:ENST00000531816.1:splice_region_variant&intron_variant:LOW:intron3/3:c.255-18C>T::,ST3GAL3:ENST00000531993.6:splice_region_variant&intron_variant:LOW:intron6/6:c.604-18C>T::,ST3GAL3:ENST00000361812.9:splice_region_variant&intron_variant:LOW:intron5/5:c.443-18C>T::,ST3GAL3:ENST00000372366.6:splice_region_variant&intron_variant:LOW:intron6/6:c.*23-18C>T::,ARTN:ENST00000414809.7:upstream_gene_variant:MODIFIER::::,ARTN:ENST00000372359.10:upstream_gene_variant:MODIFIER::::,ARTN:ENST00000498139.6:upstream_gene_variant:MODIFIER::::,ARTN:ENST00000479128.5:upstream_gene_variant:MODIFIER::::,ARTN:ENST00000472435.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]	262910 [benign DISEASE=Intellectual disability, autosomal recessive 12,Developmental and epileptic encephalopathy, 15,Early infantile epileptic encephalopathy with suppression bursts,not specified,not provided GENE=ST3GAL3];			rs2108202	0.59975	0.23195,0.63001,0.62166,0.78295,0.61063	31732,	27772	60888	0.2390	14.26	0.025		9.6>10.2/9.6>10.2/0.0>0.0,/9.6>10.2/0.0>0.0	COSV53521961	ST3GAL3|0.00|0.00|0.00|0.00|18|-13|43|-26	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36), ARTN (inh=n/a oe_syn=0.91 oe_mis=0.63 oe_lof=0.22)
chr1	43930524	43930524	A	G	het	het	wt		QUAL=24;DP=95,121,58;AF=0.45,0.50,0.00	ST3GAL3,ARTN	3'UTR,downstream_gene,upstream_gene	ST3GAL3:ENST00000372372.7:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:ENST00000361400.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:ENST00000330208.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*341A>G::,ST3GAL3:ENST00000335430.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*415A>G::,ST3GAL3:ENST00000545417.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*322A>G::,ST3GAL3:ENST00000372374.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:ENST00000643252.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:ENST00000647237.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:ENST00000642331.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:ENST00000347631.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:ENST00000361392.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:ENST00000353126.8:3_prime_UTR_variant:MODIFIER:exon10/10:c.*303A>G::,ST3GAL3:ENST00000642934.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*303A>G::,ST3GAL3:ENST00000351035.8:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000646971.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000647148.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*322A>G::,ST3GAL3:ENST00000262915.8:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000361746.9:3_prime_UTR_variant:MODIFIER:exon13/13:c.*303A>G::,ST3GAL3:ENST00000644195.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*303A>G::,ST3GAL3:ENST00000372368.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*303A>G::,ST3GAL3:ENST00000646686.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*322A>G::,ST3GAL3:ENST00000361812.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*322A>G::,ST3GAL3:ENST00000372366.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*415A>G::,ST3GAL3:ENST00000372362.6:downstream_gene_variant:MODIFIER::::,ST3GAL3:ENST00000531451.5:downstream_gene_variant:MODIFIER::::,ST3GAL3:ENST00000372365.5:downstream_gene_variant:MODIFIER::::,ST3GAL3:ENST00000372367.5:downstream_gene_variant:MODIFIER::::,ST3GAL3:ENST00000372369.5:downstream_gene_variant:MODIFIER::::,ST3GAL3:ENST00000528371.5:downstream_gene_variant:MODIFIER::::,ST3GAL3:ENST00000531816.1:downstream_gene_variant:MODIFIER::::,ST3GAL3:ENST00000531993.6:downstream_gene_variant:MODIFIER::::,ARTN:ENST00000414809.7:upstream_gene_variant:MODIFIER::::,ARTN:ENST00000372359.10:upstream_gene_variant:MODIFIER::::,ARTN:ENST00000498139.6:upstream_gene_variant:MODIFIER::::,ARTN:ENST00000479128.5:upstream_gene_variant:MODIFIER::::,ARTN:ENST00000472435.1:upstream_gene_variant:MODIFIER::::,ARTN:ENST00000372354.3:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]				rs12561948	0.03808	0.02130,0.04139,0.12959,0.03822,0.04387	137,	5523	146453	1.8380	16.52			/4.7>4.1/0.0>0.3		ST3GAL3|0.00|0.00|0.01|0.00|-1|5|-1|-48	36224396	7	125	0	0 / 0					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36), ARTN (inh=n/a oe_syn=0.91 oe_mis=0.63 oe_lof=0.22)
chr1	43930974	43930974	C	G	het	het	hom		QUAL=24;DP=227,263,222;AF=0.49,0.54,1.00	ST3GAL3,ARTN	3'UTR,downstream_gene,upstream_gene	ST3GAL3:ENST00000361400.9:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:ENST00000330208.6:3_prime_UTR_variant:MODIFIER:exon5/5:c.*791C>G::,ST3GAL3:ENST00000335430.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*865C>G::,ST3GAL3:ENST00000545417.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*772C>G::,ST3GAL3:ENST00000372374.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:ENST00000643252.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:ENST00000647237.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:ENST00000642331.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:ENST00000347631.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:ENST00000361392.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:ENST00000353126.8:3_prime_UTR_variant:MODIFIER:exon10/10:c.*753C>G::,ST3GAL3:ENST00000642934.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*753C>G::,ST3GAL3:ENST00000351035.8:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000646971.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000647148.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*772C>G::,ST3GAL3:ENST00000262915.8:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000361746.9:3_prime_UTR_variant:MODIFIER:exon13/13:c.*753C>G::,ST3GAL3:ENST00000644195.1:3_prime_UTR_variant:MODIFIER:exon12/12:c.*753C>G::,ST3GAL3:ENST00000372368.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*753C>G::,ST3GAL3:ENST00000646686.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*772C>G::,ST3GAL3:ENST00000372372.7:downstream_gene_variant:MODIFIER::::,ST3GAL3:ENST00000372362.6:downstream_gene_variant:MODIFIER::::,ST3GAL3:ENST00000531451.5:downstream_gene_variant:MODIFIER::::,ST3GAL3:ENST00000372365.5:downstream_gene_variant:MODIFIER::::,ST3GAL3:ENST00000372367.5:downstream_gene_variant:MODIFIER::::,ST3GAL3:ENST00000372369.5:downstream_gene_variant:MODIFIER::::,ST3GAL3:ENST00000528371.5:downstream_gene_variant:MODIFIER::::,ST3GAL3:ENST00000531816.1:downstream_gene_variant:MODIFIER::::,ST3GAL3:ENST00000531993.6:downstream_gene_variant:MODIFIER::::,ST3GAL3:ENST00000361812.9:downstream_gene_variant:MODIFIER::::,ST3GAL3:ENST00000372366.6:downstream_gene_variant:MODIFIER::::,ARTN:ENST00000414809.7:upstream_gene_variant:MODIFIER::::,ARTN:ENST00000372359.10:upstream_gene_variant:MODIFIER::::,ARTN:ENST00000498139.6:upstream_gene_variant:MODIFIER::::,ARTN:ENST00000479128.5:upstream_gene_variant:MODIFIER::::,ARTN:ENST00000472435.1:upstream_gene_variant:MODIFIER::::,ARTN:ENST00000372354.3:upstream_gene_variant:MODIFIER::::,ARTN:ENST00000438616.3:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	606494_[GENE=ST3GAL3_PHENOS=Developmental and epileptic encephalopathy 15, 615006 (3), Autosomal recessive; Intellectual developmental disorder, autosomal recessive 12, 611090 (3), Autosomal recessive]				rs6801	0.59998	0.23175,0.63024,0.62219,0.78311,0.61137	31768,	27771	60877	0.1650	4.28			/0.5>0.0/0.0>0.0	COSV53521971	ST3GAL3|0.00|0.00|0.00|0.00|-5|49|16|44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ST3GAL3 (inh=AR oe_syn=0.97 oe_mis=0.74 oe_lof=0.36), ARTN (inh=n/a oe_syn=0.91 oe_mis=0.63 oe_lof=0.22)
chr1	44819746	44819746	C	G	hom	het	het		QUAL=25;DP=40,5,4;AF=1.00,0.40,0.50	BTBD19,PTCH2,RNU5E-6P	downstream_gene	BTBD19:ENST00000450269.6:downstream_gene_variant:MODIFIER::::,PTCH2:ENST00000447098.6:downstream_gene_variant:MODIFIER::::,RNU5E-6P:ENST00000365574.1:downstream_gene_variant:MODIFIER::::,PTCH2:ENST00000372192.4:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell carcinoma, somatic, 605462 (3)]			AluSx (SINE/Alu)	rs72674051	0.20315	0.33339,0.18903,0.18904,0.15800,0.14242	4052,	20768	113250	-1.1880	0.37							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BTBD19 (inh=n/a oe_syn=0.65 oe_mis=0.62 oe_lof=0.32), PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64), RNU5E-6P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	44819976	44819976	C	T	hom	het	het		QUAL=24;DP=196,143,168;AF=1.00,0.48,0.55	PTCH2,RNU5E-6P,BTBD19	3'UTR,non_coding_transcript_exon,downstream_gene	PTCH2:ENST00000447098.6:3_prime_UTR_variant:MODIFIER:exon23/23:c.*713G>A::,RNU5E-6P:ENST00000365574.1:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.22G>A::,BTBD19:ENST00000450269.6:downstream_gene_variant:MODIFIER::::,PTCH2:ENST00000372192.4:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell carcinoma, somatic, 605462 (3)]			U5 (snRNA)	rs41269085	0.22787	0.37248,0.20640,0.20545,0.16929,0.15894	4645,	25394	117524	-0.3300	0.20			/7.1>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BTBD19 (inh=n/a oe_syn=0.65 oe_mis=0.62 oe_lof=0.32), PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64), RNU5E-6P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	44827194	44827194	G	A	hom	het	het		QUAL=24;DP=93,159,133;AF=0.99,0.46,0.53	PTCH2	synonymous	PTCH2:ENST00000447098.6:synonymous_variant:LOW:exon16/23:c.2487C>T:p.Asp829=:,PTCH2:ENST00000372192.4:synonymous_variant:LOW:exon16/22:c.2487C>T:p.Asp829=:		603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell carcinoma, somatic, 605462 (3)]	1166504 [benign DISEASE=not provided,not specified,Gorlin syndrome GENE=PTCH2];			rs2295996	0.14374	0.08330,0.17429,0.20291,0.16730,0.15617	1778,	18326	130350	0.4630	0.99			/0.0>0.0/0.0>0.0	COSV64709782	PTCH2|0.00|0.00|0.00|0.00|-7|-24|2|-27	23826113	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44827846	44827846	A	G	hom	het	het		QUAL=24;DP=112,236,252;AF=0.99,0.46,0.48	PTCH2	synonymous	PTCH2:ENST00000447098.6:synonymous_variant:LOW:exon14/23:c.2055T>C:p.Ala685=:,PTCH2:ENST00000372192.4:synonymous_variant:LOW:exon14/22:c.2055T>C:p.Ala685=:		603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell carcinoma, somatic, 605462 (3)]	1166505 [benign DISEASE=not provided,not specified,Gorlin syndrome GENE=PTCH2];			rs7525308	0.42382	0.58899,0.40838,0.48726,0.34962,0.34507	14638,	35236	87702	1.9440	10.67			/0.0>0.0/1.1>0.0	COSV64709500	PTCH2|0.00|0.00|0.00|0.00|29|-23|-3|2	30591961,23826113,20371205	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44828484	44828484	T	C	hom	het	het		QUAL=24;DP=75,251,223;AF=1.00,0.50,0.51	PTCH2	intron	PTCH2:ENST00000447098.6:intron_variant:MODIFIER:intron12/22:c.1590+22A>G::,PTCH2:ENST00000372192.4:intron_variant:MODIFIER:intron12/21:c.1590+22A>G::		603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell carcinoma, somatic, 605462 (3)]	1327456 [benign DISEASE=not provided,Gorlin syndrome GENE=PTCH2];			rs2273940	0.42222	0.58328,0.40771,0.48645,0.34979,0.34598	14471,	35288	87894	-2.2410	0.38			/2.2>0.0/0.0>0.3	COSV64709511	PTCH2|0.01|0.00|0.00|0.00|-41|21|18|21	20371205	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44830239	44830239	-	TA	hom	het	het		QUAL=24;DP=76,15,8;AF=0.93,0.40,0.50	PTCH2	intron	PTCH2:ENST00000447098.6:intron_variant:MODIFIER:intron6/22:c.814-210_814-209insTA::,PTCH2:ENST00000372192.4:intron_variant:MODIFIER:intron6/21:c.814-210_814-209insTA::		603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell carcinoma, somatic, 605462 (3)]	1175624 [benign DISEASE=not provided GENE=PTCH2];			rs5773854	0.63117	0.74029,0.69337,0.97307,0.54981,0.67234	31179,	33442	55982		12.49			/0.0>0.0/0.0>0.0		PTCH2|0.02|0.00|0.00|0.00|34|2|-6|-49		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44841834	44841834	G	A	hom	het	het		QUAL=25;DP=82,213,183;AF=0.98,0.54,0.51	PTCH2	splice_region&intron	PTCH2:ENST00000447098.6:splice_region_variant&intron_variant:LOW:intron2/22:c.265+13C>T::,PTCH2:ENST00000372192.4:splice_region_variant&intron_variant:LOW:intron2/21:c.265+13C>T::	regulatory_region_variant:open_chromatin_region	603673_[GENE=PTCH2_PHENOS=Medulloblastoma, somatic, 155255 (3); Basal cell carcinoma, somatic, 605462 (3)]	1327457 [benign DISEASE=not provided,Gorlin syndrome GENE=PTCH2];			rs3795720	0.35016	0.32701,0.43413,0.43752,0.34743,0.33320	9504,	34231	98803	1.5370	13.43			/0.6>0.3/0.0>0.0	COSV64709520	PTCH2|0.00|0.00|0.00|0.00|-12|13|13|-19	34990798,20371205	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTCH2 (inh=AR+AD oe_syn=1.00 oe_mis=0.92 oe_lof=0.64)
chr1	44874610	44874610	C	T	hom	het	het		QUAL=24;DP=226,313,252;AF=1.00,0.48,0.48	EIF2B3	intron,3'UTR	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron10/11:c.1202+68G>A::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron10/10:c.1202+68G>A::,EIF2B3:ENST00000372183.7:3_prime_UTR_variant:MODIFIER:exon10/10:c.*31G>A::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter 3, with or without ovarian failure, 620313 (3), Autosomal recessive]	1288223 [benign DISEASE=not provided GENE=EIF2B3];		HAL1 (LINE/L1)	rs9988451	0.43107	0.58990,0.46759,0.44533,0.35544,0.34398	15010,	35488	86458	0.3200	6.20			/0.0>0.0/5.2>2.8		EIF2B3|0.00|0.00|0.00|0.00|-2|-31|4|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44875031	44875031	T	C	hom	het	het		QUAL=24;DP=54,18,11;AF=1.00,0.61,0.55	EIF2B3	intron	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron9/11:c.1054-205A>G::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron9/10:c.1054-205A>G::,EIF2B3:ENST00000372183.7:intron_variant:MODIFIER:intron9/9:c.1054-205A>G::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter 3, with or without ovarian failure, 620313 (3), Autosomal recessive]	1232545 [benign DISEASE=not provided GENE=EIF2B3];			rs263955	0.68016	0.90429,0.70851,0.97507,0.55273,0.66307	37222,	28931	48611	0.0610	8.48			/1.5>4.1/1.1>1.8		EIF2B3|0.00|0.00|0.00|0.00|0|-25|44|-24		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44879774	44879774	T	A	hom	het	het		QUAL=25;DP=102,64,44;AF=1.00,0.48,0.57	EIF2B3	intron	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron8/11:c.975+44A>T::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron8/10:c.975+44A>T::,EIF2B3:ENST00000372183.7:intron_variant:MODIFIER:intron8/9:c.975+44A>T::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter 3, with or without ovarian failure, 620313 (3), Autosomal recessive]	261223 [benign DISEASE=not specified,not provided GENE=EIF2B3];			rs3738248	0.15037	0.11240,0.14855,0.16043,0.17342,0.15538	1839,	19205	129295	0.2800	7.44			/5.4>5.6/0.0>0.0	COSV64517062	EIF2B3|0.00|0.00|0.00|0.00|47|-33|44|32	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44897320	44897320	T	C	hom	het	het		QUAL=24;DP=143,91,71;AF=1.00,0.57,0.52	EIF2B3	intron	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron6/11:c.656+35A>G::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron6/10:c.656+35A>G::,EIF2B3:ENST00000372183.7:intron_variant:MODIFIER:intron6/9:c.656+35A>G::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter 3, with or without ovarian failure, 620313 (3), Autosomal recessive]	261222 [benign DISEASE=not specified,not provided GENE=EIF2B3];			rs263978	0.67874	0.90399,0.70909,0.97537,0.54964,0.66211	37153,	28977	48885	-1.3970	1.25			/0.0>0.0/0.0>0.0		EIF2B3|0.00|0.00|0.00|0.00|35|23|35|23	25741868,15986317,18854859	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44897628	44897628	G	C	hom	het	het		QUAL=24;DP=137,14,11;AF=1.00,0.57,0.82	EIF2B3	intron	EIF2B3:ENST00000360403.7:intron_variant:MODIFIER:intron5/11:c.567-184C>G::,EIF2B3:ENST00000620860.4:intron_variant:MODIFIER:intron5/10:c.567-184C>G::,EIF2B3:ENST00000372183.7:intron_variant:MODIFIER:intron5/9:c.567-184C>G::		606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter 3, with or without ovarian failure, 620313 (3), Autosomal recessive]	1258642 [benign DISEASE=not provided GENE=EIF2B3];			rs263979	0.25218	0.45006,0.18840,0.16893,0.18137,0.15898	5974,	26298	113418	-0.0230	2.24			/3.2>2.4/0.0>0.0		EIF2B3|0.00|0.00|0.00|0.00|15|-17|27|-12	31642026	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21)
chr1	44986555	44986555	G	C	hom	het	het		QUAL=24;DP=126,187,109;AF=1.00,0.43,0.43	EIF2B3,PPIAP35,MRPS17P1	5'UTR,downstream_gene	EIF2B3:ENST00000360403.7:5_prime_UTR_variant:MODIFIER:exon1/12:c.-72C>G::,EIF2B3:ENST00000620860.4:5_prime_UTR_variant:MODIFIER:exon1/11:c.-72C>G::,EIF2B3:ENST00000372183.7:5_prime_UTR_variant:MODIFIER:exon1/10:c.-72C>G::,PPIAP35:ENST00000411837.1:downstream_gene_variant:MODIFIER::::,MRPS17P1:ENST00000596009.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	606273_[GENE=EIF2B3_PHENOS=Leukoencephalopathy with vanishing white matter 3, with or without ovarian failure, 620313 (3), Autosomal recessive]	297453 [benign DISEASE=not provided,Vanishing white matter disease GENE=EIF2B3];			rs489676	0.47894	0.62925,0.51604,0.43852,0.41515,0.36800	18304,	36202	79214	-3.4960	0.23			/0.0>0.0/0.0>0.4			15986317	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EIF2B3 (inh=AR oe_syn=0.80 oe_mis=0.81 oe_lof=0.21), PPIAP35 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MRPS17P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	45694588	45694588	C	T	hom	hom	het		QUAL=25;DP=134,145,120;AF=1.00,1.00,0.48	TMEM69,IPP	downstream_gene	TMEM69:ENST00000372025.5:downstream_gene_variant:MODIFIER::::,IPP:ENST00000396478.4:downstream_gene_variant:MODIFIER::::						rs6658700	0.28348	0.24075,0.31062,0.34644,0.29459,0.36503	6236,	30619	108915	0.2500	7.20						15986317	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM69 (inh=n/a oe_syn=0.73 oe_mis=0.95 oe_lof=0.86), IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45698718	45698727	TTTTTTTTTT	-	hom	hom	n/a		QUAL=24;DP=28,5,0;AF=0.96,1.00,	IPP,TMEM69	3'UTR,downstream_gene	IPP:ENST00000396478.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1239_*1248del::,TMEM69:ENST00000372025.5:downstream_gene_variant:MODIFIER::::					AluJb (SINE/Alu)	rs78627575	0.31989	0.27615,0.36777,0.37533,0.31901,0.39790	6171,	29537	89037	0.7410	0.49			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM69 (inh=n/a oe_syn=0.73 oe_mis=0.95 oe_lof=0.86), IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45699174	45699174	A	T	hom	hom	het		QUAL=24;DP=171,300,179;AF=0.99,1.00,0.47	IPP,TMEM69	3'UTR,downstream_gene	IPP:ENST00000396478.4:3_prime_UTR_variant:MODIFIER:exon9/9:c.*792T>A::,TMEM69:ENST00000372025.5:downstream_gene_variant:MODIFIER::::						rs10749856	0.28637	0.24072,0.31186,0.36585,0.29755,0.36878	6365,	30818	108522	1.3890	7.58			/1.1>2.4/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TMEM69 (inh=n/a oe_syn=0.73 oe_mis=0.95 oe_lof=0.86), IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45700203	45700203	-	A	hom	hom	het	low_conf_region	QUAL=24;DP=113,245,230;AF=0.88,0.87,0.36	IPP	splice_region&intron	IPP:ENST00000396478.4:splice_region_variant&intron_variant:LOW:intron8/8:c.1531-14dup::						rs550999501	0.28500	0.22719,0.31104,0.36819,0.29961,0.37198	6027,	30281	106209		11.47			/11.2>11.2/0.0>0.0		IPP|0.02|0.00|0.00|0.00|-19|-17|-19|-17		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45727474	45727474	-	TCCC	hom	hom	wt	low_conf_region	QUAL=24;DP=18,11,12;AF=0.78,1.00,0.00	IPP	intron	IPP:ENST00000396478.4:intron_variant:MODIFIER:intron5/8:c.1048+153_1048+156dup::					(CCTT)n (Simple_repeat)	rs200134370	0.30851	0.38751,0.29509,0.32306,0.27658,0.33804	6650,	30965	99215		0.58			/0.0>0.0/2.6>2.6				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45729540	45729542	AAC	-	hom	hom	het		QUAL=24;DP=107,21,19;AF=0.99,1.00,0.53	IPP	intron	IPP:ENST00000396478.4:intron_variant:MODIFIER:intron4/8:c.880+72_880+74del::	regulatory_region_variant:enhancer					rs139068713	0.28062	0.23465,0.30894,0.32863,0.29404,0.36392	6085,	30477	109329	1.0420	8.03			/1.0>1.0/0.0>0.0		IPP|0.00|0.00|0.00|0.00|45|27|-21|-25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45729703	45729703	T	C	hom	hom	het		QUAL=24;DP=230,65,60;AF=1.00,0.97,0.57	IPP	missense	IPP:ENST00000396478.4:missense_variant:MODERATE:exon4/9:c.791A>G:p.Lys264Arg:	regulatory_region_variant:enhancer					rs28375469	0.28191	0.23517,0.30963,0.34357,0.29488,0.36531	6190,	30511	109253	7.6030	18.58	0.185	0.08	/0.0>0.0/0.0>0.0	COSV63431879	IPP|0.00|0.00|0.00|0.00|6|-38|-46|8	32327693,33777101	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45740727	45740727	G	A	het	n/a	n/a		QUAL=24;DP=8,2,0;AF=1.00,1.00,	IPP	intron	IPP:ENST00000396478.4:intron_variant:MODIFIER:intron3/8:c.724+174C>T::						rs28647556	0.53607	0.56869,0.48864,0.37563,0.53799,0.51040	21888,	37499	70337	0.1770	8.93			/3.9>3.2/0.0>0.0		IPP|0.00|0.00|0.00|0.00|-14|16|-5|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	45740868	45740868	A	G	hom	hom	het		QUAL=24;DP=140,37,25;AF=1.00,1.00,0.68	IPP	intron	IPP:ENST00000396478.4:intron_variant:MODIFIER:intron3/8:c.724+33T>C::						rs28507722	0.28180	0.23489,0.31018,0.34406,0.29469,0.36483	6182,	30527	109313	1.3640	10.20			/1.0>0.9/0.0>0.0	COSV63433613	IPP|0.00|0.00|0.00|0.01|33|29|-29|33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IPP (inh=n/a oe_syn=1.07 oe_mis=0.92 oe_lof=0.43)
chr1	46189486	46189486	T	C	hom	hom	hom		QUAL=24;DP=139,131,141;AF=0.99,1.00,1.00	POMGNT1,TSPAN1	missense,missense&splice_region,downstream_gene	POMGNT1:ENST00000371984.8:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000371992.1:missense_variant&splice_region_variant:MODERATE:exon21/23:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000396420.8:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000686737.1:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000685444.1:missense_variant:MODERATE:exon20/21:c.1768A>G:p.Met590Val:,POMGNT1:ENST00000688608.1:missense_variant:MODERATE:exon20/21:c.1768A>G:p.Met590Val:,POMGNT1:ENST00000692369.1:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000687683.1:missense_variant:MODERATE:exon21/22:c.1867A>G:p.Met623Val:,POMGNT1:ENST00000687149.1:missense_variant:MODERATE:exon20/21:c.1906A>G:p.Met636Val:,TSPAN1:ENST00000372003.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	167524 [benign DISEASE=Muscle eye brain disease,not provided,not specified,Autosomal recessive limb-girdle muscular dystrophy type 2O,Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3,Retinitis pigmentosa 76,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 GENE=TSPAN1];			rs6659553	0.94819	0.81929,0.98223,1.00000,0.99944,0.99917	68989,	6435	7891	5.8290	18.03	0.326	0.04	2.6>0.4/0.0>0.0/2.6>0.4,/0.0>0.0/2.6>0.4			24033266,17878207,25373335,36012197,28765568	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSPAN1 (inh=AR oe_syn=1.16 oe_mis=0.87 oe_lof=0.79), POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46191979	46191979	T	C	hom	het	hom		QUAL=24;DP=68,74,89;AF=0.94,0.49,0.99	POMGNT1	intron	POMGNT1:ENST00000371984.8:intron_variant:MODIFIER:intron17/21:c.1539+119A>G::,POMGNT1:ENST00000371992.1:intron_variant:MODIFIER:intron17/22:c.1539+119A>G::,POMGNT1:ENST00000396420.8:intron_variant:MODIFIER:intron17/21:c.1539+119A>G::,POMGNT1:ENST00000686737.1:intron_variant:MODIFIER:intron17/21:c.1539+119A>G::,POMGNT1:ENST00000685444.1:intron_variant:MODIFIER:intron16/20:c.1440+119A>G::,POMGNT1:ENST00000688608.1:intron_variant:MODIFIER:intron16/20:c.1440+119A>G::,POMGNT1:ENST00000692369.1:intron_variant:MODIFIER:intron17/21:c.1539+119A>G::,POMGNT1:ENST00000687683.1:intron_variant:MODIFIER:intron17/21:c.1539+119A>G::,POMGNT1:ENST00000687149.1:intron_variant:MODIFIER:intron17/20:c.1539+119A>G::		606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	667975 [benign DISEASE=not provided GENE=TSPAN1];		MIR (SINE/MIR)	rs7521880	0.34883	0.34885,0.36206,0.15971,0.35277,0.43434	9407,	34230	99018	-0.1390	5.42			/7.5>8.1/0.0>0.0	COSV64339342	POMGNT1|0.00|0.00|0.00|0.00|24|-39|1|21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46192656	46192656	A	G	hom	het	hom		QUAL=24;DP=118,169,165;AF=0.99,0.48,1.00	POMGNT1	intron	POMGNT1:ENST00000371984.8:intron_variant:MODIFIER:intron14/21:c.1212-66T>C::,POMGNT1:ENST00000371992.1:intron_variant:MODIFIER:intron14/22:c.1212-66T>C::,POMGNT1:ENST00000396420.8:intron_variant:MODIFIER:intron14/21:c.1212-66T>C::,POMGNT1:ENST00000686737.1:intron_variant:MODIFIER:intron14/21:c.1212-66T>C::,POMGNT1:ENST00000685444.1:intron_variant:MODIFIER:intron13/20:c.1113-66T>C::,POMGNT1:ENST00000688608.1:intron_variant:MODIFIER:intron13/20:c.1113-66T>C::,POMGNT1:ENST00000692369.1:intron_variant:MODIFIER:intron14/21:c.1212-66T>C::,POMGNT1:ENST00000687683.1:intron_variant:MODIFIER:intron14/21:c.1212-66T>C::,POMGNT1:ENST00000687149.1:intron_variant:MODIFIER:intron14/20:c.1212-66T>C::		606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	671038 [benign DISEASE=not provided,Retinitis pigmentosa 76,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 GENE=TSPAN1];			rs2292484	0.34829	0.34786,0.36172,0.16047,0.35234,0.43403	9318,	34228	98918	0.2780	11.96			/4.3>4.1/0.0>0.0	COSV64341376	POMGNT1|0.00|0.00|0.00|0.00|48|-20|-11|46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46192671	46192671	G	A	hom	het	hom		QUAL=24;DP=117,161,154;AF=0.98,0.47,1.00	POMGNT1	intron	POMGNT1:ENST00000371984.8:intron_variant:MODIFIER:intron14/21:c.1212-81C>T::,POMGNT1:ENST00000371992.1:intron_variant:MODIFIER:intron14/22:c.1212-81C>T::,POMGNT1:ENST00000396420.8:intron_variant:MODIFIER:intron14/21:c.1212-81C>T::,POMGNT1:ENST00000686737.1:intron_variant:MODIFIER:intron14/21:c.1212-81C>T::,POMGNT1:ENST00000685444.1:intron_variant:MODIFIER:intron13/20:c.1113-81C>T::,POMGNT1:ENST00000688608.1:intron_variant:MODIFIER:intron13/20:c.1113-81C>T::,POMGNT1:ENST00000692369.1:intron_variant:MODIFIER:intron14/21:c.1212-81C>T::,POMGNT1:ENST00000687683.1:intron_variant:MODIFIER:intron14/21:c.1212-81C>T::,POMGNT1:ENST00000687149.1:intron_variant:MODIFIER:intron14/20:c.1212-81C>T::		606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	671037 [benign DISEASE=not provided,Retinitis pigmentosa 76,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 GENE=TSPAN1];			rs2292485	0.34813	0.34732,0.36207,0.15970,0.35239,0.43314	9301,	34219	98905	0.1270	6.54			/0.0>0.0/0.0>0.0	COSV64341379	POMGNT1|0.00|0.00|0.00|0.00|30|-35|31|-26		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46193432	46193432	T	C	hom	het	hom		QUAL=24;DP=79,293,275;AF=1.00,0.51,1.00	POMGNT1	intron	POMGNT1:ENST00000371984.8:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:ENST00000371992.1:intron_variant:MODIFIER:intron11/22:c.1027-44A>G::,POMGNT1:ENST00000396420.8:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:ENST00000686737.1:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:ENST00000685444.1:intron_variant:MODIFIER:intron10/20:c.928-44A>G::,POMGNT1:ENST00000688608.1:intron_variant:MODIFIER:intron10/20:c.928-44A>G::,POMGNT1:ENST00000692369.1:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:ENST00000687683.1:intron_variant:MODIFIER:intron11/21:c.1027-44A>G::,POMGNT1:ENST00000687149.1:intron_variant:MODIFIER:intron11/20:c.1027-44A>G::		606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	260869 [benign DISEASE=Autosomal recessive limb-girdle muscular dystrophy type 2O,Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3,not specified,not provided,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3,Retinitis pigmentosa 76 GENE=TSPAN1];			rs7527668	0.37749	0.44590,0.37340,0.16019,0.35341,0.43530	11099,	35200	94654	-0.3030	6.57			/0.0>0.0/2.3>1.5	COSV64339664	POMGNT1|0.03|0.00|0.00|0.00|-28|10|47|-19	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46193691	46193691	T	C	hom	het	hom		QUAL=24;DP=67,120,154;AF=0.97,0.50,1.00	POMGNT1	intron	POMGNT1:ENST00000371984.8:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:ENST00000371992.1:intron_variant:MODIFIER:intron10/22:c.951-52A>G::,POMGNT1:ENST00000396420.8:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:ENST00000686737.1:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:ENST00000685444.1:intron_variant:MODIFIER:intron9/20:c.852-52A>G::,POMGNT1:ENST00000688608.1:intron_variant:MODIFIER:intron9/20:c.852-52A>G::,POMGNT1:ENST00000692369.1:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:ENST00000687683.1:intron_variant:MODIFIER:intron10/21:c.951-52A>G::,POMGNT1:ENST00000687149.1:intron_variant:MODIFIER:intron10/20:c.951-52A>G::		606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	671035 [benign DISEASE=not provided,Retinitis pigmentosa 76,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 GENE=TSPAN1];			rs7527935	0.34889	0.34870,0.36242,0.16016,0.35274,0.43459	9418,	34213	99001	-0.0180	0.92			/0.0>0.0/1.3>2.0	COSV64339668	POMGNT1|0.00|0.00|0.00|0.00|-43|4|4|42		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	46194623	46194623	T	C	hom	het	hom		QUAL=24;DP=133,260,198;AF=1.00,0.43,0.99	POMGNT1	synonymous,intron	POMGNT1:ENST00000371984.8:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:ENST00000371992.1:synonymous_variant:LOW:exon8/23:c.681A>G:p.Lys227=:,POMGNT1:ENST00000396420.8:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:ENST00000686737.1:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:ENST00000685444.1:intron_variant:MODIFIER:intron7/20:c.652+221A>G::,POMGNT1:ENST00000688608.1:intron_variant:MODIFIER:intron7/20:c.652+221A>G::,POMGNT1:ENST00000692369.1:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:ENST00000687683.1:synonymous_variant:LOW:exon8/22:c.681A>G:p.Lys227=:,POMGNT1:ENST00000687149.1:synonymous_variant:LOW:exon8/21:c.681A>G:p.Lys227=:	regulatory_region_variant:enhancer	606822_[GENE=POMGNT1_PHENOS=Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 3, 613157 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with impaired intellectual development), type B, 3, 613151 (3), Autosomal recessive; Retinitis pigmentosa 76, 617123 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 3, 253280 (3), Autosomal recessive]	95761 [benign DISEASE=Autosomal recessive limb-girdle muscular dystrophy type 2O,Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B3,Retinal dystrophy,not provided,not specified,Retinitis pigmentosa 76,Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3,Congenital Muscular Dystrophy, alpha-dystroglycan related,Muscle eye brain disease GENE=TSPAN1];			rs2292487	0.34936	0.34980,0.36244,0.15984,0.35304,0.43467	9438,	34255	98951	0.3970	8.20	0.048		/0.0>0.0/0.0>0.3	COSV64339346	POMGNT1|0.00|0.00|0.00|0.00|-1|-32|5|29	25741868,24033266,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POMGNT1 (inh=AR oe_syn=1.02 oe_mis=0.88 oe_lof=0.79)
chr1	47250369	47250370	AA	-	het	wt	het		QUAL=25;DP=110,16,181;AF=0.45,0.00,0.52	STIL	3'UTR,downstream_gene	STIL:ENST00000360380.7:3_prime_UTR_variant:MODIFIER:exon18/18:c.*766_*767del::,STIL:ENST00000371877.8:3_prime_UTR_variant:MODIFIER:exon17/17:c.*766_*767del::,STIL:ENST00000337817.10:3_prime_UTR_variant:MODIFIER:exon19/19:c.*766_*767del::,STIL:ENST00000396221.6:downstream_gene_variant:MODIFIER::::,STIL:ENST00000682977.1:downstream_gene_variant:MODIFIER::::,STIL:ENST00000447475.7:downstream_gene_variant:MODIFIER::::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	297544 [benign DISEASE=Primary Microcephaly, Recessive GENE=STIL];			rs75930208	0.42480	0.16929,0.43011,0.44760,0.52124,0.55122	15821,	32917	87415	1.6070	1.99			/2.2>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47251517	47251517	A	G	het	wt	het		QUAL=24;DP=104,128,173;AF=0.57,0.00,0.44	STIL	synonymous	STIL:ENST00000360380.7:synonymous_variant:LOW:exon18/18:c.3483T>C:p.Pro1161=:,STIL:ENST00000371877.8:synonymous_variant:LOW:exon17/17:c.3486T>C:p.Pro1162=:,STIL:ENST00000337817.10:synonymous_variant:LOW:exon19/19:c.3345T>C:p.Pro1115=:,STIL:ENST00000396221.6:synonymous_variant:LOW:exon17/17:c.3432T>C:p.Pro1144=:,STIL:ENST00000682977.1:synonymous_variant:LOW:exon18/18:c.3345T>C:p.Pro1115=:,STIL:ENST00000447475.7:synonymous_variant:LOW:exon19/19:c.3291T>C:p.Pro1097=:		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	94095 [benign DISEASE=not specified,Microcephaly 7, primary, autosomal recessive,not provided GENE=STIL];			rs2758735	0.42582	0.17105,0.43066,0.44741,0.52187,0.55089	15910,	32962	87354	-0.8210	1.11			/3.5>2.5/0.0>0.0		STIL|0.00|0.00|0.00|0.00|17|46|38|-13	25741868,18414213,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47260415	47260415	T	C	het	het	het		QUAL=24;DP=212,175,117;AF=0.51,0.47,0.47	STIL	missense	STIL:ENST00000360380.7:missense_variant:MODERATE:exon17/18:c.2951A>G:p.His984Arg:,STIL:ENST00000371877.8:missense_variant:MODERATE:exon16/17:c.2954A>G:p.His985Arg:,STIL:ENST00000337817.10:missense_variant:MODERATE:exon18/19:c.2813A>G:p.His938Arg:,STIL:ENST00000396221.6:missense_variant:MODERATE:exon16/17:c.2900A>G:p.His967Arg:,STIL:ENST00000682977.1:missense_variant:MODERATE:exon17/18:c.2813A>G:p.His938Arg:,STIL:ENST00000447475.7:missense_variant:MODERATE:exon18/19:c.2759A>G:p.His920Arg:		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	94094 [benign DISEASE=not specified,Microcephaly 7, primary, autosomal recessive,not provided GENE=STIL];			rs13376679	0.25264	0.20150,0.21475,0.02542,0.31368,0.20901	5206,	28021	113695	0.0110	2.22	0.030	0.07	/0.0>0.0/0.0>0.0	COSV54551803	STIL|0.00|0.00|0.00|0.00|35|-50|-26|3	25741868,23757202,23772360,35773235	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47272449	47272449	T	-	hom	wt	hom		QUAL=25;DP=28,12,7;AF=0.86,0.00,0.86	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron13/17:c.2218-208del::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron12/16:c.2218-208del::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron14/18:c.2077-208del::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron12/16:c.2218-208del::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron13/17:c.2077-208del::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron14/18:c.2077-208del::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	1295564 [benign DISEASE=not provided GENE=STIL];		AluJr (SINE/Alu)	rs60685133	0.52645	0.34479,0.50075,0.46839,0.60576,0.67231	20773,	35231	69063	-0.3060	0.59			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47281321	47281321	G	A	het	het	het		QUAL=24;DP=168,44,20;AF=0.50,0.41,0.45	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron12/17:c.1249-112C>T::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron11/16:c.1249-112C>T::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron13/18:c.1108-112C>T::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron11/16:c.1249-112C>T::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron12/17:c.1108-112C>T::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron13/18:c.1108-112C>T::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	1246005 [benign DISEASE=not provided GENE=STIL];			rs11211505	0.25872	0.22175,0.21709,0.02528,0.31401,0.20887	5413,	28495	112661	-0.5560	0.29			/0.0>0.0/0.0>0.0		STIL|0.00|0.00|0.00|0.00|3|-48|19|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47281418	47281418	T	C	het	het	hom		QUAL=24;DP=64,7,3;AF=0.47,0.57,1.00	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron12/17:c.1249-209A>G::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron11/16:c.1249-209A>G::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron13/18:c.1108-209A>G::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron11/16:c.1249-209A>G::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron12/17:c.1108-209A>G::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron13/18:c.1108-209A>G::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	1182531 [benign DISEASE=not provided GENE=STIL];		L2c (LINE/L2)	rs12145974	0.25875	0.22228,0.21687,0.02546,0.31390,0.20818	5417,	28507	112701	0.3230	11.89			/3.8>3.8/1.4>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47287733	47287733	G	A	het	wt	het		QUAL=24;DP=161,16,54;AF=0.40,0.00,0.54	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron10/17:c.1024-73C>T::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron9/16:c.1024-73C>T::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron11/18:c.883-73C>T::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron9/16:c.1024-73C>T::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron10/17:c.883-73C>T::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron11/18:c.883-73C>T::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	673949 [benign DISEASE=not provided GENE=STIL];			rs12125261	0.38253	0.09306,0.40761,0.22399,0.51075,0.45519	13922,	30266	93800	0.7330	13.91			/6.4>6.5/0.0>0.0	COSV54548877	STIL|0.00|0.00|0.00|0.00|-40|-44|15|-38		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47299818	47299818	T	C	het	hom	het		QUAL=24;DP=130,55,45;AF=0.45,1.00,0.67	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron7/17:c.701+87A>G::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron6/16:c.701+87A>G::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron8/18:c.560+87A>G::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron6/16:c.701+87A>G::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron7/17:c.560+87A>G::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron8/18:c.560+87A>G::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	670465 [benign DISEASE=not provided GENE=STIL];			rs9436838	0.58236	0.83991,0.57325,0.58085,0.48574,0.45317	27982,	32627	63533	-0.3510	4.64			/2.3>0.0/0.0>0.3		STIL|0.00|0.00|0.00|0.00|3|-40|5|-44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47301469	47301469	C	A	het	hom	het		QUAL=25;DP=169,43,26;AF=0.49,1.00,0.46	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron6/17:c.453+92G>T::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron5/16:c.453+92G>T::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron6/18:c.453+92G>T::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron5/16:c.453+92G>T::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron5/17:c.453+92G>T::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron6/18:c.453+92G>T::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	670581 [benign DISEASE=not provided GENE=STIL];			rs6689687	0.58252	0.83986,0.57276,0.58398,0.48583,0.45366	27965,	32611	63455	0.1760	2.40			/0.0>0.0/0.0>0.0	COSV54552578	STIL|0.00|0.00|0.00|0.00|-3|19|36|41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47302242	47302242	G	A	het	hom	het		QUAL=24;DP=244,258,185;AF=0.51,0.99,0.54	STIL	missense	STIL:ENST00000360380.7:missense_variant:MODERATE:exon5/18:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000371877.8:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000337817.10:missense_variant:MODERATE:exon5/19:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000396221.6:missense_variant:MODERATE:exon4/17:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000682977.1:missense_variant:MODERATE:exon4/18:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus],STIL:ENST00000447475.7:missense_variant:MODERATE:exon5/19:c.257C>T:p.Ala86Val:PF15253 [SCL-interrupting locus protein N-terminus]		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	21354 [benign DISEASE=not provided,Microcephaly 7, primary, autosomal recessive,not specified GENE=STIL];			rs3125630	0.57515	0.83141,0.56929,0.55267,0.47908,0.44867	27290,	32831	64569	5.3540	17.43	0.173	0.05	/5.9>5.3/0.0>0.0	COSV54548838	STIL|0.00|0.00|0.00|0.00|-35|0|2|-8	25741868,20301772,23772360	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47304769	47304769	A	C	het	hom	het		QUAL=24;DP=71,77,64;AF=0.56,0.99,0.53	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron4/17:c.152+120T>G::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron3/16:c.152+120T>G::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron4/18:c.152+120T>G::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron3/16:c.152+120T>G::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron3/17:c.152+120T>G::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron4/18:c.152+120T>G::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	670580 [benign DISEASE=not provided GENE=STIL];			rs3122615	0.57500	0.83095,0.56862,0.55130,0.47920,0.44913	27294,	32869	64641	-0.1650	2.51			/10.5>9.0/0.0>0.0		STIL|0.01|0.00|0.00|0.00|-1|2|-1|-47		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47305114	47305114	T	A	het	wt	het		QUAL=24;DP=142,30,56;AF=0.45,0.00,0.55	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron3/17:c.45-118A>T::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron2/16:c.45-118A>T::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron3/18:c.45-118A>T::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron2/16:c.45-118A>T::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron2/17:c.45-118A>T::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron3/18:c.45-118A>T::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	670141 [benign DISEASE=not provided GENE=STIL];			rs6692734	0.38194	0.09252,0.40834,0.22379,0.50949,0.45377	13921,	30279	94051	-0.4510	0.16			/0.0>0.0/0.0>0.0	COSV54552742	STIL|0.00|0.00|0.00|0.00|-16|7|45|-42		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	47305134	47305134	T	C	het	het	het		QUAL=24;DP=123,28,22;AF=0.55,0.61,0.59	STIL	intron	STIL:ENST00000360380.7:intron_variant:MODIFIER:intron3/17:c.45-138A>G::,STIL:ENST00000371877.8:intron_variant:MODIFIER:intron2/16:c.45-138A>G::,STIL:ENST00000337817.10:intron_variant:MODIFIER:intron3/18:c.45-138A>G::,STIL:ENST00000396221.6:intron_variant:MODIFIER:intron2/16:c.45-138A>G::,STIL:ENST00000682977.1:intron_variant:MODIFIER:intron2/17:c.45-138A>G::,STIL:ENST00000447475.7:intron_variant:MODIFIER:intron3/18:c.45-138A>G::		181590_[GENE=STIL_PHENOS=Microcephaly 7, primary, autosomal recessive, 612703 (3), Autosomal recessive]	1293134 [benign DISEASE=not provided GENE=STIL];			rs12129594	0.25494	0.20244,0.21750,0.02550,0.31707,0.20928	5305,	28180	113366	-0.4610	1.00			/0.0>0.0/0.0>0.0	COSV54549757	STIL|0.00|0.00|0.00|0.00|1|-36|1|33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					STIL (inh=AR oe_syn=0.87 oe_mis=0.88 oe_lof=0.24)
chr1	50600416	50600416	T	C	het	wt	het		QUAL=24;DP=165,16,135;AF=0.44,0.00,0.47	FAF1	intron	FAF1:ENST00000396153.7:intron_variant:MODIFIER:intron8/18:c.745-4200A>G::					Charlie1a (DNA/hAT-Charlie)	rs6679854	0.23239	0.17851,0.23894,0.00328,0.28097,0.24161	4538,	26271	116757	0.3190	4.10			/4.6>4.4/6.0>1.7	COSV65639546			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FAF1 (inh=n/a oe_syn=0.86 oe_mis=0.68 oe_lof=0.12)
chr1	53196294	53196294	G	A	het	hom	wt		QUAL=24;DP=62,34,17;AF=0.42,0.97,0.00	CPT2	upstream_gene	CPT2:ENST00000636867.1:upstream_gene_variant:MODIFIER::::,CPT2:ENST00000636891.1:upstream_gene_variant:MODIFIER::::,CPT2:ENST00000637252.1:upstream_gene_variant:MODIFIER::::,CPT2:ENST00000636935.1:upstream_gene_variant:MODIFIER::::,CPT2:ENST00000635862.1:upstream_gene_variant:MODIFIER::::,CPT2:ENST00000371486.4:upstream_gene_variant:MODIFIER::::		600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal recessive, Autosomal dominant; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal recessive, Autosomal dominant]	1236333 [benign DISEASE=not provided GENE=CPT2];			rs10888776	0.45490	0.27751,0.44725,0.72267,0.54128,0.27177	17099,	34961	82871	0.1590	8.75							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78)
chr1	53197151	53197151	C	A	het	het	wt		QUAL=24;DP=9,107,16;AF=0.56,0.60,0.00	CPT2	intron	CPT2:ENST00000636867.1:intron_variant:MODIFIER:intron1/4:c.152+56C>A::,CPT2:ENST00000636891.1:intron_variant:MODIFIER:intron1/4:c.152+56C>A::,CPT2:ENST00000637252.1:intron_variant:MODIFIER:intron1/5:c.152+56C>A::,CPT2:ENST00000636935.1:intron_variant:MODIFIER:intron1/3:c.152+56C>A::,CPT2:ENST00000635862.1:intron_variant:MODIFIER:intron1/5:c.152+56C>A::,CPT2:ENST00000371486.4:intron_variant:MODIFIER:intron1/4:c.152+56C>A::	regulatory_region_variant:open_chromatin_region	600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal recessive, Autosomal dominant; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal recessive, Autosomal dominant]	1177631 [benign DISEASE=not provided,Carnitine palmitoyl transferase II deficiency, neonatal form,Carnitine palmitoyl transferase II deficiency, severe infantile form GENE=CPT2];			rs72673121	0.14490	0.03940,0.14794,0.05110,0.21532,0.09304	2092,	17869	130147	-0.0020	7.30			/3.2>2.3/0.0>0.0		CPT2|0.00|0.00|0.00|0.00|30|28|9|28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78)
chr1	53210776	53210776	G	A	het	hom	wt		QUAL=24;DP=167,230,16;AF=0.49,1.00,0.00	CPT2,CZIB	missense,intron,downstream_gene	CPT2:ENST00000636867.1:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000636891.1:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000637252.1:missense_variant:MODERATE:exon4/6:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000636935.1:intron_variant:MODIFIER:intron3/3:c.341-2488G>A::,CPT2:ENST00000635862.1:missense_variant:MODERATE:exon4/6:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase],CPT2:ENST00000371486.4:missense_variant:MODERATE:exon4/5:c.1102G>A:p.Val368Ile:PF00755 [Choline/Carnitine o-acyltransferase],CZIB:ENST00000294360.5:downstream_gene_variant:MODIFIER::::		600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal recessive, Autosomal dominant; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal recessive, Autosomal dominant]	92429 [benign DISEASE=Carnitine palmitoyltransferase II deficiency,CPT2-related disorder,not specified,Carnitine palmitoyl transferase II deficiency, neonatal form,Carnitine palmitoyl transferase II deficiency, severe infantile form,not provided GENE=CPT2]; 30118 [risk factor DISEASE=Encephalopathy, acute, infection-induced, susceptibility to, 4 GENE=CPT2];	CM139511 [CLASS=DP MUT=ALT PHEN="Influenza infection-associated encephalopathy" GENE=CPT2];		rs1799821	0.45889	0.28929,0.44948,0.72224,0.54224,0.27150	17298,	35151	82243	-0.0480	0.07	0.232	0.07	/0.0>0.0/0.0>0.0	COSV53758728	CPT2|0.00|0.00|0.00|0.00|-20|-15|-50|21	15986317,23757202,15811315,18306170,20934285,21697855,22809552,26874509,27156515,26010953,33170162,26460316,36358356,25361188,34234772	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78), CZIB (inh=n/a oe_syn=1.14 oe_mis=0.98 oe_lof=0.84)
chr1	53213557	53213557	A	G	het	het	wt		QUAL=24;DP=123,236,16;AF=0.46,0.46,0.00	CPT2,CZIB	missense,3'UTR,downstream_gene	CPT2:ENST00000636867.1:missense_variant:MODERATE:exon5/5:c.1870A>G:p.Met624Val:,CPT2:ENST00000636891.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*192A>G::,CPT2:ENST00000637252.1:missense_variant:MODERATE:exon6/6:c.1975A>G:p.Met659Val:,CPT2:ENST00000636935.1:missense_variant:MODERATE:exon4/4:c.634A>G:p.Met212Val:,CPT2:ENST00000635862.1:missense_variant:MODERATE:exon6/6:c.1906A>G:p.Met636Val:,CPT2:ENST00000371486.4:missense_variant:MODERATE:exon5/5:c.1939A>G:p.Met647Val:,CZIB:ENST00000294360.5:downstream_gene_variant:MODIFIER::::		600650_[GENE=CPT2_PHENOS={Encephalopathy, acute, infection-induced, 4, susceptibility to}, 614212 (3), Autosomal recessive, Autosomal dominant; CPT II deficiency, infantile, 600649 (3), Autosomal recessive; CPT II deficiency, lethal neonatal, 608836 (3), Autosomal recessive; CPT II deficiency, myopathic, stress-induced, 255110 (3), Autosomal recessive, Autosomal dominant]	92433 [benign DISEASE=Carnitine palmitoyl transferase II deficiency, severe infantile form,not specified,Carnitine palmitoyl transferase II deficiency, neonatal form,Carnitine palmitoyltransferase II deficiency,not provided GENE=CPT2];	CM1720321 [CLASS=DM? MUT=ALT PHEN="Carnitine palmitoyltransferase II deficiency" GENE=CPT2];		rs1799822	0.15152	0.05147,0.16331,0.08211,0.21677,0.09428	2188,	18698	129214	7.4310	21.10	0.285	0.08	/2.1>3.1/0.0>0.0	COSV53759353	CPT2|0.02|0.00|0.00|0.00|-50|2|33|45	23757202,33031748,27156515,31201655,35347128,32778093,33170162,33414548,15647998,36635386	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CPT2 (inh=AR+AD oe_syn=1.12 oe_mis=0.94 oe_lof=0.78), CZIB (inh=n/a oe_syn=1.14 oe_mis=0.98 oe_lof=0.84)
chr1	54849678	54849678	T	C	hom	hom	hom		QUAL=24;DP=128,157,130;AF=1.00,1.00,1.00	DHCR24	3'UTR,downstream_gene	DHCR24:ENST00000371269.9:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2555A>G::,DHCR24:ENST00000535035.6:3_prime_UTR_variant:MODIFIER:exon10/10:c.*2555A>G::,DHCR24:ENST00000436604.2:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	297612 [benign DISEASE=not provided,Desmosterolosis GENE=DHCR24];			rs657688	0.99942	0.99812,0.99967,0.99981,0.99997,1.00000	76062,	88	88	-0.6870	1.69			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54850268	54850268	G	T	het	het	wt		QUAL=24;DP=227,385,73;AF=0.47,0.50,0.00	DHCR24	3'UTR,downstream_gene	DHCR24:ENST00000371269.9:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1965C>A::,DHCR24:ENST00000535035.6:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1965C>A::,DHCR24:ENST00000436604.2:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	297621 [benign DISEASE=Desmosterolosis,not provided GENE=DHCR24];			rs11555500	0.02387	0.00712,0.01457,0.00039,0.03887,0.00497	75,	3486	148680	0.8670	6.52			/4.0>2.8/0.0>0.0		DHCR24|0.00|0.00|0.00|0.00|32|-20|26|-20		0	19	0	0 / 0					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54850409	54850409	A	C	hom	hom	hom		QUAL=24;DP=168,259,190;AF=1.00,1.00,1.00	DHCR24	3'UTR,downstream_gene	DHCR24:ENST00000371269.9:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1824T>G::,DHCR24:ENST00000535035.6:3_prime_UTR_variant:MODIFIER:exon10/10:c.*1824T>G::,DHCR24:ENST00000436604.2:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	297623 [benign DISEASE=Desmosterolosis,not provided GENE=DHCR24];			rs654561	0.98937	0.96841,0.99693,0.99246,0.99969,0.96998	74573,	1570	1620	-0.2930	2.00			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54854229	54854229	A	G	hom	hom	hom		QUAL=24;DP=7,9,3;AF=1.00,1.00,1.00	DHCR24	synonymous	DHCR24:ENST00000371269.9:synonymous_variant:LOW:exon7/9:c.1026T>C:p.Ile342=:,DHCR24:ENST00000535035.6:synonymous_variant:LOW:exon8/10:c.1062T>C:p.Ile354=:,DHCR24:ENST00000436604.2:synonymous_variant:LOW:exon7/10:c.1026T>C:p.Ile342=:		606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	297654 [benign DISEASE=not provided,Desmosterolosis GENE=DHCR24];			rs718265	0.66464	0.61713,0.62006,0.41125,0.69690,0.80348	33909,	33148	50944	1.6670	10.72			/0.0>0.0/0.0>0.0	COSV64875204	DHCR24|0.00|0.00|0.00|0.00|5|-34|-48|2	17510943,21901424,17579359,34680591,24489783	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54871277	54871277	C	G	hom	hom	hom		QUAL=25;DP=58,112,101;AF=1.00,1.00,1.00	DHCR24	intron	DHCR24:ENST00000371269.9:intron_variant:MODIFIER:intron5/8:c.876+73G>C::,DHCR24:ENST00000535035.6:intron_variant:MODIFIER:intron5/9:c.876+73G>C::,DHCR24:ENST00000436604.2:intron_variant:MODIFIER:intron5/9:c.876+73G>C::		606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	1278679 [benign DISEASE=not provided GENE=DHCR24];			rs608458	0.61722	0.53361,0.55450,0.37287,0.67130,0.78654	29740,	34393	58217	-0.2220	1.27			/4.6>5.2/0.0>0.0	COSV64874146	DHCR24|0.00|0.00|0.00|0.00|-18|40|-18|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54876242	54876242	T	G	hom	hom	hom		QUAL=24;DP=107,43,28;AF=0.99,1.00,1.00	DHCR24	intron	DHCR24:ENST00000371269.9:intron_variant:MODIFIER:intron2/8:c.388-195A>C::,DHCR24:ENST00000535035.6:intron_variant:MODIFIER:intron2/9:c.388-195A>C::,DHCR24:ENST00000436604.2:intron_variant:MODIFIER:intron2/9:c.388-195A>C::		606418_[GENE=DHCR24_PHENOS=Desmosterolosis, 602398 (3), Autosomal recessive]	1260254 [benign DISEASE=not provided GENE=DHCR24];			rs638944	0.51081	0.35472,0.44821,0.40155,0.58231,0.69809	21052,	35521	74341	-0.2660	1.83			/0.0>0.0/0.0>0.0			15986317,17510943,21901424	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DHCR24 (inh=AR oe_syn=0.93 oe_mis=0.76 oe_lof=0.29)
chr1	54998739	54998739	A	G	hom	het	hom		QUAL=24;DP=14,3,7;AF=1.00,0.67,1.00	BSND	upstream_gene	BSND:ENST00000651561.1:upstream_gene_variant:MODIFIER::::		606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	1224218 [benign DISEASE=not provided GENE=BSND];			rs2500338	0.63297	0.38653,0.70288,0.32810,0.77792,0.69872	32756,	30766	55828	0.4130	5.26							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	54998838	54998838	C	G	hom	het	hom		QUAL=25;DP=59,52,55;AF=0.97,0.44,0.96	BSND	upstream_gene	BSND:ENST00000651561.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	1234155 [benign DISEASE=not provided GENE=BSND];			rs2500339	0.62913	0.38546,0.67448,0.31257,0.77779,0.69880	32419,	30855	56411	0.4310	16.42							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	54999070	54999070	T	C	hom	het	hom		QUAL=24;DP=248,540,531;AF=0.99,0.48,1.00	BSND	5'UTR	BSND:ENST00000651561.1:5_prime_UTR_variant:MODIFIER:exon1/4:c.-117T>C::	regulatory_region_variant:open_chromatin_region	606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	297673 [benign DISEASE=Bartter disease type 4A,not provided GENE=BSND];			rs2500340	0.66949	0.52259,0.68813,0.32803,0.77874,0.69983	35230,	31362	50268	-0.3600	0.42			/0.0>0.0/0.1>0.0	COSV64870665	BSND|0.00|0.00|0.00|0.00|-3|40|34|-3	33462484	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	54999117	54999117	C	G	hom	het	hom		QUAL=24;DP=245,629,572;AF=0.99,0.47,1.00	BSND	5'UTR	BSND:ENST00000651561.1:5_prime_UTR_variant:MODIFIER:exon1/4:c.-70C>G::		606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	297674 [benign DISEASE=Bartter disease type 4A,not provided GENE=BSND];	CR2045392 [CLASS=DP MUT=ALT PHEN="Joubert syndrome modifier of" GENE=BSND];		rs2500341	0.66969	0.52276,0.68767,0.33586,0.77855,0.69996	35246,	31361	50237	-1.0610	2.30			/5.7>3.7/0.0>0.0	COSV64871304	BSND|0.00|0.00|0.00|0.00|48|10|-13|10	19646679,31879347	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	55007370	55007370	G	A	het	het	n/a		QUAL=24;DP=3,9,2;AF=0.67,1.00,0.00	BSND	intron	BSND:ENST00000651561.1:intron_variant:MODIFIER:intron3/3:c.548+98G>A::	regulatory_region_variant:enhancer	606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	1221679 [benign DISEASE=not provided GENE=BSND];			rs6687801	0.48797	0.62179,0.31076,0.21582,0.47069,0.51781	18974,	35927	77519	0.2380	0.90			/0.0>0.0/8.1>4.3	COSV64870849	BSND|0.00|0.00|0.00|0.00|21|48|-44|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	55008652	55008652	A	C	het	hom	wt		QUAL=24;DP=221,452,16;AF=0.54,1.00,0.00	BSND	3'UTR	BSND:ENST00000651561.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*24A>C::		606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	297681 [benign DISEASE=Bartter disease type 4A,not provided GENE=BSND];			rs6682884	0.41781	0.49223,0.28454,0.30513,0.42528,0.28827	13683,	36116	88458	0.5590	5.25			/0.6>0.0/0.0>0.0	COSV64871593	BSND|0.00|0.00|0.00|0.00|-5|2|-21|-50	17652939	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	55008803	55008803	C	G	het	hom	wt		QUAL=24;DP=122,124,16;AF=0.47,1.00,0.00	BSND	3'UTR	BSND:ENST00000651561.1:3_prime_UTR_variant:MODIFIER:exon4/4:c.*175C>G::		606412_[GENE=BSND_PHENOS=Sensorineural deafness with mild renal dysfunction, 602522 (3), Autosomal recessive; Bartter syndrome, type 4a, 602522 (3), Autosomal recessive]	368877 [benign DISEASE=Bartter syndrome,not provided GENE=BSND];			rs4339899	0.45435	0.59062,0.29652,0.30962,0.43035,0.45449	16463,	36111	82909	-1.1140	0.04			/6.9>6.8/0.0>0.0	COSV64871308	BSND|0.00|0.00|0.01|0.00|-44|16|-44|16		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					BSND (inh=AR oe_syn=1.20 oe_mis=0.99 oe_lof=1.19)
chr1	56875054	56875054	C	A	het	wt	hom		QUAL=24;DP=136,16,141;AF=0.43,0.00,0.99	C8A	missense	C8A:ENST00000695677.1:missense_variant:MODERATE:exon3/11:c.277C>A:p.Gln93Lys:,C8A:ENST00000695678.1:missense_variant:MODERATE:exon3/11:c.277C>A:p.Gln93Lys:,C8A:ENST00000695681.1:missense_variant:MODERATE:exon3/11:c.277C>A:p.Gln93Lys:,C8A:ENST00000361249.4:missense_variant:MODERATE:exon3/11:c.277C>A:p.Gln93Lys:		120950_[GENE=C8A_PHENOS=C8 deficiency, type I, 613790 (3), Autosomal recessive]	17039 [benign DISEASE=not provided,Type I complement component 8 deficiency,not specified,COMPLEMENT COMPONENT 8, ALPHA SUBUNIT, A/B POLYMORPHISM GENE=C8A];			rs652785	0.32529	0.20992,0.24886,0.45984,0.38070,0.50313	8671,	32119	102593	0.0330	7.54	0.099	0.07	/0.0>0.0/2.5>2.0	COSV63484431	C8A|0.00|0.00|0.00|0.00|-7|-2|39|-2	24033266,15986317,7649542,20029952,25798599	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	56885772	56885772	G	A	het	het	wt		QUAL=24;DP=129,21,12;AF=0.45,0.52,0.00	C8A	intron	C8A:ENST00000695677.1:intron_variant:MODIFIER:intron6/10:c.856-155G>A::,C8A:ENST00000695678.1:intron_variant:MODIFIER:intron6/10:c.856-155G>A::,C8A:ENST00000695681.1:intron_variant:MODIFIER:intron6/10:c.787-155G>A::,C8A:ENST00000361249.4:intron_variant:MODIFIER:intron6/10:c.856-155G>A::		120950_[GENE=C8A_PHENOS=C8 deficiency, type I, 613790 (3), Autosomal recessive]			AluSc5 (SINE/Alu)	rs139789526	0.12215	0.02997,0.14338,0.00097,0.17652,0.06174	1504,	15531	133231	-0.9510	1.82			/0.0>0.0/0.0>0.0		C8A|0.00|0.00|0.00|0.00|26|-38|26|43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	56906918	56906918	C	T	het	het	hom		QUAL=24;DP=154,41,20;AF=0.60,0.59,1.00	C8A	intron	C8A:ENST00000695677.1:intron_variant:MODIFIER:intron8/10:c.1226+122C>T::,C8A:ENST00000695678.1:intron_variant:MODIFIER:intron8/10:c.1226+122C>T::,C8A:ENST00000695681.1:intron_variant:MODIFIER:intron8/10:c.1153+126C>T::,C8A:ENST00000361249.4:intron_variant:MODIFIER:intron8/10:c.1222+126C>T::		120950_[GENE=C8A_PHENOS=C8 deficiency, type I, 613790 (3), Autosomal recessive]				rs619545	0.78447	0.92574,0.66983,0.99729,0.71417,0.88933	47692,	23964	32790	0.2660	8.05			/0.0>0.0/0.0>0.0		C8A|0.00|0.00|0.00|0.00|30|-36|-38|5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	56912740	56912740	T	C	hom	hom	hom		QUAL=24;DP=97,35,44;AF=1.00,1.00,1.00	C8A	intron	C8A:ENST00000695677.1:intron_variant:MODIFIER:intron10/10:c.1552+115T>C::,C8A:ENST00000695678.1:intron_variant:MODIFIER:intron10/10:c.1603+115T>C::,C8A:ENST00000695681.1:intron_variant:MODIFIER:intron10/10:c.1534+115T>C::,C8A:ENST00000361249.4:intron_variant:MODIFIER:intron10/10:c.1603+115T>C::		120950_[GENE=C8A_PHENOS=C8 deficiency, type I, 613790 (3), Autosomal recessive]				rs623077	0.88837	0.91411,0.90147,0.93176,0.85949,0.96559	60194,	14830	16992	-0.4330	2.95			/0.0>0.0/0.0>0.0	COSV63483457	C8A|0.00|0.00|0.00|0.00|-17|45|14|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8A (inh=AR oe_syn=1.13 oe_mis=1.17 oe_lof=0.85)
chr1	56929091	56929098	GGCTAGAG	-	hom	hom	hom		QUAL=24;DP=67,49,61;AF=1.00,1.00,1.00	C8B	downstream_gene	C8B:ENST00000371237.9:downstream_gene_variant:MODIFIER::::,C8B:ENST00000695842.1:downstream_gene_variant:MODIFIER::::,C8B:ENST00000696164.1:downstream_gene_variant:MODIFIER::::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]				rs3040448	0.82914	0.70510,0.88566,0.94597,0.86385,0.89855	37956,	14472	18626	0.2160	1.66							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56929347	56929347	A	G	het	wt	het	low_conf_region	QUAL=24;DP=277,51,529;AF=0.53,0.00,0.49	C8B	3'UTR	C8B:ENST00000371237.9:3_prime_UTR_variant:MODIFIER:exon12/12:c.*57T>C::,C8B:ENST00000695842.1:3_prime_UTR_variant:MODIFIER:exon11/11:c.*57T>C::,C8B:ENST00000696164.1:3_prime_UTR_variant:MODIFIER:exon13/13:c.*57T>C::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]				rs2795	0.31845	0.21858,0.36666,0.51728,0.32574,0.51413	8251,	31944	103684	0.0380	4.60			/0.0>0.0/0.0>0.0		C8B|0.00|0.00|0.00|0.00|44|-11|-39|43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56929578	56929578	T	C	hom	hom	hom		QUAL=24;DP=135,242,249;AF=1.00,1.00,1.00	C8B	splice_region&intron	C8B:ENST00000371237.9:splice_region_variant&intron_variant:LOW:intron11/11:c.1622-20A>G::,C8B:ENST00000695842.1:splice_region_variant&intron_variant:LOW:intron10/10:c.1493-20A>G::,C8B:ENST00000696164.1:splice_region_variant&intron_variant:LOW:intron12/12:c.1622-20A>G::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]	1168190 [benign DISEASE=Type II complement component 8 deficiency,not provided,not specified GENE=C8B];			rs605648	0.85055	0.78093,0.89261,0.93479,0.85886,0.96538	55346,	18823	22757	-2.3430	0.04			8.8>8.4/8.8>8.4/0.0>0.0		C8B|0.00|0.00|0.00|0.00|-20|-2|-15|39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56929748	56929748	C	G	het	wt	het		QUAL=24;DP=49,16,20;AF=0.51,0.00,0.50	C8B	intron	C8B:ENST00000371237.9:intron_variant:MODIFIER:intron11/11:c.1622-190G>C::,C8B:ENST00000695842.1:intron_variant:MODIFIER:intron10/10:c.1493-190G>C::,C8B:ENST00000696164.1:intron_variant:MODIFIER:intron12/12:c.1622-190G>C::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]			L2b (LINE/L2)	rs653804	0.31847	0.21862,0.36683,0.51829,0.32575,0.51624	8245,	31905	103565	-0.2680	0.76			/1.0>0.6/0.0>0.0			34814699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56929761	56929761	C	G	het	het	wt		QUAL=24;DP=46,10,16;AF=0.50,0.30,0.00	C8B	intron	C8B:ENST00000371237.9:intron_variant:MODIFIER:intron11/11:c.1622-203G>C::,C8B:ENST00000695842.1:intron_variant:MODIFIER:intron10/10:c.1493-203G>C::,C8B:ENST00000696164.1:intron_variant:MODIFIER:intron12/12:c.1622-203G>C::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]			L2b (LINE/L2)	rs2281598	0.13552	0.05572,0.22491,0.33944,0.13943,0.16397	1753,	17106	131484	-3.3980	0.01			/1.0>0.7/0.0>0.0		C8B|0.00|0.00|0.00|0.00|-13|48|-40|22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56931628	56931628	G	A	het	wt	het		QUAL=24;DP=182,19,28;AF=0.45,0.00,0.50	C8B	intron	C8B:ENST00000371237.9:intron_variant:MODIFIER:intron11/11:c.1621+182C>T::,C8B:ENST00000695842.1:intron_variant:MODIFIER:intron10/10:c.1492+182C>T::,C8B:ENST00000696164.1:intron_variant:MODIFIER:intron12/12:c.1621+182C>T::	regulatory_region_variant:enhancer,TF_binding_site_variant	120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]				rs683824	0.31867	0.21894,0.36733,0.51904,0.32569,0.51435	8250,	31939	103563	-0.9450	0.51			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56932065	56932065	G	C	het	wt	het		QUAL=24;DP=132,19,54;AF=0.50,0.00,0.56	C8B	intron	C8B:ENST00000371237.9:intron_variant:MODIFIER:intron10/11:c.1553-187C>G::,C8B:ENST00000695842.1:intron_variant:MODIFIER:intron9/10:c.1424-187C>G::,C8B:ENST00000696164.1:intron_variant:MODIFIER:intron11/12:c.1553-187C>G::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]				rs612563	0.31864	0.21884,0.36713,0.51829,0.32581,0.51474	8264,	31918	103592	-0.2810	8.82			/1.8>1.1/0.0>0.0	COSV64777108	C8B|0.05|0.00|0.15|0.00|17|-11|-28|28	29875488	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56940719	56940719	T	C	het	hom	het		QUAL=24;DP=89,34,28;AF=0.45,1.00,0.46	C8B	intron	C8B:ENST00000371237.9:intron_variant:MODIFIER:intron9/11:c.1398+130A>G::,C8B:ENST00000695842.1:intron_variant:MODIFIER:intron8/10:c.1269+130A>G::,C8B:ENST00000696164.1:intron_variant:MODIFIER:intron10/12:c.1398+130A>G::		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]				rs6669836	0.43408	0.29802,0.46621,0.40890,0.50740,0.34208	15005,	35932	85972	0.0150	3.42			/0.0>0.0/0.0>1.0	COSV64777813	C8B|0.00|0.00|0.00|0.00|0|50|0|9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	56956811	56956811	C	T	hom	hom	hom		QUAL=24;DP=295,267,250;AF=1.00,1.00,1.00	C8B	missense	C8B:ENST00000371237.9:missense_variant:MODERATE:exon3/12:c.349G>A:p.Gly117Arg:,C8B:ENST00000695842.1:missense_variant:MODERATE:exon3/11:c.349G>A:p.Gly117Arg:,C8B:ENST00000696164.1:missense_variant:MODERATE:exon4/13:c.349G>A:p.Gly117Arg:		120960_[GENE=C8B_PHENOS=C8 deficiency, type II, 613789 (3), Autosomal recessive]	1169777 [benign DISEASE=Type II complement component 8 deficiency,not provided GENE=C8B];			rs1013579	0.97885	0.99446,0.97278,0.99942,0.96795,0.98901	72967,	3090	3220	0.9500	9.76	0.036	0.04	/0.0>0.0/2.1>0.0			20438785,25798599,28240269,29875488,34648354,35078996	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C8B (inh=AR oe_syn=1.26 oe_mis=1.12 oe_lof=0.98)
chr1	63406210	63406210	A	G	het	hom	het		QUAL=24;DP=200,105,85;AF=0.52,1.00,0.65	ALG6	intron	ALG6:ENST00000263440.6:intron_variant:MODIFIER:intron5/14:c.347-107A>G::		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]	1180566 [benign DISEASE=ALG6-congenital disorder of glycosylation 1C,not provided GENE=ALG6];			rs1012872	0.35927	0.36389,0.44562,0.48395,0.33027,0.47010	10044,	34495	97343	0.0500	8.90			/0.0>0.0/1.5>0.0	COSV54765676	ALG6|0.00|0.00|0.00|0.00|1|38|0|-9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39)
chr1	63407200	63407200	A	G	het	hom	het		QUAL=24;DP=241,101,93;AF=0.49,1.00,0.43	ALG6	intron	ALG6:ENST00000263440.6:intron_variant:MODIFIER:intron7/14:c.494+74A>G::		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]	1180568 [benign DISEASE=ALG6-congenital disorder of glycosylation 1C,not provided GENE=ALG6];			rs6588028	0.59662	0.79113,0.64969,0.67601,0.48284,0.64093	28564,	33511	61283	-0.5080	0.28			/4.4>3.8/0.0>0.0		ALG6|0.00|0.00|0.00|0.00|-22|24|-34|-48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39)
chr1	63411459	63411459	G	T	het	hom	het		QUAL=24;DP=59,13,12;AF=0.61,1.00,0.50	ALG6	intron	ALG6:ENST00000263440.6:intron_variant:MODIFIER:intron8/14:c.680+128G>T::		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]	1230601 [benign DISEASE=not provided GENE=ALG6];			rs12125868	0.35884	0.36218,0.44591,0.48492,0.33031,0.47076	10013,	34497	97419	-0.1420	0.79			/6.6>7.2/8.3>3.4		ALG6|0.00|0.00|0.00|0.00|-8|-1|-6|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39)
chr1	63415881	63415881	C	T	het	hom	het		QUAL=24;DP=250,86,64;AF=0.57,1.00,0.44	ALG6	missense	ALG6:ENST00000263440.6:missense_variant:MODERATE:exon11/15:c.911C>T:p.Ser304Phe:PF03155 [ALG6 ALG8 glycosyltransferase family]		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]	95531 [benign/likely benign DISEASE=not specified,not provided,ALG6-congenital disorder of glycosylation 1C GENE=ALG6];			rs4630153	0.75744	0.86663,0.76547,0.85891,0.68440,0.86366	44209,	26770	36888	0.6530	13.44	0.187	0.04	/1.0>1.0/0.0>0.0	COSV54765155		25741868,23757202,21899441	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39)
chr1	63437781	63437781	T	C	het	hom	het		QUAL=24;DP=55,21,14;AF=0.58,1.00,0.57	ALG6,ITGB3BP	3'UTR,downstream_gene	ALG6:ENST00000263440.6:3_prime_UTR_variant:MODIFIER:exon15/15:c.*761T>C::,ITGB3BP:ENST00000271002.15:downstream_gene_variant:MODIFIER::::,ITGB3BP:ENST00000371092.7:downstream_gene_variant:MODIFIER::::		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]	297858 [benign DISEASE=ALG6-congenital disorder of glycosylation 1C,not provided GENE=ALG6];			rs3009572	0.60572	0.81984,0.65324,0.67472,0.48454,0.64372	29568,	32694	59776	-0.1410	1.12			/6.4>6.1/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39), ITGB3BP (inh=n/a oe_syn=1.01 oe_mis=0.85 oe_lof=0.85)
chr1	63438623	63438623	T	C	het	hom	het		QUAL=24;DP=80,29,26;AF=0.54,1.00,0.46	ALG6,ITGB3BP	downstream_gene	ALG6:ENST00000263440.6:downstream_gene_variant:MODIFIER::::,ITGB3BP:ENST00000271002.15:downstream_gene_variant:MODIFIER::::,ITGB3BP:ENST00000371092.7:downstream_gene_variant:MODIFIER::::		604566_[GENE=ALG6_PHENOS=Congenital disorder of glycosylation, type Ic, 603147 (3), Autosomal recessive]				rs3009573	0.76221	0.87387,0.76929,0.85896,0.68965,0.86464	44757,	26421	36169	0.0920	2.43							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ALG6 (inh=AR oe_syn=0.92 oe_mis=0.73 oe_lof=0.39), ITGB3BP (inh=n/a oe_syn=1.01 oe_mis=0.85 oe_lof=0.85)
chr1	67009294	67009294	C	T	hom	hom	hom		QUAL=25;DP=33,5,3;AF=1.00,1.00,1.00	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron10/11:c.877-127G>A::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1246419 [benign DISEASE=not provided GENE=SLC35D1];		A-rich (Low_complexity)	rs2755271	0.58259	0.33348,0.70981,0.83822,0.66098,0.76516	27892,	32767	63445	-0.8890	2.32			/0.0>0.0/6.2>0.0		SLC35D1|0.00|0.00|0.02|0.00|-49|9|9|5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67021436	67021436	C	A	hom	hom	hom		QUAL=25;DP=125,123,102;AF=0.99,1.00,1.00	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron9/11:c.797+99G>T::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1231615 [benign DISEASE=not provided GENE=SLC35D1];			rs2065002	0.58044	0.32583,0.70975,0.83695,0.66072,0.77227	27770,	32602	63712	-1.7600	0.08			/0.0>0.0/0.0>0.0	COSV52431286	SLC35D1|0.00|0.00|0.00|0.00|-7|11|12|-34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67021718	67021718	G	C	hom	hom	hom		QUAL=25;DP=52,41,34;AF=0.92,1.00,0.97	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron8/11:c.730-116C>G::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1234073 [benign DISEASE=not provided GENE=SLC35D1];		(ACACAG)n (Simple_repeat)	rs11576753	0.53013	0.28020,0.65823,0.77873,0.61555,0.69558	19421,	29384	60472	-1.0760	0.85			/1.0>0.9/0.0>0.3	COSV52430323	SLC35D1|0.00|0.00|0.00|0.00|-26|-33|41|21	34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67021724	67021724	G	C	hom	hom	hom		QUAL=25;DP=60,37,29;AF=0.93,1.00,0.97	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron8/11:c.730-122C>G::	regulatory_region_variant:enhancer	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1246882 [benign DISEASE=not provided GENE=SLC35D1];		(ACACAG)n (Simple_repeat)	rs11208992	0.65023	0.47813,0.73471,0.83081,0.68648,0.78631	24461,	28938	41882	0.2770	1.60			/1.0>0.5/0.0>0.0		SLC35D1|0.00|0.00|0.00|0.00|48|-39|35|21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67042051	67042051	T	A	hom	hom	hom		QUAL=25;DP=102,67,45;AF=1.00,1.00,1.00	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron8/11:c.729+185A>T::	regulatory_region_variant:open_chromatin_region	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1233310 [benign DISEASE=not provided GENE=SLC35D1];			rs2815375	0.74846	0.66089,0.84118,0.83675,0.77431,0.87775	43028,	27816	38270	-0.2340	1.32			/0.0>0.0/0.0>0.0		SLC35D1|0.00|0.00|0.00|0.00|-27|3|-3|19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67042398	67042401	CACT	-	het	het	wt		QUAL=25;DP=194,255,25;AF=0.49,0.50,0.00	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron7/11:c.637-73_637-70del::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1247932 [benign DISEASE=not provided GENE=SLC35D1];		(CA)n (Simple_repeat)	rs10543599	0.31595	0.09416,0.39195,0.50176,0.38775,0.57327	9213,	29542	103854	1.5870	2.90			/3.1>2.6/3.1>2.4		SLC35D1|0.01|0.00|0.00|0.00|-13|42|23|13		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67047220	67047220	G	T	hom	hom	hom		QUAL=24;DP=171,112,106;AF=1.00,1.00,1.00	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron7/11:c.636+45C>A::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1234892 [benign DISEASE=Schneckenbecken dysplasia,not provided GENE=SLC35D1];			rs1024229	0.69021	0.76724,0.67489,0.64060,0.66217,0.75125	36465,	32029	47109	-0.7010	4.20			/4.1>2.5/0.0>0.0		SLC35D1|0.00|0.00|0.00|0.00|36|45|-22|45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67047237	67047237	A	C	hom	hom	hom		QUAL=24;DP=181,141,121;AF=0.99,1.00,1.00	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron7/11:c.636+28T>G::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1270736 [benign DISEASE=not provided,Schneckenbecken dysplasia GENE=SLC35D1];			rs1024230	0.69016	0.76696,0.67480,0.64062,0.66231,0.75062	36454,	32021	47107	-0.2060	5.29			/0.0>0.3/0.0>7.0		SLC35D1|0.00|0.00|0.01|0.01|28|42|1|28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67049626	67049626	C	T	hom	hom	hom		QUAL=24;DP=156,32,24;AF=1.00,1.00,1.00	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron6/11:c.533+156G>A::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1287418 [benign DISEASE=not provided GENE=SLC35D1];			rs2755257	0.53166	0.34016,0.58136,0.63971,0.60724,0.67973	22710,	35439	71229	-0.9060	0.05			/5.0>3.8/0.0>0.0		SLC35D1|0.00|0.00|0.00|0.00|18|39|18|-13		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67050633	67050633	T	A	hom	hom	hom		QUAL=24;DP=176,27,20;AF=0.99,1.00,1.00	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron4/11:c.393-129A>T::		610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1261093 [benign DISEASE=not provided GENE=SLC35D1];			rs2815383	0.50005	0.22718,0.56666,0.63479,0.61022,0.67523	21338,	33391	76051	1.1760	4.66			/0.0>0.0/0.0>0.0		SLC35D1|0.00|0.00|0.00|0.00|-14|-12|-14|6	35164939	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67051804	67051804	A	-	het	hom	wt		QUAL=24;DP=83,4,4;AF=0.55,1.00,0.00	SLC35D1	intron	SLC35D1:ENST00000235345.6:intron_variant:MODIFIER:intron4/11:c.392+208del::	regulatory_region_variant:open_chromatin_region	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1286317 [benign DISEASE=not provided GENE=SLC35D1];			rs34503429	0.63119	0.68443,0.58904,0.64280,0.62158,0.74357	30553,	34710	55986	0.4550	6.21			/1.5>1.5/0.0>0.0		SLC35D1|0.00|0.00|0.00|0.00|11|17|-28|40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67054377	67054378	CA	-	het	hom	het		QUAL=24;DP=34,12,8;AF=0.32,1.00,0.50	SLC35D1	upstream_gene	SLC35D1:ENST00000235345.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1250615 [benign DISEASE=not provided GENE=SLC35D1];			rs3840439	0.62522	0.64648,0.58944,0.63818,0.63195,0.74751	29938,	35084	56922	0.1920	4.91							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67054400	67054400	C	T	het	wt	het		QUAL=24;DP=12,7,6;AF=0.75,0.00,0.50	SLC35D1	upstream_gene	SLC35D1:ENST00000235345.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1243207 [benign DISEASE=not provided GENE=SLC35D1];			rs3806321	0.14505	0.08316,0.22758,0.27174,0.15153,0.14605	1881,	18314	130116	-0.6420	0.60							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	67054457	67054457	T	G	hom	hom	n/a		QUAL=24;DP=5,3,2;AF=1.00,1.00,1.00	SLC35D1	upstream_gene	SLC35D1:ENST00000235345.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	610804_[GENE=SLC35D1_PHENOS=Schneckenbecken dysplasia, 269250 (3), Autosomal recessive]	1282317 [benign DISEASE=not provided GENE=SLC35D1];			rs2025087	0.76128	0.80634,0.75771,0.86109,0.74120,0.84349	44286,	27201	36303	-1.1250	0.92						34006833	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC35D1 (inh=AR oe_syn=1.25 oe_mis=0.99 oe_lof=0.45)
chr1	75724531	75724531	G	A	het	het	het		QUAL=24;DP=15,100,71;AF=0.93,0.43,0.51	ACADM	5'UTR,upstream_gene	ACADM:ENST00000680964.1:5_prime_UTR_variant:MODIFIER:exon1/12:c.-257G>A::,ACADM:ENST00000541113.6:5_prime_UTR_variant:MODIFIER:exon1/11:c.-257G>A::,ACADM:ENST00000680805.1:5_prime_UTR_variant:MODIFIER:exon1/11:c.-257G>A::,ACADM:ENST00000681790.1:upstream_gene_variant:MODIFIER::::,ACADM:ENST00000370834.9:upstream_gene_variant:MODIFIER::::,ACADM:ENST00000370841.9:upstream_gene_variant:MODIFIER::::,ACADM:ENST00000679687.1:upstream_gene_variant:MODIFIER::::,ACADM:ENST00000420607.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]	298063 [benign/likely benign DISEASE=not provided,Medium-chain acyl-coenzyme A dehydrogenase deficiency GENE=ACADM];			rs17848068	0.26879	0.26103,0.23270,0.02492,0.28897,0.21532	5739,	29400	111206	-2.2320	0.78			/5.7>4.9/0.0>1.1		ACADM|0.00|0.00|0.00|0.00|18|-4|17|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	75724883	75724883	C	T	hom	het	het		QUAL=24;DP=11,8,7;AF=0.91,0.38,0.57	ACADM	intron	ACADM:ENST00000680964.1:intron_variant:MODIFIER:intron1/11:c.30+66C>T::,ACADM:ENST00000541113.6:intron_variant:MODIFIER:intron1/10:c.30+66C>T::,ACADM:ENST00000680805.1:intron_variant:MODIFIER:intron1/10:c.30+66C>T::,ACADM:ENST00000681790.1:intron_variant:MODIFIER:intron1/11:c.-250+66C>T::,ACADM:ENST00000370834.9:intron_variant:MODIFIER:intron1/12:c.30+66C>T::,ACADM:ENST00000370841.9:intron_variant:MODIFIER:intron1/11:c.30+66C>T::,ACADM:ENST00000679687.1:intron_variant:MODIFIER:intron1/6:c.30+66C>T::,ACADM:ENST00000420607.6:intron_variant:MODIFIER:intron1/11:c.30+66C>T::	regulatory_region_variant:open_chromatin_region,TF_binding_site_variant	607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]	1292156 [benign DISEASE=not provided GENE=ACADM];			rs116034618	0.11503	0.02957,0.12736,0.00058,0.16116,0.09826	1325,	14847	134607	-0.2630	0.70			/1.0>1.6/0.0>0.0		ACADM|0.00|0.00|0.01|0.00|16|-8|-26|15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	75728545	75728545	T	-	hom	hom	hom		QUAL=24;DP=184,229,179;AF=0.99,0.99,0.99	ACADM	intron	ACADM:ENST00000680964.1:intron_variant:MODIFIER:intron2/11:c.118+60del::,ACADM:ENST00000541113.6:intron_variant:MODIFIER:intron2/10:c.118+60del::,ACADM:ENST00000680805.1:intron_variant:MODIFIER:intron2/10:c.118+60del::,ACADM:ENST00000681790.1:intron_variant:MODIFIER:intron1/11:c.-249-3186del::,ACADM:ENST00000370834.9:intron_variant:MODIFIER:intron2/12:c.118+60del::,ACADM:ENST00000370841.9:intron_variant:MODIFIER:intron2/11:c.118+60del::,ACADM:ENST00000679687.1:intron_variant:MODIFIER:intron1/6:c.30+3731del::,ACADM:ENST00000420607.6:intron_variant:MODIFIER:intron2/11:c.130+60del::		607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]	226050 [benign DISEASE=not provided,Medium-chain acyl-coenzyme A dehydrogenase deficiency GENE=ACADM];			rs796117827	0.99999	0.99998,1.00000,1.00000,1.00000,1.00000	76150,	1	1	0.0000	4.67			/0.0>0.0/0.0>0.0			25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	75728621	75728621	A	G	hom	hom	hom		QUAL=25;DP=178,107,82;AF=1.00,1.00,1.00	ACADM	intron	ACADM:ENST00000680964.1:intron_variant:MODIFIER:intron2/11:c.118+133A>G::,ACADM:ENST00000541113.6:intron_variant:MODIFIER:intron2/10:c.118+133A>G::,ACADM:ENST00000680805.1:intron_variant:MODIFIER:intron2/10:c.118+133A>G::,ACADM:ENST00000681790.1:intron_variant:MODIFIER:intron1/11:c.-249-3113A>G::,ACADM:ENST00000370834.9:intron_variant:MODIFIER:intron2/12:c.118+133A>G::,ACADM:ENST00000370841.9:intron_variant:MODIFIER:intron2/11:c.118+133A>G::,ACADM:ENST00000679687.1:intron_variant:MODIFIER:intron1/6:c.30+3804A>G::,ACADM:ENST00000420607.6:intron_variant:MODIFIER:intron2/11:c.130+133A>G::		607008_[GENE=ACADM_PHENOS=Acyl-CoA dehydrogenase, medium chain, deficiency of, 201450 (3), Autosomal recessive]	1261087 [benign DISEASE=not provided GENE=ACADM];			rs1146572	0.92679	0.97019,0.85771,0.74865,0.93320,0.92182	65617,	9885	11147	-0.1760	1.43			/0.0>0.0/0.4>0.0	COSV63720717			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACADM (inh=AR oe_syn=0.98 oe_mis=0.90 oe_lof=0.80)
chr1	92474854	92474854	C	T	het	het	wt		QUAL=24;DP=113,165,16;AF=0.59,0.49,0.00	GFI1	3'UTR	GFI1:ENST00000294702.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:ENST00000370332.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::,GFI1:ENST00000427103.6:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1175G>A::		600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]				rs41313373	0.09475	0.02305,0.11596,0.02004,0.12753,0.08966	887,	12642	137734	2.7080	13.43			/2.9>1.8/6.4>7.2			35088123,36333501	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92478758	92478763	AGAGAG	-	hom	het	het	low_conf_region	QUAL=24;DP=80,239,158;AF=0.74,0.59,0.54	GFI1	splice_region&intron	GFI1:ENST00000294702.6:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:ENST00000370332.5:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::,GFI1:ENST00000427103.6:splice_region_variant&intron_variant:LOW:intron5/6:c.925-10_925-5del::		600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]	298185 [benign/likely benign DISEASE=Neutropenia, severe congenital, 2, autosomal dominant,Nonimmune chronic idiopathic neutropenia of adults,not provided,Severe congenital neutropenia GENE=GFI1];		(AG)n (Simple_repeat)	rs35896485	0.11123	0.06204,0.14576,0.02535,0.13185,0.11100	941,	13494	122864	3.1660	8.59			/15.4>15.4/0.0>0.0		GFI1|0.00|0.00|0.00|0.00|47|-12|-19|-3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92483141	92483141	C	T	het	het	wt		QUAL=24;DP=28,14,7;AF=0.57,0.57,0.00	GFI1	intron	GFI1:ENST00000294702.6:intron_variant:MODIFIER:intron2/6:c.116-95G>A::,GFI1:ENST00000370332.5:intron_variant:MODIFIER:intron2/6:c.116-95G>A::,GFI1:ENST00000427103.6:intron_variant:MODIFIER:intron2/6:c.116-95G>A::	regulatory_region_variant:open_chromatin_region	600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]				rs530464819	0.00916	0.00156,0.00771,0.00000,0.01221,0.00621	13,	1370	150944	-0.0260	8.75			/0.0>0.0/0.0>0.0		GFI1|0.00|0.00|0.00|0.00|-39|-48|23|-13		11	729	0	0 / 0					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92483381	92483381	C	T	het	wt	het		QUAL=24;DP=104,16,266;AF=0.50,0.00,0.46	GFI1	missense	GFI1:ENST00000294702.6:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:ENST00000370332.5:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:,GFI1:ENST00000427103.6:missense_variant:MODERATE:exon2/7:c.107G>A:p.Ser36Asn:	regulatory_region_variant:open_chromatin_region	600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]	259699 [benign DISEASE=not provided,not specified,Neutropenia, severe congenital, 2, autosomal dominant GENE=GFI1];	CM1621865 [CLASS=DFP MUT=ALT PHEN="Myelodysplastic syndrome association with" GENE=GFI1];		rs34631763	0.04037	0.01024,0.04292,0.00000,0.05924,0.01055	183,	5785	146209	2.4960	18.00	0.057	0.14	/0.0>3.8/0.0>0.0	COSV54042707	GFI1|0.00|0.00|0.00|0.00|-9|18|-8|14	25741868,24033266,20075157,27080012,31013831,34760702,26447191,31649884,31508375	126	3636	0	0 / 0					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92486100	92486100	-	A	hom	het	het		QUAL=25;DP=163,136,88;AF=0.72,0.44,0.61	GFI1	intron,upstream_gene	GFI1:ENST00000294702.6:intron_variant:MODIFIER:intron1/6:c.-100+625dup::,GFI1:ENST00000370332.5:upstream_gene_variant:MODIFIER::::,GFI1:ENST00000427103.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter,TF_binding_site_variant	600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]				rs112925059	0.12243	0.05113,0.15932,0.02686,0.15639,0.11787	1261,	15416	128584		4.90			/5.6>6.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	92486661	92486661	A	-	hom	hom	hom		QUAL=24;DP=28,19,20;AF=1.00,1.00,1.00	GFI1	intron,upstream_gene	GFI1:ENST00000294702.6:intron_variant:MODIFIER:intron1/6:c.-100+65del::,GFI1:ENST00000370332.5:upstream_gene_variant:MODIFIER::::,GFI1:ENST00000427103.6:upstream_gene_variant:MODIFIER::::	TF_binding_site_variant	600871_[GENE=GFI1_PHENOS=?Neutropenia, nonimmune chronic idiopathic, of adults, 607847 (3), Autosomal dominant; Neutropenia, severe congenital 2, autosomal dominant, 613107 (3), Autosomal dominant]				rs66635255	0.99999	0.99998,0.99994,1.00000,1.00000,1.00000	76115,	2	2	-0.4670	12.13			/4.7>2.2/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GFI1 (inh=AD oe_syn=0.70 oe_mis=0.72 oe_lof=0.25)
chr1	97078196	97078196	G	A	het	het	het		QUAL=24;DP=246,440,323;AF=0.46,0.48,0.50	DPYD	3'UTR	DPYD:ENST00000370192.8:3_prime_UTR_variant:MODIFIER:exon23/23:c.*780C>T::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100064 [benign DISEASE=not provided,Dihydropyrimidine dehydrogenase deficiency GENE=DPYD];			rs291593	0.28984	0.22798,0.29314,0.60773,0.27551,0.46801	6941,	30150	107884	-1.0340	1.19			/0.0>0.0/0.0>0.0			24944790,34449663,32235849,34026625,23960437,36063648,28481884,34442436	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97078208	97078208	C	T	het	het	het		QUAL=24;DP=214,464,340;AF=0.49,0.47,0.50	DPYD	3'UTR	DPYD:ENST00000370192.8:3_prime_UTR_variant:MODIFIER:exon23/23:c.*768G>A::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100065 [benign DISEASE=not provided,Dihydropyrimidine dehydrogenase deficiency GENE=DPYD];			rs291592	0.45199	0.31700,0.57518,0.97071,0.45305,0.61483	17004,	34621	83209	0.1450	1.25			/0.8>1.1/0.0>0.0			32235849,23960437,36063648,28481884	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97078403	97078403	C	T	het	wt	het		QUAL=24;DP=177,113,213;AF=0.50,0.00,0.44	DPYD	3'UTR	DPYD:ENST00000370192.8:3_prime_UTR_variant:MODIFIER:exon23/23:c.*573G>A::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100067 [benign DISEASE=Dihydropyrimidine dehydrogenase deficiency,not provided GENE=DPYD];			rs1042482	0.06248	0.01458,0.04528,0.12934,0.07902,0.17717	400,	8712	142726	0.2650	2.94			/0.0>0.0/0.0>0.0			24944790,36063648	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97079215	97079215	T	C	hom	hom	hom		QUAL=24;DP=75,277,292;AF=1.00,1.00,1.00	DPYD	intron	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron22/22:c.2908-69A>G::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	1222833 [benign DISEASE=not provided GENE=DPYD];			rs290855	0.80231	0.71062,0.86799,0.98820,0.81336,0.89237	49303,	23408	30064	0.5570	6.13			/0.0>0.0/0.0>0.0		DPYD|0.00|0.00|0.00|0.00|-38|-17|-32|32	20587604	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97082275	97082275	G	A	hom	hom	hom		QUAL=24;DP=182,164,126;AF=1.00,1.00,1.00	DPYD	intron	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron22/22:c.2907+55C>T::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	1255090 [benign DISEASE=not provided GENE=DPYD];			rs290854	0.99997	0.99995,1.00000,1.00000,0.99997,1.00000	76119,	4	4	0.2870	1.87			/7.2>7.4/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97450068	97450068	A	G	het	het	wt		QUAL=24;DP=204,187,22;AF=0.45,0.52,0.00	DPYD	synonymous	DPYD:ENST00000370192.8:synonymous_variant:LOW:exon14/23:c.1896T>C:p.Phe632=:PF01180 [Dihydroorotate dehydrogenase]		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100088 [drug response DISEASE=Dihydropyrimidine dehydrogenase deficiency,not provided,not specified,fluorouracil response - Toxicity,capecitabine response - Toxicity GENE=DPYD];			rs17376848	0.04377	0.02150,0.07272,0.12355,0.04521,0.03875	194,	6276	145586	0.2880	3.09			/1.4>0.7/0.0>0.0	COSV100928729	DPYD|0.00|0.00|0.00|0.00|-15|-5|-9|-5	25741868,35582139,35743735,17697348,21362212,33035787,19104657,26099996,29065426,23942539,33194059,16115930,19473056,21498394,30545124,14635116,25782327,18299612,19530960,20819423,24923815,25677447,26794347,33305610,14523039,16007086,23588312,34959317,27487151,34050721,36063648,33228198,34064668,36980706,31076604,35846994,25915935,28481884,34442436,33235483,36430399,25614737,33317085,37469403	58	2326	0	0 / 0					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97515686	97515686	T	C	hom	hom	het	low_conf_region	QUAL=24;DP=165,54,44;AF=1.00,1.00,0.45	DPYD	intron	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron13/22:c.1740+40A>G::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100090 [benign DISEASE=not provided GENE=DPYD];			rs2811178	0.61794	0.62664,0.65424,0.75233,0.58568,0.62650	29120,	35548	57988	-0.0810	0.52			/5.8>5.3/0.0>0.0		DPYD|0.00|0.00|0.00|0.00|39|40|40|-15	35743735,23960437,34959317,36172669,36430399	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97516150	97516150	C	T	hom	hom	het		QUAL=24;DP=82,6,3;AF=1.00,1.00,0.67	DPYD	intron	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron12/22:c.1525-209G>A::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	1282683 [benign DISEASE=not provided GENE=DPYD];			rs1337752	0.61687	0.62108,0.65382,0.75215,0.58648,0.62329	29023,	35534	58122	-0.0740	0.84			/3.7>0.0/0.0>0.0		DPYD|0.00|0.00|0.00|0.00|-31|-1|-11|1	35743735	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97549850	97549850	A	T	het	wt	het		QUAL=25;DP=98,16,21;AF=0.54,0.00,0.52	DPYD,SEC63P1	intron,downstream_gene	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron11/22:c.1340-106T>A::,SEC63P1:ENST00000425785.1:downstream_gene_variant:MODIFIER::::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]	100099 [benign DISEASE=not provided GENE=DPYD];			rs61789183	0.08627	0.02220,0.07671,0.00039,0.12800,0.04805	777,	11583	139137	0.9650	7.22			/0.0>0.0/0.0>0.0		DPYD|0.00|0.00|0.00|0.00|39|-48|45|-21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77), SEC63P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97719971	97719971	A	G	hom	hom	hom		QUAL=24;DP=104,150,123;AF=1.00,1.00,1.00	DPYD	intron,3'UTR	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron5/22:c.483+1539T>C::,DPYD:ENST00000306031.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*917T>C::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]				rs2151562	0.99527	0.98309,0.99928,1.00000,0.99999,1.00000	75209,	714	718	0.4060	2.43			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97720521	97720521	T	C	hom	hom	hom		QUAL=24;DP=147,191,136;AF=1.00,1.00,1.00	DPYD	intron,3'UTR	DPYD:ENST00000370192.8:intron_variant:MODIFIER:intron5/22:c.483+989A>G::,DPYD:ENST00000306031.5:3_prime_UTR_variant:MODIFIER:exon6/6:c.*367A>G::		612779_[GENE=DPYD_PHENOS=Dihydropyrimidine dehydrogenase deficiency, 274270 (3), Autosomal recessive; 5-fluorouracil toxicity, 274270 (3), Autosomal recessive]				rs1333718	0.99531	0.98331,0.99921,1.00000,0.99997,1.00000	75222,	708	712	0.7280	16.37			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DPYD (inh=AR oe_syn=1.03 oe_mis=1.03 oe_lof=0.77)
chr1	97994504	97994504	A	C	het	het	wt		QUAL=24;DP=67,88,16;AF=0.42,0.51,0.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-15189T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1069+412T>G::					AluSx (SINE/Alu)	rs1256082170						-0.3580	4.06			/0.0>0.0/0.0>0.0				0	3	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97994550	97994550	G	A	hom	het	hom		QUAL=25;DP=69,126,86;AF=1.00,0.53,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-15235C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/4:n.1069+366C>T::					AluSx (SINE/Alu)	rs9440288	0.83999	0.82589,0.88901,0.94179,0.83450,0.84880	53831,	20147	24347	-1.3540	0.37			/0.0>0.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97995576	97995576	G	C	hom	het	hom		QUAL=24;DP=65,286,273;AF=1.00,0.48,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-16261C>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-576C>G::					L2a (LINE/L2)	rs9324380	0.91477	0.97699,0.93515,0.94266,0.87862,0.89278	63912,	11461	12977	-4.7770	0.00			/0.0>0.0/0.0>0.0			29942086,35764056,29326435	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97995701	97995701	-	TTGT	hom	het	hom		QUAL=24;DP=67,224,221;AF=0.81,0.39,0.93	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-16387_141-16386insACAA::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-702_985-701insACAA::						rs10655213	0.87359	0.93708,0.90556,0.94240,0.83587,0.86032	58206,	16211	19191		0.70			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97995887	97995887	C	T	het	het	het		QUAL=24;DP=79,103,96;AF=0.51,0.52,0.47	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-16572G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-887G>A::						rs9662365	0.49123	0.49901,0.51924,0.41166,0.49043,0.39307	18451,	37722	77288	-0.0280	12.26			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97996398	97996398	T	C	hom	het	hom		QUAL=24;DP=70,33,26;AF=1.00,0.58,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-17083A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-1398A>G::						rs1938570	0.86760	0.93463,0.89946,0.94213,0.82540,0.85939	57307,	17123	20103	-0.5300	0.56			/0.0>0.5/0.0>0.0			23910899	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97997365	97997365	C	A	het	het	wt		QUAL=24;DP=81,184,17;AF=0.48,0.48,0.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-18050G>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-2365G>T::						rs146033831	0.00650	0.00067,0.02884,0.06351,0.00159,0.00436	27,	934	151062	-0.1480	0.66			/0.0>0.4/1.4>9.1				4	148	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	97999972	97999972	G	A	hom	het	hom		QUAL=24;DP=79,197,204;AF=1.00,0.51,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-20657C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-4972C>T::	regulatory_region_variant:enhancer					rs2154403	0.88198	0.96635,0.90771,0.94246,0.83597,0.86022	59558,	15088	17958	0.9200	1.22			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98000284	98000284	G	A	het	wt	het		QUAL=24;DP=80,116,177;AF=0.53,0.00,0.40	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-20969C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-5284C>T::					L2a (LINE/L2)	rs116319667	0.00943	0.00294,0.00590,0.00000,0.01621,0.00497	13,	1410	150770	-0.3440	0.34			/0.1>0.7/1.3>4.6				12	668	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98002983	98002984	TA	-	hom	het	hom		QUAL=24;DP=145,234,165;AF=0.99,0.58,0.99	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-23669_141-23668del::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-7984_985-7983del::	regulatory_region_variant:enhancer					rs5776390	0.87275	0.93728,0.90707,0.94177,0.83516,0.85501	58098,	16282	19316	0.0270	0.39			/3.1>1.9/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98004131	98004131	A	-	het	het	wt		QUAL=24;DP=98,328,16;AF=0.52,0.51,0.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-24816del::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-9131del::						rs564190891	0.00218	0.00051,0.01396,0.00000,0.00109,0.00145	7,	318	151878	2.0260	13.59			/7.8>5.6/2.6>2.6				0	61	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98004495	98004495	-	AT	hom	het	hom		QUAL=24;DP=197,241,135;AF=0.98,0.49,0.99	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-25181_141-25180insAT::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-9496_985-9495insAT::						rs10655252	0.84708	0.84675,0.89444,0.94227,0.83511,0.85563	54654,	19377	23231		0.21			/7.6>7.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98005049	98005049	A	G	hom	het	hom		QUAL=25;DP=71,25,20;AF=1.00,0.44,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-25734T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-10049T>C::	regulatory_region_variant:enhancer					rs10747495	0.88184	0.96643,0.90893,0.94236,0.83553,0.85557	59535,	15084	17976	0.6310	4.91			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98006652	98006652	A	G	het	het	wt		QUAL=24;DP=60,97,16;AF=0.42,0.41,0.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-27337T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-11652T>C::					(ATTAC)n (Simple_repeat)	rs78878051	0.01794	0.01418,0.04946,0.17320,0.00224,0.04867	130,	2467	149317	1.1380	8.32			/0.0>0.0/0.0>1.1				31	465	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98007323	98007323	C	T	hom	het	hom		QUAL=24;DP=132,254,193;AF=0.99,0.56,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-28008G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-12323G>A::	regulatory_region_variant:open_chromatin_region					rs1938564	0.80459	0.70181,0.88206,0.94232,0.83358,0.84462	49567,	22925	29645	-0.2730	0.90			/0.0>0.7/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98007402	98007402	T	A	hom	het	hom		QUAL=24;DP=78,183,171;AF=1.00,0.55,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-28087A>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-12402A>T::	regulatory_region_variant:open_chromatin_region					rs1938563	0.88096	0.96306,0.90873,0.94227,0.83551,0.85521	59249,	15175	18063	0.4550	3.22			/1.2>3.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98008160	98008160	T	A	hom	het	hom		QUAL=25;DP=132,129,117;AF=1.00,0.55,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-28845A>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-13160A>T::						rs1938562	0.88105	0.96320,0.90913,0.94219,0.83544,0.85557	59253,	15164	18046	1.1500	4.91			/0.0>0.8/0.2>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98009211	98009211	C	T	hom	het	hom		QUAL=25;DP=115,163,116;AF=1.00,0.50,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-29896G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-14211G>A::						rs2391902	0.81141	0.72542,0.88401,0.94195,0.83372,0.84413	50286,	22478	28600	0.3390	14.91			/0.0>0.0/7.7>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98009966	98009966	T	C	hom	het	hom		QUAL=24;DP=133,172,118;AF=1.00,0.52,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-30651A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-14966A>G::	regulatory_region_variant:enhancer					rs2154402	0.91454	0.97712,0.93595,0.94255,0.87828,0.88873	63775,	11455	12989	0.7240	7.43			/0.3>0.8/0.0>0.0			34743297	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98010357	98010357	G	A	hom	het	hom		QUAL=25;DP=138,126,88;AF=1.00,0.55,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-31042C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-15357C>T::						rs9324381	0.84546	0.84431,0.89327,0.94219,0.83419,0.84567	54363,	19556	23448	0.5390	2.28			/0.0>1.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98011162	98011162	G	A	hom	het	hom		QUAL=24;DP=170,279,219;AF=1.00,0.59,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-31847C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-16162C>T::						rs1938561	0.88187	0.96640,0.90888,0.94208,0.83552,0.85536	59540,	15093	17973	0.2820	3.15			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98011394	98011394	T	C	hom	het	hom		QUAL=24;DP=129,328,265;AF=1.00,0.55,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-32079A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-16394A>G::					L2c (LINE/L2)	rs9440293	0.88056	0.96308,0.90878,0.94149,0.83498,0.85593	59183,	15224	18120	-1.1320	3.58			/2.1>0.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98011402	98011402	C	T	hom	het	hom		QUAL=24;DP=133,337,266;AF=1.00,0.55,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-32087G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-16402G>A::					L2c (LINE/L2)	rs9727941	0.84469	0.84365,0.89263,0.94153,0.83356,0.84507	54270,	19618	23564	-0.2230	6.38			/0.0>0.0/2.1>1.5				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98011410	98011410	G	C	hom	het	hom		QUAL=24;DP=137,340,264;AF=1.00,0.56,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-32095C>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-16410C>G::					L2c (LINE/L2)	rs9724773	0.84478	0.84394,0.89283,0.94114,0.83352,0.84494	54256,	19621	23543	0.3430	7.12			/0.0>0.0/1.5>2.8				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98012603	98012603	-	AC	hom	het	hom		QUAL=25;DP=89,147,120;AF=0.90,0.53,0.93	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.141-33290_141-33289dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-17605_985-17604dup::					MIRb (SINE/MIR)	rs112555829	0.78341	0.75437,0.84564,0.92682,0.77938,0.81097	45626,	25080	32162		3.23			/5.7>5.7/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98012988	98012988	A	T	hom	het	hom		QUAL=24;DP=151,420,333;AF=1.00,0.48,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+33020T>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-17988T>A::					L2c (LINE/L2)	rs1938565	0.88189	0.96647,0.90888,0.94279,0.83558,0.85569	59563,	15085	17975	0.1560	12.68			/0.0>0.0/3.2>3.1				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98013425	98013425	C	T	hom	het	hom		QUAL=24;DP=52,25,22;AF=1.00,0.44,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+32583G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-18425G>A::						rs1938566	0.81147	0.72529,0.88343,0.94214,0.83384,0.84405	50371,	22513	28637	-1.1710	0.27			/0.0>0.0/0.0>0.0			36269708,32203549	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98014572	98014572	T	C	hom	het	hom		QUAL=24;DP=107,165,169;AF=1.00,0.45,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+31436A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-19572A>G::					MER102b (DNA/hAT-Charlie)	rs1938567	0.86032	0.89158,0.90292,0.94019,0.83521,0.85542	56325,	17844	21186	-0.9230	1.31			/0.0>0.0/0.0>0.5			25434007	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98014656	98014656	C	T	het	wt	het		QUAL=24;DP=106,65,125;AF=0.55,0.00,0.48	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+31352G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-19656G>A::					MER102b (DNA/hAT-Charlie)	rs11165944	0.29546	0.14852,0.35033,0.52703,0.33930,0.44653	7353,	29813	106157	-1.1420	0.39			/0.0>0.0/0.0>0.0			34560273,34910505	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98016194	98016194	C	T	het	wt	het		QUAL=24;DP=130,19,216;AF=0.48,0.00,0.47	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+29814G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-21194G>A::						rs6683447	0.27256	0.12257,0.34976,0.56726,0.31247,0.40456	6600,	28261	110659	-0.8800	1.17			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017024	98017024	G	A	hom	het	hom		QUAL=24;DP=133,171,105;AF=1.00,0.50,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28984C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22024C>T::					L1MB1 (LINE/L1)	rs2391903	0.91476	0.97719,0.93770,0.94064,0.87831,0.88900	63904,	11446	12976	0.1620	3.21			/2.7>3.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017137	98017137	A	G	hom	het	hom		QUAL=24;DP=126,244,158;AF=1.00,0.54,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28871T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22137T>C::					L1MB1 (LINE/L1)	rs1892549	0.85516	0.87445,0.89861,0.94047,0.83515,0.85685	55807,	18498	22038	-0.2100	2.93			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017272	98017272	A	G	hom	het	hom		QUAL=24;DP=154,139,122;AF=1.00,0.44,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28736T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22272T>C::					L1MB1 (LINE/L1)	rs1892550	0.85527	0.87451,0.89882,0.94026,0.83528,0.85664	55838,	18496	22028	-1.3240	0.04			/0.2>0.9/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017405	98017405	C	T	hom	het	hom		QUAL=24;DP=139,134,97;AF=1.00,0.45,0.99	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28603G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22405G>A::					L1MB1 (LINE/L1)	rs1892551	0.85541	0.87449,0.89882,0.94095,0.83529,0.85685	55842,	18503	22005	0.8610	7.77			/0.0>4.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017479	98017479	G	A	hom	het	hom		QUAL=24;DP=107,75,54;AF=1.00,0.48,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28529C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22479C>T::						rs1892552	0.85538	0.87454,0.89880,0.94071,0.83532,0.85661	55828,	18485	22003	-0.1480	0.50			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017594	98017594	A	G	hom	het	hom		QUAL=24;DP=71,34,19;AF=1.00,0.62,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28414T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22594T>C::						rs2391904	0.85518	0.87434,0.89890,0.94022,0.83522,0.85673	55819,	18492	22036	-0.2560	1.67			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98017766	98017766	T	C	hom	het	hom		QUAL=24;DP=86,49,33;AF=1.00,0.31,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+28242A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-22766A>G::						rs9324382	0.85368	0.87425,0.89738,0.93978,0.83355,0.84545	55587,	18684	22258	0.5980	7.23			/6.6>6.8/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98018596	98018596	T	C	hom	het	hom		QUAL=24;DP=60,91,53;AF=1.00,0.35,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+27412A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-23596A>G::						rs1938571	0.80467	0.70148,0.88378,0.94015,0.83360,0.84501	49708,	22965	29707	-0.1250	4.02			/0.0>0.0/0.0>1.3				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98018735	98018735	G	A	hom	het	hom		QUAL=24;DP=83,108,97;AF=1.00,0.36,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+27273C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-23735C>T::						rs4447033	0.85528	0.87448,0.89874,0.94005,0.83530,0.85697	55821,	18489	22019	0.0700	0.76			/4.8>4.2/0.0>0.0			27338279	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98018918	98018918	T	C	hom	het	hom		QUAL=25;DP=36,39,40;AF=1.00,0.36,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+27090A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-23918A>G::					AluSx1 (SINE/Alu)	rs1938572	0.85523	0.87450,0.89858,0.93977,0.83520,0.85670	55656,	18459	21967	-2.1630	0.41			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98019061	98019061	C	T	hom	het	hom		QUAL=24;DP=38,27,12;AF=1.00,0.41,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+26947G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-24061G>A::					AluSx1 (SINE/Alu)	rs1938573	0.85639	0.87532,0.89990,0.94039,0.83591,0.85827	55643,	18436	21754	-0.0450	0.96			/2.5>6.5/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98019398	98019398	G	T	hom	het	hom		QUAL=24;DP=158,223,157;AF=1.00,0.47,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+26610C>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-24398C>A::						rs1938558	0.85527	0.87451,0.89890,0.94052,0.83516,0.85679	55857,	18509	22037	1.1900	9.70			/3.1>2.6/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98019546	98019546	G	A	hom	het	hom		QUAL=24;DP=105,154,128;AF=1.00,0.43,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+26462C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-24546C>T::					MIR (SINE/MIR)	rs1938559	0.85515	0.87437,0.89885,0.94018,0.83514,0.85649	55833,	18508	22050	0.7920	3.81			/0.0>0.3/0.0>0.6				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98019636	98019636	C	T	hom	het	hom		QUAL=24;DP=245,138,106;AF=1.00,0.43,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+26372G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-24636G>A::	regulatory_region_variant:open_chromatin_region				MIR (SINE/MIR)	rs1938560	0.85528	0.87445,0.89902,0.94052,0.83521,0.85694	55853,	18490	22030	0.0020	1.38			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020017	98020017	C	T	hom	het	hom		QUAL=24;DP=97,74,88;AF=1.00,0.64,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25991G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-25017G>A::	regulatory_region_variant:open_chromatin_region,TF_binding_site_variant					rs9324383	0.85525	0.87445,0.89873,0.94059,0.83524,0.85679	55814,	18492	22022	0.5110	2.55			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020142	98020142	-	TTT	hom	wt	hom		QUAL=24;DP=41,7,8;AF=0.59,0.00,0.75	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25863_140+25865dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-25145_985-25143dup::	regulatory_region_variant:open_chromatin_region					rs10637296	0.81194	0.75052,0.87900,0.91512,0.82644,0.85026	48235,	21807	27395		1.06			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020371	98020371	T	C	hom	het	hom		QUAL=24;DP=74,108,83;AF=1.00,0.44,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25637A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-25371A>G::					AluSx1 (SINE/Alu)	rs9725319	0.85517	0.87443,0.89902,0.94044,0.83521,0.85625	55794,	18493	22031	-1.8110	0.98			/0.0>0.0/0.0>1.2				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020435	98020435	C	T	het	het	wt		QUAL=24;DP=75,161,67;AF=0.32,0.45,0.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25573G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.985-25435G>A::					AluSx1 (SINE/Alu)	rs74829086	0.01446	0.01416,0.03118,0.13541,0.00196,0.04613	89,	2022	149964	-1.7430	0.55			/0.0>0.0/0.0>2.8				27	394	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020606	98020606	T	C	hom	het	hom		QUAL=24;DP=84,73,66;AF=1.00,0.36,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25402A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+25402A>G::						rs4477335	0.85522	0.87449,0.89882,0.94015,0.83527,0.85676	55776,	18479	22013	-0.2530	4.11			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020686	98020686	-	A	hom	het	hom		QUAL=24;DP=98,26,20;AF=0.99,0.42,0.95	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25321dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+25321dup::						rs61381274	0.85464	0.87304,0.89816,0.94036,0.83498,0.85658	55626,	18533	22075		0.17			/8.9>9.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98020814	98020814	G	A	hom	het	hom		QUAL=24;DP=33,41,32;AF=1.00,0.46,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+25194C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+25194C>T::						rs4480407	0.87384	0.93728,0.90854,0.94046,0.83554,0.85741	58355,	16210	19190	0.4270	4.12			/0.2>0.4/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98021777	98021777	A	G	hom	het	hom		QUAL=24;DP=83,282,220;AF=1.00,0.57,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+24231T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+24231T>C::						rs9659624	0.85509	0.87432,0.89880,0.94029,0.83510,0.85664	55778,	18491	22039	0.7530	16.02			/10.1>10.9/0.0>0.0			33686288,37518996	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98021954	98021954	C	A	hom	het	hom		QUAL=24;DP=123,176,162;AF=1.00,0.55,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+24054G>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+24054G>T::						rs5005705	0.85378	0.87326,0.89739,0.94026,0.83418,0.84682	55565,	18665	22229	-1.3150	0.41			/0.0>0.0/0.5>0.0			36376304	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022010	98022010	C	T	hom	het	hom		QUAL=24;DP=74,122,130;AF=1.00,0.52,0.99	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23998G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23998G>A::						rs9324384	0.85528	0.87433,0.89876,0.94050,0.83538,0.85697	55792,	18497	22011	-0.6920	1.28			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022207	98022207	G	A	hom	het	hom		QUAL=24;DP=90,150,165;AF=0.99,0.51,0.99	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23801C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23801C>T::						rs4634961	0.85543	0.87468,0.89890,0.94024,0.83538,0.85652	55785,	18486	21980	-0.2480	1.81			/0.0>0.0/6.2>4.3			24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022343	98022343	C	A	hom	het	hom		QUAL=25;DP=82,218,232;AF=1.00,0.50,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23665G>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23665G>T::						rs9324385	0.85531	0.87459,0.89873,0.94030,0.83523,0.85723	55793,	18493	22005	0.0320	2.00			/4.6>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022403	98022403	G	A	hom	het	hom		QUAL=25;DP=128,270,266;AF=1.00,0.49,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23605C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23605C>T::						rs9324386	0.85534	0.87456,0.89874,0.94026,0.83533,0.85702	55817,	18495	22009	-0.1830	1.42			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022474	98022474	G	A	hom	het	hom		QUAL=24;DP=111,278,214;AF=0.99,0.49,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23534C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23534C>T::						rs9324387	0.85537	0.87451,0.89878,0.94013,0.83530,0.85738	55823,	18498	22006	-0.0660	1.54			/1.4>2.2/0.0>0.0			24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98022599	98022599	G	A	hom	het	hom		QUAL=25;DP=90,170,169;AF=1.00,0.46,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+23409C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+23409C>T::						rs9324388	0.85538	0.87469,0.89872,0.94040,0.83531,0.85714	55829,	18486	22004	0.1320	6.79			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023307	98023307	A	G	hom	het	hom		QUAL=24;DP=116,131,127;AF=1.00,0.64,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22701T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22701T>C::						rs9659996	0.85520	0.87446,0.89883,0.93999,0.83519,0.85682	55795,	18495	22025	1.6210	9.35			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023339	98023339	C	T	hom	het	hom		QUAL=24;DP=68,92,101;AF=1.00,0.58,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22669G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22669G>A::						rs9658841	0.85521	0.87445,0.89877,0.93997,0.83523,0.85646	55801,	18499	22027	-0.3040	1.59			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023524	98023524	G	A	hom	het	hom		QUAL=24;DP=68,38,26;AF=1.00,0.61,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22484C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22484C>T::						rs9661157	0.85533	0.87445,0.89919,0.94111,0.83525,0.85622	55747,	18472	21982	-0.4100	0.30			/0.0>0.0/0.0>1.4				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023721	98023721	-	TACTT	hom	het	hom		QUAL=24;DP=69,93,62;AF=0.67,0.35,0.90	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22286_140+22287insAAGTA::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22286_984+22287insAAGTA::						rs71071680	0.85478	0.87420,0.89837,0.93983,0.83478,0.85625	55536,	18471	22009		13.01			/0.0>0.2/0.0>0.9				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023774	98023774	C	T	hom	het	hom		QUAL=24;DP=68,81,52;AF=1.00,0.31,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22234G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22234G>A::						rs10747496	0.85536	0.87454,0.89898,0.94010,0.83521,0.85708	55693,	18464	21958	0.3660	2.99			/0.9>0.8/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98023922	98023922	A	G	hom	het	hom		QUAL=24;DP=146,163,125;AF=1.00,0.42,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+22086T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+22086T>C::						rs4584446	0.85523	0.87445,0.89865,0.93992,0.83525,0.85682	55748,	18466	22000	-0.0180	2.18			/8.3>8.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98024179	98024179	T	C	hom	het	hom		QUAL=24;DP=125,130,58;AF=1.00,0.51,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+21829A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+21829A>G::						rs2391905	0.85525	0.87438,0.89899,0.94011,0.83524,0.85634	55729,	18468	21990	0.2110	2.89			/0.0>0.0/0.0>0.0			24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98024456	98024457	TT	-	hom	het	hom		QUAL=24;DP=136,112,93;AF=0.94,0.55,0.92	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+21551_140+21552del::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+21551_984+21552del::					L2a (LINE/L2)	rs55633609	0.85149	0.86468,0.89698,0.93834,0.83387,0.85566	53809,	18672	22026	0.4400	0.37			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98024609	98024609	C	T	hom	het	hom		QUAL=24;DP=65,72,46;AF=1.00,0.44,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+21399G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+21399G>A::						rs4950117	0.87448	0.93919,0.90878,0.94038,0.83553,0.85682	58342,	16100	19060	0.2330	2.62			/0.0>0.0/0.0>0.0			24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98024802	98024802	G	T	hom	het	hom		QUAL=24;DP=77,169,156;AF=1.00,0.51,0.99	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+21206C>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+21206C>A::						rs4950118	0.85495	0.87447,0.89882,0.94013,0.83506,0.85676	55646,	18504	22022	0.5410	15.64			/5.9>5.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025080	98025080	T	C	hom	het	hom		QUAL=24;DP=117,172,121;AF=0.98,0.48,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20928A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20928A>G::						rs10783082	0.85512	0.87430,0.89887,0.94003,0.83515,0.85747	55673,	18451	21991	0.1160	13.17			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025214	98025214	-	TTAAGTAT	hom	het	hom		QUAL=24;DP=92,171,177;AF=0.72,0.53,0.93	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20786_140+20793dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20786_984+20793dup::						rs5776392	0.85468	0.87406,0.89850,0.94007,0.83468,0.85640	55332,	18415	21947		4.95			/0.0>0.0/0.8>0.8				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025692	98025692	A	C	hom	het	hom		QUAL=24;DP=102,192,140;AF=0.99,0.45,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20316T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20316T>G::					MIR3 (SINE/MIR)	rs4950119	0.84642	0.91501,0.88740,0.93964,0.80543,0.81063	54726,	19021	23311	-0.6610	0.99			/0.0>0.9/0.0>0.0			35396580	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025826	98025826	G	A	hom	het	hom		QUAL=24;DP=84,142,105;AF=1.00,0.42,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20182C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20182C>T::					MIRb (SINE/MIR)	rs4950120	0.85529	0.87442,0.89897,0.94051,0.83509,0.85714	55615,	18438	21940	0.1650	5.83			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98025917	98025917	A	C	hom	het	hom		QUAL=24;DP=110,134,116;AF=0.99,0.50,0.99	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+20091T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+20091T>G::					MIRb (SINE/MIR)	rs4245673	0.85512	0.87436,0.89895,0.94000,0.83515,0.85691	55680,	18455	21995	0.9310	6.87			/0.3>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98026176	98026176	T	C	hom	het	hom		QUAL=24;DP=70,216,193;AF=1.00,0.48,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+19832A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+19832A>G::						rs1938568	0.85517	0.87454,0.89887,0.94000,0.83508,0.85679	55715,	18475	22001	0.6240	14.42			/0.0>0.0/0.0>0.0			24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98026906	98026906	C	T	hom	het	hom		QUAL=24;DP=131,199,185;AF=1.00,0.47,0.99	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+19102G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+19102G>A::						rs9440393	0.85518	0.87463,0.89849,0.94005,0.83518,0.85646	55658,	18457	21977	-0.8030	0.10			/2.9>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98027024	98027024	A	G	het	het	het		QUAL=24;DP=165,285,262;AF=0.48,0.50,0.48	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+18984T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+18984T>C::						rs9440302	0.48728	0.49918,0.50402,0.37275,0.49045,0.39452	18118,	37603	77695	0.5020	4.31			/3.4>3.3/0.0>0.0			34403773,32184616,25217366	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98027298	98027298	T	C	hom	het	hom		QUAL=24;DP=116,113,95;AF=1.00,0.50,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+18710A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+18710A>G::						rs9324389	0.85524	0.87460,0.89904,0.94058,0.83517,0.85676	55673,	18439	21967	-2.3170	0.01			/0.7>0.8/0.4>8.6				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98027707	98027707	A	G	hom	het	hom		QUAL=24;DP=75,187,124;AF=1.00,0.45,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+18301T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+18301T>C::	regulatory_region_variant:enhancer					rs1938569	0.85494	0.87427,0.89879,0.94017,0.83498,0.85418	55585,	18456	21994	0.7930	3.48			/0.0>0.0/1.5>3.3				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028229	98028229	G	A	hom	het	hom		QUAL=25;DP=55,14,11;AF=0.98,0.36,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17779C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17779C>T::						rs2022864	0.85530	0.87428,0.89854,0.94026,0.83482,0.85685	55079,	18272	21728	-0.7290	0.75			/0.0>0.0/0.0>1.6				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028233	98028233	A	G	hom	het	hom		QUAL=24;DP=77,15,12;AF=0.99,0.40,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17775T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17775T>C::						rs2022865	0.85504	0.87409,0.89819,0.94021,0.83474,0.85649	55064,	18291	21771	-0.0130	6.66			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028629	98028629	G	A	hom	het	hom		QUAL=24;DP=180,153,104;AF=1.00,0.55,0.99	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17379C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17379C>T::						rs10875124	0.85494	0.87395,0.89853,0.94020,0.83505,0.85673	55379,	18405	21915	0.8880	6.55			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028644	98028644	A	C	hom	het	hom		QUAL=24;DP=181,141,97;AF=1.00,0.53,0.99	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17364T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17364T>G::						rs10875125	0.85481	0.87382,0.89852,0.94018,0.83493,0.85637	55351,	18406	21930	0.2010	1.62			/0.0>0.0/0.0>0.0			35710621	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98028832	98028832	-	A	hom	het	hom		QUAL=24;DP=102,86,50;AF=0.99,0.42,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+17175dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+17175dup::						rs11404556	0.85521	0.87431,0.89885,0.94075,0.83536,0.85682	55531,	18411	21921		5.54			/3.9>4.4/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98029050	98029050	A	G	hom	het	hom		QUAL=25;DP=138,151,132;AF=1.00,0.44,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+16958T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+16958T>C::						rs1198574	0.85529	0.87439,0.89909,0.94003,0.83541,0.85702	55533,	18387	21903	0.7640	16.51			/0.0>0.0/0.0>0.0			32184616	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98029957	98029957	T	C	hom	het	hom		QUAL=24;DP=53,129,96;AF=1.00,0.54,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+16051A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+16051A>G::						rs1198573	0.85516	0.87472,0.89821,0.94049,0.83509,0.85637	55402,	18388	21882	3.3360	17.11			/0.0>0.0/4.7>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98030956	98030956	T	-	het	wt	het		QUAL=24;DP=119,168,117;AF=0.55,0.16,0.62	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+15052del::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+15052del::						rs377025796	0.01039	0.00509,0.00380,0.06091,0.01219,0.00520	25,	1483	145973	0.9970	0.58			/0.0>0.0/1.2>1.2				26	486	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98031620	98031620	A	C	hom	het	hom		QUAL=24;DP=76,15,16;AF=1.00,0.67,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+14388T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+14388T>G::						rs1198572	0.82675	0.85219,0.87591,0.93961,0.80428,0.79954	51972,	21226	26230	-0.4610	9.57			/2.6>2.5/0.0>0.0			33686288	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98031799	98031799	A	G	het	wt	het		QUAL=24;DP=29,9,14;AF=0.48,0.00,0.57	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+14209T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+14209T>C::						rs188465986	0.00817	0.00226,0.00368,0.00000,0.01320,0.00515	7,	1069	131395	0.2980	3.60			/1.1>0.8/0.0>0.0				1	464	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98032116	98032116	A	G	hom	het	hom		QUAL=24;DP=56,35,21;AF=1.00,0.37,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+13892T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+13892T>C::						rs1198571	0.85517	0.87446,0.89869,0.94050,0.83518,0.85667	55584,	18409	21945	0.3560	4.95			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98033342	98033342	C	A	hom	het	hom		QUAL=24;DP=122,232,190;AF=1.00,0.45,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+12666G>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+12666G>T::						rs1782815	0.85382	0.87429,0.89726,0.94009,0.83388,0.84587	55509,	18612	22194	0.3820	1.77			/0.0>0.2/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98034287	98034287	T	C	hom	het	hom		QUAL=24;DP=79,159,94;AF=1.00,0.47,1.00	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+11721A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+11721A>G::	regulatory_region_variant:enhancer					rs1782813	0.86822	0.91817,0.90719,0.93998,0.83519,0.85744	57478,	16909	20015	-0.3410	3.41			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98034489	98034489	G	C	het	wt	het		QUAL=24;DP=161,121,133;AF=0.53,0.00,0.44	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+11519C>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+11519C>G::	regulatory_region_variant:enhancer				UCON1 (Unknown)	rs7554283	0.27286	0.12090,0.34914,0.56724,0.31320,0.40428	6625,	28207	110479	1.4970	13.95			/0.0>1.0/5.6>4.8			34403773,32184616,34560273	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98035455	98035455	T	C	het	wt	het		QUAL=24;DP=101,50,203;AF=0.51,0.00,0.54	MIR137HG	intron&non_coding_transcript	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+10553A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+10553A>G::	regulatory_region_variant:enhancer					rs4950101	0.23827	0.11073,0.23748,0.51175,0.28048,0.35860	5013,	26141	115625	1.6180	6.82			/4.1>2.7/0.0>0.0			24566148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98036428	98036428	T	C	hom	het	hom		QUAL=24;DP=92,92,85;AF=0.99,0.63,0.99	MIR137HG	intron&non_coding_transcript,downstream_gene	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+9580A>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+9580A>G::,MIR137HG:ENST00000667128.1:downstream_gene_variant:MODIFIER::::						rs1702294	0.82104	0.83224,0.87413,0.93973,0.80409,0.80054	51460,	21898	27206	-0.0800	0.57			/0.0>4.3/0.0>1.8			26836412,30035013,34625583,31268507,31995602,34159505,28072415,31522868,30518757,31835028,29635364,27072377,30618607,29442441,30285260,32152294,28117840,30038276,32764320,31409837,27620842,25056061	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98036603	98036603	G	C	hom	het	hom		QUAL=24;DP=99,379,360;AF=1.00,0.51,1.00	MIR137HG	intron&non_coding_transcript,downstream_gene	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+9405C>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+9405C>G::,MIR137HG:ENST00000667128.1:downstream_gene_variant:MODIFIER::::					Tigger3a (DNA/TcMar-Tigger)	rs1702293	0.91466	0.97720,0.93753,0.94073,0.87818,0.88910	63821,	11438	12976	-2.6840	0.09			/0.0>3.2/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98036784	98036784	G	A	hom	het	hom		QUAL=24;DP=85,208,231;AF=0.99,0.49,1.00	MIR137HG	intron&non_coding_transcript,downstream_gene	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+9224C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+9224C>T::,MIR137HG:ENST00000667128.1:downstream_gene_variant:MODIFIER::::					Tigger3a (DNA/TcMar-Tigger)	rs1782810	0.78284	0.69747,0.86504,0.93963,0.80383,0.79892	46981,	24966	32990	-0.0240	1.10			/2.9>3.1/0.0>0.0			23871474,28540026	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98036854	98036854	A	C	hom	het	hom		QUAL=24;DP=97,289,249;AF=1.00,0.51,1.00	MIR137HG	intron&non_coding_transcript,downstream_gene	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+9154T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+9154T>G::,MIR137HG:ENST00000667128.1:downstream_gene_variant:MODIFIER::::					Tigger3a (DNA/TcMar-Tigger)	rs1782811	0.88196	0.96655,0.91040,0.94005,0.83552,0.85685	59504,	15053	17943	-2.7810	0.38			/0.0>3.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98037038	98037038	A	C	hom	het	hom		QUAL=24;DP=92,263,208;AF=1.00,0.49,1.00	MIR137HG	intron&non_coding_transcript,downstream_gene	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+8970T>G::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+8970T>G::,MIR137HG:ENST00000667128.1:downstream_gene_variant:MODIFIER::::						rs1628294	0.91471	0.97718,0.93736,0.94091,0.87831,0.88926	63809,	11424	12964	-0.4600	1.64			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98037378	98037378	G	T	hom	het	hom		QUAL=24;DP=72,100,74;AF=1.00,0.36,1.00	MIR137HG	intron&non_coding_transcript,downstream_gene	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+8630C>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+8630C>A::,MIR137HG:ENST00000667128.1:downstream_gene_variant:MODIFIER::::				CR159174 [CLASS=DP MUT=ALT PHEN="Schizophrenia increased risk" GENE=MIR137HG];		rs1625579	0.78253	0.69624,0.86504,0.93973,0.80393,0.80021	46917,	24975	33017	-0.3280	1.34			/2.0>1.8/0.0>0.0			27895608,24174267,23637625,28798405,25921703,33708240,22910404,21926974,22078159,22850735,22883350,22982201,23459466,23507081,23776546,23786914,23871474,23910899,24132022,24275578,24339136,24361663,24391914,24625753,24718684,24820543,25044277,25154622,25241074,25395183,26123324,26429811,26836412,27028512,27095331,27096222,27481827,28234206,28958479,29042896,29118371,29599094,30026708,30035013,30122962,30610940,31586698,32127940,32525059,34625583,32184616,29858046,32920385,25311363,33939221,23637704,26609515,31522868,27525637,33967611,25200985,24468824,28659691,32406920,23375658,32910167,25084801,34938351,26305006,27706734,34686767,35733138,29635364,27072377,25217366,30566479,30618607,23453885,25941532,24160291,22883433,29442441,27196537,31354550,23595788,32566292,23284144,29033781,24866554,24653674,25434007,34950142,27244233,22777127,27733313,28812221,25250332,36092733,24342994,29657307,27650867,36414327,22547958,25958205,23805071,25844328,34566604,29529357,28117840,24566148,29893792,27396304,26005852,3496916	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98041060	98041060	-	TTCATTCA	het	het	wt		QUAL=24;DP=116,50,31;AF=0.24,0.56,0.00	MIR137HG,MIR2682	intron&non_coding_transcript,non_coding_transcript_exon,downstream_gene	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+4940_140+4947dup::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+4940_984+4947dup::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.4380_4387dup::,MIR2682:ENST00000580305.1:downstream_gene_variant:MODIFIER::::						rs35835879	0.14848	0.23225,0.13957,0.09164,0.12278,0.05115	1955,	18474	128366		0.28			/0.0>0.0/2.5>2.5				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98042140	98042140	A	G	hom	het	hom		QUAL=24;DP=59,31,15;AF=0.98,0.48,1.00	MIR137HG,MIR2682,MIR137	intron&non_coding_transcript,non_coding_transcript_exon,downstream_gene	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+3868T>C::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+3868T>C::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.3308T>C::,MIR2682:ENST00000580305.1:downstream_gene_variant:MODIFIER::::,MIR137:ENST00000385223.1:downstream_gene_variant:MODIFIER::::						rs4292998	0.79421	0.73705,0.86911,0.93955,0.80401,0.79892	48271,	24252	31300	-0.1470	6.21			/0.0>0.0/0.0>0.0			30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98042162	98042162	C	A	hom	het	hom		QUAL=24;DP=72,34,18;AF=1.00,0.50,1.00	MIR137HG,MIR2682,MIR137	intron&non_coding_transcript,non_coding_transcript_exon,downstream_gene	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+3846G>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+3846G>T::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.3286G>T::,MIR2682:ENST00000580305.1:downstream_gene_variant:MODIFIER::::,MIR137:ENST00000385223.1:downstream_gene_variant:MODIFIER::::						rs4411173	0.86825	0.91817,0.90706,0.94025,0.83522,0.85643	57613,	16941	20055	0.5130	7.84			/0.0>0.0/0.0>0.0			29500382	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98042702	98042702	C	T	hom	het	hom		QUAL=24;DP=214,440,412;AF=1.00,0.52,1.00	MIR137HG,MIR2682,MIR137	intron&non_coding_transcript,non_coding_transcript_exon,downstream_gene	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+3306G>A::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+3306G>A::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.2746G>A::,MIR2682:ENST00000580305.1:downstream_gene_variant:MODIFIER::::,MIR137:ENST00000385223.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer					rs2802535	0.79241	0.73013,0.86887,0.93929,0.80404,0.80083	47963,	24398	31522	-0.7900	0.44			/4.5>2.5/0.0>0.0			29635364,29033781,24566148,26005852	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98042932	98042932	G	A	het	het	wt		QUAL=24;DP=134,156,50;AF=0.55,0.58,0.00	MIR137HG,MIR2682,MIR137	intron&non_coding_transcript,non_coding_transcript_exon,downstream_gene	MIR137HG:ENST00000602672.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/5:n.140+3076C>T::,MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/4:n.984+3076C>T::,MIR137HG:ENST00000667128.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.2516C>T::,MIR2682:ENST00000580305.1:downstream_gene_variant:MODIFIER::::,MIR137:ENST00000385223.1:downstream_gene_variant:MODIFIER::::						rs78924727	0.01433	0.01360,0.03119,0.13522,0.00190,0.04713	90,	2001	150047	-0.2050	1.64			/0.0>0.0/0.0>0.0				26	395	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98046571	98046571	G	T	hom	het	hom		QUAL=25;DP=171,306,322;AF=1.00,0.49,1.00	MIR137HG,MIR2682,MIR137	non_coding_transcript_exon,upstream_gene	MIR137HG:ENST00000424528.2:non_coding_transcript_exon_variant:MODIFIER:exon2/5:n.543C>A::,MIR137HG:ENST00000602672.2:upstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000667128.1:upstream_gene_variant:MODIFIER::::,MIR2682:ENST00000580305.1:upstream_gene_variant:MODIFIER::::,MIR137:ENST00000385223.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter					rs2660304	0.82666	0.85172,0.87654,0.93984,0.80409,0.80067	52049,	21313	26297	1.2640	16.99			/0.0>0.0/0.0>0.0			24885463,27004216,28803920,33708240,26429811,31059093,33479212,31522868,27913161,29635364,30618607,29442441,29033781,25434007,33686288,35581276,24566148,29893792,26005852,31361772,33343624,31409837,33794697,27620842,29483656,26198764,37680447	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98047588	98047588	T	A	hom	het	hom		QUAL=24;DP=87,132,116;AF=1.00,0.53,1.00	MIR137HG,MIR2682,MIR137	intron&non_coding_transcript,upstream_gene	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.487-961A>T::,MIR137HG:ENST00000602672.2:upstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000667128.1:upstream_gene_variant:MODIFIER::::,MIR2682:ENST00000580305.1:upstream_gene_variant:MODIFIER::::,MIR137:ENST00000385223.1:upstream_gene_variant:MODIFIER::::						rs2660303	0.91380	0.97450,0.93746,0.94073,0.87794,0.88894	63706,	11563	13109	-0.2680	0.27			/0.0>0.0/0.0>0.0			27004216	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048156	98048156	-	CACACACACACC	het	wt	het		QUAL=25;DP=60,108,80;AF=0.30,0.00,0.46	MIR137HG,MIR2682,MIR137	intron&non_coding_transcript,upstream_gene	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+1221_486+1222insGGTGTGTGTGTG::,MIR137HG:ENST00000602672.2:upstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000667128.1:upstream_gene_variant:MODIFIER::::,MIR2682:ENST00000580305.1:upstream_gene_variant:MODIFIER::::,MIR137:ENST00000385223.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region				(CA)n (Simple_repeat)	rs750747213	0.00549	0.00214,0.00588,0.00097,0.00802,0.00886	2,	823	149743		2.59			/0.0>0.0/3.1>3.1				4	155	0	0 / 0					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048289	98048289	G	A	hom	het	hom		QUAL=24;DP=63,222,183;AF=1.00,0.48,0.99	MIR137HG,MIR2682,MIR137	intron&non_coding_transcript,upstream_gene	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+1089C>T::,MIR137HG:ENST00000602672.2:upstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000667128.1:upstream_gene_variant:MODIFIER::::,MIR2682:ENST00000580305.1:upstream_gene_variant:MODIFIER::::,MIR137:ENST00000385223.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:open_chromatin_region,TF_binding_site_variant					rs61786696	0.91470	0.97729,0.93735,0.94112,0.87814,0.88940	63922,	11454	12990	0.0740	8.31			/0.6>1.3/0.0>7.4			27004216	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	98048403	98048403	A	G	hom	het	hom		QUAL=24;DP=95,246,209;AF=1.00,0.49,1.00	MIR137HG,MIR2682,MIR137	intron&non_coding_transcript,upstream_gene	MIR137HG:ENST00000424528.2:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/4:n.486+975T>C::,MIR137HG:ENST00000602672.2:upstream_gene_variant:MODIFIER::::,MIR137HG:ENST00000667128.1:upstream_gene_variant:MODIFIER::::,MIR2682:ENST00000580305.1:upstream_gene_variant:MODIFIER::::,MIR137:ENST00000385223.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:open_chromatin_region,TF_binding_site_variant					rs61786697	0.91474	0.97745,0.93747,0.94057,0.87817,0.88993	63868,	11434	12972	2.6530	18.49			/7.2>7.1/0.0>0.0			27004216,33841080,32152294	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MIR137HG (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR2682 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MIR137 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	99851209	99851209	C	T	het	het	hom		QUAL=24;DP=137,43,41;AF=0.46,0.44,1.00	AGL	intron,upstream_gene	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron2/33:c.82+85C>T::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron2/33:c.82+85C>T::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron2/33:c.82+85C>T::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron2/33:c.82+85C>T::,AGL:ENST00000370161.6:upstream_gene_variant:MODIFIER::::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	676091 [benign DISEASE=not provided GENE=AGL];			rs663848	0.75877	0.91336,0.71440,0.69753,0.69603,0.76232	44500,	26469	36711	-0.2350	3.98			/6.3>6.2/0.0>0.0		AGL|0.00|0.00|0.00|0.00|48|23|-2|23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99861470	99861470	C	T	het	het	het		QUAL=25;DP=228,300,202;AF=0.54,0.46,0.48	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron2/33:c.83-33C>T::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron1/32:c.35-33C>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256750 [benign DISEASE=Glycogen storage disease type III,not specified,not provided GENE=AGL];			rs2307129	0.23525	0.38961,0.18698,0.11893,0.16976,0.19448	5046,	25669	116249	-1.0140	4.06			/0.0>0.0/3.3>1.9	COSV54053030	AGL|0.00|0.00|0.00|0.00|33|47|46|33	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99864333	99864333	G	C	het	het	hom		QUAL=24;DP=96,51,33;AF=0.54,0.39,1.00	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron4/33:c.461-53G>C::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron3/32:c.413-53G>C::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	676092 [benign DISEASE=not provided GENE=AGL];			rs535461	0.73119	0.86559,0.69402,0.69698,0.67778,0.75841	41198,	28788	40876	-0.0880	1.27			/10.6>8.7/0.0>0.0		AGL|0.01|0.00|0.00|0.00|27|0|27|28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99864681	99864681	A	G	het	het	hom		QUAL=24;DP=143,92,80;AF=0.48,0.49,1.00	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron5/33:c.664+92A>G::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron5/33:c.664+92A>G::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron5/33:c.664+92A>G::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron5/33:c.664+92A>G::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron4/32:c.616+92A>G::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	676094 [benign DISEASE=not provided GENE=AGL];		A-rich (Low_complexity)	rs538389	0.75862	0.91282,0.71498,0.69664,0.69618,0.76193	44492,	26451	36729	-0.8040	1.80			/0.0>0.0/0.0>1.4		AGL|0.00|0.00|0.00|0.00|7|4|-24|48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99864739	99864739	T	C	het	het	hom		QUAL=24;DP=122,36,29;AF=0.45,0.53,1.00	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron5/33:c.664+150T>C::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron5/33:c.664+150T>C::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron5/33:c.664+150T>C::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron5/33:c.664+150T>C::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron4/32:c.616+150T>C::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	677943 [benign DISEASE=not provided GENE=AGL];			rs539157	0.75935	0.91529,0.71534,0.69703,0.69618,0.76186	44580,	26365	36611	-1.6830	0.11			/0.0>0.0/0.0>0.0		AGL|0.00|0.00|0.00|0.00|-27|-39|-24|-10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99870232	99870232	A	G	het	het	het		QUAL=24;DP=46,11,12;AF=0.52,0.73,0.25	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron5/33:c.665-168A>G::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron5/33:c.665-168A>G::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron5/33:c.665-168A>G::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron5/33:c.665-168A>G::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron4/32:c.617-168A>G::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	679283 [benign DISEASE=not provided GENE=AGL];			rs67875069	0.23519	0.38968,0.18648,0.11921,0.16980,0.19382	5052,	25670	116332	0.0710	4.12			/0.0>0.0/0.0>0.6				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99870805	99870805	C	T	het	het	hom		QUAL=24;DP=223,118,98;AF=0.41,0.52,1.00	AGL	synonymous	AGL:ENST00000361915.8:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000294724.8:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000370163.7:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000370165.7:synonymous_variant:LOW:exon7/34:c.894C>T:p.Leu298=:PF14701 [Glycogen debranching enzyme glucanotransferase domain],AGL:ENST00000370161.6:synonymous_variant:LOW:exon6/33:c.846C>T:p.Leu282=:PF14701 [Glycogen debranching enzyme glucanotransferase domain]		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	198432 [benign DISEASE=not specified,Glycogen storage disease type III,not provided GENE=AGL];			rs2230306	0.75893	0.91290,0.71580,0.69706,0.69630,0.76268	44477,	26416	36646	1.0390	7.03			/2.6>2.2/0.0>0.0		AGL|0.01|0.12|0.00|0.00|20|-47|20|-47	25741868,37185710	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99874669	99874669	G	A	het	het	hom		QUAL=24;DP=105,229,169;AF=0.43,0.54,1.00	AGL	splice_region&intron	AGL:ENST00000361915.8:splice_region_variant&intron_variant:LOW:intron7/33:c.959-18G>A::,AGL:ENST00000294724.8:splice_region_variant&intron_variant:LOW:intron7/33:c.959-18G>A::,AGL:ENST00000370163.7:splice_region_variant&intron_variant:LOW:intron7/33:c.959-18G>A::,AGL:ENST00000370165.7:splice_region_variant&intron_variant:LOW:intron7/33:c.959-18G>A::,AGL:ENST00000370161.6:splice_region_variant&intron_variant:LOW:intron6/32:c.911-18G>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256751 [benign DISEASE=not specified,Glycogen storage disease type III,not provided GENE=AGL];			rs634880	0.73430	0.84146,0.68634,0.72012,0.69367,0.73973	41324,	28829	40337	-0.9060	6.12			11.0>11.4/11.0>11.4/8.7>7.2	COSV54049593	AGL|0.02|0.00|0.00|0.00|25|18|18|-6	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99888119	99888119	G	A	het	het	hom		QUAL=24;DP=175,264,206;AF=0.53,0.47,1.00	AGL	splice_region&intron	AGL:ENST00000361915.8:splice_region_variant&intron_variant:LOW:intron21/33:c.2812+11G>A::,AGL:ENST00000294724.8:splice_region_variant&intron_variant:LOW:intron21/33:c.2812+11G>A::,AGL:ENST00000370163.7:splice_region_variant&intron_variant:LOW:intron21/33:c.2812+11G>A::,AGL:ENST00000370165.7:splice_region_variant&intron_variant:LOW:intron21/33:c.2812+11G>A::,AGL:ENST00000370161.6:splice_region_variant&intron_variant:LOW:intron20/32:c.2764+11G>A::	regulatory_region_variant:open_chromatin_region	610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256730 [benign DISEASE=Glycogen storage disease type III,not specified,not provided GENE=AGL];			rs555929	0.66221	0.58155,0.69509,0.69957,0.69342,0.74552	33533,	33522	51310	-0.2370	0.03			/0.0>0.0/0.0>0.0	COSV54049809	AGL|0.00|0.00|0.00|0.00|2|34|-7|-20	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99892547	99892547	C	T	het	het	het		QUAL=24;DP=251,223,182;AF=0.49,0.51,0.47	AGL	missense	AGL:ENST00000361915.8:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000294724.8:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000370163.7:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000370165.7:missense_variant:MODERATE:exon24/34:c.3199C>T:p.Pro1067Ser:,AGL:ENST00000370161.6:missense_variant:MODERATE:exon23/33:c.3151C>T:p.Pro1051Ser:		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256734 [benign DISEASE=Glycogen storage disease type III,not provided,not specified GENE=AGL];			rs3753494	0.13614	0.12005,0.12641,0.02629,0.14642,0.14979	1508,	17681	131335	7.2800	22.60	0.295	0.22	/4.9>6.3/3.2>3.0		AGL|0.11|0.00|0.00|0.00|8|20|-4|-6	25741868,25803781,37185710	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99892644	99892644	G	A	het	het	hom		QUAL=24;DP=136,117,88;AF=0.46,0.49,1.00	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron24/33:c.3259+37G>A::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron23/32:c.3211+37G>A::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	256735 [benign DISEASE=not provided,Glycogen storage disease type III,not specified GENE=AGL];			rs594249	0.66264	0.58191,0.69531,0.70073,0.69358,0.74938	33611,	33527	51293	-1.8710	0.03			/0.0>1.1/0.0>0.0	COSV54049828	AGL|0.00|0.00|0.00|0.00|50|-42|-37|-41	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99900891	99900892	TT	-	het	het	hom	low_conf_region	QUAL=24;DP=106,90,96;AF=0.38,0.63,0.84	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron26/33:c.3588+43_3588+44del::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron25/32:c.3540+43_3540+44del::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1220869 [benign DISEASE=not provided GENE=AGL];		(T)n (Simple_repeat)	rs35956186	0.52539	0.42966,0.50772,0.49854,0.58641,0.47768	19110,	36543	67537	2.0190	0.82			/3.2>2.8/0.0>0.0		AGL|0.00|0.00|0.00|0.00|-23|-29|-29|-26		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99912233	99912233	C	T	het	het	het		QUAL=24;DP=48,25,13;AF=0.42,0.60,0.77	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron28/33:c.3837-172C>T::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron28/33:c.3837-172C>T::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron28/33:c.3837-172C>T::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron28/33:c.3837-172C>T::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron27/32:c.3789-172C>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	680039 [benign DISEASE=not provided GENE=AGL];			rs3818568	0.13608	0.11982,0.12751,0.02643,0.14645,0.13608	1506,	17658	131232	0.0880	2.65			/0.0>0.0/4.3>2.8		AGL|0.00|0.00|0.00|0.00|-1|-42|0|46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99915553	99915553	-	T	het	het	het	low_conf_region	QUAL=24;DP=80,55,56;AF=0.54,0.56,0.52	AGL	intron	AGL:ENST00000361915.8:intron_variant:MODIFIER:intron31/33:c.4259+80dup::,AGL:ENST00000294724.8:intron_variant:MODIFIER:intron31/33:c.4259+80dup::,AGL:ENST00000370163.7:intron_variant:MODIFIER:intron31/33:c.4259+80dup::,AGL:ENST00000370165.7:intron_variant:MODIFIER:intron31/33:c.4259+80dup::,AGL:ENST00000370161.6:intron_variant:MODIFIER:intron30/32:c.4211+80dup::	regulatory_region_variant:enhancer	610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	1292307 [benign DISEASE=not provided GENE=AGL];			rs11438303	0.43408	0.25062,0.48756,0.57115,0.52123,0.38985	14669,	34224	82868		0.95			/8.0>9.0/0.0>0.0		AGL|0.03|0.00|0.00|0.00|19|30|30|19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	99922383	99922383	C	T	het	het	hom		QUAL=24;DP=69,53,41;AF=0.52,0.45,1.00	AGL	3'UTR	AGL:ENST00000361915.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000294724.8:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000370163.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000370165.7:3_prime_UTR_variant:MODIFIER:exon34/34:c.*732C>T::,AGL:ENST00000370161.6:3_prime_UTR_variant:MODIFIER:exon33/33:c.*732C>T::		610860_[GENE=AGL_PHENOS=Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive]	291359 [benign DISEASE=Glycogen storage disease type III,not provided GENE=AGL];			rs3766600	0.61757	0.53748,0.64305,0.63367,0.65831,0.51729	29045,	35393	57889	0.8200	4.53			/6.3>5.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AGL (inh=AR oe_syn=1.02 oe_mis=1.05 oe_lof=0.64)
chr1	100190027	100190027	T	A	hom	hom	hom		QUAL=24;DP=48,13,17;AF=1.00,1.00,0.88	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6228A>T::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 620699 (3), Autosomal recessive]	291395 [benign DISEASE=Maple syrup urine disease,not provided GENE=DBT];		MER3 (DNA/hAT-Charlie)	rs4281338	0.75638	0.47578,0.85448,0.95143,0.84986,0.88318	45910,	23298	37078	-0.7220	0.12			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100190140	100190141	AA	-	het	het	wt		QUAL=24;DP=90,90,22;AF=0.51,0.66,0.00	DBT	3'UTR	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*6114_*6115del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 620699 (3), Autosomal recessive]	291396 [likely benign(replaced by megSAP based on classifications:1x1,1x3) DISEASE=not provided,Maple syrup urine disease GENE=DBT];		MLT1J2 (LTR/ERVL-MaLR)	rs3081711	0.17878	0.04510,0.16300,0.15008,0.24651,0.18491	3078,	21049	124967	0.4950	0.41			/4.5>2.7/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100190709	100190709	C	T	hom	hom	hom		QUAL=24;DP=90,140,105;AF=1.00,1.00,1.00	DBT	3'UTR,downstream_gene	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5546G>A::,DBT:ENST00000681617.1:downstream_gene_variant:MODIFIER::::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 620699 (3), Autosomal recessive]	291404 [benign DISEASE=not provided,Maple syrup urine disease GENE=DBT];			rs11166412	0.79136	0.56403,0.87592,0.95209,0.86532,0.89888	49095,	22089	31711	-0.7530	0.18			/4.2>6.5/0.0>0.0			17998437	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100191105	100191105	T	C	hom	hom	hom		QUAL=24;DP=135,208,156;AF=0.99,1.00,1.00	DBT	3'UTR,downstream_gene	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*5150A>G::,DBT:ENST00000681617.1:downstream_gene_variant:MODIFIER::::,DBT:ENST00000681780.1:downstream_gene_variant:MODIFIER::::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 620699 (3), Autosomal recessive]	291407 [benign DISEASE=not provided,Maple syrup urine disease GENE=DBT];			rs6701655	0.75872	0.47848,0.85673,0.95216,0.85184,0.89705	46158,	23105	36705	0.1090	4.51			/1.0>1.2/4.8>0.6			31234531	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100193022	100193022	G	A	hom	hom	hom		QUAL=24;DP=120,321,305;AF=0.97,1.00,1.00	DBT,RPL23AP90	3'UTR,downstream_gene,upstream_gene	DBT:ENST00000370132.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*3233C>T::,DBT:ENST00000681617.1:downstream_gene_variant:MODIFIER::::,DBT:ENST00000681780.1:downstream_gene_variant:MODIFIER::::,RPL23AP90:ENST00000603820.1:upstream_gene_variant:MODIFIER::::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 620699 (3), Autosomal recessive]	291424 [benign DISEASE=not provided,Maple syrup urine disease GENE=DBT];			rs2784174	0.75885	0.47881,0.85676,0.95193,0.85186,0.89647	46169,	23108	36686	0.1950	1.24			/0.0>0.0/0.9>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50), RPL23AP90 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	100196535	100196536	TG	-	hom	hom	hom		QUAL=24;DP=80,30,26;AF=1.00,1.00,1.00	DBT,RPL23AP90	intron,upstream_gene	DBT:ENST00000370132.8:intron_variant:MODIFIER:intron10/10:c.1282-114_1282-113del::,DBT:ENST00000681617.1:intron_variant:MODIFIER:intron11/11:c.1408-114_1408-113del::,DBT:ENST00000681780.1:intron_variant:MODIFIER:intron11/11:c.739-114_739-113del::,RPL23AP90:ENST00000603820.1:upstream_gene_variant:MODIFIER::::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 620699 (3), Autosomal recessive]				rs5776501	0.98962	0.96324,0.99750,1.00000,0.99994,0.99979	74301,	1522	1574	0.0000	0.70			/9.4>9.9/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50), RPL23AP90 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	100206504	100206504	T	C	hom	hom	hom		QUAL=24;DP=233,302,245;AF=1.00,1.00,1.00	DBT	missense,downstream_gene	DBT:ENST00000370132.8:missense_variant:MODERATE:exon9/11:c.1150A>G:p.Ser384Gly:PF00198 [2-oxoacid dehydrogenases acyltransferase (catalytic domain)],DBT:ENST00000681617.1:missense_variant:MODERATE:exon10/12:c.1276A>G:p.Ser426Gly:PF00198 [2-oxoacid dehydrogenases acyltransferase (catalytic domain)],DBT:ENST00000681780.1:missense_variant:MODERATE:exon10/12:c.607A>G:p.Ser203Gly:PF00198 [2-oxoacid dehydrogenases acyltransferase (catalytic domain)],DBT:ENST00000370131.3:downstream_gene_variant:MODIFIER::::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 620699 (3), Autosomal recessive]	128885 [benign/likely benign DISEASE=not specified,not provided,Maple syrup urine disease type 1A,Maple syrup urine disease GENE=DBT];			rs12021720	0.87599	0.76489,0.91709,0.96656,0.91101,0.95243	58729,	15839	18871	1.9390	13.99	0.117	0.04	/0.0>2.4/7.0>2.5			30409984,29334895,21827660,9621512,30541556,35657820,32583022,23112750,22437669	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100215037	100215037	-	T	hom	hom	hom	low_conf_region	QUAL=24;DP=125,63,51;AF=0.61,0.76,0.78	DBT,BRI3P1	intron,downstream_gene	DBT:ENST00000370132.8:intron_variant:MODIFIER:intron6/10:c.773-55dup::,DBT:ENST00000681617.1:intron_variant:MODIFIER:intron6/11:c.773-55dup::,DBT:ENST00000681780.1:intron_variant:MODIFIER:intron7/11:c.230-55dup::,DBT:ENST00000370131.3:intron_variant:MODIFIER:intron6/7:c.773-55dup::,BRI3P1:ENST00000440440.1:downstream_gene_variant:MODIFIER::::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 620699 (3), Autosomal recessive]	1291007 [benign DISEASE=not provided GENE=DBT];			rs11431894	0.77859	0.58679,0.84838,0.93815,0.84136,0.89152	44753,	23315	32083		0.65			/0.0>0.0/0.0>0.0		DBT|0.00|0.00|0.00|0.00|-1|-45|38|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50), BRI3P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	100218933	100218934	GG	-	hom	hom	hom		QUAL=24;DP=66,23,10;AF=0.86,1.00,1.00	DBT	intron	DBT:ENST00000370132.8:intron_variant:MODIFIER:intron4/10:c.434-187_434-186del::,DBT:ENST00000681617.1:intron_variant:MODIFIER:intron4/11:c.434-187_434-186del::,DBT:ENST00000681780.1:intron_variant:MODIFIER:intron5/11:c.-110-187_-110-186del::,DBT:ENST00000370131.3:intron_variant:MODIFIER:intron4/7:c.434-187_434-186del::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 620699 (3), Autosomal recessive]	1293954 [benign DISEASE=not provided GENE=DBT];			rs55792733	0.80968	0.61001,0.88017,0.95204,0.86822,0.90719	48886,	21126	27948	0.1350	0.47			/6.3>6.3/0.0>0.0		DBT|0.00|0.00|0.00|0.00|-19|49|25|49		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100230629	100230629	-	A	hom	hom	hom	low_conf_region	QUAL=25;DP=53,12,5;AF=0.91,0.58,1.00	DBT	intron	DBT:ENST00000370132.8:intron_variant:MODIFIER:intron4/10:c.433+103dup::,DBT:ENST00000681617.1:intron_variant:MODIFIER:intron4/11:c.433+103dup::,DBT:ENST00000681780.1:intron_variant:MODIFIER:intron5/11:c.-111+103dup::,DBT:ENST00000370131.3:intron_variant:MODIFIER:intron4/7:c.433+103dup::		248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 620699 (3), Autosomal recessive]	1291008 [benign DISEASE=not provided GENE=DBT];		A-rich (Low_complexity)	rs11394110	0.81582	0.57391,0.88936,0.96117,0.90112,0.94693	48744,	19041	26307		0.95			/8.6>8.6/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50)
chr1	100249898	100249898	G	A	hom	hom	hom		QUAL=24;DP=54,282,196;AF=0.98,1.00,0.99	DBT	upstream_gene	DBT:ENST00000370132.8:upstream_gene_variant:MODIFIER::::,DBT:ENST00000681617.1:upstream_gene_variant:MODIFIER::::,DBT:ENST00000681780.1:upstream_gene_variant:MODIFIER::::,DBT:ENST00000370131.3:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	248610_[GENE=DBT_PHENOS=Maple syrup urine disease, type II, 620699 (3), Autosomal recessive]	1263587 [benign DISEASE=not provided GENE=DBT];			rs2100217872,rs2100217887,rs2100217899,rs2100217926,rs3806235	0.72356	0.39037,0.82731,0.94109,0.84472,0.83915	43143,	23736	42034	-1.2050	0.51						29740478	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DBT (inh=AR oe_syn=0.96 oe_mis=0.83 oe_lof=0.50), RTCA-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	109228441	109228441	T	C	hom	hom	hom		QUAL=24;DP=237,230,204;AF=1.00,1.00,1.00	SARS1	splice_region&intron	SARS1:ENST00000234677.7:splice_region_variant&intron_variant:LOW:intron3/10:c.288+9T>C::,SARS1:ENST00000369923.4:splice_region_variant&intron_variant:LOW:intron3/11:c.288+9T>C::	regulatory_region_variant:enhancer	607529_[GENE=SARS1_PHENOS=Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3), Autosomal recessive]	1327978 [benign DISEASE=Neurodevelopmental disorder with microcephaly, ataxia, and seizures,not provided GENE=SARS1];			rs683182	0.70283	0.47433,0.78248,0.89348,0.79152,0.66729	39251,	28399	45199	-0.6230	1.31			/1.1>2.1/0.0>0.0	COSV52320213	SARS|0.00|0.00|0.00|0.00|3|19|13|-4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SARS1 (inh=AR oe_syn=0.82 oe_mis=0.57 oe_lof=0.07)
chr1	109229259	109229259	G	T	hom	hom	hom		QUAL=25;DP=114,26,24;AF=0.99,1.00,1.00	SARS1	intron	SARS1:ENST00000234677.7:intron_variant:MODIFIER:intron3/10:c.289-155G>T::,SARS1:ENST00000369923.4:intron_variant:MODIFIER:intron3/11:c.289-155G>T::	regulatory_region_variant:enhancer	607529_[GENE=SARS1_PHENOS=Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3), Autosomal recessive]				rs657511	0.98969	0.96480,0.99458,1.00000,0.99985,0.99979	74618,	1518	1570	1.0760	2.57			/5.2>2.0/0.0>3.6				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SARS1 (inh=AR oe_syn=0.82 oe_mis=0.57 oe_lof=0.07)
chr1	109235615	109235615	C	T	het	wt	hom		QUAL=24;DP=41,6,3;AF=0.49,0.00,1.00	SARS1	intron	SARS1:ENST00000234677.7:intron_variant:MODIFIER:intron7/10:c.969+184C>T::,SARS1:ENST00000369923.4:intron_variant:MODIFIER:intron7/11:c.969+184C>T::		607529_[GENE=SARS1_PHENOS=Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3), Autosomal recessive]			MIR (SINE/MIR)	rs4268379	0.39415	0.14542,0.47604,0.45898,0.49394,0.43461	13733,	32405	92027	0.1580	3.06			/1.9>2.2/0.0>0.0	COSV52320249	SARS|0.00|0.00|0.00|0.00|19|-44|-2|22	26487741	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SARS1 (inh=AR oe_syn=0.82 oe_mis=0.57 oe_lof=0.07)
chr1	109235955	109235955	T	C	hom	hom	hom		QUAL=24;DP=117,263,160;AF=1.00,1.00,1.00	SARS1	intron	SARS1:ENST00000234677.7:intron_variant:MODIFIER:intron7/10:c.970-22T>C::,SARS1:ENST00000369923.4:intron_variant:MODIFIER:intron7/11:c.970-22T>C::		607529_[GENE=SARS1_PHENOS=Neurodevelopmental disorder with microcephaly, ataxia, and seizures, 617709 (3), Autosomal recessive]	1327979 [benign DISEASE=Neurodevelopmental disorder with microcephaly, ataxia, and seizures,not provided GENE=SARS1];			rs658092	0.70969	0.49812,0.78582,0.89347,0.79162,0.66784	39737,	28443	44145	0.7830	13.29			/1.8>2.3/0.0>0.0	COSV52320257	SARS|0.00|0.00|0.00|0.00|-31|31|35|31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SARS1 (inh=AR oe_syn=0.82 oe_mis=0.57 oe_lof=0.07)
chr1	110167097	110167097	T	C	het	hom	het		QUAL=24;DP=236,411,333;AF=0.45,1.00,0.54	SLC6A17,SLC6A17-AS1	synonymous,non_coding_transcript_exon	SLC6A17:ENST00000331565.5:synonymous_variant:LOW:exon2/12:c.168T>C:p.Asp56=:,SLC6A17-AS1:ENST00000430098.2:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.522A>G::,SLC6A17-AS1:ENST00000443008.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.507A>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]	1333111 [benign DISEASE=not provided,Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome GENE=SLC6A17];			rs7527375	0.49570	0.49988,0.39165,0.22310,0.53405,0.35550	18682,	36789	75441	-5.6260	0.09			/0.0>0.0/0.0>0.0,/5.3>5.2/0.0>0.0	COSV58991969	SLC6A17|0.00|0.00|0.00|0.00|-34|5|25|-44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110167098	110167098	G	A	het	hom	wt		QUAL=24;DP=236,409,312;AF=0.45,1.00,0.00	SLC6A17,SLC6A17-AS1	missense,non_coding_transcript_exon	SLC6A17:ENST00000331565.5:missense_variant:MODERATE:exon2/12:c.169G>A:p.Ala57Thr:,SLC6A17-AS1:ENST00000430098.2:non_coding_transcript_exon_variant:MODIFIER:exon2/3:n.521C>T::,SLC6A17-AS1:ENST00000443008.1:non_coding_transcript_exon_variant:MODIFIER:exon2/2:n.506C>T::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]	1333112 [benign DISEASE=Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome,not provided GENE=SLC6A17];			rs12737742	0.33542	0.09642,0.29761,0.22172,0.45977,0.33515	10392,	29602	99832	0.6810	12.25	0.083	0.06	/0.0>0.0/0.0>0.0,/5.3>5.9/0.0>0.0	COSV58993671	SLC6A17|0.00|0.00|0.01|0.00|-35|-39|24|34	29259604	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110173788	110173798	TGAATGGAGCG	-	het	hom	wt		QUAL=24;DP=94,64,34;AF=0.63,1.00,0.00	SLC6A17,SLC6A17-AS1	intron,upstream_gene	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron3/11:c.445-171_445-161del::,SLC6A17-AS1:ENST00000430098.2:upstream_gene_variant:MODIFIER::::,SLC6A17-AS1:ENST00000443008.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]			Tigger15a (DNA/TcMar-Tigger)	rs67632953	0.38753	0.30149,0.31474,0.22136,0.45273,0.33514	11821,	35172	92952	0.5050	9.38			/3.3>3.3/0.1>0.0		SLC6A17|0.00|0.00|0.00|0.00|-27|0|12|21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110173889	110173889	C	T	het	hom	wt		QUAL=24;DP=103,195,34;AF=0.52,1.00,0.00	SLC6A17,SLC6A17-AS1	intron,upstream_gene	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron3/11:c.445-84C>T::,SLC6A17-AS1:ENST00000443008.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs12747833	0.33359	0.10164,0.31063,0.25880,0.45308,0.33410	10296,	30155	101377	-0.2780	1.81			/0.0>0.0/0.0>0.0	COSV58993259	SLC6A17|0.00|0.00|0.00|0.00|24|-27|-8|17		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110176467	110176467	A	G	hom	hom	hom		QUAL=25;DP=20,24,23;AF=1.00,1.00,1.00	SLC6A17,SLC6A17-AS1	intron,upstream_gene	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron5/11:c.754-162A>G::,SLC6A17-AS1:ENST00000443008.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer,TF_binding_site_variant	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs589540	0.94360	0.98082,0.95255,0.98600,0.91569,0.97287	67851,	7942	8586	-2.1500	0.10			/6.4>6.5/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21), SLC6A17-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	110192415	110192415	T	G	het	het	hom		QUAL=24;DP=46,76,78;AF=0.50,0.53,1.00	SLC6A17	intron	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron7/11:c.1107-91T>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2603583	0.63128	0.73149,0.55093,0.34805,0.63172,0.43826	30952,	34010	56022	-1.1330	0.21			/0.0>0.0/0.0>0.0		SLC6A17|0.00|0.00|0.00|0.00|41|-39|-18|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110195674	110195674	G	A	het	het	het		QUAL=25;DP=307,547,385;AF=0.50,0.53,0.54	SLC6A17	synonymous	SLC6A17:ENST00000331565.5:synonymous_variant:LOW:exon10/12:c.1581G>A:p.Ser527=:PF00209 [Sodium neurotransmitter symporter family]	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]	2585674 [benign DISEASE=Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome GENE=SLC6A17];			rs2784140	0.36762	0.10890,0.39212,0.29973,0.49656,0.39721	12541,	30834	96186	-2.0460	11.25			/0.0>1.5/0.0>0.0	COSV58991975,COSV58995492	SLC6A17|0.16|0.00|0.00|0.00|2|-41|2|-16		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110197242	110197242	A	G	het	het	het		QUAL=24;DP=14,17,11;AF=0.57,0.53,0.45	SLC6A17	intron	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron10/11:c.1653-195A>G::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2761442	0.39114	0.17264,0.40559,0.30135,0.50568,0.40506	13324,	32845	92609	0.4440	6.08			/0.0>0.2/0.0>0.0		SLC6A17|0.00|0.00|0.00|0.00|1|2|-22|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110197651	110197651	G	T	het	het	het		QUAL=24;DP=246,72,57;AF=0.54,0.58,0.40	SLC6A17	intron	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron11/11:c.1815+52G>T::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2603581	0.39034	0.19085,0.40079,0.30047,0.49547,0.40037	13013,	33338	92720	-0.2150	0.69			/2.1>2.6/0.0>0.0		SLC6A17|0.00|0.00|0.00|0.00|18|34|-41|-45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110197784	110197784	C	T	het	het	het		QUAL=24;DP=76,26,23;AF=0.50,0.38,0.30	SLC6A17	intron	SLC6A17:ENST00000331565.5:intron_variant:MODIFIER:intron11/11:c.1815+185C>T::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]			MIRb (SINE/MIR)	rs2761443	0.38152	0.16019,0.39570,0.30035,0.49576,0.40000	12779,	32513	94139	-0.7820	7.07			/0.0>0.0/0.0>0.0		SLC6A17|0.00|0.00|0.00|0.00|41|-36|-25|23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198066	110198066	C	T	het	het	het		QUAL=24;DP=96,256,256;AF=0.44,0.47,0.50	SLC6A17	splice_region&intron	SLC6A17:ENST00000331565.5:splice_region_variant&intron_variant:LOW:intron11/11:c.1816-10C>T::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]	2585675 [benign DISEASE=Progressive essential tremor-speech impairment-facial dysmorphism-intellectual disability-abnormal behavior syndrome GENE=SLC6A17];			rs2761445	0.39708	0.19340,0.40745,0.30202,0.50579,0.40408	13479,	33374	91606	-0.7130	2.23			0.8>0.8/0.8>0.8/0.0>0.0	COSV58993252	SLC6A17|0.01|0.01|0.00|0.00|-1|10|-1|44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198459	110198459	C	G	het	wt	het		QUAL=24;DP=72,118,118;AF=0.49,0.00,0.34	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*15C>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2761446	0.03463	0.00782,0.02084,0.00058,0.05301,0.03085	145,	4984	147022	1.2140	3.10			/3.7>3.1/0.0>0.0	COSV58992447	SLC6A17|0.00|0.00|0.00|0.00|43|-19|-1|-19		99	2569	0	0 / 0					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198727	110198727	G	T	het	het	hom		QUAL=24;DP=190,259,270;AF=0.49,0.58,1.00	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*283G>T::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2603580	0.63789	0.78610,0.54244,0.34455,0.61920,0.43908	31900,	33278	55108	-0.3460	0.38			/1.8>3.2/0.0>0.9				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110198961	110198961	C	G	het	het	hom		QUAL=24;DP=67,101,112;AF=0.39,0.55,1.00	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*517C>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2784141	0.63814	0.78638,0.54331,0.34536,0.61919,0.43942	31908,	33258	55046	-1.1710	0.35			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110199463	110199463	T	C	het	het	hom		QUAL=24;DP=118,340,340;AF=0.45,0.50,1.00	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1019T>C::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2603579	0.63953	0.78800,0.54614,0.34760,0.62059,0.43882	32057,	33200	54852	0.6570	4.71			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110199880	110199880	A	G	het	wt	het	low_conf_region	QUAL=24;DP=63,59,70;AF=0.40,0.00,0.24	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1436A>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]			(GATG)n (Simple_repeat)	rs2361044	0.40305	0.13885,0.42620,0.34208,0.50996,0.42107	9508,	26807	67869	-0.1920	4.81			/0.0>0.0/1.6>0.0	COSV58997534			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110199993	110199993	A	G	het	het	het		QUAL=24;DP=53,61,57;AF=0.40,0.44,0.39	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1549A>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]			GA-rich (Low_complexity)	rs12133992	0.35553	0.09945,0.37360,0.28398,0.49182,0.36629	11526,	28244	92986	0.3660	3.25			/0.0>0.0/2.3>2.9				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110200370	110200370	T	G	het	het	het		QUAL=24;DP=77,169,141;AF=0.58,0.45,0.54	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1926T>G::		610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs2784142	0.38537	0.17027,0.40290,0.30250,0.49660,0.38784	12841,	32630	93002	0.3880	8.97			/2.7>4.2/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110200966	110200966	G	C	het	het	wt		QUAL=24;DP=81,375,165;AF=0.52,0.53,0.00	SLC6A17	3'UTR	SLC6A17:ENST00000331565.5:3_prime_UTR_variant:MODIFIER:exon12/12:c.*2522G>C::	regulatory_region_variant:enhancer	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs151008748	0.02007	0.00453,0.02374,0.00000,0.02409,0.00416	61,	2931	149085	-0.6850	6.30			/0.0>0.4/0.3>1.4		SLC6A17|0.00|0.00|0.00|0.00|-40|50|6|-25		1	13	0	0 / 0					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	110202393	110202393	T	G	het	het	hom		QUAL=24;DP=151,41,31;AF=0.44,0.54,1.00	SLC6A17	downstream_gene	SLC6A17:ENST00000331565.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site	610299_[GENE=SLC6A17_PHENOS=Intellectual developmental disorder, autosomal recessive 48, 616269 (3), Autosomal recessive]				rs545849	0.85252	0.93391,0.86023,0.84280,0.81169,0.89498	55545,	18563	22429	0.2120	3.55							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SLC6A17 (inh=AR oe_syn=0.91 oe_mis=0.69 oe_lof=0.21)
chr1	114714048	114714048	G	A	het	hom	wt		QUAL=24;DP=70,52,16;AF=0.53,1.00,0.00	NRAS,CSDE1	intron,downstream_gene	NRAS:ENST00000369535.5:intron_variant:MODIFIER:intron2/6:c.112-70C>T::,CSDE1:ENST00000339438.10:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000689989.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000689217.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000438362.7:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000688211.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000358528.9:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000692719.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000610726.5:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000689732.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000693467.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000686235.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000684913.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000686025.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000686781.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000687759.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000692672.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000529046.6:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000686667.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000689885.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000691032.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000692044.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000690207.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000261443.9:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000530886.5:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000369530.5:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000534699.5:downstream_gene_variant:MODIFIER::::		164790_[GENE=NRAS_PHENOS=Noonan syndrome 6, 613224 (3), Autosomal dominant; ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3); Melanocytic nevus syndrome, congenital, somatic, 137550 (3); Epidermal nevus, somatic, 162900 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Neurocutaneous melanosis, somatic, 249400 (3); Colorectal cancer, somatic, 114500 (3)]	1231751 [benign DISEASE=not specified,not provided GENE=NRAS];			rs969273	0.76335	0.93459,0.82284,0.99827,0.64058,0.83368	45883,	24341	35995	0.3140	2.45			/0.0>0.0/0.0>0.0	COSV99794035	NRAS|0.00|0.00|0.00|0.00|-28|5|2|35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NRAS (inh=AD oe_syn=1.00 oe_mis=0.53 oe_lof=0.19), CSDE1 (inh=n/a oe_syn=0.96 oe_mis=0.55 oe_lof=0.05)
chr1	114716780	114716780	C	T	het	het	wt		QUAL=24;DP=184,129,16;AF=0.60,0.38,0.00	NRAS,CSDE1	upstream_gene,downstream_gene	NRAS:ENST00000369535.5:upstream_gene_variant:MODIFIER::::,CSDE1:ENST00000339438.10:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000689989.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000689217.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000438362.7:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000688211.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000358528.9:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000692719.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000610726.5:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000689732.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000693467.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000686235.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000684913.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000686025.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000686781.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000687759.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000692672.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000529046.6:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000686667.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000689885.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000691032.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000692044.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000690207.1:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000261443.9:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000530886.5:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000369530.5:downstream_gene_variant:MODIFIER::::,CSDE1:ENST00000534699.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter,TF_binding_site_variant	164790_[GENE=NRAS_PHENOS=Noonan syndrome 6, 613224 (3), Autosomal dominant; ?RAS-associated autoimmune lymphoproliferative syndrome type IV, somatic, 614470 (3); Melanocytic nevus syndrome, congenital, somatic, 137550 (3); Epidermal nevus, somatic, 162900 (3); Schimmelpenning-Feuerstein-Mims syndrome, somatic mosaic, 163200 (3); Thyroid carcinoma, follicular, somatic, 188470 (3); Neurocutaneous melanosis, somatic, 249400 (3); Colorectal cancer, somatic, 114500 (3)]										2.4560	22.10					NRAS|0.00|0.00|0.00|0.00|24|-4|25|1		0	2	0	0 / 0					NRAS (inh=AD oe_syn=1.00 oe_mis=0.53 oe_lof=0.19), CSDE1 (inh=n/a oe_syn=0.96 oe_mis=0.55 oe_lof=0.05)
chr1	115029744	115029744	A	G	het	het	hom		QUAL=24;DP=163,179,123;AF=0.48,0.48,1.00	TSHB	upstream_gene	TSHB:ENST00000256592.3:upstream_gene_variant:MODIFIER::::		188540_[GENE=TSHB_PHENOS=Hypothyroidism, congenital, nongoitrous 4, 275100 (3), Autosomal recessive]				rs1321108	0.42222	0.29002,0.40478,0.49709,0.49976,0.38626	14275,	35505	87655	1.2730	15.57						24366283,23344678,25506236,26180634,27362444	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSHB (inh=AR oe_syn=1.13 oe_mis=0.90 oe_lof=0.87)
chr1	115033402	115033402	A	G	hom	hom	hom		QUAL=24;DP=261,148,135;AF=1.00,1.00,1.00	TSHB	missense	TSHB:ENST00000256592.3:missense_variant:MODERATE:exon2/3:c.40A>G:p.Thr14Ala:		188540_[GENE=TSHB_PHENOS=Hypothyroidism, congenital, nongoitrous 4, 275100 (3), Autosomal recessive]	256640 [benign DISEASE=Congenital hypothyroidism,not provided,Isolated thyroid-stimulating hormone deficiency,not specified GENE=TSHB];			rs10776792	0.97661	0.99403,0.98651,1.00000,0.96626,0.96542	72590,	3449	3559	0.2070	2.69	0.052	0.05	/2.8>2.9/0.0>0.0			25741868,28515030,31242667	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSHB (inh=AR oe_syn=1.13 oe_mis=0.90 oe_lof=0.87)
chr1	115033790	115033790	T	A	het	het	wt		QUAL=24;DP=47,11,7;AF=0.57,0.36,0.00	TSHB	intron	TSHB:ENST00000256592.3:intron_variant:MODIFIER:intron2/2:c.163-183T>A::		188540_[GENE=TSHB_PHENOS=Hypothyroidism, congenital, nongoitrous 4, 275100 (3), Autosomal recessive]				rs17477369	0.04830	0.01864,0.05272,0.01294,0.06598,0.04996	203,	6943	144799	-0.0780	1.42			/10.8>9.9/0.0>0.0		TSHB|0.00|0.00|0.00|0.00|-9|20|35|-2		103	1066	0	0 / 0					TSHB (inh=AR oe_syn=1.13 oe_mis=0.90 oe_lof=0.87)
chr1	115033861	115033861	C	G	het	het	hom		QUAL=24;DP=96,30,25;AF=0.28,0.53,1.00	TSHB	intron	TSHB:ENST00000256592.3:intron_variant:MODIFIER:intron2/2:c.163-112C>G::		188540_[GENE=TSHB_PHENOS=Hypothyroidism, congenital, nongoitrous 4, 275100 (3), Autosomal recessive]	1268415 [benign DISEASE=not provided GENE=TSHB];			rs28566771	0.46459	0.43640,0.41961,0.49806,0.50043,0.38725	16622,	37306	81306	-0.5090	2.35			/2.1>2.4/0.0>0.0	COSV56655935	TSHB|0.00|0.00|0.00|0.00|4|5|28|-32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TSHB (inh=AR oe_syn=1.13 oe_mis=0.90 oe_lof=0.87)
chr1	115286692	115286692	G	A	hom	hom	het		QUAL=24;DP=155,391,277;AF=0.99,0.99,0.51	NGF-AS1,NGF	intron&non_coding_transcript,missense,5'UTR	NGF-AS1:ENST00000425449.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.207+3452G>A::,NGF:ENST00000676038.2:missense_variant:MODERATE:exon4/4:c.104C>T:p.Ala35Val:,NGF:ENST00000369512.3:missense_variant:MODERATE:exon3/3:c.104C>T:p.Ala35Val:,NGF:ENST00000680116.1:missense_variant:MODERATE:exon4/4:c.104C>T:p.Ala35Val:,NGF:ENST00000681124.1:5_prime_UTR_variant:MODIFIER:exon3/3:c.-368C>T::,NGF:ENST00000675637.2:missense_variant:MODERATE:exon2/2:c.104C>T:p.Ala35Val:,NGF:ENST00000679806.1:missense_variant:MODERATE:exon3/3:c.104C>T:p.Ala35Val:,NGF:ENST00000680540.1:missense_variant:MODERATE:exon1/1:c.104C>T:p.Ala35Val:,NGF:ENST00000680752.1:missense_variant:MODERATE:exon3/3:c.104C>T:p.Ala35Val:		162030_[GENE=NGF_PHENOS=Neuropathy, hereditary sensory and autonomic, type V, 608654 (3), Autosomal recessive]	291993 [benign DISEASE=Congenital sensory neuropathy with selective loss of small myelinated fibers,not specified,not provided GENE=NGF];			rs6330	0.35557	0.19171,0.35811,0.16175,0.45534,0.22056	10911,	32269	98035	1.7880	21.80	0.097	0.07	/0.0>0.0/0.0>0.0,/1.2>1.0/0.0>0.0	COSV65687373	NGF|0.00|0.00|0.00|0.00|18|-46|2|-46	21294249,21358750,19063739,17192954,17212826,18520591,18763222,22330829,23195334,23772677,23964269,25162994,26989097,27486327,28413930,29499660,30214536,30981636,35040003,35088019,35893041,28507530,30283335,26579581,31996124,33170162,26215504,32599917,26675984,37222241,22832952,23388219,23565345,27196537,29453651,32894097,35746645,28751869,30983028,31577263,36224396,22301435,19038326,18179783	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NGF-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NGF (inh=AR oe_syn=1.17 oe_mis=0.80 oe_lof=0.00)
chr1	115338434	115338434	G	A	hom	hom	het		QUAL=25;DP=24,51,38;AF=0.96,1.00,0.50	NGF-AS1,NGF	intron&non_coding_transcript,intron,5'UTR,upstream_gene	NGF-AS1:ENST00000425449.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/1:n.208-27236G>A::,NGF:ENST00000679806.1:intron_variant:MODIFIER:intron1/2:c.-137+174C>T::,NGF:ENST00000680752.1:5_prime_UTR_variant:MODIFIER:exon1/3:c.-206C>T::,NGF:ENST00000676038.2:upstream_gene_variant:MODIFIER::::,NGF:ENST00000369512.3:upstream_gene_variant:MODIFIER::::,NGF:ENST00000680116.1:upstream_gene_variant:MODIFIER::::,NGF:ENST00000681124.1:upstream_gene_variant:MODIFIER::::,NGF:ENST00000675637.2:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	162030_[GENE=NGF_PHENOS=Neuropathy, hereditary sensory and autonomic, type V, 608654 (3), Autosomal recessive]	667672 [benign DISEASE=not provided GENE=NGF];			rs11102930	0.54488	0.35528,0.52127,0.42737,0.64872,0.51269	23903,	34995	69161	0.2770	7.46			/0.0>0.0/0.0>0.0,/2.3>3.3/0.0>0.0			19063739,27486327,21178826,22468730,30418350,31996124,35280258,33066277,35746645,19038326	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NGF-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), NGF (inh=AR oe_syn=1.17 oe_mis=0.80 oe_lof=0.00)
chr1	119421632	119421632	T	C	het	het	wt		QUAL=24;DP=38,35,24;AF=0.53,0.49,0.00	HSD3B2	intron	HSD3B2:ENST00000543831.5:intron_variant:MODIFIER:intron3/3:c.308-177T>C::,HSD3B2:ENST00000369416.4:intron_variant:MODIFIER:intron3/3:c.308-177T>C::		613890_[GENE=HSD3B2_PHENOS=Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3), Autosomal recessive]	1243214 [benign DISEASE=not provided GENE=HSD3B2];			rs58154933	0.24625	0.52258,0.21061,0.25176,0.11245,0.25504	6969,	23251	113833	-1.0750	0.31			/4.2>3.5/0.0>0.0		HSD3B2|0.00|0.00|0.00|0.00|-30|36|1|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD3B2 (inh=AR oe_syn=1.33 oe_mis=0.87 oe_lof=0.99)
chr1	119422896	119422896	C	T	het	het	wt		QUAL=24;DP=226,324,17;AF=0.57,0.40,0.00	HSD3B2	3'UTR	HSD3B2:ENST00000543831.5:3_prime_UTR_variant:MODIFIER:exon4/4:c.*276C>T::,HSD3B2:ENST00000369416.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*276C>T::		613890_[GENE=HSD3B2_PHENOS=Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3), Autosomal recessive]	292274 [benign DISEASE=3 beta-Hydroxysteroid dehydrogenase deficiency,not provided GENE=HSD3B2];			rs1819698	0.24323	0.50973,0.20986,0.25357,0.11233,0.25633	6746,	23507	115117	0.6820	3.25			/3.6>3.5/0.0>0.0		HSD3B2|0.00|0.00|0.00|0.00|30|-33|-7|10	21708280,28652652,19197249,20660004,22638611,34536543,25114582,23284679,19168589,25600087,23375657,27814623,23593537,19230916	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD3B2 (inh=AR oe_syn=1.33 oe_mis=0.87 oe_lof=0.99)
chr1	119422941	119422941	C	G	het	het	wt		QUAL=24;DP=209,325,17;AF=0.55,0.41,0.00	HSD3B2	3'UTR	HSD3B2:ENST00000543831.5:3_prime_UTR_variant:MODIFIER:exon4/4:c.*321C>G::,HSD3B2:ENST00000369416.4:3_prime_UTR_variant:MODIFIER:exon4/4:c.*321C>G::		613890_[GENE=HSD3B2_PHENOS=Adrenal hyperplasia, congenital, due to 3-beta-hydroxysteroid dehydrogenase 2 deficiency, 201810 (3), Autosomal recessive]	292275 [benign DISEASE=3 beta-Hydroxysteroid dehydrogenase deficiency,not provided GENE=HSD3B2];			rs1361530	0.19208	0.34125,0.18883,0.25193,0.10719,0.25404	3645,	21961	123037	-0.6320	0.94			/0.0>0.0/0.0>0.0		HSD3B2|0.00|0.00|0.00|0.00|-15|14|0|-35	21708280,28652652,23284679,19168589	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					HSD3B2 (inh=AR oe_syn=1.33 oe_mis=0.87 oe_lof=0.99)
chr1	147756741	147756741	C	T	het	wt	het		QUAL=24;DP=131,16,195;AF=0.50,0.00,0.55	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1421G>A::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1421G>A::	regulatory_region_variant:promoter	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs11240121	0.31443	0.47760,0.36941,0.47157,0.20828,0.39062	8628,	30507	104143	-0.2490	0.89			/0.0>0.0/0.0>0.0			36653681	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147757430	147757430	G	A	het	wt	het		QUAL=24;DP=133,111,289;AF=0.41,0.00,0.49	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*732C>T::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*732C>T::	regulatory_region_variant:enhancer	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs1043802	0.25823	0.36398,0.30615,0.25495,0.19310,0.35889	5582,	28097	112781	0.3330	2.87			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147757496	147757520	GGGCATTTGCCAGAGGTACATACCA	-	het	het	het	low_conf_region	QUAL=25;DP=142,344,353;AF=0.42,0.39,0.48	GJA5	3'UTR	GJA5:ENST00000579774.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*642_*666del::,GJA5:ENST00000621517.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*642_*666del::	regulatory_region_variant:enhancer	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]				rs11267274	0.48798	0.58493,0.52868,0.59937,0.43186,0.45084	18246,	37260	77384	0.2250	5.40			/0.0>0.0/8.1>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147760380	147760380	A	G	het	wt	het		QUAL=24;DP=146,53,79;AF=0.50,0.00,0.38	GJA5	intron	GJA5:ENST00000579774.3:intron_variant:MODIFIER:intron1/1:c.-34+119T>C::,GJA5:ENST00000621517.1:intron_variant:MODIFIER:intron1/1:c.-33-1109T>C::	regulatory_region_variant:enhancer	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]			L2c (LINE/L2)	rs12136839	0.03340	0.01108,0.02308,0.00019,0.05659,0.00734	127,	4799	146225	-1.2540	0.12			/0.0>0.0/5.5>0.0			25893100	1	3	0	0 / 0					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	147760632	147760632	T	C	het	het	het		QUAL=24;DP=197,238,169;AF=0.49,0.59,0.56	GJA5	intron,upstream_gene	GJA5:ENST00000621517.1:intron_variant:MODIFIER:intron1/1:c.-33-1361A>G::,GJA5:ENST00000579774.3:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	121013_[GENE=GJA5_PHENOS=Atrial fibrillation, familial, 11, 614049 (3), Autosomal dominant; Atrial standstill, digenic (GJA5/SCN5A), 108770 (3), Autosomal dominant]		CR112614 [CLASS=DFP MUT=ALT PHEN="Atrial fibrillation association with" GENE=GJA5];	L2c (LINE/L2)	rs10465885	0.45703	0.38725,0.53640,0.54988,0.47745,0.46202	15920,	37637	82541	-0.3630	1.20			/2.8>2.7/0.0>0.0			33350184,21076161,23134779,23040431,27826129,31270966,22690879,36915790,24065925,28775688,29504899,25893100,37382580,28496873,25200600,26516624,29915175,35453689,30061737	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJA5 (inh=AD oe_syn=0.95 oe_mis=0.79 oe_lof=0.39)
chr1	150799227	150799227	T	C	hom	hom	hom		QUAL=24;DP=242,363,341;AF=1.00,1.00,1.00	CTSK,UBE2D3P3	synonymous,intron,upstream_gene	CTSK:ENST00000678337.1:synonymous_variant:LOW:exon6/7:c.867A>G:p.Ala289=:PF00112 [Papain family cysteine protease],CTSK:ENST00000676716.1:synonymous_variant:LOW:exon5/6:c.708A>G:p.Ala236=:PF00112 [Papain family cysteine protease],CTSK:ENST00000676966.1:synonymous_variant:LOW:exon7/8:c.831A>G:p.Ala277=:PF00112 [Papain family cysteine protease],CTSK:ENST00000443913.2:synonymous_variant:LOW:exon7/8:c.1008A>G:p.Ala336=:PF00112 [Papain family cysteine protease],CTSK:ENST00000271651.8:synonymous_variant:LOW:exon7/8:c.831A>G:p.Ala277=:PF00112 [Papain family cysteine protease],CTSK:ENST00000676751.1:intron_variant:MODIFIER:intron6/6:c.784+317A>G::,CTSK:ENST00000676970.1:synonymous_variant:LOW:exon7/8:c.843A>G:p.Ala281=:PF00112 [Papain family cysteine protease],CTSK:ENST00000677887.1:synonymous_variant:LOW:exon8/9:c.873A>G:p.Ala291=:PF00112 [Papain family cysteine protease],CTSK:ENST00000679260.1:synonymous_variant:LOW:exon6/7:c.612A>G:p.Ala204=:PF00112 [Papain family cysteine protease],CTSK:ENST00000676824.1:synonymous_variant:LOW:exon8/9:c.831A>G:p.Ala277=:PF00112 [Papain family cysteine protease],UBE2D3P3:ENST00000426992.2:upstream_gene_variant:MODIFIER::::		601105_[GENE=CTSK_PHENOS=Pycnodysostosis, 265800 (3), Autosomal recessive]	1166561 [benign DISEASE=Pyknodysostosis,not provided GENE=CTSK];			rs10788796	0.97606	0.92438,0.98647,0.99112,0.99888,0.97697	72612,	3418	3646	-7.3880	0.12			/1.0>2.4/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTSK (inh=AR oe_syn=0.89 oe_mis=0.79 oe_lof=0.55), UBE2D3P3 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	150808106	150808106	T	C	het	wt	het		QUAL=24;DP=102,16,33;AF=0.46,0.00,0.61	CTSK,ARNT,RNU6-1309P	intron,upstream_gene,downstream_gene	CTSK:ENST00000271651.8:intron_variant:MODIFIER:intron1/7:c.-2+108A>G::,CTSK:ENST00000676751.1:intron_variant:MODIFIER:intron1/6:c.-2+108A>G::,CTSK:ENST00000676970.1:intron_variant:MODIFIER:intron1/7:c.-2+108A>G::,CTSK:ENST00000677887.1:intron_variant:MODIFIER:intron1/8:c.-53+108A>G::,CTSK:ENST00000679260.1:intron_variant:MODIFIER:intron1/6:c.-2+108A>G::,CTSK:ENST00000676824.1:intron_variant:MODIFIER:intron2/8:c.-2+108A>G::,CTSK:ENST00000678337.1:upstream_gene_variant:MODIFIER::::,CTSK:ENST00000676716.1:upstream_gene_variant:MODIFIER::::,CTSK:ENST00000676966.1:upstream_gene_variant:MODIFIER::::,CTSK:ENST00000443913.2:upstream_gene_variant:MODIFIER::::,ARNT:ENST00000358595.10:downstream_gene_variant:MODIFIER::::,ARNT:ENST00000354396.6:downstream_gene_variant:MODIFIER::::,ARNT:ENST00000515192.5:downstream_gene_variant:MODIFIER::::,ARNT:ENST00000505755.5:downstream_gene_variant:MODIFIER::::,RNU6-1309P:ENST00000363305.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	601105_[GENE=CTSK_PHENOS=Pycnodysostosis, 265800 (3), Autosomal recessive]				rs4379678	0.07394	0.01404,0.06653,0.18364,0.09375,0.10298	585,	10092	141048	-0.7520	5.69			/3.0>3.4/0.0>5.1			18366646,32117071,22844403,20628624,22674224	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CTSK (inh=AR oe_syn=0.89 oe_mis=0.79 oe_lof=0.55), ARNT (inh=n/a oe_syn=0.95 oe_mis=0.70 oe_lof=0.15), RNU6-1309P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	151341298	151341298	A	G	het	wt	hom		QUAL=24;DP=128,16,90;AF=0.47,0.00,1.00	RFX5	3'UTR,downstream_gene	RFX5:ENST00000290524.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:ENST00000452671.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*888T>C::,RFX5:ENST00000368870.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer,TF_binding_site_variant	601863_[GENE=RFX5_PHENOS=?MHC class II deficiency 5, 620818 (3), Autosomal recessive; MHC class II deficiency 3, 620816 (3), Autosomal recessive]	292600 [benign DISEASE=MHC class II deficiency,not provided GENE=RFX5];			rs7552906	0.62907	0.62269,0.60598,0.64277,0.65139,0.62281	30209,	35198	56380	0.2160	3.05			/0.0>0.0/0.0>0.0			31922974	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR oe_syn=0.75 oe_mis=0.93 oe_lof=0.76)
chr1	151341903	151341903	T	C	het	het	hom		QUAL=24;DP=85,144,114;AF=0.56,0.49,1.00	RFX5	3'UTR	RFX5:ENST00000290524.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:ENST00000452671.7:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::,RFX5:ENST00000368870.6:3_prime_UTR_variant:MODIFIER:exon11/11:c.*283A>G::	regulatory_region_variant:enhancer	601863_[GENE=RFX5_PHENOS=?MHC class II deficiency 5, 620818 (3), Autosomal recessive; MHC class II deficiency 3, 620816 (3), Autosomal recessive]	292605 [benign DISEASE=not provided,MHC class II deficiency GENE=RFX5];		MLT1K (LTR/ERVL-MaLR)	rs1752387	0.78373	0.83941,0.77366,0.69735,0.77754,0.72238	46969,	25220	32882	-1.7860	0.95			/1.9>1.5/0.0>0.0	COSV51841510		31922974,29559957	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR oe_syn=0.75 oe_mis=0.93 oe_lof=0.76)
chr1	151342811	151342811	G	C	het	wt	het		QUAL=24;DP=62,107,138;AF=0.53,0.00,0.51	RFX5,RFX5-AS1	missense,upstream_gene	RFX5:ENST00000290524.8:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:PF14621 [RFX5 DNA-binding domain],RFX5:ENST00000452671.7:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:PF14621 [RFX5 DNA-binding domain],RFX5:ENST00000368870.6:missense_variant:MODERATE:exon11/11:c.1226C>G:p.Pro409Arg:PF14621 [RFX5 DNA-binding domain],RFX5-AS1:ENST00000455503.2:upstream_gene_variant:MODIFIER::::		601863_[GENE=RFX5_PHENOS=?MHC class II deficiency 5, 620818 (3), Autosomal recessive; MHC class II deficiency 3, 620816 (3), Autosomal recessive]	292612 [benign DISEASE=not provided,not specified,MHC class II deficiency GENE=RFX5];			rs2233854	0.11321	0.03031,0.11252,0.00135,0.17069,0.08737	1331,	14568	134970	1.7820	18.04	0.027	0.08	/0.0>0.0/0.0>0.0	COSV51839208	RFX5|0.00|0.00|0.01|0.00|1|-45|-22|30	24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR oe_syn=0.75 oe_mis=0.93 oe_lof=0.76), RFX5-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	151343685	151343685	G	A	hom	hom	hom		QUAL=24;DP=85,132,94;AF=1.00,1.00,1.00	RFX5,RFX5-AS1	synonymous,upstream_gene	RFX5:ENST00000290524.8:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:ENST00000452671.7:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5:ENST00000368870.6:synonymous_variant:LOW:exon9/11:c.753C>T:p.Leu251=:,RFX5-AS1:ENST00000455503.2:upstream_gene_variant:MODIFIER::::		601863_[GENE=RFX5_PHENOS=?MHC class II deficiency 5, 620818 (3), Autosomal recessive; MHC class II deficiency 3, 620816 (3), Autosomal recessive]	403373 [benign DISEASE=not specified,not provided,MHC class II deficiency GENE=RFX5];			rs1752386	0.97876	0.92530,0.99392,1.00000,0.99982,0.99959	73019,	2968	3234	0.0830	3.10			/0.0>0.0/0.0>0.0			24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RFX5 (inh=AR oe_syn=0.75 oe_mis=0.93 oe_lof=0.76), RFX5-AS1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	152302209	152302209	T	A	hom	hom	hom		QUAL=25;DP=40,107,63;AF=1.00,1.00,1.00	CCDST,FLG	intron&non_coding_transcript,3'UTR	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-30374T>A::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-30374T>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+376T>A::,FLG:ENST00000368799.2:3_prime_UTR_variant:MODIFIER:exon3/3:c.*491A>T::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]				rs1933061	0.99801	0.99938,0.99902,1.00000,0.99628,0.99938	75868,	304	304	-2.4350	0.05			/1.5>0.8/0.0>0.0,/0.2>1.7/5.3>4.4				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152303673	152303673	C	T	het	het	het		QUAL=24;DP=91,251,222;AF=0.55,0.53,0.51	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-28910C>T::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28910C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+1840C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.11213G>A:p.Arg3738His:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	2585644 [benign DISEASE=Ichthyosis vulgaris GENE=FLG];			rs77422831	0.15694	0.03418,0.32711,0.56719,0.13547,0.37563	3122,	17600	128090	-2.0090	0.43	0.024	0.08	/0.0>0.0/0.0>0.4,/0.1>0.0/0.0>0.0	COSV64245538	FLG|0.00|0.00|0.00|0.00|-11|23|7|-47	27678121	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152303983	152303983	C	T	wt	het	het		QUAL=24;DP=67,393,285;AF=0.00,0.41,0.19	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-28600C>T::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28600C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2150C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10903G>A:p.Asp3635Asn:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1246453 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs75448155	0.03551	0.00502,0.08690,0.15410,0.03212,0.11809	0,	4625	125629	1.6980	18.17	0.103	0.16	/0.0>0.0/0.0>0.0	COSV64238118	FLG|0.00|0.00|0.00|0.00|9|-1|-47|42	34484176	0	5461	0	0 / 0					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304296	152304296	C	A	het	hom	wt	low_conf_region	QUAL=24;DP=90,113,202;AF=0.47,0.85,0.43	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-28287C>A::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28287C>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2463C>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10590G>T:p.Arg3530Ser:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1237029 [benign DISEASE=not provided GENE=FLG];			rs72697000	0.14573	0.03299,0.30080,0.50638,0.13061,0.34780	2023,	17792	128010	-1.4330	3.23	0.060	0.23	/0.6>0.0/0.0>0.0,/0.0>0.0/0.0>0.0	COSV64247197	FLG|0.00|0.00|0.00|0.00|2|0|2|-8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304395	152304395	A	G	het	hom	het	low_conf_region	QUAL=24;DP=116,98,178;AF=0.41,0.99,0.42	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-28188A>G::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28188A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2562A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10491T>C:p.Asp3497=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1231010 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs3126066	0.28626	0.47278,0.37784,0.60631,0.13913,0.40590	8377,	26270	107274	-1.9970	0.22			/0.0>0.0/0.0>0.0	COSV64245547,COSV64251897	FLG|0.00|0.00|0.00|0.00|49|-35|-8|23	29774148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304413	152304413	A	G	het	hom	het	low_conf_region	QUAL=24;DP=116,98,182;AF=0.38,0.99,0.42	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-28170A>G::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28170A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2580A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10473T>C:p.Asn3491=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1272130 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs3126067	0.35410	0.69987,0.40806,0.61166,0.14145,0.40791	14195,	24675	96793	-2.0410	0.08			/0.0>0.0/0.0>0.0,/0.0>0.0/0.0>0.2	COSV64247205	FLG|0.00|0.00|0.00|0.00|31|-14|-26|5	32315356,29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304579	152304579	C	G	het	hom	het	low_conf_region	QUAL=24;DP=91,86,138;AF=0.37,0.87,0.44	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-28004C>G::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-28004C>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2746C>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.10307G>C:p.Gly3436Ala:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	2585645 [benign DISEASE=Ichthyosis vulgaris GENE=FLG];			rs2065955	0.34639	0.69262,0.40143,0.59797,0.13859,0.38894	13411,	24756	97322	-0.7110	6.73	0.026	0.10	/0.0>0.0/0.0>4.1,/0.0>0.0/0.0>0.0	COSV64245550	FLG|0.00|0.00|0.00|0.00|30|13|19|-27	29281699,29774148,36358356,27535066	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304692	152304692	A	G	het	hom	het		QUAL=24;DP=99,150,181;AF=0.45,1.00,0.40	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-27891A>G::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27891A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+2859A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10194T>C:p.Ser3398=:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	2585646 [benign DISEASE=Ichthyosis vulgaris GENE=FLG];			rs3091276	0.30289	0.51000,0.38968,0.61593,0.14490,0.41996	9204,	26261	102809	-1.2340	0.14			/4.7>0.0/0.0>0.0,/1.7>1.2/0.0>0.0	COSV64246356	FLG|0.00|0.00|0.00|0.00|26|-18|26|27	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304869	152304869	C	T	het	het	het	low_conf_region	QUAL=24;DP=110,337,235;AF=0.44,0.48,0.47	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-27714C>T::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27714C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3036C>T::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.10017G>A:p.Gln3339=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	2585647 [benign DISEASE=Ichthyosis vulgaris GENE=FLG];			rs2065956	0.15646	0.03393,0.32710,0.56597,0.13544,0.37726	3149,	17453	128055	-0.3080	0.37			/0.0>0.0/0.0>0.0,/0.0>0.0/1.2>0.0	COSV64237848	FLG|0.00|0.00|0.00|0.00|-12|3|-10|0	21163515,29281699,19733298,29774148,24831437,36366871	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152304920	152304920	T	C	het	hom	het	low_conf_region	QUAL=25;DP=113,319,207;AF=0.52,0.99,0.49	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-27663T>C::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27663T>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3087T>C::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.9966A>G:p.Gln3322=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1302748 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs6681433	0.20077	0.12832,0.35841,0.59037,0.15936,0.43916	4070,	22287	121125	-1.1510	0.14			/0.0>0.0/0.0>0.0,/2.2>3.5/0.0>0.0	COSV64251428	FLG|0.00|0.00|0.00|0.00|-1|44|-22|-43	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152305241	152305241	C	A	het	hom	het	low_conf_region	QUAL=24;DP=86,314,259;AF=0.43,1.00,0.39	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-27342C>A::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27342C>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3408C>A::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.9645G>T:p.Val3215=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1246798 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs9436066	0.29957	0.47189,0.38815,0.65057,0.15963,0.43844	8549,	27766	104898	-4.7800	0.10			/0.0>0.0/0.0>0.0,/0.0>0.0/3.7>0.0	COSV64238716	FLG|0.00|0.00|0.00|0.00|-32|-45|19|3	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152305350	152305350	A	C	het	hom	wt	low_conf_region	QUAL=25;DP=115,109,41;AF=0.20,0.98,0.00	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-27233A>C::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-27233A>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+3517A>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.9536T>G:p.Val3179Gly:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1175078 [benign DISEASE=not provided,Ichthyosis vulgaris,not specified GENE=FLG];			rs2065957	0.26533	0.44843,0.34285,0.57461,0.13511,0.36441	6670,	23058	100784	-1.7610	0.11	0.034	0.04	/0.0>0.0/0.1>1.1,/1.1>0.0/0.0>0.0	COSV64246955	FLG|0.00|0.00|0.00|0.00|-43|-18|9|2	29281699,34833463,36358356	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306079	152306079	T	C	het	het	het	low_mappability	QUAL=26;DP=96,156,192;AF=0.22,0.44,0.20	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-26504T>C::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26504T>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4246T>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.8807A>G:p.Asp2936Gly:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1242222 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs80221306	0.15847	0.10181,0.26948,0.41216,0.12909,0.31087	5,	21100	112098	-0.3070	7.58	0.020	0.13	/0.0>0.0/0.0>0.0	COSV64237772	FLG|0.00|0.00|0.00|0.00|-45|46|1|15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306213	152306213	C	A	het	hom	het		QUAL=24;DP=142,293,347;AF=0.58,1.00,0.59	CCDST,FLG	intron&non_coding_transcript,synonymous	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-26370C>A::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26370C>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4380C>A::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.8673G>T:p.Val2891=:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1222401 [benign DISEASE=Ichthyosis vulgaris,not provided GENE=FLG];			rs57672167	0.23103	0.23003,0.37490,0.60175,0.15928,0.43548	5993,	20435	107913	-4.9140	0.39			/0.0>0.0/0.0>0.0,/0.0>0.0/3.7>0.0	COSV64247949	FLG|0.00|0.00|0.00|0.00|-3|-45|19|3	34833463	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152306380	152306380	T	G	het	het	het		QUAL=25;DP=164,361,345;AF=0.24,0.21,0.19	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-26203T>G::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-26203T>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+4547T>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.8506A>C:p.Ser2836Arg:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1246169 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs11582087	0.11916	0.03450,0.23839,0.39830,0.10015,0.26264	0,	15924	117712	-0.6650	12.76	0.032	0.52	/2.2>2.4/0.0>0.0,/0.0>0.0/0.0>0.0	COSV64235994	FLG|0.00|0.00|0.00|0.00|8|39|-18|39	36358356	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307253	152307253	C	T	het	hom	het		QUAL=24;DP=116,234,227;AF=0.52,0.98,0.52	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-25330C>T::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25330C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5420C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7633G>A:p.Gly2545Arg:PF03516 [Filaggrin]		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1302747 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs3126072	0.30961	0.51556,0.39635,0.62336,0.16029,0.44268	9467,	27155	102773	-1.6190	0.14	0.024	0.07	/0.0>0.0/0.0>0.0,/3.9>0.0/0.0>0.0	COSV64248815	FLG|0.00|0.00|0.00|0.00|-2|4|41|-11	29281699,36358356	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307365	152307365	G	C	het	hom	het		QUAL=24;DP=98,221,225;AF=0.53,1.00,0.52	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-25218G>C::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25218G>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5532G>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7521C>G:p.His2507Gln:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1302746 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs3126074	0.30123	0.47561,0.39275,0.62079,0.16034,0.44277	8634,	28195	105463	-5.2830	0.01	0.015	0.09	/0.0>0.0/0.6>0.0,/5.6>5.7/0.0>0.0	COSV100910597	FLG|0.00|0.00|0.00|0.00|-1|-5|22|-5	29281699,36358356	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307444	152307444	A	G	het	hom	het		QUAL=24;DP=105,212,221;AF=0.49,1.00,0.53	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-25139A>G::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25139A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5611A>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7442T>C:p.Leu2481Ser:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1302745 [benign DISEASE=Ichthyosis vulgaris,not provided GENE=FLG];			rs55650366	0.20280	0.13404,0.35955,0.59563,0.15935,0.43624	4064,	22441	120169	-1.1930	0.02	0.014	0.05	/3.5>3.5/0.0>0.0,/0.0>0.0/0.6>3.2	COSV64245556	FLG|0.00|0.00|0.00|0.00|-1|-37|-1|24	29281699,36358356	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307556	152307556	T	C	het	hom	het		QUAL=24;DP=111,242,228;AF=0.50,1.00,0.48	CCDST,FLG	intron&non_coding_transcript,missense	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-25027T>C::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-25027T>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5723T>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7330A>G:p.Lys2444Glu:		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1222131 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs71625200	0.20277	0.13422,0.35926,0.59617,0.15931,0.43517	4077,	22515	120583	-1.0410	0.28	0.027	0.06	/0.0>0.0/0.0>0.0	COSV64248823	FLG|0.00|0.00|0.00|0.00|-42|-3|-42|-5	29281699,36358356,36284733	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307694	152307694	C	G	het	hom	het	low_mappability	QUAL=24;DP=78,219,197;AF=0.42,0.98,0.40	CCDST,FLG	intron&non_coding_transcript,missense,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-24889C>G::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24889C>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5861C>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7192G>C:p.Glu2398Gln:,CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1239802 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs71625201	0.17935	0.12425,0.30496,0.47965,0.14895,0.36659	1663,	23336	121994	-1.6180	0.76	0.016	0.15	/0.0>0.0/0.0>0.0	COSV64237400	FLG|0.00|0.00|0.00|0.00|-43|12|-16|50	29281699,36358356	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307789	152307789	C	G	het	hom	het	low_mappability	QUAL=24;DP=110,155,192;AF=0.32,0.81,0.34	CCDST,FLG	intron&non_coding_transcript,missense,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-24794C>G::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24794C>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+5956C>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7097G>C:p.Ser2366Thr:PF03516 [Filaggrin],CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1265666 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs71625202	0.14733	0.03623,0.28064,0.43641,0.14419,0.33243	411,	21152	127170	-0.1640	1.34	0.089	0.13	/0.0>0.0/0.0>0.0,/0.0>0.0/0.0>1.5	COSV64236000	FLG|0.00|0.00|0.00|0.00|-30|-1|4|35	36358356	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307871	152307871	C	T	het	het	het	low_conf_region	QUAL=24;DP=99,136,220;AF=0.42,0.74,0.31	CCDST,FLG	intron&non_coding_transcript,missense,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-24712C>T::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24712C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6038C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.7015G>A:p.Asp2339Asn:PF03516 [Filaggrin],CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	2585648 [benign DISEASE=Ichthyosis vulgaris GENE=FLG];			rs139476473	0.15160	0.03633,0.29575,0.46139,0.14572,0.35013	1053,	20529	126675	1.6960	16.75	0.141	0.17	/0.0>0.0/0.0>0.0	COSV64236201	FLG|0.00|0.00|0.00|0.00|9|-1|8|-18	29281699,36358356	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152307896	152307896	G	A	het	hom	het		QUAL=24;DP=98,147,215;AF=0.55,0.99,0.35	CCDST,FLG	intron&non_coding_transcript,synonymous,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-24687G>A::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24687G>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6063G>A::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6990C>T:p.His2330=:PF03516 [Filaggrin],CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1179883 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs6664985	0.30023	0.47916,0.38835,0.61675,0.15910,0.43640	8570,	27959	105117	-5.0360	1.70			/4.1>3.4/0.0>0.0,/2.0>2.1/0.0>0.0	COSV64242880	FLG|0.00|0.00|0.00|0.00|-16|47|27|-50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308306	152308306	A	G	het	hom	het		QUAL=24;DP=117,224,190;AF=0.66,1.00,0.61	CCDST,FLG	intron&non_coding_transcript,missense,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-24277A>G::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24277A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.462+6473A>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6580T>C:p.Tyr2194His:,CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1244740 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs2184953	0.36992	0.70163,0.42261,0.63238,0.16261,0.45163	14590,	26809	95367	-5.5540	0.10	0.007	0.09	/0.7>1.4/0.0>0.0,/0.0>0.0/0.0>0.0	COSV64235971	FLG|0.00|0.00|0.00|0.00|30|-19|-8|2	32315356,28487959,18434257,27206134,29281699,29774148,36358356,24831437	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308388	152308388	A	G	het	hom	het		QUAL=24;DP=60,231,157;AF=0.62,1.00,0.66	CCDST,FLG	intron&non_coding_transcript,synonymous,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-24195A>G::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24195A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6518A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6498T>C:p.Ser2166=:,CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1223320 [benign DISEASE=Ichthyosis vulgaris,not provided GENE=FLG];			rs2184954	0.30457	0.48076,0.39426,0.63077,0.16102,0.44939	8811,	28346	104960	-3.3990	1.04			/0.0>0.0/0.0>0.0,/2.9>2.3/0.0>0.0	COSV100910603	FLG|0.00|0.00|0.00|0.00|22|-25|27|-29		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308424	152308424	T	G	het	het	wt		QUAL=24;DP=78,201,167;AF=0.27,0.41,0.30	CCDST,FLG	intron&non_coding_transcript,missense,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-24159T>G::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24159T>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6482T>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6462A>C:p.Gln2154His:,CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1174419 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs74129452	0.22684	0.35336,0.29591,0.42170,0.12690,0.31727	0,	32896	112122	-4.1840	0.01	0.107	0.09	/0.5>0.0/0.9>0.4,/0.0>0.0/0.0>0.0	COSV64235975	FLG|0.00|0.00|0.00|0.00|-9|-32|-9|-8	36358356	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308531	152308531	A	G	het	het	het		QUAL=25;DP=113,197,193;AF=0.25,0.29,0.30	CCDST,FLG	intron&non_coding_transcript,missense,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-24052A>G::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24052A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6375A>G::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6355T>C:p.Tyr2119His:,CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1221916 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs7512553	0.22885	0.35890,0.29921,0.42210,0.12606,0.30896	0,	34144	115052	-0.1890	0.55	0.036	0.06	/0.0>0.0/0.0>0.0,/1.3>1.7/0.0>0.0	COSV64247222	FLG|0.00|0.00|0.00|0.00|36|-9|-45|2	36358356	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308532	152308532	A	G	het	het	het		QUAL=24;DP=114,200,195;AF=0.25,0.30,0.29	CCDST,FLG	intron&non_coding_transcript,synonymous,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-24051A>G::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24051A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6374A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.6354T>C:p.His2118=:,CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1179898 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs7512554	0.22866	0.35856,0.29861,0.42242,0.12585,0.30802	0,	34159	115229	-2.6100	0.29			/0.0>4.8/0.0>0.0,/1.3>1.3/0.0>0.0	COSV64247223	FLG|0.00|0.00|0.00|0.00|35|-10|-46|7		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308563	152308563	G	A	het	het	het		QUAL=25;DP=125,206,205;AF=0.23,0.32,0.32	CCDST,FLG	intron&non_coding_transcript,missense,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-24020G>A::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-24020G>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6343G>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6323C>T:p.Ala2108Val:,CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1179724 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs7522925	0.22829	0.35928,0.29829,0.42157,0.12533,0.30386	0,	34238	115740	-3.2620	0.23	0.065	0.09	/1.9>0.3/0.0>0.0,/0.0>0.5/0.0>0.0	COSV64245563	FLG|0.00|0.00|0.00|0.00|-41|43|44|-40	29774148,36358356	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152308828	152308828	A	C	het	het	het		QUAL=25;DP=80,217,247;AF=0.33,0.37,0.37	CCDST,FLG	intron&non_coding_transcript,missense,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-23755A>C::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23755A>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-6078A>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.6058T>G:p.Ser2020Ala:PF03516 [Filaggrin],CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1266162 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs7512857	0.21898	0.33332,0.29401,0.42002,0.12332,0.30174	2,	32590	116252	0.0140	4.83	0.029	0.11	/0.0>0.0/0.0>0.0	COSV64245569	FLG|0.00|0.00|0.00|0.00|27|-22|-3|23	36358356	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309003	152309003	G	T	het	hom	het		QUAL=24;DP=174,238,265;AF=0.59,1.00,0.66	CCDST,FLG	intron&non_coding_transcript,missense,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-23580G>T::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23580G>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5903G>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5883C>A:p.His1961Gln:,CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1278608 [benign DISEASE=Ichthyosis vulgaris,not provided GENE=FLG];			rs3126079	0.36873	0.70072,0.42150,0.63037,0.16215,0.44578	14590,	26824	95880	-7.0030	0.00	0.023	0.10	/2.5>3.1/0.0>0.0,/1.4>0.0/0.0>0.0	COSV64242281	FLG|0.00|0.00|0.00|0.00|35|-5|-49|-9	36358356	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309214	152309214	C	T	het	het	het		QUAL=24;DP=95,139,173;AF=0.47,0.47,0.51	CCDST,FLG	intron&non_coding_transcript,missense,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-23369C>T::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23369C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5692C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5672G>A:p.Arg1891Gln:PF03516 [Filaggrin],CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1247656 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs12407748	0.15646	0.03405,0.32740,0.56563,0.13556,0.37322	3095,	17507	127759	-2.7720	0.06	0.045	0.07	/0.0>0.0/0.0>0.0,/6.0>2.3/0.0>0.0	COSV64235683	FLG|0.00|0.00|0.00|0.00|-2|-10|-25|-27	29774148	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309472	152309472	G	A	het	het	het		QUAL=24;DP=77,222,156;AF=0.53,0.33,0.54	CCDST,FLG	intron&non_coding_transcript,missense,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-23111G>A::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-23111G>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5434G>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5414C>T:p.Ala1805Val:,CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1248526 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs12405241	0.15665	0.03415,0.32682,0.56704,0.13545,0.37363	3084,	17504	127446	-5.8650	0.36	0.098	0.14	/0.0>0.0/3.2>0.1,/0.0>0.0/0.0>0.0	COSV64247244	FLG|0.00|0.00|0.00|0.00|25|-11|2|-11	33282748	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309791	152309791	G	A	het	het	het		QUAL=24;DP=82,194,183;AF=0.49,0.49,0.56	CCDST,FLG	intron&non_coding_transcript,missense,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-22792G>A::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22792G>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5115G>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5095C>T:p.Arg1699Cys:PF03516 [Filaggrin],CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	2585649 [benign DISEASE=Ichthyosis vulgaris GENE=FLG];			rs12405278	0.15689	0.03406,0.32706,0.56957,0.13550,0.37542	3131,	17553	127979	-0.0710	18.55	0.054	0.22	/6.5>6.5/0.0>0.0,/0.6>0.2/0.0>0.0	COSV64245576	FLG|0.00|0.00|0.00|0.00|2|-22|2|9	22209813,36865480	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152309835	152309835	C	T	het	het	het		QUAL=24;DP=101,186,175;AF=0.48,0.52,0.57	CCDST,FLG	intron&non_coding_transcript,missense,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-22748C>T::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22748C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-5071C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.5051G>A:p.Arg1684His:PF03516 [Filaggrin],CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	2585650 [benign DISEASE=Ichthyosis vulgaris GENE=FLG];			rs12407807	0.16645	0.06692,0.32979,0.56979,0.13569,0.37463	3226,	18843	126673	-4.5020	0.96	0.071	0.10	/0.0>0.0/0.0>0.4,/1.8>2.1/0.0>0.0	COSV64247251	FLG|0.00|0.00|0.00|0.00|-8|40|30|-35	36358356,33282748	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310441	152310441	G	T	het	het	het		QUAL=24;DP=94,180,163;AF=0.50,0.51,0.47	CCDST,FLG	intron&non_coding_transcript,missense,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-22142G>T::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-22142G>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4465G>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4445C>A:p.Ser1482Tyr:,CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1277512 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs11204978	0.15621	0.03394,0.32654,0.56617,0.13528,0.37163	3085,	17499	127851	0.0040	14.87	0.058	0.19	/0.0>0.0/0.0>5.9,/0.0>0.0/0.0>0.0	COSV64247255	FLG|0.00|0.00|0.00|0.00|-14|3|-36|29	29281699,29774148,33282748	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310760	152310760	T	C	het	hom	het		QUAL=25;DP=94,202,226;AF=0.50,0.99,0.46	CCDST,FLG	intron&non_coding_transcript,missense,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-21823T>C::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-21823T>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4146T>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4126A>G:p.Arg1376Gly:PF03516 [Filaggrin],CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1178727 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs11581433	0.20231	0.13307,0.35858,0.59593,0.15920,0.43546	4085,	22554	121142	-3.1550	0.01	0.008	0.05	/0.0>0.0/0.0>0.0,/1.4>2.2/0.0>0.0	COSV64246547	FLG|0.00|0.00|0.00|0.00|-7|-19|5|12	29281699,36358356	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152310807	152310807	C	T	het	het	het		QUAL=24;DP=101,209,203;AF=0.52,0.47,0.48	CCDST,FLG	intron&non_coding_transcript,missense,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-21776C>T::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-21776C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-4099C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.4079G>A:p.Arg1360His:PF03516 [Filaggrin],CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1253040 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs11586631	0.15713	0.03450,0.32659,0.56925,0.13547,0.37484	3120,	17586	127810	-3.9920	0.94	0.022	0.08	/0.0>0.0/0.0>0.4,/1.8>2.1/0.0>0.0	COSV64245581	FLG|0.00|0.00|0.00|0.00|-11|34|35|-9	29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152311386	152311386	G	C	het	hom	het		QUAL=24;DP=87,159,162;AF=0.56,0.99,0.52	CCDST,FLG	intron&non_coding_transcript,missense,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-21197G>C::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-21197G>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-3520G>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.3500C>G:p.Ala1167Gly:,CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1298018 [benign DISEASE=Ichthyosis vulgaris,not provided GENE=FLG];			rs58001094	0.36577	0.69811,0.41858,0.62331,0.16165,0.44241	14310,	26651	95837	-2.4700	0.01	0.046	0.05	/0.0>0.0/4.1>0.0,/0.0>0.0/0.0>0.0	COSV64238211	FLG|0.00|0.00|0.00|0.00|-47|19|-27|19	32315356,29281699,36358356	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152311499	152311499	A	G	het	hom	het		QUAL=24;DP=93,202,163;AF=0.49,1.00,0.52	CCDST,FLG	intron&non_coding_transcript,synonymous,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-21084A>G::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-21084A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-3407A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.3387T>C:p.Ser1129=:,CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1245184 [benign DISEASE=Ichthyosis vulgaris,not provided GENE=FLG];			rs66831674	0.30125	0.47557,0.39183,0.62065,0.16022,0.44209	8669,	28293	105843	-2.6140	0.68			/4.7>0.0/0.0>0.0,/1.7>1.2/0.0>0.0	COSV64248837	FLG|0.00|0.00|0.00|0.00|26|-18|26|27	34224231,29281699	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152311901	152311901	G	A	het	het	wt		QUAL=24;DP=87,195,165;AF=0.49,0.53,0.00	CCDST,FLG	intron&non_coding_transcript,synonymous,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-20682G>A::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20682G>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-3005G>A::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.2985C>T:p.His995=:,CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	2639302 [likely benign DISEASE=not provided GENE=FLG];			rs373872833	0.00010	0.00007,0.00081,0.00000,0.00000,0.00000	0,	15	149649	-1.2540	0.75			/0.0>0.0/0.0>0.0,/3.2>3.2/0.0>0.0	COSV64236179	FLG|0.00|0.00|0.00|0.00|-14|-47|5|28		0	4	0	0 / 0					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312378	152312378	A	G	het	hom	het		QUAL=25;DP=84,135,115;AF=0.50,0.99,0.64	CCDST,FLG	intron&non_coding_transcript,synonymous,upstream_gene	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-20205A>G::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-20205A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2528A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.2508T>C:p.Asp836=:,CCDST:ENST00000665223.1:upstream_gene_variant:MODIFIER::::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1230019 [benign DISEASE=Ichthyosis vulgaris,not provided GENE=FLG];			rs3120653	0.31067	0.50796,0.39816,0.62137,0.16106,0.43989	9106,	28164	102902	-2.3270	0.15			/0.0>0.0/0.0>0.0,/0.0>0.0/2.9>4.6	COSV104425295,COSV64244277	FLG|0.00|0.00|0.00|0.00|35|36|-1|36	29281699,36669978	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152312623	152312623	C	T	het	hom	het		QUAL=24;DP=87,195,216;AF=0.53,1.00,0.51	CCDST,FLG	intron&non_coding_transcript,missense,non_coding_transcript_exon	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-19960C>T::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19960C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-2283C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.2263G>A:p.Glu755Lys:,CCDST:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.48C>T::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	377878 [benign DISEASE=not specified,Ichthyosis vulgaris,not provided GENE=FLG];			rs74129461	0.18558	0.07722,0.35042,0.58814,0.15897,0.43237	3759,	20632	123538	-0.4630	10.71	0.032	0.12	/0.0>0.0/0.0>0.0	COSV64248843	FLG|0.00|0.00|0.00|0.00|-4|-1|15|-16	29281699,36358356,36669978	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313454	152313454	G	A	het	hom	het		QUAL=24;DP=101,197,182;AF=0.59,0.99,0.47	CCDST,FLG	intron&non_coding_transcript,missense,non_coding_transcript_exon	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-19129G>A::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19129G>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1452G>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.1432C>T:p.Pro478Ser:,CCDST:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.879G>A::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	666623 [benign DISEASE=not provided,not specified,Ichthyosis vulgaris GENE=FLG];	CM084968 [CLASS=DP MUT=ALT PHEN="Psoriasis increased risk association with" GENE=FLG];		rs11584340	0.20334	0.13833,0.35845,0.59154,0.15898,0.43421	4073,	22644	120632	-1.8060	0.01	0.042	0.04	/0.0>0.0/0.0>0.0	COSV64239594	FLG|0.00|0.00|0.00|0.00|-32|18|19|35	18193244,28866311,29281699,29774148,24521637,32325630,36358356,36366871,36669978,36865480,37510360	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313526	152313526	T	C	het	hom	het		QUAL=25;DP=89,204,189;AF=0.44,1.00,0.48	CCDST,FLG	intron&non_coding_transcript,missense,non_coding_transcript_exon	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-19057T>C::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19057T>C::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1380T>C::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.1360A>G:p.Thr454Ala:,CCDST:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.951T>C::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	666624 [benign DISEASE=not specified,not provided,Ichthyosis vulgaris GENE=FLG];	CM1611993 [CLASS=R MUT=ALT PHEN="Ichthyosis vulgaris" GENE=FLG];		rs2011331	0.30265	0.47851,0.39438,0.62376,0.16020,0.44282	8775,	28334	105726	-1.3090	0.05	0.077	0.06	/0.0>0.0/0.2>3.9,/1.0>1.7/0.0>0.0	COSV64245598	FLG|0.00|0.00|0.00|0.00|-37|-11|5|-10	29281699,36358356,36669978	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313556	152313556	C	T	het	het	het		QUAL=25;DP=108,213,199;AF=0.42,0.44,0.50	CCDST,FLG	intron&non_coding_transcript,missense,non_coding_transcript_exon	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-19027C>T::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-19027C>T::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1350C>T::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.1330G>A:p.Gly444Arg:,CCDST:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.981C>T::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1249558 [benign DISEASE=not provided,Ichthyosis vulgaris GENE=FLG];			rs11588170	0.15653	0.03394,0.32694,0.56621,0.13550,0.37458	3092,	17545	127861	-0.3500	11.66	0.041	0.15	/4.1>3.6/0.0>0.0,/0.0>0.0/0.0>0.0	COSV64247273	FLG|0.00|0.00|0.00|0.00|-2|20|4|-40	29281699,33282748,36865480	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313650	152313650	A	G	het	wt	het		QUAL=24;DP=85,172,199;AF=0.51,0.00,0.49	CCDST,FLG	intron&non_coding_transcript,synonymous,non_coding_transcript_exon	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-18933A>G::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-18933A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1256A>G::,FLG:ENST00000368799.2:synonymous_variant:LOW:exon3/3:c.1236T>C:p.Arg412=:PF03516 [Filaggrin],CCDST:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.1075A>G::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1259919 [benign DISEASE=FLG-related disorder,not provided,not specified GENE=FLG];			rs11582620	0.09128	0.02131,0.07865,0.10060,0.12355,0.19769	912,	12006	137678	-4.6310	2.09			/5.5>5.9/0.0>0.0,/0.0>0.0/0.0>0.0	COSV64236548	FLG|0.00|0.00|0.00|0.00|-18|2|-19|28	21163515,27206134,29281699,19733298,29774148,36366871	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152313891	152313891	C	A	het	hom	het		QUAL=24;DP=123,180,143;AF=0.54,0.99,0.44	CCDST,FLG	intron&non_coding_transcript,missense,non_coding_transcript_exon	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-18692C>A::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-18692C>A::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-1015C>A::,FLG:ENST00000368799.2:missense_variant:MODERATE:exon3/3:c.995G>T:p.Gly332Val:,CCDST:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon1/5:n.1316C>A::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	2585651 [benign DISEASE=Ichthyosis vulgaris GENE=FLG];			rs41267154	0.20078	0.12848,0.35729,0.59274,0.15899,0.43440	4027,	22453	121433	-0.4760	13.57	0.023	0.19	/0.0>0.0/0.0>0.0	COSV64246426	FLG|0.00|0.00|0.00|0.00|-7|38|2|38	34224231,29281699,36358356,33282748	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152314866	152314866	T	-	het	hom	het	low_conf_region	QUAL=26;DP=31,29,20;AF=0.61,0.90,0.70	CCDST,FLG	intron&non_coding_transcript,intron,non_coding_transcript_exon	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-17706del::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-17706del::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron4/8:n.463-29del::,FLG:ENST00000368799.2:intron_variant:MODIFIER:intron2/2:c.139-119del::,CCDST:ENST00000665223.1:non_coding_transcript_exon_variant:MODIFIER:exon2/5:n.1717del::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]	1288712 [benign DISEASE=not provided GENE=FLG];			rs34224823	0.19521	0.04473,0.36340,0.60672,0.18421,0.44388	4018,	20513	117701	-0.2050	0.13			/6.1>6.2/0.0>0.0,/0.0>0.0/0.0>0.0		FLG|0.00|0.00|0.00|0.00|-28|-29|-28|-33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	152325041	152325041	A	G	het	hom	het		QUAL=24;DP=143,47,26;AF=0.51,1.00,0.62	CCDST,FLG	intron&non_coding_transcript,intron	CCDST:ENST00000630125.3:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/7:n.180-7542A>G::,CCDST:ENST00000669830.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron3/7:n.359-7542A>G::,CCDST:ENST00000420707.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron5/8:n.515-7542A>G::,FLG:ENST00000368799.2:intron_variant:MODIFIER:intron1/2:c.-22+148T>C::,CCDST:ENST00000665223.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/4:n.1798-7542A>G::		135940_[GENE=FLG_PHENOS=Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3), Autosomal dominant]				rs12407553	0.20222	0.13309,0.35831,0.59549,0.15899,0.43439	4069,	22564	121124	0.1790	2.88			/8.0>8.2/0.0>0.0,/3.1>3.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CCDST (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), FLG (inh=AR+AD oe_syn=1.94 oe_mis=2.15 oe_lof=2.42)
chr1	154576245	154576245	T	C	hom	het	hom		QUAL=24;DP=59,99,126;AF=0.98,0.52,1.00	CHRNB2	3'UTR	CHRNB2:ENST00000368476.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*313T>C::,CHRNB2:ENST00000637900.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*313T>C::		118507_[GENE=CHRNB2_PHENOS=Epilepsy, nocturnal frontal lobe, 3, 605375 (3)]				rs2072660	0.70587	0.56247,0.75899,0.73560,0.76776,0.80311	38432,	30489	44733	-2.5390	0.39			/0.0>0.0/1.3>2.4		CHRNB2|0.00|0.00|0.00|0.00|-50|15|2|-5	21467728,17373692,18593715,15154117,17503330,18534558,18571741,19259974,19760673,20854418,25036316,21606948,16314871,20736995,22180580,23691092,24667010,25640319,25778907,24486638,23350800,26301171,23824835,24057800,25259584,28054193,33217458,24569419,25774163,23264444,19698703,19665479,19854014,35213538,37359362	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46)
chr1	154579534	154579534	C	G	het	wt	het		QUAL=24;DP=114,80,284;AF=0.48,0.00,0.47	CHRNB2,ADAR	3'UTR,downstream_gene	CHRNB2:ENST00000368476.4:3_prime_UTR_variant:MODIFIER:exon6/6:c.*3602C>G::,CHRNB2:ENST00000637900.1:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000713626.1:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000679899.1:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000680270.2:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000681056.2:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000368474.9:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000680305.1:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000713630.1:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000713631.1:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000713632.1:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000648231.2:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000368471.8:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000649022.2:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000713633.1:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000713634.1:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000526905.3:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000649749.1:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000648311.1:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000649724.2:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000529168.2:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000648871.2:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000471068.3:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000494866.2:downstream_gene_variant:MODIFIER::::,ADAR:ENST00000681683.1:downstream_gene_variant:MODIFIER::::		118507_[GENE=CHRNB2_PHENOS=Epilepsy, nocturnal frontal lobe, 3, 605375 (3)]&146920_[GENE=ADAR_PHENOS=Dyschromatosis symmetrica hereditaria, 127400 (3), Autosomal dominant; Aicardi-Goutieres syndrome 6, 615010 (3), Autosomal recessive]				rs1049998302	0.00001	0.00000,0.00000,0.00000,0.00003,0.00000	0,	2	152176	-0.4080	0.55			/9.1>8.7/0.0>0.0		CHRNB2|0.00|0.00|0.00|0.00|-29|17|22|-31		0	8	0	0 / 0					CHRNB2 (inh=AD oe_syn=1.02 oe_mis=0.67 oe_lof=0.46), ADAR (inh=AR+AD oe_syn=1.13 oe_mis=0.75 oe_lof=0.26)
chr1	155235878	155235878	G	T	hom	hom	hom	low_conf_region	QUAL=24;DP=93,237,231;AF=1.00,1.00,1.00	GBA1,MTX1LP	intron,downstream_gene	GBA1:ENST00000368373.8:intron_variant:MODIFIER:intron8/10:c.1225-34C>A::,GBA1:ENST00000327247.9:intron_variant:MODIFIER:intron9/11:c.1225-34C>A::,GBA1:ENST00000427500.7:intron_variant:MODIFIER:intron7/9:c.1078-34C>A::,GBA1:ENST00000428024.3:intron_variant:MODIFIER:intron7/9:c.964-34C>A::,MTX1LP:ENST00000440904.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	606463_[GENE=GBA1_PHENOS={Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant]	256871 [benign DISEASE=Gaucher disease,not provided,Gaucher disease perinatal lethal,Gaucher disease type I,not specified GENE=GBA1];			rs3115534	0.95313	0.84102,0.98286,0.99961,0.99802,0.99854	68998,	5966	7080	0.1160	1.68			/0.0>0.0/0.0>0.0			25741868,35870639,23418865,37398408,37633302	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTX1LP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA1 (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155237596	155237596	A	T	het	wt	het		QUAL=24;DP=193,16,140;AF=0.52,0.00,0.54	GBA1,MTX1LP	splice_region&intron,downstream_gene	GBA1:ENST00000368373.8:splice_region_variant&intron_variant:LOW:intron6/10:c.762-18T>A::,GBA1:ENST00000327247.9:splice_region_variant&intron_variant:LOW:intron7/11:c.762-18T>A::,GBA1:ENST00000427500.7:splice_region_variant&intron_variant:LOW:intron5/9:c.615-18T>A::,GBA1:ENST00000428024.3:splice_region_variant&intron_variant:LOW:intron5/9:c.501-18T>A::,MTX1LP:ENST00000440904.1:downstream_gene_variant:MODIFIER::::		606463_[GENE=GBA1_PHENOS={Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant]	198756 [benign/likely benign DISEASE=Gaucher disease type I,Gaucher disease type II,Gaucher disease type III,Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Parkinson disease, late-onset,Lewy body dementia,Gaucher disease perinatal lethal,not specified,not provided GENE=GBA1];	CS2317343 [CLASS=DM? MUT=ALT PHEN="Parkinson disease" GENE=GBA];		rs140335079	0.00863	0.00269,0.01221,0.00019,0.01332,0.00249	6,	1302	151032	0.7750	2.09			10.8>7.9/10.8>7.9/0.0>0.0		GBA|0.01|0.03|0.00|0.00|-2|-18|-17|-35	25741868,32714263,34380910	8	1096	0	0 / 0	2	"[2] ahfausu1 19.11.2024"			MTX1LP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA1 (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155238856	155238856	T	C	hom	hom	hom		QUAL=24;DP=34,46,35;AF=1.00,1.00,1.00	GBA1,MTX1LP	intron,downstream_gene	GBA1:ENST00000368373.8:intron_variant:MODIFIER:intron4/10:c.455-206A>G::,GBA1:ENST00000327247.9:intron_variant:MODIFIER:intron5/11:c.455-206A>G::,GBA1:ENST00000427500.7:intron_variant:MODIFIER:intron3/9:c.308-206A>G::,GBA1:ENST00000428024.3:intron_variant:MODIFIER:intron3/9:c.194-206A>G::,MTX1LP:ENST00000440904.1:downstream_gene_variant:MODIFIER::::		606463_[GENE=GBA1_PHENOS={Lewy body dementia, susceptibility to}, 127750 (3), Autosomal dominant; Gaucher disease, type II, 230900 (3), Autosomal recessive; Gaucher disease, type IIIC, 231005 (3), Autosomal recessive; Gaucher disease, type III, 231000 (3), Autosomal recessive; Gaucher disease, type I, 230800 (3), Autosomal recessive; Gaucher disease, perinatal lethal, 608013 (3), Autosomal recessive; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Multifactorial, Autosomal dominant]				rs7416991	0.56911	0.30387,0.63250,0.29640,0.70266,0.64301	27041,	32398	65478	0.3340	3.69			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTX1LP (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GBA1 (inh=AR+AD oe_syn=1.05 oe_mis=0.81 oe_lof=0.51)
chr1	155752715	155752715	C	G	hom	het	het		QUAL=25;DP=31,3,3;AF=1.00,0.67,1.00	GON4L,MSTO2P	intron,downstream_gene	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron29/31:c.5843-125G>C::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron29/31:c.5843-125G>C::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron29/31:c.5843-128G>C::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron29/31:c.5843-128G>C::,MSTO2P:ENST00000314835.5:downstream_gene_variant:MODIFIER::::					AluJr (SINE/Alu)	rs12134456	0.25675	0.05923,0.22062,0.00407,0.37741,0.20456	6619,	25798	113004	-0.3730	1.94			/0.0>0.0/2.4>0.0		GON4L|0.00|0.00|0.00|0.00|-16|-32|-43|5	31152163,31578528,32888493,35810165,31676860	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MSTO2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155767594	155767594	C	T	hom	hom	hom		QUAL=24;DP=40,156,118;AF=1.00,1.00,1.00	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron19/31:c.2647-53G>A::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron19/20:c.2647-53G>A::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron19/20:c.2647-53G>A::						rs849712	0.93632	0.77780,0.97619,1.00000,0.99952,0.99896	67330,	7522	9670	-0.1340	11.09			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155767635	155767638	ACAC	-	hom	hom	hom		QUAL=24;DP=86,121,94;AF=0.80,0.90,0.87	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron19/31:c.2647-97_2647-94del::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron19/31:c.2647-97_2647-94del::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron19/31:c.2647-97_2647-94del::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron19/31:c.2647-97_2647-94del::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron19/20:c.2647-97_2647-94del::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron19/20:c.2647-97_2647-94del::					(AC)n (Simple_repeat)	rs3831996	0.51858	0.28052,0.58002,0.29175,0.63954,0.58847	21761,	34058	72020	0.5100	0.96			/2.9>2.9/0.0>0.0		GON4L|0.01|0.00|0.00|0.00|-32|-8|13|9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155776550	155776550	T	-	hom	hom	hom	low_conf_region	QUAL=24;DP=150,153,78;AF=0.83,0.90,0.96	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron15/31:c.2092-69del::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron15/31:c.2092-69del::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron15/31:c.2092-69del::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron15/31:c.2092-69del::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron15/20:c.2092-69del::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron15/20:c.2092-69del::					AluJr (SINE/Alu)	rs60525991	0.86129	0.64312,0.93252,0.99862,0.94852,0.95985	56486,	15127	20631	0.4820	0.59			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155783885	155783885	A	G	hom	hom	hom		QUAL=25;DP=158,107,76;AF=1.00,1.00,1.00	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron14/31:c.1892+101T>C::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron14/31:c.1892+101T>C::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron14/31:c.1892+101T>C::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron14/31:c.1892+101T>C::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron14/20:c.1892+101T>C::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron14/20:c.1892+101T>C::						rs822019	0.83472	0.54411,0.92366,0.99904,0.95108,0.93872	55509,	16011	25153	-0.8600	2.49			/3.3>2.8/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155785306	155785306	G	A	hom	hom	hom		QUAL=24;DP=235,305,250;AF=1.00,1.00,1.00	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron13/31:c.1788+28C>T::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron13/20:c.1788+28C>T::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron13/20:c.1788+28C>T::						rs822021	0.93609	0.77733,0.97617,1.00000,0.99952,0.99896	67400,	7581	9721	-1.0920	6.51			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155785448	155785448	T	C	hom	hom	hom		QUAL=24;DP=154,265,230;AF=1.00,1.00,1.00	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron12/31:c.1748-74A>G::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron12/31:c.1748-74A>G::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron12/31:c.1748-74A>G::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron12/31:c.1748-74A>G::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron12/20:c.1748-74A>G::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron12/20:c.1748-74A>G::					L3b (LINE/CR1)	rs822022	0.86318	0.64073,0.93514,0.99923,0.95126,0.96128	58214,	14962	20826	-0.4910	9.39			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155804808	155804808	T	C	hom	hom	hom		QUAL=24;DP=50,32,30;AF=1.00,1.00,1.00	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron11/31:c.1645+141A>G::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron11/31:c.1645+141A>G::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron11/31:c.1645+141A>G::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron11/31:c.1645+141A>G::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron11/20:c.1645+141A>G::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron11/20:c.1645+141A>G::						rs822016	0.86932	0.66059,0.93730,0.99981,0.95153,0.96210	58698,	14593	19841	0.4160	4.36			/1.0>2.5/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155813972	155813972	C	T	hom	hom	hom		QUAL=24;DP=64,10,14;AF=0.98,1.00,1.00	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron9/31:c.1282-168G>A::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron9/31:c.1282-168G>A::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron9/31:c.1282-168G>A::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron9/31:c.1282-168G>A::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron9/20:c.1282-168G>A::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron9/20:c.1282-168G>A::						rs822012	0.83553	0.54722,0.92398,0.99904,0.95092,0.93913	55585,	16034	25040	-0.1590	7.31			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155814581	155814581	G	A	hom	hom	hom		QUAL=24;DP=144,97,76;AF=1.00,1.00,1.00	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron8/31:c.1162-132C>T::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron8/31:c.1162-132C>T::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron8/31:c.1162-132C>T::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron8/31:c.1162-132C>T::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron8/20:c.1162-132C>T::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron8/20:c.1162-132C>T::					AluSx (SINE/Alu)	rs822013	0.93622	0.77764,0.97599,1.00000,0.99953,0.99896	67359,	7573	9693	-1.4210	0.82			/6.0>5.2/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155815788	155815791	AACT	-	hom	hom	hom		QUAL=24;DP=157,299,228;AF=0.99,1.00,0.99	GON4L	splice_region&intron	GON4L:ENST00000368331.6:splice_region_variant&intron_variant:LOW:intron8/31:c.1161+14_1161+17del::,GON4L:ENST00000615926.4:splice_region_variant&intron_variant:LOW:intron8/31:c.1161+14_1161+17del::,GON4L:ENST00000437809.5:splice_region_variant&intron_variant:LOW:intron8/31:c.1161+14_1161+17del::,GON4L:ENST00000271883.9:splice_region_variant&intron_variant:LOW:intron8/31:c.1161+14_1161+17del::,GON4L:ENST00000361040.9:splice_region_variant&intron_variant:LOW:intron8/20:c.1161+14_1161+17del::,GON4L:ENST00000622608.2:splice_region_variant&intron_variant:LOW:intron8/20:c.1161+14_1161+17del::						rs148569012	0.86305	0.63981,0.93543,0.99942,0.95120,0.96122	57992,	14941	20775	-0.2520	12.69			/4.5>4.5/4.2>4.2				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155853180	155853180	C	T	hom	hom	hom		QUAL=25;DP=20,16,10;AF=1.00,1.00,1.00	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron2/31:c.505+96G>A::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron2/31:c.505+96G>A::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron2/31:c.505+96G>A::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron2/31:c.505+96G>A::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron2/20:c.505+96G>A::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron2/20:c.505+96G>A::	regulatory_region_variant:enhancer					rs822490	0.53280	0.28105,0.58958,0.29488,0.66331,0.59830	23768,	33511	71067	-1.2110	0.32			/0.0>0.0/0.0>0.8	COSV55201923	GON4L|0.00|0.00|0.00|0.00|19|-8|-11|19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	155853211	155853211	T	C	hom	hom	hom		QUAL=25;DP=37,21,26;AF=1.00,1.00,1.00	GON4L	intron	GON4L:ENST00000368331.6:intron_variant:MODIFIER:intron2/31:c.505+65A>G::,GON4L:ENST00000615926.4:intron_variant:MODIFIER:intron2/31:c.505+65A>G::,GON4L:ENST00000437809.5:intron_variant:MODIFIER:intron2/31:c.505+65A>G::,GON4L:ENST00000271883.9:intron_variant:MODIFIER:intron2/31:c.505+65A>G::,GON4L:ENST00000361040.9:intron_variant:MODIFIER:intron2/20:c.505+65A>G::,GON4L:ENST00000622608.2:intron_variant:MODIFIER:intron2/20:c.505+65A>G::						rs822491	0.99971	0.99916,0.99954,1.00000,1.00000,1.00000	76129,	44	44	-0.0960	2.00			/5.7>6.1/0.0>1.5				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GON4L (inh=n/a oe_syn=1.03 oe_mis=0.86 oe_lof=0.20)
chr1	156137743	156137743	C	T	het	het	wt		QUAL=24;DP=149,357,16;AF=0.61,0.55,0.00	LMNA	synonymous,intron,splice_region&synonymous	LMNA:ENST00000368301.6:synonymous_variant:LOW:exon13/13:c.1698C>T:p.His566=:,LMNA:ENST00000676385.2:intron_variant:MODIFIER:intron11/12:c.1608+511C>T::,LMNA:ENST00000675939.1:splice_region_variant&synonymous_variant:LOW:exon11/13:c.1698C>T:p.His566=:,LMNA:ENST00000675667.1:splice_region_variant&synonymous_variant:LOW:exon11/12:c.1698C>T:p.His566=:,LMNA:ENST00000683032.1:splice_region_variant&synonymous_variant:LOW:exon11/13:c.1698C>T:p.His566=:,LMNA:ENST00000682650.1:intron_variant:MODIFIER:intron10/11:c.1608+511C>T::,LMNA:ENST00000361308.9:splice_region_variant&synonymous_variant:LOW:exon11/13:c.1698C>T:p.His566=:,LMNA:ENST00000677389.1:synonymous_variant:LOW:exon10/10:c.1698C>T:p.His566=:,LMNA:ENST00000368300.9:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1698C>T:p.His566=:,LMNA:ENST00000368299.7:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1698C>T:p.His566=:,LMNA:ENST00000448611.6:splice_region_variant&synonymous_variant:LOW:exon10/13:c.1362C>T:p.His454=:,LMNA:ENST00000368297.5:synonymous_variant:LOW:exon11/11:c.1455C>T:p.His485=:,LMNA:ENST00000504687.7:splice_region_variant&synonymous_variant:LOW:exon10/12:c.1140C>T:p.His380=:,LMNA:ENST00000473598.6:splice_region_variant&synonymous_variant:LOW:exon11/13:c.1401C>T:p.His467=:	regulatory_region_variant:CTCF_binding_site	150330_[GENE=LMNA_PHENOS=Mandibuloacral dysplasia, 248370 (3), Autosomal recessive; Heart-hand syndrome, Slovenian type, 610140 (3), Autosomal dominant; Cardiomyopathy, dilated, 1A, 115200 (3), Autosomal dominant; Emery-Dreifuss muscular dystrophy 3, autosomal recessive, 616516 (3), Autosomal recessive; Restrictive dermopathy 2, 619793 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2B1, 605588 (3), Autosomal recessive; Emery-Dreifuss muscular dystrophy 2, autosomal dominant, 181350 (3), Autosomal dominant; Hutchinson-Gilford progeria, 176670 (3), Autosomal dominant; Lipodystrophy, familial partial, type 2, 151660 (3), Autosomal dominant; Muscular dystrophy, congenital, 613205 (3), Autosomal dominant; Malouf syndrome, 212112 (3), Autosomal dominant]	48048 [benign DISEASE=Mandibuloacral dysplasia with type A lipodystrophy,Dilated cardiomyopathy 1A,Emery-Dreifuss muscular dystrophy 2, autosomal dominant,not provided,Cardiomyopathy,Lipoatrophy with Diabetes, Hepatic Steatosis, Hypertrophic Cardiomyopathy, and Leukomelanodermic Papules,Limb-girdle muscular dystrophy, recessive,Congenital muscular dystrophy due to LMNA mutation,Charcot-Marie-Tooth disease type 2B1,Hutchinson-Gilford syndrome,Familial partial lipodystrophy, Dunnigan type,Emery-Dreifuss muscular dystrophy,not specified,Primary dilated cardiomyopathy,Charcot-Marie-Tooth disease,Charcot-Marie-Tooth disease type 2,Cardiovascular phenotype,Lethal tight skin contracture syndrome GENE=LMNA];	CM003892 [CLASS=DP MUT=ALT PHEN="Metabolic syndrome association with" GENE=LMNA];		rs4641	0.21269	0.09316,0.28280,0.25213,0.26113,0.30530	4005,	24361	119829	-1.6030	8.61			9.3>7.8/0.3>0.0/9.3>7.8,/0.3>0.0/9.3>7.8	COSV61541921	LMNA|0.00|0.00|0.00|0.00|-29|0|0|7	25741868,24033266,15637659,16262891,17327437,17327460,17327461,17994215,19841875,20127487,20501691,21108632,22303384,22340368,24244950,26365620,26379929,26602028,27182706,28785654,25649378,21980471,34021172,23800289,26634508,27409638,25151201,23090008,24019745,27896052,24831476,32698886,33953703	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LMNA (inh=AR+AD oe_syn=0.95 oe_mis=0.67 oe_lof=0.07)
chr1	156815564	156815564	T	C	hom	hom	hom		QUAL=24;DP=72,39,45;AF=1.00,1.00,1.00	SH2D2A,NTRK1	intron,upstream_gene	SH2D2A:ENST00000368198.7:intron_variant:MODIFIER:intron2/8:c.70-343A>G::,SH2D2A:ENST00000368199.8:intron_variant:MODIFIER:intron2/8:c.124-343A>G::,SH2D2A:ENST00000392306.2:intron_variant:MODIFIER:intron2/8:c.124-343A>G::,NTRK1:ENST00000674537.2:upstream_gene_variant:MODIFIER::::,NTRK1:ENST00000392302.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter,TF_binding_site_variant	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667736 [benign DISEASE=not provided GENE=NTRK1];			rs2150906	0.85514	0.67862,0.86251,0.93634,0.94165,0.89747	56527,	16970	22026	-1.7110	0.04			/0.0>0.0/0.0>0.0	COSV63885495,COSV63885550	SH2D2A|0.06|0.00|0.00|0.00|13|-22|13|42	30738251	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SH2D2A (inh=n/a oe_syn=0.86 oe_mis=0.91 oe_lof=0.68), NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156815825	156815825	G	A	hom	hom	hom		QUAL=24;DP=198,299,210;AF=1.00,1.00,1.00	SH2D2A,NTRK1	intron,5'UTR	SH2D2A:ENST00000368198.7:intron_variant:MODIFIER:intron2/8:c.69+181C>T::,SH2D2A:ENST00000368199.8:intron_variant:MODIFIER:intron2/8:c.123+181C>T::,SH2D2A:ENST00000392306.2:intron_variant:MODIFIER:intron2/8:c.123+181C>T::,NTRK1:ENST00000674537.2:5_prime_UTR_variant:MODIFIER:exon1/18:c.-217G>A::,NTRK1:ENST00000392302.7:5_prime_UTR_variant:MODIFIER:exon1/17:c.-77G>A::	regulatory_region_variant:open_chromatin_region	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	380853 [benign DISEASE=not provided,not specified,Hereditary insensitivity to pain with anhidrosis,X-linked lymphoproliferative disease due to SH2D1A deficiency GENE=NTRK1];			rs1800601	0.63518	0.50570,0.69555,0.81869,0.67654,0.64703	31223,	34065	55431	-1.8390	0.50			/0.0>0.0/0.0>2.2,/0.0>0.0/0.0>0.0	COSV63884607	SH2D2A|0.04|0.00|0.00|0.00|-33|39|-2|18	35484167,20219210,30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SH2D2A (inh=n/a oe_syn=0.86 oe_mis=0.91 oe_lof=0.68), NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156815971	156815971	G	-	hom	hom	hom		QUAL=24;DP=107,104,84;AF=0.97,1.00,1.00	SH2D2A,NTRK1	intron	SH2D2A:ENST00000368198.7:intron_variant:MODIFIER:intron2/8:c.69+35del::,SH2D2A:ENST00000368199.8:intron_variant:MODIFIER:intron2/8:c.123+35del::,SH2D2A:ENST00000392306.2:intron_variant:MODIFIER:intron2/8:c.123+35del::,NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron1/17:c.-204+133del::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron1/16:c.-64+133del::	regulatory_region_variant:open_chromatin_region	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	1225268 [benign DISEASE=not provided GENE=NTRK1];			rs11325907	0.56422	0.33673,0.64646,0.81772,0.64231,0.64703	25694,	34084	66014	0.2390	1.15			/0.0>0.0/0.0>0.0		SH2D2A|0.00|0.00|0.00|0.00|-41|-32|8|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SH2D2A (inh=n/a oe_syn=0.86 oe_mis=0.91 oe_lof=0.68), NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156815979	156815979	A	G	hom	hom	hom		QUAL=24;DP=85,103,78;AF=1.00,1.00,1.00	SH2D2A,NTRK1	intron	SH2D2A:ENST00000368198.7:intron_variant:MODIFIER:intron2/8:c.69+27T>C::,SH2D2A:ENST00000368199.8:intron_variant:MODIFIER:intron2/8:c.123+27T>C::,SH2D2A:ENST00000392306.2:intron_variant:MODIFIER:intron2/8:c.123+27T>C::,NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron1/17:c.-204+141A>G::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron1/16:c.-64+141A>G::	regulatory_region_variant:open_chromatin_region	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667767 [benign DISEASE=not provided,Hereditary insensitivity to pain with anhidrosis GENE=NTRK1];			rs7546838	0.59830	0.45549,0.65890,0.81703,0.64244,0.64766	27797,	35013	60833	-1.3060	0.31			/0.0>0.0/0.0>0.0,/4.6>5.3/0.0>0.0	COSV63884348	SH2D2A|0.00|0.00|0.00|0.00|2|-50|27|2	36501135	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SH2D2A (inh=n/a oe_syn=0.86 oe_mis=0.91 oe_lof=0.68), NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156815987	156815987	G	A	hom	hom	hom		QUAL=24;DP=87,88,74;AF=0.97,1.00,1.00	SH2D2A,NTRK1	splice_region&intron,intron	SH2D2A:ENST00000368198.7:splice_region_variant&intron_variant:LOW:intron2/8:c.69+19C>T::,SH2D2A:ENST00000368199.8:splice_region_variant&intron_variant:LOW:intron2/8:c.123+19C>T::,SH2D2A:ENST00000392306.2:splice_region_variant&intron_variant:LOW:intron2/8:c.123+19C>T::,NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron1/17:c.-204+149G>A::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron1/16:c.-64+149G>A::	regulatory_region_variant:open_chromatin_region	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667768 [benign DISEASE=not provided,Hereditary insensitivity to pain with anhidrosis GENE=NTRK1];			rs1800600	0.65467	0.57495,0.70014,0.81738,0.67648,0.65415	32702,	33733	52293	-0.7970	0.45			/0.0>0.0/0.0>0.0,/4.6>3.9/0.0>0.0		SH2D2A|0.00|0.00|0.00|0.00|-49|46|19|-9	18554728	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SH2D2A (inh=n/a oe_syn=0.86 oe_mis=0.91 oe_lof=0.68), NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156868349	156868349	T	C	hom	hom	hom		QUAL=24;DP=61,29,32;AF=1.00,1.00,1.00	NTRK1	intron,downstream_gene	NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron7/17:c.412+100T>C::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron6/16:c.412+100T>C::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron5/15:c.574+100T>C::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron5/16:c.574+100T>C::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron5/15:c.574+100T>C::,NTRK1:ENST00000675461.1:downstream_gene_variant:MODIFIER::::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667738 [benign DISEASE=not provided,Hereditary insensitivity to pain with anhidrosis GENE=NTRK1];			rs1800879	0.62948	0.63809,0.64560,0.94956,0.60359,0.73257	30584,	34561	56347	-4.5820	0.00			/0.0>0.0/0.0>0.0		NTRK1|0.00|0.00|0.00|0.00|-10|15|34|-11	35484167,18077166,16373086	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156871467	156871467	A	C	hom	hom	hom		QUAL=24;DP=76,53,42;AF=1.00,1.00,1.00	NTRK1	intron	NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron8/17:c.556-156A>C::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron7/16:c.556-156A>C::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron6/15:c.718-156A>C::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron6/16:c.718-156A>C::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron6/15:c.718-156A>C::	regulatory_region_variant:enhancer	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667741 [benign DISEASE=not provided,Hereditary insensitivity to pain with anhidrosis GENE=NTRK1];			rs2644614	0.97976	0.93005,0.99262,1.00000,0.99950,0.99979	73182,	2844	3082	-0.5680	1.59			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156876441	156876441	G	A	het	wt	hom		QUAL=24;DP=148,24,150;AF=0.51,0.00,1.00	NTRK1	synonymous	NTRK1:ENST00000674537.2:synonymous_variant:LOW:exon15/18:c.1494G>A:p.Gln498=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000392302.7:synonymous_variant:LOW:exon14/17:c.1494G>A:p.Gln498=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000368196.7:synonymous_variant:LOW:exon13/16:c.1656G>A:p.Gln552=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000524377.7:synonymous_variant:LOW:exon14/17:c.1674G>A:p.Gln558=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000358660.3:synonymous_variant:LOW:exon13/16:c.1665G>A:p.Gln555=:PF07714 [Protein tyrosine and serine/threonine kinase]	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:TF_binding_site	191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	292889 [benign DISEASE=not provided,Hereditary insensitivity to pain with anhidrosis,not specified GENE=NTRK1];			rs6334	0.20080	0.13842,0.22636,0.34526,0.21780,0.24068	3219,	24122	121630	0.2210	9.25			/0.0>0.0/3.2>5.3	COSV62323674	NTRK1|0.00|0.00|0.00|0.00|-32|-8|1|42	23195334,21178826,29054434,30283335,33004033,20003389,29453651,31577263,16373086	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156879002	156879002	C	T	het	hom	wt		QUAL=25;DP=25,19,15;AF=0.44,0.95,0.00	NTRK1	intron	NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron15/17:c.1626-120C>T::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron14/16:c.1626-120C>T::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron13/15:c.1788-120C>T::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron14/16:c.1806-120C>T::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron13/15:c.1797-120C>T::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667763 [benign DISEASE=not provided GENE=NTRK1];			rs2768756	0.52092	0.17382,0.55495,0.04936,0.72379,0.37104	25599,	28020	72854	-0.1740	3.00			/9.4>9.9/0.0>0.0	COSV62329334	NTRK1|0.01|0.00|0.00|0.00|13|7|13|12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156879016	156879016	T	C	het	hom	het		QUAL=24;DP=27,22,17;AF=0.41,1.00,0.41	NTRK1	intron	NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron15/17:c.1626-106T>C::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron14/16:c.1626-106T>C::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron13/15:c.1788-106T>C::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron14/16:c.1806-106T>C::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron13/15:c.1797-106T>C::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667764 [benign DISEASE=not provided GENE=NTRK1];			rs2768757	0.79550	0.68018,0.79025,0.38891,0.89144,0.55669	49422,	22124	31098	-1.5260	0.09			/9.4>8.4/0.3>0.0	COSV62328512	NTRK1|0.00|0.00|0.00|0.00|25|-1|5|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156879203	156879203	C	T	het	hom	wt		QUAL=24;DP=49,129,17;AF=0.33,0.97,0.00	NTRK1	synonymous	NTRK1:ENST00000674537.2:synonymous_variant:LOW:exon16/18:c.1707C>T:p.Ala569=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000392302.7:synonymous_variant:LOW:exon15/17:c.1707C>T:p.Ala569=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000368196.7:synonymous_variant:LOW:exon14/16:c.1869C>T:p.Ala623=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000524377.7:synonymous_variant:LOW:exon15/17:c.1887C>T:p.Ala629=:PF07714 [Protein tyrosine and serine/threonine kinase],NTRK1:ENST00000358660.3:synonymous_variant:LOW:exon14/16:c.1878C>T:p.Ala626=:PF07714 [Protein tyrosine and serine/threonine kinase]		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	138564 [benign DISEASE=not specified,Hereditary insensitivity to pain with anhidrosis,not provided GENE=NTRK1];			rs6337	0.53279	0.21403,0.55839,0.05056,0.72397,0.37084	25958,	29045	70997	-3.9860	3.77			/0.8>1.5/0.0>0.0	COSV62325231	NTRK1|0.00|0.00|0.00|0.00|13|40|-50|12	26384852,20003389,33986442,16373086	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156880312	156880312	G	C	het	hom	het		QUAL=24;DP=19,29,25;AF=0.58,1.00,0.56	NTRK1	intron	NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron17/17:c.2025+155G>C::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron16/16:c.2025+155G>C::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron15/15:c.2187+155G>C::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron16/16:c.2205+155G>C::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron15/15:c.2196+155G>C::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667765 [benign DISEASE=not provided GENE=NTRK1];			rs2274499	0.82776	0.67170,0.83792,0.47359,0.93262,0.68682	53412,	18784	26136	0.0000	5.65			/1.2>1.5/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156880320	156880320	T	G	het	hom	het		QUAL=24;DP=19,31,26;AF=0.63,1.00,0.54	NTRK1	intron	NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron17/17:c.2025+163T>G::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron16/16:c.2025+163T>G::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron15/15:c.2187+163T>G::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron16/16:c.2205+163T>G::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron15/15:c.2196+163T>G::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	667766 [benign DISEASE=not provided GENE=NTRK1];			rs2274500	0.82795	0.67168,0.83814,0.47269,0.93315,0.68674	53451,	18756	26112	-3.5770	0.05			/0.0>0.0/0.0>0.0			29029385	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	156881249	156881249	T	G	hom	n/a	n/a		QUAL=25;DP=6,2,1;AF=1.00,1.00,0.00	NTRK1	intron	NTRK1:ENST00000674537.2:intron_variant:MODIFIER:intron17/17:c.2026-208T>G::,NTRK1:ENST00000392302.7:intron_variant:MODIFIER:intron16/16:c.2026-208T>G::,NTRK1:ENST00000368196.7:intron_variant:MODIFIER:intron15/15:c.2188-208T>G::,NTRK1:ENST00000524377.7:intron_variant:MODIFIER:intron16/16:c.2206-208T>G::,NTRK1:ENST00000358660.3:intron_variant:MODIFIER:intron15/15:c.2197-208T>G::		191315_[GENE=NTRK1_PHENOS=Insensitivity to pain, congenital, with anhidrosis, 256800 (3), Autosomal recessive]	670556 [benign DISEASE=not provided GENE=NTRK1];			rs2768758	0.97973	0.92887,0.99360,1.00000,0.99987,1.00000	73195,	2823	3087	-0.4380	5.11			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NTRK1 (inh=AR oe_syn=1.00 oe_mis=0.87 oe_lof=0.43)
chr1	160039331	160039331	A	C	het	wt	het		QUAL=24;DP=51,59,68;AF=0.59,0.00,0.46	KCNJ10	intron,3'UTR	KCNJ10:ENST00000639408.2:intron_variant:MODIFIER:intron3/3:c.587+1171T>G::,KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2715T>G::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2062T>G::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2062T>G::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2062T>G::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293090 [benign DISEASE=not provided,EAST syndrome,Autosomal recessive nonsyndromic hearing loss 4 GENE=KCNJ10];			rs1053074	0.45638	0.61348,0.44247,0.33470,0.39837,0.46995	16616,	35504	81876	1.6730	5.75			/0.0>0.0/0.0>0.0	COSV63635370	KCNJ10|0.00|0.00|0.00|0.00|-50|-6|-11|-5	16451705,25874548,32021205,17660461,19864112	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160039353	160039353	G	C	hom	hom	hom		QUAL=24;DP=48,59,59;AF=1.00,1.00,1.00	KCNJ10	intron,3'UTR	KCNJ10:ENST00000639408.2:intron_variant:MODIFIER:intron3/3:c.587+1149C>G::,KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2693C>G::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*2040C>G::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2040C>G::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*2040C>G::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293091 [benign DISEASE=not provided,Autosomal recessive nonsyndromic hearing loss 4,EAST syndrome GENE=KCNJ10];			rs2486254	0.99764	0.99201,0.99881,1.00000,0.99993,1.00000	74969,	352	356	0.1670	3.92			/2.4>1.2/0.0>2.7				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160039629	160039629	A	C	hom	hom	hom		QUAL=25;DP=126,277,263;AF=1.00,1.00,1.00	KCNJ10	intron,3'UTR	KCNJ10:ENST00000639408.2:intron_variant:MODIFIER:intron3/3:c.587+873T>G::,KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron2/2:c.487+2417T>G::,KCNJ10:ENST00000644903.1:3_prime_UTR_variant:MODIFIER:exon2/2:c.*1764T>G::,KCNJ10:ENST00000638728.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1764T>G::,KCNJ10:ENST00000638868.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1764T>G::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	293102 [benign DISEASE=not provided,EAST syndrome,Autosomal recessive nonsyndromic hearing loss 4 GENE=KCNJ10];			rs2486253	0.81887	0.81806,0.82616,0.96115,0.80533,0.82392	51109,	22358	27556	0.2820	7.38			/0.0>0.0/0.0>0.0	COSV105294526		33187755,32021205,25008907	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160042703	160042703	G	A	wt	het	het		QUAL=24;DP=75,94,65;AF=0.00,0.54,0.42	KCNJ10	intron	KCNJ10:ENST00000639408.2:intron_variant:MODIFIER:intron1/3:c.1-171C>T::,KCNJ10:ENST00000637644.1:intron_variant:MODIFIER:intron1/2:c.1-171C>T::,KCNJ10:ENST00000644903.1:intron_variant:MODIFIER:intron1/1:c.1-171C>T::,KCNJ10:ENST00000638728.1:intron_variant:MODIFIER:intron2/2:c.1-171C>T::,KCNJ10:ENST00000638868.1:intron_variant:MODIFIER:intron2/2:c.1-171C>T::		602208_[GENE=KCNJ10_PHENOS=Enlarged vestibular aqueduct, digenic, 600791 (3), Autosomal recessive; SESAME syndrome, 612780 (3), Autosomal recessive]	682044 [benign DISEASE=not provided GENE=KCNJ10];		AluSx (SINE/Alu)	rs3120973	0.23802	0.06214,0.23869,0.32457,0.31550,0.23047	5340,	25529	115915	-1.1120	0.70			/5.5>5.0/0.0>0.0		KCNJ10|0.00|0.00|0.00|0.00|-14|40|37|-48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCNJ10 (inh=AR oe_syn=1.02 oe_mis=0.72 oe_lof=0.29)
chr1	160277395	160277395	G	C	het	hom	wt		QUAL=24;DP=111,206,120;AF=0.44,1.00,0.00	PEX19	3'UTR	PEX19:ENST00000368072.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*2156C>G::		600279_[GENE=PEX19_PHENOS=Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3), Autosomal recessive]	293196 [benign DISEASE=Peroxisome biogenesis disorder 12A (Zellweger),not provided GENE=PEX19];		Charlie10 (DNA/hAT-Charlie)	rs10594	0.45516	0.35025,0.47724,0.34601,0.50397,0.60874	16145,	36924	82850	0.4650	2.14			/7.1>5.3/0.0>0.0	COSV63619513		20819849,16451705,19001172,25284319	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PEX19 (inh=AR oe_syn=1.11 oe_mis=1.17 oe_lof=0.52)
chr1	160282002	160282002	A	G	het	hom	wt		QUAL=24;DP=104,149,16;AF=0.47,1.00,0.00	PEX19	intron	PEX19:ENST00000368072.10:intron_variant:MODIFIER:intron5/7:c.594+37T>C::		600279_[GENE=PEX19_PHENOS=Peroxisome biogenesis disorder 12A (Zellweger), 614886 (3), Autosomal recessive]	1227462 [benign DISEASE=not provided,Peroxisome biogenesis disorder 12A (Zellweger) GENE=PEX19];			rs2795067	0.64370	0.86298,0.57641,0.46575,0.55635,0.70357	33038,	31813	54183	-1.4240	0.11			/2.5>1.4/0.0>0.0	COSV63619299	PEX19|0.00|0.00|0.00|0.00|-41|-50|35|37,RP11-574F21.3|0.00|0.00|0.00|0.00|-41|-50|35|37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PEX19 (inh=AR oe_syn=1.11 oe_mis=1.17 oe_lof=0.52)
chr1	161170488	161170488	A	-	het	het	wt		QUAL=24;DP=90,224,16;AF=0.51,0.46,0.00	PPOX,USP21,B4GALT3	frameshift,intron,downstream_gene	PPOX:ENST00000352210.9:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:PF01593 [Flavin containing amine oxidoreductase],PPOX:ENST00000367999.9:frameshift_variant:HIGH:exon10/13:c.1067del:p.Gln356ArgfsTer10:PF01593 [Flavin containing amine oxidoreductase],PPOX:ENST00000544598.5:intron_variant:MODIFIER:intron3/5:c.223-132del::,PPOX:ENST00000535223.5:intron_variant:MODIFIER:intron2/3:c.88-132del::,PPOX:ENST00000462866.5:intron_variant:MODIFIER:intron1/3:c.88-132del::,USP21:ENST00000289865.12:downstream_gene_variant:MODIFIER::::,USP21:ENST00000368002.8:downstream_gene_variant:MODIFIER::::,USP21:ENST00000368001.1:downstream_gene_variant:MODIFIER::::,USP21:ENST00000696603.2:downstream_gene_variant:MODIFIER::::,B4GALT3:ENST00000319769.10:downstream_gene_variant:MODIFIER::::,B4GALT3:ENST00000622395.4:downstream_gene_variant:MODIFIER::::,B4GALT3:ENST00000367998.5:downstream_gene_variant:MODIFIER::::		600923_[GENE=PPOX_PHENOS=Variegate porphyria, childhood-onset, 620483 (3), Autosomal recessive; Variegate porphyria, 176200 (3), Autosomal dominant]										7.2260				/6.0>0.0/0.0>0.0		PPOX|0.00|0.00|0.12|0.04|32|3|-26|32		0	2	0	0 / 0					USP21 (inh=AD oe_syn=0.95 oe_mis=0.69 oe_lof=0.31), PPOX (inh=AD oe_syn=1.05 oe_mis=0.83 oe_lof=0.30), B4GALT3 (inh=AD oe_syn=0.94 oe_mis=0.74 oe_lof=0.34)
chr1	161306644	161306644	A	G	hom	hom	hom		QUAL=24;DP=99,125,88;AF=1.00,1.00,1.00	MPZ	intron	MPZ:ENST00000533357.5:intron_variant:MODIFIER:intron3/5:c.448+64T>C::,MPZ:ENST00000672602.2:intron_variant:MODIFIER:intron3/5:c.448+64T>C::,MPZ:ENST00000491222.5:intron_variant:MODIFIER:intron2/4:c.-141+64T>C::,MPZ:ENST00000672287.2:intron_variant:MODIFIER:intron2/4:c.-141+64T>C::,MPZ:ENST00000526189.3:intron_variant:MODIFIER:intron3/5:c.367+145T>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter	159440_[GENE=MPZ_PHENOS=Charcot-Marie-Tooth disease, type 2I, 607677 (3), Autosomal dominant; Dejerine-Sottas disease, 145900 (3), Autosomal recessive, Autosomal dominant; Charcot-Marie-Tooth disease, type 1B, 118200 (3), Autosomal dominant; Roussy-Levy syndrome, 180800 (3), Autosomal dominant; Charcot-Marie-Tooth disease, dominant intermediate D, 607791 (3), Autosomal dominant; Hypomyelinating neuropathy, congenital, 2, 618184 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 2J, 607736 (3), Autosomal dominant]	683189 [benign DISEASE=not provided GENE=MPZ];			rs6674383	1.00000	1.00000,1.00000,1.00000,1.00000,1.00000	76137,	0	0	-1.2910	0.88			/0.0>0.0/1.0>5.3				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MPZ (inh=AR+AD oe_syn=0.82 oe_mis=0.77 oe_lof=0.25)
chr1	167430497	167430497	A	C	het	wt	het		QUAL=24;DP=39,21,33;AF=0.54,0.00,0.48	CD247,POU2F1	intron,downstream_gene	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron7/7:c.429+2527T>G::,POU2F1:ENST00000367866.7:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000429375.6:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000541643.7:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000367862.9:downstream_gene_variant:MODIFIER::::,CD247:ENST00000392122.4:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700155.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000470379.2:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700156.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700157.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700158.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000362089.10:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700106.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700165.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700134.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700107.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700159.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700160.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700108.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700109.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000476733.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer,TF_binding_site_variant	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]				rs870875	0.36828	0.30140,0.46961,0.42929,0.36057,0.45458	10630,	34800	96160	-0.7870	0.47			/0.0>0.0/0.0>0.0			25569266,23936387	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167430524	167430524	T	G	hom	hom	hom		QUAL=25;DP=43,43,43;AF=1.00,1.00,1.00	CD247,POU2F1	intron,downstream_gene	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron7/7:c.429+2500A>C::,POU2F1:ENST00000367866.7:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000429375.6:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000541643.7:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000367862.9:downstream_gene_variant:MODIFIER::::,CD247:ENST00000392122.4:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700155.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000470379.2:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700156.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700157.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700158.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000362089.10:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700106.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700165.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700134.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700107.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700159.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700160.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700108.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700109.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000476733.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]				rs870876	0.86052	0.79655,0.88758,0.76680,0.88523,0.90779	56609,	17818	21240	-1.5450	1.77			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167430631	167430631	-	AG	hom	hom	hom		QUAL=24;DP=85,112,122;AF=0.99,0.97,0.98	CD247,POU2F1	intron,downstream_gene	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron7/7:c.429+2391_429+2392dup::,POU2F1:ENST00000367866.7:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000429375.6:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000541643.7:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000367862.9:downstream_gene_variant:MODIFIER::::,CD247:ENST00000392122.4:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700155.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000470379.2:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700156.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700157.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700158.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000362089.10:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700106.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700165.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700134.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700107.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700159.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700160.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700108.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700109.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000476733.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]				rs5778549	0.98767	0.95822,0.99275,0.99981,0.99977,0.99959	74344,	1794	1878		0.30			/1.1>1.4/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167430725	167430725	T	C	hom	hom	hom		QUAL=25;DP=141,275,299;AF=1.00,1.00,1.00	CD247,POU2F1	intron,3'UTR,downstream_gene	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron7/7:c.429+2299A>G::,CD247:ENST00000392122.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::,CD247:ENST00000700155.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*956A>G::,CD247:ENST00000470379.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*956A>G::,CD247:ENST00000700156.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*956A>G::,CD247:ENST00000700157.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*956A>G::,CD247:ENST00000700158.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::,CD247:ENST00000362089.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*956A>G::,CD247:ENST00000700106.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::,CD247:ENST00000700165.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*956A>G::,CD247:ENST00000700134.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*956A>G::,CD247:ENST00000700107.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::,CD247:ENST00000700159.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*956A>G::,CD247:ENST00000700160.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::,CD247:ENST00000700108.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::,CD247:ENST00000700109.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*956A>G::,POU2F1:ENST00000367866.7:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000429375.6:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000541643.7:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000367862.9:downstream_gene_variant:MODIFIER::::,CD247:ENST00000476733.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]				rs947480	0.98771	0.95831,0.99282,1.00000,0.99977,0.99959	74364,	1791	1873	-1.3400	2.42			/1.4>1.2/0.0>0.0			37521845	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167430837	167430837	T	A	hom	hom	hom		QUAL=24;DP=162,344,335;AF=0.99,1.00,1.00	CD247,POU2F1	intron,3'UTR,downstream_gene	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron7/7:c.429+2187A>T::,CD247:ENST00000392122.4:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::,CD247:ENST00000700155.1:3_prime_UTR_variant:MODIFIER:exon5/5:c.*844A>T::,CD247:ENST00000470379.2:3_prime_UTR_variant:MODIFIER:exon6/6:c.*844A>T::,CD247:ENST00000700156.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*844A>T::,CD247:ENST00000700157.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*844A>T::,CD247:ENST00000700158.1:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::,CD247:ENST00000362089.10:3_prime_UTR_variant:MODIFIER:exon8/8:c.*844A>T::,CD247:ENST00000700106.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::,CD247:ENST00000700165.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*844A>T::,CD247:ENST00000700134.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*844A>T::,CD247:ENST00000700107.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::,CD247:ENST00000700159.1:3_prime_UTR_variant:MODIFIER:exon7/7:c.*844A>T::,CD247:ENST00000700160.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::,CD247:ENST00000700108.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::,CD247:ENST00000700109.1:3_prime_UTR_variant:MODIFIER:exon9/9:c.*844A>T::,POU2F1:ENST00000367866.7:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000429375.6:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000541643.7:downstream_gene_variant:MODIFIER::::,POU2F1:ENST00000367862.9:downstream_gene_variant:MODIFIER::::,CD247:ENST00000476733.6:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer,TF_binding_site_variant	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]				rs1052231	0.81878	0.75914,0.85995,0.76497,0.83640,0.86884	51239,	22207	27597	-0.1800	0.35			/0.0>0.0/0.0>0.0			25569266,33902375,18178846,30064597,19422667,34233083,23861880	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					POU2F1 (inh=n/a oe_syn=1.01 oe_mis=0.69 oe_lof=0.18), CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167434267	167434267	A	G	hom	hom	hom		QUAL=24;DP=90,22,20;AF=1.00,1.00,1.00	CD247	intron,downstream_gene	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron5/7:c.337-191T>C::,CD247:ENST00000392122.4:intron_variant:MODIFIER:intron5/7:c.334-191T>C::,CD247:ENST00000700155.1:intron_variant:MODIFIER:intron3/4:c.52-191T>C::,CD247:ENST00000470379.2:intron_variant:MODIFIER:intron3/5:c.49-191T>C::,CD247:ENST00000700156.1:intron_variant:MODIFIER:intron4/6:c.49-191T>C::,CD247:ENST00000700157.1:intron_variant:MODIFIER:intron4/6:c.178-191T>C::,CD247:ENST00000700158.1:intron_variant:MODIFIER:intron5/7:c.49-191T>C::,CD247:ENST00000362089.10:intron_variant:MODIFIER:intron5/7:c.337-191T>C::,CD247:ENST00000700106.1:intron_variant:MODIFIER:intron6/8:c.361-191T>C::,CD247:ENST00000700165.1:intron_variant:MODIFIER:intron5/6:c.337-191T>C::,CD247:ENST00000700134.1:intron_variant:MODIFIER:intron4/6:c.253-191T>C::,CD247:ENST00000700107.1:intron_variant:MODIFIER:intron6/8:c.358-191T>C::,CD247:ENST00000700159.1:intron_variant:MODIFIER:intron5/6:c.334-191T>C::,CD247:ENST00000700160.1:intron_variant:MODIFIER:intron6/8:c.49-191T>C::,CD247:ENST00000700108.1:intron_variant:MODIFIER:intron6/8:c.49-191T>C::,CD247:ENST00000700109.1:intron_variant:MODIFIER:intron6/8:c.52-191T>C::,CD247:ENST00000476733.6:intron_variant:MODIFIER:intron3/5:c.52-191T>C::,CD247:ENST00000700161.1:downstream_gene_variant:MODIFIER::::,CD247:ENST00000700142.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]	1259945 [benign DISEASE=not provided GENE=CD247];			rs952962	0.86288	0.80332,0.88992,0.76746,0.88580,0.90896	56810,	17684	20866	-1.3100	0.49			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167438449	167438449	T	C	hom	hom	hom		QUAL=24;DP=162,111,104;AF=1.00,1.00,1.00	CD247	intron,missense	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron4/7:c.300+121A>G::,CD247:ENST00000392122.4:intron_variant:MODIFIER:intron4/7:c.300+121A>G::,CD247:ENST00000700155.1:intron_variant:MODIFIER:intron2/4:c.15+121A>G::,CD247:ENST00000470379.2:intron_variant:MODIFIER:intron2/5:c.15+121A>G::,CD247:ENST00000700156.1:intron_variant:MODIFIER:intron3/6:c.15+121A>G::,CD247:ENST00000700157.1:intron_variant:MODIFIER:intron3/6:c.144+121A>G::,CD247:ENST00000700158.1:intron_variant:MODIFIER:intron4/7:c.15+121A>G::,CD247:ENST00000362089.10:intron_variant:MODIFIER:intron4/7:c.300+121A>G::,CD247:ENST00000700106.1:intron_variant:MODIFIER:intron5/8:c.324+121A>G::,CD247:ENST00000700165.1:intron_variant:MODIFIER:intron4/6:c.300+121A>G::,CD247:ENST00000700134.1:intron_variant:MODIFIER:intron4/6:c.252+169A>G::,CD247:ENST00000700107.1:intron_variant:MODIFIER:intron5/8:c.324+121A>G::,CD247:ENST00000700159.1:intron_variant:MODIFIER:intron4/6:c.300+121A>G::,CD247:ENST00000700160.1:intron_variant:MODIFIER:intron5/8:c.15+121A>G::,CD247:ENST00000700108.1:intron_variant:MODIFIER:intron5/8:c.15+121A>G::,CD247:ENST00000700109.1:intron_variant:MODIFIER:intron5/8:c.15+121A>G::,CD247:ENST00000476733.6:intron_variant:MODIFIER:intron2/5:c.15+121A>G::,CD247:ENST00000700161.1:missense_variant:MODERATE:exon2/2:c.136A>G:p.Arg46Gly:,CD247:ENST00000700142.1:missense_variant:MODERATE:exon4/4:c.421A>G:p.Arg141Gly:	regulatory_region_variant:promoter	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]	1192703 [benign DISEASE=not provided,not specified,Immunodeficiency 25 GENE=CD247];			rs2462553	0.86556	0.80772,0.89118,0.77498,0.88805,0.90858	57158,	17384	20456	-2.3710	0.05			/4.9>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167438836	167438836	C	A	hom	hom	hom		QUAL=24;DP=120,56,39;AF=0.99,1.00,1.00	CD247	intron	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron3/7:c.220-186G>T::,CD247:ENST00000392122.4:intron_variant:MODIFIER:intron3/7:c.220-186G>T::,CD247:ENST00000700155.1:intron_variant:MODIFIER:intron1/4:c.-66-186G>T::,CD247:ENST00000470379.2:intron_variant:MODIFIER:intron1/5:c.-66-186G>T::,CD247:ENST00000700156.1:intron_variant:MODIFIER:intron2/6:c.-66-186G>T::,CD247:ENST00000700157.1:intron_variant:MODIFIER:intron2/6:c.64-186G>T::,CD247:ENST00000700158.1:intron_variant:MODIFIER:intron3/7:c.-66-186G>T::,CD247:ENST00000362089.10:intron_variant:MODIFIER:intron3/7:c.220-186G>T::,CD247:ENST00000700106.1:intron_variant:MODIFIER:intron4/8:c.244-186G>T::,CD247:ENST00000700165.1:intron_variant:MODIFIER:intron3/6:c.220-186G>T::,CD247:ENST00000700134.1:intron_variant:MODIFIER:intron3/6:c.220-186G>T::,CD247:ENST00000700107.1:intron_variant:MODIFIER:intron4/8:c.244-186G>T::,CD247:ENST00000700159.1:intron_variant:MODIFIER:intron3/6:c.220-186G>T::,CD247:ENST00000700160.1:intron_variant:MODIFIER:intron4/8:c.-66-186G>T::,CD247:ENST00000700108.1:intron_variant:MODIFIER:intron4/8:c.-66-186G>T::,CD247:ENST00000700109.1:intron_variant:MODIFIER:intron4/8:c.-66-186G>T::,CD247:ENST00000476733.6:intron_variant:MODIFIER:intron1/5:c.-66-186G>T::,CD247:ENST00000700161.1:intron_variant:MODIFIER:intron1/1:c.-66-186G>T::,CD247:ENST00000700142.1:intron_variant:MODIFIER:intron3/3:c.220-186G>T::	regulatory_region_variant:promoter	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]	1258083 [benign DISEASE=not provided GENE=CD247];			rs2258497	0.86010	0.82275,0.87889,0.77614,0.87310,0.89177	56361,	18110	21280	-1.1210	0.08			/3.7>0.0/0.8>0.0	COSV62979487	CD247|0.00|0.00|0.00|0.00|-15|48|36|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167439433	167439433	C	T	het	hom	het		QUAL=24;DP=76,287,224;AF=0.54,0.99,0.50	CD247	intron,5'UTR	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron2/7:c.163-33G>A::,CD247:ENST00000392122.4:intron_variant:MODIFIER:intron2/7:c.163-33G>A::,CD247:ENST00000700155.1:5_prime_UTR_variant:MODIFIER:exon1/5:c.-156G>A::,CD247:ENST00000470379.2:5_prime_UTR_variant:MODIFIER:exon1/6:c.-156G>A::,CD247:ENST00000700156.1:intron_variant:MODIFIER:intron1/6:c.-123-33G>A::,CD247:ENST00000700157.1:intron_variant:MODIFIER:intron1/6:c.7-33G>A::,CD247:ENST00000700158.1:intron_variant:MODIFIER:intron2/7:c.-123-33G>A::,CD247:ENST00000362089.10:intron_variant:MODIFIER:intron2/7:c.163-33G>A::,CD247:ENST00000700106.1:intron_variant:MODIFIER:intron3/8:c.187-33G>A::,CD247:ENST00000700165.1:intron_variant:MODIFIER:intron2/6:c.163-33G>A::,CD247:ENST00000700134.1:intron_variant:MODIFIER:intron2/6:c.163-33G>A::,CD247:ENST00000700107.1:intron_variant:MODIFIER:intron3/8:c.187-33G>A::,CD247:ENST00000700159.1:intron_variant:MODIFIER:intron2/6:c.163-33G>A::,CD247:ENST00000700160.1:intron_variant:MODIFIER:intron3/8:c.-123-33G>A::,CD247:ENST00000700108.1:intron_variant:MODIFIER:intron3/8:c.-123-33G>A::,CD247:ENST00000700109.1:intron_variant:MODIFIER:intron3/8:c.-123-33G>A::,CD247:ENST00000476733.6:5_prime_UTR_variant:MODIFIER:exon1/6:c.-156G>A::,CD247:ENST00000700161.1:5_prime_UTR_variant:MODIFIER:exon1/2:c.-156G>A::,CD247:ENST00000700142.1:intron_variant:MODIFIER:intron2/3:c.163-33G>A::	regulatory_region_variant:promoter	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]	1179252 [benign DISEASE=not specified,not provided GENE=CD247];			rs840016	0.28239	0.08766,0.30610,0.10503,0.40316,0.29193	7494,	28006	109256	0.5350	10.22			/1.7>1.6/0.0>0.0	COSV62980812	CD247|0.00|0.00|0.00|0.00|-38|-41|-4|46	20453842,20933377,22294642,22355377,26119816,33344378	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39)
chr1	167518349	167518349	C	G	het	wt	het		QUAL=24;DP=49,16,67;AF=0.53,0.00,0.55	CD247,AKR1D1P1	intron,upstream_gene	CD247:ENST00000700105.1:intron_variant:MODIFIER:intron1/7:c.58+59G>C::,CD247:ENST00000392122.4:intron_variant:MODIFIER:intron1/7:c.58+59G>C::,CD247:ENST00000362089.10:intron_variant:MODIFIER:intron1/7:c.58+59G>C::,CD247:ENST00000700106.1:intron_variant:MODIFIER:intron1/8:c.-64+59G>C::,CD247:ENST00000700165.1:intron_variant:MODIFIER:intron1/6:c.58+59G>C::,CD247:ENST00000700134.1:intron_variant:MODIFIER:intron1/6:c.58+59G>C::,CD247:ENST00000700107.1:intron_variant:MODIFIER:intron1/8:c.-64+59G>C::,CD247:ENST00000700159.1:intron_variant:MODIFIER:intron1/6:c.58+59G>C::,CD247:ENST00000700160.1:intron_variant:MODIFIER:intron1/8:c.-327+59G>C::,CD247:ENST00000700108.1:intron_variant:MODIFIER:intron1/8:c.-537+59G>C::,CD247:ENST00000700109.1:intron_variant:MODIFIER:intron1/8:c.-537+59G>C::,CD247:ENST00000700142.1:intron_variant:MODIFIER:intron1/3:c.58+59G>C::,AKR1D1P1:ENST00000457236.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	186780_[GENE=CD247_PHENOS=?Immunodeficiency 25, 610163 (3), Autosomal recessive]	1237879 [benign DISEASE=not provided,not specified GENE=CD247];		(CCACTC)n (Simple_repeat)	rs35864197	0.14285	0.07556,0.12918,0.01797,0.18845,0.23837	1775,	18187	130427	0.8050	4.07			/6.0>6.5/1.2>1.3		CD247|0.00|0.00|0.00|0.00|-3|-16|-7|13		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CD247 (inh=AR oe_syn=0.87 oe_mis=1.09 oe_lof=0.39), AKR1D1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	179550354	179550354	G	A	hom	hom	hom		QUAL=24;DP=8,3,5;AF=1.00,1.00,1.00	AXDND1,NPHS2	intron,downstream_gene	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-4158G>A::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-4158G>A::,NPHS2:ENST00000367615.9:downstream_gene_variant:MODIFIER::::,NPHS2:ENST00000367616.4:downstream_gene_variant:MODIFIER::::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]				rs3767840	0.61424	0.60359,0.63924,0.46942,0.62516,0.59146	28819,	35690	58612	0.0230	2.87			/0.0>0.0/1.5>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179550745	179550745	T	C	hom	hom	hom		QUAL=24;DP=112,330,273;AF=1.00,1.00,1.00	AXDND1,NPHS2	intron,3'UTR	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3767T>C::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3767T>C::,NPHS2:ENST00000367615.9:3_prime_UTR_variant:MODIFIER:exon8/8:c.*428A>G::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*428A>G::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	224486 [benign DISEASE=not provided,Nephrotic syndrome, type 2 GENE=NPHS2];			rs1060775	0.90446	0.84172,0.93595,0.96437,0.92970,0.87796	62401,	12806	14536	0.2640	1.31			/1.6>1.9/0.0>0.0,/6.6>6.7/0.0>0.0		AXDND1|0.00|0.00|0.00|0.00|40|41|40|-31,NPHS2|0.00|0.00|0.00|0.00|-1|-4|-13|41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179550915	179550915	T	C	het	wt	hom		QUAL=24;DP=125,170,121;AF=0.46,0.00,1.00	AXDND1,NPHS2	intron,3'UTR	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3597T>C::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3597T>C::,NPHS2:ENST00000367615.9:3_prime_UTR_variant:MODIFIER:exon8/8:c.*258A>G::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*258A>G::	regulatory_region_variant:promoter	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	224485 [benign DISEASE=not provided,Nephrotic syndrome, type 2 GENE=NPHS2];			rs2274622	0.24173	0.12703,0.30240,0.35659,0.28107,0.35077	4898,	26972	115336	0.2590	2.72			/2.7>2.3/0.0>0.0,/0.0>0.0/0.7>1.2		AXDND1|0.00|0.00|0.00|0.00|-2|50|50|5,NPHS2|0.00|0.00|0.00|0.00|29|23|-22|-19	17942957	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179551016	179551016	C	T	hom	hom	hom		QUAL=24;DP=116,263,194;AF=1.00,0.99,1.00	AXDND1,NPHS2	intron,3'UTR	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3496C>T::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3496C>T::,NPHS2:ENST00000367615.9:3_prime_UTR_variant:MODIFIER:exon8/8:c.*157G>A::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*157G>A::	regulatory_region_variant:promoter	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	224483 [benign DISEASE=not provided,Nephrotic syndrome, type 2 GENE=NPHS2];			rs1410590	0.90721	0.85144,0.93671,0.96413,0.92974,0.87806	62802,	12522	14128	-1.5440	0.46			/0.5>1.6/0.0>0.0,/0.0>0.0/2.8>0.0			23269701,17236131	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179551119	179551119	C	G	hom	hom	hom		QUAL=24;DP=151,175,131;AF=0.99,0.99,0.99	AXDND1,NPHS2	intron,3'UTR	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3393C>G::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3393C>G::,NPHS2:ENST00000367615.9:3_prime_UTR_variant:MODIFIER:exon8/8:c.*54G>C::,NPHS2:ENST00000367616.4:3_prime_UTR_variant:MODIFIER:exon7/7:c.*54G>C::	regulatory_region_variant:enhancer	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	293845 [benign DISEASE=not provided,Nephrotic syndrome, type 2,not specified GENE=NPHS2];			rs1410591	0.61479	0.60378,0.63894,0.46842,0.62648,0.59119	28879,	35713	58567	0.9520	4.16			/1.4>2.1/3.0>2.9,/0.0>0.0/0.0>0.0	COSV62634863	AXDND1|0.00|0.00|0.00|0.00|16|-2|-3|-2,NPHS2|0.00|0.00|0.00|0.00|-7|-32|-48|37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179551371	179551371	G	A	hom	hom	hom		QUAL=24;DP=350,183,128;AF=0.99,1.00,0.99	AXDND1,NPHS2	intron,synonymous	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-3141G>A::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-3141G>A::,NPHS2:ENST00000367615.9:synonymous_variant:LOW:exon8/8:c.954C>T:p.Ala318=:,NPHS2:ENST00000367616.4:synonymous_variant:LOW:exon7/7:c.750C>T:p.Ala250=:	regulatory_region_variant:enhancer	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	260432 [benign DISEASE=Nephrotic syndrome, type 2,not provided,Steroid-resistant nephrotic syndrome,not specified GENE=NPHS2];			rs1410592	0.61410	0.60372,0.63881,0.46779,0.62520,0.59127	28814,	35712	58654	-0.5620	0.17			/0.0>0.0/0.0>0.0,/3.8>3.6/0.0>0.0	COSV62634578	AXDND1|0.00|0.00|0.00|0.00|21|-33|21|-16,NPHS2|0.00|0.00|0.00|0.00|-44|13|-29|19	25741868,20947785,31754646,24070238	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179552549	179552549	T	C	het	het	wt		QUAL=24;DP=149,124,19;AF=0.45,0.48,0.00	AXDND1,NPHS2	intron	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-1963T>C::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-1963T>C::,NPHS2:ENST00000367615.9:intron_variant:MODIFIER:intron7/7:c.873+54A>G::,NPHS2:ENST00000367616.4:intron_variant:MODIFIER:intron6/6:c.669+54A>G::	regulatory_region_variant:enhancer	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1227202 [benign DISEASE=not provided GENE=NPHS2];			rs11808359	0.04669	0.01153,0.03271,0.00000,0.06995,0.02580	265,	6577	145121	-0.1000	1.78			/3.5>3.2/0.0>0.0,/0.0>0.0/0.0>0.0		AXDND1|0.00|0.00|0.00|0.00|34|11|-10|-26,NPHS2|0.00|0.00|0.00|0.00|-5|-40|5|-4		131	3013	0	0 / 0					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179552797	179552797	G	T	hom	het	hom		QUAL=24;DP=157,103,84;AF=1.00,0.46,1.00	AXDND1,NPHS2	intron	AXDND1:ENST00000617277.4:intron_variant:MODIFIER:intron24/24:c.*1207-1715G>T::,AXDND1:ENST00000367618.8:intron_variant:MODIFIER:intron25/25:c.3032-1715G>T::,NPHS2:ENST00000367615.9:intron_variant:MODIFIER:intron6/7:c.795-116C>A::,NPHS2:ENST00000367616.4:intron_variant:MODIFIER:intron5/6:c.591-116C>A::	regulatory_region_variant:enhancer	604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1289362 [benign DISEASE=not provided GENE=NPHS2];			rs2274626	0.41668	0.55266,0.43649,0.43203,0.35213,0.39668	13881,	35611	88719	-0.3310	0.91			/0.0>0.0/0.0>0.0		AXDND1|0.00|0.00|0.00|0.00|8|1|8|39,NPHS2|0.00|0.00|0.00|0.00|5|24|5|-30	17903305,17942957,17236131	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					AXDND1 (inh=AR oe_syn=0.99 oe_mis=1.04 oe_lof=0.78), NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179559905	179559905	G	A	het	het	wt		QUAL=25;DP=75,52,17;AF=0.48,0.46,0.00	NPHS2	intron	NPHS2:ENST00000367615.9:intron_variant:MODIFIER:intron3/7:c.452-144C>T::,NPHS2:ENST00000367616.4:intron_variant:MODIFIER:intron3/6:c.452-144C>T::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	1232335 [benign DISEASE=not provided GENE=NPHS2];		MER94 (DNA/hAT-Blackjack)	rs41267604	0.05181	0.03092,0.03422,0.00000,0.06959,0.02577	272,	7340	144282	-0.0400	5.48			/11.3>11.9/0.0>0.0		NPHS2|0.00|0.00|0.00|0.00|-11|-5|-10|23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76)
chr1	179575763	179575763	T	C	n/a	hom	hom		QUAL=24;DP=1,13,4;AF=0.00,1.00,1.00	NPHS2,RNU5F-2P	synonymous,upstream_gene	NPHS2:ENST00000367615.9:synonymous_variant:LOW:exon1/8:c.102A>G:p.Gly34=:,NPHS2:ENST00000367616.4:synonymous_variant:LOW:exon1/7:c.102A>G:p.Gly34=:,RNU5F-2P:ENST00000516066.1:upstream_gene_variant:MODIFIER::::		604766_[GENE=NPHS2_PHENOS=Nephrotic syndrome, type 2, 600995 (3), Autosomal recessive]	260424 [benign DISEASE=Nephrotic syndrome, type 2,not specified,not provided,Steroid-resistant nephrotic syndrome GENE=NPHS2];			rs1079292	0.94739	0.84393,0.97556,0.97784,0.99278,0.94074	68595,	6880	8000	-0.4120	0.62			/0.0>0.0/0.0>0.0	COSV62634486	NPHS2|0.00|0.00|0.00|0.00|-16|48|18|-1	25741868,20947785,19406966,31754646	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NPHS2 (inh=AR oe_syn=1.01 oe_mis=0.86 oe_lof=0.76), RNU5F-2P (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	180230249	180230249	-	AG	het	wt	hom		QUAL=24;DP=31,9,11;AF=0.45,0.00,1.00	LHX4	upstream_gene	LHX4:ENST00000263726.4:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]			G-rich (Low_complexity)	rs138033992	0.41427	0.45472,0.33652,0.17137,0.43424,0.38331	13174,	35650	87658		17.38							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35)
chr1	180248115	180248115	C	T	het	wt	hom		QUAL=25;DP=100,22,38;AF=0.50,0.00,1.00	LHX4	intron	LHX4:ENST00000263726.4:intron_variant:MODIFIER:intron1/5:c.77-170C>T::	regulatory_region_variant:promoter	602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]	1269459 [benign DISEASE=not provided GENE=LHX4];		MER91A (DNA/hAT-Tip100)	rs4652490	0.18340	0.20215,0.13410,0.15875,0.19665,0.08240	2696,	22523	124295	-0.3180	6.27			/0.4>0.4/6.8>3.4		LHX4|0.00|0.00|0.01|0.00|46|0|-34|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35)
chr1	180266593	180266593	C	T	het	het	wt		QUAL=24;DP=75,107,17;AF=0.52,0.42,0.00	LHX4,ACBD6	splice_region&synonymous,downstream_gene	LHX4:ENST00000263726.4:splice_region_variant&synonymous_variant:LOW:exon3/6:c.450C>T:p.Asn150=:,ACBD6:ENST00000642319.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]&616352_[GENE=ACBD6_PHENOS=Neurodevelopmental disorder with progressive movement abnormalities, 620785 (3), Autosomal recessive]	262223 [benign DISEASE=not provided,not specified,Short stature-pituitary and cerebellar defects-small sella turcica syndrome GENE=LHX4];			rs16855642	0.03906	0.10355,0.01823,0.01448,0.01121,0.01782	265,	5416	146282	-0.7690	9.03			9.9>9.3/0.0>0.0/9.9>9.3		LHX4|0.00|0.00|0.00|0.00|37|-47|-2|1	25741868	31	1335	0	0 / 0					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35), ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180271375	180271375	T	C	het	wt	het		QUAL=24;DP=67,16,77;AF=0.52,0.00,0.47	LHX4,ACBD6	splice_region&intron,3'UTR	LHX4:ENST00000263726.4:splice_region_variant&intron_variant:LOW:intron3/5:c.452-5T>C::,ACBD6:ENST00000642319.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1850A>G::	regulatory_region_variant:enhancer	602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]&616352_[GENE=ACBD6_PHENOS=Neurodevelopmental disorder with progressive movement abnormalities, 620785 (3), Autosomal recessive]	293866 [benign DISEASE=not provided,Short stature-pituitary and cerebellar defects-small sella turcica syndrome GENE=LHX4];			rs2764449	0.05752	0.01485,0.04532,0.01817,0.07858,0.07172	358,	8040	143466	1.0550	6.04			10.0>9.2/10.0>9.2/0.0>0.0,/0.0>0.0/0.2>0.0	COSV55378051	LHX4|0.00|0.00|0.00|0.00|-11|5|14|22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35), ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180271617	180271617	C	T	het	het	het		QUAL=24;DP=69,63,45;AF=0.55,0.51,0.49	LHX4,ACBD6	intron,3'UTR	LHX4:ENST00000263726.4:intron_variant:MODIFIER:intron4/5:c.606+83C>T::,ACBD6:ENST00000642319.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1608G>A::	regulatory_region_variant:enhancer,TF_binding_site_variant	602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]&616352_[GENE=ACBD6_PHENOS=Neurodevelopmental disorder with progressive movement abnormalities, 620785 (3), Autosomal recessive]	1266198 [benign DISEASE=not provided GENE=LHX4];			rs3845397	0.39943	0.16837,0.33071,0.56362,0.49926,0.59131	14042,	32514	91112	-3.5160	0.17			/4.2>3.8/0.0>0.0,/1.9>2.2/3.6>0.0	COSV55372623	LHX4|0.00|0.00|0.00|0.00|17|2|-24|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35), ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180274389	180274389	A	G	het	het	het		QUAL=24;DP=109,191,155;AF=0.50,0.57,0.48	LHX4,ACBD6	missense,intron	LHX4:ENST00000263726.4:missense_variant:MODERATE:exon6/6:c.983A>G:p.Asn328Ser:,ACBD6:ENST00000642319.1:intron_variant:MODIFIER:intron10/13:c.*936+262T>C::		602146_[GENE=LHX4_PHENOS=Pituitary hormone deficiency, combined, 4, 262700 (3), Autosomal dominant]&616352_[GENE=ACBD6_PHENOS=Neurodevelopmental disorder with progressive movement abnormalities, 620785 (3), Autosomal recessive]	262225 [benign DISEASE=not specified,not provided,Short stature-pituitary and cerebellar defects-small sella turcica syndrome GENE=LHX4];			rs7536561	0.41921	0.18765,0.34420,0.59332,0.51844,0.60731	15289,	33132	88266	2.5250	15.65	0.264	0.06	/0.6>5.7/0.0>0.0,/0.0>0.0/0.0>0.0	COSV55374116	LHX4|0.00|0.00|0.00|0.00|1|25|23|-35	25741868,34868058,23199197,25938945,29998616,36827438	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LHX4 (inh=AD oe_syn=1.06 oe_mis=0.88 oe_lof=0.35), ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180288557	180288557	A	C	hom	hom	hom		QUAL=24;DP=154,204,156;AF=0.99,1.00,1.00	ACBD6	intron	ACBD6:ENST00000642319.1:intron_variant:MODIFIER:intron7/13:c.695-40T>G::,ACBD6:ENST00000367595.4:intron_variant:MODIFIER:intron7/7:c.695-40T>G::	regulatory_region_variant:enhancer	616352_[GENE=ACBD6_PHENOS=Neurodevelopmental disorder with progressive movement abnormalities, 620785 (3), Autosomal recessive]				rs2254465	0.94975	0.96069,0.94302,0.98842,0.94443,0.91151	68706,	7157	7649	-3.9170	0.02			/0.3>0.0/3.2>3.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180314524	180314524	T	C	hom	hom	hom		QUAL=24;DP=84,36,32;AF=1.00,1.00,1.00	ACBD6	intron	ACBD6:ENST00000642319.1:intron_variant:MODIFIER:intron7/13:c.694+168A>G::,ACBD6:ENST00000367595.4:intron_variant:MODIFIER:intron7/7:c.694+168A>G::		616352_[GENE=ACBD6_PHENOS=Neurodevelopmental disorder with progressive movement abnormalities, 620785 (3), Autosomal recessive]			AluSx1 (SINE/Alu)	rs2764433	0.95634	0.98295,0.94617,0.98825,0.94469,0.91162	69734,	6211	6651	-2.3750	0.15			/0.0>0.1/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180397348	180397348	G	C	het	hom	het		QUAL=25;DP=60,27,17;AF=0.52,1.00,0.35	ACBD6	intron	ACBD6:ENST00000642319.1:intron_variant:MODIFIER:intron6/13:c.663+168C>G::,ACBD6:ENST00000367595.4:intron_variant:MODIFIER:intron6/7:c.663+168C>G::	regulatory_region_variant:enhancer,TF_binding_site_variant	616352_[GENE=ACBD6_PHENOS=Neurodevelopmental disorder with progressive movement abnormalities, 620785 (3), Autosomal recessive]			L1MB5 (LINE/L1)	rs10798759	0.54966	0.39794,0.51618,0.56506,0.62356,0.66833	23804,	35920	68434	-0.2870	0.56			/0.0>0.0/0.0>0.0		ACBD6|0.00|0.00|0.00|0.00|-31|20|47|-29		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	180413647	180413647	T	A	het	hom	het		QUAL=24;DP=78,7,7;AF=0.40,1.00,0.57	ACBD6	intron	ACBD6:ENST00000642319.1:intron_variant:MODIFIER:intron4/13:c.468-176A>T::,ACBD6:ENST00000367595.4:intron_variant:MODIFIER:intron4/7:c.468-176A>T::		616352_[GENE=ACBD6_PHENOS=Neurodevelopmental disorder with progressive movement abnormalities, 620785 (3), Autosomal recessive]				rs4421553	0.48623	0.18673,0.48663,0.56342,0.62030,0.66066	20797,	32304	78084	-0.5460	0.76			/0.6>8.3/0.0>0.0		ACBD6|0.01|0.00|0.00|0.00|-11|-2|24|25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACBD6 (inh=n/a oe_syn=1.08 oe_mis=0.98 oe_lof=0.68)
chr1	183186170	183186170	G	A	het	hom	wt		QUAL=24;DP=246,500,253;AF=0.56,1.00,0.00	LAMC2	upstream_gene	LAMC2:ENST00000493293.5:upstream_gene_variant:MODIFIER::::,LAMC2:ENST00000264144.5:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	293977 [benign DISEASE=not provided,Junctional epidermolysis bullosa GENE=LAMC2];			rs2276543	0.27313	0.19538,0.31554,0.38086,0.27885,0.33942	5967,	29604	110544	3.4730	22.00						30072576,29875488,34648354,35078996	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183186565	183186565	C	A	het	hom	wt		QUAL=24;DP=63,13,16;AF=0.44,1.00,0.00	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron1/21:c.79+134C>A::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron1/22:c.79+134C>A::	regulatory_region_variant:open_chromatin_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1250223 [benign DISEASE=not provided GENE=LAMC2];			rs6678888	0.31667	0.24099,0.33559,0.46383,0.31666,0.38189	7121,	31067	97773	0.9110	8.06			/3.8>1.8/0.0>0.0		LAMC2|0.00|0.00|0.00|0.00|-44|21|35|-21	36325427	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183186581	183186581	T	-	het	hom	het		QUAL=25;DP=58,10,13;AF=0.47,0.90,0.46	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron1/21:c.79+150del::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron1/22:c.79+150del::	regulatory_region_variant:open_chromatin_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1178172 [benign DISEASE=not provided GENE=LAMC2];			rs60707856	0.55976	0.68890,0.56893,0.72653,0.47505,0.56128	24562,	35827	66813	0.6650	3.78			/4.9>6.0/0.0>0.0	COSV51452174,COSV51455144	LAMC2|0.00|0.00|0.00|0.00|-30|6|-48|-36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183186582	183186582	C	A	het	hom	het		QUAL=24;DP=58,9,13;AF=0.47,1.00,0.46	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron1/21:c.79+151C>A::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron1/22:c.79+151C>A::	regulatory_region_variant:open_chromatin_region	150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1253775 [benign DISEASE=not provided GENE=LAMC2];			rs61418038	0.55977	0.68892,0.56893,0.72644,0.47506,0.56170	24565,	35830	66816	0.0720	6.25			/4.9>5.1/0.0>0.0		LAMC2|0.00|0.00|0.00|0.00|4|6|-50|-38		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183207835	183207835	-	T	het	wt	het	low_conf_region	QUAL=24;DP=144,88,74;AF=0.44,0.00,0.32	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron1/21:c.80-31dup::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron1/22:c.80-31dup::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1224645 [benign DISEASE=not provided GENE=LAMC2];			rs10668798	0.17480	0.19734,0.16567,0.25335,0.15825,0.22760	2248,	19901	115173		2.16			/0.8>2.0/1.5>1.5	COSV51458071	LAMC2|0.00|0.00|0.00|0.00|46|33|-3|46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183208083	183208083	A	G	het	hom	wt		QUAL=24;DP=136,241,69;AF=0.47,1.00,0.00	LAMC2	splice_region&intron	LAMC2:ENST00000493293.5:splice_region_variant&intron_variant:LOW:intron2/21:c.268+14A>G::,LAMC2:ENST00000264144.5:splice_region_variant&intron_variant:LOW:intron2/22:c.268+14A>G::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	259785 [benign DISEASE=not provided,Junctional epidermolysis bullosa,Junctional epidermolysis bullosa, non-Herlitz type,not specified,Junctional epidermolysis bullosa gravis of Herlitz GENE=LAMC2];		GA-rich (Low_complexity)	rs647347	0.45869	0.46778,0.47999,0.55200,0.42873,0.50957	16149,	37328	82166	-1.3710	0.07			/0.0>0.0/2.5>1.4	COSV51456075,COSV51458451	LAMC2|0.00|0.00|0.00|0.00|48|-13|-14|-26	25741868,36969605	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183236389	183236390	AA	-	het	hom	het	low_conf_region	QUAL=25;DP=185,117,84;AF=0.56,0.65,0.63	LAMC2	intron	LAMC2:ENST00000493293.5:intron_variant:MODIFIER:intron16/21:c.2457-55_2457-54del::,LAMC2:ENST00000264144.5:intron_variant:MODIFIER:intron16/22:c.2457-55_2457-54del::		150292_[GENE=LAMC2_PHENOS=Epidermolysis bullosa, junctional 3B, severe, 619786 (3), Autosomal recessive; Epidermolysis bullosa, junctional 3A, intermediate, 619785 (3), Autosomal recessive]	1278088 [benign DISEASE=not provided GENE=LAMC2];		AluJb (SINE/Alu)	rs34154823	0.39424	0.26061,0.38946,0.43055,0.44338,0.33388	9351,	30177	75103	0.3020	1.36			/0.0>0.0/0.0>0.0		LAMC2|0.00|0.00|0.00|0.00|20|31|47|-15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMC2 (inh=AR oe_syn=0.95 oe_mis=0.96 oe_lof=0.48)
chr1	183555720	183555720	C	A	hom	hom	hom		QUAL=24;DP=149,360,327;AF=1.00,1.00,0.99	NCF2,SMG7	3'UTR,downstream_gene	NCF2:ENST00000367535.8:3_prime_UTR_variant:MODIFIER:exon15/15:c.*398G>T::,NCF2:ENST00000413720.5:3_prime_UTR_variant:MODIFIER:exon14/14:c.*398G>T::,NCF2:ENST00000418089.5:3_prime_UTR_variant:MODIFIER:exon13/13:c.*398G>T::,NCF2:ENST00000367536.5:3_prime_UTR_variant:MODIFIER:exon16/16:c.*398G>T::,NCF2:ENST00000697351.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*398G>T::,NCF2:ENST00000697330.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*398G>T::,SMG7:ENST00000367537.7:downstream_gene_variant:MODIFIER::::,SMG7:ENST00000688051.1:downstream_gene_variant:MODIFIER::::,SMG7:ENST00000508461.5:downstream_gene_variant:MODIFIER::::,SMG7:ENST00000685780.1:downstream_gene_variant:MODIFIER::::,SMG7:ENST00000347615.6:downstream_gene_variant:MODIFIER::::,SMG7:ENST00000507469.5:downstream_gene_variant:MODIFIER::::,SMG7:ENST00000515829.6:downstream_gene_variant:MODIFIER::::		608515_[GENE=NCF2_PHENOS=Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive]	294066 [benign DISEASE=Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2,not provided GENE=NCF2];			rs796860	0.90159	0.93726,0.89476,0.99807,0.87732,0.94749	61969,	13248	14974	-2.0460	0.32			/0.0>0.0/0.0>0.0			24163247,30567305	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMG7 (inh=n/a oe_syn=0.96 oe_mis=0.75 oe_lof=0.12), NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	183556317	183556317	T	G	hom	hom	hom		QUAL=24;DP=63,108,113;AF=1.00,0.99,1.00	NCF2,SMG7	intron,downstream_gene	NCF2:ENST00000367535.8:intron_variant:MODIFIER:intron14/14:c.1469-87A>C::,NCF2:ENST00000413720.5:intron_variant:MODIFIER:intron13/13:c.1334-87A>C::,NCF2:ENST00000418089.5:intron_variant:MODIFIER:intron12/12:c.1226-87A>C::,NCF2:ENST00000367536.5:intron_variant:MODIFIER:intron15/15:c.1469-87A>C::,NCF2:ENST00000697351.1:intron_variant:MODIFIER:intron13/13:c.1361-87A>C::,NCF2:ENST00000697330.1:intron_variant:MODIFIER:intron15/15:c.1469-87A>C::,SMG7:ENST00000367537.7:downstream_gene_variant:MODIFIER::::,SMG7:ENST00000688051.1:downstream_gene_variant:MODIFIER::::,SMG7:ENST00000508461.5:downstream_gene_variant:MODIFIER::::,SMG7:ENST00000685780.1:downstream_gene_variant:MODIFIER::::,SMG7:ENST00000347615.6:downstream_gene_variant:MODIFIER::::,SMG7:ENST00000507469.5:downstream_gene_variant:MODIFIER::::,SMG7:ENST00000515829.6:downstream_gene_variant:MODIFIER::::		608515_[GENE=NCF2_PHENOS=Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive]	1226524 [benign DISEASE=not specified,not provided GENE=NCF2];			rs699244	0.89355	0.90648,0.89342,0.99807,0.87863,0.94751	60855,	14292	16202	0.3840	0.99			/0.0>0.0/0.7>2.3	COSV61633935		17897462	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					SMG7 (inh=n/a oe_syn=0.96 oe_mis=0.75 oe_lof=0.12), NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	183565800	183565800	C	T	hom	het	hom		QUAL=25;DP=150,253,193;AF=1.00,0.51,1.00	NCF2	intron	NCF2:ENST00000367535.8:intron_variant:MODIFIER:intron9/14:c.925-21G>A::,NCF2:ENST00000413720.5:intron_variant:MODIFIER:intron8/13:c.790-21G>A::,NCF2:ENST00000418089.5:intron_variant:MODIFIER:intron7/12:c.682-21G>A::,NCF2:ENST00000367536.5:intron_variant:MODIFIER:intron10/15:c.925-21G>A::,NCF2:ENST00000697351.1:intron_variant:MODIFIER:intron8/13:c.817-21G>A::,NCF2:ENST00000697330.1:intron_variant:MODIFIER:intron10/15:c.925-21G>A::		608515_[GENE=NCF2_PHENOS=Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive]	1235081 [benign DISEASE=Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2,not provided,not specified GENE=NCF2];			rs2296164	0.45505	0.35993,0.56039,0.61536,0.47397,0.46844	16111,	36872	82746	-2.9130	0.01			/0.0>0.0/0.0>0.0	COSV62315476	NCF2|0.00|0.00|0.00|0.00|-21|9|-29|-21	25416100,24163247,30567305,24239855	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	183573252	183573252	T	C	hom	het	hom		QUAL=24;DP=258,266,192;AF=0.98,0.55,1.00	NCF2	missense,intron	NCF2:ENST00000367535.8:missense_variant:MODERATE:exon5/15:c.542A>G:p.Lys181Arg:,NCF2:ENST00000413720.5:missense_variant:MODERATE:exon4/14:c.407A>G:p.Lys136Arg:,NCF2:ENST00000418089.5:intron_variant:MODIFIER:intron3/12:c.367-2413A>G::,NCF2:ENST00000367536.5:missense_variant:MODERATE:exon6/16:c.542A>G:p.Lys181Arg:,NCF2:ENST00000697351.1:intron_variant:MODIFIER:intron4/13:c.501+1235A>G::,NCF2:ENST00000697330.1:missense_variant:MODERATE:exon6/16:c.542A>G:p.Lys181Arg:	regulatory_region_variant:enhancer	608515_[GENE=NCF2_PHENOS=Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive]	256116 [benign DISEASE=not specified,not provided,Granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2 GENE=NCF2];			rs2274064	0.45725	0.36437,0.56119,0.62009,0.47303,0.51059	16273,	36957	82501	0.6150	16.60	0.084	0.06	/0.0>4.8/1.1>0.0	COSV62314890	NCF2|0.00|0.00|0.00|0.00|-1|40|37|4	25741868,24033266,16608528,23821607,25416100,24163247,24239855,28926565,24159917	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	183587156	183587156	A	G	het	het	wt		QUAL=24;DP=75,26,17;AF=0.39,0.42,0.00	NCF2	intron	NCF2:ENST00000367535.8:intron_variant:MODIFIER:intron1/14:c.175-179T>C::,NCF2:ENST00000413720.5:intron_variant:MODIFIER:intron1/13:c.175-179T>C::,NCF2:ENST00000418089.5:intron_variant:MODIFIER:intron1/12:c.175-179T>C::,NCF2:ENST00000367536.5:intron_variant:MODIFIER:intron2/15:c.175-179T>C::,NCF2:ENST00000697351.1:intron_variant:MODIFIER:intron1/13:c.175-179T>C::,NCF2:ENST00000697330.1:intron_variant:MODIFIER:intron2/15:c.175-179T>C::	regulatory_region_variant:promoter	608515_[GENE=NCF2_PHENOS=Chronic granulomatous disease 2, autosomal recessive, 233710 (3), Autosomal recessive]	1287540 [benign DISEASE=not provided GENE=NCF2];			rs789192	0.49352	0.67530,0.47363,0.16641,0.43869,0.32187	19755,	35539	77021	0.2970	1.43			/0.0>0.0/0.0>0.0	COSV62315307	NCF2|0.00|0.00|0.00|0.00|9|50|-29|-6	30567305	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NCF2 (inh=AR oe_syn=1.01 oe_mis=0.82 oe_lof=0.49)
chr1	196651787	196651787	C	T	het	het	wt		QUAL=24;DP=164,61,16;AF=0.47,0.52,0.00	CFH	5'UTR,upstream_gene	CFH:ENST00000359637.3:5_prime_UTR_variant:MODIFIER:exon1/9:c.-331C>T::,CFH:ENST00000695968.1:upstream_gene_variant:MODIFIER::::,CFH:ENST00000695969.1:upstream_gene_variant:MODIFIER::::,CFH:ENST00000695970.1:upstream_gene_variant:MODIFIER::::,CFH:ENST00000695971.1:upstream_gene_variant:MODIFIER::::,CFH:ENST00000695974.1:upstream_gene_variant:MODIFIER::::,CFH:ENST00000695976.1:upstream_gene_variant:MODIFIER::::,CFH:ENST00000695978.1:upstream_gene_variant:MODIFIER::::,CFH:ENST00000695979.1:upstream_gene_variant:MODIFIER::::,CFH:ENST00000695981.1:upstream_gene_variant:MODIFIER::::,CFH:ENST00000696023.1:upstream_gene_variant:MODIFIER::::,CFH:ENST00000696027.1:upstream_gene_variant:MODIFIER::::,CFH:ENST00000696028.1:upstream_gene_variant:MODIFIER::::,CFH:ENST00000696029.1:upstream_gene_variant:MODIFIER::::,CFH:ENST00000695984.1:upstream_gene_variant:MODIFIER::::,CFH:ENST00000696030.1:upstream_gene_variant:MODIFIER::::,CFH:ENST00000367429.9:upstream_gene_variant:MODIFIER::::,CFH:ENST00000630130.2:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	1249325 [benign DISEASE=not provided,CFH-related disorder GENE=CFH];	CR033844 [CLASS=DP MUT=ALT PHEN="Haemolytic uraemic syndrome association with" GENE=CFH];		rs3753394	0.22773	0.07444,0.27692,0.52755,0.28678,0.27769	5012,	24603	117429	-0.3120	3.08			/0.0>0.0/0.0>0.0			18483746,19861685,26559391,31118930,33224962,27805046,22253485,30696427,22035603,26152901,17167412,19026761,18421087,20161815,15870199,18316707,18515590,19187823,20132989,21784901,22509112,23687431,23919682,24365176,24558588,25205864,26296146,27252648,29844195,30225264,30300269,31815877,31925659,33643312,21067572,21111031,31525397,19162324,23966370,26852301,30073298,33976403,35052395,33387109,31883521,22622361,22223611,23431077,20595690,34150810,27500215,19373492,19878229,23441108,24722444,36189289,30046676,36793547,33920896,36749597,36660127,24904082,35682771,32923941,23747994,36845135,22153652,34502390,32244370,37067365,25735482,23028341,35925583,31428128,24201651,36275662,22246034,32954088,29929468,33456587,24272913,36939807,20523265,37069997,17517971,18371543,15163532,19854291,20850857,20304497	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196685194	196685194	A	C	het	het	het		QUAL=24;DP=284,267,209;AF=0.49,0.48,0.48	CFH	synonymous,intron	CFH:ENST00000359637.3:synonymous_variant:LOW:exon6/9:c.729A>C:p.Ala243=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695968.1:synonymous_variant:LOW:exon5/8:c.738A>C:p.Ala246=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695969.1:synonymous_variant:LOW:exon7/17:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695970.1:synonymous_variant:LOW:exon7/21:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695971.1:synonymous_variant:LOW:exon7/22:c.921A>C:p.Ala307=:,CFH:ENST00000695974.1:synonymous_variant:LOW:exon7/21:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695976.1:synonymous_variant:LOW:exon8/23:c.732A>C:p.Ala244=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695978.1:synonymous_variant:LOW:exon7/11:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695979.1:synonymous_variant:LOW:exon7/10:c.921A>C:p.Ala307=:,CFH:ENST00000695981.1:synonymous_variant:LOW:exon7/23:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696023.1:synonymous_variant:LOW:exon7/10:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696027.1:synonymous_variant:LOW:exon7/22:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696028.1:synonymous_variant:LOW:exon7/22:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696029.1:synonymous_variant:LOW:exon7/22:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.244+12031A>C::,CFH:ENST00000696030.1:synonymous_variant:LOW:exon7/10:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000367429.9:synonymous_variant:LOW:exon7/22:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000630130.2:synonymous_variant:LOW:exon7/10:c.921A>C:p.Ala307=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695987.1:synonymous_variant:LOW:exon7/10:c.732A>C:p.Ala244=:PF00084 [Sushi repeat (SCR repeat)]		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	294488 [benign DISEASE=not provided,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,Atypical hemolytic-uremic syndrome,Basal laminar drusen,Age related macular degeneration 4,Factor H deficiency,Hemolytic uremic syndrome, atypical, susceptibility to, 1 GENE=CFH];			rs1061147	0.62964	0.57829,0.72961,0.94771,0.61754,0.72036	30604,	34373	56221	-0.1750	3.94			/0.0>0.0/0.0>0.0	COSV62778986	CFH|0.00|0.00|0.00|0.00|-1|10|37|10	17314151,18043728,19796758,27239600,21637784,24453474,24586071,17167412,19026761,16936733,15870199,16299065,22558131,28011711,20339564,27068115,31031394,28729648,30571950,33102952,31919107,36161202,29706360,33920896,24634144,33564431,23326517,30389424,29854987,34648354,25756647,32179765,27239594,37215422,29606303,36211394,28293111,15163532	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196689367	196689367	G	T	het	het	het	low_conf_region	QUAL=24;DP=93,17,15;AF=0.55,0.18,0.53	CFH	intron	CFH:ENST00000359637.3:intron_variant:MODIFIER:intron6/8:c.773-53G>T::,CFH:ENST00000695968.1:intron_variant:MODIFIER:intron5/7:c.782-53G>T::,CFH:ENST00000695969.1:intron_variant:MODIFIER:intron7/16:c.965-53G>T::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron7/20:c.965-53G>T::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron7/21:c.965-74G>T::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron7/20:c.965-53G>T::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron8/22:c.776-53G>T::,CFH:ENST00000695978.1:intron_variant:MODIFIER:intron7/10:c.965-53G>T::,CFH:ENST00000695979.1:intron_variant:MODIFIER:intron7/9:c.965-74G>T::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron7/22:c.965-53G>T::,CFH:ENST00000696023.1:intron_variant:MODIFIER:intron7/9:c.965-53G>T::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron7/21:c.965-53G>T::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron7/21:c.965-53G>T::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron7/21:c.965-53G>T::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.244+16204G>T::,CFH:ENST00000696030.1:intron_variant:MODIFIER:intron7/9:c.965-128G>T::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron7/21:c.965-53G>T::,CFH:ENST00000630130.2:intron_variant:MODIFIER:intron7/9:c.965-53G>T::,CFH:ENST00000695987.1:intron_variant:MODIFIER:intron7/9:c.776-53G>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	1276326 [benign DISEASE=not provided GENE=CFH];			rs482934	0.69167	0.78572,0.75960,0.94822,0.61937,0.72063	37084,	30988	46876	-0.1410	1.93			/1.6>4.3/0.0>0.0	COSV62776949	CFH|0.00|0.00|0.00|0.00|13|29|47|-1	19796758,24453474,34648354,37215422	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196689775	196689775	G	A	het	het	het		QUAL=25;DP=72,13,17;AF=0.49,0.54,0.29	CFH	intron	CFH:ENST00000359637.3:intron_variant:MODIFIER:intron7/8:c.967+161G>A::,CFH:ENST00000695968.1:intron_variant:MODIFIER:intron6/7:c.976+161G>A::,CFH:ENST00000695969.1:intron_variant:MODIFIER:intron8/16:c.1159+161G>A::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron8/20:c.1159+161G>A::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron8/21:c.1138+161G>A::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron8/20:c.1159+161G>A::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron9/22:c.970+161G>A::,CFH:ENST00000695978.1:intron_variant:MODIFIER:intron8/10:c.1159+161G>A::,CFH:ENST00000695979.1:intron_variant:MODIFIER:intron8/9:c.1138+161G>A::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron8/22:c.1159+161G>A::,CFH:ENST00000696023.1:intron_variant:MODIFIER:intron8/9:c.1159+161G>A::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron8/21:c.1159+161G>A::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron8/21:c.1159+161G>A::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron8/21:c.1159+161G>A::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.244+16612G>A::,CFH:ENST00000696030.1:intron_variant:MODIFIER:intron8/9:c.1084+161G>A::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron8/21:c.1159+161G>A::,CFH:ENST00000630130.2:intron_variant:MODIFIER:intron8/9:c.1159+161G>A::,CFH:ENST00000695987.1:intron_variant:MODIFIER:intron8/9:c.970+161G>A::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	1289573 [benign DISEASE=not provided GENE=CFH];			rs12029785	0.64502	0.62899,0.73759,0.94858,0.61835,0.72061	32031,	33871	53897	-0.2900	0.54			/0.0>0.0/0.0>0.0		CFH|0.00|0.00|0.00|0.00|21|0|31|-1	24453474,34648354	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196690107	196690107	C	T	het	het	het		QUAL=24;DP=191,108,104;AF=0.58,0.49,0.41	CFH	missense,intron	CFH:ENST00000359637.3:missense_variant:MODERATE:exon8/9:c.1012C>T:p.His338Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695968.1:missense_variant:MODERATE:exon7/8:c.1021C>T:p.His341Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695969.1:missense_variant:MODERATE:exon9/17:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695970.1:missense_variant:MODERATE:exon9/21:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695971.1:missense_variant:MODERATE:exon9/22:c.1183C>T:p.His395Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695974.1:missense_variant:MODERATE:exon9/21:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695976.1:missense_variant:MODERATE:exon10/23:c.1015C>T:p.His339Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695978.1:missense_variant:MODERATE:exon9/11:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695979.1:missense_variant:MODERATE:exon9/10:c.1183C>T:p.His395Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695981.1:missense_variant:MODERATE:exon9/23:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696023.1:missense_variant:MODERATE:exon9/10:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696027.1:missense_variant:MODERATE:exon9/22:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696028.1:missense_variant:MODERATE:exon9/22:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696029.1:missense_variant:MODERATE:exon9/22:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.244+16944C>T::,CFH:ENST00000696030.1:missense_variant:MODERATE:exon9/10:c.1129C>T:p.His377Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000367429.9:missense_variant:MODERATE:exon9/22:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000630130.2:missense_variant:MODERATE:exon9/10:c.1204C>T:p.His402Tyr:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695987.1:missense_variant:MODERATE:exon9/10:c.1015C>T:p.His339Tyr:PF00084 [Sushi repeat (SCR repeat)]		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	294490 [benign(replaced by megSAP based on classifications:12x1,1x3) DISEASE=Atypical hemolytic-uremic syndrome,not provided,Age related macular degeneration 4,Hemolytic uremic syndrome, atypical, susceptibility to, 1,Basal laminar drusen,Factor H deficiency,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II GENE=CFH];			rs1061170	0.64451	0.62884,0.73769,0.94862,0.61774,0.71992	31992,	33919	53999	-8.3310	0.00	0.086	0.08	/0.0>0.0/0.0>0.0	COSV62776341	CFH|0.01|0.01|0.00|0.00|12|-44|12|21	18248681,16519819,16723442,17697822,18162041,19076828,19692124,18541031,29334895,29700787,23820649,19861685,20203157,23251215,26559391,31118930,33224962,27306948,16080115,17314151,22022419,34260947,34260948,22253485,30696427,24498017,18043728,19796758,22035603,22059990,26152901,27239600,21637784,22969267,23873044,25132797,24453474,24586071,25786237,15761122,17167412,17917691,19026761,19958499,20961462,21072178,22259222,22618592,24526414,25276841,25883802,33765843,22936692,26681391,16936733,21807600,23523162,23577725,19825847,26493033,20157618,22694956,23620142,20378180,24692129,23289807,29096998,32034129,32100327,33210016,33320170,34563268,34945728,20385826,22155603,29579787,26490493,26961928,32407518,17591627,20157352,23112570,15870199,16299065,17022693,17877809,17962488,18316707,18515590,19187823,19259132,19823576,20132989,20581873,20678803,20689796,21394116,21555552,21609242,21784901,21811649,21850184,21856016,22019782,22046503,22174912,22509112,22536038,22558131,22666427,23103884,23111182,23289808,2368743	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196701627	196701627	C	T	het	het	het		QUAL=24;DP=150,88,62;AF=0.51,0.56,0.45	CFH	intron,3'UTR,downstream_gene	CFH:ENST00000695969.1:intron_variant:MODIFIER:intron9/16:c.1336+11388C>T::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron9/20:c.1336+11388C>T::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron9/21:c.1315+11388C>T::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron9/20:c.1336+11388C>T::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron10/22:c.1147+11388C>T::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron9/22:c.1336+11388C>T::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron9/21:c.1336+11388C>T::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron9/21:c.1336+11388C>T::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron9/21:c.1336+11388C>T::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.245-26719C>T::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron9/21:c.1336+11388C>T::,CFH:ENST00000695987.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*296C>T::,CFH:ENST00000359637.3:downstream_gene_variant:MODIFIER::::,CFH:ENST00000695968.1:downstream_gene_variant:MODIFIER::::,CFH:ENST00000695978.1:downstream_gene_variant:MODIFIER::::,CFH:ENST00000695979.1:downstream_gene_variant:MODIFIER::::,CFH:ENST00000696023.1:downstream_gene_variant:MODIFIER::::,CFH:ENST00000696030.1:downstream_gene_variant:MODIFIER::::,CFH:ENST00000630130.2:downstream_gene_variant:MODIFIER::::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]			LTR26 (LTR/ERV1)	rs4658046	0.64744	0.64005,0.73976,0.94753,0.61712,0.71892	32309,	33774	53578	-1.8450	0.11			/0.0>0.0/2.4>2.1			24453474,16936733,32843070,34648354,35078996	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196701709	196701709	A	G	het	het	het		QUAL=25;DP=86,18,14;AF=0.49,0.50,0.57	CFH	intron,3'UTR,downstream_gene	CFH:ENST00000695969.1:intron_variant:MODIFIER:intron9/16:c.1336+11470A>G::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron9/20:c.1336+11470A>G::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron9/21:c.1315+11470A>G::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron9/20:c.1336+11470A>G::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron10/22:c.1147+11470A>G::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron9/22:c.1336+11470A>G::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron9/21:c.1336+11470A>G::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron9/21:c.1336+11470A>G::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron9/21:c.1336+11470A>G::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.245-26637A>G::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron9/21:c.1336+11470A>G::,CFH:ENST00000695987.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*378A>G::,CFH:ENST00000359637.3:downstream_gene_variant:MODIFIER::::,CFH:ENST00000695968.1:downstream_gene_variant:MODIFIER::::,CFH:ENST00000695978.1:downstream_gene_variant:MODIFIER::::,CFH:ENST00000695979.1:downstream_gene_variant:MODIFIER::::,CFH:ENST00000696023.1:downstream_gene_variant:MODIFIER::::,CFH:ENST00000696030.1:downstream_gene_variant:MODIFIER::::,CFH:ENST00000630130.2:downstream_gene_variant:MODIFIER::::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]				rs10754199	0.64753	0.63986,0.74001,0.94791,0.61728,0.71876	32307,	33749	53541	-0.5760	3.61			/7.0>7.5/0.0>0.0			16936733,20385819,29875488,34648354,37725382	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196713817	196713817	G	A	het	het	het		QUAL=24;DP=262,257,192;AF=0.42,0.48,0.49	CFH	synonymous,intron	CFH:ENST00000695969.1:synonymous_variant:LOW:exon10/17:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695970.1:synonymous_variant:LOW:exon10/21:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695971.1:synonymous_variant:LOW:exon10/22:c.1398G>A:p.Ala466=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695974.1:synonymous_variant:LOW:exon10/21:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695976.1:synonymous_variant:LOW:exon11/23:c.1230G>A:p.Ala410=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695981.1:synonymous_variant:LOW:exon10/23:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696027.1:synonymous_variant:LOW:exon10/22:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696028.1:synonymous_variant:LOW:exon10/22:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696029.1:synonymous_variant:LOW:exon10/22:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.245-14529G>A::,CFH:ENST00000367429.9:synonymous_variant:LOW:exon10/22:c.1419G>A:p.Ala473=:PF00084 [Sushi repeat (SCR repeat)]		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	294491 [benign DISEASE=CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,Hemolytic uremic syndrome, atypical, susceptibility to, 1,Factor H deficiency,Age related macular degeneration 4,Basal laminar drusen,Atypical hemolytic-uremic syndrome,not provided GENE=CFH];	CM062504 [CLASS=DP MUT=ALT PHEN="Membranoproliferative glomerulonephritis association" GENE=CFH];		rs2274700	0.43938	0.46485,0.48502,0.44382,0.40791,0.55856	14793,	37092	85078	0.4850	3.73			/2.7>3.0/0.0>0.0	COSV66406791	CFH|0.00|0.00|0.00|0.00|20|-26|20|37	29700787,22022419,18043728,19796758,22035603,27239600,21637784,23873044,26838040,24453474,17917691,22618592,22936692,26681391,16936733,21807600,23523162,19825847,24692129,18421087,20161815,30179527,15870199,16299065,17962488,20132989,20678803,22046503,22558131,23687431,24860613,25612476,25771815,27778189,27832277,30225264,22905135,20339564,16612335,17327825,18081690,20843825,21402993,22324898,22699975,22848687,24289920,32578437,28358029,26852301,19692168,27625572,32328755,31819893,21882633,29142592,23441108,19025119,29033536,29263899,23582991,33564431,24391822,26634245,36275200,29875488,34502390,35625740,29376001,36911400,29854987,36615095,32610483,32179765,20523265,15163532,18596911	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196715438	196715438	C	T	het	het	wt		QUAL=24;DP=100,18,16;AF=0.59,0.22,0.00	CFH	intron	CFH:ENST00000695969.1:intron_variant:MODIFIER:intron10/16:c.1520-155C>T::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron10/20:c.1520-155C>T::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron10/21:c.1499-155C>T::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron10/20:c.1520-155C>T::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron11/22:c.1331-155C>T::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron10/22:c.1520-155C>T::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron10/21:c.1520-155C>T::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron10/21:c.1520-155C>T::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron10/21:c.1520-155C>T::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.245-12908C>T::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron10/21:c.1520-155C>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]				rs535465835	0.00007	0.00010,0.00000,0.00000,0.00009,0.00000	0,	11	152099	-2.4820	0.29			/2.1>3.5/0.0>0.0		CFH|0.00|0.00|0.00|0.00|20|39|-38|39		0	1	0	0 / 0					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196715444	196715444	C	T	het	het	wt		QUAL=25;DP=107,22,16;AF=0.56,0.27,0.00	CFH	intron	CFH:ENST00000695969.1:intron_variant:MODIFIER:intron10/16:c.1520-149C>T::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron10/20:c.1520-149C>T::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron10/21:c.1499-149C>T::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron10/20:c.1520-149C>T::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron11/22:c.1331-149C>T::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron10/22:c.1520-149C>T::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron10/21:c.1520-149C>T::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron10/21:c.1520-149C>T::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron10/21:c.1520-149C>T::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.245-12902C>T::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron10/21:c.1520-149C>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	1265873 [benign DISEASE=not provided GENE=CFH];			rs6664877	0.19714	0.26815,0.15256,0.05508,0.17504,0.31841	3298,	23367	122027	-1.1770	0.75			/2.1>2.4/0.0>0.0		CFH|0.00|0.00|0.00|0.00|14|33|-2|33	34648354,37480051	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196715445	196715445	A	G	het	het	wt		QUAL=26;DP=108,25,16;AF=0.57,0.28,0.00	CFH	intron	CFH:ENST00000695969.1:intron_variant:MODIFIER:intron10/16:c.1520-148A>G::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron10/20:c.1520-148A>G::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron10/21:c.1499-148A>G::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron10/20:c.1520-148A>G::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron11/22:c.1331-148A>G::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron10/22:c.1520-148A>G::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron10/21:c.1520-148A>G::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron10/21:c.1520-148A>G::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron10/21:c.1520-148A>G::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.245-12901A>G::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron10/21:c.1520-148A>G::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	1290753 [benign DISEASE=not provided GENE=CFH];			rs6677460	0.23185	0.35039,0.16713,0.05493,0.19531,0.32539	4765,	25729	116819	0.0970	1.83			/2.1>2.3/0.0>0.0		CFH|0.00|0.00|0.00|0.00|32|2|32|-37	32321835,34648354,35870639	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196715495	196715495	G	T	het	het	het		QUAL=24;DP=137,62,44;AF=0.43,0.42,0.55	CFH	intron	CFH:ENST00000695969.1:intron_variant:MODIFIER:intron10/16:c.1520-98G>T::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron10/20:c.1520-98G>T::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron10/21:c.1499-98G>T::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron10/20:c.1520-98G>T::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron11/22:c.1331-98G>T::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron10/22:c.1520-98G>T::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron10/21:c.1520-98G>T::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron10/21:c.1520-98G>T::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron10/21:c.1520-98G>T::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron2/9:c.245-12851G>T::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron10/21:c.1520-98G>T::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	1258057 [benign DISEASE=not provided GENE=CFH];			rs203674	0.65558	0.73571,0.74130,0.94770,0.57899,0.71168	33427,	32796	52354	-0.9460	0.49			/2.7>2.3/0.0>0.0		CFH|0.00|0.00|0.00|0.00|30|1|-18|1	18541031,21197116,18043728,19796758,22035603,22059990,26152901,27239600,15870199,30073298,28729648,19878229,25735482,24272913	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196736796	196736796	C	A	het	het	het	low_conf_region	QUAL=24;DP=16,13,4;AF=0.25,0.38,0.50	CFH	intron	CFH:ENST00000695969.1:intron_variant:MODIFIER:intron15/16:c.2414-28C>A::,CFH:ENST00000695970.1:intron_variant:MODIFIER:intron15/20:c.2414-28C>A::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron15/21:c.2393-28C>A::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron14/20:c.2237-28C>A::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron16/22:c.2225-28C>A::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron15/22:c.2414-28C>A::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron15/21:c.2408-28C>A::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron15/21:c.2414-28C>A::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron15/21:c.2414-28C>A::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron3/9:c.422-28C>A::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron15/21:c.2414-28C>A::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	1274202 [benign DISEASE=not provided GENE=CFH];		(TTAATT)n (Simple_repeat)	rs375046	0.67314	0.79664,0.74755,0.94279,0.57777,0.71983	35104,	31016	49152	-1.3850	0.09			/0.2>0.4/0.0>0.0		CFH|0.00|0.05|0.00|0.00|31|28|31|40	22834933,24453474	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196740686	196740686	G	T	het	het	wt		QUAL=24;DP=283,217,16;AF=0.53,0.52,0.00	CFH	intron,missense,downstream_gene	CFH:ENST00000695970.1:intron_variant:MODIFIER:intron17/20:c.2783-1189G>T::,CFH:ENST00000695971.1:missense_variant:MODERATE:exon18/22:c.2829G>T:p.Gln943His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695974.1:missense_variant:MODERATE:exon17/21:c.2673G>T:p.Gln891His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695976.1:missense_variant:MODERATE:exon19/23:c.2661G>T:p.Gln887His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695981.1:missense_variant:MODERATE:exon18/23:c.2850G>T:p.Gln950His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696027.1:missense_variant:MODERATE:exon18/22:c.2844G>T:p.Gln948His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696028.1:missense_variant:MODERATE:exon18/22:c.2850G>T:p.Gln950His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000696029.1:missense_variant:MODERATE:exon18/22:c.2850G>T:p.Gln950His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695984.1:missense_variant:MODERATE:exon6/10:c.858G>T:p.Gln286His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000367429.9:missense_variant:MODERATE:exon18/22:c.2850G>T:p.Gln950His:PF00084 [Sushi repeat (SCR repeat)],CFH:ENST00000695969.1:downstream_gene_variant:MODIFIER::::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	294510 [likely benign(replaced by megSAP based on classifications:1x1,7x2,2x3) DISEASE=Atypical hemolytic-uremic syndrome,Basal laminar drusen,CFH-Related Dense Deposit Disease / Membranoproliferative Glomerulonephritis Type II,Hemolytic uremic syndrome, atypical, susceptibility to, 1,not provided,Age related macular degeneration 4,not specified GENE=CFH];	CM034428 [CLASS=DM? MUT=ALT PHEN="Haemolytic uraemic syndrome" GENE=CFH];		rs149474608	0.00399	0.00113,0.00386,0.00000,0.00610,0.00021	0,	607	151541	-0.6000	14.71	0.321	0.18	/0.0>0.0/1.0>0.0	COSV99054698	CFH|0.00|0.00|0.00|0.00|-41|-22|-16|12	35877417,14583443,32641076,27007659,30377230,29148534,28752844,28056875,25814826,37744338	1	439	0	0 / 0	2	"[2] Ute Grasshoff 30.01.2015 [n/a] comment imported from detected variant: conflicting evidence"			CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196741786	196741786	T	C	het	het	wt		QUAL=24;DP=123,87,17;AF=0.59,0.55,0.00	CFH	intron,downstream_gene	CFH:ENST00000695970.1:intron_variant:MODIFIER:intron17/20:c.2783-89T>C::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron18/21:c.2936-89T>C::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron17/20:c.2780-89T>C::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron19/22:c.2768-89T>C::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron18/22:c.2957-89T>C::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron18/21:c.2951-89T>C::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron18/21:c.2885-89T>C::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron18/21:c.2957-95T>C::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron6/9:c.965-89T>C::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron18/21:c.2957-89T>C::,CFH:ENST00000695969.1:downstream_gene_variant:MODIFIER::::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]	1228859 [benign DISEASE=not provided GENE=CFH];			rs16840522	0.22618	0.33105,0.16774,0.05451,0.19485,0.32340	4486,	25458	117796	0.6700	3.39			/7.6>7.7/0.0>0.0	COSV66408666	CFH|0.00|0.00|0.00|0.00|1|16|32|-22	17314151,34260948,23873044,24453474,32321835,35078996	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	196746205	196746205	G	A	het	het	wt		QUAL=24;DP=72,13,10;AF=0.58,0.46,0.00	CFH	intron	CFH:ENST00000695970.1:intron_variant:MODIFIER:intron20/20:c.3319+206G>A::,CFH:ENST00000695971.1:intron_variant:MODIFIER:intron21/21:c.3472+206G>A::,CFH:ENST00000695974.1:intron_variant:MODIFIER:intron20/20:c.3316+206G>A::,CFH:ENST00000695976.1:intron_variant:MODIFIER:intron22/22:c.3304+206G>A::,CFH:ENST00000695981.1:intron_variant:MODIFIER:intron21/22:c.3493+206G>A::,CFH:ENST00000696027.1:intron_variant:MODIFIER:intron21/21:c.3487+206G>A::,CFH:ENST00000696028.1:intron_variant:MODIFIER:intron21/21:c.3421+206G>A::,CFH:ENST00000696029.1:intron_variant:MODIFIER:intron21/21:c.3487+206G>A::,CFH:ENST00000695984.1:intron_variant:MODIFIER:intron9/9:c.1501+206G>A::,CFH:ENST00000367429.9:intron_variant:MODIFIER:intron21/21:c.3493+206G>A::		134370_[GENE=CFH_PHENOS={Macular degeneration, age-related, 4}, 610698 (3), Autosomal dominant; Basal laminar drusen, 126700 (3), Autosomal dominant; Complement factor H deficiency, 609814 (3), Autosomal recessive, Autosomal dominant; {Hemolytic uremic syndrome, atypical, susceptibility to, 1}, 235400 (3), Autosomal recessive, Autosomal dominant]			AluY (SINE/Alu)	rs34231058	0.03632	0.00728,0.02911,0.04294,0.04653,0.10212	171,	5184	146608	0.5070	4.15			/0.0>0.0/0.0>0.0		CFH|0.03|0.00|0.00|0.00|-41|4|25|-18		77	1465	0	0 / 0					CFH (inh=AR+AD oe_syn=1.15 oe_mis=0.89 oe_lof=0.20)
chr1	197084011	197084011	T	C	het	het	het		QUAL=24;DP=83,9,7;AF=0.53,0.44,0.43	ASPM	downstream_gene	ASPM:ENST00000367409.9:downstream_gene_variant:MODIFIER::::,ASPM:ENST00000680265.1:downstream_gene_variant:MODIFIER::::,ASPM:ENST00000294732.11:downstream_gene_variant:MODIFIER::::,ASPM:ENST00000680710.1:downstream_gene_variant:MODIFIER::::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	1252618 [benign DISEASE=not provided GENE=ASPM];			rs1332660	0.17620	0.04440,0.33414,0.69434,0.16189,0.30863	3862,	19081	125327	-0.1650	7.02							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197084243	197084243	G	A	hom	hom	hom		QUAL=24;DP=219,198,138;AF=1.00,1.00,1.00	ASPM	3'UTR,downstream_gene	ASPM:ENST00000367409.9:3_prime_UTR_variant:MODIFIER:exon28/28:c.*81C>T::,ASPM:ENST00000680265.1:3_prime_UTR_variant:MODIFIER:exon29/29:c.*81C>T::,ASPM:ENST00000294732.11:3_prime_UTR_variant:MODIFIER:exon27/27:c.*81C>T::,ASPM:ENST00000680710.1:downstream_gene_variant:MODIFIER::::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	294591 [benign DISEASE=not provided,Microcephaly 5, primary, autosomal recessive GENE=ASPM];			rs12677	0.78430	0.45213,0.87156,0.99923,0.91017,0.89867	49995,	19250	32794	3.0170	3.75			/1.1>0.7/0.0>0.0			18541031	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197086652	197086652	T	C	hom	hom	hom		QUAL=24;DP=80,32,28;AF=1.00,1.00,1.00	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron27/27:c.10331+151A>G::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron28/28:c.10553+151A>G::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron26/26:c.5576+151A>G::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron27/27:c.10307+151A>G::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	678055 [benign DISEASE=not provided GENE=ASPM];			rs10733087	0.78383	0.45096,0.87150,0.99923,0.91024,0.89855	50021,	19257	32901	-0.6590	1.67			/0.0>0.0/0.0>0.0		ASPM|0.00|0.00|0.00|0.00|-1|50|0|-9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197086795	197086795	T	C	hom	hom	hom		QUAL=24;DP=169,137,108;AF=1.00,1.00,1.00	ASPM	splice_region&intron	ASPM:ENST00000367409.9:splice_region_variant&intron_variant:LOW:intron27/27:c.10331+8A>G::,ASPM:ENST00000680265.1:splice_region_variant&intron_variant:LOW:intron28/28:c.10553+8A>G::,ASPM:ENST00000294732.11:splice_region_variant&intron_variant:LOW:intron26/26:c.5576+8A>G::,ASPM:ENST00000680710.1:splice_region_variant&intron_variant:LOW:intron27/27:c.10307+8A>G::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	157775 [benign DISEASE=not provided,not specified,Microcephaly 5, primary, autosomal recessive GENE=ASPM];			rs10754213	0.78400	0.45135,0.87166,0.99922,0.91035,0.89826	50011,	19253	32861	-0.0560	2.01			/0.0>0.0/0.0>0.3			25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197090748	197090748	G	A	hom	hom	hom		QUAL=24;DP=96,53,41;AF=0.99,1.00,1.00	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron23/27:c.9636+102C>T::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron24/28:c.9858+102C>T::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron22/26:c.4881+102C>T::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron23/27:c.9612+102C>T::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	673924 [benign DISEASE=not provided GENE=ASPM];			rs4915315	0.77014	0.40625,0.86547,0.97885,0.90991,0.89851	48995,	19112	34950	-2.4770	0.06			/0.0>0.0/1.9>0.7		ASPM|0.00|0.00|0.00|0.00|-28|20|22|-10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197090762	197090762	A	G	hom	hom	hom		QUAL=24;DP=100,66,47;AF=1.00,1.00,1.00	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron23/27:c.9636+88T>C::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron24/28:c.9858+88T>C::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron22/26:c.4881+88T>C::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron23/27:c.9612+88T>C::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	673923 [benign DISEASE=not provided GENE=ASPM];			rs10754214	0.76257	0.37985,0.86361,0.97886,0.90979,0.89789	48505,	18942	36102	0.7910	8.28			/0.6>0.0/0.0>0.0		ASPM|0.00|0.00|0.00|0.00|6|-10|-24|8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197090798	197090798	A	G	hom	hom	hom		QUAL=24;DP=104,101,80;AF=1.00,1.00,1.00	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron23/27:c.9636+52T>C::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron24/28:c.9858+52T>C::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron22/26:c.4881+52T>C::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron23/27:c.9612+52T>C::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	673922 [benign DISEASE=Microcephaly 5, primary, autosomal recessive,not provided GENE=ASPM];			rs4915316	0.76234	0.37922,0.86354,0.97886,0.90974,0.89805	48479,	18938	36130	1.5570	2.96			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197101646	197101646	C	T	het	het	het		QUAL=24;DP=63,205,190;AF=0.54,0.45,0.46	ASPM	synonymous,intron	ASPM:ENST00000367409.9:synonymous_variant:LOW:exon18/28:c.7605G>A:p.Val2535=:PF00612 [IQ calmodulin-binding motif],ASPM:ENST00000680265.1:synonymous_variant:LOW:exon18/29:c.7605G>A:p.Val2535=:PF00612 [IQ calmodulin-binding motif],ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron17/26:c.4066-5482G>A::,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon18/28:c.7605G>A:p.Val2535=:PF00612 [IQ calmodulin-binding motif]	regulatory_region_variant:enhancer	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21603 [benign DISEASE=Microcephaly 5, primary, autosomal recessive,not provided,not specified GENE=ASPM];			rs10922162	0.17545	0.04186,0.33467,0.69574,0.16193,0.30460	3836,	18937	125057	0.1710	0.64			/6.3>4.0/0.0>0.0	COSV54139486	ASPM|0.00|0.00|0.00|0.00|-2|-10|3|0	25741868,18414213,20301772,21297427,15355437,35330488,23381943	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197101685	197101685	T	C	hom	hom	hom		QUAL=24;DP=74,164,155;AF=1.00,1.00,1.00	ASPM	synonymous,intron	ASPM:ENST00000367409.9:synonymous_variant:LOW:exon18/28:c.7566A>G:p.Leu2522=:,ASPM:ENST00000680265.1:synonymous_variant:LOW:exon18/29:c.7566A>G:p.Leu2522=:,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron17/26:c.4066-5521A>G::,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon18/28:c.7566A>G:p.Leu2522=:	regulatory_region_variant:enhancer	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21602 [benign DISEASE=not specified,not provided,Microcephaly 5, primary, autosomal recessive GENE=ASPM];			rs1412640	0.81194	0.54747,0.88377,0.99922,0.91052,0.89897	52044,	19096	28532	-0.3560	0.52			/0.0>0.0/0.0>0.0		ASPM|0.00|0.00|0.00|0.00|32|-21|-39|11	25741868,20301772	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197101771	197101771	A	G	hom	hom	hom		QUAL=24;DP=86,175,168;AF=1.00,1.00,1.00	ASPM	missense,intron	ASPM:ENST00000367409.9:missense_variant:MODERATE:exon18/28:c.7480T>C:p.Tyr2494His:,ASPM:ENST00000680265.1:missense_variant:MODERATE:exon18/29:c.7480T>C:p.Tyr2494His:,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron17/26:c.4066-5607T>C::,ASPM:ENST00000680710.1:missense_variant:MODERATE:exon18/28:c.7480T>C:p.Tyr2494His:	regulatory_region_variant:enhancer	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21599 [benign DISEASE=not specified,not provided,Microcephaly 5, primary, autosomal recessive GENE=ASPM];			rs964201	0.99666	0.99923,0.99789,0.99981,0.99418,0.99772	75442,	507	507	3.0690	14.73	0.191	0.05	/0.0>0.0/0.0>0.0			25741868,18414213,20301772,16141009,25480035	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197122407	197122407	A	T	hom	hom	hom		QUAL=24;DP=133,251,203;AF=1.00,1.00,1.00	ASPM	synonymous	ASPM:ENST00000367409.9:synonymous_variant:LOW:exon14/28:c.3579T>A:p.Ser1193=:PF00307 [Calponin homology (CH) domain],ASPM:ENST00000680265.1:synonymous_variant:LOW:exon14/29:c.3579T>A:p.Ser1193=:PF00307 [Calponin homology (CH) domain],ASPM:ENST00000294732.11:synonymous_variant:LOW:exon14/27:c.3579T>A:p.Ser1193=:PF00307 [Calponin homology (CH) domain],ASPM:ENST00000680710.1:synonymous_variant:LOW:exon14/28:c.3579T>A:p.Ser1193=:PF00307 [Calponin homology (CH) domain]		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21578 [benign DISEASE=Microcephaly 5, primary, autosomal recessive,not provided,not specified GENE=ASPM];			rs4915337	0.78385	0.45126,0.87169,0.99884,0.91008,0.89839	49988,	19263	32881	-0.2950	4.45			/4.5>2.7/0.0>0.0		ASPM|0.00|0.00|0.00|0.00|-25|-8|-19|48	25741868,18541031,20301772,16631353	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197123968	197123968	A	T	hom	n/a	hom		QUAL=24;DP=89,2,5;AF=1.00,1.00,1.00	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron13/27:c.3390+142T>A::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron13/28:c.3390+142T>A::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron13/26:c.3390+142T>A::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron13/27:c.3390+142T>A::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	670423 [benign DISEASE=not provided GENE=ASPM];			rs6685259	0.89085	0.81954,0.91675,0.99923,0.91157,0.90041	60556,	14464	16612	-2.2250	0.04			/0.0>0.0/0.0>0.0			34260948	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197124702	197124702	T	C	hom	hom	n/a		QUAL=24;DP=15,3,0;AF=1.00,1.00,	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron12/27:c.3168+168A>G::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron12/28:c.3168+168A>G::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron12/26:c.3168+168A>G::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron12/27:c.3168+168A>G::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	1227779 [benign DISEASE=not provided GENE=ASPM];		(AT)n (Simple_repeat)	rs4915338	0.75991	0.37818,0.86125,0.97945,0.90512,0.89584	47886,	19062	36282	0.9350	4.41			/0.0>0.0/0.0>0.0		ASPM|0.00|0.00|0.00|0.00|-44|43|5|15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197124900	197124900	C	T	het	het	het		QUAL=24;DP=279,184,152;AF=0.50,0.48,0.48	ASPM	synonymous	ASPM:ENST00000367409.9:synonymous_variant:LOW:exon12/28:c.3138G>A:p.Arg1046=:,ASPM:ENST00000680265.1:synonymous_variant:LOW:exon12/29:c.3138G>A:p.Arg1046=:,ASPM:ENST00000294732.11:synonymous_variant:LOW:exon12/27:c.3138G>A:p.Arg1046=:,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon12/28:c.3138G>A:p.Arg1046=:		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21573 [benign DISEASE=not provided,not specified,Microcephaly 5, primary, autosomal recessive GENE=ASPM];			rs6676084	0.25663	0.15899,0.25286,0.12548,0.31063,0.29635	5403,	28173	112909	-1.3250	0.09			/0.0>0.0/0.0>0.0	COSV54127589,COSV54135932	ASPM|0.00|0.00|0.00|0.00|35|1|-30|1	25741868,18414213,20301772,21297427,36376304	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197128343	197128343	-	A	hom	hom	hom		QUAL=25;DP=90,6,10;AF=0.59,0.67,0.80	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron10/27:c.2936+146dup::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron10/28:c.2936+146dup::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron10/26:c.2936+146dup::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron10/27:c.2936+146dup::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	1242265 [benign DISEASE=not provided GENE=ASPM];			rs200280533	0.68613	0.38702,0.79573,0.95121,0.77046,0.82067	34325,	25968	43284		4.04			/10.7>12.0/3.2>3.2		ASPM|0.05|0.00|0.00|0.00|-3|33|-3|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197129013	197129013	G	C	hom	hom	hom		QUAL=25;DP=143,31,18;AF=1.00,1.00,1.00	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron9/27:c.2760+174C>G::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron9/28:c.2760+174C>G::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron9/26:c.2760+174C>G::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron9/27:c.2760+174C>G::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	678053 [benign DISEASE=not provided GENE=ASPM];			rs6695300	0.86514	0.73272,0.90086,0.99923,0.91102,0.90046	57431,	16694	20508	-1.2280	0.53			/2.7>1.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197132491	197132491	T	C	hom	hom	hom		QUAL=24;DP=72,42,41;AF=0.99,1.00,1.00	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron6/27:c.2420-139A>G::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron6/28:c.2420-139A>G::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron6/26:c.2420-139A>G::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron6/27:c.2420-139A>G::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	678052 [benign DISEASE=not provided GENE=ASPM];			rs3737111	0.45713	0.28483,0.59537,0.82193,0.47362,0.60626	17230,	34973	82455	-0.8560	1.99			/0.0>0.0/0.4>8.6		ASPM|0.00|0.00|0.02|0.00|-43|-34|1|-37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197133615	197133615	A	G	het	het	het		QUAL=24;DP=141,73,70;AF=0.48,0.45,0.40	ASPM	splice_region&intron	ASPM:ENST00000367409.9:splice_region_variant&intron_variant:LOW:intron5/27:c.2174-20T>C::,ASPM:ENST00000680265.1:splice_region_variant&intron_variant:LOW:intron5/28:c.2174-20T>C::,ASPM:ENST00000294732.11:splice_region_variant&intron_variant:LOW:intron5/26:c.2174-20T>C::,ASPM:ENST00000680710.1:splice_region_variant&intron_variant:LOW:intron5/27:c.2174-20T>C::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	95887 [benign DISEASE=Microcephaly 5, primary, autosomal recessive,not provided,not specified GENE=ASPM];			rs4915344	0.17637	0.04425,0.33445,0.69505,0.16190,0.30962	3872,	19092	125324	0.8830	9.07			6.9>6.5/6.9>6.5/0.0>0.0	COSV54132578	ASPM|0.00|0.18|0.00|0.00|34|-20|-20|-50	25741868,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197133709	197133709	A	C	hom	hom	hom		QUAL=25;DP=97,22,16;AF=1.00,1.00,1.00	ASPM	intron	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron5/27:c.2174-114T>G::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron5/28:c.2174-114T>G::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron5/26:c.2174-114T>G::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron5/27:c.2174-114T>G::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	678051 [benign DISEASE=not provided GENE=ASPM];			rs4915345	0.81226	0.54806,0.88375,0.99923,0.91024,0.89904	52159,	19159	28539	-0.7650	0.59			/0.0>0.0/6.7>5.5				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63)
chr1	197135020	197135020	A	-	hom	hom	hom		QUAL=24;DP=103,39,25;AF=1.00,1.00,1.00	ASPM,SEPTIN14P12	intron,downstream_gene	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron5/27:c.2173+76del::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron5/28:c.2173+76del::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron5/26:c.2173+76del::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron5/27:c.2173+76del::,SEPTIN14P12:ENST00000442280.1:downstream_gene_variant:MODIFIER::::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	673908 [benign DISEASE=not provided GENE=ASPM];			rs35659894	0.76233	0.37941,0.86318,0.97879,0.90968,0.89789	48526,	18964	36170	0.2300	0.67			/3.7>3.9/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	197139563	197139563	C	T	hom	hom	n/a		QUAL=24;DP=45,10,0;AF=0.98,1.00,	ASPM,SEPTIN14P12	intron,upstream_gene	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron4/27:c.2026+204G>A::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron4/28:c.2026+204G>A::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron4/26:c.2026+204G>A::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron4/27:c.2026+204G>A::,SEPTIN14P12:ENST00000442280.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	678050 [benign DISEASE=not provided GENE=ASPM];		L1MA4 (LINE/L1)	rs10737687	0.76230	0.37899,0.86333,0.97893,0.90969,0.89801	48529,	18959	36177	0.3670	5.26			/0.0>0.0/0.0>0.3				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	197139816	197139816	A	G	het	wt	het		QUAL=24;DP=256,16,108;AF=0.42,0.00,0.44	ASPM,SEPTIN14P12	synonymous,upstream_gene	ASPM:ENST00000367409.9:synonymous_variant:LOW:exon4/28:c.1977T>C:p.Ile659=:,ASPM:ENST00000680265.1:synonymous_variant:LOW:exon4/29:c.1977T>C:p.Ile659=:,ASPM:ENST00000294732.11:synonymous_variant:LOW:exon4/27:c.1977T>C:p.Ile659=:,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon4/28:c.1977T>C:p.Ile659=:,SEPTIN14P12:ENST00000442280.1:upstream_gene_variant:MODIFIER::::		605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	21561 [benign DISEASE=Microcephaly 5, primary, autosomal recessive,not provided,not specified GENE=ASPM];			rs17550662	0.04095	0.00902,0.03098,0.00000,0.06365,0.01078	178,	5880	146058	2.0950	4.33			/3.5>3.0/0.0>0.0		ASPM|0.01|0.00|0.00|0.00|39|-16|-49|47	18414213,20301772,21297427	146	4541	0	0 / 0					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	197139912	197139912	C	T	hom	hom	hom		QUAL=24;DP=234,88,65;AF=1.00,1.00,1.00	ASPM,SEPTIN14P12	intron,upstream_gene	ASPM:ENST00000367409.9:intron_variant:MODIFIER:intron3/27:c.1922-41G>A::,ASPM:ENST00000680265.1:intron_variant:MODIFIER:intron3/28:c.1922-41G>A::,ASPM:ENST00000294732.11:intron_variant:MODIFIER:intron3/26:c.1922-41G>A::,ASPM:ENST00000680710.1:intron_variant:MODIFIER:intron3/27:c.1922-41G>A::,SEPTIN14P12:ENST00000442280.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	157788 [benign DISEASE=Microcephaly 5, primary, autosomal recessive,not specified,not provided GENE=ASPM];			rs1332663	0.78405	0.45155,0.87178,0.99923,0.91004,0.89859	50033,	19261	32867	-0.9920	2.08			/4.9>4.8/0.0>0.0	COSV54136485			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	197143403	197143403	G	A	hom	hom	hom		QUAL=24;DP=90,52,61;AF=1.00,1.00,0.98	ASPM,SEPTIN14P12	synonymous,upstream_gene	ASPM:ENST00000367409.9:synonymous_variant:LOW:exon3/28:c.849C>T:p.Ser283=:,ASPM:ENST00000680265.1:synonymous_variant:LOW:exon3/29:c.849C>T:p.Ser283=:,ASPM:ENST00000294732.11:synonymous_variant:LOW:exon3/27:c.849C>T:p.Ser283=:,ASPM:ENST00000680710.1:synonymous_variant:LOW:exon3/28:c.849C>T:p.Ser283=:,SEPTIN14P12:ENST00000442280.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	95890 [benign DISEASE=Microcephaly 5, primary, autosomal recessive,not provided,not specified GENE=ASPM];			rs6677082	0.76248	0.37945,0.86352,0.97897,0.90971,0.89793	48504,	18949	36121	0.2230	5.49			/0.0>0.0/0.0>0.0		ASPM|0.00|0.00|0.00|0.00|45|25|24|0	25741868,18541031,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	197143943	197143943	G	A	hom	hom	hom		QUAL=24;DP=83,21,14;AF=1.00,1.00,1.00	ASPM,SEPTIN14P12	splice_region&intron,upstream_gene	ASPM:ENST00000367409.9:splice_region_variant&intron_variant:LOW:intron2/27:c.441+14C>T::,ASPM:ENST00000680265.1:splice_region_variant&intron_variant:LOW:intron2/28:c.441+14C>T::,ASPM:ENST00000294732.11:splice_region_variant&intron_variant:LOW:intron2/26:c.441+14C>T::,ASPM:ENST00000680710.1:splice_region_variant&intron_variant:LOW:intron2/27:c.441+14C>T::,SEPTIN14P12:ENST00000442280.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	605481_[GENE=ASPM_PHENOS=Microcephaly 5, primary, autosomal recessive, 608716 (3), Autosomal recessive]	95888 [benign/likely benign DISEASE=not provided,Microcephaly 5, primary, autosomal recessive,not specified GENE=ASPM];			rs1571964	0.76258	0.37956,0.86352,0.97914,0.90961,0.89830	48502,	18956	36102	0.1980	4.53			/1.1>0.8/0.0>0.0			25741868,18414213,23757202	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ASPM (inh=AR oe_syn=1.17 oe_mis=1.05 oe_lof=0.63), SEPTIN14P12 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	198692539	198692539	G	A	het	wt	het		QUAL=24;DP=49,4,7;AF=0.47,0.00,0.86	PTPRC	intron,3'UTR	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron3/29:c.100+166G>A::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron3/32:c.100+166G>A::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron3/30:c.100+166G>A::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron2/28:c.-456+166G>A::,PTPRC:ENST00000367364.5:3_prime_UTR_variant:MODIFIER:exon3/3:c.*155G>A::,PTPRC:ENST00000413409.6:intron_variant:MODIFIER:intron3/3:c.100+166G>A::	regulatory_region_variant:open_chromatin_region	151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]				rs115067628	0.00983	0.00232,0.00472,0.00019,0.01550,0.00850	17,	1459	150313	-0.7680	0.30			/5.4>5.7/0.0>0.0		PTPRC|0.00|0.00|0.00|0.00|7|-42|2|-44		16	636	0	0 / 0					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198709964	198709964	G	A	het	het	wt		QUAL=24;DP=73,13,7;AF=0.47,0.54,0.00	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron8/29:c.688+140G>A::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron11/32:c.1171+140G>A::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron9/30:c.886+140G>A::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron7/28:c.133+140G>A::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]	1288182 [benign DISEASE=not provided GENE=PTPRC];		L1M4 (LINE/L1)	rs10753834	0.08425	0.02300,0.09409,0.00039,0.12330,0.00954	754,	11299	139211	-0.2870	2.76			/4.4>3.8/0.0>0.0		PTPRC|0.00|0.00|0.00|0.00|39|-25|-45|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198732160	198732160	T	C	hom	het	hom		QUAL=25;DP=58,19,17;AF=1.00,0.63,1.00	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron15/29:c.1492-140T>C::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron18/32:c.1975-140T>C::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron16/30:c.1690-140T>C::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron14/28:c.937-140T>C::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]	1280542 [benign DISEASE=not provided GENE=PTPRC];			rs1932433	0.60680	0.65506,0.55582,0.35243,0.62748,0.42523	28273,	35419	59593	-0.9970	0.47			/1.9>1.0/0.0>0.0		PTPRC|0.00|0.00|0.00|0.00|50|36|-46|50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198749603	198749603	A	G	het	het	wt		QUAL=24;DP=213,109,17;AF=0.47,0.50,0.00	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron25/29:c.2589+54A>G::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron28/32:c.3072+54A>G::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron26/30:c.2787+54A>G::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron24/28:c.2034+54A>G::	regulatory_region_variant:open_chromatin_region	151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]				rs549239314	0.00099	0.00048,0.00033,0.00000,0.00171,0.00000	0,	150	151852	-0.6400	0.05			/5.5>6.0/0.0>0.0		PTPRC|0.00|0.00|0.00|0.00|-49|10|-49|-50		0	85	0	0 / 0					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	198754594	198754594	-	TAAG	hom	het	n/a		QUAL=24;DP=83,8,2;AF=0.93,0.25,1.00	PTPRC	intron	PTPRC:ENST00000348564.11:intron_variant:MODIFIER:intron29/29:c.3162+192_3162+195dup::,PTPRC:ENST00000442510.8:intron_variant:MODIFIER:intron32/32:c.3645+192_3645+195dup::,PTPRC:ENST00000697631.1:intron_variant:MODIFIER:intron30/30:c.3360+192_3360+195dup::,PTPRC:ENST00000697632.1:intron_variant:MODIFIER:intron28/28:c.2607+192_2607+195dup::		151460_[GENE=PTPRC_PHENOS=Immunodeficiency 105, severe combined, 619924 (3), Autosomal recessive]	1286830 [benign DISEASE=not provided GENE=PTPRC];			rs34412391	0.25054	0.10628,0.21957,0.09151,0.35343,0.13920	5666,	26550	113320		0.50			/0.6>0.0/0.4>8.1		PTPRC|0.01|0.00|0.01|0.00|-38|48|0|-43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PTPRC (inh=AR oe_syn=1.07 oe_mis=0.87 oe_lof=0.11)
chr1	201039454	201039454	-	G	hom	het	het		QUAL=25;DP=55,56,30;AF=1.00,0.54,0.53	CACNA1S	downstream_gene	CACNA1S:ENST00000362061.4:downstream_gene_variant:MODIFIER::::,CACNA1S:ENST00000681874.1:downstream_gene_variant:MODIFIER::::,CACNA1S:ENST00000367338.7:downstream_gene_variant:MODIFIER::::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]				rs35360610	0.55028	0.78566,0.43076,0.41651,0.47908,0.32587	24852,	33959	68373		0.90							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201040428	201040428	A	G	hom	het	het		QUAL=24;DP=134,83,63;AF=0.99,0.48,0.52	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron42/43:c.5227-54T>C::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron41/42:c.5167-54T>C::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron41/42:c.5170-54T>C::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678243 [benign DISEASE=not provided,Hypokalemic periodic paralysis, type 1 GENE=CACNA1S];			rs1546416	0.35827	0.41553,0.29386,0.29714,0.35329,0.26223	10014,	34480	97636	-0.3470	0.90			/3.4>2.9/3.0>4.8	COSV62945146	CACNA1S|0.00|0.00|0.00|0.00|20|-14|-2|37	19825159,32765863	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201040769	201040769	T	C	hom	hom	hom		QUAL=24;DP=57,46,30;AF=1.00,1.00,1.00	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron41/43:c.5135-56A>G::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron40/42:c.5075-56A>G::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron40/42:c.5078-56A>G::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678241 [benign DISEASE=not provided,Hypokalemic periodic paralysis, type 1 GENE=CACNA1S];			rs6427875	0.99328	0.99755,0.99125,1.00000,0.98962,0.99420	75142,	1005	1023	-4.2510	0.00			/3.8>4.9/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201041734	201041734	T	C	hom	het	het		QUAL=24;DP=63,107,92;AF=1.00,0.44,0.49	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron40/43:c.5049-145A>G::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron39/42:c.4989-145A>G::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron39/42:c.4992-145A>G::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678239 [benign DISEASE=not provided GENE=CACNA1S];			rs6675915	0.55292	0.79375,0.43124,0.42543,0.47920,0.32795	25171,	33785	68023	-0.0780	2.82			/0.0>0.0/0.0>0.4	COSV62945328	CACNA1S|0.00|0.00|0.00|0.00|-50|31|29|-34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201043469	201043469	G	A	hom	het	n/a		QUAL=24;DP=10,4,2;AF=1.00,1.00,0.00	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon40/44:c.4860C>T:p.Pro1620=:,CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon39/43:c.4800C>T:p.Pro1600=:,CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon39/43:c.4803C>T:p.Pro1601=:	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254841 [benign DISEASE=Thyrotoxic periodic paralysis, susceptibility to, 1,not provided,Hypokalemic periodic paralysis, type 1,Malignant hyperthermia, susceptibility to, 5,not specified,Congenital myopathy 18 GENE=CACNA1S];			rs41267497	0.10444	0.02963,0.08995,0.00039,0.16190,0.02199	1166,	13548	136168	-1.2030	0.18			/3.6>4.3/0.0>0.0		CACNA1S|0.01|0.00|0.00|0.00|-16|38|39|-36	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201044208	201044208	T	C	hom	het	het		QUAL=24;DP=76,190,130;AF=0.97,0.57,0.52	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron39/43:c.4797+120A>G::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron38/42:c.4737+120A>G::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron38/42:c.4740+120A>G::	regulatory_region_variant:CTCF_binding_site	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678237 [benign DISEASE=not provided GENE=CACNA1S];			rs2297906	0.55170	0.78853,0.43120,0.42428,0.47954,0.32743	24939,	33873	68055	-0.2290	1.63			/1.1>2.1/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|37|-43|8|-4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201050977	201050977	A	G	wt	het	het		QUAL=24;DP=79,276,211;AF=0.00,0.49,0.53	CACNA1S	splice_region&intron	CACNA1S:ENST00000362061.4:splice_region_variant&intron_variant:LOW:intron33/43:c.4113+7T>C::,CACNA1S:ENST00000681874.1:splice_region_variant&intron_variant:LOW:intron32/42:c.4053+7T>C::,CACNA1S:ENST00000367338.7:splice_region_variant&intron_variant:LOW:intron32/42:c.4056+7T>C::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	199680 [benign DISEASE=Hypokalemic periodic paralysis, type 1,not specified,not provided,Malignant hyperthermia, susceptibility to, 5 GENE=CACNA1S];			rs6702590	0.77877	0.92881,0.80226,0.99399,0.66578,0.87542	47269,	23955	33661	-0.1500	0.18			/1.4>0.2/0.0>0.9		CACNA1S|0.00|0.00|0.00|0.00|31|45|7|2	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201051232	201051232	G	A	hom	het	het		QUAL=24;DP=121,140,114;AF=0.97,0.52,0.40	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron32/43:c.3954-89C>T::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron31/42:c.3894-89C>T::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron31/42:c.3897-89C>T::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	680202 [benign DISEASE=not provided GENE=CACNA1S];			rs12138260	0.10498	0.02898,0.08964,0.00039,0.16302,0.02195	1185,	13610	136246	-1.2270	0.56			/1.1>0.7/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|-32|15|11|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201054308	201054308	C	T	wt	het	het		QUAL=25;DP=42,29,23;AF=0.00,0.38,0.48	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron29/43:c.3666+197G>A::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron28/42:c.3606+197G>A::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron28/42:c.3610-721G>A::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	1238693 [benign DISEASE=not provided GENE=CACNA1S];			rs3818873	0.53241	0.37699,0.64574,0.85648,0.53846,0.81390	22827,	35312	71110	-0.0660	4.05			/0.3>2.3/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|-13|-1|16|-28	32765863	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201062179	201062179	A	C	wt	het	het		QUAL=24;DP=49,170,121;AF=0.00,0.53,0.40	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron23/43:c.2907-89T>G::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron22/42:c.2847-89T>G::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron23/42:c.2907-89T>G::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	1192645 [benign DISEASE=not provided,Hypokalemic periodic paralysis, type 1 GENE=CACNA1S];			rs2297903	0.51682	0.48249,0.60502,0.76099,0.49063,0.69971	20686,	37083	73349	-1.5020	5.36			/8.1>7.6/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|42|-17|1|29		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201069559	201069559	A	G	het	het	wt		QUAL=24;DP=213,428,26;AF=0.46,0.51,0.00	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon18/44:c.2403T>C:p.Phe801=:PF00520 [Ion transport protein],CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon18/43:c.2403T>C:p.Phe801=:PF00520 [Ion transport protein],CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon18/43:c.2403T>C:p.Phe801=:PF00520 [Ion transport protein]	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254814 [benign DISEASE=Hypokalemic periodic paralysis, type 1,not provided,Malignant hyperthermia, susceptibility to, 5,not specified GENE=CACNA1S];			rs7415038	0.42098	0.52570,0.33569,0.00155,0.44821,0.17116	14607,	34771	88005	4.8560	10.23			/0.0>0.0/0.0>0.0	COSV62939654	CACNA1S|0.00|0.00|0.00|0.00|42|-36|4|42	25741868,19825159,20681998	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201073349	201073351	CTG	-	het	hom	wt		QUAL=24;DP=77,22,22;AF=0.69,1.00,0.00	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron15/43:c.2157+198_2157+200del::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron15/42:c.2157+198_2157+200del::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron15/42:c.2157+198_2157+200del::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678223 [benign DISEASE=not provided GENE=CACNA1S];			rs71138316	0.70571	0.49876,0.72714,0.95997,0.77527,0.89846	39118,	28761	44619	0.2530	5.38			/0.0>0.0/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|-36|27|27|-31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201073490	201073490	G	A	het	hom	wt		QUAL=24;DP=81,140,22;AF=0.49,1.00,0.00	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron15/43:c.2157+59C>T::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron15/42:c.2157+59C>T::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron15/42:c.2157+59C>T::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678298 [benign DISEASE=Hypokalemic periodic paralysis, type 1,not provided GENE=CACNA1S];			rs9333652	0.43951	0.34498,0.47676,0.95898,0.40163,0.76266	16107,	34555	85149	0.1200	1.37			/7.7>7.9/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|-15|-44|46|0	19825159	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201074718	201074719	CT	-	het	hom	wt		QUAL=24;DP=104,93,16;AF=0.57,0.99,0.00	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron13/43:c.1949-99_1949-98del::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron13/42:c.1949-99_1949-98del::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron13/42:c.1949-99_1949-98del::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678222 [benign DISEASE=not provided,Hypokalemic periodic paralysis, type 1 GENE=CACNA1S];			rs66932448	0.71979	0.54702,0.73276,0.95997,0.77586,0.89855	40306,	28710	42558	-0.2410	0.76			/0.0>0.0/0.5>0.0		CACNA1S|0.00|0.00|0.00|0.00|-30|-50|42|16		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201075620	201075620	A	G	het	hom	wt		QUAL=24;DP=151,278,44;AF=0.52,1.00,0.00	CACNA1S	splice_region&intron	CACNA1S:ENST00000362061.4:splice_region_variant&intron_variant:LOW:intron12/43:c.1828-5T>C::,CACNA1S:ENST00000681874.1:splice_region_variant&intron_variant:LOW:intron12/42:c.1828-5T>C::,CACNA1S:ENST00000367338.7:splice_region_variant&intron_variant:LOW:intron12/42:c.1828-5T>C::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254804 [benign/likely benign DISEASE=Hypokalemic periodic paralysis, type 1,Thyrotoxic periodic paralysis, susceptibility to, 1,Malignant hyperthermia, susceptibility to, 5,not provided,not specified GENE=CACNA1S];			rs1998721	0.72067	0.54969,0.73317,0.96060,0.77599,0.89863	40485,	28696	42506	-0.5120	0.36			11.3>10.7/11.3>10.7/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|-15|-5|-5|-4	25741868,27182706,32765863	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201076897	201076897	G	T	het	het	wt		QUAL=24;DP=82,337,24;AF=0.48,0.53,0.00	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron12/43:c.1827+23C>A::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron12/42:c.1827+23C>A::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron12/42:c.1827+23C>A::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	1293266 [benign DISEASE=not provided GENE=CACNA1S];		L2c (LINE/L2)	rs7549030	0.06782	0.07817,0.04882,0.00019,0.07043,0.02528	410,	9506	141936	-0.1210	1.37			/2.5>1.1/0.0>0.0		CACNA1S|0.00|0.00|0.01|0.00|32|-44|-49|23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201077251	201077251	T	G	het	hom	wt		QUAL=24;DP=70,172,24;AF=0.41,1.00,0.00	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron11/43:c.1620-124A>C::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron11/42:c.1620-124A>C::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron11/42:c.1620-124A>C::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678221 [benign DISEASE=not provided GENE=CACNA1S];			rs925060	0.71363	0.56855,0.67456,0.81528,0.78144,0.86868	39327,	29692	43478	0.2580	3.99			/1.1>0.0/2.2>3.1		CACNA1S|0.00|0.00|0.00|0.00|45|-34|0|-21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201077260	201077260	A	G	het	hom	wt		QUAL=24;DP=80,152,24;AF=0.44,1.00,0.00	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron11/43:c.1620-133T>C::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron11/42:c.1620-133T>C::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron11/42:c.1620-133T>C::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678220 [benign DISEASE=not provided GENE=CACNA1S];			rs6672094	0.80425	0.79452,0.77685,0.95935,0.79796,0.90920	49234,	23649	29723	-4.3810	0.07			/1.1>0.0/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|36|2|-9|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201077934	201077934	G	A	hom	het	hom		QUAL=24;DP=143,267,260;AF=0.99,0.48,1.00	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon11/44:c.1564C>T:p.Leu522=:PF00520 [Ion transport protein],CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon11/43:c.1564C>T:p.Leu522=:PF00520 [Ion transport protein],CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon11/43:c.1564C>T:p.Leu522=:PF00520 [Ion transport protein]		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254801 [benign DISEASE=Thyrotoxic periodic paralysis, susceptibility to, 1,not provided,Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis, type 1,not specified,Congenital myopathy 18 GENE=CACNA1S];	CM023570 [CLASS=DP MUT=ALT PHEN="Hypokalaemic periodic paralysis association with" GENE=CACNA1S];		rs4915476	0.22500	0.25942,0.24827,0.04025,0.22098,0.09979	4049,	26148	117958	4.9060	8.72			/0.0>0.0/0.0>0.0	COSV62944479	CACNA1S|0.00|0.00|0.00|0.00|46|-6|15|45	25741868,26648445,11940049	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201077947	201077947	A	G	hom	het	hom		QUAL=24;DP=185,286,267;AF=0.99,0.50,1.00	CACNA1S	synonymous	CACNA1S:ENST00000362061.4:synonymous_variant:LOW:exon11/44:c.1551T>C:p.Gly517=:PF00520 [Ion transport protein],CACNA1S:ENST00000681874.1:synonymous_variant:LOW:exon11/43:c.1551T>C:p.Gly517=:PF00520 [Ion transport protein],CACNA1S:ENST00000367338.7:synonymous_variant:LOW:exon11/43:c.1551T>C:p.Gly517=:PF00520 [Ion transport protein]		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	254800 [benign DISEASE=not provided,not specified,Malignant hyperthermia, susceptibility to, 5,Hypokalemic periodic paralysis, type 1 GENE=CACNA1S];			rs4915477	0.68486	0.89310,0.65120,0.23441,0.65059,0.29527	37788,	28607	47941	-1.1500	0.90			/0.0>0.0/0.0>0.0	COSV62938741	CACNA1S|0.00|0.00|0.00|0.00|33|42|-45|42	25741868,26648445,18325191	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201083071	201083071	T	C	hom	het	hom		QUAL=24;DP=205,258,181;AF=1.00,0.50,0.99	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron10/43:c.1393+91A>G::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron10/42:c.1393+91A>G::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron10/42:c.1393+91A>G::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678296 [benign DISEASE=not provided GENE=CACNA1S];			rs3767511	0.22259	0.26075,0.22714,0.03358,0.22070,0.10460	3963,	25940	118282	-0.0180	2.48			/0.0>0.0/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|-42|10|1|11		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201083512	201083512	G	A	het	hom	het		QUAL=25;DP=92,65,48;AF=0.45,1.00,0.58	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron9/43:c.1233-190C>T::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron9/42:c.1233-190C>T::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron9/42:c.1233-190C>T::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678219 [benign DISEASE=not provided GENE=CACNA1S];		MIRb (SINE/MIR)	rs4915478	0.63311	0.73225,0.68906,0.99749,0.51726,0.81950	31669,	32933	55789	-1.0690	0.10			/4.5>4.5/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|-16|14|15|14		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201089564	201089564	T	C	hom	hom	het		QUAL=24;DP=156,166,143;AF=0.99,1.00,0.50	CACNA1S	intron	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron5/43:c.695-101A>G::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron5/42:c.695-101A>G::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron5/42:c.695-101A>G::	regulatory_region_variant:enhancer	114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	678218 [benign DISEASE=not provided GENE=CACNA1S];			rs2296384	0.58384	0.59056,0.51433,0.38532,0.62385,0.51514	26229,	36341	63297	-0.0040	3.18			/0.0>0.0/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|0|14|1|9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39)
chr1	201110404	201110404	C	T	het	het	wt		QUAL=25;DP=126,188,46;AF=0.47,0.50,0.00	CACNA1S,ASCL5	intron,downstream_gene	CACNA1S:ENST00000362061.4:intron_variant:MODIFIER:intron1/43:c.153-135G>A::,CACNA1S:ENST00000681874.1:intron_variant:MODIFIER:intron1/42:c.153-135G>A::,CACNA1S:ENST00000367338.7:intron_variant:MODIFIER:intron1/42:c.153-135G>A::,ASCL5:ENST00000449188.3:downstream_gene_variant:MODIFIER::::		114208_[GENE=CACNA1S_PHENOS={Thyrotoxic periodic paralysis, susceptibility to, 1}, 188580 (3), Autosomal dominant; Congenital myopathy 18 due to dihydropyridine receptor defect, 620246 (3), Autosomal recessive, Autosomal dominant; Hypokalemic periodic paralysis, type 1, 170400 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 5}, 601887 (3), Autosomal dominant]	1298108 [benign DISEASE=not provided GENE=CACNA1S];			rs111530734	0.02049	0.00555,0.01647,0.00000,0.02479,0.00290	60,	3001	149189	-0.8410	0.47			/0.0>0.0/0.0>0.0		CACNA1S|0.00|0.00|0.00|0.00|7|20|32|1	31211845	3	619	0	0 / 0					CACNA1S (inh=AD oe_syn=1.10 oe_mis=1.01 oe_lof=0.39), ASCL5 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209614868	209614868	T	C	hom	het	het		QUAL=24;DP=134,72,41;AF=0.99,0.46,0.59	CAMK1G,LAMB3	downstream_gene	CAMK1G:ENST00000361322.3:downstream_gene_variant:MODIFIER::::,CAMK1G:ENST00000651530.1:downstream_gene_variant:MODIFIER::::,CAMK1G:ENST00000009105.5:downstream_gene_variant:MODIFIER::::,LAMB3:ENST00000356082.9:downstream_gene_variant:MODIFIER::::,LAMB3:ENST00000391911.5:downstream_gene_variant:MODIFIER::::,LAMB3:ENST00000367030.7:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	368859 [benign DISEASE=not provided,Junctional epidermolysis bullosa GENE=LAMB3];			rs926387	0.74832	0.92191,0.75755,0.75581,0.65893,0.70066	43706,	26419	38285	-1.4470	0.24							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209615169	209615169	G	A	het	het	wt		QUAL=24;DP=166,262,23;AF=0.53,0.46,0.00	LAMB3,CAMK1G	3'UTR,downstream_gene	LAMB3:ENST00000356082.9:3_prime_UTR_variant:MODIFIER:exon23/23:c.*102C>T::,LAMB3:ENST00000391911.5:3_prime_UTR_variant:MODIFIER:exon22/22:c.*102C>T::,LAMB3:ENST00000367030.7:3_prime_UTR_variant:MODIFIER:exon23/23:c.*102C>T::,CAMK1G:ENST00000361322.3:downstream_gene_variant:MODIFIER::::,CAMK1G:ENST00000651530.1:downstream_gene_variant:MODIFIER::::,CAMK1G:ENST00000009105.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	295059 [benign DISEASE=Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa,Junctional epidermolysis bullosa gravis of Herlitz,Amelogenesis imperfecta type 1A,not provided GENE=LAMB3];	CR1010233 [CLASS=DP MUT=ALT PHEN="Cervical cancer increased risk association with" GENE=LAMB3];		rs2566	0.27414	0.24763,0.35211,0.34700,0.27351,0.27113	5835,	30033	110423	1.1420	9.38			/0.0>0.0/0.0>0.0	COSV50521190	LAMB3|0.00|0.00|0.00|0.00|-8|40|2|-29	20163849,21627860,21692980,23554684,23614619,29963045,28584635,31882771,25363238,23320911,25337271,25132800,36305754	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209618217	209618217	C	T	het	het	wt		QUAL=24;DP=185,63,37;AF=0.59,0.37,0.00	LAMB3,CAMK1G	intron,downstream_gene	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron19/22:c.2910-169G>A::,LAMB3:ENST00000391911.5:intron_variant:MODIFIER:intron18/21:c.2910-169G>A::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron19/22:c.2910-169G>A::,CAMK1G:ENST00000361322.3:downstream_gene_variant:MODIFIER::::,CAMK1G:ENST00000651530.1:downstream_gene_variant:MODIFIER::::,CAMK1G:ENST00000009105.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1286389 [benign DISEASE=not provided GENE=LAMB3];			rs2076220	0.29097	0.30655,0.35735,0.34572,0.27363,0.27186	6538,	31188	107864	-0.0670	2.48			/0.0>0.0/0.0>0.0		LAMB3|0.00|0.00|0.00|0.00|-8|31|16|-37		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209618270	209618270	G	A	het	het	wt		QUAL=24;DP=172,45,37;AF=0.48,0.40,0.00	LAMB3,CAMK1G	intron,downstream_gene	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron19/22:c.2909+182C>T::,LAMB3:ENST00000391911.5:intron_variant:MODIFIER:intron18/21:c.2909+182C>T::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron19/22:c.2909+182C>T::,CAMK1G:ENST00000361322.3:downstream_gene_variant:MODIFIER::::,CAMK1G:ENST00000651530.1:downstream_gene_variant:MODIFIER::::,CAMK1G:ENST00000009105.5:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1276454 [benign DISEASE=not provided GENE=LAMB3];			rs2076221	0.34736	0.50051,0.37947,0.34362,0.27449,0.27273	9959,	32903	99243	-0.2600	1.32			/1.3>1.2/0.0>0.0	COSV50524219	LAMB3|0.00|0.00|0.00|0.00|-19|30|31|-21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209618670	209618670	-	C	hom	hom	hom		QUAL=24;DP=184,195,141;AF=0.96,0.98,0.97	LAMB3,CAMK1G,MIR4260	splice_region&intron,downstream_gene	LAMB3:ENST00000356082.9:splice_region_variant&intron_variant:LOW:intron18/22:c.2702-12dup::,LAMB3:ENST00000391911.5:splice_region_variant&intron_variant:LOW:intron17/21:c.2702-12dup::,LAMB3:ENST00000367030.7:splice_region_variant&intron_variant:LOW:intron18/22:c.2702-12dup::,CAMK1G:ENST00000361322.3:downstream_gene_variant:MODIFIER::::,CAMK1G:ENST00000651530.1:downstream_gene_variant:MODIFIER::::,CAMK1G:ENST00000009105.5:downstream_gene_variant:MODIFIER::::,MIR4260:ENST00000583107.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255590 [benign DISEASE=not specified,not provided,Junctional epidermolysis bullosa,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa, non-Herlitz type GENE=LAMB3];			rs397807887	0.95655	0.98776,0.97498,0.99981,0.93174,0.98965	69774,	6173	6619		4.82			/8.9>8.3/0.0>0.0			25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					CAMK1G (inh=n/a oe_syn=1.14 oe_mis=0.73 oe_lof=0.40), LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55), MIR4260 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209622922	209622922	G	A	het	het	wt		QUAL=24;DP=51,14,12;AF=0.53,0.36,0.00	LAMB3,MIR4260	intron,downstream_gene	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron17/22:c.2556+60C>T::,LAMB3:ENST00000391911.5:intron_variant:MODIFIER:intron16/21:c.2556+60C>T::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron17/22:c.2556+60C>T::,MIR4260:ENST00000583107.1:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1180485 [benign DISEASE=Junctional epidermolysis bullosa gravis of Herlitz,not provided,Junctional epidermolysis bullosa, non-Herlitz type,Amelogenesis imperfecta type 1A GENE=LAMB3];			rs3737913	0.27476	0.24688,0.35401,0.35210,0.27438,0.26952	5857,	30052	110244	-4.6550	0.00			/0.0>0.0/3.0>2.5	COSV61915383	LAMB3|0.00|0.00|0.00|0.00|-14|-38|30|-2	25368101	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55), MIR4260 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209625908	209625908	A	G	het	het	hom		QUAL=24;DP=219,495,382;AF=0.37,0.51,1.00	LAMB3,MIR4260	synonymous,upstream_gene	LAMB3:ENST00000356082.9:synonymous_variant:LOW:exon14/23:c.1716T>C:p.Cys572=:PF00053 [Laminin EGF domain],LAMB3:ENST00000391911.5:synonymous_variant:LOW:exon13/22:c.1716T>C:p.Cys572=:PF00053 [Laminin EGF domain],LAMB3:ENST00000367030.7:synonymous_variant:LOW:exon14/23:c.1716T>C:p.Cys572=:PF00053 [Laminin EGF domain],MIR4260:ENST00000583107.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255587 [benign DISEASE=Junctional epidermolysis bullosa,not specified,Amelogenesis imperfecta type 1A,not provided,Junctional epidermolysis bullosa gravis of Herlitz,Junctional epidermolysis bullosa, non-Herlitz type GENE=LAMB3];			rs2179402	0.74880	0.77118,0.75157,0.82347,0.72703,0.73964	42713,	28566	38242	-0.9660	0.27			/0.0>0.0/0.0>0.0	COSV61918520	LAMB3|0.00|0.00|0.00|0.00|17|-43|-12|2	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55), MIR4260 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209627765	209627765	C	T	het	het	hom		QUAL=25;DP=202,24,24;AF=0.53,0.54,1.00	LAMB3,MIR4260	intron,upstream_gene	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron11/22:c.1289-186G>A::,LAMB3:ENST00000391911.5:intron_variant:MODIFIER:intron10/21:c.1289-186G>A::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron11/22:c.1289-186G>A::,MIR4260:ENST00000583107.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:enhancer,TF_binding_site_variant	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1180469 [benign DISEASE=not provided,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Amelogenesis imperfecta type 1A GENE=LAMB3];			rs61822212	0.17188	0.04276,0.12647,0.01643,0.24859,0.13993	3048,	20070	126070	-1.1520	0.11			/0.0>0.0/0.0>1.3		LAMB3|0.00|0.00|0.00|0.00|41|21|31|41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55), MIR4260 (inh=AR oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	209630750	209630750	G	A	hom	hom	hom		QUAL=24;DP=113,158,124;AF=1.00,1.00,1.00	LAMB3	splice_region&intron	LAMB3:ENST00000356082.9:splice_region_variant&intron_variant:LOW:intron8/22:c.823-15C>T::,LAMB3:ENST00000391911.5:splice_region_variant&intron_variant:LOW:intron7/21:c.823-15C>T::,LAMB3:ENST00000367030.7:splice_region_variant&intron_variant:LOW:intron8/22:c.823-15C>T::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255598 [benign DISEASE=Junctional epidermolysis bullosa,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,not specified,not provided,Amelogenesis imperfecta type 1A GENE=LAMB3];			rs4844863	0.84138	0.82879,0.82934,0.82808,0.84569,0.80046	53887,	20132	24114	-1.8920	1.48			8.4>7.7/8.4>7.7/0.0>0.0	COSV61919103	LAMB3|0.00|0.00|0.00|0.00|-15|-39|46|-14	25741868,25363238	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209634627	209634627	G	A	hom	hom	hom		QUAL=24;DP=37,91,58;AF=1.00,1.00,1.00	LAMB3	synonymous	LAMB3:ENST00000356082.9:synonymous_variant:LOW:exon6/23:c.384C>T:p.Pro128=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000391911.5:synonymous_variant:LOW:exon5/22:c.384C>T:p.Pro128=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000367030.7:synonymous_variant:LOW:exon6/23:c.384C>T:p.Pro128=:PF00055 [Laminin N-terminal (Domain VI)]	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255596 [benign DISEASE=not specified,Junctional epidermolysis bullosa,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,not provided,Amelogenesis imperfecta type 1A GENE=LAMB3];			rs1130667	0.30981	0.13921,0.26561,0.24106,0.39710,0.32469	8286,	30462	104784	-4.0090	0.15			/0.0>0.0/0.0>0.0	COSV61916410	LAMB3|0.00|0.00|0.00|0.00|-19|11|11|-34	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209638541	209638541	T	G	hom	hom	hom		QUAL=24;DP=264,210,137;AF=1.00,1.00,1.00	LAMB3	synonymous	LAMB3:ENST00000356082.9:synonymous_variant:LOW:exon4/23:c.291A>C:p.Ser97=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000391911.5:synonymous_variant:LOW:exon3/22:c.291A>C:p.Ser97=:PF00055 [Laminin N-terminal (Domain VI)],LAMB3:ENST00000367030.7:synonymous_variant:LOW:exon4/23:c.291A>C:p.Ser97=:PF00055 [Laminin N-terminal (Domain VI)]	regulatory_region_variant:enhancer,regulatory_region_variant:CTCF_binding_site	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	255592 [benign DISEASE=Junctional epidermolysis bullosa gravis of Herlitz,not specified,not provided,Amelogenesis imperfecta type 1A,Junctional epidermolysis bullosa,Junctional epidermolysis bullosa, non-Herlitz type GENE=LAMB3];			rs2076356	0.55948	0.41975,0.50216,0.27621,0.65046,0.48338	25024,	35021	66981	-0.8890	4.31			/2.8>3.2/0.0>0.0	COSV61915034	LAMB3|0.00|0.00|0.00|0.00|2|-4|-7|-4	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209638718	209638718	T	C	hom	hom	hom		QUAL=24;DP=105,103,68;AF=1.00,1.00,1.00	LAMB3	intron	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron3/22:c.184-70A>G::,LAMB3:ENST00000391911.5:intron_variant:MODIFIER:intron2/21:c.184-70A>G::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron3/22:c.184-70A>G::	regulatory_region_variant:enhancer	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1180480 [benign DISEASE=not provided,Junctional epidermolysis bullosa, non-Herlitz type,Junctional epidermolysis bullosa gravis of Herlitz,Amelogenesis imperfecta type 1A GENE=LAMB3];			rs2076357	0.58592	0.38589,0.61558,0.63541,0.67785,0.67526	27358,	34317	62921	-0.6750	1.65			/0.6>2.0/0.0>0.0	COSV61915925	LAMB3|0.00|0.00|0.00|0.00|-30|42|48|31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209651362	209651362	A	T	hom	hom	hom		QUAL=24;DP=89,84,81;AF=0.99,1.00,1.00	LAMB3	intron,upstream_gene	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron1/22:c.-37-381T>A::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron1/22:c.-37-381T>A::,LAMB3:ENST00000391911.5:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1252656 [benign DISEASE=not provided GENE=LAMB3];			rs10779510	0.87721	0.80002,0.90663,0.99923,0.89136,0.94785	58808,	15932	18694	-0.3030	2.20			/4.3>7.6/0.0>0.0		LAMB3|0.00|0.00|0.00|0.00|-2|-44|3|-8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209652041	209652041	T	C	hom	hom	hom		QUAL=24;DP=73,35,32;AF=1.00,1.00,1.00	LAMB3	intron,upstream_gene	LAMB3:ENST00000356082.9:intron_variant:MODIFIER:intron1/22:c.-38+328A>G::,LAMB3:ENST00000367030.7:intron_variant:MODIFIER:intron1/22:c.-38+208A>G::,LAMB3:ENST00000391911.5:upstream_gene_variant:MODIFIER::::		150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1285919 [benign DISEASE=not provided GENE=LAMB3];		MIR3 (SINE/MIR)	rs10863778	0.84460	0.80470,0.86029,0.69930,0.86655,0.78961	54338,	19722	23624	0.3640	3.64			/2.5>1.9/0.0>0.0		LAMB3|0.00|0.00|0.00|0.00|2|-20|34|4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209652603	209652603	C	G	hom	hom	hom		QUAL=24;DP=46,25,17;AF=0.98,1.00,1.00	LAMB3	upstream_gene	LAMB3:ENST00000356082.9:upstream_gene_variant:MODIFIER::::,LAMB3:ENST00000391911.5:upstream_gene_variant:MODIFIER::::,LAMB3:ENST00000367030.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:promoter	150310_[GENE=LAMB3_PHENOS=Epidermolysis bullosa, junctional 1B, severe, 226700 (3), Autosomal recessive; Epidermolysis bullosa, junctional 1A, intermediate, 226650 (3), Autosomal recessive; Amelogenesis imperfecta, type IA, 104530 (3), Autosomal dominant]	1242415 [benign DISEASE=not provided GENE=LAMB3];			rs7519942	0.92539	0.92139,0.92772,0.99923,0.91622,0.95526	65190,	10521	11361	-0.5090	0.53							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LAMB3 (inh=AR+AD oe_syn=1.07 oe_mis=1.06 oe_lof=0.55)
chr1	209786269	209786269	G	T	het	het	wt		QUAL=24;DP=130,185,16;AF=0.57,0.50,0.00	IRF6,TRAF3IP3,C1orf74	3'UTR,downstream_gene,upstream_gene	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*2151C>A::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*2151C>A::,TRAF3IP3:ENST00000367025.8:downstream_gene_variant:MODIFIER::::,TRAF3IP3:ENST00000367026.7:downstream_gene_variant:MODIFIER::::,TRAF3IP3:ENST00000367024.5:downstream_gene_variant:MODIFIER::::,TRAF3IP3:ENST00000477431.1:downstream_gene_variant:MODIFIER::::,C1orf74:ENST00000294811.2:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295175 [benign DISEASE=Orofacial cleft 6, susceptibility to,not provided,Van der Woude syndrome 1 GENE=IRF6];			rs1044516	0.22880	0.26626,0.32849,0.54990,0.17287,0.31056	4643,	25513	117297	-0.3060	2.58			/0.0>0.0/0.0>0.0			33195260,20652317,31495697,30410503,25663376,31122291,27033726	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209786527	209786527	G	A	hom	hom	hom		QUAL=24;DP=104,117,119;AF=1.00,0.99,0.99	IRF6,TRAF3IP3,C1orf74	3'UTR,downstream_gene,upstream_gene	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1893C>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1893C>T::,TRAF3IP3:ENST00000367025.8:downstream_gene_variant:MODIFIER::::,TRAF3IP3:ENST00000367026.7:downstream_gene_variant:MODIFIER::::,TRAF3IP3:ENST00000367024.5:downstream_gene_variant:MODIFIER::::,TRAF3IP3:ENST00000477431.1:downstream_gene_variant:MODIFIER::::,C1orf74:ENST00000294811.2:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295178 [benign DISEASE=Orofacial cleft 6, susceptibility to,Van der Woude syndrome 1,not provided GENE=IRF6];			rs680331	0.80868	0.84710,0.82649,0.80612,0.79172,0.77969	49784,	23379	29087	-0.0200	3.03			/1.4>1.0/0.0>0.0			21319277,23248214	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787091	209787091	G	A	het	het	wt		QUAL=24;DP=94,187,156;AF=0.45,0.50,0.00	IRF6,TRAF3IP3,C1orf74	3'UTR,downstream_gene,upstream_gene	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*1329C>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*1329C>T::,TRAF3IP3:ENST00000367025.8:downstream_gene_variant:MODIFIER::::,TRAF3IP3:ENST00000367026.7:downstream_gene_variant:MODIFIER::::,TRAF3IP3:ENST00000367024.5:downstream_gene_variant:MODIFIER::::,TRAF3IP3:ENST00000477431.1:downstream_gene_variant:MODIFIER::::,C1orf74:ENST00000294811.2:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295184 [benign DISEASE=Orofacial cleft 6, susceptibility to,Van der Woude syndrome 1,not provided GENE=IRF6];		AluJo (SINE/Alu)	rs2235372	0.22580	0.26936,0.32847,0.47206,0.17246,0.30905	4432,	25450	117656	-1.0050	0.97			/0.0>0.0/0.0>0.0	COSV50551228		23121717	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TRAF3IP3 (inh=n/a oe_syn=0.81 oe_mis=0.88 oe_lof=0.62), C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787577	209787577	A	C	het	wt	hom		QUAL=24;DP=61,123,45;AF=0.46,0.00,1.00	IRF6,C1orf74	3'UTR,upstream_gene	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*843T>G::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*843T>G::,C1orf74:ENST00000294811.2:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295189 [benign DISEASE=Orofacial cleft 6, susceptibility to,Van der Woude syndrome 1,not provided GENE=IRF6];			rs599021	0.36280	0.26092,0.30084,0.24195,0.43267,0.35310	10687,	33724	96770	0.2660	4.05			/0.0>0.0/0.7>0.0			18278815,17438386,20652317,19388848,37020525	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787580	209787580	T	C	het	het	wt		QUAL=24;DP=62,122,32;AF=0.53,0.45,0.00	IRF6,C1orf74	3'UTR,upstream_gene	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*840A>G::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*840A>G::,C1orf74:ENST00000294811.2:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295190 [benign DISEASE=Orofacial cleft 6, susceptibility to,Van der Woude syndrome 1,not provided GENE=IRF6];			rs742214	0.22465	0.26632,0.32740,0.47233,0.17240,0.30822	4389,	25356	117812	-0.9660	0.22			/0.0>1.8/0.7>0.0			30410503	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787678	209787678	T	A	het	het	wt		QUAL=25;DP=52,81,32;AF=0.48,0.49,0.00	IRF6,C1orf74	3'UTR,upstream_gene	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*742A>T::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*742A>T::,C1orf74:ENST00000294811.2:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295193 [benign DISEASE=Orofacial cleft 6, susceptibility to,Van der Woude syndrome 1,not provided GENE=IRF6];			rs742215	0.23054	0.28610,0.32956,0.47378,0.17253,0.30944	4602,	25638	116288	0.9740	10.89			/0.0>0.0/0.0>0.0	COSV54213600		23121717	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209787969	209787969	T	C	het	het	wt		QUAL=24;DP=128,239,32;AF=0.45,0.47,0.00	IRF6,C1orf74	3'UTR,upstream_gene	IRF6:ENST00000367021.8:3_prime_UTR_variant:MODIFIER:exon9/9:c.*451A>G::,IRF6:ENST00000542854.5:3_prime_UTR_variant:MODIFIER:exon7/7:c.*451A>G::,C1orf74:ENST00000294811.2:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295199 [benign DISEASE=Orofacial cleft 6, susceptibility to,Van der Woude syndrome 1,not provided GENE=IRF6];			rs17317411	0.10724	0.02993,0.11418,0.04041,0.15158,0.18657	1155,	13996	135740	0.3090	11.23			/0.0>1.1/0.0>0.0	COSV54213602		20652317,28593555,23121717,30689861	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF74 (inh=n/a oe_syn=0.80 oe_mis=0.83 oe_lof=0.48), IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209790458	209790458	G	A	het	het	wt		QUAL=24;DP=91,127,16;AF=0.52,0.52,0.00	IRF6	intron	IRF6:ENST00000367021.8:intron_variant:MODIFIER:intron7/8:c.1060+37C>T::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron5/6:c.775+37C>T::	regulatory_region_variant:enhancer	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	1291060 [benign DISEASE=not provided GENE=IRF6];			rs2235373	0.21561	0.23460,0.32375,0.47105,0.17235,0.30731	4035,	24747	119389	-0.8660	1.76			/0.0>0.0/0.0>0.0	COSV65418889		18278815,17438386,20652317,19388848,33137956,25592222,19444471,36901988,28593555,35865051,30273098,37020525,36484949	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209792242	209792242	G	C	het	hom	wt		QUAL=24;DP=196,261,20;AF=0.46,1.00,0.00	IRF6	intron	IRF6:ENST00000367021.8:intron_variant:MODIFIER:intron6/8:c.667+27C>G::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron4/6:c.382+27C>G::	regulatory_region_variant:enhancer	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	259926 [benign DISEASE=not provided,not specified,Autosomal dominant popliteal pterygium syndrome GENE=IRF6];			rs2235375	0.36730	0.28802,0.49431,0.56480,0.37018,0.43162	10639,	34586	96228	0.0730	2.36			/2.6>2.7/0.0>0.0	COSV65418892	IRF6|0.00|0.00|0.00|0.00|2|-22|23|27	25741868,17318851,18278815,33195260,17438386,32533457,20215007,15558496,25853057,23940636,19734457,35633982,33334172,28712851,36901988,37020525,36484949,25489771,20631690	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209795339	209795339	C	A	het	hom	wt		QUAL=24;DP=341,460,32;AF=0.45,1.00,0.00	IRF6	synonymous	IRF6:ENST00000367021.8:synonymous_variant:LOW:exon5/9:c.459G>T:p.Ser153=:,IRF6:ENST00000542854.5:synonymous_variant:LOW:exon3/7:c.174G>T:p.Ser58=:	regulatory_region_variant:open_chromatin_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	259925 [benign DISEASE=Orofacial cleft 6, susceptibility to,Van der Woude syndrome 1,Autosomal dominant popliteal pterygium syndrome,Van der Woude syndrome,Popliteal pterygium syndrome,not provided,not specified GENE=IRF6];			rs2013162	0.36507	0.27983,0.49516,0.56576,0.37009,0.43008	10526,	34471	96567	-1.7160	0.29			/0.0>0.0/0.0>0.0	COSV65418898	IRF6|0.01|0.00|0.00|0.00|-22|47|-22|-49	25741868,20403199,29065370,18278815,33195260,20436469,18978678,27511269,17438386,20652317,19521098,19937600,21319277,23029012,31448957,18209213,29211286,21859832,21204206,15558496,25853057,23940636,16096995,19734457,22440537,31156544,33200192,35633982,33406080,17616516,36901988,28593555,25704602,36158961,25663376,27706679,36294409,35075162,37020525,34788792,36484949,25489771,29291710,18452891,37533311	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209795573	209795573	G	A	het	het	wt		QUAL=24;DP=162,80,32;AF=0.51,0.53,0.00	IRF6	intron	IRF6:ENST00000367021.8:intron_variant:MODIFIER:intron4/8:c.380-155C>T::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron2/6:c.95-155C>T::	regulatory_region_variant:open_chromatin_region	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	1291056 [benign DISEASE=not provided GENE=IRF6];			rs17015224	0.17002	0.22495,0.14188,0.06470,0.15903,0.21393	2374,	21110	126228	-0.1270	1.21			/0.0>0.0/0.0>0.0	COSV65418901	IRF6|0.01|0.00|0.00|0.00|-22|40|-35|50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209796557	209796557	G	C	het	hom	wt		QUAL=24;DP=210,86,17;AF=0.47,0.99,0.00	IRF6	splice_region&intron	IRF6:ENST00000367021.8:splice_region_variant&intron_variant:LOW:intron3/8:c.175-5C>G::,IRF6:ENST00000542854.5:splice_region_variant&intron_variant:LOW:intron1/6:c.-111-5C>G::	regulatory_region_variant:open_chromatin_region,regulatory_region_variant:CTCF_binding_site	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	259923 [benign DISEASE=not specified,Autosomal dominant popliteal pterygium syndrome,Van der Woude syndrome,Orofacial cleft 6, susceptibility to,Popliteal pterygium syndrome,Van der Woude syndrome 1,not provided GENE=IRF6];			rs7552506	0.31974	0.27167,0.31308,0.15519,0.35681,0.33479	7900,	32677	103135	1.3340	11.38			9.7>6.9/9.7>6.9/0.0>0.0,/9.7>6.9/0.0>0.0	COSV65419346	IRF6|0.00|0.02|0.00|0.00|-18|-5|-5|-23	25741868,33195260,20652317,19937600,18209213,17551329,28593555,32108996,25489771	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209802041	209802041	A	G	het	wt	hom		QUAL=25;DP=257,45,263;AF=0.50,0.00,1.00	IRF6	splice_region&5'UTR,intron	IRF6:ENST00000367021.8:splice_region_variant&5_prime_UTR_variant:LOW:exon2/9:c.-73T>C::,IRF6:ENST00000542854.5:intron_variant:MODIFIER:intron1/6:c.-112+3906T>C::	regulatory_region_variant:promoter	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]	295214 [benign DISEASE=Orofacial cleft 6, susceptibility to,not specified,not provided,Van der Woude syndrome 1 GENE=IRF6];			rs861019	0.43295	0.50533,0.32923,0.24158,0.43319,0.34967	14703,	36396	86182	-0.2070	1.13			/10.8>11.0/0.0>0.0	COSV65419778	IRF6|0.00|0.00|0.00|0.00|2|-16|-1|44	17318851,18278815,33195260,17438386,20652317,19388848,23029012,31495697,16160700,18209213,19561605,21834040,29211286,33406080,28593555,18452891,37762190	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209806268	209806268	C	G	het	hom	wt		QUAL=24;DP=37,53,16;AF=0.59,1.00,0.00	IRF6	upstream_gene	IRF6:ENST00000367021.8:upstream_gene_variant:MODIFIER::::,IRF6:ENST00000542854.5:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]				rs7545538	0.40283	0.28588,0.51517,0.56684,0.42787,0.47433	12825,	35644	90864	0.9250	9.28						25592222	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	209806290	209806290	C	T	het	hom	wt		QUAL=24;DP=41,39,16;AF=0.66,1.00,0.00	IRF6	upstream_gene	IRF6:ENST00000367021.8:upstream_gene_variant:MODIFIER::::,IRF6:ENST00000542854.5:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	607199_[GENE=IRF6_PHENOS={Orofacial cleft 6}, 608864 (3), Autosomal dominant; Popliteal pterygium syndrome 1, 119500 (3), Autosomal dominant; van der Woude syndrome 1, 119300 (3), Autosomal dominant]				rs7545542	0.37459	0.27989,0.50118,0.56609,0.38521,0.44014	11103,	34795	95167	0.5000	6.66						33817668	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IRF6 (inh=AD oe_syn=0.78 oe_mis=0.52 oe_lof=0.00)
chr1	215622731	215622732	AA	-	hom	n/a	n/a		QUAL=24;DP=11,2,1;AF=1.00,1.00,0.00	KCTD3,USH2A	downstream_gene	KCTD3:ENST00000259154.9:downstream_gene_variant:MODIFIER::::,USH2A:ENST00000307340.8:downstream_gene_variant:MODIFIER::::,USH2A:ENST00000674083.1:downstream_gene_variant:MODIFIER::::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]				rs34483623	0.98311	0.94353,0.99305,0.99807,0.99912,0.99855	73388,	2515	2565	-1.3290	0.11							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCTD3 (inh=AR oe_syn=0.86 oe_mis=0.62 oe_lof=0.25), USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215622854	215622854	-	TTATT	het	wt	het		QUAL=24;DP=37,16,19;AF=0.35,0.00,0.21	KCTD3,USH2A	downstream_gene	KCTD3:ENST00000259154.9:downstream_gene_variant:MODIFIER::::,USH2A:ENST00000307340.8:downstream_gene_variant:MODIFIER::::,USH2A:ENST00000674083.1:downstream_gene_variant:MODIFIER::::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]				rs75551431	0.23585	0.09984,0.24576,0.43493,0.27879,0.51581	4942,	25919	115999		1.47							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCTD3 (inh=AR oe_syn=0.86 oe_mis=0.62 oe_lof=0.25), USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215623008	215623008	T	G	het	hom	wt		QUAL=24;DP=136,266,20;AF=0.51,1.00,0.00	USH2A,KCTD3	3'UTR,downstream_gene	USH2A:ENST00000307340.8:3_prime_UTR_variant:MODIFIER:exon72/72:c.*2773A>C::,USH2A:ENST00000674083.1:3_prime_UTR_variant:MODIFIER:exon73/73:c.*2773A>C::,KCTD3:ENST00000259154.9:downstream_gene_variant:MODIFIER::::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]				rs6667509	0.10448	0.11524,0.09717,0.05721,0.10240,0.12847	858,	14181	136255	2.2060	3.80			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCTD3 (inh=AR oe_syn=0.86 oe_mis=0.62 oe_lof=0.25), USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215624672	215624672	G	A	hom	hom	hom		QUAL=24;DP=114,219,206;AF=1.00,1.00,1.00	USH2A,KCTD3	3'UTR,downstream_gene	USH2A:ENST00000307340.8:3_prime_UTR_variant:MODIFIER:exon72/72:c.*1109C>T::,USH2A:ENST00000674083.1:3_prime_UTR_variant:MODIFIER:exon73/73:c.*1109C>T::,KCTD3:ENST00000259154.9:downstream_gene_variant:MODIFIER::::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]				rs2797255	0.99070	0.96793,0.99673,1.00000,0.99984,1.00000	74741,	1348	1416	-0.3060	0.14			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					KCTD3 (inh=AR oe_syn=0.86 oe_mis=0.62 oe_lof=0.25), USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215634665	215634665	G	A	het	wt	het		QUAL=24;DP=175,16,136;AF=0.48,0.00,0.50	USH2A,SNORD116	missense,upstream_gene	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon70/72:c.15091C>T:p.Arg5031Trp:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon70/73:c.15091C>T:p.Arg5031Trp:,SNORD116:ENST00000365628.1:upstream_gene_variant:MODIFIER::::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48455 [benign/likely benign DISEASE=Usher syndrome type 2A,Retinitis pigmentosa 39,not provided,not specified GENE=USH2A];	CM165975 [CLASS=DM? MUT=ALT PHEN="Retinitis pigmentosa" GENE=USH2A];		rs56038610	0.01333	0.00315,0.00334,0.00000,0.01741,0.00976	24,	1981	150237	3.1780	13.28	0.089	0.08	/0.0>0.0/0.0>0.0	COSV99048303	USH2A|0.00|0.01|0.00|0.00|-43|38|38|-34	24033266,18273898,21569298,26927203	14	1279	0	0 / 0	1	"[3] auto-classification 14.09.2017 [1] harmuth 08.05.2018"			USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215674720	215674720	C	T	het	wt	het		QUAL=24;DP=142,16,246;AF=0.46,0.00,0.50	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon63/72:c.13191G>A:p.Glu4397=:PF00041 [Fibronectin type III domain],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon63/73:c.13191G>A:p.Glu4397=:PF00041 [Fibronectin type III domain]		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48413 [benign DISEASE=not specified,not provided,Usher syndrome type 2A,Retinal dystrophy GENE=USH2A];			rs2009923	0.15849	0.05592,0.16261,0.35078,0.18484,0.29049	2357,	19396	128014	0.2990	0.49			/2.5>3.2/0.0>0.0	COSV56336645	USH2A|0.00|0.00|0.00|0.00|-16|-46|21|-46	25741868,24033266,20145675	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215675299	215675299	T	C	het	hom	het		QUAL=24;DP=113,222,204;AF=0.44,0.99,0.52	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon63/72:c.12612A>G:p.Thr4204=:,USH2A:ENST00000674083.1:synonymous_variant:LOW:exon63/73:c.12612A>G:p.Thr4204=:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	177993 [benign DISEASE=not specified,not provided,Retinal dystrophy,Usher syndrome type 2A,Retinitis pigmentosa 39 GENE=USH2A];			rs2797235	0.74788	0.63473,0.79902,0.64476,0.81315,0.67993	43060,	27670	38360	0.1010	0.36			/0.0>0.0/0.0>0.0	COSV56342874		24033266,21686329,20145675	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215675702	215675702	C	G	het	wt	het		QUAL=24;DP=88,16,105;AF=0.50,0.00,0.47	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron62/71:c.12295-86G>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron62/72:c.12295-86G>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1290576 [benign DISEASE=not provided GENE=USH2A];			rs4443864	0.19618	0.12172,0.19005,0.35648,0.21222,0.33534	3259,	23328	122292	-1.2320	0.56			/0.0>0.0/0.0>0.0	COSV56377492	USH2A|0.00|0.00|0.00|0.00|21|-40|21|48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215680015	215680015	G	A	het	het	wt		QUAL=24;DP=76,15,4;AF=0.47,0.47,0.00	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron62/71:c.12294+134C>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron62/72:c.12294+134C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1236125 [benign DISEASE=not provided GENE=USH2A];			rs10864183	0.20503	0.12706,0.25088,0.39057,0.21497,0.51203	3729,	23749	121001	1.0170	15.79			/0.8>2.0/0.4>8.2	COSV56344121	USH2A|0.00|0.00|0.00|0.00|1|10|2|10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215680407	215680407	T	-	hom	hom	het		QUAL=24;DP=191,94,67;AF=0.54,0.87,0.66	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron61/71:c.12067-31del::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron61/72:c.12067-31del::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1225305 [benign DISEASE=not provided,Usher syndrome type 2A,Retinitis pigmentosa 39 GENE=USH2A];			rs5780842	0.89318	0.76205,0.94341,0.99403,0.94266,0.92040	58959,	13221	15683	1.7360	0.52			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215680493	215680493	A	G	het	het	wt		QUAL=24;DP=117,34,16;AF=0.55,0.59,0.00	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron61/71:c.12067-117T>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron61/72:c.12067-117T>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1247988 [benign DISEASE=not provided GENE=USH2A];			rs12140451	0.19252	0.12408,0.19436,0.29333,0.21178,0.48728	3165,	22869	122465	-0.4630	0.53			/2.4>3.5/0.0>0.0	COSV56344126	USH2A|0.00|0.00|0.00|0.00|-37|0|-37|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215680558	215680558	G	C	het	het	wt		QUAL=24;DP=81,9,4;AF=0.54,0.67,0.00	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron61/71:c.12067-182C>G::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron61/72:c.12067-182C>G::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1174446 [benign DISEASE=not provided GENE=USH2A];			rs4375237	0.26042	0.31445,0.27064,0.39167,0.21614,0.52370	5557,	28385	112177	-0.3540	0.71			/0.0>3.4/0.0>0.0	COSV56344135	USH2A|0.00|0.00|0.00|0.00|-1|13|13|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215728150	215728150	C	T	hom	hom	het		QUAL=24;DP=220,642,543;AF=1.00,0.99,0.42	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon61/72:c.11946G>A:p.Leu3982=:PF00041 [Fibronectin type III domain],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon61/73:c.11946G>A:p.Leu3982=:PF00041 [Fibronectin type III domain]		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48387 [benign DISEASE=Retinal dystrophy,Usher syndrome type 2A,not provided,not specified GENE=USH2A];			rs2820718	0.16834	0.16886,0.11234,0.00387,0.18562,0.13572	2291,	21024	126504	0.7290	5.29			/0.0>0.0/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|4|-16|17|6	25741868,24033266,18665195,31817543	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215741409	215741409	G	T	het	wt	het		QUAL=24;DP=208,16,192;AF=0.53,0.00,0.52	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon60/72:c.11677C>A:p.Pro3893Thr:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon60/73:c.11677C>A:p.Pro3893Thr:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48380 [benign/likely benign DISEASE=not provided,Retinitis pigmentosa 39,Usher syndrome type 2A,Retinal dystrophy,not specified GENE=USH2A];	CM165987 [CLASS=DM? MUT=ALT PHEN="Usher syndrome 2" GENE=USH2A];		rs41303285	0.01283	0.00335,0.00334,0.00019,0.01949,0.01246	19,	1914	150146	6.1100	22.30	0.340	0.17	/0.0>0.0/0.0>0.0	COSV99048391	USH2A|0.00|0.00|0.00|0.00|-2|48|41|-34	24033266,20507924,18273898,29216386,17405132,22004887,25999674,25133751,20145675,21569298,26927203	21	1408	0	0 / 0	3	"[3] auto-classification 14.09.2017"		"DVD: Benign; gnomAD: 59 homo cases; ClinVar: Class1 (all 6 entries)"	USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215743079	215743079	C	T	hom	hom	het		QUAL=25;DP=95,51,38;AF=1.00,1.00,0.45	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron59/71:c.11548+98G>A::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron59/72:c.11548+98G>A::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1290577 [benign DISEASE=not provided GENE=USH2A];			rs2797223	0.14995	0.12305,0.10847,0.00504,0.17215,0.11231	1869,	19037	129105	1.8500	17.12			/0.0>0.0/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|-27|-1|-6|-22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215782390	215782390	-	AA	hom	het	het		QUAL=24;DP=62,9,8;AF=0.95,0.67,0.50	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron53/71:c.10586-196_10586-195dup::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron53/72:c.10586-196_10586-195dup::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1222339 [benign DISEASE=not provided GENE=USH2A];			rs35071811	0.36223	0.45140,0.32700,0.28058,0.32798,0.34579	10280,	34434	96828		1.96			/1.7>1.9/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|-15|46|46|-34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215782595	215782595	T	G	hom	het	het		QUAL=24;DP=27,11,10;AF=0.96,0.55,0.40	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron53/71:c.10585+143A>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron53/72:c.10585+143A>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	678884 [benign DISEASE=Usher syndrome type 2A,not provided GENE=USH2A];			rs6665799	0.36277	0.45259,0.32729,0.28284,0.32815,0.34611	10340,	34489	96907	-0.6860	0.56			/0.0>0.0/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|32|37|24|34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215782962	215782962	A	G	hom	hom	hom		QUAL=24;DP=81,27,22;AF=0.99,1.00,1.00	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron52/71:c.10388-27T>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron52/72:c.10388-27T>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1177015 [benign DISEASE=not provided,Usher syndrome type 2A GENE=USH2A];			rs7518466	0.59076	0.72145,0.58248,0.63339,0.52487,0.49253	27139,	35499	62193	-0.8160	0.05			/0.0>0.0/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|4|-27|-27|-41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215786825	215786825	T	G	hom	hom	hom		QUAL=24;DP=206,368,286;AF=1.00,1.00,1.00	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon52/72:c.10232A>C:p.Glu3411Ala:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon52/73:c.10232A>C:p.Glu3411Ala:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48344 [benign DISEASE=Usher syndrome type 2A,Retinal dystrophy,not provided,not specified GENE=USH2A];			rs10864198	0.57994	0.68383,0.57878,0.63306,0.52483,0.49336	25969,	36173	63821	2.9590	13.26	0.086	0.04	/0.8>1.6/0.0>0.0	COSV56336661	USH2A|0.00|0.02|0.00|0.00|-3|49|-14|-12	25741868,24033266,23757202,21686329,20145675,18665195,31817543,29986705	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215877945	215877945	A	G	wt	het	het		QUAL=24;DP=37,138,136;AF=0.00,0.54,0.45	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron42/71:c.8559-65T>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron42/72:c.8559-65T>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1177604 [benign DISEASE=Usher syndrome type 2A,not provided GENE=USH2A];			rs7518358	0.24336	0.33955,0.21237,0.43709,0.19446,0.37173	4943,	27122	115064	0.8390	15.22			/0.0>0.0/0.0>0.0	COSV56431732	USH2A|0.00|0.00|0.00|0.00|7|-25|25|-8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215879207	215879207	A	G	wt	het	het		QUAL=24;DP=43,65,80;AF=0.00,0.38,0.50	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron41/71:c.8224-109T>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron41/72:c.8224-109T>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1180911 [benign DISEASE=not provided GENE=USH2A];			rs6669557	0.17538	0.18876,0.17498,0.33068,0.16912,0.22608	2402,	21880	125470	0.6750	7.45			/0.0>0.0/0.0>0.0	COSV56388299	USH2A|0.00|0.00|0.00|0.00|27|-41|-9|8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215993112	215993112	T	G	het	wt	het		QUAL=24;DP=129,16,94;AF=0.48,0.00,0.57	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon35/72:c.6713A>C:p.Glu2238Ala:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon35/73:c.6713A>C:p.Glu2238Ala:	regulatory_region_variant:CTCF_binding_site	608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48568 [benign/likely benign DISEASE=not provided,Usher syndrome type 2A,Retinitis pigmentosa 39,not specified GENE=USH2A];	CM140482 [CLASS=DM? MUT=ALT PHEN="Retinitis pigmentosa autosomal recessive" GENE=USH2A];		rs41277212	0.01921	0.00565,0.01360,0.00039,0.02723,0.01285	47,	2832	149362	4.8150	21.90	0.274	0.15	/0.0>1.9/0.0>0.0	COSV56370381	USH2A|0.00|0.00|0.00|0.00|-15|30|43|45	24033266,17085681,18273898,29343940	43	1998	0	0 / 0		"[3] auto-classification 14.09.2017 [n/a] ahmazzp1 30.04.2024"		"DVD: Benign"	USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215999038	215999038	A	G	hom	hom	hom		QUAL=24;DP=180,229,188;AF=0.99,1.00,1.00	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon34/72:c.6506T>C:p.Ile2169Thr:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon34/73:c.6506T>C:p.Ile2169Thr:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48562 [benign DISEASE=not provided,Usher syndrome type 2A,Retinal dystrophy,not specified GENE=USH2A];			rs10864219	0.50971	0.42971,0.55809,0.84322,0.50172,0.61333	20321,	36752	74444	2.3650	15.36	0.114	0.11	/0.0>0.0/1.5>0.6	COSV56370398	USH2A|0.00|0.00|0.00|0.00|20|2|-2|2	25741868,24033266,21686329,20145675,18665195,31817543,37664790	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	215999243	215999243	G	A	hom	hom	hom		QUAL=24;DP=62,6,5;AF=1.00,1.00,1.00	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron33/71:c.6486-185C>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron33/72:c.6486-185C>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1267088 [benign DISEASE=not provided GENE=USH2A];			rs1436780	0.94589	0.94301,0.94202,0.99981,0.94294,0.95419	68148,	7736	8240	0.3710	6.26			/10.2>10.2/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216046439	216046439	A	G	het	hom	het		QUAL=25;DP=201,147,125;AF=0.49,1.00,0.50	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon32/72:c.6317T>C:p.Ile2106Thr:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon32/73:c.6317T>C:p.Ile2106Thr:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	167815 [benign DISEASE=not specified,not provided,Retinal dystrophy,Usher syndrome type 2A GENE=USH2A];			rs6657250	0.66737	0.76554,0.50531,0.44512,0.67568,0.50021	34553,	32192	50490	1.2600	12.08	0.133	0.05	/0.0>0.0/0.0>0.0	COSV56342913	USH2A|0.00|0.00|0.00|0.00|18|-8|-8|16	24033266,21686329,18665195,31817543,29283788	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216048379	216048379	C	T	hom	het	hom		QUAL=24;DP=144,141,78;AF=1.00,0.53,1.00	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron31/71:c.6163+155G>A::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron31/72:c.6163+155G>A::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1297779 [benign DISEASE=not provided GENE=USH2A];			rs10864227	0.36993	0.17959,0.29666,0.48873,0.46003,0.37277	11715,	32767	95715	3.5030	21.10			/0.9>1.3/1.6>5.5	COSV56436962	USH2A|0.00|0.00|0.00|0.00|36|2|-1|38	29283788	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216073334	216073334	G	-	het	het	het		QUAL=24;DP=102,141,103;AF=0.55,0.55,0.52	USH2A,USH2A-AS2	intron,intron&non_coding_transcript	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron27/71:c.5573-34del::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron27/72:c.5573-34del::,USH2A-AS2:ENST00000446411.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.136+736del::,USH2A-AS2:ENST00000430890.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron1/2:n.78+530del::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1243806 [benign DISEASE=Retinitis pigmentosa 39,not provided,Usher syndrome type 2A GENE=USH2A];			rs35944387	0.72283	0.74392,0.76162,0.94297,0.69287,0.78190	39957,	29821	42079	0.8790	14.75			/0.0>0.0/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|-33|-39|-28|21	21686329	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS2 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216084852	216084852	G	T	het	het	het		QUAL=24;DP=156,177,133;AF=0.49,0.51,0.51	USH2A,USH2A-AS2	synonymous,intron&non_coding_transcript	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon25/72:c.5013C>A:p.Gly1671=:PF02210 [Laminin G domain],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon25/73:c.5013C>A:p.Gly1671=:PF02210 [Laminin G domain],USH2A-AS2:ENST00000446411.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.266-1870G>T::,USH2A-AS2:ENST00000430890.5:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.208-1870G>T::,USH2A-AS2:ENST00000442606.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.207-1870G>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48527 [benign DISEASE=not specified,Usher syndrome type 2A,Retinal dystrophy,not provided GENE=USH2A];			rs56110889	0.16226	0.19350,0.13495,0.00039,0.17992,0.05758	2188,	20295	127371	0.1710	6.79			/5.1>3.6/0.0>0.0,/0.0>0.0/0.0>0.0	COSV56425186	USH2A|0.00|0.00|0.00|0.00|25|-17|25|1	25741868,24033266,23757202,17085681	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS2 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216174110	216174110	C	A	het	wt	het		QUAL=24;DP=113,26,108;AF=0.43,0.00,0.45	USH2A	intron,3'UTR	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron21/71:c.4627+1142G>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron21/72:c.4627+1142G>T::,USH2A:ENST00000366942.3:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1128G>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	295405 [benign DISEASE=not provided,Retinitis pigmentosa,Usher syndrome type 2A GENE=USH2A];			rs401269	0.20332	0.16370,0.20353,0.21856,0.23453,0.21975	3217,	24461	121061	-0.1820	6.14			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216174214	216174214	A	G	het	wt	het		QUAL=24;DP=112,26,56;AF=0.44,0.00,0.54	USH2A	intron,3'UTR	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron21/71:c.4627+1038T>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron21/72:c.4627+1038T>C::,USH2A:ENST00000366942.3:3_prime_UTR_variant:MODIFIER:exon21/21:c.*1024T>C::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	295407 [benign DISEASE=Retinitis pigmentosa,Usher syndrome type 2A,not provided GENE=USH2A];			rs439940	0.20413	0.16638,0.20368,0.22029,0.23457,0.22017	3240,	24577	121089	0.8240	3.59			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216175422	216175422	C	T	het	hom	het		QUAL=24;DP=153,399,456;AF=0.57,0.99,0.50	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon21/72:c.4457G>A:p.Arg1486Lys:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon21/73:c.4457G>A:p.Arg1486Lys:,USH2A:ENST00000366942.3:missense_variant:MODERATE:exon21/21:c.4457G>A:p.Arg1486Lys:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	177992 [benign DISEASE=not specified,Retinal dystrophy,not provided,Usher syndrome type 2A GENE=USH2A];			rs1805049	0.62892	0.57642,0.66180,0.76226,0.62256,0.70975	30324,	34979	56423	-1.5240	9.76	0.024	0.08	/3.0>3.1/0.0>1.9	COSV56346078	USH2A|0.01|0.00|0.00|0.00|27|-1|27|0	24033266,21686329,20145675,18665195,31817543	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216196766	216196766	C	T	het	wt	het		QUAL=24;DP=187,19,93;AF=0.51,0.00,0.51	USH2A,USH2A-AS1,MRPS18BP1	intron,intron&non_coding_transcript,downstream_gene	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron18/71:c.4082-44G>A::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron18/72:c.4082-44G>A::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron18/20:c.4082-44G>A::,USH2A-AS1:ENST00000420867.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.362+841C>T::,MRPS18BP1:ENST00000414228.1:downstream_gene_variant:MODIFIER::::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1177619 [benign DISEASE=Usher syndrome type 2A,not provided GENE=USH2A];			rs447102	0.17734	0.07132,0.19687,0.22032,0.23479,0.21898	2760,	21442	125078	-1.2300	0.04			/0.0>0.0/0.0>0.0	COSV56445389	USH2A|0.00|0.00|0.00|0.00|-44|-47|30|-48	18665195	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), MRPS18BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216196788	216196788	T	G	hom	hom	hom		QUAL=24;DP=171,95,71;AF=0.99,1.00,1.00	USH2A,USH2A-AS1,MRPS18BP1	intron,intron&non_coding_transcript,downstream_gene	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron18/71:c.4082-66A>C::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron18/72:c.4082-66A>C::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron18/20:c.4082-66A>C::,USH2A-AS1:ENST00000420867.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.362+863T>G::,MRPS18BP1:ENST00000414228.1:downstream_gene_variant:MODIFIER::::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1177620 [benign DISEASE=Usher syndrome type 2A,not provided GENE=USH2A];			rs386851	0.90538	0.97505,0.90016,0.98178,0.86649,0.93245	62624,	12564	14402	0.0510	1.85			/3.1>3.1/0.0>0.0,/3.2>3.0/0.0>0.0			18665195	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), MRPS18BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216198592	216198592	A	C	het	wt	het		QUAL=24;DP=206,16,82;AF=0.54,0.00,0.55	USH2A,USH2A-AS1,MRPS18BP1	splice_region&intron,intron&non_coding_transcript,downstream_gene	USH2A:ENST00000307340.8:splice_region_variant&intron_variant:LOW:intron17/71:c.3812-8T>G::,USH2A:ENST00000674083.1:splice_region_variant&intron_variant:LOW:intron17/72:c.3812-8T>G::,USH2A:ENST00000366942.3:splice_region_variant&intron_variant:LOW:intron17/20:c.3812-8T>G::,USH2A-AS1:ENST00000420867.1:intron_variant&non_coding_transcript_variant:MODIFIER:intron2/2:n.362+2667A>C::,MRPS18BP1:ENST00000414228.1:downstream_gene_variant:MODIFIER::::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48508 [benign DISEASE=Usher syndrome type 2A,Retinitis pigmentosa,not specified,not provided GENE=USH2A];			rs646094	0.20450	0.16374,0.20855,0.22035,0.23567,0.22012	3260,	24583	120991	2.6310	5.39			9.7>8.9/9.7>8.9/0.0>0.0,/0.0>0.0/0.0>0.0		USH2A|0.00|0.14|0.00|0.00|42|-8|44|-8	25741868,24033266,18665195,31817543	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76), USH2A-AS1 (inh=AR+AD oe_syn=n/a oe_mis=n/a oe_lof=n/a), MRPS18BP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	216217352	216217352	C	T	het	hom	het		QUAL=24;DP=179,125,110;AF=0.48,1.00,0.52	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron15/71:c.3157+35G>A::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron15/72:c.3157+35G>A::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron15/20:c.3157+35G>A::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1177621 [benign DISEASE=Usher syndrome type 2A,not provided GENE=USH2A];		L3b (LINE/CR1)	rs1324330	0.55887	0.34184,0.63247,0.76008,0.61939,0.69253	25218,	34462	67012	0.1690	1.25			/0.8>3.9/0.0>0.0	COSV56329695	USH2A|0.02|0.00|0.00|0.00|-49|39|35|-49	20145675,18665195,31817543	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216232288	216232288	T	A	het	wt	het		QUAL=24;DP=88,11,7;AF=0.52,0.00,0.43	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron13/71:c.2810-152A>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron13/72:c.2810-152A>T::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron13/20:c.2810-152A>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]				rs533694105	0.00182	0.00060,0.00111,0.00000,0.00307,0.00062	0,	278	152084	-0.2400	0.48			/0.2>1.4/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|-15|-10|34|-1		4	144	0	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216289580	216289580	C	A	het	het	wt		QUAL=24;DP=92,34,17;AF=0.45,0.53,0.00	USH2A	intron	USH2A:ENST00000307340.8:intron_variant:MODIFIER:intron10/71:c.1841-170G>T::,USH2A:ENST00000674083.1:intron_variant:MODIFIER:intron10/72:c.1841-170G>T::,USH2A:ENST00000366942.3:intron_variant:MODIFIER:intron10/20:c.1841-170G>T::		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	1216713 [likely benign DISEASE=not provided GENE=USH2A];			rs114284380	0.01329	0.00212,0.00818,0.00000,0.01828,0.00290	21,	1981	150239	3.4400	18.94			/0.1>0.8/0.0>0.0		USH2A|0.00|0.00|0.00|0.00|-32|7|8|-31		20	935	0	0 / 0					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216418661	216418661	T	C	hom	hom	hom		QUAL=25;DP=160,255,190;AF=1.00,1.00,0.99	USH2A	synonymous	USH2A:ENST00000307340.8:synonymous_variant:LOW:exon3/72:c.504A>G:p.Thr168=:PF13385 [Concanavalin A-like lectin/glucanases superfamily],USH2A:ENST00000674083.1:synonymous_variant:LOW:exon3/73:c.504A>G:p.Thr168=:PF13385 [Concanavalin A-like lectin/glucanases superfamily],USH2A:ENST00000366942.3:synonymous_variant:LOW:exon3/21:c.504A>G:p.Thr168=:PF13385 [Concanavalin A-like lectin/glucanases superfamily]		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48528 [benign DISEASE=Retinal dystrophy,not specified,not provided,Usher syndrome type 2A,Retinitis pigmentosa GENE=USH2A];			rs4253963	0.61723	0.50109,0.65701,0.83294,0.65072,0.62407	29448,	34805	58109	-0.5650	0.72			/0.0>0.0/0.0>5.2		USH2A|0.00|0.00|0.00|0.00|18|7|19|18	25741868,24033266,22876132,32313182,21686329,20145675,18665195,31817543,29283788	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	216421964	216421964	C	T	hom	hom	hom		QUAL=24;DP=115,351,278;AF=0.98,1.00,1.00	USH2A	missense	USH2A:ENST00000307340.8:missense_variant:MODERATE:exon2/72:c.373G>A:p.Ala125Thr:,USH2A:ENST00000674083.1:missense_variant:MODERATE:exon2/73:c.373G>A:p.Ala125Thr:,USH2A:ENST00000366942.3:missense_variant:MODERATE:exon2/21:c.373G>A:p.Ala125Thr:		608400_[GENE=USH2A_PHENOS=Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3), Autosomal recessive]	48507 [benign DISEASE=not provided,Retinal dystrophy,Retinitis pigmentosa,not specified,Usher syndrome type 2A GENE=USH2A];			rs10779261	0.73236	0.75563,0.72270,0.83288,0.70825,0.76037	40885,	29564	40686	0.3580	10.44	0.084	0.06	/0.0>0.0/0.2>0.0		USH2A|0.00|0.00|0.00|0.00|-27|7|5|1	25741868,24033266,32313182,21686329,20145675,18665195,31817543,37033211,30419932,29283788,33829662	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					USH2A (inh=AR oe_syn=1.16 oe_mis=1.13 oe_lof=0.76)
chr1	220150107	220150107	T	-	hom	het	het		QUAL=25;DP=83,71,66;AF=0.46,0.52,0.56	RAB3GAP2,IARS2	3'UTR,downstream_gene	RAB3GAP2:ENST00000358951.7:3_prime_UTR_variant:MODIFIER:exon35/35:c.*1144del::,IARS2:ENST00000366922.3:downstream_gene_variant:MODIFIER::::,RAB3GAP2:ENST00000691661.1:downstream_gene_variant:MODIFIER::::,RAB3GAP2:ENST00000691862.1:downstream_gene_variant:MODIFIER::::,RAB3GAP2:ENST00000690315.1:downstream_gene_variant:MODIFIER::::,RAB3GAP2:ENST00000692972.1:downstream_gene_variant:MODIFIER::::,RAB3GAP2:ENST00000687647.1:downstream_gene_variant:MODIFIER::::,RAB3GAP2:ENST00000686381.1:downstream_gene_variant:MODIFIER::::,RAB3GAP2:ENST00000687065.1:downstream_gene_variant:MODIFIER::::,RAB3GAP2:ENST00000692813.1:downstream_gene_variant:MODIFIER::::,RAB3GAP2:ENST00000685664.1:downstream_gene_variant:MODIFIER::::,RAB3GAP2:ENST00000690824.1:downstream_gene_variant:MODIFIER::::		612801_[GENE=IARS2_PHENOS=Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3), Autosomal recessive]&609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	295627 [uncertain significance DISEASE=Warburg micro syndrome,not provided,Martsolf syndrome GENE=RAB3GAP2];		FLAM_C (SINE/Alu)	rs11316594	0.47088	0.62126,0.48087,0.68899,0.38626,0.44563	14628,	33268	70258	-2.8380	0.31			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IARS2 (inh=AR oe_syn=0.94 oe_mis=0.86 oe_lof=0.25), RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220150847	220150847	A	G	het	het	wt		QUAL=24;DP=141,267,26;AF=0.50,0.53,0.00	RAB3GAP2,IARS2	3'UTR,downstream_gene	RAB3GAP2:ENST00000358951.7:3_prime_UTR_variant:MODIFIER:exon35/35:c.*404T>C::,RAB3GAP2:ENST00000691661.1:3_prime_UTR_variant:MODIFIER:exon35/35:c.*404T>C::,RAB3GAP2:ENST00000691862.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*404T>C::,RAB3GAP2:ENST00000690315.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*404T>C::,RAB3GAP2:ENST00000692972.1:3_prime_UTR_variant:MODIFIER:exon36/36:c.*404T>C::,RAB3GAP2:ENST00000687647.1:3_prime_UTR_variant:MODIFIER:exon35/35:c.*404T>C::,RAB3GAP2:ENST00000686381.1:3_prime_UTR_variant:MODIFIER:exon36/36:c.*404T>C::,RAB3GAP2:ENST00000687065.1:3_prime_UTR_variant:MODIFIER:exon36/36:c.*404T>C::,RAB3GAP2:ENST00000692813.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*404T>C::,RAB3GAP2:ENST00000685664.1:3_prime_UTR_variant:MODIFIER:exon34/34:c.*708T>C::,RAB3GAP2:ENST00000690824.1:3_prime_UTR_variant:MODIFIER:exon35/35:c.*404T>C::,IARS2:ENST00000366922.3:downstream_gene_variant:MODIFIER::::		612801_[GENE=IARS2_PHENOS=Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia, 616007 (3), Autosomal recessive]&609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	295635 [benign DISEASE=not provided,Warburg micro syndrome 2,Martsolf syndrome GENE=RAB3GAP2];			rs1059140	0.07161	0.01710,0.05995,0.06223,0.09832,0.14357	522,	9858	141348	0.2210	7.17			/0.6>2.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					IARS2 (inh=AR oe_syn=0.94 oe_mis=0.86 oe_lof=0.25), RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220157330	220157330	C	T	het	het	wt		QUAL=24;DP=196,289,17;AF=0.57,0.48,0.00	RAB3GAP2	synonymous	RAB3GAP2:ENST00000358951.7:synonymous_variant:LOW:exon31/35:c.3495G>A:p.Leu1165=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000691661.1:synonymous_variant:LOW:exon31/35:c.3507G>A:p.Leu1169=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000691862.1:synonymous_variant:LOW:exon30/34:c.3393G>A:p.Leu1131=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000690315.1:synonymous_variant:LOW:exon30/34:c.3396G>A:p.Leu1132=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000692972.1:synonymous_variant:LOW:exon32/36:c.3570G>A:p.Leu1190=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000687647.1:synonymous_variant:LOW:exon31/35:c.3231G>A:p.Leu1077=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000686381.1:synonymous_variant:LOW:exon32/36:c.3231G>A:p.Leu1077=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000687065.1:synonymous_variant:LOW:exon32/36:c.3231G>A:p.Leu1077=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000692813.1:synonymous_variant:LOW:exon30/34:c.3459G>A:p.Leu1153=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000685664.1:synonymous_variant:LOW:exon31/34:c.3495G>A:p.Leu1165=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000690824.1:synonymous_variant:LOW:exon31/35:c.3495G>A:p.Leu1165=:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus]		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	130080 [benign DISEASE=Martsolf syndrome,Warburg micro syndrome 2,not provided,not specified GENE=RAB3GAP2];			rs11547779	0.07100	0.01707,0.05934,0.06265,0.09788,0.12957	512,	9768	141212	-0.5860	4.91			/5.2>5.2/0.8>0.0	COSV62784001	RAB3GAP2|0.00|0.00|0.00|0.00|-8|50|33|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220157863	220157863	C	G	het	het	wt		QUAL=24;DP=133,248,17;AF=0.41,0.46,0.00	RAB3GAP2	missense	RAB3GAP2:ENST00000358951.7:missense_variant:MODERATE:exon30/35:c.3275G>C:p.Ser1092Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000691661.1:missense_variant:MODERATE:exon30/35:c.3287G>C:p.Ser1096Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000691862.1:missense_variant:MODERATE:exon29/34:c.3173G>C:p.Ser1058Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000690315.1:missense_variant:MODERATE:exon29/34:c.3176G>C:p.Ser1059Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000692972.1:missense_variant:MODERATE:exon31/36:c.3350G>C:p.Ser1117Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000687647.1:missense_variant:MODERATE:exon30/35:c.3011G>C:p.Ser1004Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000686381.1:missense_variant:MODERATE:exon31/36:c.3011G>C:p.Ser1004Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000687065.1:missense_variant:MODERATE:exon31/36:c.3011G>C:p.Ser1004Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000692813.1:missense_variant:MODERATE:exon29/34:c.3239G>C:p.Ser1080Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000685664.1:missense_variant:MODERATE:exon30/34:c.3275G>C:p.Ser1092Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus],RAB3GAP2:ENST00000690824.1:missense_variant:MODERATE:exon30/35:c.3275G>C:p.Ser1092Thr:PF14656 [Rab3 GTPase-activating protein regulatory subunit C-terminus]		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	130079 [benign DISEASE=not provided,Martsolf syndrome,Warburg micro syndrome 2,not specified GENE=RAB3GAP2];			rs2289189	0.07076	0.01709,0.05840,0.06170,0.09773,0.12971	509,	9755	141471	7.3560	25.90	0.181	0.26	/0.0>0.0/0.0>0.0	COSV62784008	RAB3GAP2|0.00|0.00|0.00|0.00|43|-50|-32|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220157956	220157956	C	G	het	het	wt		QUAL=24;DP=85,161,17;AF=0.52,0.53,0.00	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron29/34:c.3262-80G>C::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron29/34:c.3274-80G>C::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron28/33:c.3160-80G>C::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron28/33:c.3163-80G>C::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron30/35:c.3337-80G>C::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron29/34:c.2998-80G>C::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron30/35:c.2998-80G>C::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron30/35:c.2998-80G>C::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron28/33:c.3226-80G>C::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron29/33:c.3262-80G>C::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron29/34:c.3262-80G>C::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1293227 [benign DISEASE=not provided GENE=RAB3GAP2];			rs3767655	0.07080	0.01710,0.05836,0.06192,0.09781,0.12930	511,	9759	141495	-1.0190	0.26			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220159210	220159210	C	T	het	het	het		QUAL=24;DP=115,64,53;AF=0.51,0.55,0.43	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron29/34:c.3261+176G>A::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron29/34:c.3273+176G>A::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron28/33:c.3159+176G>A::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron28/33:c.3162+176G>A::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron30/35:c.3336+176G>A::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron29/34:c.2997+176G>A::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron30/35:c.2997+176G>A::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron30/35:c.2997+176G>A::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron28/33:c.3226-1334G>A::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron29/33:c.3261+176G>A::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron29/34:c.3261+176G>A::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1257064 [benign DISEASE=not provided GENE=RAB3GAP2];			rs2789792	0.48287	0.67933,0.48553,0.71033,0.37328,0.44846	19331,	34689	78555	-5.6310	0.11			/9.8>9.8/0.0>0.0		RAB3GAP2|0.00|0.00|0.00|0.00|-20|-1|18|5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220159534	220159534	G	A	het	het	het		QUAL=24;DP=106,38,25;AF=0.53,0.42,0.52	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron28/34:c.3226-113C>T::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron28/34:c.3238-113C>T::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron27/33:c.3124-113C>T::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron27/33:c.3127-113C>T::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron29/35:c.3301-113C>T::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron28/34:c.2962-113C>T::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron29/35:c.2962-113C>T::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron29/35:c.2962-113C>T::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron28/33:c.3226-1658C>T::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron28/33:c.3226-113C>T::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron28/34:c.3226-113C>T::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1258027 [benign DISEASE=not provided GENE=RAB3GAP2];			rs2808026	0.48279	0.67886,0.48593,0.71009,0.37330,0.44758	19334,	34723	78625	0.3150	5.16			/6.5>6.5/0.0>0.0		RAB3GAP2|0.00|0.00|0.00|0.00|-7|34|39|-17		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220172230	220172230	A	C	het	het	wt		QUAL=24;DP=102,15,16;AF=0.47,0.47,0.00	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron22/34:c.2417-181T>G::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron22/34:c.2429-181T>G::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron21/33:c.2315-181T>G::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron21/33:c.2318-181T>G::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron23/35:c.2492-181T>G::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron22/34:c.2153-181T>G::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron23/35:c.2153-181T>G::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron23/35:c.2153-181T>G::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron22/33:c.2417-181T>G::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron22/33:c.2417-181T>G::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron22/34:c.2417-181T>G::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1263789 [benign DISEASE=not provided GENE=RAB3GAP2];			rs73098558	0.12986	0.13043,0.10334,0.09950,0.13532,0.19001	1385,	17000	132472	-1.8110	0.08			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220172536	220172536	A	G	het	het	wt		QUAL=24;DP=159,112,16;AF=0.54,0.56,0.00	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron22/34:c.2416+101T>C::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron22/34:c.2428+101T>C::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron21/33:c.2314+101T>C::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron21/33:c.2317+101T>C::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron23/35:c.2491+101T>C::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron22/34:c.2152+101T>C::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron23/35:c.2152+101T>C::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron23/35:c.2152+101T>C::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron22/33:c.2416+101T>C::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron22/33:c.2416+101T>C::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron22/34:c.2416+101T>C::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1178138 [benign DISEASE=not provided GENE=RAB3GAP2];			rs41303055	0.07135	0.01713,0.05907,0.06255,0.09765,0.14633	529,	9804	141374	-0.2050	0.60			/0.0>0.0/0.0>0.0		RAB3GAP2|0.00|0.00|0.00|0.00|-17|0|-17|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220182092	220182092	T	-	het	het	wt		QUAL=24;DP=27,8,4;AF=0.44,0.38,0.00	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron21/34:c.2310+165del::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron21/34:c.2322+165del::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron20/33:c.2208+165del::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron20/33:c.2211+165del::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron22/35:c.2385+165del::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron21/34:c.2046+165del::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron22/35:c.2046+165del::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron22/35:c.2046+165del::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron21/33:c.2310+165del::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron21/33:c.2310+165del::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron21/34:c.2310+165del::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1231942 [benign DISEASE=not provided GENE=RAB3GAP2];			rs11343960	0.48087	0.67912,0.48243,0.70976,0.37211,0.41970	19065,	34598	78514	0.3420	0.48			/3.3>4.0/0.4>0.0		RAB3GAP2|0.00|0.00|0.00|0.00|2|39|2|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220193155	220193155	T	A	het	het	wt		QUAL=24;DP=115,60,16;AF=0.45,0.45,0.00	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron13/34:c.1270+85A>T::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron13/34:c.1282+85A>T::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron12/33:c.1168+85A>T::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron12/33:c.1171+85A>T::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron14/35:c.1345+85A>T::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron13/34:c.1006+85A>T::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron14/35:c.1006+85A>T::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron14/35:c.1006+85A>T::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron13/33:c.1270+85A>T::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron13/33:c.1270+85A>T::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron13/34:c.1270+85A>T::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1293232 [benign DISEASE=not provided GENE=RAB3GAP2];			rs78010602	0.06923	0.01667,0.05602,0.06383,0.09655,0.10207	482,	9579	141745	0.1860	4.75			/0.0>0.0/0.0>0.0		RAB3GAP2|0.00|0.00|0.00|0.00|2|31|2|31		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220206161	220206161	G	C	het	het	het		QUAL=24;DP=72,14,13;AF=0.50,0.29,0.46	RAB3GAP2,SNX2P1	intron,upstream_gene	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron7/34:c.613-155C>G::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron7/34:c.625-155C>G::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron6/33:c.511-155C>G::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron7/33:c.613-155C>G::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron7/35:c.613-155C>G::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron7/34:c.349-155C>G::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron8/35:c.349-155C>G::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron8/35:c.349-155C>G::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron7/33:c.613-155C>G::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron7/33:c.613-155C>G::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron7/34:c.613-155C>G::,RAB3GAP2:ENST00000689820.1:intron_variant:MODIFIER:intron7/9:c.613-155C>G::,SNX2P1:ENST00000604232.1:upstream_gene_variant:MODIFIER::::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1243694 [benign DISEASE=not provided GENE=RAB3GAP2];			rs4142940	0.45762	0.68535,0.45134,0.45285,0.35237,0.37241	17666,	34217	82431	-1.4300	3.63			/0.0>0.0/0.0>0.0	COSV52966966	RAB3GAP2|0.00|0.00|0.00|0.00|30|46|45|46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19), SNX2P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	220213730	220213730	-	T	hom	het	n/a	low_conf_region	QUAL=24;DP=31,6,0;AF=0.90,0.67,	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron3/34:c.304+125dup::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron3/34:c.316+125dup::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron3/33:c.304+125dup::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron3/33:c.304+125dup::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron3/35:c.304+125dup::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron3/34:c.40+125dup::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron4/35:c.40+125dup::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron4/35:c.40+125dup::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron3/33:c.304+125dup::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron3/33:c.304+125dup::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron3/34:c.304+125dup::,RAB3GAP2:ENST00000689820.1:intron_variant:MODIFIER:intron3/9:c.304+125dup::	regulatory_region_variant:enhancer	609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]			G-rich (Low_complexity)	rs370682557	0.11359	0.03472,0.08221,0.09653,0.13799,0.19949	702,	6185	59219		0.41			/2.1>2.7/0.0>0.0		RAB3GAP2|0.00|0.00|0.00|0.00|-1|48|-32|-43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220213741	220213741	G	A	het	het	wt	low_conf_region	QUAL=23;DP=37,9,4;AF=0.86,0.78,0.00	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron3/34:c.304+115C>T::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron3/34:c.316+115C>T::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron3/33:c.304+115C>T::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron3/33:c.304+115C>T::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron3/35:c.304+115C>T::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron3/34:c.40+115C>T::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron4/35:c.40+115C>T::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron4/35:c.40+115C>T::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron3/33:c.304+115C>T::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron3/33:c.304+115C>T::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron3/34:c.304+115C>T::,RAB3GAP2:ENST00000689820.1:intron_variant:MODIFIER:intron3/9:c.304+115C>T::	regulatory_region_variant:enhancer	609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1248119 [benign DISEASE=not provided GENE=RAB3GAP2];		G-rich (Low_complexity)	rs147804604	0.08432	0.02408,0.05678,0.08202,0.10808,0.16311	642,	7623	96723	-1.4020	0.15			/2.1>2.9/0.0>0.0	COSV52967451			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220232949	220232949	A	G	het	het	het		QUAL=24;DP=138,130,94;AF=0.45,0.52,0.51	RAB3GAP2	intron	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron1/34:c.116-86T>C::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron1/34:c.116-86T>C::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron1/33:c.116-86T>C::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron1/33:c.116-86T>C::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron1/35:c.116-86T>C::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron1/34:c.-149-86T>C::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron2/35:c.-149-86T>C::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron2/35:c.-149-86T>C::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron1/33:c.116-86T>C::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron1/33:c.116-86T>C::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron1/34:c.116-86T>C::,RAB3GAP2:ENST00000689820.1:intron_variant:MODIFIER:intron1/9:c.116-86T>C::		609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	673980 [benign DISEASE=not provided GENE=RAB3GAP2];		X10b_DNA (DNA/TcMar-Tigger)	rs10863538	0.45854	0.70928,0.45071,0.44975,0.34120,0.38200	18056,	33567	82281	0.5120	2.35			/1.5>1.7/0.3>0.1	COSV52966274	RAB3GAP2|0.00|0.00|0.00|0.00|14|-44|14|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19)
chr1	220272146	220272146	C	T	het	het	wt		QUAL=24;DP=24,70,16;AF=0.50,0.51,0.00	RAB3GAP2,AURKAP1	intron,upstream_gene	RAB3GAP2:ENST00000358951.7:intron_variant:MODIFIER:intron1/34:c.115+77G>A::,RAB3GAP2:ENST00000691661.1:intron_variant:MODIFIER:intron1/34:c.115+77G>A::,RAB3GAP2:ENST00000691862.1:intron_variant:MODIFIER:intron1/33:c.115+77G>A::,RAB3GAP2:ENST00000690315.1:intron_variant:MODIFIER:intron1/33:c.115+77G>A::,RAB3GAP2:ENST00000692972.1:intron_variant:MODIFIER:intron1/35:c.115+77G>A::,RAB3GAP2:ENST00000687647.1:intron_variant:MODIFIER:intron1/34:c.-150+210G>A::,RAB3GAP2:ENST00000686381.1:intron_variant:MODIFIER:intron2/35:c.-150+77G>A::,RAB3GAP2:ENST00000687065.1:intron_variant:MODIFIER:intron2/35:c.-150+77G>A::,RAB3GAP2:ENST00000692813.1:intron_variant:MODIFIER:intron1/33:c.115+77G>A::,RAB3GAP2:ENST00000685664.1:intron_variant:MODIFIER:intron1/33:c.115+77G>A::,RAB3GAP2:ENST00000690824.1:intron_variant:MODIFIER:intron1/34:c.115+77G>A::,RAB3GAP2:ENST00000689820.1:intron_variant:MODIFIER:intron1/9:c.115+77G>A::,AURKAP1:ENST00000451805.2:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	609275_[GENE=RAB3GAP2_PHENOS=Martsolf syndrome 1, 212720 (3), Autosomal recessive; Warburg micro syndrome 2, 614225 (3), Autosomal recessive]	1293230 [benign DISEASE=not provided GENE=RAB3GAP2];			rs2292418	0.06853	0.01670,0.05435,0.07117,0.09466,0.12117	472,	9426	140944	-2.0140	6.40			/0.0>0.0/0.0>0.0	COSV52967126	RAB3GAP2|0.00|0.00|0.00|0.00|-37|1|18|-44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RAB3GAP2 (inh=AR oe_syn=0.92 oe_mis=0.91 oe_lof=0.19), AURKAP1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	222814960	222814970	AGCGGGCCGGG	-	het	het	hom		QUAL=24;DP=6,4,3;AF=1.00,0.75,1.00	DISP1	upstream_gene	DISP1:ENST00000675850.1:upstream_gene_variant:MODIFIER::::,DISP1:ENST00000675961.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter					rs71175195	0.66361	0.71221,0.59606,0.58872,0.65330,0.64964	25442,	36523	44307	1.4500	8.90							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	222928597	222928597	A	C	het	het	het		QUAL=24;DP=175,155,136;AF=0.42,0.50,0.47	DISP1	intron	DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron2/8:c.-18+27A>C::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron2/8:c.-17-14210A>C::,DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron1/7:c.-18+27A>C::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:open_chromatin_region					rs35491159	0.31805	0.30725,0.23217,0.05436,0.35807,0.24938	8068,	32247	103739	-0.0850	5.44			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	222942767	222942767	C	T	het	het	het		QUAL=24;DP=47,94,91;AF=0.49,0.48,0.51	DISP1,NDUFB1P2	intron,upstream_gene	DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron2/8:c.-17-40C>T::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron2/8:c.-17-40C>T::,DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron1/7:c.-17-40C>T::,NDUFB1P2:ENST00000449477.1:upstream_gene_variant:MODIFIER::::			1247665 [benign DISEASE=not provided GENE=DISP1];			rs75109669	0.17718	0.19610,0.13274,0.00193,0.19620,0.07443	2537,	21856	125066	-0.0570	12.02			/0.0>0.0/0.0>0.0		DISP1|0.00|0.00|0.00|0.00|40|36|-42|6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41), NDUFB1P2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	222982872	222982872	C	T	hom	hom	hom		QUAL=25;DP=40,18,10;AF=1.00,1.00,1.00	DISP1	intron	DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron3/8:c.510-208C>T::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron3/8:c.510-208C>T::,DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron2/7:c.510-208C>T::			1182516 [benign DISEASE=not provided GENE=DISP1];			rs2926160	0.97795	0.92676,0.98882,1.00000,0.99922,0.99938	72836,	3123	3355	-3.2720	0.11			/2.6>3.4/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	222983040	222983040	C	T	hom	hom	hom		QUAL=24;DP=273,157,115;AF=1.00,1.00,1.00	DISP1	intron	DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron3/8:c.510-40C>T::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron3/8:c.510-40C>T::,DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron2/7:c.510-40C>T::			1250961 [benign DISEASE=not provided GENE=DISP1];			rs2926159	0.99972	0.99903,0.99993,1.00000,0.99999,1.00000	75818,	42	42	1.0190	10.14			/1.5>1.2/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	222983311	222983311	C	T	het	het	het		QUAL=24;DP=124,33,28;AF=0.48,0.55,0.43	DISP1	intron	DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron4/8:c.539+202C>T::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron4/8:c.539+202C>T::,DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron3/7:c.539+202C>T::			1238426 [benign DISEASE=not provided GENE=DISP1];			rs4388710	0.34121	0.18937,0.39220,0.42813,0.40637,0.32634	9525,	32763	100037	-0.5440	1.22			/0.0>0.0/0.0>0.0	COSV52666631	DISP1|0.03|0.00|0.01|0.00|25|9|-14|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	223002278	223002278	G	A	het	het	wt		QUAL=24;DP=59,84,20;AF=0.54,0.52,0.00	DISP1	intron	DISP1:ENST00000675850.1:intron_variant:MODIFIER:intron8/8:c.988-107G>A::,DISP1:ENST00000675961.1:intron_variant:MODIFIER:intron8/8:c.988-107G>A::,DISP1:ENST00000284476.7:intron_variant:MODIFIER:intron7/7:c.988-107G>A::	regulatory_region_variant:enhancer					rs190562655	0.00273	0.00099,0.00275,0.00000,0.00379,0.00104	1,	413	151809	-0.9070	0.29			/0.0>0.0/0.5>0.0		DISP1|0.00|0.00|0.00|0.00|2|22|-3|-1		1	197	0	0 / 0					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	223005219	223005219	A	C	hom	het	hom		QUAL=25;DP=61,233,240;AF=1.00,0.53,1.00	DISP1	synonymous	DISP1:ENST00000675850.1:synonymous_variant:LOW:exon9/9:c.3822A>C:p.Pro1274=:,DISP1:ENST00000675961.1:synonymous_variant:LOW:exon9/9:c.3822A>C:p.Pro1274=:,DISP1:ENST00000284476.7:synonymous_variant:LOW:exon8/8:c.3822A>C:p.Pro1274=:			262131 [benign DISEASE=not specified,not provided GENE=DISP1];			rs9441941	0.53456	0.45090,0.54933,0.49476,0.58162,0.47055	21985,	37308	70768	-0.9000	0.82			/0.0>0.0/0.0>0.0	COSV52656581	DISP1|0.00|0.00|0.00|0.00|46|-14|-48|-42	25741868,22952568,19184110	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DISP1 (inh=AD oe_syn=1.04 oe_mis=0.91 oe_lof=0.41)
chr1	225401771	225401771	C	T	het	het	wt		QUAL=24;DP=129,351,16;AF=0.53,0.44,0.00	LBR,DNAH14	3'UTR,downstream_gene	LBR:ENST00000272163.9:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1532G>A::,LBR:ENST00000338179.6:3_prime_UTR_variant:MODIFIER:exon14/14:c.*1532G>A::,DNAH14:ENST00000445597.6:downstream_gene_variant:MODIFIER::::,DNAH14:ENST00000430092.5:downstream_gene_variant:MODIFIER::::,DNAH14:ENST00000682510.1:downstream_gene_variant:MODIFIER::::,DNAH14:ENST00000439375.6:downstream_gene_variant:MODIFIER::::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	295917 [benign DISEASE=Greenberg dysplasia,not provided GENE=LBR];			rs7406	0.25275	0.51170,0.14292,0.04205,0.15935,0.30544	6972,	24497	113653	0.7850	10.12			/2.5>1.6/0.4>0.0			25079360,30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DNAH14 (inh=n/a oe_syn=0.79 oe_mis=0.80 oe_lof=1.07), LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225403048	225403048	G	C	het	het	wt		QUAL=24;DP=138,56,23;AF=0.48,0.50,0.00	LBR,DNAH14	3'UTR,downstream_gene	LBR:ENST00000272163.9:3_prime_UTR_variant:MODIFIER:exon14/14:c.*255C>G::,LBR:ENST00000338179.6:3_prime_UTR_variant:MODIFIER:exon14/14:c.*255C>G::,DNAH14:ENST00000445597.6:downstream_gene_variant:MODIFIER::::,DNAH14:ENST00000430092.5:downstream_gene_variant:MODIFIER::::,DNAH14:ENST00000682510.1:downstream_gene_variant:MODIFIER::::,DNAH14:ENST00000439375.6:downstream_gene_variant:MODIFIER::::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	295928 [benign DISEASE=not provided,Greenberg dysplasia GENE=LBR];			rs11551874	0.09168	0.03581,0.07023,0.04090,0.12025,0.25893	843,	12262	138188	0.6960	4.83			/1.4>0.8/0.0>0.0		LBR|0.00|0.00|0.00|0.00|-19|-16|44|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					DNAH14 (inh=n/a oe_syn=0.79 oe_mis=0.80 oe_lof=1.07), LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225410144	225410144	A	G	het	het	hom		QUAL=24;DP=172,95,78;AF=0.59,0.62,1.00	LBR	intron	LBR:ENST00000272163.9:intron_variant:MODIFIER:intron10/13:c.1314+147T>C::,LBR:ENST00000338179.6:intron_variant:MODIFIER:intron10/13:c.1314+147T>C::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	1225790 [benign DISEASE=not provided GENE=LBR];			rs1011319	0.74183	0.46948,0.85606,0.95764,0.84046,0.69809	44157,	24521	39269	-5.9380	0.03			/2.0>0.9/0.0>0.0			26489030,28286461	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225410607	225410607	A	C	het	het	hom		QUAL=24;DP=95,64,32;AF=0.56,0.52,1.00	LBR	intron	LBR:ENST00000272163.9:intron_variant:MODIFIER:intron9/13:c.1189-191T>G::,LBR:ENST00000338179.6:intron_variant:MODIFIER:intron9/13:c.1189-191T>G::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	1224301 [benign DISEASE=not provided GENE=LBR];		L1MC4a (LINE/L1)	rs1538930	0.58515	0.33265,0.71546,0.85232,0.66866,0.49399	27999,	32950	63062	0.0910	0.32			/0.0>0.0/0.0>0.0		LBR|0.00|0.00|0.00|0.00|50|-21|-43|34		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225411153	225411153	G	A	het	het	wt		QUAL=24;DP=63,10,11;AF=0.54,0.40,0.00	LBR	intron	LBR:ENST00000272163.9:intron_variant:MODIFIER:intron9/13:c.1188+184C>T::,LBR:ENST00000338179.6:intron_variant:MODIFIER:intron9/13:c.1188+184C>T::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	1239470 [benign DISEASE=not provided GENE=LBR];			rs17557867	0.08749	0.02223,0.06849,0.04073,0.12001,0.25404	811,	11694	138876	-2.5190	0.01			/5.4>5.4/2.4>0.0		LBR|0.00|0.00|0.00|0.00|-21|20|36|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225415401	225415401	C	T	het	het	hom	low_conf_region	QUAL=24;DP=218,142,104;AF=0.41,0.46,1.00	LBR	intron	LBR:ENST00000272163.9:intron_variant:MODIFIER:intron6/13:c.838-69G>A::,LBR:ENST00000338179.6:intron_variant:MODIFIER:intron6/13:c.838-69G>A::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	1263342 [benign DISEASE=not provided GENE=LBR];		(AT)n (Simple_repeat)	rs6702433	0.72937	0.42737,0.84990,0.95761,0.83998,0.69349	43252,	24417	41157	-0.1800	0.12			/0.0>0.0/0.0>0.0		LBR|0.00|0.00|0.00|0.00|-2|-41|22|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225419442	225419442	C	T	het	het	hom		QUAL=24;DP=74,47,20;AF=0.41,0.45,1.00	LBR	missense	LBR:ENST00000272163.9:missense_variant:MODERATE:exon5/14:c.461G>A:p.Ser154Asn:,LBR:ENST00000338179.6:missense_variant:MODERATE:exon5/14:c.461G>A:p.Ser154Asn:		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	258619 [benign DISEASE=not provided,Reynolds syndrome,Pelger-Huet anomaly,Greenberg dysplasia,not specified GENE=LBR];			rs2230419	0.72948	0.42796,0.84968,0.95695,0.83976,0.69838	43287,	24415	41159	-0.1670	0.02	0.167	0.06	/0.0>0.0/0.0>0.0	COSV55291160		25741868,24033266,26489030,28286461	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225422182	225422182	A	G	het	het	hom		QUAL=24;DP=126,18,16;AF=0.57,0.61,1.00	LBR	synonymous	LBR:ENST00000272163.9:synonymous_variant:LOW:exon3/14:c.261T>C:p.Pro87=:,LBR:ENST00000338179.6:synonymous_variant:LOW:exon3/14:c.261T>C:p.Pro87=:	regulatory_region_variant:open_chromatin_region	600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	258617 [benign DISEASE=not provided,Greenberg dysplasia,Reynolds syndrome,Pelger-Huet anomaly,not specified GENE=LBR];			rs1056608	0.68377	0.39360,0.81824,0.89251,0.79149,0.65004	38108,	27744	48080	-0.7860	1.23			/0.0>0.2/0.0>0.0		LBR|0.00|0.00|0.00|0.00|-49|39|-16|19	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225423959	225423959	C	T	het	hom	het		QUAL=24;DP=281,283,211;AF=0.52,1.00,0.49	LBR	synonymous	LBR:ENST00000272163.9:synonymous_variant:LOW:exon2/14:c.117G>A:p.Val39=:PF09465 [Lamin-B receptor of TUDOR domain],LBR:ENST00000338179.6:synonymous_variant:LOW:exon2/14:c.117G>A:p.Val39=:PF09465 [Lamin-B receptor of TUDOR domain]	regulatory_region_variant:open_chromatin_region	600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	258616 [benign DISEASE=not provided,not specified,Greenberg dysplasia,Reynolds syndrome,Pelger-Huet anomaly GENE=LBR];			rs1056607	0.71141	0.63816,0.77430,0.76044,0.73707,0.50871	38834,	30525	43889	-3.1000	0.43			/0.0>0.0/0.0>0.0	COSV55289527	LBR|0.00|0.00|0.00|0.00|-35|21|3|-48	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225424143	225424143	C	T	wt	het	het	low_conf_region	QUAL=24;DP=88,111,83;AF=0.00,0.52,0.43	LBR	intron	LBR:ENST00000272163.9:intron_variant:MODIFIER:intron1/13:c.-14-54G>A::,LBR:ENST00000338179.6:intron_variant:MODIFIER:intron1/13:c.-14-54G>A::	regulatory_region_variant:open_chromatin_region	600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	810884 [benign DISEASE=not specified,not provided GENE=LBR];			rs1340867	0.62001	0.59195,0.71231,0.76053,0.62252,0.38553	29488,	35278	57766	-1.5450	0.36			/0.0>0.0/0.0>0.0		LBR|0.00|0.00|0.00|0.00|-18|-45|35|-13		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225427864	225427864	G	C	het	hom	het		QUAL=24;DP=5,7,4;AF=0.60,1.00,0.50	LBR	intron	LBR:ENST00000272163.9:intron_variant:MODIFIER:intron1/13:c.-15+90C>G::,LBR:ENST00000338179.6:intron_variant:MODIFIER:intron1/13:c.-15+842C>G::	regulatory_region_variant:open_chromatin_region	600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]	1247977 [benign DISEASE=not provided GENE=LBR];			rs4653636	0.74171	0.64203,0.80165,0.78128,0.78226,0.56144	42236,	28169	39225	-0.2910	4.30			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	225428676	225428676	G	C	het	wt	het		QUAL=24;DP=179,22,179;AF=0.55,0.00,0.50	LBR	intron,upstream_gene	LBR:ENST00000338179.6:intron_variant:MODIFIER:intron1/13:c.-15+30C>G::,LBR:ENST00000272163.9:upstream_gene_variant:MODIFIER::::		600024_[GENE=LBR_PHENOS=Pelger-Huet anomaly, 169400 (3), Autosomal dominant; ?Reynolds syndrome, 613471 (3), Autosomal dominant; Rhizomelic skeletal dysplasia with or without Pelger-Huet anomaly, 618019 (3), Autosomal recessive; Greenberg skeletal dysplasia, 215140 (3), Autosomal recessive]				rs75691342	0.07759	0.05151,0.06105,0.03967,0.09159,0.22965	563,	10683	140383	-0.4380	4.29			/4.6>4.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LBR (inh=AR+AD oe_syn=0.87 oe_mis=0.96 oe_lof=0.24)
chr1	226363223	226363223	G	C	het	het	hom		QUAL=24;DP=103,107,71;AF=0.43,0.62,1.00	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron20/22:c.2787-63C>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron19/21:c.2658-63C>G::						rs747657	0.57735	0.45617,0.54325,0.19400,0.67087,0.62630	26425,	34949	64273	-0.6160	0.47			/0.0>0.0/0.0>0.0	COSV64690496	PARP1|0.00|0.00|0.00|0.00|-25|-18|50|24	20981448,32757651,32341527,17560163	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226363759	226363759	T	C	het	het	hom		QUAL=24;DP=69,22,25;AF=0.58,0.36,1.00	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron20/22:c.2786+184A>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron19/21:c.2657+184A>G::	regulatory_region_variant:enhancer				MLT1O (LTR/ERVL-MaLR)	rs752309	0.80969	0.84571,0.68743,0.53194,0.84039,0.80336	50378,	22442	28956	-0.2500	3.25			/0.0>0.0/0.0>0.0	COSV64689687	PARP1|0.00|0.00|0.00|0.00|-1|41|47|41		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226363828	226363828	C	G	het	het	hom		QUAL=24;DP=143,75,51;AF=0.52,0.44,1.00	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron20/22:c.2786+115G>C::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron19/21:c.2657+115G>C::	regulatory_region_variant:enhancer					rs752307	0.82084	0.86924,0.69091,0.57060,0.84051,0.88686	51774,	21367	27265	-0.7920	0.47			/2.2>4.5/0.0>0.0	COSV64689696,COSV64692544	PARP1|0.00|0.00|0.00|0.00|-28|-31|-11|-22	19249341,20522537,33284833,36329257,17560163,29403010,34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226365785	226365785	C	A	het	het	n/a	low_conf_region	QUAL=24;DP=43,10,1;AF=0.47,0.50,0.00	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron18/22:c.2505+169G>T::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron17/21:c.2376+169G>T::	regulatory_region_variant:open_chromatin_region				AluSx (SINE/Alu)	rs146042055	0.81524	0.84926,0.68801,0.57103,0.84085,0.88752	49527,	21558	27334	-0.8190	0.90			/1.5>1.9/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226365789	226365789	C	A	het	het	wt	low_conf_region	QUAL=24;DP=45,10,3;AF=0.47,0.50,0.00	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron18/22:c.2505+165G>T::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron17/21:c.2376+165G>T::	regulatory_region_variant:open_chromatin_region				AluSx (SINE/Alu)	rs34917861	0.81271	0.84855,0.68528,0.57004,0.83778,0.88664	48926,	21800	27574	-0.8680	0.86			/1.5>2.1/0.0>0.0		PARP1|0.00|0.00|0.00|0.00|14|-50|-10|5	32888493	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226365793	226365793	-	A	het	het	wt	low_conf_region	QUAL=24;DP=47,12,6;AF=0.45,0.50,0.00	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron18/22:c.2505+160dup::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron17/21:c.2376+160dup::	regulatory_region_variant:open_chromatin_region				AluSx (SINE/Alu)	rs11378196	0.81745	0.86907,0.68767,0.57010,0.83502,0.88465	49405,	21325	26829		0.44			/1.5>1.5/0.0>0.0		PARP1|0.00|0.00|0.00|0.00|10|13|15|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226366233	226366233	A	C	het	het	hom		QUAL=24;DP=68,38,20;AF=0.47,0.53,1.00	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron17/22:c.2407-181T>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron16/21:c.2278-181T>G::	regulatory_region_variant:open_chromatin_region				MIR3 (SINE/MIR)	rs2271349	0.81640	0.86878,0.69005,0.53166,0.84047,0.80307	51227,	21707	27923	-1.2250	0.35			/0.0>0.0/9.7>2.0		PARP1|0.00|0.00|0.00|0.00|-32|30|14|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226367601	226367601	A	G	het	het	wt		QUAL=24;DP=192,302,24;AF=0.48,0.47,0.00	PARP1	missense	PARP1:ENST00000366794.10:missense_variant:MODERATE:exon17/23:c.2285T>C:p.Val762Ala:PF02877 [Poly(ADP-ribose) polymerase regulatory domain],PARP1:ENST00000677203.1:missense_variant:MODERATE:exon16/22:c.2156T>C:p.Val719Ala:PF02877 [Poly(ADP-ribose) polymerase regulatory domain]			1261945 [benign DISEASE=not provided GENE=PARP1];	CM042761 [CLASS=DFP MUT=ALT PHEN="Prostate cancer susceptibility association with" GENE=PARP1];		rs1136410	0.15731	0.05387,0.30300,0.42871,0.15936,0.11245	2595,	18748	128230	8.9420	25.80	0.180	0.41	/0.0>0.0/0.9>0.0	COSV64689246	PARP1|0.00|0.00|0.00|0.00|34|33|-31|2	31818908,21976407,21767974,31413734,33112558,33147530,33528729,30337837,25111588,33893823,23139751,19249341,26648684,34691999,18191955,17267408,21989229,31288058,32103589,21606320,16465622,16857995,17203305,17220334,18701435,19109789,19124499,19318434,19822020,20150366,20211558,20353610,20486200,20559012,21037106,21129811,21385363,21420246,21700777,21810555,22127734,22687647,22740911,22792228,22850545,22969958,23608917,23633189,23644255,23720673,24172093,24203816,24340057,24500421,25106941,25179837,25231222,25493225,25911198,26921778,27055523,27099827,27285066,27323894,27415837,27588484,27840165,27866211,28765340,28956850,29399184,29484706,29662639,29667179,30183716,31489712,31584889,31609976,31762827,31983162,33108038,33284833,33706586,34406176,28206966,32355298,31374908,22868256,28749454,29937070,35117636,35600838,25837821,25178586,34944636,22430443,33534415,29577582,34295994,29156789,31171785,36006023,27105872,26491355,36632296,37182709,36581511,27959887,25998844,27209488,28423490,26388025,22591901,2918450	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226368393	226368393	T	C	hom	hom	hom		QUAL=25;DP=24,46,20;AF=1.00,1.00,1.00	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron15/22:c.2155-72A>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron14/21:c.2026-72A>G::						rs1805400	0.98486	0.94693,0.99510,1.00000,0.99993,0.99979	73938,	2148	2306	-0.5630	9.16			/0.0>0.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226374060	226374060	G	C	het	het	hom		QUAL=24;DP=112,46,33;AF=0.51,0.43,1.00	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron14/22:c.2070+166C>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron13/21:c.1941+3048C>G::						rs2377312	0.80345	0.82348,0.68651,0.53265,0.84027,0.80304	49574,	23083	29901	0.0570	2.57			/0.0>0.0/0.0>0.0	COSV64690890	PARP1|0.00|0.00|0.00|0.00|46|9|17|15	33284833	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226376990	226376990	T	C	het	het	hom		QUAL=24;DP=130,36,38;AF=0.48,0.33,1.00	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron13/22:c.1941+118A>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron13/21:c.1941+118A>G::					L1M4 (LINE/L1)	rs3219090	0.57606	0.45125,0.54260,0.19316,0.67122,0.62728	26303,	34906	64402	1.3350	8.75			/0.0>0.0/0.0>0.0	COSV64689321	PARP1|0.00|0.00|0.00|0.00|-1|-42|6|35	21976407,21983785,19925161,27099827,30824778,25077817,24535833,23393188,24906573,26998216,27221533,28759004,29641532,24642353,32226509,24980573,25837821,34898573,28667740,29753029,32856602,25307738,35045882,25380778,26342156,29890168,23580930,35005347,27993549,30190865,29799308,32341527,31568773,33383480,27644669,23537197	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226379025	226379025	A	C	het	het	hom		QUAL=24;DP=75,131,104;AF=0.53,0.47,0.99	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron12/22:c.1745+117T>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron12/21:c.1745+117T>G::						rs907190	0.80351	0.82359,0.68646,0.53283,0.84031,0.80282	49552,	23066	29876	-1.0680	3.84			/0.0>0.0/0.0>0.0	COSV64689201	PARP1|0.01|0.00|0.00|0.00|24|-44|24|30	33284833,35585065	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226379471	226379471	A	C	het	wt	het		QUAL=24;DP=119,48,147;AF=0.47,0.00,0.46	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron11/22:c.1612+102T>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron11/21:c.1612+102T>G::						rs2271345	0.13212	0.09622,0.11119,0.03101,0.15553,0.20590	1455,	17193	132051	-1.7420	0.53			/0.0>0.0/0.0>0.0	COSV64689740	PARP1|0.00|0.00|0.00|0.00|-39|16|-39|2	17560163	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226380964	226380964	T	C	het	wt	het		QUAL=24;DP=144,27,157;AF=0.48,0.00,0.45	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron9/22:c.1300+104A>G::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron9/21:c.1300+104A>G::						rs1805410	0.13229	0.09618,0.11124,0.03127,0.15576,0.20757	1464,	17204	132044	-0.1450	1.21			/0.0>0.0/0.0>0.0	COSV64689744	PARP1|0.00|0.00|0.00|0.00|1|-36|40|-22	21976407,21767974,21668397,20574454,22701660,23921907,27758874,23872737,17560163	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226383139	226383139	T	C	het	het	hom		QUAL=24;DP=94,92,72;AF=0.57,0.51,1.00	PARP1	synonymous	PARP1:ENST00000366794.10:synonymous_variant:LOW:exon8/23:c.1056A>G:p.Lys352=:,PARP1:ENST00000677203.1:synonymous_variant:LOW:exon8/22:c.1056A>G:p.Lys352=:						rs1805415	0.82750	0.89233,0.69224,0.57115,0.84077,0.88801	52689,	20623	26267	-0.1010	7.67			/0.0>0.0/0.0>0.0	COSV64689254	PARP1|0.00|0.00|0.00|0.00|17|-23|1|9	19249341,17267408,33284833,27153553,17560163,20113831	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226385663	226385663	A	G	het	het	wt		QUAL=24;DP=158,248,16;AF=0.54,0.45,0.00	PARP1	synonymous	PARP1:ENST00000366794.10:synonymous_variant:LOW:exon7/23:c.852T>C:p.Ala284=:PF21728 [],PARP1:ENST00000677203.1:synonymous_variant:LOW:exon7/22:c.852T>C:p.Ala284=:PF21728 []				CM071915 [CLASS=DP MUT=ALT PHEN="Colorectal adenoma association with" GENE=PARP1];		rs1805414	0.42460	0.54313,0.45843,0.80662,0.33155,0.37988	14757,	35050	87496	-2.5750	0.04			/0.0>0.0/0.0>0.0	COSV64689261	PARP1|0.00|0.00|0.00|0.00|17|-37|-46|1	18805967,21767974,27746584,29662639,30183716,31609976,31762827,33284833,19604089,21695249,23803078,37329186,32352035,17560163,20113831	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226388569	226388569	A	G	het	het	wt		QUAL=24;DP=171,101,16;AF=0.59,0.47,0.00	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron5/22:c.717+87T>C::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron5/21:c.717+87T>C::						rs2255403	0.18982	0.15325,0.31107,0.46775,0.15966,0.19714	3240,	22419	123347	2.3010	7.40			/3.2>2.3/0.0>0.0	COSV64687805	PARP1|0.00|0.00|0.00|0.00|-47|-36|-8|7	20522537,34477880,36292754,17560163	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226390346	226390346	G	T	het	het	wt	low_conf_region	QUAL=24;DP=70,94,22;AF=0.30,0.48,0.00	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron4/22:c.617+64C>A::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron4/21:c.617+64C>A::						rs1805411	0.17222	0.10681,0.30753,0.42818,0.15915,0.11291	2810,	20577	125913	-0.1320	1.50			/0.0>0.0/0.0>0.0	COSV64688261	PARP1|0.00|0.00|0.00|0.00|-8|-48|-46|-8	33284833,21487324	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226390398	226390398	T	C	hom	hom	het		QUAL=25;DP=94,162,122;AF=0.99,0.99,0.54	PARP1	splice_region&intron	PARP1:ENST00000366794.10:splice_region_variant&intron_variant:LOW:intron4/22:c.617+12A>G::,PARP1:ENST00000677203.1:splice_region_variant&intron_variant:LOW:intron4/21:c.617+12A>G::						rs1805403	0.83419	0.93842,0.82252,0.93999,0.77254,0.75331	53472,	19970	25226	-5.7450	0.03			/0.0>0.0/0.0>0.0		PARP1|0.00|0.00|0.00|0.00|12|34|19|12	27746584,19657367	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226392088	226392102	ACGTTGAGCTAGCAC	-	het	het	wt		QUAL=24;DP=127,54,17;AF=0.52,0.54,0.00	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron3/22:c.402+97_402+111del::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron3/21:c.402+97_402+111del::						rs201956818	0.01478	0.00269,0.01006,0.00019,0.01880,0.00103	31,	2190	150106	3.0680	4.43			/0.0>0.0/10.7>0.1		PARP1|0.00|0.00|0.00|0.00|41|3|-16|3		11	1073	0	0 / 0					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226402008	226402008	C	T	het	het	wt		QUAL=24;DP=129,31,17;AF=0.43,0.48,0.00	PARP1	intron	PARP1:ENST00000366794.10:intron_variant:MODIFIER:intron2/22:c.286+206G>A::,PARP1:ENST00000677203.1:intron_variant:MODIFIER:intron2/21:c.286+206G>A::						rs2666428	0.44250	0.61291,0.46218,0.80637,0.32937,0.37640	16357,	34550	84744	-0.5930	1.36			/9.9>9.1/4.8>0.0	COSV104680319	PARP1|0.00|0.00|0.00|0.00|18|0|18|1	21976407,31413734,33391423,29937070,35600838,33791158,36292754,32780923	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226402257	226402257	G	A	het	het	wt		QUAL=24;DP=294,470,20;AF=0.47,0.48,0.00	PARP1	synonymous	PARP1:ENST00000366794.10:synonymous_variant:LOW:exon2/23:c.243C>T:p.Asp81=:PF00645 [Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region],PARP1:ENST00000677203.1:synonymous_variant:LOW:exon2/22:c.243C>T:p.Asp81=:PF00645 [Poly(ADP-ribose) polymerase and DNA-Ligase Zn-finger region]	regulatory_region_variant:open_chromatin_region					rs1805404	0.17922	0.13101,0.30994,0.42910,0.15935,0.11304	2956,	21366	124924	3.1620	10.49			/0.0>0.0/0.0>0.0	COSV64687027	PARP1|0.00|0.00|0.00|0.00|-4|-11|33|-43	17267408,20486200,30183716,31609976,33284833,27462201,36292754,32888493,23576132,20113831	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226407946	226407946	C	G	het	het	wt		QUAL=24;DP=44,146,16;AF=0.50,0.50,0.00	PARP1	5'UTR	PARP1:ENST00000366794.10:5_prime_UTR_variant:MODIFIER:exon1/23:c.-17G>C::,PARP1:ENST00000677203.1:5_prime_UTR_variant:MODIFIER:exon1/22:c.-17G>C::	regulatory_region_variant:open_chromatin_region,TF_binding_site_variant					rs907187	0.16138	0.05389,0.30459,0.43004,0.16316,0.11381	2730,	19085	127547	0.9510	11.81			/0.4>2.7/0.0>0.0	COSV64687065	PARP1|0.00|0.00|0.00|0.00|28|5|29|-46	21767974,17267408,21989229,31288058,32103589,36292754,26261599,37329186,17560163,20113831	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					PARP1 (inh=n/a oe_syn=1.18 oe_mis=0.90 oe_lof=0.32)
chr1	226977534	226977534	C	T	het	het	wt		QUAL=24;DP=18,26,17;AF=0.50,0.54,0.00	COQ8A	splice_region&intron	COQ8A:ENST00000366778.5:splice_region_variant&intron_variant:LOW:intron5/14:c.574+11C>T::,COQ8A:ENST00000366777.4:splice_region_variant&intron_variant:LOW:intron5/14:c.730+11C>T::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]				rs759489004	0.00001	0.00000,0.00000,0.00000,0.00000,0.00000	0,	1	152147	0.7940	4.76			/0.0>0.0/0.0>0.0		ADCK3|0.00|0.00|0.00|0.00|-10|-49|-2|-9		0	3	0	0 / 0					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226982597	226982597	A	G	het	wt	hom		QUAL=24;DP=58,16,139;AF=0.60,0.00,0.99	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron6/14:c.698-81A>G::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron6/14:c.854-81A>G::		606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	671530 [benign DISEASE=Autosomal recessive ataxia due to ubiquinone deficiency,not provided GENE=COQ8A];			rs2297412	0.44079	0.47111,0.39602,0.20856,0.46713,0.23269	15036,	36806	84846	-2.7470	0.63			/0.0>0.0/0.0>0.0		ADCK3|0.00|0.00|0.00|0.00|50|23|-26|50	27863252,33356394	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226982842	226982842	C	G	het	wt	het		QUAL=24;DP=116,16,177;AF=0.61,0.00,0.47	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron7/14:c.784-52C>G::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron7/14:c.940-52C>G::		606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	671531 [benign DISEASE=Autosomal recessive ataxia due to ubiquinone deficiency,not provided GENE=COQ8A];			rs2297413	0.20270	0.13102,0.23359,0.31289,0.23046,0.15377	3384,	24085	121357	0.6420	4.89			/2.3>1.1/0.0>0.0	COSV64657732	ADCK3|0.00|0.00|0.00|0.00|28|11|-29|-46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226983509	226983509	G	A	het	hom	wt		QUAL=24;DP=67,175,29;AF=0.46,0.99,0.00	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron8/14:c.925-43G>A::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron8/14:c.1081-43G>A::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	671619 [benign DISEASE=not provided GENE=COQ8A];			rs12739480	0.10601	0.03611,0.06156,0.05087,0.14297,0.20489	1142,	13847	136035	-0.4310	0.93			/0.0>0.0/0.0>0.0	COSV64659018	ADCK3|0.00|0.00|0.00|0.00|43|-13|41|35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226983884	226983884	T	-	het	wt	hom		QUAL=24;DP=91,27,47;AF=0.47,0.00,1.00	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1100+32del::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1256+32del::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1183738 [benign DISEASE=Autosomal recessive ataxia due to ubiquinone deficiency,not provided GENE=COQ8A];			rs3215919	0.36919	0.29286,0.32560,0.13821,0.44302,0.20004	10969,	34237	95981	-0.8150	0.44			/8.1>7.2/0.0>0.0		ADCK3|0.00|0.00|0.03|0.00|-35|11|40|-1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984036	226984036	G	T	het	wt	het		QUAL=24;DP=58,39,66;AF=0.62,0.00,0.56	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1101-58G>T::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1257-58G>T::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1291028 [benign DISEASE=not provided GENE=COQ8A];			rs1574184	0.24681	0.26919,0.23394,0.24091,0.24305,0.16293	4062,	26271	104961	1.7960	0.13			/0.0>0.0/0.0>0.0	COSV64656763	ADCK3|0.00|0.00|0.00|0.00|-40|33|-6|-40		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984038	226984038	G	T	het	wt	het		QUAL=24;DP=61,39,66;AF=0.67,0.00,0.55	COQ8A	intron	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron10/14:c.1101-56G>T::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron10/14:c.1257-56G>T::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1188901 [benign DISEASE=Autosomal recessive ataxia due to ubiquinone deficiency,not provided GENE=COQ8A];			rs1574185	0.23475	0.24010,0.21914,0.23553,0.24095,0.15936	3741,	25570	107744	-0.1650	0.34			/0.0>0.0/0.0>0.8		ADCK3|0.00|0.00|0.00|0.00|3|31|-42|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226984589	226984589	C	T	het	wt	hom		QUAL=24;DP=181,80,326;AF=0.50,0.00,0.98	COQ8A	synonymous	COQ8A:ENST00000366778.5:synonymous_variant:LOW:exon12/15:c.1284C>T:p.Phe428=:PF03109 [ABC1 atypical kinase-like domain],COQ8A:ENST00000366777.4:synonymous_variant:LOW:exon12/15:c.1440C>T:p.Phe480=:PF03109 [ABC1 atypical kinase-like domain]	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	128274 [benign DISEASE=Autosomal recessive ataxia due to ubiquinone deficiency,not specified,not provided,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type GENE=COQ8A];			rs12593	0.34990	0.20304,0.31877,0.17319,0.45397,0.19934	10346,	32528	98880	-0.2170	1.65			/0.0>0.0/0.0>0.0	COSV64656797	ADCK3|0.00|0.00|0.00|0.00|23|-41|-24|-4	31816047,34127677	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69)
chr1	226985202	226985202	G	A	het	wt	hom		QUAL=24;DP=64,80,201;AF=0.63,0.00,0.98	COQ8A,CDC42BPA	intron,downstream_gene	COQ8A:ENST00000366778.5:intron_variant:MODIFIER:intron13/14:c.1417-52G>A::,COQ8A:ENST00000366777.4:intron_variant:MODIFIER:intron13/14:c.1573-52G>A::,CDC42BPA:ENST00000366767.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000334218.9:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366769.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366766.8:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	676090 [benign DISEASE=not provided,Autosomal recessive ataxia due to ubiquinone deficiency GENE=COQ8A];			rs2297415	0.37785	0.28848,0.33357,0.16699,0.46067,0.20029	11510,	34426	94588	-2.2820	2.08			/0.0>1.2/0.0>0.0	COSV62011699,COSV62017351	ADCK3|0.00|0.00|0.00|0.00|2|10|27|-43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226985234	226985234	C	G	het	wt	hom		QUAL=24;DP=70,80,234;AF=0.67,0.00,1.00	COQ8A,CDC42BPA	splice_region&intron,downstream_gene	COQ8A:ENST00000366778.5:splice_region_variant&intron_variant:LOW:intron13/14:c.1417-20C>G::,COQ8A:ENST00000366777.4:splice_region_variant&intron_variant:LOW:intron13/14:c.1573-20C>G::,CDC42BPA:ENST00000366767.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000334218.9:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366769.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366766.8:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	518313 [benign/likely benign DISEASE=not specified,not provided,Autosomal recessive ataxia due to ubiquinone deficiency GENE=COQ8A];			rs2297416	0.37355	0.27242,0.33375,0.16705,0.46082,0.20046	11316,	34165	95249	0.0300	2.77			12.3>10.9/12.3>10.9/0.0>3.0	COSV62011473	ADCK3|0.02|0.00|0.00|0.00|28|20|-5|30		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226986444	226986444	T	C	het	wt	hom		QUAL=25;DP=61,19,90;AF=0.48,0.00,1.00	COQ8A,CDC42BPA	splice_region&intron,downstream_gene	COQ8A:ENST00000366778.5:splice_region_variant&intron_variant:LOW:intron14/14:c.1504-9T>C::,COQ8A:ENST00000366777.4:splice_region_variant&intron_variant:LOW:intron14/14:c.1660-9T>C::,CDC42BPA:ENST00000366767.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000334218.9:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366769.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366766.8:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	296024 [benign DISEASE=Autosomal recessive ataxia due to ubiquinone deficiency,Autosomal recessive cerebellar ataxia,not provided,not specified GENE=COQ8A];			rs7552783	0.44276	0.41577,0.37151,0.21367,0.50337,0.26436	15306,	36566	84546	-3.6360	7.16			11.5>10.7/11.5>10.7/0.0>0.0	COSV62011703,COSV62011928	ADCK3|0.00|0.00|0.00|0.00|-36|19|8|-30	26503814,32439900	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226986509	226986509	T	C	het	wt	hom		QUAL=24;DP=105,19,119;AF=0.41,0.00,1.00	COQ8A,CDC42BPA	synonymous,downstream_gene	COQ8A:ENST00000366778.5:synonymous_variant:LOW:exon15/15:c.1560T>C:p.Ser520=:,COQ8A:ENST00000366777.4:synonymous_variant:LOW:exon15/15:c.1716T>C:p.Ser572=:,CDC42BPA:ENST00000366767.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000334218.9:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366769.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366766.8:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	128275 [benign DISEASE=Autosomal recessive ataxia due to ubiquinone deficiency,Autosomal recessive cerebellar ataxia,not specified,not provided GENE=COQ8A];			rs3738725	0.41311	0.31479,0.35508,0.21775,0.50332,0.26286	13643,	35315	88935	-5.5320	0.00			/0.0>0.0/0.0>0.5	COSV62011476	ADCK3|0.00|0.00|0.00|0.00|2|28|1|28	32888494	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226987122	226987122	-	T	het	wt	hom		QUAL=24;DP=154,19,385;AF=0.50,0.00,1.00	COQ8A,CDC42BPA	3'UTR,downstream_gene	COQ8A:ENST00000366778.5:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::,COQ8A:ENST00000366777.4:3_prime_UTR_variant:MODIFIER:exon15/15:c.*389dup::,CDC42BPA:ENST00000366767.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000334218.9:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366769.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366766.8:downstream_gene_variant:MODIFIER::::		606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	296038 [benign DISEASE=Autosomal recessive cerebellar ataxia,Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type GENE=COQ8A];			rs11420839	0.40325	0.29385,0.35066,0.16976,0.50047,0.24221	13228,	34860	90740		0.84			/2.3>3.5/0.0>0.0		ADCK3|0.00|0.00|0.00|0.00|21|20|26|16		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226987544	226987544	-	T	het	wt	hom		QUAL=25;DP=171,53,226;AF=0.43,0.00,0.98	COQ8A,CDC42BPA	downstream_gene	COQ8A:ENST00000366778.5:downstream_gene_variant:MODIFIER::::,COQ8A:ENST00000366777.4:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366767.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000334218.9:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366769.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366766.8:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	296050 [benign DISEASE=Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type,Autosomal recessive cerebellar ataxia,Autosomal recessive ataxia due to ubiquinone deficiency,not provided GENE=COQ8A];			rs3215920	0.37241	0.18620,0.33977,0.16827,0.50122,0.24139	12091,	32424	95392		1.66			/0.0>0.0/0.0>0.0		ADCK3|0.00|0.00|0.00|0.00|-21|-2|-4|-34	34594039	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226987552	226987552	C	T	het	wt	hom		QUAL=24;DP=163,53,218;AF=0.47,0.00,1.00	COQ8A,CDC42BPA	downstream_gene	COQ8A:ENST00000366778.5:downstream_gene_variant:MODIFIER::::,COQ8A:ENST00000366777.4:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366767.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000334218.9:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366769.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366766.8:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	368867 [benign DISEASE=Coenzyme Q10 deficiency, Spinocerebellar Ataxia Type,Autosomal recessive cerebellar ataxia,not provided GENE=COQ8A];			rs10495274	0.52545	0.37992,0.48233,0.34318,0.63492,0.39619	22090,	35678	72122	-0.9260	0.75							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	226987666	226987666	G	T	het	wt	hom		QUAL=24;DP=117,53,75;AF=0.49,0.00,1.00	COQ8A,CDC42BPA	downstream_gene	COQ8A:ENST00000366778.5:downstream_gene_variant:MODIFIER::::,COQ8A:ENST00000366777.4:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366767.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000334218.9:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366769.7:downstream_gene_variant:MODIFIER::::,CDC42BPA:ENST00000366766.8:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:enhancer	606980_[GENE=COQ8A_PHENOS=Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive]	1250369 [benign DISEASE=not provided GENE=COQ8A];			rs6426558	0.40291	0.28317,0.35000,0.21649,0.50191,0.26243	13209,	34878	90838	-0.4880	0.53						27863252,30595370	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					COQ8A (inh=AR oe_syn=1.27 oe_mis=1.12 oe_lof=0.69), CDC42BPA (inh=n/a oe_syn=0.95 oe_mis=0.77 oe_lof=0.19)
chr1	228159235	228159235	G	A	het	het	wt		QUAL=24;DP=42,130,17;AF=0.52,0.54,0.00	GJC2,IBA57-DT	3'UTR,downstream_gene	GJC2:ENST00000366714.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*157G>A::,IBA57-DT:ENST00000496552.1:downstream_gene_variant:MODIFIER::::		608803_[GENE=GJC2_PHENOS=Lymphatic malformation 3, 613480 (3), Autosomal dominant; ?Spastic paraplegia 44, autosomal recessive, 613206 (3), Autosomal recessive; Leukodystrophy, hypomyelinating, 2, 608804 (3), Autosomal recessive]	1265470 [likely benign(replaced by megSAP based on classifications:1x1,1x3) DISEASE=Hereditary spastic paraplegia,not provided GENE=GJC2];			rs45491398	0.05758	0.01597,0.04056,0.00077,0.09062,0.02235	366,	8040	143566	-1.8580	0.33			/0.0>0.0/0.0>0.0		GJC2|0.00|0.00|0.00|0.00|2|-48|21|39		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJC2 (inh=AR+AD oe_syn=0.94 oe_mis=0.67 oe_lof=0.54), IBA57-DT (inh=n/a oe_syn=1.01 oe_mis=1.00 oe_lof=n/a)
chr1	228159651	228159651	A	G	hom	hom	hom		QUAL=25;DP=31,13,8;AF=1.00,1.00,1.00	GJC2,IBA57-DT	3'UTR,downstream_gene	GJC2:ENST00000366714.3:3_prime_UTR_variant:MODIFIER:exon2/2:c.*573A>G::,IBA57-DT:ENST00000496552.1:downstream_gene_variant:MODIFIER::::		608803_[GENE=GJC2_PHENOS=Lymphatic malformation 3, 613480 (3), Autosomal dominant; ?Spastic paraplegia 44, autosomal recessive, 613206 (3), Autosomal recessive; Leukodystrophy, hypomyelinating, 2, 608804 (3), Autosomal recessive]				rs6668719	0.84778	0.64499,0.88628,0.76062,0.94724,0.92555	56004,	16934	23152	0.0710	2.21			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GJC2 (inh=AR+AD oe_syn=0.94 oe_mis=0.67 oe_lof=0.54), IBA57-DT (inh=n/a oe_syn=1.01 oe_mis=1.00 oe_lof=n/a)
chr1	228424743	228424743	A	G	het	hom	het		QUAL=25;DP=80,46,51;AF=0.48,1.00,0.55	H3-4	downstream_gene	H3-4:ENST00000366696.2:downstream_gene_variant:MODIFIER::::						rs1188473	0.89819	0.94553,0.94597,0.67486,0.89199,0.85388	61643,	13425	15497	-0.2750	0.81							n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					H3-4 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	228425137	228425137	G	T	het	hom	het		QUAL=24;DP=220,385,285;AF=0.51,1.00,0.46	H3-4	synonymous	H3-4:ENST00000366696.2:synonymous_variant:LOW:exon1/1:c.189C>A:p.Ile63=:PF00125 [Core histone H2A/H2B/H3/H4]						rs2230656	0.73695	0.40722,0.86582,0.66305,0.88638,0.84741	44727,	22765	40057	2.0500	6.41			/4.6>4.0/2.5>1.5	COSV64210568	HIST3H3|0.06|0.00|0.03|0.00|-19|-7|-1|6	30066433,29405169	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					H3-4 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	228425351	228425351	T	C	het	hom	het		QUAL=24;DP=40,31,34;AF=0.38,1.00,0.41	H3-4	5'UTR	H3-4:ENST00000366696.2:5_prime_UTR_variant:MODIFIER:exon1/1:c.-26A>G::						rs1188474	0.89233	0.92631,0.94059,0.67459,0.89197,0.85439	60816,	14222	16392	-2.8600	0.18			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					H3-4 (inh=n/a oe_syn=1.79 oe_mis=1.55 oe_lof=1.60)
chr1	229432484	229432484	T	G	hom	hom	hom		QUAL=24;DP=8,19,19;AF=1.00,1.00,1.00	ACTA1	intron	ACTA1:ENST00000684723.1:intron_variant:MODIFIER:intron2/5:c.320-53A>C::,ACTA1:ENST00000366684.7:intron_variant:MODIFIER:intron3/6:c.455-53A>C::,ACTA1:ENST00000366683.4:intron_variant:MODIFIER:intron3/6:c.455-53A>C::	regulatory_region_variant:enhancer	102610_[GENE=ACTA1_PHENOS=Congenital myopathy 2B, severe infantile, autosomal recessive, 620265 (3), Autosomal recessive; ?Myopathy, scapulohumeroperoneal, 616852 (3), Autosomal dominant; Congenital myopathy 2C, severe infantile, autosomal dominant, 620278 (3), Autosomal dominant; Congenital myopathy 2A, typical, autosomal dominant, 161800 (3), Autosomal dominant]	676564 [benign DISEASE=not provided,Progressive scapulohumeroperoneal distal myopathy,Congenital myopathy with fiber type disproportion,Actin accumulation myopathy GENE=ACTA1];			rs527621	0.99844	0.99972,0.99891,1.00000,0.99899,0.99661	72854,	228	228	-1.3790	3.12			/0.0>0.0/0.0>0.0			19562689	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTA1 (inh=AR+AD oe_syn=0.87 oe_mis=0.21 oe_lof=0.74)
chr1	229434056	229434056	A	G	het	het	het		QUAL=25;DP=67,113,75;AF=0.63,0.56,0.49	ACTA1	5'UTR	ACTA1:ENST00000684723.1:5_prime_UTR_variant:MODIFIER:exon1/6:c.-59T>C::,ACTA1:ENST00000366684.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-65T>C::,ACTA1:ENST00000366683.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-65T>C::	regulatory_region_variant:open_chromatin_region	102610_[GENE=ACTA1_PHENOS=Congenital myopathy 2B, severe infantile, autosomal recessive, 620265 (3), Autosomal recessive; ?Myopathy, scapulohumeroperoneal, 616852 (3), Autosomal dominant; Congenital myopathy 2C, severe infantile, autosomal dominant, 620278 (3), Autosomal dominant; Congenital myopathy 2A, typical, autosomal dominant, 161800 (3), Autosomal dominant]	296060 [benign DISEASE=not provided,Actin accumulation myopathy,Congenital myopathy with fiber type disproportion,Familial restrictive cardiomyopathy GENE=ACTA1];			rs605430	0.63253	0.75816,0.65701,0.45752,0.58007,0.65590	31003,	33974	55760	0.5810	17.59			/3.9>4.3/0.0>0.0	COSV64203106		19562689	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTA1 (inh=AR+AD oe_syn=0.87 oe_mis=0.21 oe_lof=0.74)
chr1	229434057	229434057	G	A	het	het	het		QUAL=24;DP=71,114,75;AF=0.59,0.54,0.49	ACTA1	5'UTR	ACTA1:ENST00000684723.1:5_prime_UTR_variant:MODIFIER:exon1/6:c.-60C>T::,ACTA1:ENST00000366684.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-66C>T::,ACTA1:ENST00000366683.4:5_prime_UTR_variant:MODIFIER:exon1/7:c.-66C>T::	regulatory_region_variant:open_chromatin_region	102610_[GENE=ACTA1_PHENOS=Congenital myopathy 2B, severe infantile, autosomal recessive, 620265 (3), Autosomal recessive; ?Myopathy, scapulohumeroperoneal, 616852 (3), Autosomal dominant; Congenital myopathy 2C, severe infantile, autosomal dominant, 620278 (3), Autosomal dominant; Congenital myopathy 2A, typical, autosomal dominant, 161800 (3), Autosomal dominant]	296062 [benign DISEASE=not provided,Actin accumulation myopathy,Congenital myopathy with fiber type disproportion,Familial restrictive cardiomyopathy,Alpha-actinopathy GENE=ACTA1];			rs605428	0.63233	0.75791,0.65701,0.45681,0.57992,0.65555	30999,	33977	55805	0.2370	15.73			/3.9>4.7/0.0>0.0	COSV64204088		19562689	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					ACTA1 (inh=AR+AD oe_syn=0.87 oe_mis=0.21 oe_lof=0.74)
chr1	231241335	231241335	C	T	hom	het	hom		QUAL=25;DP=219,317,251;AF=0.96,0.55,0.99	GNPAT,C1orf131	5'UTR,upstream_gene	GNPAT:ENST00000366647.9:5_prime_UTR_variant:MODIFIER:exon1/16:c.-44C>T::,C1orf131:ENST00000318906.6:upstream_gene_variant:MODIFIER::::,C1orf131:ENST00000366651.7:upstream_gene_variant:MODIFIER::::,C1orf131:ENST00000366649.7:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region,TF_binding_site_variant	602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	296108 [benign DISEASE=Rhizomelic chondrodysplasia punctata type 2,not specified,not provided GENE=GNPAT];			rs518686	0.54886	0.56892,0.59268,0.61664,0.53351,0.62355	23102,	37252	68598	0.1320	9.66			/0.0>0.0/0.0>0.0	COSV59641814	GNPAT|0.00|0.00|0.00|0.00|5|-14|-2|43		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					C1ORF131 (inh=n/a oe_syn=0.99 oe_mis=1.03 oe_lof=1.12), GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231250866	231250866	T	A	hom	het	hom		QUAL=24;DP=183,92,74;AF=0.99,0.48,1.00	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron1/15:c.79-95T>A::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	1244833 [benign DISEASE=not provided GENE=GNPAT];			rs508908	0.59126	0.69125,0.61063,0.62136,0.54489,0.62749	27026,	35819	62127	-0.4300	0.84			/0.9>0.0/0.0>0.0		GNPAT|0.00|0.00|0.00|0.00|-32|-5|-32|-5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231260370	231260370	-	TA	hom	het	hom		QUAL=24;DP=123,38,20;AF=0.75,0.42,0.95	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron2/15:c.262-136_262-135insAT::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	1274329 [benign DISEASE=not provided GENE=GNPAT];			rs3215759	0.59087	0.69024,0.61024,0.61992,0.54480,0.62911	26977,	35822	62164		1.75			/0.0>0.0/2.8>2.8		GNPAT|0.00|0.00|0.00|0.00|29|-32|-2|-32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231265159	231265159	A	G	hom	het	hom		QUAL=25;DP=26,15,17;AF=1.00,0.67,1.00	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron4/15:c.569-134A>G::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	671168 [benign DISEASE=not provided GENE=GNPAT];		FLAM_C (SINE/Alu)	rs849714	0.57952	0.64991,0.60820,0.62167,0.54516,0.61965	25884,	36373	63953	-0.7750	2.21			/0.6>0.0/0.0>0.0		GNPAT|0.00|0.00|0.00|0.00|1|6|23|13		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231265458	231265458	T	C	hom	het	het		QUAL=24;DP=91,232,178;AF=1.00,0.51,0.48	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron5/15:c.696+38T>C::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	1256935 [benign DISEASE=not provided GENE=GNPAT];			rs6702011	0.26756	0.27993,0.32696,0.23551,0.25389,0.26306	5528,	29642	111410	-0.6780	7.13			/0.0>0.0/0.0>0.0	COSV64154015	GNPAT|0.00|0.00|0.00|0.00|-44|47|-49|-38		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231265850	231265850	T	C	hom	het	het		QUAL=24;DP=130,253,163;AF=1.00,0.48,0.48	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron6/15:c.772+63T>C::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	1244648 [benign DISEASE=not provided GENE=GNPAT];			rs532226	0.54401	0.56185,0.59077,0.61803,0.52928,0.60917	22693,	37346	69346	0.0210	1.87			/1.9>2.1/0.0>0.0	COSV64153524	GNPAT|0.00|0.00|0.00|0.00|34|-2|19|-2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231266156	231266156	G	A	hom	het	het		QUAL=24;DP=348,258,202;AF=1.00,0.50,0.49	GNPAT	synonymous	GNPAT:ENST00000366647.9:synonymous_variant:LOW:exon7/16:c.915G>A:p.Glu305=:PF19277 [Glycerol-3-phosphate acyltransferase C-terminal region]		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	260363 [benign DISEASE=Rhizomelic chondrodysplasia punctata type 2,not specified,not provided GENE=GNPAT];			rs574553	0.58853	0.68993,0.60820,0.62070,0.54116,0.62054	26814,	35859	62565	1.6320	3.46			/0.0>0.0/0.0>0.0	COSV64153484	GNPAT|0.00|0.00|0.04|0.00|-19|-34|13|-34	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231267519	231267519	T	C	hom	het	hom		QUAL=24;DP=110,17,22;AF=1.00,0.53,1.00	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron8/15:c.1056-161T>C::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	671169 [benign DISEASE=not provided GENE=GNPAT];			rs474297	0.54651	0.56271,0.59277,0.61698,0.53315,0.60892	22859,	37313	68899	-0.4310	0.98			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231268084	231268084	C	T	hom	het	hom		QUAL=24;DP=85,14,7;AF=1.00,0.43,1.00	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron9/15:c.1279+181C>T::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	671188 [benign DISEASE=not provided GENE=GNPAT];		AluY (SINE/Alu)	rs579924	0.54633	0.56260,0.59241,0.61576,0.53304,0.60964	22857,	37296	68930	-0.9420	0.78			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231270549	231270549	T	C	hom	n/a	het		QUAL=24;DP=67,2,11;AF=1.00,0.00,0.36	GNPAT	intron	GNPAT:ENST00000366647.9:intron_variant:MODIFIER:intron9/15:c.1280-209T>C::		602744_[GENE=GNPAT_PHENOS=Rhizomelic chondrodysplasia punctata, type 2, 222765 (3), Autosomal recessive]	671190 [benign DISEASE=not provided GENE=GNPAT];			rs3767758	0.54398	0.56181,0.59078,0.61712,0.52932,0.60934	22684,	37343	69337	2.2510	9.60			/5.0>4.6/0.0>0.0		GNPAT|0.00|0.00|0.00|0.00|0|-41|35|-21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					GNPAT (inh=AR oe_syn=1.01 oe_mis=0.90 oe_lof=0.23)
chr1	231364607	231364607	-	T	hom	hom	het		QUAL=24;DP=119,211,180;AF=0.99,0.97,0.49	EGLN1	3'UTR	EGLN1:ENST00000366641.4:3_prime_UTR_variant:MODIFIER:exon5/5:c.*1803dup::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]				rs541569859	0.57406	0.40925,0.55300,0.56026,0.65359,0.57978	25910,	35418	64728		4.50			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231366499	231366499	T	A	hom	het	het	low_conf_region	QUAL=21;DP=83,194,184;AF=0.90,0.98,0.43	EGLN1	intron	EGLN1:ENST00000366641.4:intron_variant:MODIFIER:intron4/4:c.1217-24A>T::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	1292828 [benign DISEASE=not provided,not specified GENE=EGLN1];			rs1435167	0.57177	0.41923,0.54710,0.55793,0.64866,0.57723	25170,	35831	64539	-0.5900	5.94			/0.4>0.6/0.0>0.0	COSV64150067	EGLN1|0.00|0.00|0.00|0.00|-24|-33|-32|-23	35710628	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231366564	231366564	T	C	hom	hom	het		QUAL=24;DP=215,126,113;AF=1.00,1.00,0.42	EGLN1	intron	EGLN1:ENST00000366641.4:intron_variant:MODIFIER:intron4/4:c.1217-89A>G::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	1257712 [benign DISEASE=not specified,not provided GENE=EGLN1];			rs1435166	0.52325	0.26103,0.53078,0.55372,0.64166,0.56636	22837,	33874	72480	-0.6810	0.28			/5.7>6.6/0.0>0.0	COSV64149252	EGLN1|0.00|0.00|0.00|0.00|-10|-31|5|25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231370811	231370811	G	A	hom	hom	het		QUAL=24;DP=189,98,58;AF=1.00,1.00,0.36	EGLN1	intron	EGLN1:ENST00000366641.4:intron_variant:MODIFIER:intron2/4:c.1012-113C>T::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	1265678 [benign DISEASE=not provided,not specified GENE=EGLN1];			rs2256908	0.54627	0.31692,0.54174,0.56009,0.65166,0.57753	24293,	34491	69005	1.5660	5.72			/0.0>0.0/2.1>0.0	COSV64149687	EGLN1|0.00|0.00|0.00|0.00|1|23|2|-6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231423480	231423480	A	G	het	wt	hom		QUAL=24;DP=92,63,71;AF=0.52,0.00,1.00	EGLN1	upstream_gene	EGLN1:ENST00000366641.4:upstream_gene_variant:MODIFIER::::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	296223 [benign DISEASE=not provided,Erythrocytosis, familial, 3 GENE=EGLN1];			rs12406290	0.19280	0.21257,0.21138,0.48128,0.15452,0.34576	3247,	22851	122857	2.9670	8.61						32185192,25431923,36675214	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	231424474	231424474	A	G	het	wt	hom		QUAL=24;DP=151,97,209;AF=0.54,0.00,1.00	EGLN1	upstream_gene	EGLN1:ENST00000366641.4:upstream_gene_variant:MODIFIER::::		606425_[GENE=EGLN1_PHENOS=Erythrocytosis, familial, 3, 609820 (3), Autosomal dominant; Hemoglobin, high altitude adaptation, 609070 (3), Autosomal dominant]	296240 [benign DISEASE=not provided,Erythrocytosis, familial, 3 GENE=EGLN1];			rs2153364	0.19347	0.21243,0.21191,0.48263,0.15511,0.35605	3277,	22898	122778	0.2220	5.47						32478477,32185192,32718338,36244759,25431923,36675214	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EGLN1 (inh=AD oe_syn=1.29 oe_mis=0.58 oe_lof=0.06)
chr1	235380162	235380175	TGTGTGTGTGTGTG	-	het	wt	het	low_conf_region	QUAL=26;DP=152,142,171;AF=0.76,0.00,0.59	TBCE	intron	TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron2/15:c.-211+52_-211+65del::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron2/16:c.100+52_100+65del::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron2/15:c.100+52_100+65del::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron2/15:c.100+52_100+65del::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron2/16:c.100+52_100+65del::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron2/17:c.100+52_100+65del::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron2/14:c.100+52_100+65del::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron1/15:c.100+52_100+65del::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1245486 [benign DISEASE=not provided GENE=TBCE];		(TG)n (Simple_repeat)	rs10524346	0.28166	0.15156,0.25437,0.11767,0.37238,0.12273	6206,	26955	100403	0.6670	1.85			/0.0>0.0/0.5>0.5		TBCE|0.00|0.00|0.01|0.00|-29|-11|-46|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235430867	235430867	A	G	het	wt	hom		QUAL=24;DP=158,17,98;AF=0.51,0.00,1.00	TBCE,RPS21P1	intron,upstream_gene	TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron6/15:c.321+63A>G::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron7/16:c.660+63A>G::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron7/15:c.660+63A>G::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron6/15:c.474+63A>G::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron7/16:c.660+63A>G::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron7/17:c.660+63A>G::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron5/14:c.471+63A>G::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron6/15:c.660+63A>G::,RPS21P1:ENST00000434479.2:upstream_gene_variant:MODIFIER::::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1229298 [benign DISEASE=not provided GENE=TBCE];			rs2291687	0.72488	0.90996,0.72175,0.66183,0.64010,0.58699	41130,	28031	41859	-0.2960	0.97			/3.9>5.6/0.0>0.0	COSV64005596	TBCE|0.00|0.00|0.00|0.00|0|16|-41|5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54), RPS21P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	235430935	235430935	A	G	het	wt	hom		QUAL=24;DP=115,17,45;AF=0.59,0.00,1.00	TBCE,RPS21P1	intron,upstream_gene	TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron6/15:c.321+131A>G::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron7/16:c.660+131A>G::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron7/15:c.660+131A>G::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron6/15:c.474+131A>G::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron7/16:c.660+131A>G::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron7/17:c.660+131A>G::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron5/14:c.471+131A>G::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron6/15:c.660+131A>G::,RPS21P1:ENST00000434479.2:upstream_gene_variant:MODIFIER::::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1245648 [benign DISEASE=not provided GENE=TBCE];			rs2291688	0.48781	0.40134,0.57173,0.64407,0.49972,0.46682	18492,	37174	77864	-0.3340	1.13			/3.5>5.0/0.0>6.2	COSV64005600	TBCE|0.00|0.00|0.00|0.00|0|19|-1|-15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54), RPS21P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	235435658	235435658	C	T	het	wt	hom		QUAL=24;DP=156,16,79;AF=0.44,0.00,1.00	TBCE,RPS21P1	intron,downstream_gene	TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron7/15:c.399-87C>T::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron8/16:c.738-87C>T::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron8/15:c.738-87C>T::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron7/15:c.552-87C>T::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron8/16:c.738-87C>T::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron9/17:c.891-87C>T::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron6/14:c.549-87C>T::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron7/15:c.738-87C>T::,RPS21P1:ENST00000434479.2:downstream_gene_variant:MODIFIER::::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1265656 [benign DISEASE=not provided GENE=TBCE];			rs2055127	0.49733	0.39825,0.57870,0.65205,0.51584,0.47218	19265,	37069	76411	-0.4370	0.21			/3.8>3.1/0.0>0.0	COSV64005614	TBCE|0.00|0.00|0.00|0.00|14|-8|-37|-8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54), RPS21P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	235436814	235436814	T	C	het	wt	hom		QUAL=24;DP=82,9,14;AF=0.57,0.00,1.00	TBCE,RPS21P1	intron,downstream_gene	TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron10/15:c.624+206T>C::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron11/16:c.963+206T>C::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron11/15:c.963+206T>C::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron10/15:c.777+206T>C::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron11/16:c.963+206T>C::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron12/17:c.1116+206T>C::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron9/14:c.774+206T>C::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron10/15:c.963+206T>C::,RPS21P1:ENST00000434479.2:downstream_gene_variant:MODIFIER::::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1251326 [benign DISEASE=not provided GENE=TBCE];			rs6429082	0.54987	0.54531,0.60263,0.65297,0.53314,0.48300	23163,	37246	68414	-4.3450	0.02			/0.0>0.0/0.0>0.0		TBCE|0.00|0.00|0.00|0.00|6|14|14|-36	21976109,19557161,34855049,30595370,31844048	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54), RPS21P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	235438643	235438643	G	T	het	wt	hom		QUAL=24;DP=70,17,46;AF=0.53,0.00,1.00	TBCE	intron	TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron11/15:c.778-126G>T::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron12/16:c.1117-126G>T::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron12/15:c.1117-126G>T::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron11/15:c.931-126G>T::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron12/16:c.1117-126G>T::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron13/17:c.1270-126G>T::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron10/14:c.928-126G>T::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron11/15:c.1117-126G>T::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1285897 [benign DISEASE=not provided GENE=TBCE];			rs3819974	0.71781	0.88756,0.71712,0.66957,0.63833,0.58330	40174,	28801	42909	-3.3610	0.03			/0.0>0.0/0.0>0.0	COSV64005625	TBCE|0.00|0.00|0.00|0.00|46|1|-11|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235439089	235439089	G	A	het	wt	hom		QUAL=24;DP=83,17,28;AF=0.42,0.00,1.00	TBCE	intron	TBCE:ENST00000651186.1:intron_variant:MODIFIER:intron12/15:c.931+167G>A::,TBCE:ENST00000406207.5:intron_variant:MODIFIER:intron13/16:c.1270+167G>A::,TBCE:ENST00000645899.1:intron_variant:MODIFIER:intron13/15:c.1270+167G>A::,TBCE:ENST00000644578.1:intron_variant:MODIFIER:intron12/15:c.1150+101G>A::,TBCE:ENST00000642610.2:intron_variant:MODIFIER:intron13/16:c.1270+167G>A::,TBCE:ENST00000543662.4:intron_variant:MODIFIER:intron14/17:c.1423+167G>A::,TBCE:ENST00000366601.8:intron_variant:MODIFIER:intron11/14:c.1081+167G>A::,TBCE:ENST00000644217.1:intron_variant:MODIFIER:intron12/15:c.1336+101G>A::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]	1262727 [benign DISEASE=not provided GENE=TBCE];			rs2270538	0.68437	0.79409,0.69335,0.67048,0.63207,0.56866	36056,	31882	47962	-1.5350	0.29			/0.0>0.0/0.0>0.0	COSV64005629	TBCE|0.00|0.00|0.00|0.00|-21|5|14|-45		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54)
chr1	235449005	235449005	C	T	het	wt	hom		QUAL=24;DP=53,18,84;AF=0.43,0.00,0.99	TBCE,B3GALNT2	3'UTR,downstream_gene	TBCE:ENST00000406207.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*243C>T::,TBCE:ENST00000642610.2:3_prime_UTR_variant:MODIFIER:exon17/17:c.*243C>T::,B3GALNT2:ENST00000366600.8:3_prime_UTR_variant:MODIFIER:exon12/12:c.*1201G>A::,TBCE:ENST00000651186.1:downstream_gene_variant:MODIFIER::::,TBCE:ENST00000645899.1:downstream_gene_variant:MODIFIER::::,TBCE:ENST00000644578.1:downstream_gene_variant:MODIFIER::::,TBCE:ENST00000543662.4:downstream_gene_variant:MODIFIER::::,TBCE:ENST00000366601.8:downstream_gene_variant:MODIFIER::::,TBCE:ENST00000644217.1:downstream_gene_variant:MODIFIER::::,B3GALNT2:ENST00000676288.1:downstream_gene_variant:MODIFIER::::,B3GALNT2:ENST00000675555.1:downstream_gene_variant:MODIFIER::::		604934_[GENE=TBCE_PHENOS=Kenny-Caffey syndrome, type 1, 244460 (3), Autosomal recessive; Hypoparathyroidism-retardation-dysmorphism syndrome, 241410 (3), Autosomal recessive; Encephalopathy, progressive, with amyotrophy and optic atrophy, 617207 (3), Autosomal recessive]&610194_[GENE=B3GALNT2_PHENOS=Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 11, 615181 (3), Autosomal recessive]				rs704705	0.73759	0.92391,0.72762,0.66982,0.65283,0.61104	42530,	27163	39925	0.6550	7.01			/9.4>8.6/0.0>0.0,/0.0>0.0/0.0>0.0	COSV64003592			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					TBCE (inh=AR oe_syn=1.05 oe_mis=0.98 oe_lof=0.54), B3GALNT2 (inh=AR oe_syn=0.91 oe_mis=0.84 oe_lof=0.55)
chr1	235662343	235662343	G	A	het	wt	het		QUAL=24;DP=69,54,30;AF=0.41,0.00,0.33	LYST	3'UTR	LYST:ENST00000389793.7:3_prime_UTR_variant:MODIFIER:exon53/53:c.*597C>T::	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]				rs1400168809	0.00002	0.00000,0.00000,0.00000,0.00004,0.00000	0,	3	152139	1.0680	7.06			/3.6>4.8/0.0>3.9		LYST|0.00|0.00|0.00|0.00|-41|1|2|-25		0	2	0	0 / 0					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235663083	235663083	A	-	hom	hom	het		QUAL=24;DP=230,326,233;AF=0.88,0.91,0.56	LYST	splice_region&intron	LYST:ENST00000389793.7:splice_region_variant&intron_variant:LOW:intron52/52:c.11268-5del::	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	403065 [benign/likely benign DISEASE=Chediak-Higashi syndrome,not provided,Autoinflammatory syndrome,not specified GENE=LYST];	CD181021 [CLASS=DM? MUT=ALT PHEN="Haemophagocytic lymphohistiocytosis" GENE=LYST];		rs36014994	0.55357	0.77355,0.38953,0.04966,0.52591,0.17572	24874,	32902	66654	-0.6940	2.17			/8.6>6.9/0.0>0.0		LYST|0.05|0.01|0.00|0.00|-42|-4|-4|2	24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235664143	235664143	T	C	hom	hom	het		QUAL=24;DP=105,91,68;AF=0.99,1.00,0.54	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron51/52:c.11196-88A>G::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1276755 [benign DISEASE=not provided,not specified GENE=LYST];			rs3819013	0.40444	0.26665,0.33305,0.04596,0.52275,0.15651	14018,	33462	90560	-0.2940	2.10			/3.1>2.8/0.0>1.1	COSV67704793	LYST|0.00|0.00|0.00|0.00|-40|-28|1|22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235664341	235664341	C	T	hom	hom	het		QUAL=24;DP=56,25,14;AF=1.00,1.00,0.50	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron51/52:c.11195+124G>A::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	684368 [benign DISEASE=not provided GENE=LYST];			rs12092604	0.53773	0.72524,0.38738,0.04572,0.52446,0.17443	23867,	33998	70264	-0.5320	0.47			/3.5>3.0/2.2>4.9	COSV67704799	LYST|0.00|0.00|0.00|0.00|43|1|-1|1		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235693238	235693238	-	C	hom	hom	hom		QUAL=24;DP=79,51,36;AF=1.00,1.00,1.00	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron47/52:c.10701+111dup::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	684366 [benign DISEASE=not provided GENE=LYST];		AluY (SINE/Alu)	rs5781839	0.95053	0.98795,0.94472,0.99016,0.92703,0.98324	68853,	7077	7535		0.39			/0.0>0.0/0.0>0.0		LYST|0.00|0.00|0.00|0.00|-32|-23|-40|-30		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235693601	235693601	G	A	hom	hom	het		QUAL=25;DP=199,85,85;AF=0.99,1.00,0.49	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron46/52:c.10565-115C>T::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1249412 [benign DISEASE=not specified,not provided GENE=LYST];			rs3754232	0.40386	0.25760,0.35576,0.04505,0.52155,0.16114	13986,	33419	90619	0.4190	0.46			/0.0>0.0/0.0>0.0	COSV67704843	LYST|0.00|0.00|0.00|0.00|-49|19|7|-8		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235697040	235697040	C	T	hom	hom	het		QUAL=24;DP=67,23,29;AF=1.00,1.00,0.59	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron46/52:c.10564+43G>A::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254908 [benign DISEASE=not specified,not provided GENE=LYST];			rs7541057	0.53232	0.72213,0.38055,0.04517,0.51693,0.17068	23488,	34002	71144	-1.8750	0.06			/0.0>0.0/2.3>0.0		LYST|0.00|0.00|0.00|0.00|43|21|43|31	25741868,34469753	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235709365	235709365	T	C	hom	hom	het	low_conf_region	QUAL=24;DP=179,56,47;AF=0.99,1.00,0.51	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron43/52:c.9926-57A>G::	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	684363 [benign DISEASE=not provided,not specified GENE=LYST];			rs2275856	0.50022	0.82245,0.36248,0.06930,0.40963,0.19631	22476,	31104	75988	-0.7320	1.59			/2.4>0.0/0.0>0.0		LYST|0.00|0.00|0.00|0.00|43|-2|43|25		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235723976	235723976	G	T	hom	hom	het		QUAL=25;DP=133,116,99;AF=0.99,1.00,0.52	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron39/52:c.9315+52C>A::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	684361 [benign DISEASE=not provided,not specified GENE=LYST];			rs6667717	0.49809	0.82126,0.36078,0.06330,0.40665,0.19453	22326,	31056	76288	-2.6600	0.01			/0.0>0.0/3.6>5.9	COSV67704991	LYST|0.00|0.00|0.00|0.00|-31|13|-1|-30	18485661	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235733426	235733426	C	T	hom	hom	het		QUAL=24;DP=104,84,63;AF=0.99,1.00,0.51	LYST,LDHAP2	intron,upstream_gene	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron34/52:c.8801+77G>A::,LDHAP2:ENST00000437325.2:upstream_gene_variant:MODIFIER::::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	684360 [benign DISEASE=not provided,not specified GENE=LYST];			rs6429275	0.49986	0.82161,0.36239,0.06233,0.40939,0.19609	22409,	31101	75963	-0.6810	6.16			/2.3>5.0/0.0>0.0	COSV67705001	LYST|0.00|0.00|0.00|0.00|-2|-9|-2|-9		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24), LDHAP2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	235746185	235746185	T	C	het	het	wt		QUAL=24;DP=145,21,15;AF=0.47,0.57,0.00	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron29/52:c.7972+151A>G::	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1268311 [benign DISEASE=not provided GENE=LYST];			rs10926565	0.27280	0.33652,0.21158,0.01909,0.26977,0.16113	5980,	29522	110580	-0.0390	6.63			/0.0>0.0/2.5>10.6		LYST|0.00|0.00|0.01|0.00|42|-44|1|28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235755389	235755393	AAAAG	-	hom	hom	hom		QUAL=24;DP=80,60,48;AF=0.96,0.98,0.98	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron25/52:c.7229+85_7229+89del::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	801635 [benign DISEASE=not specified,not provided,Chediak-Higashi syndrome GENE=LYST];		AluSx3 (SINE/Alu), (AAAAG)n (Simple_repeat)	rs71174459	0.35600	0.31434,0.30598,0.07387,0.40511,0.20770	9222,	31696	90704	0.1310	0.85			/3.8>3.8/0.0>0.0		LYST|0.01|0.00|0.00|0.00|-3|4|-3|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235758928	235758928	T	C	het	het	wt		QUAL=25;DP=84,43,16;AF=0.60,0.44,0.00	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron23/52:c.6881+44A>G::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254935 [benign DISEASE=not provided,not specified GENE=LYST];			rs3738519	0.29706	0.41684,0.22389,0.01931,0.27083,0.16286	7337,	30503	106905	-3.8310	0.02			/3.8>5.4/0.0>0.0		LYST|0.00|0.00|0.00|0.00|43|44|44|38	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235765937	235765937	A	G	hom	hom	het		QUAL=25;DP=98,35,22;AF=0.99,1.00,0.55	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron21/52:c.6121+142T>C::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1287899 [benign DISEASE=not provided GENE=LYST];		L2d2 (LINE/L2)	rs12565325	0.40658	0.49541,0.33174,0.06281,0.40904,0.19536	13248,	35242	90108	-0.1930	2.22			/0.0>0.0/0.0>0.0	COSV67705039	LYST|0.02|0.00|0.00|0.00|12|-13|12|23		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235777150	235777150	C	T	hom	hom	het		QUAL=24;DP=241,236,202;AF=1.00,1.00,0.43	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon17/53:c.5373G>A:p.Lys1791=:		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254927 [benign DISEASE=not specified,not provided,Chediak-Higashi syndrome GENE=LYST];			rs2273584	0.40428	0.49308,0.32642,0.06279,0.40750,0.18854	13097,	35198	90464	0.6210	8.20			/1.0>0.0/0.0>0.0	COSV67705051	LYST|0.00|0.00|0.00|0.00|-35|45|36|-34	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235781886	235781886	G	A	het	het	het		QUAL=24;DP=135,153,93;AF=0.44,0.51,0.54	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron15/52:c.5023+41C>T::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254924 [benign DISEASE=not provided,not specified GENE=LYST];		AluJo (SINE/Alu)	rs72763416	0.10686	0.07059,0.10566,0.04344,0.13743,0.03238	969,	14312	135822	-0.9540	0.55			/0.0>0.0/0.0>0.0	COSV67705060	LYST|0.00|0.00|0.00|0.00|6|-6|41|-6	25741868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235781994	235781994	T	C	hom	hom	het		QUAL=24;DP=184,231,150;AF=0.99,1.00,0.51	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon15/53:c.4956A>G:p.Leu1652=:		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254923 [benign DISEASE=not provided,not specified,Chediak-Higashi syndrome GENE=LYST];			rs6696123	0.40507	0.49452,0.32600,0.06323,0.40786,0.19511	13168,	35223	90413	-0.3850	2.58			/2.8>4.4/0.0>0.0	COSV67705068	LYST|0.00|0.00|0.00|0.00|-11|48|50|3	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235782202	235782202	A	G	hom	hom	het		QUAL=24;DP=59,8,8;AF=1.00,1.00,0.50	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron14/52:c.4863-115T>C::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	684345 [benign DISEASE=not provided GENE=LYST];		AluY (SINE/Alu)	rs2011390	0.80325	0.89846,0.76450,0.84133,0.75687,0.77221	48494,	23200	29440	-1.8820	0.38			/0.0>0.0/0.0>0.0		LYST|0.00|0.00|0.00|0.00|10|-23|-33|0		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235800154	235800154	C	A	het	het	het		QUAL=24;DP=63,23,12;AF=0.52,0.39,0.42	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron10/52:c.4006+166G>T::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1251917 [benign DISEASE=not provided GENE=LYST];		AluJr (SINE/Alu)	rs72763422	0.10667	0.06970,0.10509,0.04339,0.13756,0.03235	954,	14144	134438	-0.4020	5.52			/0.0>0.6/0.0>0.0	COSV67705088			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235806982	235806982	A	G	het	het	wt		QUAL=24;DP=112,7,4;AF=0.46,0.71,0.00	LYST	intron	LYST:ENST00000389793.7:intron_variant:MODIFIER:intron5/52:c.2364-210T>C::		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	1222779 [benign DISEASE=not provided GENE=LYST];			rs41315862	0.10853	0.07539,0.10688,0.04370,0.13801,0.03257	995,	14530	135696	1.0580	5.86			/0.0>0.0/0.0>0.0		LYST|0.00|0.00|0.00|0.00|25|0|-20|44		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235808463	235808463	A	G	het	het	het		QUAL=24;DP=70,261,197;AF=0.54,0.52,0.51	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon5/53:c.2355T>C:p.Leu785=:		606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254915 [benign/likely benign DISEASE=not provided,not specified,Chediak-Higashi syndrome GENE=LYST];			rs3768066	0.10722	0.07090,0.10549,0.04362,0.13808,0.03297	973,	14305	135319	-0.0390	4.67			/6.0>6.5/0.0>0.0		LYST|0.00|0.00|0.00|0.00|41|-9|-8|24	25741868,32450446	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235809135	235809135	T	C	hom	hom	het		QUAL=24;DP=181,280,198;AF=0.99,1.00,0.52	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon5/53:c.1683A>G:p.Leu561=:	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254912 [benign DISEASE=not provided,Chediak-Higashi syndrome,not specified GENE=LYST];			rs3820553	0.40525	0.49469,0.32742,0.06279,0.40814,0.19415	13180,	35233	90393	-0.4290	0.47			/4.1>4.9/0.0>0.0	COSV67705097	LYST|0.00|0.00|0.00|0.00|28|-4|46|28	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	235809567	235809567	T	C	hom	hom	het		QUAL=24;DP=119,206,179;AF=1.00,1.00,0.58	LYST	synonymous	LYST:ENST00000389793.7:synonymous_variant:LOW:exon5/53:c.1251A>G:p.Gln417=:	regulatory_region_variant:enhancer	606897_[GENE=LYST_PHENOS=Chediak-Higashi syndrome, 214500 (3), Autosomal recessive]	254910 [benign DISEASE=Chediak-Higashi syndrome,not provided,not specified GENE=LYST];			rs1063128	0.40548	0.49486,0.32744,0.06245,0.40825,0.19518	13179,	35237	90313	-0.0510	1.88			/6.9>8.3/0.0>0.0	COSV67705101	LYST|0.00|0.00|0.00|0.00|-1|-8|-1|-8	25741868,24033266	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					LYST (inh=AR oe_syn=1.01 oe_mis=0.91 oe_lof=0.24)
chr1	236394471	236394471	G	A	hom	hom	hom		QUAL=24;DP=251,289,225;AF=1.00,1.00,1.00	EDARADD	intron,missense,upstream_gene	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron1/5:c.-5-14745G>A::,EDARADD:ENST00000334232.9:missense_variant:MODERATE:exon1/6:c.27G>A:p.Met9Ile:,EDARADD:ENST00000359362.6:upstream_gene_variant:MODIFIER::::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	262600 [benign DISEASE=Hypohidrotic ectodermal dysplasia,Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant,not specified,not provided,Hypohidrotic Ectodermal Dysplasia, Recessive,Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive GENE=EDARADD];			rs966365	0.76615	0.55140,0.85818,0.91879,0.84076,0.91649	46083,	24421	35585	-0.0690	7.82	0.132	0.19	/0.0>0.0/0.0>1.3	COSV62061862	EDARADD|0.00|0.00|0.00|0.07|34|-16|38|34	25741868,18466582,31452656	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236394628	236394628	G	A	hom	hom	hom		QUAL=24;DP=94,41,33;AF=1.00,1.00,1.00	EDARADD	intron,upstream_gene	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron1/5:c.-5-14588G>A::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron1/5:c.61+123G>A::,EDARADD:ENST00000359362.6:upstream_gene_variant:MODIFIER::::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	439637 [benign DISEASE=not specified,not provided GENE=EDARADD];			rs966364	0.76194	0.53673,0.85656,0.91904,0.84081,0.91605	45731,	24473	36223	0.3730	4.13			/1.8>1.1/0.0>0.0		EDARADD|0.00|0.00|0.00|0.00|31|-4|-26|-30	17160898	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236409089	236409089	G	A	hom	hom	hom		QUAL=24;DP=92,40,57;AF=0.99,1.00,1.00	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron1/5:c.-5-127G>A::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron1/5:c.62-127G>A::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron1/5:c.32-127G>A::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1295882 [benign DISEASE=not provided GENE=EDARADD];			rs659901	0.67718	0.67031,0.67963,0.37304,0.69963,0.67499	34701,	32061	48369	-0.9900	0.37			/0.0>0.0/4.3>6.4	COSV62066165			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236409175	236409175	A	G	het	het	hom		QUAL=24;DP=180,161,172;AF=0.50,0.55,1.00	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron1/5:c.-5-41A>G::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron1/5:c.62-41A>G::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron1/5:c.32-41A>G::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1255368 [benign DISEASE=not provided,Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive,Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant GENE=EDARADD];			rs669710	0.53336	0.47974,0.48852,0.26267,0.58976,0.49564	22076,	36854	70874	0.2780	1.13			/3.7>3.9/0.0>0.4	COSV62061755	EDARADD|0.00|0.00|0.00|0.00|1|41|0|48		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236414461	236414461	T	C	het	het	hom		QUAL=25;DP=53,17,16;AF=0.47,0.29,1.00	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.94+162T>C::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.160+162T>C::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.130+162T>C::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1295767 [benign DISEASE=not provided GENE=EDARADD];			rs625444	0.66210	0.50148,0.64483,0.56071,0.70561,0.66479	17419,	32829	34533	0.2880	2.47			/8.1>7.9/0.0>0.0	COSV105889711	EDARADD|0.00|0.00|0.00|0.00|35|14|-5|-21		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236414462	236414462	C	T	het	het	hom		QUAL=24;DP=54,17,16;AF=0.46,0.29,1.00	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.94+163C>T::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.160+163C>T::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.130+163C>T::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1290224 [benign DISEASE=not provided GENE=EDARADD];			rs625443	0.44569	0.18806,0.44965,0.22720,0.58687,0.49249	17471,	32832	84290	-0.4690	0.85			/8.1>8.3/0.0>0.0		EDARADD|0.00|0.00|0.00|0.00|13|-14|4|-22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236414500	236414500	G	A	het	het	hom		QUAL=24;DP=43,6,6;AF=0.40,0.33,1.00	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.94+201G>A::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.160+201G>A::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.130+201G>A::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1295803 [benign DISEASE=not provided GENE=EDARADD];			rs665150	0.43663	0.15589,0.44682,0.22727,0.58680,0.49212	17210,	31961	85649	0.4660	1.77			/0.0>0.0/0.0>0.0		EDARADD|0.00|0.00|0.00|0.00|46|-25|-27|19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236427197	236427197	C	G	het	het	hom		QUAL=25;DP=54,33,13;AF=0.43,0.36,1.00	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.95-195C>G::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.161-195C>G::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.131-195C>G::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1224591 [benign DISEASE=not provided GENE=EDARADD];		LTR53 (LTR/ERVL)	rs1759388	0.47917	0.29974,0.46232,0.22882,0.58812,0.47344	18784,	35245	79145	-2.2650	0.22			/0.7>2.5/0.5>0.7	COSV62063292	EDARADD|0.00|0.00|0.00|0.00|0|3|-21|3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236427263	236427263	C	T	het	het	hom		QUAL=24;DP=96,77,33;AF=0.44,0.44,1.00	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.95-129C>T::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.161-129C>T::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.131-129C>T::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1295875 [benign DISEASE=not provided GENE=EDARADD];		LTR53 (LTR/ERVL)	rs1778861	0.44960	0.19655,0.45320,0.22868,0.58768,0.47364	17657,	33033	83671	1.0310	4.88			/7.4>7.3/0.0>0.0		EDARADD|0.00|0.00|0.00|0.00|17|-6|31|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236427329	236427329	C	T	het	het	hom		QUAL=24;DP=122,140,77;AF=0.52,0.51,1.00	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.95-63C>T::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.161-63C>T::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.131-63C>T::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1237172 [benign DISEASE=not provided GENE=EDARADD];		LTR53 (LTR/ERVL)	rs636378	0.44937	0.19625,0.45310,0.22909,0.58765,0.47418	17619,	32956	83560	-0.1690	2.12			/0.0>0.0/0.0>0.0		EDARADD|0.00|0.00|0.00|0.00|5|-11|-35|-12		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236427359	236427359	G	C	het	het	hom		QUAL=24;DP=151,154,90;AF=0.52,0.51,0.99	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron3/5:c.95-33G>C::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron3/5:c.161-33G>C::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron3/5:c.131-33G>C::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1255369 [benign DISEASE=not provided,Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant,Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive GENE=EDARADD];		(T)n (Simple_repeat)	rs636048	0.44891	0.19686,0.45337,0.22968,0.58686,0.46911	17453,	32911	83253	0.8960	5.98			/0.0>0.0/0.0>0.0		EDARADD|0.00|0.00|0.00|0.00|39|-41|33|-42		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236427516	236427516	T	G	het	het	hom		QUAL=24;DP=119,74,42;AF=0.50,0.55,1.00	EDARADD	intron	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron4/5:c.153+66T>G::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron4/5:c.219+66T>G::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron4/5:c.189+66T>G::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1222286 [benign DISEASE=not provided GENE=EDARADD];			rs635487	0.47879	0.29917,0.46238,0.22827,0.58796,0.47365	18753,	35271	79225	0.7230	5.51			/0.0>0.0/0.0>0.0		EDARADD|0.00|0.00|0.00|0.00|-32|7|-32|-33		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61)
chr1	236482140	236482140	C	T	het	hom	het		QUAL=24;DP=22,68,58;AF=0.45,0.99,0.40	EDARADD,ENO1P1	intron,upstream_gene	EDARADD:ENST00000637660.1:intron_variant:MODIFIER:intron5/5:c.200-127C>T::,EDARADD:ENST00000334232.9:intron_variant:MODIFIER:intron5/5:c.266-127C>T::,EDARADD:ENST00000359362.6:intron_variant:MODIFIER:intron5/5:c.236-127C>T::,ENO1P1:ENST00000366587.4:upstream_gene_variant:MODIFIER::::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	1247629 [benign DISEASE=not provided GENE=EDARADD];			rs603158	0.66239	0.66762,0.59726,0.41673,0.68525,0.66939	33230,	33219	50805	-0.1690	0.19			/0.0>0.1/0.0>0.0		EDARADD|0.00|0.00|0.00|0.00|46|-7|-2|15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484211	236484211	T	C	het	hom	het		QUAL=25;DP=181,225,142;AF=0.54,1.00,0.49	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::,EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1562T>C::,ENO1P1:ENST00000366587.4:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1047T>C::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	296476 [benign/likely benign DISEASE=not provided,Hypohidrotic Ectodermal Dysplasia, Recessive,Hypohidrotic ectodermal dysplasia GENE=EDARADD];			rs7513402	0.31391	0.23063,0.32947,0.10739,0.36784,0.33880	8026,	31683	104329	-1.7820	1.52			/2.5>1.6/0.0>0.0	COSV62064204			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484250	236484250	C	G	het	hom	het		QUAL=24;DP=220,225,127;AF=0.56,1.00,0.53	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::,EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1601C>G::,ENO1P1:ENST00000366587.4:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1086C>G::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	296479 [benign/likely benign DISEASE=not provided,Hypohidrotic Ectodermal Dysplasia, Recessive,Hypohidrotic ectodermal dysplasia GENE=EDARADD];			rs3916983	0.23246	0.15329,0.26850,0.10386,0.27783,0.27233	4538,	26289	116771	0.7020	1.69			/0.0>0.0/0.0>0.0	COSV62063742			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236484436	236484436	C	T	het	hom	het		QUAL=24;DP=104,129,73;AF=0.55,0.99,0.53	EDARADD,ENO1P1	3'UTR,non_coding_transcript_exon	EDARADD:ENST00000637660.1:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::,EDARADD:ENST00000334232.9:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::,EDARADD:ENST00000359362.6:3_prime_UTR_variant:MODIFIER:exon6/6:c.*1787C>T::,ENO1P1:ENST00000366587.4:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1272C>T::		606603_[GENE=EDARADD_PHENOS=Ectodermal dysplasia 11B, hypohidrotic/hair/tooth type, autosomal recessive, 614941 (3), Autosomal recessive; Ectodermal dysplasia 11A, hypohidrotic/hair/tooth type, autosomal dominant, 614940 (3), Autosomal dominant]	296481 [benign/likely benign DISEASE=Hypohidrotic Ectodermal Dysplasia, Recessive,not provided,Hypohidrotic ectodermal dysplasia GENE=EDARADD];			rs6428955	0.17847	0.06230,0.20139,0.05182,0.24127,0.22689	2990,	21138	124828	-0.0630	0.22			/0.0>0.0/0.4>0.0	COSV62066249			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					EDARADD (inh=AR+AD oe_syn=0.98 oe_mis=0.72 oe_lof=0.61), ENO1P1 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236795232	236795232	G	T	het	hom	het		QUAL=24;DP=15,29,23;AF=0.47,1.00,0.48	MTR	upstream_gene	MTR:ENST00000366577.10:upstream_gene_variant:MODIFIER::::,MTR:ENST00000674797.2:upstream_gene_variant:MODIFIER::::,MTR:ENST00000535889.6:upstream_gene_variant:MODIFIER::::,MTR:ENST00000679842.1:upstream_gene_variant:MODIFIER::::,MTR:ENST00000681102.1:upstream_gene_variant:MODIFIER::::,MTR:ENST00000681177.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1249677 [benign DISEASE=not provided GENE=MTR];	CR1417888 [CLASS=DP MUT=ALT PHEN="Congenital heart disease association with" GENE=MTR];		rs28372871	0.46352	0.53497,0.47331,0.48760,0.42594,0.41473	16601,	37282	81578	-0.5370	1.20						27808252,35334827,32819312,37422868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236808886	236808886	A	G	het	wt	het		QUAL=24;DP=204,51,168;AF=0.50,0.00,0.54	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron4/32:c.409+113A>G::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron3/31:c.61+113A>G::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron4/31:c.409+113A>G::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron4/30:c.409+113A>G::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron4/31:c.409+113A>G::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron4/29:c.409+113A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1232929 [benign DISEASE=not provided GENE=MTR];			rs12759827	0.18260	0.05280,0.19936,0.00116,0.26974,0.06260	3384,	21016	124378	-0.5500	1.05			/0.0>0.0/0.0>0.3		MTR|0.00|0.00|0.00|0.00|-34|31|22|-6	18381459,21274745,23940529,22941668,29763473,33499176,35677930	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236815692	236815692	-	TCTG	het	hom	het	low_conf_region	QUAL=24;DP=179,192,118;AF=0.52,0.93,0.54	MTR,RPSAP21	intron,upstream_gene	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron7/32:c.669+32_669+33insGTCT::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron6/31:c.321+32_321+33insGTCT::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron7/31:c.669+32_669+33insGTCT::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron7/30:c.669+32_669+33insGTCT::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron7/31:c.669+32_669+33insGTCT::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron7/29:c.669+32_669+33insGTCT::,RPSAP21:ENST00000414293.2:upstream_gene_variant:MODIFIER::::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1263040 [benign DISEASE=not provided GENE=MTR];			rs5781924	0.72269	0.91486,0.67758,0.81568,0.62964,0.73711	40944,	27766	42076		2.68			/0.0>0.0/0.0>0.0		MTR|0.00|0.00|0.00|0.00|-29|-23|-29|-15		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46), RPSAP21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236816297	236816297	A	G	het	hom	het		QUAL=24;DP=61,19,13;AF=0.56,1.00,0.54	MTR,RPSAP21	intron,upstream_gene	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron7/32:c.670-152A>G::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron6/31:c.322-152A>G::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron7/31:c.670-152A>G::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron7/30:c.670-152A>G::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron7/31:c.670-152A>G::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron7/29:c.670-152A>G::,RPSAP21:ENST00000414293.2:upstream_gene_variant:MODIFIER::::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1241010 [benign DISEASE=not provided GENE=MTR];			rs3795708	0.35003	0.20756,0.40884,0.40545,0.40942,0.30447	10066,	33069	98791	-2.4980	0.01			/7.9>8.2/0.0>0.0	COSV63969853	MTR|0.00|0.00|0.00|0.00|48|-26|48|-14	25598430	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46), RPSAP21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236825293	236825293	-	T	het	hom	het		QUAL=24;DP=144,50,39;AF=0.58,1.00,0.67	MTR,RPSAP21	intron,downstream_gene	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron9/32:c.866-40dup::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron8/31:c.518-40dup::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron9/31:c.866-40dup::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron9/30:c.866-40dup::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron9/31:c.866-40dup::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron9/29:c.866-40dup::,RPSAP21:ENST00000414293.2:downstream_gene_variant:MODIFIER::::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1236260 [benign DISEASE=not provided GENE=MTR];			rs5781926	0.34674	0.20768,0.40281,0.40242,0.40890,0.29387	9856,	32860	99046		0.59			/3.0>4.5/0.0>0.0		MTR|0.00|0.00|0.00|0.00|9|45|45|-47		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46), RPSAP21 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	236838626	236838626	A	G	het	hom	het		QUAL=24;DP=122,256,180;AF=0.56,1.00,0.51	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron15/32:c.1515+27A>G::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron14/31:c.1167+27A>G::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron15/31:c.1515+27A>G::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron15/30:c.1515+27A>G::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron15/31:c.1515+27A>G::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron15/29:c.1515+27A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1278171 [benign DISEASE=not provided GENE=MTR];			rs3820568	0.35584	0.21189,0.41378,0.43416,0.41369,0.29730	10406,	33317	97989	-0.9150	0.08			/7.0>8.1/0.0>0.0		MTR|0.00|0.00|0.00|0.00|-26|-27|13|-27		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236838732	236838732	A	C	het	hom	het		QUAL=24;DP=204,85,56;AF=0.47,1.00,0.64	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron15/32:c.1515+133A>C::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron14/31:c.1167+133A>C::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron15/31:c.1515+133A>C::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron15/30:c.1515+133A>C::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron15/31:c.1515+133A>C::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron15/29:c.1515+133A>C::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1178281 [benign DISEASE=not provided GENE=MTR];		(ATATAC)n (Simple_repeat)	rs55748381	0.35583	0.21202,0.41335,0.43643,0.41374,0.29739	10393,	33320	97950	0.5030	1.60			/0.0>0.0/0.0>3.1	COSV63964088	MTR|0.00|0.00|0.00|0.00|26|2|-35|-5		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236850251	236850251	T	-	het	n/a	n/a		QUAL=24;DP=4,2,0;AF=0.50,1.00,	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron15/32:c.1516-93del::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron14/31:c.1168-93del::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron15/31:c.1516-93del::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron15/30:c.1516-93del::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron15/31:c.1516-2270del::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron15/29:c.1516-9582del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1273851 [benign DISEASE=not provided GENE=MTR];		(TAATAT)n (Simple_repeat)	rs146375090	0.35035	0.20256,0.40849,0.43155,0.41002,0.29672	10047,	32906	98276	-0.0150	3.26			/0.0>0.0/0.0>0.0	COSV63965667	MTR|0.00|0.00|0.01|0.00|50|25|-48|-27		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236850253	236850253	T	A	het	hom	n/a		QUAL=24;DP=6,3,0;AF=0.33,1.00,	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron15/32:c.1516-91T>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron14/31:c.1168-91T>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron15/31:c.1516-91T>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron15/30:c.1516-91T>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron15/31:c.1516-2268T>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron15/29:c.1516-9580T>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1259363 [benign DISEASE=not provided GENE=MTR];		(TAATAT)n (Simple_repeat)	rs200399202	0.35043	0.20267,0.40854,0.43136,0.41009,0.29693	10047,	32912	98252	1.4860	7.45			/0.0>0.0/0.0>0.0	COSV63964431	MTR|0.00|0.00|0.00|0.00|47|22|-40|-30		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236850615	236850617	TGA	-	het	hom	het		QUAL=24;DP=60,72,47;AF=0.60,0.97,0.51	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron16/32:c.1695+95_1695+97del::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron15/31:c.1347+95_1347+97del::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron16/31:c.1695+95_1695+97del::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron16/30:c.1695+95_1695+97del::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron15/31:c.1516-1903_1516-1901del::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron15/29:c.1516-9215_1516-9213del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1229225 [benign DISEASE=not provided GENE=MTR];			rs35913043	0.46966	0.52897,0.47521,0.66114,0.43279,0.40689	17062,	37008	80324	0.6900	2.45			/0.0>0.0/0.0>0.0		MTR|0.00|0.00|0.00|0.00|28|3|22|-28		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236852328	236852328	C	T	het	hom	wt		QUAL=24;DP=60,4,3;AF=0.45,1.00,0.00	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron16/32:c.1696-193C>T::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron15/31:c.1348-193C>T::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron16/31:c.1696-193C>T::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron16/30:c.1696-193C>T::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron15/31:c.1516-193C>T::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron15/29:c.1516-7505C>T::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1262193 [benign DISEASE=not provided GENE=MTR];			rs2275568	0.42559	0.40485,0.45585,0.45960,0.43195,0.38438	13924,	36700	87118	0.0500	0.48			/0.0>0.0/0.0>0.0		MTR|0.00|0.00|0.00|0.00|36|-32|-18|30	19834535,29445423	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236860033	236860033	T	C	het	hom	het		QUAL=24;DP=67,98,77;AF=0.57,1.00,0.60	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron19/32:c.2043+111T>C::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron18/31:c.1695+111T>C::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron19/31:c.2043+111T>C::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron19/30:c.2043+111T>C::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron18/31:c.1863+111T>C::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron16/29:c.1605+111T>C::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1183329 [benign DISEASE=not provided GENE=MTR];			rs10925254	0.65370	0.68807,0.65873,0.63135,0.63444,0.72880	28891,	29068	46010	1.0330	6.88			/0.0>0.0/0.0>0.0	COSV63965200	MTR|0.00|0.00|0.00|0.00|13|34|-1|12	32492698	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236860094	236860094	A	G	hom	hom	hom		QUAL=24;DP=15,66,30;AF=0.93,1.00,0.93	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron19/32:c.2043+172A>G::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron18/31:c.1695+172A>G::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron19/31:c.2043+172A>G::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron19/30:c.2043+172A>G::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron18/31:c.1863+172A>G::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron16/29:c.1605+172A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1290727 [benign DISEASE=not provided GENE=MTR];		MER20 (DNA/hAT-Charlie)	rs45534439	0.44689	0.25731,0.50913,0.57389,0.50985,0.33312	4842,	17736	33938	-0.9390	0.13			/8.2>8.6/0.0>0.0	COSV63966199	MTR|0.00|0.00|0.00|0.00|16|4|-49|4		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874528	236874528	G	A	het	hom	n/a		QUAL=24;DP=32,4,0;AF=0.63,1.00,	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron23/32:c.2474-198G>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron22/31:c.2126-198G>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron22/31:c.2321-198G>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-6227G>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron22/31:c.2294-198G>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron20/29:c.2036-198G>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1286676 [benign DISEASE=not provided GENE=MTR];		AluSx1 (SINE/Alu)	rs4659737	0.64537	0.67491,0.64270,0.61430,0.62944,0.70784	31567,	33970	53358	-1.7780	1.09			/0.0>0.0/0.0>0.0		MTR|0.00|0.00|0.00|0.00|16|-5|27|-22		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874553	236874553	C	A	hom	hom	n/a		QUAL=25;DP=44,7,0;AF=0.98,1.00,	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron23/32:c.2474-173C>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron22/31:c.2126-173C>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron22/31:c.2321-173C>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-6202C>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron22/31:c.2294-173C>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron20/29:c.2036-173C>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1246495 [benign DISEASE=not provided GENE=MTR];		AluSx1 (SINE/Alu)	rs2712831	0.99931	0.99769,0.99967,1.00000,0.99996,1.00000	75398,	102	104	-0.6200	1.15			/0.0>0.6/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874699	236874699	T	-	wt	hom	het	low_conf_region	QUAL=24;DP=83,70,37;AF=0.00,0.86,0.70	MTR	splice_region&intron,intron	MTR:ENST00000366577.10:splice_region_variant&intron_variant:LOW:intron23/32:c.2474-18del::,MTR:ENST00000674797.2:splice_region_variant&intron_variant:LOW:intron22/31:c.2126-18del::,MTR:ENST00000535889.6:splice_region_variant&intron_variant:LOW:intron22/31:c.2321-18del::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-6047del::,MTR:ENST00000681102.1:splice_region_variant&intron_variant:LOW:intron22/31:c.2294-18del::,MTR:ENST00000681177.1:splice_region_variant&intron_variant:LOW:intron20/29:c.2036-18del::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1220586 [benign DISEASE=Methylcobalamin deficiency type cblG,not provided GENE=MTR];			rs150727404	0.64180	0.74671,0.63454,0.79663,0.58182,0.70091	30400,	32915	52303	0.3150	0.10			/2.2>1.9/0.0>0.0		MTR|0.00|0.00|0.00|0.00|20|46|28|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874708	236874708	T	A	het	hom	het	low_conf_region	QUAL=24;DP=118,72,45;AF=0.30,0.89,0.60	MTR	splice_region&intron,intron	MTR:ENST00000366577.10:splice_region_variant&intron_variant:LOW:intron23/32:c.2474-18T>A::,MTR:ENST00000674797.2:splice_region_variant&intron_variant:LOW:intron22/31:c.2126-18T>A::,MTR:ENST00000535889.6:splice_region_variant&intron_variant:LOW:intron22/31:c.2321-18T>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-6047T>A::,MTR:ENST00000681102.1:splice_region_variant&intron_variant:LOW:intron22/31:c.2294-18T>A::,MTR:ENST00000681177.1:splice_region_variant&intron_variant:LOW:intron20/29:c.2036-18T>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	378884 [benign DISEASE=not specified,not provided,Methylcobalamin deficiency type cblG GENE=MTR];			rs10925256	0.45600	0.53409,0.46487,0.49815,0.41721,0.38812	12440,	35543	72085	-0.6490	1.87			0.0>0.0/2.2>1.9/0.0>0.0,/2.2>1.9/0.0>0.0	COSV63966075	MTR|0.00|0.03|0.00|0.00|36|18|18|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236874861	236874861	T	C	het	wt	het		QUAL=24;DP=81,16,127;AF=0.47,0.00,0.51	MTR	splice_region&intron,intron	MTR:ENST00000366577.10:splice_region_variant&intron_variant:LOW:intron24/32:c.2594+15T>C::,MTR:ENST00000674797.2:splice_region_variant&intron_variant:LOW:intron23/31:c.2246+15T>C::,MTR:ENST00000535889.6:splice_region_variant&intron_variant:LOW:intron23/31:c.2441+15T>C::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron22/30:c.2406-5894T>C::,MTR:ENST00000681102.1:splice_region_variant&intron_variant:LOW:intron23/31:c.2414+15T>C::,MTR:ENST00000681177.1:splice_region_variant&intron_variant:LOW:intron21/29:c.2156+15T>C::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138288 [benign DISEASE=not provided,Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not specified GENE=MTR];			rs1770449	0.27533	0.08151,0.32270,0.18704,0.36859,0.27331	7105,	27690	110280	-0.1570	1.95			/0.0>0.0/0.0>0.0	COSV63964725	MTR|0.00|0.00|0.00|0.00|-30|-15|-15|-10	25741868,19493349,21254359,22496743,20180013,21743092,30911047,35802641,37296303,35495149	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236885262	236885262	G	A	het	hom	het		QUAL=24;DP=332,149,114;AF=0.55,1.00,0.49	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron26/32:c.2775+43G>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron25/31:c.2427+43G>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron25/31:c.2622+43G>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron24/30:c.2586+43G>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron25/31:c.2595+43G>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron23/29:c.2337+43G>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1258762 [benign DISEASE=not provided GENE=MTR];			rs2275566	0.71631	0.89381,0.67243,0.81439,0.63063,0.72585	40163,	28597	43139	-1.2850	0.07			/5.7>4.7/0.0>0.0		MTR|0.00|0.00|0.00|0.00|-43|-42|-39|-43	21146954	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236886153	236886153	C	T	het	het	wt		QUAL=24;DP=106,91,28;AF=0.47,0.56,0.00	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron26/32:c.2776-139C>T::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron25/31:c.2428-139C>T::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron25/31:c.2623-139C>T::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron24/30:c.2587-139C>T::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron25/31:c.2596-139C>T::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron23/29:c.2338-139C>T::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1187579 [likely benign DISEASE=not provided GENE=MTR];			rs41295948	0.01553	0.00436,0.02353,0.00000,0.02353,0.00228	21,	2324	149936	-0.6570	1.61			/0.0>0.0/0.0>0.0		MTR|0.00|0.00|0.00|0.00|30|-11|-16|24		44	1474	0	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236889492	236889492	T	A	het	hom	het		QUAL=24;DP=97,43,26;AF=0.52,1.00,0.46	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron28/32:c.3007+156T>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron27/31:c.2659+156T>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron27/31:c.2854+156T>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron26/30:c.2818+156T>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron27/31:c.2827+156T>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron25/29:c.2569+156T>A::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1278175 [benign DISEASE=not provided GENE=MTR];			rs3768150	0.69182	0.81073,0.66307,0.81569,0.62933,0.72437	37073,	31070	46870	-1.5090	0.04			/5.5>4.0/0.0>0.0		MTR|0.00|0.00|0.00|0.00|36|8|11|36	21274745,22941668,29763473	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236891269	236891269	A	G	het	hom	het		QUAL=24;DP=100,145,101;AF=0.54,1.00,0.50	MTR	synonymous	MTR:ENST00000366577.10:synonymous_variant:LOW:exon29/33:c.3144A>G:p.Ala1048=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000674797.2:synonymous_variant:LOW:exon28/32:c.2796A>G:p.Ala932=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000535889.6:synonymous_variant:LOW:exon28/32:c.2991A>G:p.Ala997=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000679842.1:synonymous_variant:LOW:exon27/31:c.2955A>G:p.Ala985=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681102.1:synonymous_variant:LOW:exon28/32:c.2964A>G:p.Ala988=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681177.1:synonymous_variant:LOW:exon26/30:c.2706A>G:p.Ala902=:PF02965 [Vitamin B12 dependent methionine synthase activation domain]		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138290 [benign DISEASE=not provided,Disorders of Intracellular Cobalamin Metabolism,Methylcobalamin deficiency type cblG,not specified GENE=MTR];			rs2229276	0.34722	0.19555,0.40179,0.44227,0.40655,0.30440	9997,	32798	99250	-1.1170	0.08			/4.4>3.2/0.0>0.0	COSV63966508	MTR|0.00|0.00|0.00|0.00|-29|2|48|-7	33195260,19493349,22496743,19683694,21960995,20718043,18842806,21597034,35334827,37296303	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236891499	236891499	A	G	het	hom	het		QUAL=24;DP=45,17,11;AF=0.42,1.00,0.36	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron29/32:c.3204+170A>G::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron28/31:c.2856+170A>G::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron28/31:c.3051+170A>G::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron27/30:c.3015+170A>G::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron28/31:c.3024+170A>G::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron26/29:c.2766+170A>G::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1235800 [benign DISEASE=not provided GENE=MTR];			rs2282369	0.67856	0.82454,0.63815,0.75970,0.60950,0.63928	35858,	31464	48878	-1.8070	0.13			/0.0>0.0/0.0>0.0		MTR|0.00|0.00|0.00|0.00|49|-44|-10|50	22941668,29763473,25950259	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236894308	236894308	G	A	het	hom	het		QUAL=24;DP=97,175,140;AF=0.51,1.00,0.50	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron29/32:c.3205-49G>A::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron28/31:c.2857-49G>A::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron28/31:c.3052-49G>A::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron27/30:c.3016-49G>A::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron28/31:c.3025-49G>A::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron26/29:c.2767-49G>A::	regulatory_region_variant:open_chromatin_region	156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1270532 [benign DISEASE=not provided GENE=MTR];			rs2297965	0.55967	0.45784,0.58534,0.55707,0.60216,0.60917	24204,	36550	66842	-0.5020	1.37			/0.0>0.0/0.0>0.0	COSV63966743	MTR|0.00|0.00|0.00|0.00|25|49|49|-16	22941668,29763473	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236895444	236895444	C	A	het	hom	het		QUAL=24;DP=216,310,223;AF=0.50,1.00,0.46	MTR	synonymous	MTR:ENST00000366577.10:synonymous_variant:LOW:exon31/33:c.3492C>A:p.Arg1164=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000674797.2:synonymous_variant:LOW:exon30/32:c.3144C>A:p.Arg1048=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000535889.6:synonymous_variant:LOW:exon30/32:c.3339C>A:p.Arg1113=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000679842.1:synonymous_variant:LOW:exon29/31:c.3303C>A:p.Arg1101=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681102.1:synonymous_variant:LOW:exon30/32:c.3312C>A:p.Arg1104=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681177.1:synonymous_variant:LOW:exon28/30:c.3054C>A:p.Arg1018=:PF02965 [Vitamin B12 dependent methionine synthase activation domain]		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138283 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism,Methylcobalamin deficiency type cblG,not specified,not provided GENE=MTR];			rs12070777	0.34886	0.20205,0.40456,0.43370,0.40678,0.29834	10037,	32979	99021	0.0910	2.06			/0.0>0.0/0.0>0.0	COSV63966512	MTR|0.00|0.00|0.00|0.00|-27|45|8|-29		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236895528	236895528	C	T	wt	het	het		QUAL=25;DP=101,182,168;AF=0.00,0.53,0.43	MTR	synonymous	MTR:ENST00000366577.10:synonymous_variant:LOW:exon31/33:c.3576C>T:p.Leu1192=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000674797.2:synonymous_variant:LOW:exon30/32:c.3228C>T:p.Leu1076=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000535889.6:synonymous_variant:LOW:exon30/32:c.3423C>T:p.Leu1141=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000679842.1:synonymous_variant:LOW:exon29/31:c.3387C>T:p.Leu1129=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681102.1:synonymous_variant:LOW:exon30/32:c.3396C>T:p.Leu1132=:PF02965 [Vitamin B12 dependent methionine synthase activation domain],MTR:ENST00000681177.1:synonymous_variant:LOW:exon28/30:c.3138C>T:p.Leu1046=:PF02965 [Vitamin B12 dependent methionine synthase activation domain]		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138284 [benign DISEASE=not provided,Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism,not specified GENE=MTR];			rs1131449	0.54442	0.45633,0.56104,0.55253,0.57840,0.60624	22919,	36904	69240	-3.3670	0.05			/0.0>0.0/0.0>0.0	COSV63964165	MTR|0.00|0.00|0.00|0.00|5|-39|5|22	19683694,20615890,21274745,21960995	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236895696	236895696	-	TATT	het	hom	het		QUAL=25;DP=108,16,13;AF=0.33,0.88,0.54	MTR	intron	MTR:ENST00000366577.10:intron_variant:MODIFIER:intron31/32:c.3598+147_3598+150dup::,MTR:ENST00000674797.2:intron_variant:MODIFIER:intron30/31:c.3250+147_3250+150dup::,MTR:ENST00000535889.6:intron_variant:MODIFIER:intron30/31:c.3445+147_3445+150dup::,MTR:ENST00000679842.1:intron_variant:MODIFIER:intron29/30:c.3409+147_3409+150dup::,MTR:ENST00000681102.1:intron_variant:MODIFIER:intron30/31:c.3418+147_3418+150dup::,MTR:ENST00000681177.1:intron_variant:MODIFIER:intron28/29:c.3160+147_3160+150dup::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	1239035 [benign DISEASE=not provided GENE=MTR];			rs75739277	0.71845	0.90941,0.66861,0.81514,0.62601,0.72656	40486,	28181	42775		1.74			/9.1>9.1/0.0>0.0		MTR|0.00|0.00|0.00|0.00|34|0|45|32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236897133	236897133	G	T	het	hom	het		QUAL=25;DP=205,245,200;AF=0.42,0.99,0.50	MTR	splice_region&intron	MTR:ENST00000366577.10:splice_region_variant&intron_variant:LOW:intron32/32:c.3711+15G>T::,MTR:ENST00000674797.2:splice_region_variant&intron_variant:LOW:intron31/31:c.3363+15G>T::,MTR:ENST00000535889.6:splice_region_variant&intron_variant:LOW:intron31/31:c.3558+15G>T::,MTR:ENST00000679842.1:splice_region_variant&intron_variant:LOW:intron30/30:c.3522+15G>T::,MTR:ENST00000681102.1:splice_region_variant&intron_variant:LOW:intron31/31:c.3531+15G>T::,MTR:ENST00000681177.1:splice_region_variant&intron_variant:LOW:intron29/29:c.3273+15G>T::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	138285 [benign DISEASE=not provided,not specified,Methylcobalamin deficiency type cblG,Disorders of Intracellular Cobalamin Metabolism GENE=MTR];			rs3820571	0.70804	0.87705,0.66237,0.81374,0.62521,0.72538	39187,	29296	44398	-0.2020	0.28			/0.0>0.0/0.0>0.0		MTR|0.00|0.00|0.00|0.00|-29|-15|-15|-4	19493349,37296303,23430981	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236897756	236897756	A	C	het	hom	het		QUAL=24;DP=129,154,80;AF=0.55,1.00,0.53	MTR	3'UTR,downstream_gene	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*112A>C::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*112A>C::,MTR:ENST00000535889.6:3_prime_UTR_variant:MODIFIER:exon32/32:c.*112A>C::,MTR:ENST00000679842.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681102.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681177.1:downstream_gene_variant:MODIFIER::::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296587 [benign DISEASE=not provided,Disorders of Intracellular Cobalamin Metabolism GENE=MTR];			rs2853522	0.56195	0.46380,0.58559,0.55819,0.60271,0.61524	24373,	36499	66451	-1.1490	2.90			/0.5>0.7/0.0>0.0		MTR|0.00|0.00|0.00|0.00|21|43|10|-22	22856873,30884202,33033524,36538104	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236898405	236898405	T	-	hom	hom	het		QUAL=24;DP=53,49,45;AF=0.62,0.90,0.64	MTR	3'UTR,downstream_gene	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*773del::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*773del::,MTR:ENST00000535889.6:downstream_gene_variant:MODIFIER::::,MTR:ENST00000679842.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681102.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681177.1:downstream_gene_variant:MODIFIER::::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296595 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism GENE=MTR];		AluY (SINE/Alu)	rs796166778	0.68117	0.84069,0.63825,0.80294,0.60296,0.70273	32770,	30222	44822	0.1060	0.29			/3.0>2.9/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236898549	236898549	G	A	het	wt	het		QUAL=25;DP=23,19,34;AF=0.26,0.00,0.59	MTR	3'UTR,downstream_gene	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*905G>A::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*905G>A::,MTR:ENST00000535889.6:downstream_gene_variant:MODIFIER::::,MTR:ENST00000679842.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681102.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681177.1:downstream_gene_variant:MODIFIER::::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296598 [benign DISEASE=not provided,Disorders of Intracellular Cobalamin Metabolism GENE=MTR];	CR1417889 [CLASS=DP MUT=ALT PHEN="Congenital heart disease association with" GENE=MTR];	AluY (SINE/Alu)	rs1131450	0.28409	0.13411,0.32065,0.18711,0.35883,0.25283	6952,	29084	108332	0.1710	3.72			/0.0>0.0/0.0>0.0			27808252,32819312,35201488,37422868	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236898898	236898898	A	C	het	hom	het		QUAL=24;DP=104,217,243;AF=0.59,1.00,0.47	MTR	3'UTR,downstream_gene	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1254A>C::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1254A>C::,MTR:ENST00000535889.6:downstream_gene_variant:MODIFIER::::,MTR:ENST00000679842.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681102.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681177.1:downstream_gene_variant:MODIFIER::::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296610 [benign DISEASE=not provided,Disorders of Intracellular Cobalamin Metabolism GENE=MTR];			rs2853523	0.71939	0.91089,0.66966,0.81282,0.62660,0.72697	40641,	28114	42672	-0.2280	6.99			/2.3>2.1/0.0>0.0			21146954,22856873,18381459,23940529,20871623,32791502,36538104	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236899005	236899005	A	G	het	hom	het		QUAL=24;DP=136,267,295;AF=0.52,0.99,0.52	MTR	3'UTR,downstream_gene	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*1361A>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*1361A>G::,MTR:ENST00000535889.6:downstream_gene_variant:MODIFIER::::,MTR:ENST00000679842.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681102.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681177.1:downstream_gene_variant:MODIFIER::::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296611 [benign DISEASE=not provided,Disorders of Intracellular Cobalamin Metabolism GENE=MTR];			rs1050993	0.71953	0.91086,0.66970,0.81330,0.62673,0.72692	40667,	28118	42664	-0.4520	0.71			/0.0>0.0/8.9>6.3			19493349,21254359,22496743,18381459,19064578,20180013,21743092,30911047,35802641,35677930,37296303,36554656,23430981,36538104,35495149	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236900035	236900035	G	C	het	hom	het		QUAL=24;DP=81,187,207;AF=0.47,0.99,0.53	MTR	3'UTR,downstream_gene	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2391G>C::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2391G>C::,MTR:ENST00000535889.6:downstream_gene_variant:MODIFIER::::,MTR:ENST00000679842.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681102.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681177.1:downstream_gene_variant:MODIFIER::::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296631 [benign DISEASE=not provided,Disorders of Intracellular Cobalamin Metabolism GENE=MTR];		L1ME3F (LINE/L1)	rs1050996	0.68882	0.80838,0.65686,0.81685,0.62530,0.72605	36752,	31263	47329	-0.1630	2.28			/3.4>3.9/0.0>0.0			22941668,29763473,36538104	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236900204	236900204	A	G	het	hom	het		QUAL=24;DP=122,122,108;AF=0.44,1.00,0.55	MTR	3'UTR,downstream_gene	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2560A>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2560A>G::,MTR:ENST00000535889.6:downstream_gene_variant:MODIFIER::::,MTR:ENST00000679842.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681102.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681177.1:downstream_gene_variant:MODIFIER::::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296633 [benign DISEASE=not provided,Disorders of Intracellular Cobalamin Metabolism GENE=MTR];		L1ME3F (LINE/L1)	rs9779	0.34581	0.20179,0.40257,0.43900,0.40428,0.29734	9845,	32878	99448	-1.1570	0.06			/0.7>0.6/0.0>0.0		MTR|0.00|0.00|0.00|0.00|-26|27|-43|-19		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236900409	236900409	-	A	het	hom	het		QUAL=24;DP=75,87,86;AF=0.37,0.92,0.48	MTR	3'UTR,downstream_gene	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2774dup::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2774dup::,MTR:ENST00000535889.6:downstream_gene_variant:MODIFIER::::,MTR:ENST00000679842.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681102.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681177.1:downstream_gene_variant:MODIFIER::::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296635 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism GENE=MTR];		L1ME3F (LINE/L1)	rs34686098	0.72614	0.74130,0.72365,0.63134,0.72159,0.75913	32793,	33336	37308		0.24			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236900418	236900419	AG	-	het	wt	het		QUAL=24;DP=77,50,97;AF=0.53,0.00,0.46	MTR	3'UTR,downstream_gene	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*2775_*2776del::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*2775_*2776del::,MTR:ENST00000535889.6:downstream_gene_variant:MODIFIER::::,MTR:ENST00000679842.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681102.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681177.1:downstream_gene_variant:MODIFIER::::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296637 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism GENE=MTR];		L1ME3F (LINE/L1)	rs1553332314	0.27934	0.08683,0.32968,0.18381,0.37273,0.27292	7187,	27960	109216	0.5750	0.53			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236901326	236901326	T	G	het	hom	het		QUAL=24;DP=129,328,313;AF=0.61,0.99,0.48	MTR	3'UTR,downstream_gene	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*3682T>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*3682T>G::,MTR:ENST00000535889.6:downstream_gene_variant:MODIFIER::::,MTR:ENST00000679842.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681102.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681177.1:downstream_gene_variant:MODIFIER::::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296655 [benign DISEASE=not provided,Disorders of Intracellular Cobalamin Metabolism GENE=MTR];			rs6676866	0.56282	0.46834,0.58602,0.55614,0.60240,0.60984	24402,	36552	66302	1.5210	4.82			/2.0>0.4/0.0>0.0		MTR|0.00|0.00|0.00|0.00|-36|-20|25|-20	21146954,19493349,18381459,21274745,37296303	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236902026	236902026	C	T	het	hom	het		QUAL=24;DP=62,92,87;AF=0.53,1.00,0.44	MTR	3'UTR,downstream_gene	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4382C>T::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4382C>T::,MTR:ENST00000535889.6:downstream_gene_variant:MODIFIER::::,MTR:ENST00000679842.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681102.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681177.1:downstream_gene_variant:MODIFIER::::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296668 [benign DISEASE=not provided,Disorders of Intracellular Cobalamin Metabolism GENE=MTR];			rs4659746	0.56841	0.48268,0.59175,0.55784,0.60335,0.60931	24930,	36518	65586	-0.6270	0.68			/0.0>0.0/3.4>0.3				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236902283	236902283	G	T	het	hom	het		QUAL=24;DP=79,156,139;AF=0.51,1.00,0.56	MTR	3'UTR,downstream_gene	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4639G>T::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4639G>T::,MTR:ENST00000535889.6:downstream_gene_variant:MODIFIER::::,MTR:ENST00000679842.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681102.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681177.1:downstream_gene_variant:MODIFIER::::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296673 [benign DISEASE=not provided,Disorders of Intracellular Cobalamin Metabolism GENE=MTR];			rs10925264	0.71921	0.91063,0.66938,0.81367,0.62648,0.72621	40542,	28074	42616	-0.3300	0.39			/1.3>6.8/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236902510	236902510	T	G	het	het	wt		QUAL=25;DP=59,160,48;AF=0.53,0.56,0.00	MTR	3'UTR,downstream_gene	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*4866T>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*4866T>G::,MTR:ENST00000535889.6:downstream_gene_variant:MODIFIER::::,MTR:ENST00000679842.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681102.1:downstream_gene_variant:MODIFIER::::,MTR:ENST00000681177.1:downstream_gene_variant:MODIFIER::::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296677 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism GENE=MTR];		L2c (LINE/L2)	rs45563435	0.01556	0.00438,0.02340,0.00000,0.02358,0.00228	21,	2328	149918	-0.3180	1.28			/2.0>1.5/0.0>1.1		MTR|0.00|0.00|0.00|0.00|-15|17|0|-3		21	892	0	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	236902814	236902814	A	G	het	wt	het		QUAL=24;DP=61,60,85;AF=0.48,0.00,0.59	MTR	3'UTR,downstream_gene	MTR:ENST00000366577.10:3_prime_UTR_variant:MODIFIER:exon33/33:c.*5170A>G::,MTR:ENST00000674797.2:3_prime_UTR_variant:MODIFIER:exon32/32:c.*5170A>G::,MTR:ENST00000535889.6:downstream_gene_variant:MODIFIER::::		156570_[GENE=MTR_PHENOS={Neural tube defects, folate-sensitive, susceptibility to}, 601634 (3), Autosomal recessive; Homocystinuria-megaloblastic anemia, cblG complementation type, 250940 (3), Autosomal recessive]	296679 [benign DISEASE=Disorders of Intracellular Cobalamin Metabolism GENE=MTR];			rs6680753	0.01967	0.00607,0.02131,0.00000,0.02730,0.00083	53,	2888	149216	0.5290	1.94			/3.3>0.1/0.0>3.9		MTR|0.00|0.00|0.00|0.00|1|-50|-5|-10		9	820	0	0 / 0					MTR (inh=AR oe_syn=1.05 oe_mis=0.78 oe_lof=0.46)
chr1	240775804	240775804	G	A	het	wt	hom		QUAL=24;DP=136,16,146;AF=0.47,0.00,0.99	RGS7,THAP12P8	intron,3'UTR,upstream_gene	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron16/16:c.1360-7526C>T::,RGS7:ENST00000440928.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*416C>T::,RGS7:ENST00000348120.6:3_prime_UTR_variant:MODIFIER:exon15/15:c.*416C>T::,RGS7:ENST00000366563.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:ENST00000366564.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*359C>T::,RGS7:ENST00000366565.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::,RGS7:ENST00000693043.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*416C>T::,RGS7:ENST00000691979.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*416C>T::,RGS7:ENST00000685936.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*416C>T::,RGS7:ENST00000688703.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*416C>T::,RGS7:ENST00000689640.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*416C>T::,RGS7:ENST00000690614.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*416C>T::,RGS7:ENST00000687448.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*359C>T::,RGS7:ENST00000689602.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::,RGS7:ENST00000691485.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::,RGS7:ENST00000692410.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::,RGS7:ENST00000690019.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*359C>T::,RGS7:ENST00000688633.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*359C>T::,RGS7:ENST00000689115.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*416C>T::,RGS7:ENST00000691989.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*416C>T::,RGS7:ENST00000686465.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*359C>T::,RGS7:ENST00000686908.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*359C>T::,RGS7:ENST00000688737.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*359C>T::,RGS7:ENST00000688863.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*359C>T::,THAP12P8:ENST00000447914.2:upstream_gene_variant:MODIFIER::::						rs35557904	0.17245	0.33098,0.09772,0.12980,0.12022,0.10195	3037,	20137	125783	0.6560	15.04			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240775852	240775852	A	G	het	wt	hom		QUAL=24;DP=136,16,181;AF=0.48,0.00,0.99	RGS7,THAP12P8	intron,3'UTR,upstream_gene	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron16/16:c.1360-7574T>C::,RGS7:ENST00000440928.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*368T>C::,RGS7:ENST00000348120.6:3_prime_UTR_variant:MODIFIER:exon15/15:c.*368T>C::,RGS7:ENST00000366563.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:ENST00000366564.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*311T>C::,RGS7:ENST00000366565.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::,RGS7:ENST00000693043.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*368T>C::,RGS7:ENST00000691979.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*368T>C::,RGS7:ENST00000685936.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*368T>C::,RGS7:ENST00000688703.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*368T>C::,RGS7:ENST00000689640.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*368T>C::,RGS7:ENST00000690614.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*368T>C::,RGS7:ENST00000687448.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*311T>C::,RGS7:ENST00000689602.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::,RGS7:ENST00000691485.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::,RGS7:ENST00000692410.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::,RGS7:ENST00000690019.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*311T>C::,RGS7:ENST00000688633.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*311T>C::,RGS7:ENST00000689115.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*368T>C::,RGS7:ENST00000691989.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*368T>C::,RGS7:ENST00000686465.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*311T>C::,RGS7:ENST00000686908.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*311T>C::,RGS7:ENST00000688737.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*311T>C::,RGS7:ENST00000688863.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*311T>C::,THAP12P8:ENST00000447914.2:upstream_gene_variant:MODIFIER::::						rs16840577	0.17223	0.33060,0.09774,0.12989,0.12011,0.10183	3037,	20130	125942	2.4410	16.08			/0.0>0.1/0.0>0.0		RGS7|0.01|0.00|0.00|0.00|6|-46|6|2		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240776091	240776091	C	T	het	wt	het		QUAL=24;DP=195,16,550;AF=0.41,0.00,0.47	RGS7,THAP12P8	intron,3'UTR,upstream_gene	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron16/16:c.1360-7813G>A::,RGS7:ENST00000440928.6:3_prime_UTR_variant:MODIFIER:exon19/19:c.*129G>A::,RGS7:ENST00000348120.6:3_prime_UTR_variant:MODIFIER:exon15/15:c.*129G>A::,RGS7:ENST00000366563.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:ENST00000366564.5:3_prime_UTR_variant:MODIFIER:exon17/17:c.*72G>A::,RGS7:ENST00000366565.5:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::,RGS7:ENST00000693043.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*129G>A::,RGS7:ENST00000691979.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*129G>A::,RGS7:ENST00000685936.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*129G>A::,RGS7:ENST00000688703.1:3_prime_UTR_variant:MODIFIER:exon19/19:c.*129G>A::,RGS7:ENST00000689640.1:3_prime_UTR_variant:MODIFIER:exon14/14:c.*129G>A::,RGS7:ENST00000690614.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*129G>A::,RGS7:ENST00000687448.1:3_prime_UTR_variant:MODIFIER:exon20/20:c.*72G>A::,RGS7:ENST00000689602.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::,RGS7:ENST00000691485.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::,RGS7:ENST00000692410.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::,RGS7:ENST00000690019.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*72G>A::,RGS7:ENST00000688633.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*72G>A::,RGS7:ENST00000689115.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*129G>A::,RGS7:ENST00000691989.1:3_prime_UTR_variant:MODIFIER:exon17/17:c.*129G>A::,RGS7:ENST00000686465.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*72G>A::,RGS7:ENST00000686908.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*72G>A::,RGS7:ENST00000688737.1:3_prime_UTR_variant:MODIFIER:exon16/16:c.*72G>A::,RGS7:ENST00000688863.1:3_prime_UTR_variant:MODIFIER:exon18/18:c.*72G>A::,THAP12P8:ENST00000447914.2:upstream_gene_variant:MODIFIER::::						rs12757054	0.06096	0.03904,0.04578,0.02439,0.08227,0.08385	354,	8571	142929	1.5850	14.25			/0.0>1.4/0.0>0.0	COSV58544216		21698121	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240776374	240776374	T	C	het	wt	hom		QUAL=24;DP=85,22,32;AF=0.38,0.00,0.97	RGS7,THAP12P8	intron,upstream_gene	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron16/16:c.1360-8096A>G::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron18/18:c.*7-161A>G::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron14/14:c.*7-161A>G::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron17/17:c.*7-161A>G::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron16/16:c.1360-161A>G::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron17/17:c.1414-161A>G::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron15/15:c.*7-161A>G::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron17/17:c.*7-161A>G::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron19/19:c.*7-161A>G::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron18/18:c.*7-161A>G::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron13/13:c.*7-161A>G::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron19/19:c.*7-161A>G::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron19/19:c.1282-161A>G::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron17/17:c.1282-161A>G::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron17/17:c.1282-161A>G::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron17/17:c.1282-161A>G::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron15/15:c.1309-161A>G::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron16/16:c.1432-161A>G::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron16/16:c.*7-161A>G::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron16/16:c.*7-161A>G::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron15/15:c.1156-161A>G::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron15/15:c.1357-161A>G::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron15/15:c.1240-161A>G::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron17/17:c.1414-161A>G::,THAP12P8:ENST00000447914.2:upstream_gene_variant:MODIFIER::::					(CCTC)n (Simple_repeat)	rs3795681	0.16303	0.31475,0.09035,0.11856,0.11736,0.09388	2676,	18855	124271	0.4360	7.80			/0.0>0.0/2.5>1.9	COSV58530577	RGS7|0.00|0.00|0.00|0.00|-43|-6|-43|-6		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20), THAP12P8 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chr1	240811913	240811913	T	C	het	hom	wt		QUAL=24;DP=255,236,16;AF=0.54,1.00,0.00	RGS7	splice_region&intron,intron	RGS7:ENST00000690539.1:splice_region_variant&intron_variant:LOW:intron14/16:c.1082+5A>G::,RGS7:ENST00000440928.6:splice_region_variant&intron_variant:LOW:intron14/18:c.1082+5A>G::,RGS7:ENST00000348120.6:splice_region_variant&intron_variant:LOW:intron11/14:c.923+5A>G::,RGS7:ENST00000366563.5:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::,RGS7:ENST00000366564.5:splice_region_variant&intron_variant:LOW:intron14/16:c.1082+5A>G::,RGS7:ENST00000366565.5:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::,RGS7:ENST00000693043.1:splice_region_variant&intron_variant:LOW:intron12/15:c.923+5A>G::,RGS7:ENST00000691979.1:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::,RGS7:ENST00000685936.1:splice_region_variant&intron_variant:LOW:intron16/19:c.1004+5A>G::,RGS7:ENST00000688703.1:splice_region_variant&intron_variant:LOW:intron15/18:c.1004+5A>G::,RGS7:ENST00000689640.1:splice_region_variant&intron_variant:LOW:intron10/13:c.806+5A>G::,RGS7:ENST00000690614.1:splice_region_variant&intron_variant:LOW:intron16/19:c.1004+5A>G::,RGS7:ENST00000687448.1:splice_region_variant&intron_variant:LOW:intron17/19:c.1004+5A>G::,RGS7:ENST00000689602.1:splice_region_variant&intron_variant:LOW:intron15/17:c.1004+5A>G::,RGS7:ENST00000691485.1:splice_region_variant&intron_variant:LOW:intron15/17:c.1004+5A>G::,RGS7:ENST00000692410.1:splice_region_variant&intron_variant:LOW:intron15/17:c.1004+5A>G::,RGS7:ENST00000690019.1:splice_region_variant&intron_variant:LOW:intron13/15:c.1031+5A>G::,RGS7:ENST00000688633.1:splice_region_variant&intron_variant:LOW:intron14/16:c.1154+5A>G::,RGS7:ENST00000689115.1:splice_region_variant&intron_variant:LOW:intron12/16:c.923+5A>G::,RGS7:ENST00000691989.1:splice_region_variant&intron_variant:LOW:intron13/16:c.971+5A>G::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron13/15:c.878+1705A>G::,RGS7:ENST00000686908.1:splice_region_variant&intron_variant:LOW:intron13/15:c.1079+5A>G::,RGS7:ENST00000688737.1:splice_region_variant&intron_variant:LOW:intron13/15:c.962+5A>G::,RGS7:ENST00000688863.1:splice_region_variant&intron_variant:LOW:intron14/17:c.1082+5A>G::						rs2275742	0.46985	0.25976,0.42946,0.46287,0.57945,0.43231	18439,	34524	80566	0.2170	16.16			8.4>10.6/0.0>0.0/8.4>10.6,/0.0>0.0/8.4>10.6	COSV58534718	RGS7|0.00|0.00|0.00|0.00|32|5|5|32		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240812135	240812135	C	T	het	hom	wt		QUAL=24;DP=172,94,16;AF=0.47,1.00,0.00	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron13/16:c.957-92G>A::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron13/18:c.957-92G>A::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron10/14:c.798-92G>A::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron13/17:c.957-92G>A::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron13/16:c.957-92G>A::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron13/17:c.957-92G>A::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron11/15:c.798-92G>A::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron13/17:c.957-92G>A::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron15/19:c.879-92G>A::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron14/18:c.879-92G>A::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron9/13:c.681-92G>A::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron15/19:c.879-92G>A::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron16/19:c.879-92G>A::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron14/17:c.879-92G>A::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron14/17:c.879-92G>A::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron14/17:c.879-92G>A::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron12/15:c.906-92G>A::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron13/16:c.1029-92G>A::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron11/16:c.798-92G>A::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron12/16:c.846-92G>A::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron13/15:c.878+1483G>A::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron12/15:c.954-92G>A::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron12/15:c.837-92G>A::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron13/17:c.957-92G>A::						rs2275744	0.46987	0.25967,0.42968,0.46339,0.57958,0.43332	18451,	34511	80571	0.1520	8.18			/0.0>0.0/0.0>0.0	COSV58543544	RGS7|0.00|0.00|0.00|0.00|18|22|-2|18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240814664	240814664	G	T	hom	hom	het		QUAL=25;DP=168,108,64;AF=0.99,1.00,0.44	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron12/16:c.845+52C>A::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron12/18:c.845+52C>A::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron9/14:c.686+52C>A::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron12/17:c.845+52C>A::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron12/16:c.845+52C>A::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron12/17:c.845+52C>A::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron10/15:c.686+52C>A::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron12/17:c.845+52C>A::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron14/19:c.767+52C>A::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron13/18:c.767+52C>A::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron8/13:c.569+52C>A::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron14/19:c.767+52C>A::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron15/19:c.767+52C>A::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron13/17:c.767+52C>A::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron13/17:c.767+52C>A::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron13/17:c.767+52C>A::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron11/15:c.794+52C>A::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron12/16:c.917+52C>A::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron10/16:c.686+52C>A::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron12/16:c.845+52C>A::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron12/15:c.767+52C>A::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron11/15:c.842+52C>A::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron11/15:c.725+52C>A::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron12/17:c.845+52C>A::						rs12744536	0.61024	0.40578,0.58528,0.47915,0.72893,0.58420	29915,	32971	59273	-1.0950	0.05			/0.0>0.0/0.0>0.0	COSV58534726	RGS7|0.00|0.00|0.00|0.00|-48|-20|48|36		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240816503	240816503	G	A	hom	hom	hom		QUAL=24;DP=180,56,39;AF=1.00,1.00,1.00	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron10/16:c.685-88C>T::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron10/18:c.685-88C>T::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron7/14:c.526-88C>T::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron10/17:c.685-88C>T::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron10/16:c.685-88C>T::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron10/17:c.685-88C>T::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron8/15:c.526-88C>T::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron10/17:c.685-88C>T::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron12/19:c.607-88C>T::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron11/18:c.607-88C>T::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron6/13:c.409-88C>T::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron12/19:c.607-88C>T::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron13/19:c.607-88C>T::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron11/17:c.607-88C>T::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron11/17:c.607-88C>T::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron11/17:c.607-88C>T::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron9/15:c.634-88C>T::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron10/16:c.757-88C>T::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron8/16:c.526-88C>T::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron10/16:c.685-88C>T::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron10/15:c.607-88C>T::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron9/15:c.682-88C>T::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron10/15:c.685-1747C>T::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron10/17:c.685-88C>T::						rs3738068	0.75704	0.79830,0.65550,0.58895,0.77590,0.63702	43929,	27334	36970	-2.2010	0.00			/4.2>3.8/0.0>0.0	COSV58537200			n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240816570	240816570	A	T	het	wt	hom		QUAL=25;DP=54,14,11;AF=0.44,0.00,1.00	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron10/16:c.685-155T>A::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron10/18:c.685-155T>A::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron7/14:c.526-155T>A::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron10/17:c.685-155T>A::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron10/16:c.685-155T>A::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron10/17:c.685-155T>A::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron8/15:c.526-155T>A::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron10/17:c.685-155T>A::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron12/19:c.607-155T>A::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron11/18:c.607-155T>A::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron6/13:c.409-155T>A::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron12/19:c.607-155T>A::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron13/19:c.607-155T>A::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron11/17:c.607-155T>A::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron11/17:c.607-155T>A::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron11/17:c.607-155T>A::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron9/15:c.634-155T>A::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron10/16:c.757-155T>A::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron8/16:c.526-155T>A::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron10/16:c.685-155T>A::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron10/15:c.607-155T>A::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron9/15:c.682-155T>A::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron10/15:c.685-1814T>A::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron10/17:c.685-155T>A::						rs3738069	0.21094	0.27669,0.19770,0.11975,0.19582,0.17702	3600,	24903	120085	0.9480	4.57			/5.0>4.4/0.0>0.0		RGS7|0.00|0.00|0.00|0.00|-35|-11|-38|-46		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240936822	240936822	G	T	hom	hom	het		QUAL=24;DP=39,10,8;AF=0.97,1.00,0.75	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron4/16:c.227-116C>A::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron4/18:c.227-116C>A::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron3/14:c.226+46257C>A::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron4/17:c.227-116C>A::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron4/16:c.227-116C>A::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron4/17:c.227-116C>A::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron4/15:c.226+46257C>A::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron4/17:c.227-116C>A::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron6/19:c.149-116C>A::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron5/18:c.149-116C>A::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron4/13:c.227-116C>A::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron6/19:c.149-116C>A::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron7/19:c.149-116C>A::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron5/17:c.149-116C>A::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron5/17:c.149-116C>A::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron5/17:c.149-116C>A::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron3/15:c.176-116C>A::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron4/16:c.227-116C>A::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron4/16:c.226+46257C>A::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron4/16:c.227-116C>A::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron4/15:c.149-116C>A::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron4/15:c.227-116C>A::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron4/15:c.227-116C>A::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron4/17:c.227-116C>A::					LTR10B1 (LTR/ERV1)	rs261857	0.39363	0.28230,0.45905,0.25523,0.43525,0.37542	12290,	35292	92232	-1.4410	12.61			/0.0>0.0/0.0>0.0	COSV58539328	RGS7|0.00|0.00|0.00|0.00|0|-33|3|-18		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	240983022	240983022	A	G	het	het	wt		QUAL=24;DP=215,82,16;AF=0.52,0.54,0.00	RGS7	intron	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron4/18:c.226+57T>C::,RGS7:ENST00000348120.6:intron_variant:MODIFIER:intron3/14:c.226+57T>C::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron4/17:c.226+57T>C::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron4/17:c.226+57T>C::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron4/15:c.226+57T>C::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron4/17:c.226+57T>C::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron6/19:c.148+57T>C::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron5/18:c.148+57T>C::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron4/13:c.226+57T>C::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron6/19:c.148+57T>C::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron7/19:c.148+57T>C::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron5/17:c.148+57T>C::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron5/17:c.148+57T>C::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron5/17:c.148+57T>C::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron3/15:c.176-46316T>C::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron4/16:c.226+57T>C::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron4/15:c.148+57T>C::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron4/15:c.226+57T>C::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron4/15:c.226+57T>C::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron4/17:c.226+57T>C::						rs7520707	0.37099	0.31954,0.40818,0.28848,0.39688,0.39490	10708,	35000	95654	0.7580	1.73			/4.3>3.2/0.0>0.0		RGS7|0.00|0.00|0.00|0.00|15|-35|49|29		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241355798	241355798	T	A	hom	hom	hom		QUAL=24;DP=421,423,288;AF=1.00,1.00,1.00	RGS7	5'UTR,upstream_gene	RGS7:ENST00000690539.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:ENST00000440928.6:5_prime_UTR_variant:MODIFIER:exon2/19:c.-22A>T::,RGS7:ENST00000366563.5:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:ENST00000366564.5:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:ENST00000366565.5:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:ENST00000693043.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-22A>T::,RGS7:ENST00000691979.1:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:ENST00000685936.1:5_prime_UTR_variant:MODIFIER:exon2/20:c.-288A>T::,RGS7:ENST00000688703.1:5_prime_UTR_variant:MODIFIER:exon2/19:c.-218A>T::,RGS7:ENST00000689640.1:5_prime_UTR_variant:MODIFIER:exon2/14:c.-22A>T::,RGS7:ENST00000690614.1:5_prime_UTR_variant:MODIFIER:exon2/20:c.-562A>T::,RGS7:ENST00000687448.1:5_prime_UTR_variant:MODIFIER:exon2/20:c.-393A>T::,RGS7:ENST00000689602.1:5_prime_UTR_variant:MODIFIER:exon2/18:c.-216A>T::,RGS7:ENST00000691485.1:5_prime_UTR_variant:MODIFIER:exon2/18:c.-444A>T::,RGS7:ENST00000692410.1:5_prime_UTR_variant:MODIFIER:exon2/18:c.-204A>T::,RGS7:ENST00000690019.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-22A>T::,RGS7:ENST00000688633.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:ENST00000689115.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:ENST00000691989.1:5_prime_UTR_variant:MODIFIER:exon2/17:c.-22A>T::,RGS7:ENST00000686465.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-100A>T::,RGS7:ENST00000686908.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-22A>T::,RGS7:ENST00000688737.1:5_prime_UTR_variant:MODIFIER:exon2/16:c.-22A>T::,RGS7:ENST00000688863.1:5_prime_UTR_variant:MODIFIER:exon2/18:c.-22A>T::,RGS7:ENST00000348120.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter					rs4659599	0.95542	0.87476,0.98045,0.99671,0.98743,0.98775	69661,	6104	6786	1.4650	10.77			/0.0>0.0/0.0>0.4				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241356017	241356017	A	G	het	hom	het		QUAL=24;DP=126,57,28;AF=0.46,1.00,0.39	RGS7	intron,upstream_gene	RGS7:ENST00000690539.1:intron_variant:MODIFIER:intron1/16:c.-50-191T>C::,RGS7:ENST00000440928.6:intron_variant:MODIFIER:intron1/18:c.-50-191T>C::,RGS7:ENST00000366563.5:intron_variant:MODIFIER:intron1/17:c.-50-191T>C::,RGS7:ENST00000366564.5:intron_variant:MODIFIER:intron1/16:c.-50-191T>C::,RGS7:ENST00000366565.5:intron_variant:MODIFIER:intron1/17:c.-50-191T>C::,RGS7:ENST00000693043.1:intron_variant:MODIFIER:intron1/15:c.-50-191T>C::,RGS7:ENST00000691979.1:intron_variant:MODIFIER:intron1/17:c.-160-81T>C::,RGS7:ENST00000685936.1:intron_variant:MODIFIER:intron1/19:c.-316-191T>C::,RGS7:ENST00000688703.1:intron_variant:MODIFIER:intron1/18:c.-246-191T>C::,RGS7:ENST00000689640.1:intron_variant:MODIFIER:intron1/13:c.-50-191T>C::,RGS7:ENST00000690614.1:intron_variant:MODIFIER:intron1/19:c.-590-191T>C::,RGS7:ENST00000687448.1:intron_variant:MODIFIER:intron1/19:c.-421-191T>C::,RGS7:ENST00000689602.1:intron_variant:MODIFIER:intron1/17:c.-244-191T>C::,RGS7:ENST00000691485.1:intron_variant:MODIFIER:intron1/17:c.-472-191T>C::,RGS7:ENST00000692410.1:intron_variant:MODIFIER:intron1/17:c.-232-191T>C::,RGS7:ENST00000690019.1:intron_variant:MODIFIER:intron1/15:c.-50-191T>C::,RGS7:ENST00000688633.1:intron_variant:MODIFIER:intron1/16:c.-50-191T>C::,RGS7:ENST00000689115.1:intron_variant:MODIFIER:intron1/16:c.-50-191T>C::,RGS7:ENST00000691989.1:intron_variant:MODIFIER:intron1/16:c.-50-191T>C::,RGS7:ENST00000686465.1:intron_variant:MODIFIER:intron1/15:c.-128-191T>C::,RGS7:ENST00000686908.1:intron_variant:MODIFIER:intron1/15:c.-50-191T>C::,RGS7:ENST00000688737.1:intron_variant:MODIFIER:intron1/15:c.-50-191T>C::,RGS7:ENST00000688863.1:intron_variant:MODIFIER:intron1/17:c.-50-191T>C::,RGS7:ENST00000348120.6:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter					rs6677041	0.84360	0.76488,0.82121,0.93603,0.88714,0.77812	54458,	19481	23805	0.9460	5.08			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241356888	241356888	T	C	n/a	hom	hom		QUAL=24;DP=0,16,17;AF=,1.00,1.00	RGS7	splice_region&intron,upstream_gene	RGS7:ENST00000690539.1:splice_region_variant&intron_variant:LOW:intron1/16:c.-51+11A>G::,RGS7:ENST00000440928.6:splice_region_variant&intron_variant:LOW:intron1/18:c.-51+11A>G::,RGS7:ENST00000366563.5:splice_region_variant&intron_variant:LOW:intron1/17:c.-51+11A>G::,RGS7:ENST00000366564.5:splice_region_variant&intron_variant:LOW:intron1/16:c.-51+11A>G::,RGS7:ENST00000366565.5:splice_region_variant&intron_variant:LOW:intron1/17:c.-51+11A>G::,RGS7:ENST00000691979.1:splice_region_variant&intron_variant:LOW:intron1/17:c.-161+11A>G::,RGS7:ENST00000685936.1:splice_region_variant&intron_variant:LOW:intron1/19:c.-317+11A>G::,RGS7:ENST00000688703.1:splice_region_variant&intron_variant:LOW:intron1/18:c.-247+11A>G::,RGS7:ENST00000689640.1:splice_region_variant&intron_variant:LOW:intron1/13:c.-51+11A>G::,RGS7:ENST00000690614.1:splice_region_variant&intron_variant:LOW:intron1/19:c.-591+11A>G::,RGS7:ENST00000687448.1:splice_region_variant&intron_variant:LOW:intron1/19:c.-422+11A>G::,RGS7:ENST00000689602.1:splice_region_variant&intron_variant:LOW:intron1/17:c.-245+11A>G::,RGS7:ENST00000691485.1:splice_region_variant&intron_variant:LOW:intron1/17:c.-473+11A>G::,RGS7:ENST00000692410.1:splice_region_variant&intron_variant:LOW:intron1/17:c.-233+11A>G::,RGS7:ENST00000690019.1:splice_region_variant&intron_variant:LOW:intron1/15:c.-51+11A>G::,RGS7:ENST00000688633.1:splice_region_variant&intron_variant:LOW:intron1/16:c.-51+11A>G::,RGS7:ENST00000689115.1:splice_region_variant&intron_variant:LOW:intron1/16:c.-51+11A>G::,RGS7:ENST00000691989.1:splice_region_variant&intron_variant:LOW:intron1/16:c.-51+11A>G::,RGS7:ENST00000686465.1:splice_region_variant&intron_variant:LOW:intron1/15:c.-129+11A>G::,RGS7:ENST00000686908.1:splice_region_variant&intron_variant:LOW:intron1/15:c.-51+11A>G::,RGS7:ENST00000688737.1:splice_region_variant&intron_variant:LOW:intron1/15:c.-51+11A>G::,RGS7:ENST00000688863.1:splice_region_variant&intron_variant:LOW:intron1/17:c.-51+11A>G::,RGS7:ENST00000348120.6:upstream_gene_variant:MODIFIER::::,RGS7:ENST00000693043.1:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter					rs1891130	0.95563	0.87564,0.98059,0.99681,0.98745,0.98776	69365,	6051	6723	-0.1090	15.46			/0.0>0.0/1.7>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					RGS7 (inh=n/a oe_syn=1.00 oe_mis=0.58 oe_lof=0.20)
chr1	241503933	241503933	C	T	het	het	hom		QUAL=24;DP=119,141,114;AF=0.49,0.49,1.00	FH	intron	FH:ENST00000366560.4:intron_variant:MODIFIER:intron7/9:c.1108+109G>A::,FH:ENST00000683521.1:intron_variant:MODIFIER:intron7/8:c.1108+109G>A::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	1270362 [benign DISEASE=not provided GENE=FH];			rs4660099	0.27375	0.10154,0.24948,0.20919,0.37203,0.23268	6756,	28162	110560	-1.7330	0.38			/0.0>0.3/0.0>0.0	COSV63818865	FH|0.00|0.00|0.00|0.00|-5|19|-36|-50		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241503944	241503944	G	T	het	het	hom		QUAL=24;DP=116,158,119;AF=0.48,0.48,1.00	FH	intron	FH:ENST00000366560.4:intron_variant:MODIFIER:intron7/9:c.1108+98C>A::,FH:ENST00000683521.1:intron_variant:MODIFIER:intron7/8:c.1108+98C>A::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	1264123 [benign DISEASE=not provided GENE=FH];			rs4659607	0.73734	0.78244,0.68860,0.56465,0.72474,0.84770	41542,	29177	39991	-0.6400	0.47			/4.6>0.4/0.0>0.0	COSV63818713	FH|0.01|0.00|0.00|0.00|8|-3|8|-3		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241511819	241511819	G	C	het	het	hom		QUAL=25;DP=80,14,14;AF=0.45,0.36,1.00	FH	intron	FH:ENST00000366560.4:intron_variant:MODIFIER:intron4/9:c.555+148C>G::,FH:ENST00000683521.1:intron_variant:MODIFIER:intron4/8:c.555+148C>G::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	1291013 [benign DISEASE=not provided GENE=FH];			rs6673988	0.33572	0.31401,0.26797,0.21056,0.37421,0.23464	8702,	33611	100943	0.4080	9.40			/0.0>0.0/0.0>1.6	COSV63819132	FH|0.00|0.00|0.00|0.00|31|4|1|-10		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	241513458	241513458	C	T	het	het	hom		QUAL=24;DP=173,91,66;AF=0.60,0.46,1.00	FH	intron	FH:ENST00000366560.4:intron_variant:MODIFIER:intron3/9:c.378+145G>A::,FH:ENST00000683521.1:intron_variant:MODIFIER:intron3/8:c.378+145G>A::		136850_[GENE=FH_PHENOS=Leiomyomatosis and renal cell cancer, 150800 (3), Autosomal dominant; Fumarase deficiency, 606812 (3), Autosomal recessive]	1181498 [benign DISEASE=not provided GENE=FH];			rs10926500	0.39964	0.43732,0.32988,0.35155,0.40027,0.32738	12199,	36309	91199	-0.0780	4.27			/0.0>0.0/0.0>0.0		FH|0.00|0.00|0.00|0.00|27|36|22|-13		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					FH (inh=AR+AD oe_syn=1.04 oe_mis=0.79 oe_lof=0.28)
chr1	247417907	247417907	T	C	het	het	het		QUAL=24;DP=38,46,68;AF=0.47,0.52,0.46	NLRP3	intron,upstream_gene	NLRP3:ENST00000697408.2:intron_variant:MODIFIER:intron3/11:c.-106-322T>C::,NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron1/10:c.-106-322T>C::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron1/8:c.-748-146T>C::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron1/9:c.-748-146T>C::,NLRP3:ENST00000348069.7:upstream_gene_variant:MODIFIER::::,NLRP3:ENST00000366496.7:upstream_gene_variant:MODIFIER::::,NLRP3:ENST00000697350.1:upstream_gene_variant:MODIFIER::::,NLRP3:ENST00000474792.2:upstream_gene_variant:MODIFIER::::,NLRP3:ENST00000643234.2:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs12137901	0.25831	0.33550,0.26590,0.29780,0.21748,0.20286	5345,	28607	112837	-0.9840	2.07			/1.0>0.6/0.0>0.0			35428826,33015616,33922655,37051231,36189256,36673016,26662437,26782387,26722603	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247418258	247418258	A	T	het	het	wt		QUAL=24;DP=164,403,68;AF=0.48,0.52,0.00	NLRP3	5'UTR,upstream_gene	NLRP3:ENST00000697408.2:5_prime_UTR_variant:MODIFIER:exon4/12:c.-77A>T::,NLRP3:ENST00000391828.8:5_prime_UTR_variant:MODIFIER:exon2/11:c.-77A>T::,NLRP3:ENST00000391827.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-543A>T::,NLRP3:ENST00000336119.8:5_prime_UTR_variant:MODIFIER:exon2/10:c.-543A>T::,NLRP3:ENST00000348069.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-543A>T::,NLRP3:ENST00000366496.7:5_prime_UTR_variant:MODIFIER:exon1/8:c.-543A>T::,NLRP3:ENST00000697350.1:5_prime_UTR_variant:MODIFIER:exon1/10:c.-77A>T::,NLRP3:ENST00000474792.2:upstream_gene_variant:MODIFIER::::,NLRP3:ENST00000643234.2:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296927 [benign DISEASE=Familial cold autoinflammatory syndrome 1,Chronic infantile neurological, cutaneous and articular syndrome,Familial amyloid nephropathy with urticaria AND deafness GENE=NLRP3];			rs116502550	0.00685	0.00068,0.00138,0.00000,0.00847,0.00084	13,	1009	150007	0.2370	6.05			/0.0>0.0/0.0>0.0		NLRP3|0.00|0.00|0.00|0.00|-29|-5|32|-29		4	425	0	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247418390	247418390	T	C	hom	hom	hom		QUAL=24;DP=87,146,161;AF=1.00,1.00,1.00	NLRP3	intron,5'UTR,upstream_gene	NLRP3:ENST00000697408.2:intron_variant:MODIFIER:intron4/11:c.-45+100T>C::,NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron2/10:c.-45+100T>C::,NLRP3:ENST00000391827.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-411T>C::,NLRP3:ENST00000336119.8:5_prime_UTR_variant:MODIFIER:exon2/10:c.-411T>C::,NLRP3:ENST00000348069.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-411T>C::,NLRP3:ENST00000366496.7:5_prime_UTR_variant:MODIFIER:exon1/8:c.-411T>C::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron1/9:c.-45+100T>C::,NLRP3:ENST00000474792.2:upstream_gene_variant:MODIFIER::::,NLRP3:ENST00000643234.2:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296931 [benign DISEASE=Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome,Familial cold autoinflammatory syndrome 1,not provided GENE=NLRP3];		AluSx1 (SINE/Alu)	rs7523422	0.99784	0.99253,0.99909,1.00000,0.99996,1.00000	75768,	319	329	-2.9180	2.12			/0.0>0.0/0.0>0.0			37521845	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247418570	247418570	G	A	het	het	het		QUAL=24;DP=72,70,68;AF=0.64,0.46,0.56	NLRP3	intron,5'UTR,upstream_gene	NLRP3:ENST00000697408.2:intron_variant:MODIFIER:intron4/11:c.-44-187G>A::,NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron2/10:c.-44-187G>A::,NLRP3:ENST00000391827.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-231G>A::,NLRP3:ENST00000336119.8:5_prime_UTR_variant:MODIFIER:exon2/10:c.-231G>A::,NLRP3:ENST00000348069.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-231G>A::,NLRP3:ENST00000366496.7:5_prime_UTR_variant:MODIFIER:exon1/8:c.-231G>A::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron1/9:c.-44-187G>A::,NLRP3:ENST00000474792.2:upstream_gene_variant:MODIFIER::::,NLRP3:ENST00000643234.2:upstream_gene_variant:MODIFIER::::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296932 [benign DISEASE=Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome,Familial cold autoinflammatory syndrome 1,not provided GENE=NLRP3];		AluSx1 (SINE/Alu)	rs138900557	0.03464	0.00712,0.01725,0.00135,0.05135,0.02175	139,	4997	147009	0.3990	3.73			/0.0>0.0/0.0>0.0		NLRP3|0.00|0.00|0.00|0.00|21|-37|-33|21		5	129	0	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247418761	247418761	G	T	het	het	het		QUAL=24;DP=101,254,231;AF=0.50,0.51,0.41	NLRP3	5'UTR	NLRP3:ENST00000697408.2:5_prime_UTR_variant:MODIFIER:exon5/12:c.-40G>T::,NLRP3:ENST00000391828.8:5_prime_UTR_variant:MODIFIER:exon3/11:c.-40G>T::,NLRP3:ENST00000391827.3:5_prime_UTR_variant:MODIFIER:exon2/9:c.-40G>T::,NLRP3:ENST00000336119.8:5_prime_UTR_variant:MODIFIER:exon2/10:c.-40G>T::,NLRP3:ENST00000348069.7:5_prime_UTR_variant:MODIFIER:exon1/7:c.-40G>T::,NLRP3:ENST00000366496.7:5_prime_UTR_variant:MODIFIER:exon1/8:c.-40G>T::,NLRP3:ENST00000697350.1:5_prime_UTR_variant:MODIFIER:exon2/10:c.-40G>T::,NLRP3:ENST00000474792.2:5_prime_UTR_variant:MODIFIER:exon1/3:c.-40G>T::,NLRP3:ENST00000643234.2:5_prime_UTR_variant:MODIFIER:exon1/9:c.-40G>T::	regulatory_region_variant:promoter	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296937 [benign DISEASE=Autoinflammatory syndrome,Chronic infantile neurological, cutaneous and articular syndrome,Familial amyloid nephropathy with urticaria AND deafness,Familial cold autoinflammatory syndrome 1,not provided GENE=NLRP3];			rs73136263	0.04367	0.03805,0.02150,0.00174,0.05151,0.02175	167,	6314	145582	-0.3700	2.76			/0.0>0.0/0.0>0.0		NLRP3|0.00|0.00|0.00|0.00|-4|-42|-6|42	33015616	73	2282	0	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247424175	247424175	G	A	het	het	het		QUAL=24;DP=92,157,152;AF=0.54,0.55,0.41	NLRP3	synonymous	NLRP3:ENST00000697408.2:synonymous_variant:LOW:exon7/12:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000391828.8:synonymous_variant:LOW:exon5/11:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000391827.3:synonymous_variant:LOW:exon4/9:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000336119.8:synonymous_variant:LOW:exon4/10:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000348069.7:synonymous_variant:LOW:exon3/7:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000366496.7:synonymous_variant:LOW:exon3/8:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000697350.1:synonymous_variant:LOW:exon4/10:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000474792.2:synonymous_variant:LOW:exon3/3:c.726G>A:p.Ala242=:PF05729 [NACHT domain],NLRP3:ENST00000643234.2:synonymous_variant:LOW:exon3/9:c.726G>A:p.Ala242=:PF05729 [NACHT domain]		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	138528 [benign DISEASE=not specified,not provided,Keratitis fugax hereditaria,Cryopyrin associated periodic syndrome,Chronic infantile neurological, cutaneous and articular syndrome,Familial amyloid nephropathy with urticaria AND deafness,Familial cold autoinflammatory syndrome 1 GENE=NLRP3];			rs3806268	0.42008	0.11522,0.40983,0.54407,0.56091,0.55211	16371,	31048	88062	-2.2250	0.21			/0.0>0.0/0.0>0.0	COSV60221462	NLRP3|0.00|0.00|0.00|0.00|45|20|40|23	25741868,24033266,32313131,35428826,32576967,30131971,30123371,36051474,28116820,31467293,32871918,34390315,35313392,36057006,34354741,33922655,37051231,28847925,36105941,37081890,34791504,36870425,26722603,36204643,32499599,34830358,36781235,20940146,22318840,37665559	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247424229	247424229	A	G	hom	hom	hom		QUAL=24;DP=91,129,118;AF=1.00,1.00,1.00	NLRP3	synonymous	NLRP3:ENST00000697408.2:synonymous_variant:LOW:exon7/12:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000391828.8:synonymous_variant:LOW:exon5/11:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000391827.3:synonymous_variant:LOW:exon4/9:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000336119.8:synonymous_variant:LOW:exon4/10:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000348069.7:synonymous_variant:LOW:exon3/7:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000366496.7:synonymous_variant:LOW:exon3/8:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000697350.1:synonymous_variant:LOW:exon4/10:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000474792.2:synonymous_variant:LOW:exon3/3:c.780A>G:p.Arg260=:PF05729 [NACHT domain],NLRP3:ENST00000643234.2:synonymous_variant:LOW:exon3/9:c.780A>G:p.Arg260=:PF05729 [NACHT domain]		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	403243 [benign DISEASE=Cryopyrin associated periodic syndrome,Keratitis fugax hereditaria,not specified,not provided,Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,Chronic infantile neurological, cutaneous and articular syndrome GENE=NLRP3];			rs4925543	0.92845	0.85513,0.95245,0.99748,0.95837,0.89002	65767,	9714	10886	-0.0360	3.10			/0.0>0.4/0.0>1.4			24033266,33015616,28847925,37521845	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247425793	247425793	-	A	het	het	het		QUAL=24;DP=115,87,72;AF=0.43,0.62,0.50	NLRP3	intron,downstream_gene	NLRP3:ENST00000697408.2:intron_variant:MODIFIER:intron7/11:c.2150+204dup::,NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron5/10:c.2150+204dup::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2150+204dup::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron4/9:c.2150+204dup::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2150+204dup::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron3/7:c.2150+204dup::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron4/9:c.2150+204dup::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron3/8:c.2150+204dup::,NLRP3:ENST00000474792.2:downstream_gene_variant:MODIFIER::::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs369266215	0.03720	0.00789,0.01992,0.06430,0.05280,0.02640	148,	5268	143996		1.16			/0.0>0.0/0.0>0.0		NLRP3|0.00|0.00|0.00|0.00|-18|-23|-28|-23		66	988	0	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247434027	247434027	C	T	hom	hom	hom	low_conf_region	QUAL=25;DP=88,54,34;AF=1.00,0.96,0.91	NLRP3	intron	NLRP3:ENST00000697408.2:intron_variant:MODIFIER:intron8/11:c.2322-76C>T::,NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-76C>T::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-76C>T::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-76C>T::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-76C>T::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-76C>T::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-76C>T::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-136C>T::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	2628109 [benign DISEASE=not specified GENE=NLRP3];			rs12124866	0.91727	0.83217,0.94641,0.98897,0.94902,0.88085	60341,	10424	11824	-2.1460	0.41			/0.0>0.0/0.0>0.0		NLRP3|0.00|0.00|0.05|0.00|36|-6|-7|35		n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247434063	247434063	G	A	wt	hom	hom		QUAL=24;DP=169,99,70;AF=0.00,1.00,1.00	NLRP3	intron	NLRP3:ENST00000697408.2:intron_variant:MODIFIER:intron8/11:c.2322-40G>A::,NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron6/10:c.2322-40G>A::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron4/8:c.2151-40G>A::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron5/9:c.2322-40G>A::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron3/6:c.2151-40G>A::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron4/7:c.2322-40G>A::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron5/9:c.2322-40G>A::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron4/8:c.2322-100G>A::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	2628120 [benign DISEASE=not specified GENE=NLRP3];			rs10925022	0.30919	0.43168,0.25473,0.35814,0.25879,0.18620	10057,	21875	93813	-1.8440	0.10			/4.1>3.1/7.0>4.0			33015616	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247434355	247434355	G	-	hom	hom	hom		QUAL=24;DP=86,104,89;AF=1.00,0.97,1.00	NLRP3	intron	NLRP3:ENST00000697408.2:intron_variant:MODIFIER:intron9/11:c.2492+85del::,NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron7/10:c.2492+85del::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron5/8:c.2321+85del::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron6/9:c.2492+85del::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron4/6:c.2321+85del::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron5/7:c.2492+85del::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron6/9:c.2492+85del::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron5/8:c.2432+85del::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs3835304	0.53277	0.31404,0.48071,0.51840,0.64595,0.59191	23232,	34575	71071	-1.0870	0.03			/0.0>0.0/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247435768	247435768	T	C	hom	hom	hom		QUAL=25;DP=49,18,19;AF=1.00,1.00,1.00	NLRP3	intron	NLRP3:ENST00000697408.2:intron_variant:MODIFIER:intron9/11:c.2492+1495T>C::,NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron7/10:c.2493-202T>C::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron5/8:c.2322-202T>C::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron6/9:c.2493-202T>C::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron4/6:c.2321+1495T>C::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron5/7:c.2492+1495T>C::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron6/9:c.2493-202T>C::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron5/8:c.2433-202T>C::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	1169053 [benign DISEASE=Cryopyrin associated periodic syndrome GENE=NLRP3];			rs4612666	0.64860	0.45661,0.65549,0.54768,0.74893,0.65477	33309,	32006	53432	0.4010	1.61			/0.0>0.0/0.0>0.0	COSV60223405	NLRP3|0.00|0.00|0.00|0.00|-23|-9|9|-18	27417569,32152480,22110538,22112657,24901306,27446957,29214547,24971461,28503575,20650817,30208882,18576390,21258359,29102545,29430721,33533549,35528000,28116820,32871918,19767079,23973727,24967817,26444566,26854620,27455015,29573224,29850543,29888470,30811631,31978095,34199122,34504564,34596590,35313259,35695647,26440629,32922288,34367252,34501201,31751447,34354741,33922655,36812929,30447690,37051231,36595748,36105941,34769275,26118952,36932407,36673016,34210954,21083527,29026154,36836487,25101079,37081890,24003382,35095918,36429405,28607508,29734345,33424869,35862251,33849530,37370025,36870425,35920179,26722603,36204643,34172780,34830358,32733479,36833379,35238332,28366820,33951966,35833125,33855388,37332933,37564647,37762961	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247435930	247435930	G	A	het	het	het		QUAL=24;DP=47,63,39;AF=0.49,0.51,0.41	NLRP3	intron	NLRP3:ENST00000697408.2:intron_variant:MODIFIER:intron9/11:c.2492+1657G>A::,NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron7/10:c.2493-40G>A::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron5/8:c.2322-40G>A::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron6/9:c.2493-40G>A::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron4/6:c.2321+1657G>A::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron5/7:c.2492+1657G>A::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron6/9:c.2493-40G>A::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron5/8:c.2433-40G>A::		606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	1259697 [benign DISEASE=not specified,not provided GENE=NLRP3];			rs10754557	0.51566	0.24429,0.50144,0.67399,0.62373,0.60420	22548,	33202	73542	-0.6010	0.25			/0.0>0.0/6.0>8.2			34345180,29850521,32104685,33922655,36812929,35707771,36836487,37325658,33925158,22318840	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33)
chr1	247448358	247448359	AG	-	het	wt	het		QUAL=24;DP=95,20,39;AF=0.56,0.00,0.54	NLRP3,OR2B11	intron,downstream_gene	NLRP3:ENST00000697408.2:intron_variant:MODIFIER:intron11/11:c.2835-45_2835-44del::,NLRP3:ENST00000391828.8:intron_variant:MODIFIER:intron10/10:c.3006-45_3006-44del::,NLRP3:ENST00000391827.3:intron_variant:MODIFIER:intron8/8:c.2835-45_2835-44del::,NLRP3:ENST00000336119.8:intron_variant:MODIFIER:intron9/9:c.3006-45_3006-44del::,NLRP3:ENST00000348069.7:intron_variant:MODIFIER:intron6/6:c.2664-45_2664-44del::,NLRP3:ENST00000366496.7:intron_variant:MODIFIER:intron7/7:c.2835-45_2835-44del::,NLRP3:ENST00000697350.1:intron_variant:MODIFIER:intron9/9:c.3006-45_3006-44del::,NLRP3:ENST00000643234.2:intron_variant:MODIFIER:intron8/8:c.2946-45_2946-44del::,OR2B11:ENST00000641527.1:downstream_gene_variant:MODIFIER::::,OR2B11:ENST00000641149.2:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs201053423	0.04078	0.01062,0.03924,0.03261,0.05511,0.10448	184,	5691	142517	-0.3360	1.41			/0.0>0.8/0.0>0.0		NLRP3|0.01|0.00|0.00|0.00|27|3|-46|47	33462484	70	2428	0	0 / 0					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33), OR2B11 (inh=n/a oe_syn=1.03 oe_mis=0.94 oe_lof=0.83)
chr1	247448734	247448734	G	C	hom	hom	hom		QUAL=24;DP=352,502,384;AF=1.00,1.00,1.00	NLRP3,OR2B11	3'UTR,downstream_gene	NLRP3:ENST00000391828.8:3_prime_UTR_variant:MODIFIER:exon11/11:c.*230G>C::,NLRP3:ENST00000391827.3:3_prime_UTR_variant:MODIFIER:exon9/9:c.*230G>C::,NLRP3:ENST00000336119.8:3_prime_UTR_variant:MODIFIER:exon10/10:c.*230G>C::,NLRP3:ENST00000348069.7:3_prime_UTR_variant:MODIFIER:exon7/7:c.*230G>C::,NLRP3:ENST00000366496.7:3_prime_UTR_variant:MODIFIER:exon8/8:c.*230G>C::,NLRP3:ENST00000697350.1:3_prime_UTR_variant:MODIFIER:exon10/10:c.*230G>C::,NLRP3:ENST00000697408.2:downstream_gene_variant:MODIFIER::::,NLRP3:ENST00000643234.2:downstream_gene_variant:MODIFIER::::,OR2B11:ENST00000641527.1:downstream_gene_variant:MODIFIER::::,OR2B11:ENST00000641149.2:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:CTCF_binding_site,regulatory_region_variant:open_chromatin_region	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]	296956 [benign DISEASE=Atypical hemolytic-uremic syndrome,Autoinflammatory syndrome,Cryopyrin associated periodic syndrome,Familial cold autoinflammatory syndrome 1,Familial amyloid nephropathy with urticaria AND deafness,not provided,Chronic infantile neurological, cutaneous and articular syndrome GENE=NLRP3];			rs10754558	0.63581	0.74346,0.71093,0.58585,0.58443,0.61127	31464,	33801	55405	0.2860	6.01			/4.4>6.3/0.0>0.0	COSV59510002	NLRP3|0.00|0.00|0.00|0.00|-42|36|-42|46	30182779,34834553,27810495,22110538,33868225,34161370,22112657,23110140,24901306,27446957,29214547,30728751,24144834,26833430,28503575,29385859,26698117,30208882,34345180,36051474,18576390,21258359,29102545,29430721,33533549,35407478,28116820,32871918,34390315,35313392,36057006,31405022,19767079,23973727,26444566,27455015,29850543,29888470,34504564,34596590,35313259,35695647,25297810,26440629,28139755,16642435,20370570,20502346,21245836,22227487,23031505,26236392,26689701,26945813,27060062,27110561,27942564,28456882,28764843,29230505,29732382,31448710,32020248,32689633,33193317,34367252,34636069,34956329,35204842,26273672,33434563,31751447,26462562,35987511,30783474,28702029,33922655,29507526,35328662,30447690,37051231,36595748,36105941,36199683,34769275,32973739,36932407,36673016,35000611,25788762,21083527,29026154,36836487,35022530,26662437,37081890,23658628,35664004,34177937,35095918,33613533,30618791,21163704,37197397,34595244,37325658,33424869,35862251,36620210,30214462,33849530,37370025,36870425,2678238	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33), OR2B11 (inh=n/a oe_syn=1.03 oe_mis=0.94 oe_lof=0.83)
chr1	247449133	247449133	A	T	hom	n/a	hom		QUAL=24;DP=21,1,3;AF=1.00,0.00,1.00	OR2B11,NLRP3	3'UTR,downstream_gene	OR2B11:ENST00000641527.1:3_prime_UTR_variant:MODIFIER:exon3/3:c.*1896T>A::,NLRP3:ENST00000697408.2:downstream_gene_variant:MODIFIER::::,NLRP3:ENST00000391828.8:downstream_gene_variant:MODIFIER::::,NLRP3:ENST00000391827.3:downstream_gene_variant:MODIFIER::::,NLRP3:ENST00000336119.8:downstream_gene_variant:MODIFIER::::,NLRP3:ENST00000348069.7:downstream_gene_variant:MODIFIER::::,NLRP3:ENST00000366496.7:downstream_gene_variant:MODIFIER::::,NLRP3:ENST00000697350.1:downstream_gene_variant:MODIFIER::::,NLRP3:ENST00000643234.2:downstream_gene_variant:MODIFIER::::,OR2B11:ENST00000641149.2:downstream_gene_variant:MODIFIER::::	regulatory_region_variant:open_chromatin_region	606416_[GENE=NLRP3_PHENOS=CINCA syndrome, 607115 (3), Autosomal dominant; Familial cold inflammatory syndrome 1, 120100 (3), Autosomal dominant; Keratoendothelitis fugax hereditaria, 148200 (3), Autosomal dominant; Deafness, autosomal dominant 34, with or without inflammation, 617772 (3), Autosomal dominant; Muckle-Wells syndrome, 191900 (3), Autosomal dominant]				rs4925547	0.36346	0.24370,0.47350,0.54498,0.39588,0.46266	10804,	33672	96816	0.5200	9.06			/5.0>4.3/0.0>0.0				n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					NLRP3 (inh=AD oe_syn=1.28 oe_mis=0.74 oe_lof=0.33), OR2B11 (inh=n/a oe_syn=1.03 oe_mis=0.94 oe_lof=0.83)
chrMT	72	72	T	C	hom	wt	hom		QUAL=255376;DP=4362,4222,3908;AF=0.99,0.00,0.99;MQM=58;SAP=1407;ABP=0;SAR=5262;SAF=2957	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs879158303	0.02502					-0.0730								1220	43	0	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	73	73	A	G	wt	hom	wt		QUAL=122492;DP=4322,4305,3948;AF=0.01,1.00,0.00;MQM=55;SAP=282;ABP=0;SAR=2541;SAF=1795	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::			3066071 [affects DISEASE=Venous thromboembolism GENE=];			rs869183622	0.71574					-1.2370							34002094,35453788	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	150	150	C	T	wt	hom	wt		QUAL=129638;DP=4152,4005,3299;AF=0.00,0.99,0.00;MQM=60;SAP=902;ABP=0;SAR=2630;SAF=1347	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs62581312	0.16628					-3.9110							34002094,33728047,29774306,24040623	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	152	152	T	C	wt	hom	wt		QUAL=129638;DP=4152,4005,3299;AF=0.00,0.99,0.00;MQM=60;SAP=902;ABP=0;SAR=2630;SAF=1347	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs117135796	0.31733					-1.7640							33062421,36238361,31380278	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	195	195	T	C	wt	hom	wt		QUAL=109620;DP=3721,3387,2443;AF=0.00,1.00,0.00;MQM=60;SAP=975;ABP=0;SAR=2314;SAF=1081	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs2857291	0.27606					0.2630							22723804,27217714,33062421,36238361,31380278,26550561,24040623,37477801	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	215	215	A	G	wt	hom	wt		QUAL=101854;DP=3348,3152,2043;AF=0.00,0.99,0.00;MQM=60;SAP=1015;ABP=0;SAR=2173;SAF=964	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs879219259	0.00821					0.8940								459	73	0	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	263	263	A	G	hom	hom	hom		QUAL=199389;DP=2691,2355,1163;AF=1.00,1.00,1.00;MQM=60;SAP=2915;ABP=0;SAR=4541;SAF=1658	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::			441147 [not provided DISEASE=not provided GENE=];			rs2853515	0.99070					0.1780							22723804,33062421,35453788,29695379	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	295	295	C	T	wt	hom	wt		QUAL=58342;DP=2190,1911,784;AF=0.00,0.99,0.00;MQM=60;SAP=795;ABP=0;SAR=1368;SAF=535	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs41528348	0.05604					-2.8920							35328073,31380278	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	302	302	-	CC	hom	wt	het		QUAL=52691;DP=798,1342,317;AF=0.05,0.00,0.02;MQM=60;SAP=1775;ABP=163;SAR=816;SAF=0	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs878871521	0.00000												36360199	1196	3156	2	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	302	302	-	CCC	wt	wt	het		QUAL=52691;DP=798,1342,317;AF=0.05,0.00,0.02;MQM=58;SAP=162;ABP=414;SAR=73;SAF=0	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs878871521	0.00000												36360199	62	769	0	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	310	310	-	C	hom	wt	hom		QUAL=52691;DP=798,1342,317;AF=0.05,0.00,0.02;MQM=59;SAP=46;ABP=640;SAR=20;SAF=0	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs369786048	0.62551												36360199	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	310	310	-	TC	wt	hom	wt		QUAL=52691;DP=798,1342,317;AF=0.05,0.00,0.02;MQM=60;SAP=478;ABP=674;SAR=913;SAF=381	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs1556422422	0.00427													287	15	0	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	319	319	T	C	wt	hom	wt		QUAL=51007;DP=2010,1675,476;AF=0.00,0.99,0.00;MQM=60;SAP=341;ABP=0;SAR=1087;SAF=578	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs879055956	0.00671					-0.2030								422	6	0	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	430	430	T	C	wt	hom	wt		QUAL=55553;DP=2925,1864,1270;AF=0.00,0.99,0.00;MQM=60;SAP=545;ABP=0;SAR=588;SAF=1269	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs1603218409	0.00019					-1.1600								19	1	0	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	489	489	T	C	wt	hom	wt		QUAL=66890;DP=3076,2281,1861;AF=0.00,0.99,0.00;MQM=60;SAP=363;ABP=0;SAR=828;SAF=1441	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::						rs28625645	0.10935					-1.4590							34976016,26116242,35453788,31380278,35032707,24040623	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	513	513	G	A	wt	hom	wt		QUAL=66975;DP=3214,2306,1875;AF=0.00,0.99,0.00;MQM=60;SAP=67;ABP=0;SAR=1017;SAF=1277	MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2,MT-TW	upstream_gene,downstream_gene	MT-TF:ENST00000387314.1:upstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:upstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TW:ENST00000387382.1:upstream_gene_variant:MODIFIER::::						rs879162984	0.01117					-2.2930							34976016	519	85	0	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	750	750	A	G	hom	hom	hom		QUAL=292729;DP=3363,3133,2672;AF=1.00,1.00,1.00;MQM=59;SAP=172;ABP=0;SAR=5004;SAF=4159	MT-RNR1,MT-TF,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2,MT-TW,MT-TA,MT-TN	non_coding_transcript_exon,downstream_gene,upstream_gene	MT-RNR1:ENST00000389680.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.103A>G::,MT-TF:ENST00000387314.1:downstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TW:ENST00000387382.1:upstream_gene_variant:MODIFIER::::,MT-TA:ENST00000387392.1:downstream_gene_variant:MODIFIER::::,MT-TN:ENST00000387400.1:downstream_gene_variant:MODIFIER::::			441148 [association not found DISEASE=not provided,Venous thromboembolism GENE=MT-RNR1];			rs2853518	0.98341					6.9050				/0.0>0.0/0.0>0.0			35328073,35453788,31380278,35130313	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	1438	1438	A	G	hom	hom	hom		QUAL=710654;DP=8324,7287,6312;AF=1.00,1.00,1.00;MQM=56;SAP=541;ABP=0;SAR=12117;SAF=9788	MT-RNR1,MT-TF,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2,MT-TW,MT-TA,MT-TN,MT-TC,MT-TY,MT-CO1	non_coding_transcript_exon,downstream_gene,upstream_gene	MT-RNR1:ENST00000389680.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.791A>G::,MT-TF:ENST00000387314.1:downstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:upstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:upstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TW:ENST00000387382.1:upstream_gene_variant:MODIFIER::::,MT-TA:ENST00000387392.1:downstream_gene_variant:MODIFIER::::,MT-TN:ENST00000387400.1:downstream_gene_variant:MODIFIER::::,MT-TC:ENST00000387405.1:downstream_gene_variant:MODIFIER::::,MT-TY:ENST00000387409.1:downstream_gene_variant:MODIFIER::::,MT-CO1:ENST00000361624.2:upstream_gene_variant:MODIFIER::::			42220 [benign DISEASE=not specified,not provided GENE=MT-RNR1];			rs2001030	0.95610					0.2380				/0.0>0.0/0.0>0.0			24033266,9519725,18830133,33728047,35453788,31380278,35130313,29695379	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	1850	1850	T	C	wt	hom	wt		QUAL=121831;DP=5777,3827,3336;AF=0.00,0.99,0.00;MQM=60;SAP=11;ABP=0;SAR=1839;SAF=1959	MT-RNR2,MT-TF,MT-RNR1,MT-TV,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2,MT-TW,MT-TA,MT-TN,MT-TC,MT-TY,MT-CO1	non_coding_transcript_exon,downstream_gene,upstream_gene	MT-RNR2:ENST00000387347.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.180T>C::,MT-TF:ENST00000387314.1:downstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:downstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:downstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TW:ENST00000387382.1:upstream_gene_variant:MODIFIER::::,MT-TA:ENST00000387392.1:downstream_gene_variant:MODIFIER::::,MT-TN:ENST00000387400.1:downstream_gene_variant:MODIFIER::::,MT-TC:ENST00000387405.1:downstream_gene_variant:MODIFIER::::,MT-TY:ENST00000387409.1:downstream_gene_variant:MODIFIER::::,MT-CO1:ENST00000361624.2:upstream_gene_variant:MODIFIER::::						rs878878913	0.00445					2.0490				/0.2>0.0/0.0>0.0				314	17	0	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	2487	2487	A	C	wt	het	het		QUAL=704;DP=3345,1401,1230;AF=0.01,0.22,0.22;MQM=57;SAP=1321;ABP=1794;SAR=607;SAF=0	MT-RNR2,MT-TF,MT-RNR1,MT-TV,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2,MT-TW,MT-TA,MT-TN,MT-TC,MT-TY,MT-CO1,MT-TS1	non_coding_transcript_exon,downstream_gene,upstream_gene	MT-RNR2:ENST00000387347.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.817A>C::,MT-TF:ENST00000387314.1:downstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:downstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:downstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TW:ENST00000387382.1:upstream_gene_variant:MODIFIER::::,MT-TA:ENST00000387392.1:downstream_gene_variant:MODIFIER::::,MT-TN:ENST00000387400.1:downstream_gene_variant:MODIFIER::::,MT-TC:ENST00000387405.1:downstream_gene_variant:MODIFIER::::,MT-TY:ENST00000387409.1:downstream_gene_variant:MODIFIER::::,MT-CO1:ENST00000361624.2:upstream_gene_variant:MODIFIER::::,MT-TS1:ENST00000387416.2:downstream_gene_variant:MODIFIER::::						rs1603218760	0.00000					1.7730				/0.0>0.0/0.0>0.0				0	0	0	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	2706	2706	A	G	hom	hom	hom		QUAL=182540;DP=3123,1476,1283;AF=1.00,1.00,1.00;MQM=60;SAP=213;ABP=0;SAR=3311;SAF=2557	MT-RNR2,MT-TF,MT-RNR1,MT-TV,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2,MT-TW,MT-TA,MT-TN,MT-TC,MT-TY,MT-CO1,MT-TS1,MT-TD,MT-CO2	non_coding_transcript_exon,downstream_gene,upstream_gene	MT-RNR2:ENST00000387347.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.1036A>G::,MT-TF:ENST00000387314.1:downstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:downstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:downstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:upstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:upstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TW:ENST00000387382.1:upstream_gene_variant:MODIFIER::::,MT-TA:ENST00000387392.1:downstream_gene_variant:MODIFIER::::,MT-TN:ENST00000387400.1:downstream_gene_variant:MODIFIER::::,MT-TC:ENST00000387405.1:downstream_gene_variant:MODIFIER::::,MT-TY:ENST00000387409.1:downstream_gene_variant:MODIFIER::::,MT-CO1:ENST00000361624.2:upstream_gene_variant:MODIFIER::::,MT-TS1:ENST00000387416.2:downstream_gene_variant:MODIFIER::::,MT-TD:ENST00000387419.1:upstream_gene_variant:MODIFIER::::,MT-CO2:ENST00000361739.1:upstream_gene_variant:MODIFIER::::					LSU-rRNA_Hsa (rRNA)	rs2854128	0.73949					-0.0780				/0.0>0.0/0.0>0.0			34002094,30242290,36833212,34980117,32387288,36238361,35453788,35499074,31380278,36360199,29695379	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	4216	4216	T	C	wt	hom	wt		QUAL=105736;DP=3607,3473,3080;AF=0.00,0.99,0.00;MQM=45;SAP=248;ABP=0;SAR=2044;SAF=1419	MT-ND1,MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-TI,MT-TQ,MT-TM,MT-ND2,MT-TW,MT-TA,MT-TN,MT-TC,MT-TY,MT-CO1,MT-TS1,MT-TD,MT-CO2,MT-TK,MT-ATP8,MT-ATP6,MT-CO3	missense,downstream_gene,upstream_gene	MT-ND1:ENST00000361390.2:missense_variant:MODERATE:exon1/1:c.910T>C:p.Tyr304His:PF00146 [NADH dehydrogenase],MT-TF:ENST00000387314.1:downstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:downstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:downstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:downstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:downstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:upstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:downstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:upstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:upstream_gene_variant:MODIFIER::::,MT-TW:ENST00000387382.1:upstream_gene_variant:MODIFIER::::,MT-TA:ENST00000387392.1:downstream_gene_variant:MODIFIER::::,MT-TN:ENST00000387400.1:downstream_gene_variant:MODIFIER::::,MT-TC:ENST00000387405.1:downstream_gene_variant:MODIFIER::::,MT-TY:ENST00000387409.1:downstream_gene_variant:MODIFIER::::,MT-CO1:ENST00000361624.2:upstream_gene_variant:MODIFIER::::,MT-TS1:ENST00000387416.2:downstream_gene_variant:MODIFIER::::,MT-TD:ENST00000387419.1:upstream_gene_variant:MODIFIER::::,MT-CO2:ENST00000361739.1:upstream_gene_variant:MODIFIER::::,MT-TK:ENST00000387421.1:upstream_gene_variant:MODIFIER::::,MT-ATP8:ENST00000361851.1:upstream_gene_variant:MODIFIER::::,MT-ATP6:ENST00000361899.2:upstream_gene_variant:MODIFIER::::,MT-CO3:ENST00000362079.2:upstream_gene_variant:MODIFIER::::			9724 [benign DISEASE=Leber optic atrophy,Leigh syndrome,not provided GENE=MT-ND1];			rs1599988	0.11756					0.2170			0.13	/0.0>0.0/0.2>0.0	COSV62293824		34837699,1732158,1900003,7635294,20301353,22723804,29370225,1417830,30684245,33475980,35328073,35682771,27594409,31380278,34478492,35130313,35773337,37477801	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	4580	4580	G	A	hom	wt	hom		QUAL=101481;DP=2319,1793,1597;AF=0.99,0.00,0.99;MQM=33;SAP=33;ABP=0;SAR=2056;SAF=1824	MT-ND2,MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-TW,MT-TA,MT-TN,MT-TC,MT-TY,MT-CO1,MT-TS1,MT-TD,MT-CO2,MT-TK,MT-ATP8,MT-ATP6,MT-CO3	synonymous,downstream_gene,upstream_gene	MT-ND2:ENST00000361453.3:synonymous_variant:LOW:exon1/1:c.111G>A:p.Met37=:PF00361 [Proton-conducting membrane transporter],MT-TF:ENST00000387314.1:downstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:downstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:downstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:downstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:downstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:downstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:downstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:upstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:downstream_gene_variant:MODIFIER::::,MT-TW:ENST00000387382.1:upstream_gene_variant:MODIFIER::::,MT-TA:ENST00000387392.1:downstream_gene_variant:MODIFIER::::,MT-TN:ENST00000387400.1:downstream_gene_variant:MODIFIER::::,MT-TC:ENST00000387405.1:downstream_gene_variant:MODIFIER::::,MT-TY:ENST00000387409.1:downstream_gene_variant:MODIFIER::::,MT-CO1:ENST00000361624.2:upstream_gene_variant:MODIFIER::::,MT-TS1:ENST00000387416.2:downstream_gene_variant:MODIFIER::::,MT-TD:ENST00000387419.1:upstream_gene_variant:MODIFIER::::,MT-CO2:ENST00000361739.1:upstream_gene_variant:MODIFIER::::,MT-TK:ENST00000387421.1:upstream_gene_variant:MODIFIER::::,MT-ATP8:ENST00000361851.1:upstream_gene_variant:MODIFIER::::,MT-ATP6:ENST00000361899.2:upstream_gene_variant:MODIFIER::::,MT-CO3:ENST00000362079.2:upstream_gene_variant:MODIFIER::::						rs28357975	0.02425					-3.5290				/4.1>3.3/0.0>0.0			24917144	960	13	1	0 / 0					MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	4769	4769	A	G	hom	hom	hom		QUAL=166155;DP=2022,2037,1858;AF=1.00,1.00,1.00;MQM=36;SAP=1995;ABP=0;SAR=1790;SAF=4118	MT-ND2,MT-TF,MT-RNR1,MT-TV,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-TW,MT-TA,MT-TN,MT-TC,MT-TY,MT-CO1,MT-TS1,MT-TD,MT-CO2,MT-TK,MT-ATP8,MT-ATP6,MT-CO3	synonymous,downstream_gene,upstream_gene	MT-ND2:ENST00000361453.3:synonymous_variant:LOW:exon1/1:c.300A>G:p.Met100=:PF00361 [Proton-conducting membrane transporter],MT-TF:ENST00000387314.1:downstream_gene_variant:MODIFIER::::,MT-RNR1:ENST00000389680.2:downstream_gene_variant:MODIFIER::::,MT-TV:ENST00000387342.1:downstream_gene_variant:MODIFIER::::,MT-RNR2:ENST00000387347.2:downstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:downstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:downstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:downstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:upstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:downstream_gene_variant:MODIFIER::::,MT-TW:ENST00000387382.1:upstream_gene_variant:MODIFIER::::,MT-TA:ENST00000387392.1:downstream_gene_variant:MODIFIER::::,MT-TN:ENST00000387400.1:downstream_gene_variant:MODIFIER::::,MT-TC:ENST00000387405.1:downstream_gene_variant:MODIFIER::::,MT-TY:ENST00000387409.1:downstream_gene_variant:MODIFIER::::,MT-CO1:ENST00000361624.2:upstream_gene_variant:MODIFIER::::,MT-TS1:ENST00000387416.2:downstream_gene_variant:MODIFIER::::,MT-TD:ENST00000387419.1:upstream_gene_variant:MODIFIER::::,MT-CO2:ENST00000361739.1:upstream_gene_variant:MODIFIER::::,MT-TK:ENST00000387421.1:upstream_gene_variant:MODIFIER::::,MT-ATP8:ENST00000361851.1:upstream_gene_variant:MODIFIER::::,MT-ATP6:ENST00000361899.2:upstream_gene_variant:MODIFIER::::,MT-CO3:ENST00000362079.2:upstream_gene_variant:MODIFIER::::			441150 [benign DISEASE=not provided,Mitochondrial disease GENE=MT-ND2];			rs3021086	0.98387					-20.0000				/1.3>0.2/0.0>0.0			35453788,31380278,35130313	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahharmf1 10.08.2021; most likely WT; NGSD: >13000 other homo samples; gnomAD 3.1: >98% are also homo"			MT-TF (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TV (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	7028	7028	C	T	hom	hom	hom		QUAL=309114;DP=3034,3975,3457;AF=0.99,1.00,1.00;MQM=43;SAP=347;ABP=0;SAR=4578;SAF=5864	MT-CO1,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2,MT-TW,MT-TA,MT-TN,MT-TC,MT-TY,MT-TS1,MT-TD,MT-CO2,MT-TK,MT-ATP8,MT-ATP6,MT-CO3,MT-TG,MT-ND3,MT-TR,MT-ND4L,MT-ND4	synonymous,downstream_gene,upstream_gene	MT-CO1:ENST00000361624.2:synonymous_variant:LOW:exon1/1:c.1125C>T:p.Ala375=:PF00115 [Cytochrome C and Quinol oxidase polypeptide I],MT-RNR2:ENST00000387347.2:downstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:downstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:downstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:downstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:upstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:downstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:downstream_gene_variant:MODIFIER::::,MT-TW:ENST00000387382.1:downstream_gene_variant:MODIFIER::::,MT-TA:ENST00000387392.1:upstream_gene_variant:MODIFIER::::,MT-TN:ENST00000387400.1:upstream_gene_variant:MODIFIER::::,MT-TC:ENST00000387405.1:upstream_gene_variant:MODIFIER::::,MT-TY:ENST00000387409.1:upstream_gene_variant:MODIFIER::::,MT-TS1:ENST00000387416.2:downstream_gene_variant:MODIFIER::::,MT-TD:ENST00000387419.1:upstream_gene_variant:MODIFIER::::,MT-CO2:ENST00000361739.1:upstream_gene_variant:MODIFIER::::,MT-TK:ENST00000387421.1:upstream_gene_variant:MODIFIER::::,MT-ATP8:ENST00000361851.1:upstream_gene_variant:MODIFIER::::,MT-ATP6:ENST00000361899.2:upstream_gene_variant:MODIFIER::::,MT-CO3:ENST00000362079.2:upstream_gene_variant:MODIFIER::::,MT-TG:ENST00000387429.1:upstream_gene_variant:MODIFIER::::,MT-ND3:ENST00000361227.2:upstream_gene_variant:MODIFIER::::,MT-TR:ENST00000387439.1:upstream_gene_variant:MODIFIER::::,MT-ND4L:ENST00000361335.1:upstream_gene_variant:MODIFIER::::,MT-ND4:ENST00000361381.2:upstream_gene_variant:MODIFIER::::			1676315 [benign DISEASE=Mitochondrial disease GENE=MT-CO1];			rs2015062	0.74940					-9.1980				/2.7>2.9/0.0>0.0			30713765,24917144,24148579,36238361,35453788,31380278,35130313,29695379,35773337,37388495	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	7476	7476	C	T	wt	hom	wt		QUAL=46944;DP=3920,1606,1385;AF=0.00,0.99,0.00;MQM=43;SAP=208;ABP=0;SAR=603;SAF=991	MT-TS1,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2,MT-TW,MT-TA,MT-TN,MT-TC,MT-TY,MT-CO1,MT-TD,MT-CO2,MT-TK,MT-ATP8,MT-ATP6,MT-CO3,MT-TG,MT-ND3,MT-TR,MT-ND4L,MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5	non_coding_transcript_exon,downstream_gene,upstream_gene	MT-TS1:ENST00000387416.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.39G>A::,MT-RNR2:ENST00000387347.2:downstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:downstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:downstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:downstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:upstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:downstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:downstream_gene_variant:MODIFIER::::,MT-TW:ENST00000387382.1:downstream_gene_variant:MODIFIER::::,MT-TA:ENST00000387392.1:upstream_gene_variant:MODIFIER::::,MT-TN:ENST00000387400.1:upstream_gene_variant:MODIFIER::::,MT-TC:ENST00000387405.1:upstream_gene_variant:MODIFIER::::,MT-TY:ENST00000387409.1:upstream_gene_variant:MODIFIER::::,MT-CO1:ENST00000361624.2:downstream_gene_variant:MODIFIER::::,MT-TD:ENST00000387419.1:upstream_gene_variant:MODIFIER::::,MT-CO2:ENST00000361739.1:upstream_gene_variant:MODIFIER::::,MT-TK:ENST00000387421.1:upstream_gene_variant:MODIFIER::::,MT-ATP8:ENST00000361851.1:upstream_gene_variant:MODIFIER::::,MT-ATP6:ENST00000361899.2:upstream_gene_variant:MODIFIER::::,MT-CO3:ENST00000362079.2:upstream_gene_variant:MODIFIER::::,MT-TG:ENST00000387429.1:upstream_gene_variant:MODIFIER::::,MT-ND3:ENST00000361227.2:upstream_gene_variant:MODIFIER::::,MT-TR:ENST00000387439.1:upstream_gene_variant:MODIFIER::::,MT-ND4L:ENST00000361335.1:upstream_gene_variant:MODIFIER::::,MT-ND4:ENST00000361381.2:upstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:upstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:upstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:upstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:upstream_gene_variant:MODIFIER::::			42228 [benign DISEASE=not specified,Mitochondrial disease,MELAS syndrome GENE=MT-TS1];		tRNA-Ser-TCA(m) (tRNA)	rs201950015	0.01102					-0.8360				/0.0>0.0/0.0>0.0			24033266,15286157,18790089,8155739,8728705,9384601,19371214,21621438,35328073,35130313,31965079	605	15	0	0 / 0					MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	7789	7789	G	A	wt	hom	wt		QUAL=150780;DP=7553,5190,5686;AF=0.00,0.98,0.00;MQM=58;SAP=3789;ABP=0;SAR=1064;SAF=4050	MT-CO2,MT-RNR2,MT-TL1,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2,MT-TW,MT-TA,MT-TN,MT-TC,MT-TY,MT-CO1,MT-TS1,MT-TD,MT-TK,MT-ATP8,MT-ATP6,MT-CO3,MT-TG,MT-ND3,MT-TR,MT-ND4L,MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5	synonymous,downstream_gene,upstream_gene	MT-CO2:ENST00000361739.1:synonymous_variant:LOW:exon1/1:c.204G>A:p.Leu68=:PF02790 [Cytochrome C oxidase subunit II transmembrane domain],MT-RNR2:ENST00000387347.2:downstream_gene_variant:MODIFIER::::,MT-TL1:ENST00000386347.1:downstream_gene_variant:MODIFIER::::,MT-ND1:ENST00000361390.2:downstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:downstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:upstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:downstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:downstream_gene_variant:MODIFIER::::,MT-TW:ENST00000387382.1:downstream_gene_variant:MODIFIER::::,MT-TA:ENST00000387392.1:upstream_gene_variant:MODIFIER::::,MT-TN:ENST00000387400.1:upstream_gene_variant:MODIFIER::::,MT-TC:ENST00000387405.1:upstream_gene_variant:MODIFIER::::,MT-TY:ENST00000387409.1:upstream_gene_variant:MODIFIER::::,MT-CO1:ENST00000361624.2:downstream_gene_variant:MODIFIER::::,MT-TS1:ENST00000387416.2:upstream_gene_variant:MODIFIER::::,MT-TD:ENST00000387419.1:downstream_gene_variant:MODIFIER::::,MT-TK:ENST00000387421.1:upstream_gene_variant:MODIFIER::::,MT-ATP8:ENST00000361851.1:upstream_gene_variant:MODIFIER::::,MT-ATP6:ENST00000361899.2:upstream_gene_variant:MODIFIER::::,MT-CO3:ENST00000362079.2:upstream_gene_variant:MODIFIER::::,MT-TG:ENST00000387429.1:upstream_gene_variant:MODIFIER::::,MT-ND3:ENST00000361227.2:upstream_gene_variant:MODIFIER::::,MT-TR:ENST00000387439.1:upstream_gene_variant:MODIFIER::::,MT-ND4L:ENST00000361335.1:upstream_gene_variant:MODIFIER::::,MT-ND4:ENST00000361381.2:upstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:upstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:upstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:upstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:upstream_gene_variant:MODIFIER::::			376897 [benign DISEASE=not provided GENE=MT-CO2];			rs386829014	0.01099					-9.8780				/6.2>5.0/0.0>0.0			25741868,31380278	546	55	3	0 / 0					MT-RNR2 (inh=n/a oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	8860	8860	A	G	hom	hom	hom		QUAL=170859;DP=1658,2272,2090;AF=0.99,1.00,1.00;MQM=35;SAP=19;ABP=0;SAR=3112;SAF=2899	MT-ATP6,MT-ND1,MT-TI,MT-TQ,MT-TM,MT-ND2,MT-TW,MT-TA,MT-TN,MT-TC,MT-TY,MT-CO1,MT-TS1,MT-TD,MT-CO2,MT-TK,MT-ATP8,MT-CO3,MT-TG,MT-ND3,MT-TR,MT-ND4L,MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5	missense,downstream_gene,upstream_gene	MT-ATP6:ENST00000361899.2:missense_variant:MODERATE:exon1/1:c.334A>G:p.Thr112Ala:PF00119 [ATP synthase A chain],MT-ND1:ENST00000361390.2:downstream_gene_variant:MODIFIER::::,MT-TI:ENST00000387365.1:downstream_gene_variant:MODIFIER::::,MT-TQ:ENST00000387372.1:upstream_gene_variant:MODIFIER::::,MT-TM:ENST00000387377.1:downstream_gene_variant:MODIFIER::::,MT-ND2:ENST00000361453.3:downstream_gene_variant:MODIFIER::::,MT-TW:ENST00000387382.1:downstream_gene_variant:MODIFIER::::,MT-TA:ENST00000387392.1:upstream_gene_variant:MODIFIER::::,MT-TN:ENST00000387400.1:upstream_gene_variant:MODIFIER::::,MT-TC:ENST00000387405.1:upstream_gene_variant:MODIFIER::::,MT-TY:ENST00000387409.1:upstream_gene_variant:MODIFIER::::,MT-CO1:ENST00000361624.2:downstream_gene_variant:MODIFIER::::,MT-TS1:ENST00000387416.2:upstream_gene_variant:MODIFIER::::,MT-TD:ENST00000387419.1:downstream_gene_variant:MODIFIER::::,MT-CO2:ENST00000361739.1:downstream_gene_variant:MODIFIER::::,MT-TK:ENST00000387421.1:downstream_gene_variant:MODIFIER::::,MT-ATP8:ENST00000361851.1:downstream_gene_variant:MODIFIER::::,MT-CO3:ENST00000362079.2:upstream_gene_variant:MODIFIER::::,MT-TG:ENST00000387429.1:upstream_gene_variant:MODIFIER::::,MT-ND3:ENST00000361227.2:upstream_gene_variant:MODIFIER::::,MT-TR:ENST00000387439.1:upstream_gene_variant:MODIFIER::::,MT-ND4L:ENST00000361335.1:upstream_gene_variant:MODIFIER::::,MT-ND4:ENST00000361381.2:upstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:upstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:upstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:upstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:upstream_gene_variant:MODIFIER::::			693004 [benign DISEASE=Leigh syndrome GENE=MT-ATP6];			rs2001031	0.99381					0.2660			0.11	/0.0>0.0/0.0>0.0			36066780,33728047,35453788,37674615	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] ahharmf1 10.08.2021; most likely WT variant; MitoMap: in >99% of gnomAD 3.1 sequences homo; NGSD: almost existing in each sample homo"			MT-ND1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TI (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TQ (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TM (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	10398	10398	A	G	wt	hom	wt		QUAL=120304;DP=4721,3738,3116;AF=0.00,0.99,0.00;MQM=60;SAP=202;ABP=0;SAR=1575;SAF=2160	MT-ND3,MT-ND2,MT-TW,MT-TA,MT-TN,MT-TC,MT-TY,MT-CO1,MT-TS1,MT-TD,MT-CO2,MT-TK,MT-ATP8,MT-ATP6,MT-CO3,MT-TG,MT-TR,MT-ND4L,MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB	missense,downstream_gene,upstream_gene	MT-ND3:ENST00000361227.2:missense_variant:MODERATE:exon1/1:c.340A>G:p.Thr114Ala:,MT-ND2:ENST00000361453.3:downstream_gene_variant:MODIFIER::::,MT-TW:ENST00000387382.1:downstream_gene_variant:MODIFIER::::,MT-TA:ENST00000387392.1:upstream_gene_variant:MODIFIER::::,MT-TN:ENST00000387400.1:upstream_gene_variant:MODIFIER::::,MT-TC:ENST00000387405.1:upstream_gene_variant:MODIFIER::::,MT-TY:ENST00000387409.1:upstream_gene_variant:MODIFIER::::,MT-CO1:ENST00000361624.2:downstream_gene_variant:MODIFIER::::,MT-TS1:ENST00000387416.2:upstream_gene_variant:MODIFIER::::,MT-TD:ENST00000387419.1:downstream_gene_variant:MODIFIER::::,MT-CO2:ENST00000361739.1:downstream_gene_variant:MODIFIER::::,MT-TK:ENST00000387421.1:downstream_gene_variant:MODIFIER::::,MT-ATP8:ENST00000361851.1:downstream_gene_variant:MODIFIER::::,MT-ATP6:ENST00000361899.2:downstream_gene_variant:MODIFIER::::,MT-CO3:ENST00000362079.2:downstream_gene_variant:MODIFIER::::,MT-TG:ENST00000387429.1:downstream_gene_variant:MODIFIER::::,MT-TR:ENST00000387439.1:upstream_gene_variant:MODIFIER::::,MT-ND4L:ENST00000361335.1:upstream_gene_variant:MODIFIER::::,MT-ND4:ENST00000361381.2:upstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:upstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:upstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:upstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:upstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:downstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:upstream_gene_variant:MODIFIER::::			9713 [benign DISEASE=Parkinson disease, resistance to,not provided,Leigh syndrome GENE=MT-ND3];			rs2853826	0.41848					-0.3380			0.06	/1.3>0.6/0.0>0.0			23133645,24437375,30713765,24917144,34120353,34976016,6343397,17066297,26116242,26336829,32396277,36632296,33585966,28826375,37369829,33062421,30531304,35453788,35885965,31380278,36360199,33116761,35130313,23944767,35773337,35163579,25580814,30275759	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	10499	10499	A	G	wt	hom	wt		QUAL=122882;DP=4629,3758,3083;AF=0.00,0.99,0.00;MQM=60;SAP=7;ABP=0;SAR=1913;SAF=1832	MT-ND4L,MT-ND2,MT-TW,MT-TA,MT-TN,MT-TC,MT-TY,MT-CO1,MT-TS1,MT-TD,MT-CO2,MT-TK,MT-ATP8,MT-ATP6,MT-CO3,MT-TG,MT-ND3,MT-TR,MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB	synonymous,downstream_gene,upstream_gene	MT-ND4L:ENST00000361335.1:synonymous_variant:LOW:exon1/1:c.30A>G:p.Leu10=:PF00420 [NADH-ubiquinone/plastoquinone oxidoreductase chain 4L],MT-ND2:ENST00000361453.3:downstream_gene_variant:MODIFIER::::,MT-TW:ENST00000387382.1:downstream_gene_variant:MODIFIER::::,MT-TA:ENST00000387392.1:upstream_gene_variant:MODIFIER::::,MT-TN:ENST00000387400.1:upstream_gene_variant:MODIFIER::::,MT-TC:ENST00000387405.1:upstream_gene_variant:MODIFIER::::,MT-TY:ENST00000387409.1:upstream_gene_variant:MODIFIER::::,MT-CO1:ENST00000361624.2:downstream_gene_variant:MODIFIER::::,MT-TS1:ENST00000387416.2:upstream_gene_variant:MODIFIER::::,MT-TD:ENST00000387419.1:downstream_gene_variant:MODIFIER::::,MT-CO2:ENST00000361739.1:downstream_gene_variant:MODIFIER::::,MT-TK:ENST00000387421.1:downstream_gene_variant:MODIFIER::::,MT-ATP8:ENST00000361851.1:downstream_gene_variant:MODIFIER::::,MT-ATP6:ENST00000361899.2:downstream_gene_variant:MODIFIER::::,MT-CO3:ENST00000362079.2:downstream_gene_variant:MODIFIER::::,MT-TG:ENST00000387429.1:downstream_gene_variant:MODIFIER::::,MT-ND3:ENST00000361227.2:downstream_gene_variant:MODIFIER::::,MT-TR:ENST00000387439.1:downstream_gene_variant:MODIFIER::::,MT-ND4:ENST00000361381.2:upstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:upstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:upstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:upstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:upstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:downstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:upstream_gene_variant:MODIFIER::::			376866 [benign DISEASE=not provided GENE=MT-ND4L];			rs1057520074	0.00742					-1.0050				/1.7>0.0/0.0>0.0			25741868	412	19	0	0 / 0					MT-ND2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TW (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TA (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TN (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TC (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TY (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	11251	11251	A	G	wt	hom	wt		QUAL=179482;DP=6536,5638,4787;AF=0.00,0.99,0.00;MQM=60;SAP=78;ABP=0;SAR=2586;SAF=3026	MT-ND4,MT-CO1,MT-TS1,MT-TD,MT-CO2,MT-TK,MT-ATP8,MT-ATP6,MT-CO3,MT-TG,MT-ND3,MT-TR,MT-ND4L,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	synonymous,downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:synonymous_variant:LOW:exon1/1:c.492A>G:p.Leu164=:PF00361 [Proton-conducting membrane transporter],MT-CO1:ENST00000361624.2:downstream_gene_variant:MODIFIER::::,MT-TS1:ENST00000387416.2:upstream_gene_variant:MODIFIER::::,MT-TD:ENST00000387419.1:downstream_gene_variant:MODIFIER::::,MT-CO2:ENST00000361739.1:downstream_gene_variant:MODIFIER::::,MT-TK:ENST00000387421.1:downstream_gene_variant:MODIFIER::::,MT-ATP8:ENST00000361851.1:downstream_gene_variant:MODIFIER::::,MT-ATP6:ENST00000361899.2:downstream_gene_variant:MODIFIER::::,MT-CO3:ENST00000362079.2:downstream_gene_variant:MODIFIER::::,MT-TG:ENST00000387429.1:downstream_gene_variant:MODIFIER::::,MT-ND3:ENST00000361227.2:downstream_gene_variant:MODIFIER::::,MT-TR:ENST00000387439.1:downstream_gene_variant:MODIFIER::::,MT-ND4L:ENST00000361335.1:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:upstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:upstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:upstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:upstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:downstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:upstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:downstream_gene_variant:MODIFIER::::						rs869096886	0.11009					-6.9950				/0.0>0.0/0.0>0.0	COSV62293827		32635923,29370225,33895935,35328073,35082309,35885965,37477801	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	11377	11377	G	A	wt	hom	wt		QUAL=146058;DP=6187,4568,4080;AF=0.00,0.99,0.00;MQM=60;SAP=415;ABP=0;SAR=2734;SAF=1806	MT-ND4,MT-CO1,MT-TS1,MT-TD,MT-CO2,MT-TK,MT-ATP8,MT-ATP6,MT-CO3,MT-TG,MT-ND3,MT-TR,MT-ND4L,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	synonymous,downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:synonymous_variant:LOW:exon1/1:c.618G>A:p.Lys206=:PF00361 [Proton-conducting membrane transporter],MT-CO1:ENST00000361624.2:downstream_gene_variant:MODIFIER::::,MT-TS1:ENST00000387416.2:upstream_gene_variant:MODIFIER::::,MT-TD:ENST00000387419.1:downstream_gene_variant:MODIFIER::::,MT-CO2:ENST00000361739.1:downstream_gene_variant:MODIFIER::::,MT-TK:ENST00000387421.1:downstream_gene_variant:MODIFIER::::,MT-ATP8:ENST00000361851.1:downstream_gene_variant:MODIFIER::::,MT-ATP6:ENST00000361899.2:downstream_gene_variant:MODIFIER::::,MT-CO3:ENST00000362079.2:downstream_gene_variant:MODIFIER::::,MT-TG:ENST00000387429.1:downstream_gene_variant:MODIFIER::::,MT-ND3:ENST00000361227.2:downstream_gene_variant:MODIFIER::::,MT-TR:ENST00000387439.1:downstream_gene_variant:MODIFIER::::,MT-ND4L:ENST00000361335.1:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:upstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:upstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:upstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:upstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:downstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:upstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:downstream_gene_variant:MODIFIER::::						rs193302938	0.01361					1.9500				/0.0>0.0/0.3>0.0				661	79	1	0 / 0					MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	11719	11719	G	A	wt	hom	wt		QUAL=166539;DP=6980,5349,4200;AF=0.00,1.00,0.01;MQM=57;SAP=14;ABP=0;SAR=2778;SAF=2610	MT-ND4,MT-CO1,MT-TS1,MT-TD,MT-CO2,MT-TK,MT-ATP8,MT-ATP6,MT-CO3,MT-TG,MT-ND3,MT-TR,MT-ND4L,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	synonymous,downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:synonymous_variant:LOW:exon1/1:c.960G>A:p.Gly320=:PF00361 [Proton-conducting membrane transporter],MT-CO1:ENST00000361624.2:downstream_gene_variant:MODIFIER::::,MT-TS1:ENST00000387416.2:upstream_gene_variant:MODIFIER::::,MT-TD:ENST00000387419.1:downstream_gene_variant:MODIFIER::::,MT-CO2:ENST00000361739.1:downstream_gene_variant:MODIFIER::::,MT-TK:ENST00000387421.1:downstream_gene_variant:MODIFIER::::,MT-ATP8:ENST00000361851.1:downstream_gene_variant:MODIFIER::::,MT-ATP6:ENST00000361899.2:downstream_gene_variant:MODIFIER::::,MT-CO3:ENST00000362079.2:downstream_gene_variant:MODIFIER::::,MT-TG:ENST00000387429.1:downstream_gene_variant:MODIFIER::::,MT-ND3:ENST00000361227.2:downstream_gene_variant:MODIFIER::::,MT-TR:ENST00000387439.1:downstream_gene_variant:MODIFIER::::,MT-ND4L:ENST00000361335.1:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:upstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:upstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:upstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:upstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:downstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:upstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:downstream_gene_variant:MODIFIER::::			3027424 [association DISEASE=Venous thromboembolism GENE=MT-ND4];			rs2853495	0.71104					-12.2800				/0.0>0.0/0.0>0.0	COSV104668829		27716073,33895935,34002094,27877219,24148579,36238361,35453788,35885965,31380278,29695379,37388495	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-CO1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS1 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TD (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	12612	12612	A	G	wt	hom	wt		QUAL=165169;DP=7668,5156,4375;AF=0.00,0.99,0.00;MQM=60;SAP=168;ABP=0;SAR=2253;SAF=2877	MT-ND5,MT-CO2,MT-TK,MT-ATP8,MT-ATP6,MT-CO3,MT-TG,MT-ND3,MT-TR,MT-ND4L,MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	synonymous,downstream_gene,upstream_gene	MT-ND5:ENST00000361567.2:synonymous_variant:LOW:exon1/1:c.276A>G:p.Val92=:PF00662 [NADH-Ubiquinone oxidoreductase (complex I) chain 5 N-terminus],MT-CO2:ENST00000361739.1:downstream_gene_variant:MODIFIER::::,MT-TK:ENST00000387421.1:downstream_gene_variant:MODIFIER::::,MT-ATP8:ENST00000361851.1:downstream_gene_variant:MODIFIER::::,MT-ATP6:ENST00000361899.2:downstream_gene_variant:MODIFIER::::,MT-CO3:ENST00000362079.2:downstream_gene_variant:MODIFIER::::,MT-TG:ENST00000387429.1:downstream_gene_variant:MODIFIER::::,MT-ND3:ENST00000361227.2:downstream_gene_variant:MODIFIER::::,MT-TR:ENST00000387439.1:downstream_gene_variant:MODIFIER::::,MT-ND4L:ENST00000361335.1:downstream_gene_variant:MODIFIER::::,MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:downstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:upstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:downstream_gene_variant:MODIFIER::::						rs28359172	0.05775					-3.2010				/7.0>0.0/0.0>0.0			34002094,35328073,31380278,29695379	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-CO2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TK (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP8 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	13708	13708	G	A	wt	hom	wt		QUAL=52676;DP=4615,1719,1558;AF=0.00,0.99,0.00;MQM=60;SAP=5;ABP=0;SAR=830;SAF=872	MT-ND5,MT-ATP6,MT-CO3,MT-TG,MT-ND3,MT-TR,MT-ND4L,MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	missense,downstream_gene,upstream_gene	MT-ND5:ENST00000361567.2:missense_variant:MODERATE:exon1/1:c.1372G>A:p.Ala458Thr:PF06455 [NADH dehydrogenase subunit 5 C-terminus],MT-ATP6:ENST00000361899.2:downstream_gene_variant:MODIFIER::::,MT-CO3:ENST00000362079.2:downstream_gene_variant:MODIFIER::::,MT-TG:ENST00000387429.1:downstream_gene_variant:MODIFIER::::,MT-ND3:ENST00000361227.2:downstream_gene_variant:MODIFIER::::,MT-TR:ENST00000387439.1:downstream_gene_variant:MODIFIER::::,MT-ND4L:ENST00000361335.1:downstream_gene_variant:MODIFIER::::,MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:downstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:upstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:downstream_gene_variant:MODIFIER::::			9696 [benign DISEASE=Leber optic atrophy,Leigh syndrome GENE=MT-ND5];			rs28359178	0.07564					0.6330			0.13	/3.6>3.8/0.0>0.0			29594131,19387457,24917144,1732158,1900003,7635294,20301353,34002094,1417830,1764087,33585966,33475980,35328073,24148579,25925750,33491309,31380278,35130313,29695379,35773337,37477801	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	13722	13722	A	G	wt	hom	wt		QUAL=55453;DP=4703,1813,1674;AF=0.00,0.99,0.00;MQM=60;SAP=28;ABP=0;SAR=825;SAF=968	MT-ND5,MT-ATP6,MT-CO3,MT-TG,MT-ND3,MT-TR,MT-ND4L,MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	synonymous,downstream_gene,upstream_gene	MT-ND5:ENST00000361567.2:synonymous_variant:LOW:exon1/1:c.1386A>G:p.Leu462=:PF06455 [NADH dehydrogenase subunit 5 C-terminus],MT-ATP6:ENST00000361899.2:downstream_gene_variant:MODIFIER::::,MT-CO3:ENST00000362079.2:downstream_gene_variant:MODIFIER::::,MT-TG:ENST00000387429.1:downstream_gene_variant:MODIFIER::::,MT-ND3:ENST00000361227.2:downstream_gene_variant:MODIFIER::::,MT-TR:ENST00000387439.1:downstream_gene_variant:MODIFIER::::,MT-ND4L:ENST00000361335.1:downstream_gene_variant:MODIFIER::::,MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:downstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:upstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:downstream_gene_variant:MODIFIER::::			377244 [benign DISEASE=not provided GENE=MT-ND5];			rs386829190	0.00757					-7.6180				/0.0>0.0/0.0>0.0			25741868	419	30	3	0 / 0					MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	14133	14133	A	G	wt	hom	wt		QUAL=97341;DP=3925,3085,2802;AF=0.00,0.99,0.00;MQM=60;SAP=28;ABP=0;SAR=1635;SAF=1445	MT-ND5,MT-ATP6,MT-CO3,MT-TG,MT-ND3,MT-TR,MT-ND4L,MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	synonymous,downstream_gene,upstream_gene	MT-ND5:ENST00000361567.2:synonymous_variant:LOW:exon1/1:c.1797A>G:p.Leu599=:PF06455 [NADH dehydrogenase subunit 5 C-terminus],MT-ATP6:ENST00000361899.2:downstream_gene_variant:MODIFIER::::,MT-CO3:ENST00000362079.2:downstream_gene_variant:MODIFIER::::,MT-TG:ENST00000387429.1:downstream_gene_variant:MODIFIER::::,MT-ND3:ENST00000361227.2:downstream_gene_variant:MODIFIER::::,MT-TR:ENST00000387439.1:downstream_gene_variant:MODIFIER::::,MT-ND4L:ENST00000361335.1:downstream_gene_variant:MODIFIER::::,MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:downstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:upstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:downstream_gene_variant:MODIFIER::::			377029 [benign DISEASE=not provided GENE=MT-ND5];			rs879100848	0.00794					-7.4090				/0.0>0.0/0.0>0.0			25741868	413	30	0	0 / 0					MT-ATP6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	14370	14370	A	G	hom	wt	hom		QUAL=193562;DP=3989,2366,2182;AF=0.99,0.00,0.99;MQM=60;SAP=50;ABP=0;SAR=3245;SAF=2880	MT-ND6,MT-CO3,MT-TG,MT-ND3,MT-TR,MT-ND4L,MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-TE,MT-CYB,MT-TT,MT-TP	synonymous,downstream_gene,upstream_gene	MT-ND6:ENST00000361681.2:synonymous_variant:LOW:exon1/1:c.304T>C:p.Leu102=:PF00499 [NADH-ubiquinone/plastoquinone oxidoreductase chain 6],MT-CO3:ENST00000362079.2:downstream_gene_variant:MODIFIER::::,MT-TG:ENST00000387429.1:downstream_gene_variant:MODIFIER::::,MT-ND3:ENST00000361227.2:downstream_gene_variant:MODIFIER::::,MT-TR:ENST00000387439.1:downstream_gene_variant:MODIFIER::::,MT-ND4L:ENST00000361335.1:downstream_gene_variant:MODIFIER::::,MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:downstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:upstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:downstream_gene_variant:MODIFIER::::						rs1603224697	0.00067					-11.2190				/0.0>0.0/0.0>0.0				37	1	0	0 / 0					MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	14766	14766	C	T	wt	hom	wt		QUAL=71944;DP=3302,2296,2106;AF=0.00,1.00,0.01;MQM=60;SAP=258;ABP=0;SAR=895;SAF=1416	MT-CYB,MT-CO3,MT-TG,MT-ND3,MT-TR,MT-ND4L,MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-TT,MT-TP	missense,downstream_gene,upstream_gene	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.20C>T:p.Thr7Ile:,MT-CO3:ENST00000362079.2:downstream_gene_variant:MODIFIER::::,MT-TG:ENST00000387429.1:downstream_gene_variant:MODIFIER::::,MT-ND3:ENST00000361227.2:downstream_gene_variant:MODIFIER::::,MT-TR:ENST00000387439.1:downstream_gene_variant:MODIFIER::::,MT-ND4L:ENST00000361335.1:downstream_gene_variant:MODIFIER::::,MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:upstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:downstream_gene_variant:MODIFIER::::			140587 [benign DISEASE=Leigh syndrome,Venous thromboembolism,Familial cancer of breast GENE=MT-CYB];			rs193302980	0.70679					0.1160			0.14	/0.0>0.0/0.0>0.0			34002094,35453788,32943110,34069212,35130313,35773337	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-CO3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TG (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15257	15257	G	A	wt	hom	wt		QUAL=122790;DP=4513,3836,3618;AF=0.00,0.99,0.00;MQM=60;SAP=24;ABP=0;SAR=1810;SAF=2001	MT-CYB,MT-ND3,MT-TR,MT-ND4L,MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-TT,MT-TP	missense,downstream_gene,upstream_gene	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.511G>A:p.Asp171Asn:PF00033 [Cytochrome b/b6/petB],MT-ND3:ENST00000361227.2:downstream_gene_variant:MODIFIER::::,MT-TR:ENST00000387439.1:downstream_gene_variant:MODIFIER::::,MT-ND4L:ENST00000361335.1:downstream_gene_variant:MODIFIER::::,MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:upstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:downstream_gene_variant:MODIFIER::::			9674 [benign DISEASE=Leber optic atrophy,Leigh syndrome GENE=MT-CYB];			rs41518645	0.01274					6.1030			0.12	/0.0>0.0/0.0>0.0	COSV62378578		1732158,7635294,20301353,35118571,34002094,1764087,7901141,8240104,8321540,8755941,28993255,35328073,35885965,37163093,35130313	721	66	1	0 / 0					MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15326	15326	A	G	hom	hom	hom		QUAL=371534;DP=4477,3661,3495;AF=1.00,1.00,1.00;MQM=60;SAP=213;ABP=0;SAR=6341;SAF=5281	MT-CYB,MT-ND3,MT-TR,MT-ND4L,MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-TT,MT-TP	missense,downstream_gene,upstream_gene	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.580A>G:p.Thr194Ala:PF00033 [Cytochrome b/b6/petB],MT-ND3:ENST00000361227.2:downstream_gene_variant:MODIFIER::::,MT-TR:ENST00000387439.1:downstream_gene_variant:MODIFIER::::,MT-ND4L:ENST00000361335.1:downstream_gene_variant:MODIFIER::::,MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:upstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:downstream_gene_variant:MODIFIER::::			140592 [benign DISEASE=Leigh syndrome,Mitochondrial disease,Familial cancer of breast GENE=MT-CYB];			rs2853508	0.99342					-5.3890			0.06	/0.0>0.0/0.0>0.0			35118571,35453788,31267007,35885965,34069212,35130313,37674615	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	1	"[1] harmuth 09.04.2018"		"most likely WT variant; in 98,6% of all full length sequences (MitoMap); FH 09.04.2018"	MT-ND3 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15452	15452	C	A	wt	hom	wt		QUAL=108182;DP=6695,3403,3241;AF=0.00,0.99,0.00;MQM=60;SAP=15;ABP=0;SAR=1624;SAF=1758	MT-CYB,MT-TR,MT-ND4L,MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-TT,MT-TP	missense,downstream_gene,upstream_gene	MT-CYB:ENST00000361789.2:missense_variant:MODERATE:exon1/1:c.706C>A:p.Leu236Ile:,MT-TR:ENST00000387439.1:downstream_gene_variant:MODIFIER::::,MT-ND4L:ENST00000361335.1:downstream_gene_variant:MODIFIER::::,MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:upstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:downstream_gene_variant:MODIFIER::::			143925 [benign DISEASE=Leigh syndrome,Ovarian neoplasm GENE=MT-CYB];			rs193302994	0.11031					-2.5920			0.09	/2.6>1.4/0.0>0.0			32635923,29370225,35260714,35328073,35130313	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-TR (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4L (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	15904	15904	C	T	hom	wt	hom		QUAL=302564;DP=6006,3779,3326;AF=0.99,0.00,0.99;MQM=60;SAP=24;ABP=0;SAR=4776;SAF=4475	MT-TT,MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TP	non_coding_transcript_exon,downstream_gene,upstream_gene	MT-TT:ENST00000387460.2:non_coding_transcript_exon_variant:MODIFIER:exon1/1:n.17C>T::,MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:downstream_gene_variant:MODIFIER::::			690224 [benign DISEASE=MELAS syndrome GENE=MT-TT];			rs35788393	0.02238					-0.9230				/0.0>0.0/0.0>0.0			34976016,32943110,31965079,37377596	978	18	0	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16069	16069	C	T	wt	hom	wt		QUAL=119589;DP=5788,3749,3614;AF=0.00,0.99,0.00;MQM=60;SAP=21;ABP=0;SAR=1776;SAF=1950	MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::						rs147903261	0.05621					-2.0290							31380278,28813576	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16126	16126	T	C	wt	hom	wt		QUAL=124476;DP=5750,3926,4040;AF=0.00,0.99,0.00;MQM=60;SAP=167;ABP=0;SAR=1683;SAF=2226	MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::						rs147029798	0.14321					-0.6180							31380278,35032707	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16145	16145	G	A	wt	hom	wt		QUAL=125022;DP=5694,3951,4067;AF=0.00,0.99,0.00;MQM=60;SAP=147;ABP=0;SAR=1705;SAF=2214	MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::						rs41419246	0.02836					-1.2640							35328073,31380278	1290	128	0	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16231	16231	T	C	wt	hom	wt		QUAL=150306;DP=6732,4808,4472;AF=0.00,0.99,0.00;MQM=60;SAP=112;ABP=0;SAR=2133;SAF=2621	MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::					(CAACTAT)n (Simple_repeat)	rs386829286	0.00778					-0.3440								439	35	0	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16261	16261	C	T	wt	hom	wt		QUAL=150550;DP=7169,4802,4292;AF=0.00,0.99,0.00;MQM=60;SAP=27;ABP=0;SAR=2259;SAF=2486	MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::						rs138126107	0.03654					-1.3990							31380278,35032707	1580	160	0	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16298	16298	T	C	hom	wt	hom		QUAL=333186;DP=6122,4825,4222;AF=0.99,0.00,0.99;MQM=60;SAP=110;ABP=0;SAR=5464;SAF=4756	MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::						rs148377232	0.04984					-0.9170								1793	160	0	0 / 0					MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
chrMT	16519	16519	T	C	hom	wt	hom		QUAL=374779;DP=6867,4961,4675;AF=1.00,0.02,1.00;MQM=59;SAP=4;ABP=0;SAR=5836;SAF=5768	MT-ND4,MT-TH,MT-TS2,MT-TL2,MT-ND5,MT-ND6,MT-TE,MT-CYB,MT-TT,MT-TP	downstream_gene,upstream_gene	MT-ND4:ENST00000361381.2:downstream_gene_variant:MODIFIER::::,MT-TH:ENST00000387441.1:downstream_gene_variant:MODIFIER::::,MT-TS2:ENST00000387449.1:downstream_gene_variant:MODIFIER::::,MT-TL2:ENST00000387456.1:downstream_gene_variant:MODIFIER::::,MT-ND5:ENST00000361567.2:downstream_gene_variant:MODIFIER::::,MT-ND6:ENST00000361681.2:upstream_gene_variant:MODIFIER::::,MT-TE:ENST00000387459.1:upstream_gene_variant:MODIFIER::::,MT-CYB:ENST00000361789.2:downstream_gene_variant:MODIFIER::::,MT-TT:ENST00000387460.2:downstream_gene_variant:MODIFIER::::,MT-TP:ENST00000387461.2:upstream_gene_variant:MODIFIER::::						rs3937033	0.65725					-0.2250							22723804,36360199,26550561,24040623,37477801	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)	n/a (AF>5%)		"hohe Frequenz [1] ahbecks1 15.09.2021 [n/a] ahbecks1 15.09.2021"			MT-ND4 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TH (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TS2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TL2 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND5 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-ND6 (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TE (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-CYB (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TT (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a), MT-TP (inh=MT oe_syn=n/a oe_mis=n/a oe_lof=n/a)
